Citrus Sinensis ID: 018036

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360--
Protein Sequence
MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC
Secondary Structure (PSIPRED)
cccccccccccHHHHccccccEEEccccccccccHHHHHccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHccccccEEEEcccccEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHccccccccccccEEEEcccccEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHccccHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccEEHcccccccHHHHHHHHccccEEEcccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHHHHHHHHHHHHHcEccccccEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEcccHHccEEcccccHEEHHHHHHHHHHcccccccEEEEEEcccccccccHcccc
Coil and Loop (DISEMBL)
msrnnfsgiipvEIGHCLLLTYLDlsqnhlsgpipvqiTQIHILNYLNVSWNQlnaslpkemgnmksltsadfshnnfsgeipefgqysffnstsftgnphlcgsylnpcnyssttpihnqngnkshvpgKYKLLFALGLLLCSLVFAVLAIIKTrkfrknsnswkltafqkldfgsddilecvkdnnvigrggagvvyrgvtpngEQVAVKKLLGitkgsshdnglSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYeympngslgevlhgkrgsfLKWEMRLKIAIEAAKGLsylhhdcspliihrdvksnnillnsdfeAHVADFGLAKylqdtgasecmSAVAgsygyiapvlgwyc
Flexible Loop (DISEMBL)
msrnnfsgiiPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKtrkfrknsnswkltafqkldfgsddILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLgitkgsshdnglsaeirtlgkirhrnIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC
Low Complexity Region (SEG)
MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNGNKSHVPGKYKllfalglllcslvfavlaIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNvigrggagvvyrgvTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC
Disordered region (IsUnstruct)
*****FSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA********************NFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN****KSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY*
Disordered Region (DISOPRED)
MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSY*************************YKLLFALGLLLCSLVFAVLAI*******************KLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLL***********L*AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC
Disordered Region (DISEMBL)
MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC
Disordered Region (DISPRO)
*SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNY*************SHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	362	2.2.26 [Sep-21-2011]
O65440	992	Leucine-rich repeat recep	yes	no	0.983	0.358	0.724	1e-139
O49545	1003	Leucine-rich repeat recep	no	no	0.977	0.352	0.649	1e-129
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.955	0.345	0.633	1e-126
Q9SYQ8	980	Receptor protein kinase C	no	no	0.966	0.357	0.551	1e-107
C0LGV1	1135	LRR receptor-like serine/	no	no	0.980	0.312	0.399	4e-78
Q9LHP4	1141	Receptor-like protein kin	no	no	0.994	0.315	0.391	5e-75
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.964	0.335	0.417	9e-75
C0LGX3	993	LRR receptor-like serine/	no	no	0.964	0.351	0.420	3e-69
Q9SGP2	996	Receptor-like protein kin	no	no	0.941	0.342	0.412	3e-69
C0LGF5	1072	Probable LRR receptor-lik	no	no	0.964	0.325	0.432	4e-69

>sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3

 Score =  494 bits (1271), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 263/363 (72%), Positives = 298/363 (82%), Gaps = 7/363 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MSRNNFSG  P E G C+ LTYLDLS N +SG IPVQI+QI ILNYLNVSWN  N SLP 
Sbjct: 521 MSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPN 580

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS---STTP 117
           E+G MKSLTSADFSHNNFSG +P  GQ+S+FN+TSF GNP LCG   NPCN S   S + 
Sbjct: 581 ELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQ 640

Query: 118 IHNQNGNKS--HVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNS-NSWKLTAFQKLD 174
           + NQN  +S   +  K+KL F LGLL   LVF VLA++K R+ RKN+ N WKL  FQKL 
Sbjct: 641 LLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG 700

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
           F S+ ILECVK+N+VIG+GG G+VY+GV PNGE+VAVKKLL ITKGSSHDNGL+AEI+TL
Sbjct: 701 FRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTL 760

Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
           G+IRHRNIVRL AFCSNK+ NLLVYEYMPNGSLGEVLHGK G FLKWE RL+IA+EAAKG
Sbjct: 761 GRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKG 820

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-LQDTGASECMSAVAGSYGY 353
           L YLHHDCSPLIIHRDVKSNNILL  +FEAHVADFGLAK+ +QD GASECMS++AGSYGY
Sbjct: 821 LCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGY 880

Query: 354 IAP 356
           IAP
Sbjct: 881 IAP 883

Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  461 bits (1185), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 232/357 (64%), Positives = 283/357 (79%), Gaps = 3/357 (0%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           S N FSG I  EI  C LLT++DLS+N LSG IP +IT + ILNYLN+S N L  S+P  
Sbjct: 511 SHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGS 570

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
           + +M+SLTS DFS+NN SG +P  GQ+S+FN TSF GNP LCG YL PC        H Q
Sbjct: 571 ISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGH-Q 629

Query: 122 NGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
           + +K  +    KLL  LGLL+CS+ FAV+AIIK R  +K S S  W+LTAFQ+LDF  DD
Sbjct: 630 SHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDD 689

Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
           +L+ +K++N+IG+GGAG+VY+GV PNG+ VAVK+L  +++GSSHD+G +AEI+TLG+IRH
Sbjct: 690 VLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRH 749

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           R+IVRL  FCSN ETNLLVYEYMPNGSLGEVLHGK+G  L W+ R KIA+EAAKGL YLH
Sbjct: 750 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLH 809

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIAP
Sbjct: 810 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  451 bits (1161), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 228/360 (63%), Positives = 278/360 (77%), Gaps = 14/360 (3%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           S N FSG I  EI  C LLT++DLS+N LSG IP ++T + ILNYLN+S N L  S+P  
Sbjct: 512 SHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVT 571

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
           + +M+SLTS DFS+NN SG +P  GQ+S+FN TSF GN HLCG YL PC          +
Sbjct: 572 IASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCG---------K 622

Query: 122 NGNKSHV---PGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--WKLTAFQKLDFG 176
             ++SHV       KLL  LGLL CS+VFA++AIIK R  R  S +  W+LTAFQ+LDF 
Sbjct: 623 GTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFT 682

Query: 177 SDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
            DD+L+ +K++N+IG+GGAG+VY+G  P G+ VAVK+L  ++ GSSHD+G +AEI+TLG+
Sbjct: 683 CDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGR 742

Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           IRHR+IVRL  FCSN ETNLLVYEYMPNGSLGEVLHGK+G  L W  R KIA+EAAKGL 
Sbjct: 743 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLC 802

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           YLHHDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIAP
Sbjct: 803 YLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 862

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score =  390 bits (1001), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 197/357 (55%), Positives = 254/357 (71%), Gaps = 7/357 (1%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           S NN +G IP  I  C  L  +DLS+N ++G IP  I  +  L  LN+S NQL  S+P  
Sbjct: 512 SANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTG 571

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
           +GNM SLT+ D S N+ SG +P  GQ+  FN TSF GN +LC  +   C    T P    
Sbjct: 572 IGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSC---PTRPGQTS 628

Query: 122 NGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
           + N + +    +++  +   +  L+   +AI +  K +KN  S  WKLTAFQKLDF S+D
Sbjct: 629 DHNHTALFSPSRIVITVIAAITGLILISVAIRQMNK-KKNQKSLAWKLTAFQKLDFKSED 687

Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
           +LEC+K+ N+IG+GGAG+VYRG  PN   VA+K+L+G   G S D+G +AEI+TLG+IRH
Sbjct: 688 VLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRS-DHGFTAEIQTLGRIRH 746

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           R+IVRL  + +NK+TNLL+YEYMPNGSLGE+LHG +G  L+WE R ++A+EAAKGL YLH
Sbjct: 747 RHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKGLCYLH 806

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HDCSPLI+HRDVKSNNILL+SDFEAHVADFGLAK+L D  ASECMS++AGSYGYIAP
Sbjct: 807 HDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAP 863

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  291 bits (746), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 162/406 (39%), Positives = 234/406 (57%), Gaps = 51/406 (12%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNY-LNVSWNQLNASLP 59
           +S+N+F+G IP  +GHC  L  LDLS N++SG IP ++  I  L+  LN+SWN L+  +P
Sbjct: 570 LSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIP 629

Query: 60  KE-----------------------MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF 96
           +                        +  +++L S + SHN FSG +P+   +        
Sbjct: 630 ERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEM 689

Query: 97  TGNPHLCGSYLNPCNYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSL----VFAVLAI 152
            GN  LC      C  S+++ +  Q G  SH     +L  A+GLL+       V  VLA+
Sbjct: 690 EGNNGLCSKGFRSCFVSNSSQLTTQRGVHSH-----RLRIAIGLLISVTAVLAVLGVLAV 744

Query: 153 IKTRKFRKNSN---------SWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVT 203
           I+ ++  ++ N         +W+ T FQKL+F  + +L+C+ + NVIG+G +G+VY+   
Sbjct: 745 IRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEM 804

Query: 204 PNGEQVAVKKLLGIT--------KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN 255
           PN E +AVKKL  +T        K S   +  SAE++TLG IRH+NIVR    C NK T 
Sbjct: 805 PNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTR 864

Query: 256 LLVYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           LL+Y+YM NGSLG +LH + G   L WE+R KI + AA+GL+YLHHDC P I+HRD+K+N
Sbjct: 865 LLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKAN 924

Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW 360
           NIL+  DFE ++ DFGLAK + D   +   + +AGSYGYIAP  G+
Sbjct: 925 NILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGY 970

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  281 bits (719), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 157/401 (39%), Positives = 222/401 (55%), Gaps = 41/401 (10%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNY-LNVSWNQLNASLP 59
           +S+N FSG IP  +G C  L  LDL  N LSG IP ++  I  L   LN+S N+L   +P
Sbjct: 569 LSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIP 628

Query: 60  KE-----------------------MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF 96
            +                       + N+++L S + S+N+FSG +P+   +   +    
Sbjct: 629 SKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDL 688

Query: 97  TGNPHLCGSYLNPC--NYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIK 154
            GN  LC S  + C   Y     + +          +  L   + L +  ++   +A+I+
Sbjct: 689 EGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIR 748

Query: 155 TRKFRKNSNS--------WKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNG 206
            R+   N           W+ T FQKL+F  D I+ C+ + NVIG+G +GVVYR    NG
Sbjct: 749 ARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNG 808

Query: 207 EQVAVKKLLGITKGSSHD-------NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           E +AVKKL        HD       +  SAE++TLG IRH+NIVR    C N+ T LL+Y
Sbjct: 809 EVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868

Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           +YMPNGSLG +LH +RGS L W++R +I + AA+GL+YLHHDC P I+HRD+K+NNIL+ 
Sbjct: 869 DYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIG 928

Query: 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW 360
            DFE ++ADFGLAK + +     C + VAGSYGYIAP  G+
Sbjct: 929 LDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGY 969

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  280 bits (717), Expect = 9e-75,   Method: Compositional matrix adjust.
 Identities = 158/378 (41%), Positives = 228/378 (60%), Gaps = 29/378 (7%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           N+ +G IP +IGHC  L  L+LSQNHL+G IP +I+ +  +  +++S N L  ++P + G
Sbjct: 522 NSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFG 581

Query: 64  NMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYL-NPCNYS------STT 116
           + K++T+ + S+N   G IP  G ++  N + F+ N  LCG  +  PCN        +  
Sbjct: 582 SSKTITTFNVSYNQLIGPIPS-GSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADI 640

Query: 117 PIHNQNGNKSHVPGK--YKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNS--------WK 166
             H++        G   + L  A+G+    LV A     K+   R +           WK
Sbjct: 641 DGHHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWK 700

Query: 167 LTAFQKLDFGSDDILECV-KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS--- 222
           LTAFQ+L+F +DD++EC+ K +N++G G  G VY+   PNGE +AVKKL G  K +    
Sbjct: 701 LTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIR 760

Query: 223 -HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL-- 279
              +G+ AE+  LG +RHRNIVRL   C+N++  +L+YEYMPNGSL ++LHG   +    
Sbjct: 761 RRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAA 820

Query: 280 -KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            +W    +IAI  A+G+ YLHHDC P+I+HRD+K +NILL++DFEA VADFG+AK +Q  
Sbjct: 821 AEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQ-- 878

Query: 339 GASECMSAVAGSYGYIAP 356
              E MS VAGSYGYIAP
Sbjct: 879 -TDESMSVVAGSYGYIAP 895

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  262 bits (669), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 155/369 (42%), Positives = 215/369 (58%), Gaps = 20/369 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           M  N   G IP  +  C  LT L+LS N L G IP ++  + +LNYL++S NQL   +P 
Sbjct: 514 MQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPA 573

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
           E+  +K L   + S N   G+IP   Q   F   SF GNP+LC   L+P       P  +
Sbjct: 574 ELLRLK-LNQFNVSDNKLYGKIPSGFQQDIFRP-SFLGNPNLCAPNLDPIR-----PCRS 626

Query: 121 QNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSDDI 180
           +   +  +P     + AL   L  L      + K +  R N    K+T FQ++ F  +DI
Sbjct: 627 KRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTN----KITIFQRVGFTEEDI 682

Query: 181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRH 239
              + ++N+IG GG+G+VYR    +G+ +AVKKL G T + +  ++   +E+ TLG++RH
Sbjct: 683 YPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRH 742

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG----SFLKWEMRLKIAIEAAKGL 295
            NIV+L   C+ +E   LVYE+M NGSLG+VLH ++     S L W  R  IA+ AA+GL
Sbjct: 743 GNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGL 802

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ---DTGASEC-MSAVAGSY 351
           SYLHHD  P I+HRDVKSNNILL+ + +  VADFGLAK L+   + G S+  MS VAGSY
Sbjct: 803 SYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSY 862

Query: 352 GYIAPVLGW 360
           GYIAP  G+
Sbjct: 863 GYIAPEYGY 871

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  262 bits (669), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 154/373 (41%), Positives = 214/373 (57%), Gaps = 32/373 (8%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           N FSG +   I     L  L+L+ N  +G IP +I  + +LNYL++S N  +  +P  + 
Sbjct: 502 NQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQ 561

Query: 64  NMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNG 123
           ++K L   + S+N  SG++P       + + SF GNP LCG     C             
Sbjct: 562 SLK-LNQLNLSYNRLSGDLPPSLAKDMYKN-SFIGNPGLCGDIKGLCGSE---------- 609

Query: 124 NKSHVPGKYKLLFALGLLLCSLVFAVLA--IIKTRKFRK----NSNSWKLTAFQKLDFGS 177
           N++   G   LL ++ +L   ++ A +A    K R F+K      + W L +F KL F  
Sbjct: 610 NEAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSE 669

Query: 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGIT-------------KGSSHD 224
            +ILE + ++NVIG G +G VY+ V  NGE VAVK+L   +             K    D
Sbjct: 670 HEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQD 729

Query: 225 NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
               AE+ TLGKIRH+NIV+L   CS ++  LLVYEYMPNGSLG++LH  +G  L W+ R
Sbjct: 730 EAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTR 789

Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG-ASEC 343
            KI ++AA+GLSYLHHD  P I+HRD+KSNNIL++ D+ A VADFG+AK +  TG A + 
Sbjct: 790 FKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKS 849

Query: 344 MSAVAGSYGYIAP 356
           MS +AGS GYIAP
Sbjct: 850 MSVIAGSCGYIAP 862

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2

 Score =  261 bits (668), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 166/384 (43%), Positives = 223/384 (58%), Gaps = 35/384 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTY-LDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
           +S N+ SG IP E+G    LT  LDLS N  +G IP   + +  L  L++S N L+  + 
Sbjct: 579 LSYNSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDI- 637

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIH 119
           K +G++ SL S + S NNFSG IP    +   ++TS+  N +LC S L+    SS T   
Sbjct: 638 KVLGSLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCHS-LDGITCSSHT--G 694

Query: 120 NQNGNKSHVPGKYKLLFALGLLLCSLVFAVLA----IIKTRKFRKN-------------- 161
             NG KS      K++    ++L S+  A+LA    I++     K               
Sbjct: 695 QNNGVKSP-----KIVALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDF 749

Query: 162 SNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGI---- 217
           S  W    FQKL    ++I+  + D NVIG+G +G+VY+   PNG+ VAVKKL       
Sbjct: 750 SYPWTFIPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNN 809

Query: 218 TKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS 277
            +G S  +  +AEI+ LG IRHRNIV+L  +CSNK   LL+Y Y PNG+L ++L G R  
Sbjct: 810 EEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNRN- 868

Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
            L WE R KIAI AA+GL+YLHHDC P I+HRDVK NNILL+S +EA +ADFGLAK + +
Sbjct: 869 -LDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMN 927

Query: 338 T-GASECMSAVAGSYGYIAPVLGW 360
           +      MS VAGSYGYIAP  G+
Sbjct: 928 SPNYHNAMSRVAGSYGYIAPEYGY 951

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	362
224053641	913	predicted protein [Populus trichocarpa]	0.983	0.389	0.857	0.0
224075393	988	predicted protein [Populus trichocarpa]	0.983	0.360	0.840	1e-177
225424960	988	PREDICTED: leucine-rich repeat receptor-	0.983	0.360	0.826	1e-175
255583922	991	Receptor protein kinase CLAVATA1 precurs	0.983	0.359	0.824	1e-167
356499319	988	PREDICTED: leucine-rich repeat receptor-	0.983	0.360	0.776	1e-163
356553634	986	PREDICTED: leucine-rich repeat receptor-	0.983	0.361	0.779	1e-163
356524179	994	PREDICTED: leucine-rich repeat receptor-	0.983	0.358	0.782	1e-162
357494021	967	Receptor-like protein kinase [Medicago t	0.983	0.368	0.736	1e-154
449478131	998	PREDICTED: leucine-rich repeat receptor-	0.961	0.348	0.689	1e-138
224589616	963	leucine-rich repeat receptor-like protei	0.983	0.369	0.727	1e-138

>gi|224053641|ref|XP_002297907.1| predicted protein [Populus trichocarpa] gi|222845165|gb|EEE82712.1| predicted protein [Populus trichocarpa]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/358 (85%), Positives = 333/358 (93%), Gaps = 2/358 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MSRNN SG IP EIG C  LTYLDLSQN LSGPIPVQITQIHILNYLN+SWN LN SLPK
Sbjct: 444 MSRNNLSGNIPPEIGDCRTLTYLDLSQNQLSGPIPVQITQIHILNYLNISWNHLNQSLPK 503

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI-- 118
           E+G+MKSLTSADFSHNNFSG IPEFGQYSFFNSTSF+GNP LCGSYLNPCNYSST+P+  
Sbjct: 504 EIGSMKSLTSADFSHNNFSGSIPEFGQYSFFNSTSFSGNPQLCGSYLNPCNYSSTSPLQF 563

Query: 119 HNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
           H+QN + S VPGK+KLLFALGLL CSLVFAVLAIIKTRK R+NSNSWKLTAFQKL+FG +
Sbjct: 564 HDQNSSTSQVPGKFKLLFALGLLGCSLVFAVLAIIKTRKIRRNSNSWKLTAFQKLEFGCE 623

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           +ILECVK+NN+IGRGGAG+VYRG+ PNGE VAVKKLLGI++GSSHDNGLSAE++TLG+IR
Sbjct: 624 NILECVKENNIIGRGGAGIVYRGLMPNGEPVAVKKLLGISRGSSHDNGLSAEVQTLGQIR 683

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HRNIVRL AFCSNKETNLLVYEYMPNGSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 684 HRNIVRLLAFCSNKETNLLVYEYMPNGSLGEVLHGKRGGFLKWDTRLKIAIEAAKGLCYL 743

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLIIHRDVKSNNILL+SDFEAHVADFGLAK+LQDTGASECMSA+AGSYGYIAP
Sbjct: 744 HHDCSPLIIHRDVKSNNILLSSDFEAHVADFGLAKFLQDTGASECMSAIAGSYGYIAP 801

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075393|ref|XP_002304615.1| predicted protein [Populus trichocarpa] gi|222842047|gb|EEE79594.1| predicted protein [Populus trichocarpa]

 Score =  627 bits (1616), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 301/358 (84%), Positives = 326/358 (91%), Gaps = 2/358 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MSRNN SG IP EIG C  LTYLDLSQN LSGPIPV ITQIHILNYLN+SWN LN SLPK
Sbjct: 519 MSRNNLSGNIPSEIGDCPTLTYLDLSQNQLSGPIPVHITQIHILNYLNISWNHLNQSLPK 578

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI-- 118
           E+G+MKSLTSADFSHNNFSG IPEFGQYSFFNSTSF GNP LCGSYLNPCNYSS +P+  
Sbjct: 579 EIGSMKSLTSADFSHNNFSGSIPEFGQYSFFNSTSFIGNPQLCGSYLNPCNYSSMSPLQL 638

Query: 119 HNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
           H+QN ++S V GK+KLLFALGLL+CSLVFA LAIIKTRK R+NSNSWKLTAFQKL FGS+
Sbjct: 639 HDQNSSRSQVHGKFKLLFALGLLVCSLVFAALAIIKTRKIRRNSNSWKLTAFQKLGFGSE 698

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           DILEC+K+NN+IGRGGAG VYRG+   GE VAVKKLLGI+KGSSHDNGLSAE++TLG+IR
Sbjct: 699 DILECIKENNIIGRGGAGTVYRGLMATGEPVAVKKLLGISKGSSHDNGLSAEVQTLGQIR 758

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HRNIVRL AFCSNKE+NLLVYEYMPNGSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 759 HRNIVRLLAFCSNKESNLLVYEYMPNGSLGEVLHGKRGGFLKWDTRLKIAIEAAKGLCYL 818

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK+L+DTG SECMSA+AGSYGYIAP
Sbjct: 819 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKFLRDTGNSECMSAIAGSYGYIAP 876

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225424960|ref|XP_002264952.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 [Vitis vinifera]

 Score =  620 bits (1599), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 296/358 (82%), Positives = 323/358 (90%), Gaps = 2/358 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           M RNNFSGIIP EIGHCL LTYLDLSQN +SGPIPVQI QIHILNYLN+SWN +N +LPK
Sbjct: 519 MRRNNFSGIIPPEIGHCLSLTYLDLSQNQISGPIPVQIAQIHILNYLNLSWNHMNQNLPK 578

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIH- 119
           E+G MKSLTS DFSHNNFSG IP+ GQYSFFNS+SF GNP LCGSYLN CNYSS +P+  
Sbjct: 579 EIGFMKSLTSVDFSHNNFSGWIPQIGQYSFFNSSSFVGNPQLCGSYLNQCNYSSASPLES 638

Query: 120 -NQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
            NQ+   SHVPGK+KL+ AL LL+CSL+FAVLAI+KTRK RK SNSWKLTAFQKL+FGS+
Sbjct: 639 KNQHDTSSHVPGKFKLVLALSLLICSLIFAVLAIVKTRKVRKTSNSWKLTAFQKLEFGSE 698

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           DILEC+KDNNVIGRGGAG+VYRG  PNGEQVAVKKL GI+KGSSHDNGLSAEI+TLG+IR
Sbjct: 699 DILECLKDNNVIGRGGAGIVYRGTMPNGEQVAVKKLQGISKGSSHDNGLSAEIQTLGRIR 758

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HRNIVRL AFCSNKETNLLVYEYMPNGSLGEVLHGKRG  LKW+ RLKIAIEAAKGL YL
Sbjct: 759 HRNIVRLLAFCSNKETNLLVYEYMPNGSLGEVLHGKRGGHLKWDTRLKIAIEAAKGLCYL 818

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLI+HRDVKSNNILLNSD+EAHVADFGLAK+LQD G SECMSA+AGSYGYIAP
Sbjct: 819 HHDCSPLILHRDVKSNNILLNSDYEAHVADFGLAKFLQDNGTSECMSAIAGSYGYIAP 876

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255583922|ref|XP_002532709.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223527555|gb|EEF29676.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 295/358 (82%), Positives = 324/358 (90%), Gaps = 2/358 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MSRNNFS  IP EIG+C +LT+LDLSQN LSGPIPVQI+QIHILNY N+SWN LN SLPK
Sbjct: 522 MSRNNFSSNIPSEIGNCPMLTFLDLSQNQLSGPIPVQISQIHILNYFNISWNHLNQSLPK 581

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI-- 118
           E+G+MKSLTSADFSHNNFSG IPEFGQY+FFNS+SF GNP LCG  LN CN SS + +  
Sbjct: 582 EIGSMKSLTSADFSHNNFSGSIPEFGQYTFFNSSSFAGNPLLCGYDLNQCNNSSFSSLQF 641

Query: 119 HNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
           H++N +KS VPGK+KLL ALGLLLCSLVFAVLAIIKTRK RKNS SWKLTAFQKL+FG  
Sbjct: 642 HDENNSKSQVPGKFKLLVALGLLLCSLVFAVLAIIKTRKRRKNSRSWKLTAFQKLEFGCG 701

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           DILECVK+NN+IGRGGAG+VY+G+ PNGEQVAVKKLLGI+KGSSHDNGLSAEI+TLG+IR
Sbjct: 702 DILECVKENNIIGRGGAGIVYKGIMPNGEQVAVKKLLGISKGSSHDNGLSAEIQTLGRIR 761

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HRNIVRL  FCSNKE NLLVYEYMP+GSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 762 HRNIVRLLGFCSNKEMNLLVYEYMPHGSLGEVLHGKRGGFLKWDTRLKIAIEAAKGLCYL 821

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLIIHRDVKSNNILLNS+FEAHVADFGLAK+LQDTG SECMSA+AGSYGYIAP
Sbjct: 822 HHDCSPLIIHRDVKSNNILLNSEFEAHVADFGLAKFLQDTGTSECMSAIAGSYGYIAP 879

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356499319|ref|XP_003518489.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3-like [Glycine max]

 Score =  580 bits (1494), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 278/358 (77%), Positives = 311/358 (86%), Gaps = 2/358 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MS NNFSG IP EIG+CLLLTYLDLSQN L+GPIPVQ++QIHI+NYLNVSWN L+ SLP+
Sbjct: 519 MSVNNFSGSIPPEIGNCLLLTYLDLSQNQLAGPIPVQLSQIHIMNYLNVSWNHLSQSLPE 578

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
           E+G MK LTSADFSHN+FSG IPE GQ+S FNSTSF GNP LCG  LNPC +SS   + +
Sbjct: 579 ELGAMKGLTSADFSHNDFSGSIPEEGQFSVFNSTSFVGNPQLCGYELNPCKHSSNAVLES 638

Query: 121 QNGNKSH--VPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
           Q+   +   VPGKYKLLFA+ LL CSL FA LA IK+RK R++SNSWKLT FQ L+FGS+
Sbjct: 639 QDSGSARPGVPGKYKLLFAVALLACSLAFATLAFIKSRKQRRHSNSWKLTTFQNLEFGSE 698

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           DI+ C+K++NVIGRGGAGVVY G  PNGEQVAVKKLLGI KG SHDNGLSAEIRTLG+IR
Sbjct: 699 DIIGCIKESNVIGRGGAGVVYHGTMPNGEQVAVKKLLGINKGCSHDNGLSAEIRTLGRIR 758

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HR IVRL AFCSN+ETNLLVYEYMPNGSLGE+LHGKRG FLKW+ RLKIA EAAKGL YL
Sbjct: 759 HRYIVRLLAFCSNRETNLLVYEYMPNGSLGEILHGKRGEFLKWDTRLKIATEAAKGLCYL 818

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLIIHRDVKSNNILLNS+FEAHVADFGLAK+LQDTG SECMS++AGSYGYIAP
Sbjct: 819 HHDCSPLIIHRDVKSNNILLNSEFEAHVADFGLAKFLQDTGTSECMSSIAGSYGYIAP 876

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553634|ref|XP_003545159.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3-like [Glycine max]

 Score =  579 bits (1492), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 279/358 (77%), Positives = 309/358 (86%), Gaps = 2/358 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MS NNFSG IP EIG+CLLLTYLDLSQN LSGPIPVQ++QIHI+NYLNVSWN L+ SLPK
Sbjct: 517 MSVNNFSGSIPPEIGNCLLLTYLDLSQNQLSGPIPVQLSQIHIMNYLNVSWNHLSQSLPK 576

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
           E+G MK LTSADFSHN+FSG IPE GQ+S  NSTSF GNP LCG  LNPC +SS   + +
Sbjct: 577 ELGAMKGLTSADFSHNDFSGSIPEEGQFSVLNSTSFVGNPQLCGYDLNPCKHSSNAVLES 636

Query: 121 QNGNKSH--VPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
           Q+   +   VPGKYKLLFA+ LL CSL FA LA IK+RK R++SNSWKLT FQ L+FGS+
Sbjct: 637 QDSGSARPGVPGKYKLLFAVALLACSLAFATLAFIKSRKQRRHSNSWKLTTFQNLEFGSE 696

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           DI+ C+K++N IGRGGAGVVY G  PNGEQVAVKKLLGI KG SHDNGLSAEIRTLG+IR
Sbjct: 697 DIIGCIKESNAIGRGGAGVVYHGTMPNGEQVAVKKLLGINKGCSHDNGLSAEIRTLGRIR 756

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HR IVRL AFCSN+ETNLLVYEYMPNGSLGEVLHGKRG FLKW+ RLKIA EAAKGL YL
Sbjct: 757 HRYIVRLLAFCSNRETNLLVYEYMPNGSLGEVLHGKRGEFLKWDTRLKIATEAAKGLCYL 816

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLIIHRDVKSNNILLNS+FEAHVADFGLAK+LQDTG SECMS++AGSYGYIAP
Sbjct: 817 HHDCSPLIIHRDVKSNNILLNSEFEAHVADFGLAKFLQDTGTSECMSSIAGSYGYIAP 874

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356524179|ref|XP_003530709.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3-like [Glycine max]

 Score =  576 bits (1485), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 280/358 (78%), Positives = 311/358 (86%), Gaps = 2/358 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S NNFSG IP EIG+C+LLTYLDLSQN LSGPIPVQ +QIHILNYLNVSWN LN SLPK
Sbjct: 525 ISANNFSGTIPPEIGNCVLLTYLDLSQNQLSGPIPVQFSQIHILNYLNVSWNHLNQSLPK 584

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
           E+  MK LTSADFSHNNFSG IPE GQ+S FNSTSF GNP LCG    PCN SST  + +
Sbjct: 585 ELRAMKGLTSADFSHNNFSGSIPEGGQFSIFNSTSFVGNPQLCGYDSKPCNLSSTAVLES 644

Query: 121 QNGN--KSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGSD 178
           Q  +  K  VPGK+K LFAL LL CSLVFA LAIIK+RK R++SNSWKLTAFQKL++GS+
Sbjct: 645 QTKSSAKPGVPGKFKFLFALALLGCSLVFATLAIIKSRKTRRHSNSWKLTAFQKLEYGSE 704

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           DI  C+K++NVIGRGG+GVVYRG  P GE+VAVKKLLG  KGSSHDNGLSAEI+TLG+IR
Sbjct: 705 DIKGCIKESNVIGRGGSGVVYRGTMPKGEEVAVKKLLGNNKGSSHDNGLSAEIKTLGRIR 764

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HR IV+L AFCSN+ETNLLVY+YMPNGSLGEVLHGKRG FLKW+ RLKIAIEAAKGL YL
Sbjct: 765 HRYIVKLLAFCSNRETNLLVYDYMPNGSLGEVLHGKRGEFLKWDTRLKIAIEAAKGLCYL 824

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK++QD GASECMS++AGSYGYIAP
Sbjct: 825 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKFMQDNGASECMSSIAGSYGYIAP 882

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357494021|ref|XP_003617299.1| Receptor-like protein kinase [Medicago truncatula] gi|355518634|gb|AET00258.1| Receptor-like protein kinase [Medicago truncatula]

 Score =  549 bits (1414), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 266/361 (73%), Positives = 310/361 (85%), Gaps = 5/361 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MS NNFSG IP+EIG C  LT+LDLSQN LSGPIP+Q++QIHILNYLNVSWN LN +LPK
Sbjct: 495 MSFNNFSGTIPIEIGKCSSLTFLDLSQNKLSGPIPIQVSQIHILNYLNVSWNYLNQTLPK 554

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
           E+G++K LTSADFSHN+FSG +PE GQ+S FNSTSF GNP LCG  LNPCN SS+  + +
Sbjct: 555 ELGSIKGLTSADFSHNDFSGSVPEIGQFSVFNSTSFVGNPKLCGYDLNPCNKSSSETLES 614

Query: 121 QN--GNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRK-FRKNSNSWKLTAFQKLDFGS 177
           Q   G K  +P KYKLLFAL LL+CSLVFA  AI+K RK  +++SN WKLTAFQK+++GS
Sbjct: 615 QKNGGEKPGIPAKYKLLFALALLVCSLVFATFAIMKGRKGIKRDSNPWKLTAFQKIEYGS 674

Query: 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
           +DIL CVK++N+IGRGGAGVVY G  PNGE+VAVKKLLGI KG S+DNGLSAEI+TLG+I
Sbjct: 675 EDILGCVKESNIIGRGGAGVVYGGTMPNGEKVAVKKLLGINKGCSYDNGLSAEIKTLGRI 734

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           RHR IV+L AFCSN++TNLLVYEYM NGSLGEVLHGKRG FL+W++R+KIA EAAKGL Y
Sbjct: 735 RHRYIVKLLAFCSNRDTNLLVYEYMTNGSLGEVLHGKRGGFLEWDVRVKIATEAAKGLCY 794

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-LQDT-GASECMSAVAGSYGYIA 355
           LHHDC PLI+HRDVKSNNILLNS+FEAHVADFGLAK+ LQDT G SECMS++ GSYGYIA
Sbjct: 795 LHHDCCPLIVHRDVKSNNILLNSEFEAHVADFGLAKFLLQDTGGTSECMSSIVGSYGYIA 854

Query: 356 P 356
           P
Sbjct: 855 P 855

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449478131|ref|XP_004155230.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1-like [Cucumis sativus]

 Score =  498 bits (1281), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 247/358 (68%), Positives = 293/358 (81%), Gaps = 10/358 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +SRN+ SG IP EIG+C+ LTYLDLS+N+LSGPIP +I+  HILNYLN+S N LN SLPK
Sbjct: 505 LSRNSLSGEIPPEIGNCIHLTYLDLSRNNLSGPIPPEISNAHILNYLNLSRNHLNQSLPK 564

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLN-PCNYSSTTPIH 119
            +G MKSLT ADFS N+FSG++PE G  +FFN++SF GNP LCGS LN PCN+++TT   
Sbjct: 565 SLGAMKSLTVADFSFNDFSGKLPESG-LAFFNASSFAGNPQLCGSLLNNPCNFATTTT-- 621

Query: 120 NQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKN-SNSWKLTAFQKLDFGSD 178
                    P  +KL+FALGLL+CSLVFA+ A++K + F++N S+SWK+T+FQKL+F   
Sbjct: 622 ----KSGKTPTYFKLIFALGLLICSLVFAIAAVVKAKSFKRNGSSSWKMTSFQKLEFTVF 677

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           D+LECVKD NVIGRGGAG+VY G  PNG ++AVKKLLG    +SHD+G  AEI+TLG IR
Sbjct: 678 DVLECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGP-NSHDHGFRAEIQTLGNIR 736

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           HRNIVRL AFCSNKETNLLVYEYM NGSLGE LHGK+ SFL W +R KIAIEAAKGL YL
Sbjct: 737 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKASFLGWNLRYKIAIEAAKGLCYL 796

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HHDCSPLI+HRDVKSNNILLNS+FEAHVADFGLAK++ D GASECMS +AGSYGYIAP
Sbjct: 797 HHDCSPLIVHRDVKSNNILLNSNFEAHVADFGLAKFMFDGGASECMSVIAGSYGYIAP 854

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224589616|gb|ACN59341.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana]

 Score =  496 bits (1277), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 264/363 (72%), Positives = 299/363 (82%), Gaps = 7/363 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MSRNNFSG  P E G C+ LTYLDLS N +SG IPVQI+QI ILNYLNVSWN  N SLP 
Sbjct: 492 MSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPN 551

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS---STTP 117
           E+G MKSLTSADFSHNNFSG +P  GQ+S+FN+TSF GNP LCG   NPCN S   S + 
Sbjct: 552 ELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQ 611

Query: 118 IHNQNGNKS--HVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNS-NSWKLTAFQKLD 174
           + NQN  +S   +  K+KL F LGLL   LVF VLA++K R+ RKN+ N WKL  FQKL 
Sbjct: 612 LLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG 671

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
           F S+ ILECVK+N+VIG+GGAG+VY+GV PNGE+VAVKKLL ITKGSSHDNGL+AEI+TL
Sbjct: 672 FRSEHILECVKENHVIGKGGAGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTL 731

Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
           G+IRHRNIVRL AFCSNK+ NLLVYEYMPNGSLGEVLHGK G FLKWE RL+IA+EAAKG
Sbjct: 732 GRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKG 791

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-LQDTGASECMSAVAGSYGY 353
           L YLHHDCSPLIIHRDVKSNNILL  +FEAHVADFGLAK+ +QD GASECMS++AGSYGY
Sbjct: 792 LCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGY 851

Query: 354 IAP 356
           IAP
Sbjct: 852 IAP 854

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	362
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.983	0.358	0.663	1.9e-124
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.977	0.352	0.588	1.3e-107
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.964	0.348	0.577	6.7e-104
TAIR|locus:2204350	980	CLV1 "AT1G75820" [Arabidopsis	0.966	0.357	0.518	7.3e-91
UNIPROTKB|Q5Z9N5	994	P0481E08.42 "Os06g0717200 prot	0.966	0.352	0.501	5.4e-86
TAIR|locus:2161158	1041	PXY "PHLOEM INTERCALATED WITH	0.522	0.181	0.505	1.2e-70
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.5	0.161	0.526	1.4e-62
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.541	0.171	0.487	3.8e-62
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.555	0.177	0.466	9.3e-62
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.566	0.205	0.502	1.6e-60

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1223 (435.6 bits), Expect = 1.9e-124, P = 1.9e-124
 Identities = 241/363 (66%), Positives = 273/363 (75%)

Query:     1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
             MSRNNFSG  P E G C+ LTYLDLS N +SG IPVQI+QI ILNYLNVSWN  N SLP 
Sbjct:   521 MSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPN 580

Query:    61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS---STTP 117
             E+G MKSLTSADFSHNNFSG +P  GQ+S+FN+TSF GNP LCG   NPCN S   S + 
Sbjct:   581 ELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQ 640

Query:   118 IHNQNGNKSH--VPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNS-NSWKLTAFQKLD 174
             + NQN  +S   +  K+K                  ++K R+ RKN+ N WKL  FQKL 
Sbjct:   641 LLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLG 700

Query:   175 FGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
             F S+ ILECVK+N+               PNGE+VAVKKLL ITKGSSHDNGL+AEI+TL
Sbjct:   701 FRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTL 760

Query:   235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
             G+IRHRNIVRL AFCSNK+ NLLVYEYMPNGSLGEVLHGK G FLKWE RL+IA+EAAKG
Sbjct:   761 GRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKG 820

Query:   295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL-QDTGASECMSAVAGSYGY 353
             L YLHHDCSPLIIHRDVKSNNILL  +FEAHVADFGLAK++ QD GASECMS++AGSYGY
Sbjct:   821 LCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGY 880

Query:   354 IAP 356
             IAP
Sbjct:   881 IAP 883

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
 Identities = 210/357 (58%), Positives = 254/357 (71%)

Query:     2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
             S N FSG I  EI  C LLT++DLS+N LSG IP +IT + ILNYLN+S N L  S+P  
Sbjct:   511 SHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGS 570

Query:    62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
             + +M+SLTS DFS+NN SG +P  GQ+S+FN TSF GNP LCG YL PC        H Q
Sbjct:   571 ISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGH-Q 629

Query:   122 NGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
             + +K  +    K                  IIK R  +K S S  W+LTAFQ+LDF  DD
Sbjct:   630 SHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDD 689

Query:   180 ILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
             +L+ +K++N               PNG+ VAVK+L  +++GSSHD+G +AEI+TLG+IRH
Sbjct:   690 VLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRH 749

Query:   240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
             R+IVRL  FCSN ETNLLVYEYMPNGSLGEVLHGK+G  L W+ R KIA+EAAKGL YLH
Sbjct:   750 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLH 809

Query:   300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             HDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIAP
Sbjct:   810 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1029 (367.3 bits), Expect = 6.7e-104, P = 6.7e-104
 Identities = 206/357 (57%), Positives = 250/357 (70%)

Query:     2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
             S N FSG I  EI  C LLT++DLS+N LSG IP ++T + ILNYLN+S N L  S+P  
Sbjct:   512 SHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVT 571

Query:    62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
             + +M+SLTS DFS+NN SG +P  GQ+S+FN TSF GN HLCG YL PC   +     +Q
Sbjct:   572 IASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGT-----HQ 626

Query:   122 NGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
             +  K  +    K                  IIK R  R  S +  W+LTAFQ+LDF  DD
Sbjct:   627 SHVKP-LSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDD 685

Query:   180 ILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
             +L+ +K++N               P G+ VAVK+L  ++ GSSHD+G +AEI+TLG+IRH
Sbjct:   686 VLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRH 745

Query:   240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
             R+IVRL  FCSN ETNLLVYEYMPNGSLGEVLHGK+G  L W  R KIA+EAAKGL YLH
Sbjct:   746 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLH 805

Query:   300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             HDCSPLI+HRDVKSNNILL+S+FEAHVADFGLAK+LQD+G SECMSA+AGSYGYIAP
Sbjct:   806 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 862

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)]

 Score = 906 (324.0 bits), Expect = 7.3e-91, P = 7.3e-91
 Identities = 185/357 (51%), Positives = 233/357 (65%)

Query:     2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
             S NN +G IP  I  C  L  +DLS+N ++G IP  I  +  L  LN+S NQL  S+P  
Sbjct:   512 SANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTG 571

Query:    62 MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ 121
             +GNM SLT+ D S N+ SG +P  GQ+  FN TSF GN +LC  +   C    T P    
Sbjct:   572 IGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSC---PTRPGQTS 628

Query:   122 NGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRKFRKNSNS--WKLTAFQKLDFGSDD 179
             + N + +    +                  I +  K +KN  S  WKLTAFQKLDF S+D
Sbjct:   629 DHNHTALFSPSRIVITVIAAITGLILISVAIRQMNK-KKNQKSLAWKLTAFQKLDFKSED 687

Query:   180 ILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
             +LEC+K+ N               PN   VA+K+L+G   G S D+G +AEI+TLG+IRH
Sbjct:   688 VLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRS-DHGFTAEIQTLGRIRH 746

Query:   240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
             R+IVRL  + +NK+TNLL+YEYMPNGSLGE+LHG +G  L+WE R ++A+EAAKGL YLH
Sbjct:   747 RHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKGLCYLH 806

Query:   300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             HDCSPLI+HRDVKSNNILL+SDFEAHVADFGLAK+L D  ASECMS++AGSYGYIAP
Sbjct:   807 HDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAP 863

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007172 "signal complex assembly" evidence=IDA

GO:0016021 "integral to membrane" evidence=TAS

GO:0030154 "cell differentiation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0016020 "membrane" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
 Identities = 183/365 (50%), Positives = 229/365 (62%)

Query:     1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
             +S N  +G IP E+  C  L  +DLS+N  SG IP  IT + IL  LNVS N+L   LP 
Sbjct:   515 VSGNALTGAIPDELIRCASLAAVDLSRNGFSGEIPESITSLKILCTLNVSRNRLTGELPP 574

Query:    61 EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYL-NPCNYSSTTPIH 119
             EM NM SLT+ D S+N+ SG +P  GQ+  FN +SF GNP LCG  + + C  S      
Sbjct:   575 EMSNMTSLTTLDVSYNSLSGPVPMQGQFLVFNESSFVGNPGLCGGPVADACPPSMAG--- 631

Query:   120 NQNGNKSHVPGKYKXXXXXXXXXXXXXXXXXXIIKTRK--------FRKNSNSWKLTAFQ 171
                G  S +  ++                    +  RK         R+ S +WK+TAFQ
Sbjct:   632 GGGGAGSQLRLRWDSKKMLVALVAAFAAVAVAFLGARKGCSAWRSAARRRSGAWKMTAFQ 691

Query:   172 KLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHDNGLSAEI 231
             KL+F ++D++ECVK++N              T  G ++A+K+L+G   G  HD G SAE+
Sbjct:   692 KLEFSAEDVVECVKEDNIIGKGGAGIVYHGVT-RGAELAIKRLVG-RGGGEHDRGFSAEV 749

Query:   232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
              TLG+IRHRNIVRL  F SN+ETNLL+YEYMPNGSLGE+LHG +G  L WE R ++A EA
Sbjct:   750 TTLGRIRHRNIVRLLGFVSNRETNLLLYEYMPNGSLGEMLHGGKGGHLGWEARARVAAEA 809

Query:   292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
             A GL YLHHDC+P IIHRDVKSNNILL+S FEAHVADFGLAK+L     SECMSA+AGSY
Sbjct:   810 ACGLCYLHHDCAPRIIHRDVKSNNILLDSAFEAHVADFGLAKFLGGA-TSECMSAIAGSY 868

Query:   352 GYIAP 356
             GYIAP
Sbjct:   869 GYIAP 873

GO:0010080 "regulation of floral meristem growth" evidence=IMP

GO:0048833 "specification of floral organ number" evidence=IMP

TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)]

 Score = 501 (181.4 bits), Expect = 1.2e-70, Sum P(2) = 1.2e-70
 Identities = 101/200 (50%), Positives = 134/200 (67%)

Query:   165 WKLTAFQKLDFGSDDILECV-KDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSS- 222
             WKLTAFQ+L+F +DD++EC+ K +N               PNGE +AVKKL G  K +  
Sbjct:   699 WKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGK 758

Query:   223 ---HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL 279
                  +G+ AE+  LG +RHRNIVRL   C+N++  +L+YEYMPNGSL ++LHG   +  
Sbjct:   759 IRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMT 818

Query:   280 ---KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
                +W    +IAI  A+G+ YLHHDC P+I+HRD+K +NILL++DFEA VADFG+AK +Q
Sbjct:   819 AAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQ 878

Query:   337 DTGASECMSAVAGSYGYIAP 356
                  E MS VAGSYGYIAP
Sbjct:   879 ---TDESMSVVAGSYGYIAP 895

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010089 "xylem development" evidence=IMP

GO:0010223 "secondary shoot formation" evidence=IMP

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 469 (170.2 bits), Expect = 1.4e-62, Sum P(2) = 1.4e-62
 Identities = 101/192 (52%), Positives = 127/192 (66%)

Query:   175 FGSDDILECVK---DNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSH-----DNG 226
             F   DILE  K   D+                P+G+ +AVKKL    +G+++     DN 
Sbjct:   807 FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNS 866

Query:   227 LSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
               AEI TLGKIRHRNIVRL +FC ++   +NLL+YEYM  GSLGE+LHG +   + W  R
Sbjct:   867 FRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTR 926

Query:   285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
               IA+ AA+GL+YLHHDC P IIHRD+KSNNIL++ +FEAHV DFGLAK + D   S+ +
Sbjct:   927 FAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI-DMPLSKSV 985

Query:   345 SAVAGSYGYIAP 356
             SAVAGSYGYIAP
Sbjct:   986 SAVAGSYGYIAP 997

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 520 (188.1 bits), Expect = 3.8e-62, Sum P(2) = 3.8e-62
 Identities = 99/203 (48%), Positives = 130/203 (64%)

Query:   165 WKLTAFQKLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGITKGSSHD 224
             W+ T FQKL+F  D I+ C+ + N                NGE +AVKKL        HD
Sbjct:   767 WQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHD 826

Query:   225 -------NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS 277
                    +  SAE++TLG IRH+NIVR    C N+ T LL+Y+YMPNGSLG +LH +RGS
Sbjct:   827 EKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGS 886

Query:   278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
              L W++R +I + AA+GL+YLHHDC P I+HRD+K+NNIL+  DFE ++ADFGLAK + +
Sbjct:   887 SLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDE 946

Query:   338 TGASECMSAVAGSYGYIAPVLGW 360
                  C + VAGSYGYIAP  G+
Sbjct:   947 GDIGRCSNTVAGSYGYIAPEYGY 969

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 488 (176.8 bits), Expect = 9.3e-62, Sum P(2) = 9.3e-62
 Identities = 98/210 (46%), Positives = 132/210 (62%)

Query:   160 KNSNSWKLTAFQKLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGEQVAVKKLLGIT- 218
             +N  +W+ T FQKL+F  + +L+C+ + N               PN E +AVKKL  +T 
Sbjct:   761 ENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTV 820

Query:   219 -------KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271
                    K S   +  SAE++TLG IRH+NIVR    C NK T LL+Y+YM NGSLG +L
Sbjct:   821 PNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLL 880

Query:   272 HGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330
             H + G   L WE+R KI + AA+GL+YLHHDC P I+HRD+K+NNIL+  DFE ++ DFG
Sbjct:   881 HERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFG 940

Query:   331 LAKYLQDTGASECMSAVAGSYGYIAPVLGW 360
             LAK + D   +   + +AGSYGYIAP  G+
Sbjct:   941 LAKLVDDGDFARSSNTIAGSYGYIAPEYGY 970

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 471 (170.9 bits), Expect = 1.6e-60, Sum P(2) = 1.6e-60
 Identities = 111/221 (50%), Positives = 138/221 (62%)

Query:   152 IIKTRKFR--KNSN--SWKLTAFQKLDFGSDDILECVKDNNXXXXXXXXXXXXXXTPNGE 207
             I K RK R  K+S   + K  +F KL F   +I +C+ + N                 GE
Sbjct:   647 IAKCRKLRALKSSTLAASKWRSFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGE 706

Query:   208 QVAVKKLLGITKGS----SHDN----GLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
              VAVKKL    KG     S D+      +AE+ TLG IRH++IVRL   CS+ +  LLVY
Sbjct:   707 VVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVY 766

Query:   260 EYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
             EYMPNGSL +VLHG R  G  L W  RL+IA++AA+GLSYLHHDC P I+HRDVKS+NIL
Sbjct:   767 EYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNIL 826

Query:   318 LNSDFEAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAP 356
             L+SD+ A VADFG+AK  Q +G+   E MS +AGS GYIAP
Sbjct:   827 LDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAP 867

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O65440	BAME3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7245	0.9834	0.3588	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	362
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-36
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.002
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.003
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  172 bits (438), Expect = 1e-47
 Identities = 112/340 (32%), Positives = 170/340 (50%), Gaps = 35/340 (10%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N  SG IP E+  C  L  LDLS N LSG IP   +++ +L+ L++S NQL+  +PK
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCG----SYLNPCNYSSTT 116
            +GN++SL   + SHN+  G +P  G +   N+++  GN  LCG    S L PC     T
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT 625

Query: 117 PIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTR------KFRKNSNSWKLTAF 170
           P              Y        L+ +LV      I+ R      +      +W+L  F
Sbjct: 626 PSW----------WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFF 675

Query: 171 QK---LDFGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNG 226
                     +DIL  +K+ NVI RG  G  Y+G +  NG Q  VK++      +  ++ 
Sbjct: 676 DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI------NDVNSI 729

Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
            S+EI  +GK++H NIV+L   C +++   L++EY+   +L EVL       L WE R K
Sbjct: 730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRK 784

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           IAI  AK L +LH  CSP ++  ++    I+++   E H+
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (346), Expect = 3e-38
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 9/160 (5%)

Query: 184 VKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           +     +G G  G VY+G           +VAVK L         +     E R + K+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLD 59

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           H NIV+L   C+ +E  ++V EYMP G L + L   R   L     L  A++ A+G+ YL
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
                   IHRD+ + N L+  +    ++DFGL++ L D 
Sbjct: 120 ESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  133 bits (336), Expect = 9e-37
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 10/160 (6%)

Query: 184 VKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           +     +G G  G VY+G           +VAVK L               E R + K+ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           H N+V+L   C+ +E   +V EYM  G L   L  K    L     L  A++ A+G+ YL
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYL 118

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
                   IHRD+ + N L+  +    ++DFGL++ L D 
Sbjct: 119 ESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  131 bits (332), Expect = 3e-36
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 16/159 (10%)

Query: 189 VIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHRN 241
            +G G  G VY+G           +VAVK L    +G+S +       E   + K+ H N
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKLSHPN 62

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
           IVRL   C+  E   +V EYMP G L + L       L  +  L++A++ AKG+ YL   
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK 121

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
           +     +HRD+ + N L+  +    ++DFGL++ + +  
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  130 bits (328), Expect = 5e-36
 Identities = 61/169 (36%), Positives = 88/169 (52%), Gaps = 9/169 (5%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           +G GG G VY       G++VA+K +      S  +  L  EI  L K+ H NIV+L   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
             ++    LV EY   GSL ++L  +    L  +  L+I ++  +GL YLH   S  IIH
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 309 RDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           RD+K  NILL+SD  +  +ADFGL+K L        +  + G+  Y+AP
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (329), Expect = 1e-35
 Identities = 64/169 (37%), Positives = 90/169 (53%), Gaps = 8/169 (4%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +G G  G VY+      G+ VAVK L   ++ S  D     EIR L ++ H NIVRL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
              +K+   LV EY   G L + L  + G   + E + KIA++  +GL YLH +    II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAK-KIALQILRGLEYLHSNG---II 120

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+K  NILL+ +    +ADFGLAK L    +S  ++   G+  Y+AP
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (326), Expect = 3e-35
 Identities = 57/170 (33%), Positives = 81/170 (47%), Gaps = 10/170 (5%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             +G G  G VY       G+ VA+K +    K       +  EI+ L K++H NIVRL 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               +++   LV EY   G L ++L  KRG   + E R     +    L YLH      I
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEAR-FYLRQILSALEYLHSKG---I 118

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRD+K  NILL+ D    +ADFGLA+ L        ++   G+  Y+AP
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 3e-32
 Identities = 52/163 (31%), Positives = 74/163 (45%), Gaps = 15/163 (9%)

Query: 188 NVIGRGGAGVVYRGV----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
             +G G  G VY+G          +VAVK L          +    E R + K+ H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-------LKWEMRLKIAIEAAKGLS 296
           RL   C+ +E   LV EYM  G L + L   R  F       L  +  L  AI+ AKG+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
           YL    S   +HRD+ + N L+  D    ++DFGL++ + D  
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  121 bits (305), Expect = 3e-32
 Identities = 63/172 (36%), Positives = 90/172 (52%), Gaps = 8/172 (4%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
            ++GRG  G VY  +    GE +AVK +            L  EIR L  ++H NIVR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 247 AFCSNKETN-LLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
               ++E N L ++ EY+  GSL  +L  K G   +  +R K   +  +GL+YLH   S 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIR-KYTRQILEGLAYLH---SN 120

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            I+HRD+K  NIL++SD    +ADFG AK L D    E   +V G+  ++AP
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (303), Expect = 6e-32
 Identities = 64/178 (35%), Positives = 98/178 (55%), Gaps = 13/178 (7%)

Query: 181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
           LE VK   V+G+G +GVVY+    P G+  A+KK+  +         L  E++TL     
Sbjct: 3   LERVK---VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCES 58

Query: 240 RNIVRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             +V+   AF    E ++ V EYM  GSL ++L  K+   +   +   IA +  KGL YL
Sbjct: 59  PYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYL 115

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H      IIHRD+K +N+L+NS  E  +ADFG++K L++T   +C + V G+  Y++P
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFV-GTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  114 bits (287), Expect = 9e-30
 Identities = 63/171 (36%), Positives = 87/171 (50%), Gaps = 14/171 (8%)

Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            IG+GG G VY+      G++VA+K +   +K          EI+ L K +H NIV  K 
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII--NEIQILKKCKHPNIV--KY 62

Query: 248 FCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           + S  K+  L +V E+   GSL ++L     +         +  E  KGL YLH   S  
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL-TESQIAYVCKELLKGLEYLH---SNG 118

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IIHRD+K+ NILL SD E  + DFGL+  L DT A   M    G+  ++AP
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 4e-27
 Identities = 55/171 (32%), Positives = 91/171 (53%), Gaps = 10/171 (5%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           ++IGRG  GVVY+G+    G+ VA+K++            +  EI  L  ++H NIV+  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPL 305
                 ++  ++ EY  NGSL +++  K G F   E  + + + +  +GL+YLH      
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIK-KFGPFP--ESLVAVYVYQVLQGLAYLHEQG--- 119

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +IHRD+K+ NIL   D    +ADFG+A  L D    +  ++V G+  ++AP
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 51/148 (34%), Positives = 78/148 (52%), Gaps = 6/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  G V+ G      +VAVK L     G+        E + + K+RH  +V+L A C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           S +E   +V EYM  GSL + L    G  L+    + +A + A+G++YL    S   IHR
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + NIL+  +    +ADFGLA+ ++D
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIED 155

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 5e-22
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 18/152 (11%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G G  GVVY+      GE VA+KK+    +  + + G+ +    EI  L +++H NIV+
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELKHPNIVK 62

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLSYLHHDC 302
           L      +    LV+EY     L + L  + G        L   I  +  +GL+Y H   
Sbjct: 63  LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCH--- 115

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
           S  I+HRD+K  NIL+N D    +ADFGLA+ 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 7e-22
 Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 15/163 (9%)

Query: 183 CVKDNNVIGRGGAGVVYRG-VTPNGEQ---VAVKKLLGITKGSSHDN---GLSAEIRTLG 235
            V    VIG G  G V RG +   G++   VA+K L    K  S D        E   +G
Sbjct: 5   YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL----KAGSSDKQRLDFLTEASIMG 60

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
           +  H NI+RL+   +     +++ EYM NGSL + L    G F      + +    A G+
Sbjct: 61  QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF-TVGQLVGMLRGIASGM 119

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            YL        +HRD+ + NIL+NS+    V+DFGL++ L+D+
Sbjct: 120 KYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 95.2 bits (235), Expect = 9e-22
 Identities = 62/176 (35%), Positives = 84/176 (47%), Gaps = 13/176 (7%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLL-GITKGSSHDNGLSAEIRTLGKIRH-RNIVRLK 246
            +G G  G VY     + + VA+K L   +   S        EI+ L  + H  NIV+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
            F  ++ +  LV EY+  GSL ++L    R   L     L I  +    L YLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 306 IIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGAS----ECMSAVAGSYGYIAP 356
           IIHRD+K  NILL+ D     + DFGLAK L D G++       S   G+ GY+AP
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 1e-21
 Identities = 51/148 (34%), Positives = 79/148 (53%), Gaps = 6/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  G V+ G+  N   VAVK L     G+       AE + + K+RH  +++L A C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           + +E   +V E M  GSL E L G  G  LK    + +A + A G++YL    +   IHR
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + N+L+  +    VADFGLA+ +++
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKE 155

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 91.0 bits (227), Expect = 4e-21
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 12/174 (6%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA--EIRTLGKIRHRNIVR 244
             IG+G  G VY      +G+   +K++       S      A  E++ L K+ H NI++
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLH--GKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                  K    +V EY   G L + +    K G     E  L   ++    L YLH   
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  I+HRD+K  NI L S+    + DFG++K L  T   +    V G+  Y++P
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDLAKTVVGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 57/169 (33%), Positives = 86/169 (50%), Gaps = 24/169 (14%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           IG G  G VY+      GE VA+KK+    +  +   G       EI+ L K+RH NIVR
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 245 LKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSF----LKWEMRLKIAIEAAKGLSYL 298
           LK   ++K      +V+EYM +  L  +L      F    +K  M+     +  +GL YL
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMK-----QLLEGLQYL 116

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
           H +    I+HRD+K +NIL+N+D    +ADFGLA+      +++  + V
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.4 bits (225), Expect = 6e-21
 Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 19/180 (10%)

Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
           DILE       +G G  G VY+ +    G+ VA+K +    +    +  +  EI  L + 
Sbjct: 6   DILEK------LGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQE--IIKEISILKQC 55

Query: 238 RHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
               IV+       K T+L +V EY   GS+ +++     +  + E+   I  +  KGL 
Sbjct: 56  DSPYIVKYYG-SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-ILYQTLKGLE 113

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           YLH   S   IHRD+K+ NILLN + +A +ADFG++  L DT A    + V G+  ++AP
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 10/150 (6%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           K+   IG G +G VY+      G++VA+KK   +     +   +  EI  +   +H NIV
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKK---MRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 244 R-LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
               ++    E   +V EYM  GSL +++       +       +  E  +GL YLH   
Sbjct: 79  DYYDSYLVGDEL-WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--- 133

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           S  +IHRD+KS+NILL+ D    +ADFG A
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 5/148 (3%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  G V+ G+  N  +VA+K L         D     E++ L ++RH++++ L A C
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAVC 71

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           S  E   ++ E M  GSL   L    G  L     + +A + A+G++YL        IHR
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + NIL+  D    VADFGLA+ +++
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKE 156

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 7/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  GVV+ G       VA+K    I +G+  ++    E + + K+ H N+V+L   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKM---IREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           + +    +V EYM NG L   L  ++G     E  L +  +  + + YL  +     IHR
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKL-GTEWLLDMCSDVCEAMEYLESNG---FIHR 124

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + N L+  D    V+DFGLA+Y+ D
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD 152

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 7/170 (4%)

Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IG G  G+V++      GE VA+KK+          N    EI+ L   +H  +V+L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
             +    +LV EYMP   L EVL  +     + +++        KG++Y+H   +  I+H
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH---ANGIMH 122

Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           RD+K  N+L+++D    +ADFGLA+ L         S    +  Y AP L
Sbjct: 123 RDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 53/155 (34%), Positives = 72/155 (46%), Gaps = 12/155 (7%)

Query: 188 NVIGRGGAGVVYRG-VTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
             +G G  G V      P     GEQVAVK L   +    H +    EI  L  + H NI
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 243 VRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           V+ K  C         L+ EY+P+GSL + L   R       + L  + +  KG+ YL  
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-LLFSSQICKGMDYLG- 126

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
             S   IHRD+ + NIL+ S+    ++DFGLAK L
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 12/175 (6%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
            VIG G   VVY  +  PN E+VA+K++  + K  +  + L  E++ + +  H N+V  K
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVV--K 63

Query: 247 AFCSNKETNLL--VYEYMPNGSLGEVL-HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
            + S    + L  V  Y+  GSL +++        L   +   +  E  KGL YLH   S
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS--AVAGSYGYIAP 356
              IHRD+K+ NILL  D    +ADFG++  L D G           G+  ++AP
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 6e-20
 Identities = 59/177 (33%), Positives = 84/177 (47%), Gaps = 19/177 (10%)

Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
           V+G G  GVV +      GE VA+KK        S D+         E++ L ++RH NI
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKE-----SEDDEDVKKTALREVKVLRQLRHENI 62

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
           V LK     K    LV+EY+   +L E+L    G      +R  I  +  + ++Y H H+
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYI-WQLLQAIAYCHSHN 120

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
               IIHRD+K  NIL++      + DFG A+ L+   AS     VA  + Y AP L
Sbjct: 121 ----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPEL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 20/158 (12%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNG-----LSAEIRTLGKIRHRNIVR 244
           IG+G  G V  G    G++VAVK L         D+        AE   +  +RH N+V+
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCL--------KDDSTAAQAFLAEASVMTTLRHPNLVQ 64

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           L           +V EYM  GSL + L  +  + +    +L  A++  +G+ YL      
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EK 121

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK---YLQDTG 339
             +HRD+ + N+L++ D  A V+DFGLAK     QD+G
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 57/172 (33%), Positives = 89/172 (51%), Gaps = 14/172 (8%)

Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS---HDNGLSAEIRTLGKIRHRNIVRL 245
           +G G  G VY G+   +G+  AVK++     G +       L  EI  L K++H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 246 KAFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
                 +E NL ++ E +P GSL ++L  K GSF +  +RL    +   GL YLH     
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTR-QILLGLEYLH---DR 121

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             +HRD+K  NIL++++    +ADFG+AK + +        +  GS  ++AP
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.0 bits (213), Expect = 2e-19
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVR-L 245
           N IG+G  GVV++ V    ++V   K + ++K +  +      E R L K+    I+R  
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           ++F    + N+++ EY  NG L ++L  +RG  L  +   +  I+   GL++LH   S  
Sbjct: 66  ESFLDKGKLNIVM-EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           I+HRD+KS N+ L++     + D G+AK L D   +   + + G+  Y++P L
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPEL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 53/160 (33%), Positives = 76/160 (47%), Gaps = 16/160 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVR-- 244
           VIG G  G VY+      G+ VA+K ++ I +    +  +  E   L K   H NI    
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIE--DEEEEIKEEYNILRKYSNHPNIATFY 69

Query: 245 ---LKAFCSNKETNL-LVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYL 298
              +K      +  L LV E    GS+ +++ G  K+G  LK E    I  E  +GL+YL
Sbjct: 70  GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           H      +IHRD+K  NILL  + E  + DFG++  L  T
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.4 bits (211), Expect = 4e-19
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 7/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           IG G  G+V+ G      +VA+K    I +G+  +     E + + K+ H  +V+L   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           + +    LV+E+M +G L + L  +RG F + E  L + ++  +G++YL       +IHR
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQ-ETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + N L+  +    V+DFG+ +++ D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD 152

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 85.0 bits (210), Expect = 7e-19
 Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 7/158 (4%)

Query: 183 CVKDNNVIGRGGAGVVYRGV--TPNGEQVAVK-KLLGITKGSSHDNGLSAEIRTLGKIRH 239
            +    VIG G  G V+RG+   P  ++VAV  K L             +E   +G+  H
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
            NI+RL+   +  +  +++ EYM NG+L + L    G F  +++ + +    A G+ YL 
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLS 124

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
            D +   +HRD+ + NIL+NS+ E  V+DFGL++ L+D
Sbjct: 125 -DMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 17/152 (11%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKG--SSHDNGL--SA--EIRTLGKIRHRNI 242
           +G G   VVY+      G  VA+KK   I  G      +G+  +A  EI+ L +++H NI
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKK---IKLGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 243 VRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           + L   F      NL V+E+M    L +V+  K       +++    +   +GL YLH  
Sbjct: 65  IGLLDVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLH-- 119

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            S  I+HRD+K NN+L+ SD    +ADFGLA+
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 22/163 (13%)

Query: 189 VIGRGGAGVVYRGVTPNGEQ------VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            +G G  G V+ G   + E       VAVK L       +  +    E   L   +H NI
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHENI 70

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKW----------EMRLKIAIE 290
           V+    C+  +  ++V+EYM +G L + L  HG   +FLK              L+IA++
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            A G+ YL    S   +HRD+ + N L+  D    + DFG+++
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.6 bits (206), Expect = 2e-18
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 7/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G+G  G V+ G      +VA+K L     G+        E + + K+RH  +V+L A  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           S +E   +V EYM  GSL + L G+ G +L+    + +A + A G++Y+        +HR
Sbjct: 71  S-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+++ NIL+  +    VADFGLA+ ++D
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIED 154

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 54/153 (35%), Positives = 79/153 (51%), Gaps = 16/153 (10%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
           N IG G  G+VYR   T +GE VA+KK+    +  +  +G+      EI  L  +RH NI
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKV----RMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 243 VRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           V LK     K  +   LV EY     L  +L      F + +++  + ++  +GL YLH 
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-LMLQLLRGLQYLHE 126

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           +    IIHRD+K +N+LL       +ADFGLA+
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 82.2 bits (203), Expect = 5e-18
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 7/149 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  G V+ G      +VA+K L    +GS       AE   + +++H  +VRL A  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           + +E   ++ EYM NGSL + L    G  L     + +A + A+G++++        IHR
Sbjct: 71  T-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHR 126

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           D+++ NIL++      +ADFGLA+ ++D 
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 7e-18
 Identities = 61/176 (34%), Positives = 78/176 (44%), Gaps = 23/176 (13%)

Query: 190 IGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDNGL----SAEIRTLGKIRHRNIV 243
           +G+G  G V   R     G+  A+K L    K              E   L +I H  IV
Sbjct: 1   LGKGSFGKVLLVRKKD-TGKLYAMKVL---KKKKIIKRKEVEHTLTERNILSRINHPFIV 56

Query: 244 RLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
           +L  AF +  E  L LV EY P G L   L  K G F +   R   A E    L YLH  
Sbjct: 57  KLHYAFQT--EEKLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAA-EIVLALEYLHSL 112

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                II+RD+K  NILL++D    + DFGLAK L   G+    +   G+  Y+AP
Sbjct: 113 G----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.8 bits (202), Expect = 9e-18
 Identities = 52/160 (32%), Positives = 85/160 (53%), Gaps = 11/160 (6%)

Query: 183 CVKDNNVIGRGGAGVVYRG-VTPNGEQ---VAVKKL-LGITKGSSHDNGLSAEIRTLGKI 237
           CVK   VIG G  G V RG +   G++   VA+K L  G T+    D    +E   +G+ 
Sbjct: 5   CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEASIMGQF 62

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
            H NI+ L+   +     +++ E+M NG+L   L    G F   ++ + +    A G+ Y
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGMLRGIAAGMKY 121

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           L  + +   +HRD+ + NIL+NS+    V+DFGL+++L+D
Sbjct: 122 LS-EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 59/178 (33%), Positives = 97/178 (54%), Gaps = 16/178 (8%)

Query: 189 VIGRGGAGVVYRGVT-PNGEQVAVKKL-LGITKGSSHDN-------GLSAEIRTLGKIRH 239
           +IG+G  G VY  +    GE +AVK++ L  T    HD+        L +EI TL  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 240 RNIVRLKAFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
            NIV+   F    E  L ++ EY+P GS+G  L    G F + ++      +  +GL+YL
Sbjct: 68  LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLR-TYGRF-EEQLVRFFTEQVLEGLAYL 124

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H   S  I+HRD+K++N+L+++D    ++DFG++K   D   ++   ++ GS  ++AP
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 13/172 (7%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
             +G G +GVV + +  P G+ +AVK +  +    +    +  E+  L K     IV   
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCSP 304
            AF +N + ++ + EYM  GSL ++L   +G     E  L KIA+   KGL+YLH     
Sbjct: 66  GAFYNNGDISICM-EYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLHEKHK- 121

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            IIHRDVK +NIL+NS  +  + DFG++  L ++ A        G+  Y+AP
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 50/177 (28%), Positives = 90/177 (50%), Gaps = 13/177 (7%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLL----GITKGSSHDNGLSAEIRTLGKIRHRNIV 243
            V+G+G  G VY G+T  G+ +AVK++      +         L  E+  L  ++H NIV
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           +    C +  T  +  E++P GS+  +L+ + G   +     K   +   G++YLH++C 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFC-KYTKQILDGVAYLHNNC- 122

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA----SECMSAVAGSYGYIAP 356
             ++HRD+K NN++L  +    + DFG A+ L   G     S  + ++ G+  ++AP
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 48/134 (35%), Positives = 75/134 (55%), Gaps = 7/134 (5%)

Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN--LLVYEYMP 263
           GEQVAVK L   + G+ H   L  EI  L  + H NIV+ K  C+    N   L+ E++P
Sbjct: 33  GEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
           +GSL E L  +  + +  + +LK A++  KG+ YL    S   +HRD+ + N+L+ S+ +
Sbjct: 92  SGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147

Query: 324 AHVADFGLAKYLQD 337
             + DFGL K ++ 
Sbjct: 148 VKIGDFGLTKAIET 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 25/159 (15%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           V+G G  G VY+GV  P GE+    VA+K L   T     +  +  E   +  + H ++V
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG-----SFLKWEMRLKIAIEAAKGLSYL 298
           RL   C +     L+ + MP G L + +   +        L W       ++ AKG+SYL
Sbjct: 73  RLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125

Query: 299 --HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
                    ++HRD+ + N+L+ +     + DFGLAK L
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.0 bits (195), Expect = 7e-17
 Identities = 49/150 (32%), Positives = 67/150 (44%), Gaps = 9/150 (6%)

Query: 190 IGRGGAGVVYRG--VTPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           +G G  GVV RG   T  G+   VAVK L         D+ L  E   +  + H N++RL
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK-EAAIMHSLDHENLIRL 61

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                     ++V E  P GSL + L                A++ A G+ YL    S  
Sbjct: 62  YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
            IHRD+ + NILL SD +  + DFGL + L
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 54/135 (40%), Positives = 69/135 (51%), Gaps = 9/135 (6%)

Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T     D     EI  L  ++H NIV+ K  C S    NL LV EY+P
Sbjct: 33  GEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90

Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL + L   R      ++ L  A +  KG+ YL    S   +HRD+ + NIL+ S+  
Sbjct: 91  YGSLRDYLQKHRERLDHRKL-LLYASQICKGMEYLG---SKRYVHRDLATRNILVESENR 146

Query: 324 AHVADFGLAKYL-QD 337
             + DFGL K L QD
Sbjct: 147 VKIGDFGLTKVLPQD 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 7/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  GVV+ G      +VA+K    I +G+  +     E + + K+ H  +V+L   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           + ++   +V E+M NG L   L  ++G   K +M L +  +  +G+ YL  +     IHR
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + N L++S     V+DFG+ +Y+ D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLD 152

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 13/148 (8%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
           IG+G  G VY+GV     +VAVK     T  S+    L      E   L +  H NIV+L
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVK-----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
              C  K+   +V E +P GSL   L  K+   L  +  L+++++AA G+ YL       
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNC-- 114

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK 333
            IHRD+ + N L+  +    ++DFG+++
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 10/175 (5%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
            +  V+G+G  G+VY         ++A+K++    + S +   L  EI     ++HRNIV
Sbjct: 11  GERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIV 68

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLHHDC 302
           +     S      +  E +P GSL  +L  K G     E  +     +  +GL YLH + 
Sbjct: 69  QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127

Query: 303 SPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              I+HRD+K +N+L+N+      ++DFG +K L   G + C     G+  Y+AP
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 38/168 (22%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
           +    IG G  GVV   V    G +VA+KK+  +      D+ + A     EI+ L  +R
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-----DDLIDAKRILREIKLLRHLR 57

Query: 239 HRNIVRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
           H NI+ L          +     +V E M    L +V+               +  +  +
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK----------SPQPLTDDHIQ 106

Query: 294 --------GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
                   GL YLH   S  +IHRD+K +NIL+NS+ +  + DFGLA+
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 10/173 (5%)

Query: 188 NVIGRGGAGVVYRGVT-PNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           N IG G  G VY  V    GE +AVK++ +      +    ++ E++ L  ++H N+V+ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVKY 64

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                ++E   +  EY   G+L E+L   R   L   +     ++  +GL+YLH   S  
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH---SHG 119

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAP 356
           I+HRD+K  NI L+ +    + DFG A  L++   +  E + ++AG+  Y+AP
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 55/154 (35%), Positives = 73/154 (47%), Gaps = 11/154 (7%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             IG G  G VY+      GE VA+K ++ +  G   +  +  EI  L + RH NIV   
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEI-IQQEISMLKECRHPNIVAY- 65

Query: 247 AFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
            F S    + L  V EY   GSL ++    RG  L       +  E  KGL+YLH     
Sbjct: 66  -FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHETG-- 121

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
             IHRD+K  NILL  D +  +ADFG++  L  T
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 6/156 (3%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E +K    +G G  G V+ G   N  +VAVK L     G+        E   +  ++H  
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDK 62

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +VRL A  + +E   ++ EYM  GSL + L    G  +     +  + + A+G++Y+   
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                IHRD+++ N+L++      +ADFGLA+ ++D
Sbjct: 123 N---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 54/172 (31%), Positives = 86/172 (50%), Gaps = 10/172 (5%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKL---LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           +G+G  G VY     + G ++AVK++       +     N L  EI+ L  ++H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                + ET  +  EYMP GS+ + L  K    L   +  K   +  +G+ YLH   S +
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLH---SNM 124

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAP 356
           I+HRD+K  NIL +S     + DFG +K LQ   +S   M +V G+  +++P
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 9/156 (5%)

Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRH 239
           ++   ++G G  G V++G+  P G+ + +    K +    G      ++  +  +G + H
Sbjct: 9   LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
             IVRL   C      L V +  P GSL + +   R S L  +  L   ++ AKG+ YL 
Sbjct: 69  AYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLE 126

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
                 ++HR++ + NILL SD    +ADFG+A  L
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 50/148 (33%), Positives = 75/148 (50%), Gaps = 7/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  G V+ G      +VAVK L     G+        E + + K+RH  +V+L A  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           S +E   +V EYM  GSL + L    G  LK    + +A + A G++Y+        IHR
Sbjct: 71  S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D++S NIL+       +ADFGLA+ ++D
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIED 154

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 19/168 (11%)

Query: 177 SDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG--LSA--EI 231
           S D  E +   N I  G  GVVYR      GE VA+KKL    K      G  +++  EI
Sbjct: 3   SVDEYEKL---NRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREI 55

Query: 232 RTLGKIRHRNIVRLK--AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
             L K++H NIV +K     SN +   +V EY+ +  L  ++   +  FL+ E++  + +
Sbjct: 56  NILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LML 113

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           +   G+++LH +    I+HRD+K++N+LLN+     + DFGLA+    
Sbjct: 114 QLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 36/81 (44%), Positives = 50/81 (61%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           NN SG IP EIG    L +LDL  N+L+GPIP  +  +  L YL +  N+L+  +P  + 
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281

Query: 64  NMKSLTSADFSHNNFSGEIPE 84
           +++ L S D S N+ SGEIPE
Sbjct: 282 SLQKLISLDLSDNSLSGEIPE 302

Length = 968

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 12/174 (6%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA--EIRTLGKIRHRNIVR-L 245
           V+GRG  G+V+       +++ + K +   +  + D  L+A  E + L  + H NI+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           + F  +K   ++V EY P G+L E +  +  S L  +  L   ++    L  LHH  + L
Sbjct: 66  ENFLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKL 121

Query: 306 IIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           I+HRD+K+ NILL+       + DFG++K L     +     V G+  YI+P L
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 56/161 (34%), Positives = 76/161 (47%), Gaps = 9/161 (5%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIR 232
           F  DD  +   D   IG G  G VY        E VA+KK+    K S+     +  E+R
Sbjct: 8   FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 233 TLGKIRHRNIVRLKAFCSNKE-TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
            L ++RH N +  K  C  +E T  LV EY   GS  ++L   +    + E+   I   A
Sbjct: 68  FLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-AICHGA 124

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
            +GL+YLH       IHRD+K+ NILL       +ADFG A
Sbjct: 125 LQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 57/159 (35%), Positives = 80/159 (50%), Gaps = 14/159 (8%)

Query: 184 VKDNNVIGRGGAGVV--YRGVTPN---GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           +K   V+G G  G V  Y     N   GE VAVK L     G  + +G   EI  L  + 
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNTSGWKKEINILKTLY 64

Query: 239 HRNIVRLKAFCSNK--ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           H NIV+ K  CS +  +   L+ EY+P GSL + L   +   L     L  A +  +G++
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMA 121

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
           YLH   S   IHRD+ + N+LL++D    + DFGLAK +
Sbjct: 122 YLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 23/175 (13%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD----NGLSAEIRTLGKIRHRNI 242
           N IG G  G VY+ +  P G   A+K + G     +H+      +  EI  L  + H N+
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYG-----NHEDTVRRQICREIEILRDVNHPNV 134

Query: 243 VRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           V+    F  N E  +L+ E+M  GSL E  H     FL       +A +   G++YLH  
Sbjct: 135 VKCHDMFDHNGEIQVLL-EFMDGGSL-EGTHIADEQFLA-----DVARQILSGIAYLH-- 185

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               I+HRD+K +N+L+NS     +ADFG+++ L  T    C S+V G+  Y++P
Sbjct: 186 -RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSV-GTIAYMSP 237

Length = 353

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 9/157 (5%)

Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRH 239
           +K   V+G G  G VY+G+  P GE V +    K+L  T G   +     E   +  + H
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
            ++VRL   C +  T  LV + MP+G L + +H  + + +  ++ L   ++ AKG+ YL 
Sbjct: 69  PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLE 126

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
                 ++HRD+ + N+L+ S     + DFGLA+ L+
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.7 bits (186), Expect = 8e-15
 Identities = 40/93 (43%), Positives = 52/93 (55%), Gaps = 1/93 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N  SG IP +IG    L  LDL  N L G IP  +T +  L +L ++ NQL   +P+
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206

Query: 61  EMGNMKSLTSADFSHNNFSGEIP-EFGQYSFFN 92
           E+G MKSL      +NN SGEIP E G  +  N
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Length = 968

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 20/157 (12%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
            IG+G  G VY+ +     + VA+K    I    + D    +  EI+ L + R   I + 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKV---IDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHHD 301
                 K + L ++ EY   GS  ++L  K G     E    IA    E   GL YLH +
Sbjct: 65  YG-SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLD--ET--YIAFILREVLLGLEYLHEE 117

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
                IHRD+K+ NILL+ + +  +ADFG++  L  T
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTST 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 11/160 (6%)

Query: 183 CVKDNNVIGRGGAGVVYRG--VTPNGEQ--VAVKKL-LGITKGSSHDNGLSAEIRTLGKI 237
           C+K   VIG G  G V  G    P   +  VA+K L  G T+    D    +E   +G+ 
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD--FLSEASIMGQF 62

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
            H NI+ L+   +  +  ++V EYM NGSL   L    G F   ++ + +    A G+ Y
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKY 121

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           L  D     +HRD+ + NIL+NS+    V+DFGL++ L+D
Sbjct: 122 LS-DMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
            IG+G  G V  G    G +VAVK +    K  +      AE   + ++RH N+V+L   
Sbjct: 13  TIGKGEFGDVMLG-DYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
              ++  L +V EYM  GSL + L  +  S L  +  LK +++  + + YL  +     +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAK---YLQDTG 339
           HRD+ + N+L++ D  A V+DFGL K     QDTG
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 6/145 (4%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IG G  GVVY+      GE VA+KK+    +          EI+ L ++ H NI++L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
             +K    LV+E+M +  L +++  ++    +  ++     +  +GL++ H   S  I+H
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIK-SYLYQLLQGLAFCH---SHGILH 121

Query: 309 RDVKSNNILLNSDFEAHVADFGLAK 333
           RD+K  N+L+N++    +ADFGLA+
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 52/170 (30%), Positives = 74/170 (43%), Gaps = 43/170 (25%)

Query: 188 NVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIR---H 239
             IG G  G VY+    N G  VA+KK+         + G+      EI  L ++    H
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS----EEGIPLSTLREIALLKQLESFEH 60

Query: 240 RNIVRLKAFCSNKETN-----LLVYEYM-----------PNGSLGEVLHGKRGSFLKWEM 283
            NIVRL   C    T+      LV+E++           P   L           +K  M
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET-------IKDLM 113

Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           R     +  +G+ +LH   S  I+HRD+K  NIL+ SD +  +ADFGLA+
Sbjct: 114 R-----QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 47/148 (31%), Positives = 77/148 (52%), Gaps = 7/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G+G  G V+ G      +VA+K L     G+        E + + K+RH  +V L A  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           S +E   +V E+M  GSL + L    G +LK    + +A + A G++Y+        IHR
Sbjct: 71  S-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHR 126

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+++ NIL+  +    +ADFGLA+ ++D
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIED 154

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 57/170 (33%), Positives = 93/170 (54%), Gaps = 12/170 (7%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-K 246
            +G G  GVV + +  P+G  +A +KL+ +    +  N +  E++ L +     IV    
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYG 66

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
           AF S+ E ++ + E+M  GSL +VL  K+   +   +  KI+I   +GL+YL       I
Sbjct: 67  AFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLREKHK--I 121

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRDVK +NIL+NS  E  + DFG++  L D+ A+   S V G+  Y++P
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 53/161 (32%), Positives = 71/161 (44%), Gaps = 16/161 (9%)

Query: 189 VIGRGGAGVVYRG--VTPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKI-RHRNI 242
           +IG G    V        N ++ A+K   K   I +       +  E   L ++  H  I
Sbjct: 8   IIGEGSFSTVVLAKEKETN-KEYAIKILDKRQLIKEKKVKY--VKIEKEVLTRLNGHPGI 64

Query: 243 VRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           ++L  +    E NL  V EY PNG L + +  K GS  +   R   A E    L YLH  
Sbjct: 65  IKL-YYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAA-EILLALEYLH-- 119

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
            S  IIHRD+K  NILL+ D    + DFG AK L    + E
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 7/148 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  GVV  G       VA+K    I +GS  ++    E + + K+ H  +V+L   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           + +    +V EYM NG L   L      F   ++ L++  +  +G++YL    S   IHR
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHR 124

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + N L++      V+DFGL++Y+ D
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD 152

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 15/181 (8%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E + + + +G G  G V +    N   +   K +           +  E+      +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 242 IVRL-KAFCSNKETNL-LVYEYMPNGSL----GEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
           IV+   AF     +++ +  EY   GSL     +V   KRG  +  ++  KIA    KGL
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKGL 118

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
           SYLH   S  IIHRD+K +NILL    +  + DFG++  L ++ A    +    S+ Y+A
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSF-YMA 171

Query: 356 P 356
           P
Sbjct: 172 P 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 28/176 (15%)

Query: 180 ILECVKDNNVIGRGGAGVVYRG--VTPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRT 233
            L  V+    +G G  G VY+G    PN       VA+K L    +          E   
Sbjct: 3   PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAEL 61

Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--------------HGKRGSFL 279
           +  ++H NIV L   C+ ++   +++EY+ +G L E L                   S L
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 280 KWEMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
                L IAI+ A G+ YL  HH      +HRD+ + N L+       ++DFGL++
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 70.3 bits (172), Expect = 8e-14
 Identities = 51/134 (38%), Positives = 76/134 (56%), Gaps = 10/134 (7%)

Query: 227 LSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL 285
           L  EIR + ++ H +I+R L A C +   NL V E+M  GS+  +L  K G+F K  + +
Sbjct: 50  LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLS-KYGAF-KEAVII 106

Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-AHVADFGLAKYL--QDTGASE 342
               +  +GLSYLH +    IIHRDVK  N+L++S  +   +ADFG A  L  + TGA E
Sbjct: 107 NYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163

Query: 343 CMSAVAGSYGYIAP 356
               + G+  ++AP
Sbjct: 164 FQGQLLGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.6 bits (173), Expect = 9e-14
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 16/157 (10%)

Query: 188 NVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             IG G  G VY+    + GE VA+KK+    +          EI+ L ++ HRNIV LK
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 247 AFCSNKETNL----------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
              ++K+  L          LV+EYM +  +G +L      F +  ++     +  +GL+
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIK-SFMKQLLEGLN 130

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           Y H       +HRD+K +NILLN+  +  +ADFGLA+
Sbjct: 131 YCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 49/166 (29%), Positives = 67/166 (40%), Gaps = 18/166 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
           + +     +G G  G VY G+           QVAVK L          + L  E   + 
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-EALIMS 64

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-----HGKRGSFLKWEMRLKIAIE 290
           K  H+NIVRL      +    ++ E M  G L   L       +R S L  +  L  A +
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAK 333
            AKG  YL        IHRD+ + N LL        A +ADFG+A+
Sbjct: 125 VAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 20/179 (11%)

Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           ++GRG  G VY     + G ++AVK++       + S   N L  EI+ L  +RH  IV+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 245 LKAFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                 + E   L    EYMP GS+ + L  K    L   +  +   +  +G+SYLH   
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLH--- 123

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS-----AVAGSYGYIAP 356
           S +I+HRD+K  NIL +S     + DFG +K +Q      CMS     +V G+  +++P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI----CMSGTGIKSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 15/166 (9%)

Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-R 238
           I E V+   V+G G  G VY+G      Q+A  K++ +T+    +  +  EI  L K   
Sbjct: 17  IFELVE---VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEE--IKLEINMLKKYSH 71

Query: 239 HRNIVRL------KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
           HRNI         K+   + +   LV E+   GS+ +++   +G+ LK +    I  E  
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           +GL++LH   +  +IHRD+K  N+LL  + E  + DFG++  L  T
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 46/127 (36%), Positives = 66/127 (51%), Gaps = 5/127 (3%)

Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           +VAVK +L  T  SS    L +E++ +  +  H NIV L   C+     L++ EY   G 
Sbjct: 67  KVAVK-MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125

Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L   L  KR SFL  E  L  + + AKG+++L    S   IHRD+ + N+LL       +
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182

Query: 327 ADFGLAK 333
            DFGLA+
Sbjct: 183 CDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 20/177 (11%)

Query: 187 NNVIGRGGAGVVYRGVT--PNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
             VIG+G  G V   V      +  A+K   K   + KGS     +  E R L ++ H  
Sbjct: 5   LRVIGKGAFGKV-CIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELNHPF 61

Query: 242 IVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           +V L  +F    E N+ LV + +  G L   L  ++  F + +++  I  E    L YLH
Sbjct: 62  LVNLWYSFQD--EENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EIVLALEYLH 117

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              S  IIHRD+K +NILL+     H+ DF +A  +         ++ +G+ GY+AP
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 57/181 (31%), Positives = 99/181 (54%), Gaps = 19/181 (10%)

Query: 189 VIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHD-------NGLSAEIRTLGKIRHR 240
           +IG G  G VY G+   +GE +AVK++   +  +S         + L+ EI  L +++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 241 NIVRLKAFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           NIV+     S    +L ++ EY+P GS+  +L+   G+F +  +R  +  +  KGL+YLH
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVR-QILKGLNYLH 123

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ----DTGASECMSAVAGSYGYIA 355
              +  IIHRD+K  NIL+++     ++DFG++K L+     T  +    ++ GS  ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 356 P 356
           P
Sbjct: 181 P 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 32/165 (19%)

Query: 190 IGRGGAGVVYRG-----VTPNGE-QVAVKKLLGITKGSSHDNGLSAEIR-------TLGK 236
           +G+G  G+VY G     V    E +VA+K +        ++N    E          + +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--------NENASMRERIEFLNEASVMKE 65

Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIA 288
               ++VRL    S  +  L+V E M  G L   L  +R              +  +++A
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            E A G++YL    +   +HRD+ + N ++  D    + DFG+ +
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 18/176 (10%)

Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
           ++G G  G+V +      G+ VA+KK L      S D+ +       EIR L ++RH N+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFL-----ESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           V L      K+   LV+E++ +  L ++     G  L      K   +  +G+ + H   
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH--- 117

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           S  IIHRD+K  NIL++      + DFG A+ L   G       VA  + Y AP L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRW-YRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 5/145 (3%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IG G  GVVY+      GE VA+KK+   T+     +    EI  L ++ H NIV+L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
              +    LV+E++ +  L + +     S +   +      +  +GL++ H   S  ++H
Sbjct: 68  IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123

Query: 309 RDVKSNNILLNSDFEAHVADFGLAK 333
           RD+K  N+L+N++    +ADFGLA+
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.0 bits (166), Expect = 5e-13
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 11/164 (6%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           + +G G  G VY GV       VAVK L    + +        E   + +I+H N+V+L 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
             C+ +    ++ E+M  G+L + L       +   + L +A + +  + YL        
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
           IHRD+ + N L+  +    VADFGL++ +      +  +A AG+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGA 165

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 5e-13
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 12/157 (7%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRL-K 246
           ++G G  G VY+G      Q+A  K++ +T     +  +  EI  L K   HRNI     
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 247 AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           AF       +     LV E+   GS+ +++   +G+ LK E    I  E  +GLS+LH  
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
               +IHRD+K  N+LL  + E  + DFG++  L  T
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.8 bits (166), Expect = 6e-13
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 10/155 (6%)

Query: 187 NNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
              IG G  G VY+GV  +P  E   VAVK     T  S  +  L  E   + +  H +I
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHI 69

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           V+L    +      +V E  P G L   L   + S L     +  + + +  L+YL    
Sbjct: 70  VKLIGVITENPV-WIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLE--- 124

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           S   +HRD+ + N+L++S     + DFGL++YL+D
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 31/168 (18%)

Query: 190 IGRGGAGVVYRG-----VTPNGEQ-VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RH 239
           +G G  G V +        PN    VAVK L    K  + +  LS   +E+  +  I +H
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRL 285
           +NI+ L   C+ +    +V EY  +G+L + L  +R                 L  +  +
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             A + A+G+ +L    S   IHRD+ + N+L+  D    +ADFGLA+
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 35/162 (21%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
            IG G  GVV   + T +G++VA+KK+       + D    A     E++ L   +H NI
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNI 66

Query: 243 VRLKAFCSNKETNL----LVYEYMPNGSLGEVLHGKR-------GSFLKWEMRLKIAIEA 291
           + ++        +     +V + M +  L  ++H  +         FL   +R       
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------- 118

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             GL Y+H   S  +IHRD+K +N+L+N D E  + DFG+A+
Sbjct: 119 --GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 29/183 (15%)

Query: 190 IGRGGAGVVY---RGVTPNGEQVAVKKLLGITK----GSSHDNGLSAEIRTLGKIRHRNI 242
           I +G  G V+   +  T  G+  A+K    I K      +  + +  E   L + +   +
Sbjct: 1   ISKGAYGRVFLAKKKST--GDIYAIKV---IKKADMIRKNQVDQVLTERDILSQAQSPYV 55

Query: 243 VRL-KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           V+L  +F   K  NL LV EY+P G L  +L    GS  +   R+ IA E    L YLH 
Sbjct: 56  VKLYYSFQGKK--NLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIA-EIVLALEYLH- 110

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY-------LQDTGASECMSAVAGSYGY 353
             S  IIHRD+K +NIL++S+    + DFGL+K          +    E    + G+  Y
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPDY 167

Query: 354 IAP 356
           IAP
Sbjct: 168 IAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 20/159 (12%)

Query: 190 IGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
           IG G  GVV+  R     G+ VA+KK +      S D+ +       EIR L +++H N+
Sbjct: 9   IGEGSYGVVFKCRNRE-TGQIVAIKKFV-----ESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
           V L      K    LV+EY  +  L E+    RG  +   +  KI  +  + +++ H H+
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340
           C    IHRDVK  NIL+    +  + DFG A+ L   G 
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 55/180 (30%), Positives = 94/180 (52%), Gaps = 13/180 (7%)

Query: 178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
           DD  E + +   +G G  GVV++        +  +KL+ +    +  N +  E++ L + 
Sbjct: 4   DDDFEKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 238 RHRNIVRL-KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
               IV    AF S+ E ++ + E+M  GSL +VL  K+   +  ++  K++I   KGL+
Sbjct: 61  NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 117

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           YL       I+HRDVK +NIL+NS  E  + DFG++  L D+ A    ++  G+  Y++P
Sbjct: 118 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 13/149 (8%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKI-RHRNIVRLK 246
           +G G  G VY       GE VA+KK+    K  S +  ++  E+++L K+  H NIV+LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM--KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 247 -AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK-IAIEAAKGLSYLHHDCSP 304
             F  N E    V+EYM  G+L +++  ++G     E  ++ I  +  +GL+++H     
Sbjct: 65  EVFRENDELYF-VFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKHG-- 119

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
              HRD+K  N+L++      +ADFGLA+
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 17/155 (10%)

Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKLLGITKGSSHDNGLSAEI----RTLGKIRHRNIVR 244
           +G GG G V    V       A+K    + K    + G    I      L +  H  IV+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKC---VKKRHIVETGQQEHIFSEKEILEECNHPFIVK 57

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA--IEAAKGLSYLHHDC 302
           L     +K+   ++ EY   G L  +L   RG F ++  R  IA  + A     YLH+  
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIACVVLA---FEYLHNRG 113

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
              II+RD+K  N+LL+S+    + DFG AK L+ 
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 9/145 (6%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           +IG G  G V +G    G++VAVK      K          E   + K+ H+N+VRL   
Sbjct: 13  IIGEGEFGAVLQG-EYTGQKVAVK----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
             +    + V E M  G+L   L  +  + +     L+ +++ A+G+ YL    S  ++H
Sbjct: 68  ILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123

Query: 309 RDVKSNNILLNSDFEAHVADFGLAK 333
           RD+ + NIL++ D  A V+DFGLA+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 5/149 (3%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           ++G+G  G V++G   +   VAVK              LS E R L +  H NIV+L   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
           C+ ++   +V E +P G     L  K+   LK +  +K A++AA G++YL    S   IH
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLE---SKNCIH 116

Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           RD+ + N L+  +    ++DFG+++   D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDD 145

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 10/168 (5%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAF 248
           +G G  GVV +        +  +KL+ +    +  N +  E++ L +     IV    AF
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
            S+ E ++ + E+M  GSL +VL  K    +  E+  K++I   +GL+YL       I+H
Sbjct: 73  YSDGEISICM-EHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMH 127

Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           RDVK +NIL+NS  E  + DFG++  L D+ A    ++  G+  Y++P
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 54/174 (31%), Positives = 76/174 (43%), Gaps = 22/174 (12%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGIT-----KGSSHDNGLSAEIRTLGKIRHRNIVR 244
           +G G  G V+       E     K++ I      K   H   +  E R L ++ H  I+R
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH---VHNEKRVLKEVSHPFIIR 65

Query: 245 LKAFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           L  F +  +   L  + EY+P G L   L    G F      L  A E    L YLH   
Sbjct: 66  L--FWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSN-STGLFYASEIVCALEYLH--- 118

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  I++RD+K  NILL+ +    + DFG AK L+D   + C     G+  Y+AP
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC-----GTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 15/173 (8%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH---RNIVR 244
           +IGRG  G VYRG   P G  VA+K ++ +       + +  E+  L ++R     NI +
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
                  K   L ++ EY   GS+  ++   +   +  +    I  E    L Y+H    
Sbjct: 67  YYG-SYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHKVG- 121

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             +IHRD+K+ NIL+ +     + DFG+A  L     S   S   G+  ++AP
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 24/168 (14%)

Query: 190 IGRGGAGVVY----RGVTPNGEQ--VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           +G G  G V+      + P  ++  VAVK L   ++ +  D    AE+ T+  ++H++IV
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV--LQHQHIV 70

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLK-----------WEMRLKIAIE 290
           R    C+     L+V+EYM +G L   L  HG     L                L IA +
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G+ YL    S   +HRD+ + N L+       + DFG+++ +  T
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 24/162 (14%)

Query: 188 NVIGRGGAGVVYRG--VTPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
            VIG+G  G VY G  +  +G+    AVK L  IT     +  L   I  +    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVL 59

Query: 244 RLKAFCSNKE-TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------LKIAIEAAKGL 295
            L   C   E + L+V  YM         HG   +F++ E         +   ++ AKG+
Sbjct: 60  SLLGICLPSEGSPLVVLPYM--------KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGM 111

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
            YL    S   +HRD+ + N +L+  F   VADFGLA+ + D
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 38/164 (23%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRN 241
           + IG G  G+V      P G +VA+KK+      S  ++         EI+ L + +H N
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKI------SPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 242 IV------RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS------FLKWEMRLKIAI 289
           I+      R  +F S  +   +V E M    L +++  +  S      FL   +R     
Sbjct: 65  IIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR----- 117

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
               GL Y+H   S  ++HRD+K +N+LLN++ +  + DFGLA+
Sbjct: 118 ----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 64.6 bits (158), Expect = 7e-12
 Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 9/176 (5%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
             IG+G  G V +     +G+ +  K++            L +E+  L +++H NIVR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 246 -KAFCSNKETNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHH-- 300
            +    + +T  +V EY   G L +++   +    +++ E   +I  +    L   H+  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           D    ++HRD+K  NI L+++    + DFGLAK L    +S   + V   Y Y++P
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGTPY-YMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 22/170 (12%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI- 237
           E +K  +VIG G  G V R +          A+K L      + H +  + E+  L K+ 
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLG 60

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEM 283
            H NI+ L   C N+    +  EY P G+L + L   R               S L  + 
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            L+ A + A G+ YL        IHRD+ + N+L+  +  + +ADFGL++
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 55/175 (31%), Positives = 88/175 (50%), Gaps = 12/175 (6%)

Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           ++G+G  G VY     + G ++AVK++       + S   N L  EI+ L  + H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 245 LKAFCSN-KETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                 +  E  L ++ E+MP GS+ + L  K    L   +  K   +  +G+SYLH   
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLH--- 123

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAP 356
           S +I+HRD+K  NIL +S     + DFG +K LQ    S   M +V G+  +++P
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 6/149 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           IG+G  G VY+G+    ++V   K++ + +       +  EI  L +     I R     
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
                  ++ EY+  GS  ++L  K G  L+      I  E  KGL YLH   S   IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLH---SERKIHR 125

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           D+K+ N+LL+   +  +ADFG+A  L DT
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDT 154

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 22/168 (13%)

Query: 184 VKDNNVIGRGGAGVVYRG-VTPNGEQV--AVKKLLGITKGSSHDNGLSAEIRTLGKI-RH 239
           +K  +VIG G  G V +  +  +G ++  A+K++        H +  + E+  L K+  H
Sbjct: 9   IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHH 67

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRL 285
            NI+ L   C ++    L  EY P+G+L + L   R               S L  +  L
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             A + A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 11/147 (7%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSA--EIRTLGKIRHRNIVRLK 246
           +G G    VY+G++  NG+ VA+K    I+  +      +A  E   L  ++H NIV L 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKV---ISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
                KET   V+EYM +  L + +    G    + +RL    +  +GL+Y+H      I
Sbjct: 70  DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---HI 124

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAK 333
           +HRD+K  N+L++   E  +ADFGLA+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 6/149 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           IG+G  G V++G+    +QV   K++ + +       +  EI  L +     + +     
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
                  ++ EY+  GS  ++L  + G F ++++   +  E  KGL YLH   S   IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLK-EILKGLDYLH---SEKKIHR 125

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           D+K+ N+LL+   +  +ADFG+A  L DT
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDT 154

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 56/161 (34%), Positives = 80/161 (49%), Gaps = 9/161 (5%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHD-NGLSAEI 231
           F  DD  +   D   IG G  G VY  R V  + E VA+KK+    K S+     +  E+
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEV 66

Query: 232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
           R L K+RH N ++ +     + T  LV EY   GS  ++L   +    + E+   +   A
Sbjct: 67  RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGA 124

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
            +GL+YLH   S  +IHRDVK+ NILL+      + DFG A
Sbjct: 125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 11/172 (6%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVRLKA 247
            IG G  G +Y     +  +  V K + +TK    +   S  E+  L K++H NIV    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF-- 64

Query: 248 FCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           F S +E   L  V EY   G L + ++ +RG     +  L   ++ + GL ++H      
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121

Query: 306 IIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           I+HRD+KS NI L+ +   A + DFG+A+ L D+   E      G+  Y++P
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 32/186 (17%)

Query: 189 VIGRGGAGVV---YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR- 244
            IG G  G+V   Y  VT  G+ VA+KKL    +  +H      E+  +  + H+NI+  
Sbjct: 23  PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80

Query: 245 LKAFCSNKETN-----LLVYEYMPNGSLGEVLH----GKRGSFLKWEMRLKIAIEAAKGL 295
           L  F   K         LV E M + +L +V+      +R S+L ++M          G+
Sbjct: 81  LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLYQMLC--------GI 131

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
            +LH   S  IIHRD+K +NI++ SD    + DFGLA+     G S  M+    +  Y A
Sbjct: 132 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 185

Query: 356 P--VLG 359
           P  +LG
Sbjct: 186 PEVILG 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 7/156 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E +K    +G G  G V+        +VAVK +     GS       AE   +  ++H  
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDK 62

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +V+L A  + KE   ++ E+M  GSL + L    GS       +  + + A+G++++   
Sbjct: 63  LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                IHRD+++ NIL+++     +ADFGLA+ ++D
Sbjct: 122 N---YIHRDLRAANILVSASLVCKIADFGLARVIED 154

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 50/167 (29%), Positives = 67/167 (40%), Gaps = 29/167 (17%)

Query: 188 NVIGRGGAGVVYRGVTPN------GEQ-VAVKKLLGITKGS--SHDNGLSAEIRTLGKIR 238
           N +G G  G VY G   +      G   VAVK L    KG+          E   +    
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAK 293
           H NIV+L   C   E   ++ E M  G L   L   R        L  +  L I ++ AK
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 294 GLSYLH--HDCSPLIIHRDVKSNNILL-----NSDFEAHVADFGLAK 333
           G  YL   H      IHRD+ + N L+     ++D    + DFGLA+
Sbjct: 118 GCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 20/179 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           ++G+G  G VY       G ++A K++       + S   + L  EI+ L  ++H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 245 LKAFCSNK-ETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                 ++ E  L ++ EYMP GS+ + L  K    L   +  K   +  +G+SYLH   
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLH--- 123

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS-----AVAGSYGYIAP 356
           S +I+HRD+K  NIL +S     + DFG +K LQ      CMS     +V G+  +++P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI----CMSGTGIRSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 56/164 (34%), Positives = 83/164 (50%), Gaps = 25/164 (15%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR-HRNI 242
           +G+G  G+V++ +     E VA+KK+       +  N   A     EI  L ++  H NI
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFD-----AFRNATDAQRTFREIMFLQELGDHPNI 69

Query: 243 VRL----KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           V+L    KA   N +   LV+EYM    L  V+   R + L+   +  I  +  K L Y+
Sbjct: 70  VKLLNVIKA--ENDKDIYLVFEYMET-DLHAVI---RANILEDVHKRYIMYQLLKALKYI 123

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           H   S  +IHRD+K +NILLNSD    +ADFGLA+ L +   + 
Sbjct: 124 H---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 15/150 (10%)

Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRT---LGKIRHRNIVRL 245
           +G G    VY+G     GE VA+K++       + +   S  IR    + +++H NIVRL
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI----HLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
                 +   +LV+EYM +  L + +  HG RG+ L          +  KG+++ H +  
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN-- 119

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             ++HRD+K  N+L+N   E  +ADFGLA+
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 28/156 (17%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNIVR 244
           IG G  G V++       E VA+K++    +    D G+  SA  EI  L +++H+NIVR
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVR 63

Query: 245 LKAFCSNKETNLLVYEYMP-------NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           L     + +   LV+EY         +   G++      SF+          +  KGL++
Sbjct: 64  LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM---------FQLLKGLAF 114

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            H   S  ++HRD+K  N+L+N + E  +ADFGLA+
Sbjct: 115 CH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 63/185 (34%), Positives = 89/185 (48%), Gaps = 15/185 (8%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHD-NGLSAEI 231
           F  +D  +   D   IG G  G VY  R V  N E VA+KK+    K S+     +  E+
Sbjct: 18  FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEV 76

Query: 232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
           + L +I+H N +  K     + T  LV EY   GS  ++L   +    + E+   I   A
Sbjct: 77  KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGA 134

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
            +GL+YLH   S  +IHRD+K+ NILL    +  +ADFG A       AS   S V   Y
Sbjct: 135 LQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPY 186

Query: 352 GYIAP 356
            ++AP
Sbjct: 187 -WMAP 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 56/177 (31%), Positives = 86/177 (48%), Gaps = 13/177 (7%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
           VIG+G  GVV   + T  GE+VA+KK+  + +  S    +  EI+ L  +RH +IV +K 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 248 FC---SNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                S +E     +V+E M    L +V+  K    L  E       +  + L Y+H   
Sbjct: 67  IMLPPSRREFKDIYVVFELM-ESDLHQVI--KANDDLTPEHHQFFLYQLLRALKYIH--- 120

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAK-YLQDTGASECMSAVAGSYGYIAPVL 358
           +  + HRD+K  NIL N+D +  + DFGLA+    DT  +   +    +  Y AP L
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 17/175 (9%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-L 245
           IG+G   VVY+ +   +G  VA+KK  +  +    +  + L  EI  L ++ H N+++ L
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYL 68

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCS 303
            +F  N E N+ V E    G L  ++ H K+   L  E  + K  ++    L ++H   S
Sbjct: 69  ASFIENNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---S 124

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA--VAGSYGYIAP 356
             I+HRD+K  N+ + +     + D GL ++     +S+  +A  + G+  Y++P
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 16/173 (9%)

Query: 190 IGRGGAGVVYRGVTPNGEQV-AVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK- 246
           +G+G  G VY+    +  Q  A+K++ LG       ++ ++ EIR L  + H NI+  K 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPNIISYKE 66

Query: 247 AFC-SNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           AF   NK    +V EY P G L + +    K+   +  +   +I I+  +GL  LH    
Sbjct: 67  AFLDGNKL--CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---E 121

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             I+HRD+KS NILL ++    + D G++K L+   A        G+  Y+AP
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----KTQIGTPHYMAP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 25/165 (15%)

Query: 190 IGRGGAGVVYRGVTPN---GEQVAVKKLLGITKGSSHDN-GLSA----EIRTLGKIRHRN 241
           IGRG  G VY+    N   G++ A+KK     KG      G+S     EI  L +++H N
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLRELKHEN 63

Query: 242 IVRL-KAFCSNKETNL-LVYEYMPNGSLGEVLH---GKRGSFLKWEMRLKIAIEAAKGLS 296
           +V L + F  + + ++ L+++Y  +  L +++      +   +   M   +  +   G+ 
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQD 337
           YLH   S  ++HRD+K  NIL+  +        + D GLA+    
Sbjct: 123 YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 58/184 (31%), Positives = 87/184 (47%), Gaps = 13/184 (7%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHD-NGLSAEIR 232
           F  DD  E     + IG G  G VY     +  E VAVKK+    K ++     +  E++
Sbjct: 14  FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
            L +++H N +  K     + T  LV EY   GS  ++L   +    + E+   I   A 
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGAL 131

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
           +GL+YLH      +IHRD+K+ NILL    +  +ADFG A     + +S   S V   Y 
Sbjct: 132 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPY- 182

Query: 353 YIAP 356
           ++AP
Sbjct: 183 WMAP 186

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 24/165 (14%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
           + +G G  G V     T  G +VA+KKL    + + H      E+R L  + H N++ L 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 246 KAFC--SNKETNLLVYEYMP--NGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLS 296
             F   S+ E    VY         L  ++  ++ S     FL +++         +GL 
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI--------LRGLK 132

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD--TG 339
           Y+H   S  IIHRD+K +NI +N D E  + DFGLA++  D  TG
Sbjct: 133 YIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 8/160 (5%)

Query: 179 DILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           DI E + +   +G G  G VY+         A  K++   +          EI  L + +
Sbjct: 5   DIWEIIGE---LGDGAFGKVYKAQHKETGLFAAAKII-QIESEEELEDFMVEIDILSECK 60

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           H NIV L      +    ++ E+   G+L  ++        + ++R  +  +  + L++L
Sbjct: 61  HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFL 119

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           H   S  +IHRD+K+ NILL  D +  +ADFG++   + T
Sbjct: 120 H---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 6/149 (4%)

Query: 190 IGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IGRG  G V+ G +  +   VAVK              L  E R L +  H NIVRL   
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLIGV 61

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
           C+ K+   +V E +  G     L  + G  LK +  +++   AA G+ YL        IH
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHC---IH 117

Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           RD+ + N L+       ++DFG+++  +D
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEED 146

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 44/172 (25%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNIV 243
           IGRG  G+V     +   E+VA+KK+      ++ DN + A     EI+ L  + H N++
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI-----ANAFDNRIDAKRTLREIKLLRHLDHENVI 67

Query: 244 RLK---------AFCSNKETNLLVYEYMPNGSLGEVLHGKRG-------SFLKWEMRLKI 287
            +K         AF        +VYE M +  L +++   +         FL   +R   
Sbjct: 68  AIKDIMPPPHREAF----NDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR--- 119

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
                 GL Y+H   S  ++HRD+K +N+LLN++ +  + DFGLA+   + G
Sbjct: 120 ------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLS-------AEIRTLGKIRHRN 241
           IG G  G VY+   P+ G  VA+K +    +  ++++GL        A ++ L    H N
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 242 IVRLKAFCSNKETN-----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           IVRL   C+   T+      LV+E++ +  L   L       L  E    +  +  +GL 
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           +LH +C   I+HRD+K  NIL+ S  +  +ADFGLA+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 23/137 (16%)

Query: 208 QVAVKKLLGITKGSSHDNGLSA---EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            VAVK L    +  + DN       E++ L ++   NI RL   C+      ++ EYM N
Sbjct: 48  LVAVKVL----RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103

Query: 265 GSLGEVL-----------HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
           G L + L              +   L +   L +A + A G+ YL    S   +HRD+ +
Sbjct: 104 GDLNQFLQKHVAETSGLACNSK--SLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT 158

Query: 314 NNILLNSDFEAHVADFG 330
            N L+  ++   +ADFG
Sbjct: 159 RNCLVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 17/149 (11%)

Query: 8   GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKS 67
           G IP +I     L  ++LS N + G IP  +  I  L  L++S+N  N S+P+ +G + S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 68  LTSADFSHNNFSGEIPEF--GQYSFFNSTSFTGNPHLCG-SYLNPCNYSSTTPIHNQNGN 124
           L   + + N+ SG +P    G+     S +FT N  LCG   L  C              
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG------------- 538

Query: 125 KSHVPGKYKLLFALGLLLCSLVFAVLAII 153
             H+    K+  A G+ +  L   + A+ 
Sbjct: 539 -PHLSVGAKIGIAFGVSVAFLFLVICAMC 566

Length = 623

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 57/182 (31%), Positives = 88/182 (48%), Gaps = 29/182 (15%)

Query: 190 IGRGGAGVVYRGV--TPNGEQ--VAVKKLLGITKGSSHDNG---LSAEIRTLGKIRHRNI 242
           +G G  G V +GV    +G++  VAVK L    K      G      E   + ++ H  I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL----KQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG---SFLKWEMRLKIAIEAAKGLSYLH 299
           VRL   C   E  +LV E  P G L + L  +R    S LK E+  ++A+    G++YL 
Sbjct: 59  VRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLK-ELAHQVAM----GMAYLE 112

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLG 359
              S   +HRD+ + N+LL +  +A ++DFG+++ L   G+    +  AG +    P L 
Sbjct: 113 ---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG-AGSDYYRATTAGRW----P-LK 163

Query: 360 WY 361
           WY
Sbjct: 164 WY 165

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 24/183 (13%)

Query: 190 IGRGGAGVVYRGVTPNGEQ--VAVKKL------LGITKGSSHDN--GLSAEIRTLGK-IR 238
           +G G  G VY+    N  Q  +A+K++       G  K     +   + +E+  + + +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 239 HRNIVRL-KAFCSNKETNLLVYEYMPNGSLGE---VLHGKRGSFLKWEMRL-KIAIEAAK 293
           H NIVR  K F  N     +V + +    LGE    L  K+  F   E R+  I ++   
Sbjct: 68  HPNIVRYYKTFLENDRL-YIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNIFVQMVL 124

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
            L YLH +    I+HRD+  NNI+L  D +  + DFGLAK          +++V G+  Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILY 179

Query: 354 IAP 356
             P
Sbjct: 180 SCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 45/143 (31%), Positives = 73/143 (51%), Gaps = 11/143 (7%)

Query: 190 IGRGGAGVVYRG-VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
           IG G  G+V        G QVAVKK+  + K    +  L  E+  +   +H NIV +  +
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHPNIVEMYSS 84

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           +    E   +V E++  G+L +++   R   +  E    + +   K LS+LH   +  +I
Sbjct: 85  YLVGDEL-WVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLH---AQGVI 137

Query: 308 HRDVKSNNILLNSDFEAHVADFG 330
           HRD+KS++ILL SD    ++DFG
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 14/153 (9%)

Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
           +G G  G VY+      G  VA+KK+L    K       L  EI+ L K++H N+V L  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74

Query: 248 FC-----SNKETNLLVYEYMP--NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
                   +K     VY   P  +  L  +L        + +++    ++  +G++YLH 
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC-YMLQLLEGINYLH- 132

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
                I+HRD+K+ NIL+++     +ADFGLA+
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 16/176 (9%)

Query: 189 VIGRG--GAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVR- 244
           V+G+G  G   +YR  T +   V  K++  +T+ S  +   +  EI  L  ++H NI+  
Sbjct: 7   VLGKGAFGEATLYRR-TEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
              F  +  T L+  EY   G+L + +  ++G   + EM L    +    +SY+H     
Sbjct: 65  YNHFMDDN-TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KA 120

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD--TGASECMSAVAGSYGYIAPVL 358
            I+HRD+K+ NI L       + DFG++K L    + A   +    G+  Y++P L
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV----GTPYYMSPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 21/161 (13%)

Query: 189 VIGRGGAGVVYRGV--TPNGEQ--VAVK--KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
           ++G G  G V  G     +G Q  VAVK  KL   T   S      +E   +    H N+
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNV 63

Query: 243 VRLKAFCSNKETN------LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAA 292
           ++L   C    +       +++  +M +G L   L   R       L  +  LK  ++ A
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            G+ YL    +   IHRD+ + N +L  D    VADFGL+K
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 39/187 (20%)

Query: 181 LECVKDNNVIGRGGAGVVYR----GVTPNGEQ--VAVKKLLGITKGSSHD--NGLSAEIR 232
           +E V+D   IG+G  G V++    G+ P      VAVK L    + +S D       E  
Sbjct: 7   IEYVRD---IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAA 60

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH-------------------- 272
            + +  H NIV+L   C+  +   L++EYM  G L E L                     
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           G     L    +L IA + A G++YL        +HRD+ + N L+  +    +ADFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 333 K--YLQD 337
           +  Y  D
Sbjct: 178 RNIYSAD 184

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 37/161 (22%)

Query: 190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           IG G  GVVY+      GE VA+KK+    +  + D G+ +    EI  L ++ H NIVR
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 245 LKAFCSNKETNL-LVYEYM-----------PNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
           L     + E  L LV+E++           P   L   L      +L +++         
Sbjct: 63  LLDVV-HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS---YL-YQL--------L 109

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           +G++Y H   S  ++HRD+K  N+L++ +    +ADFGLA+
Sbjct: 110 QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 8/150 (5%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           IG+G  G V++G+    ++V   K++ + +       +  EI  L +     + +     
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 70

Query: 250 SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
             K+T L ++ EY+  GS  ++L  + G   + ++   I  E  KGL YLH   S   IH
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIA-TILREILKGLDYLH---SEKKIH 124

Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           RD+K+ N+LL+   E  +ADFG+A  L DT
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDT 154

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 52/155 (33%), Positives = 75/155 (48%), Gaps = 23/155 (14%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
           IG G  G+V     T  G  VAVKKL    +  +H      E+  L  + H+NI+ L   
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 248 FCSNKETN-----LLVYEYMPNGSLGEVLH----GKRGSFLKWEMRLKIAIEAAKGLSYL 298
           F   K         LV E M + +L +V+H     +R S+L ++M          G+ +L
Sbjct: 89  FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC--------GIKHL 139

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           H   S  IIHRD+K +NI++ SD    + DFGLA+
Sbjct: 140 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 40/138 (28%), Positives = 71/138 (51%), Gaps = 16/138 (11%)

Query: 209 VAVKKLLG-ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VAVK L   +TK + +D     EI+ + ++++ NI+RL   C + +   ++ EYM NG L
Sbjct: 47  VAVKMLRADVTKTARND--FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 268 GEVLHGK--RGSFLK--------WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            + L  +    +F              L +A++ A G+ YL    S   +HRD+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161

Query: 318 LNSDFEAHVADFGLAKYL 335
           + + +   +ADFG+++ L
Sbjct: 162 VGNHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)

Query: 179 DILECVKDNNVIGRGGAGVV---YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
           +I     D   +G G  G+V      +T  G+ VA+KK++              E++ L 
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLT--GQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64

Query: 236 KIRHRNIVRLK-AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
            +RH NI+ L   F S  E    V E +    L  +L  +    L+ +       +  +G
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP---LEKQFIQYFLYQILRG 120

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
           L Y+H   S  ++HRD+K +NIL+N + +  + DFGLA+ +QD      M+    +  Y 
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQ----MTGYVSTRYYR 172

Query: 355 AP--VLGW 360
           AP  +L W
Sbjct: 173 APEIMLTW 180

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 39/136 (28%), Positives = 71/136 (52%), Gaps = 13/136 (9%)

Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L      ++ ++ L  EI+ + +++  NI+RL A C   +   ++ EYM NG L 
Sbjct: 49  VAVKMLREDANKNARNDFLK-EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 269 EVL--HGKRGSFLKWEMR-------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           + L  H  + +  K ++        + +A + A G+ YL    S   +HRD+ + N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 320 SDFEAHVADFGLAKYL 335
            ++   +ADFG+++ L
Sbjct: 165 KNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 10/170 (5%)

Query: 190 IGRG--GAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLS-AEIRTLGKIRHRNIVRLK 246
           IG G  G  ++ +    +G+Q  +K++  I+K S  +   S  E+  L  ++H NIV+ +
Sbjct: 8   IGEGSFGKAILVKSKE-DGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
                     +V +Y   G L + ++ +RG     +  L   ++    L ++H      I
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKI 122

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRD+KS NI L  D    + DFG+A+ L  T   E      G+  Y++P
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VELARTCIGTPYYLSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 53/158 (33%), Positives = 73/158 (46%), Gaps = 15/158 (9%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKA 247
           IG+G  G VY+     +G   AVK L  I   S  D  + AE   L  +  H N+V+   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 248 FCSNKETNL-----LVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHH 300
                +  +     LV E    GS+ E++ G    G  L   M   I   A  GL +LH+
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           +    IIHRDVK NNILL ++    + DFG++  L  T
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 19/159 (11%)

Query: 189 VIGRGGAGVVYRGVTP-----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
            +GRG  G V+           GE + + K L  TK  +  +    E+    K+ H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWE-------MRLKIAIEAAKGLS 296
           RL   C   E + ++ EY   G L + L   +    K +        ++ +  + A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 297 YL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           +L          +HRD+ + N L++S  E  V+   L+K
Sbjct: 132 HLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 22/164 (13%)

Query: 188 NVIGRGGAGVVYRG-VTPNGEQV--AVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIV 243
           +VIG G  G V +  +  +G ++  A+K++        H +  + E+  L K+  H NI+
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 59

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAI 289
            L   C ++    L  EY P+G+L + L   R               S L  +  L  A 
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           + A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 24/168 (14%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
           K   V+G G  G VY+G+  P GE+    VA+K+L   T   ++   L  E   +  + +
Sbjct: 10  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDN 68

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKR-GS--FLKWEMRLKIAIEAAKG 294
            ++ RL   C    T  L+ + MP G L + +  H    GS   L W       ++ AKG
Sbjct: 69  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           ++YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADE 163

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 22/157 (14%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLL--GITKGSSHDNGLSA--EIRTLGKIRHRNIVR 244
           IG+G  G V++       + VA+KK+L     +G      ++A  EI+ L  ++H N+V 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP----ITALREIKILQLLKHENVVN 75

Query: 245 LKAFCSNKETN--------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           L   C  K T          LV+E+  +  L  +L  K   F   E++ K+      GL 
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIK-KVMKMLLNGLY 133

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           Y+H      I+HRD+K+ NIL+  D    +ADFGLA+
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 25/166 (15%)

Query: 182 ECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDNGLS-------AEIR 232
           ECV +   IG G  G V+  R +   G  VA+K++    +  + + G+        A +R
Sbjct: 4   ECVAE---IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLR 56

Query: 233 TLGKIRHRNIVRLKAFCS----NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
            L    H N+VRL   C+    ++ET L LV+E++ +  L   L       +  E    +
Sbjct: 57  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 115

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             +  +GL +LH   S  ++HRD+K  NIL+ S  +  +ADFGLA+
Sbjct: 116 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 5/168 (2%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           V+G G  G        N +Q    K + + K SS       E   L K++H NIV  K  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
                   +V EY   G L + +  +RG     +  L+  ++   G+ ++H      ++H
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLH 123

Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           RD+KS NI L  + +  + DFG A+ L   GA  C     G+  Y+ P
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC--TYVGTPYYVPP 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 53/158 (33%), Positives = 78/158 (49%), Gaps = 15/158 (9%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRL-- 245
           IG+G  G V++ +   NG + AVK L  I      D  + AE   L  +  H N+V+   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 246 ---KAFCSNKETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHH 300
              K    N +   LV E    GS+ +++ G  KRG  ++  +   I  EA  GL +LH 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           + +   IHRDVK NNILL ++    + DFG++  L  T
Sbjct: 143 NKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 10/160 (6%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
           FG  D  E ++    +G G    VY+G +  NG+ VA+K ++ + +          E   
Sbjct: 1   FGKADSYEKLEK---LGEGSYATVYKGKSKVNGKLVALK-VIRLQEEEGTPFTAIREASL 56

Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
           L  ++H NIV L      KET  LV+EY+ +  L + +    G      ++L +  +  +
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLR 114

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           GLSY+H      I+HRD+K  N+L++   E  +ADFGLA+
Sbjct: 115 GLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 27/188 (14%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           +D   +G G  G V   +    G +VA+KKL    +          E+R L  ++H N++
Sbjct: 18  RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVI 77

Query: 244 RL-KAFCSNKETNL-------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKG 294
            L   F    + +L       LV  +M    LG+++  ++ S    E R++  + +  KG
Sbjct: 78  GLLDVFTP--DLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLS----EDRIQFLVYQMLKG 130

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
           L Y+H   +  IIHRD+K  N+ +N D E  + DFGLA+       SE M+    +  Y 
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SE-MTGYVVTRWYR 182

Query: 355 AP--VLGW 360
           AP  +L W
Sbjct: 183 APEVILNW 190

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 6/101 (5%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           N   G IP  + +   L +L L+ N L G IP ++ Q+  L ++ + +N L+  +P E+G
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233

Query: 64  NMKSLTSADFSHNNFSGEIP-EFG-----QYSFFNSTSFTG 98
            + SL   D  +NN +G IP   G     QY F      +G
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSG 274

Length = 968

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)

Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
           +K   V+G G  G VY+G+  P+GE     VA+K L   T   ++   L  E   +  + 
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVG 67

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
              + RL   C    T  LV + MP G L + +   +      ++ L   ++ AKG+SYL
Sbjct: 68  SPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSYL 125

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
                  ++HRD+ + N+L+ S     + DFGLA+ L
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 44/150 (29%), Positives = 80/150 (53%), Gaps = 14/150 (9%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           IG G  GVVY+G     G+ VA+KK+    +  S + G+ +    EI  L +++H NIV 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           L+     +    L++E++ +  L + L    +G ++  E+      +  +G+ + H   S
Sbjct: 64  LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---S 119

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             ++HRD+K  N+L+++     +ADFGLA+
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 30/158 (18%)

Query: 190 IGRGGAGVVYRG---VTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
           IG G  GVVY+    VT   E +A+KK+    +    D G+ +    EI  L +++H NI
Sbjct: 10  IGEGTYGVVYKARDRVT--NETIALKKI----RLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAI-EAAKGLS 296
           VRL+    +++   LV+EY+        L  K+       F K    +K  + +  +G++
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEA-HVADFGLAK 333
           Y H   S  ++HRD+K  N+L++    A  +ADFGLA+
Sbjct: 117 YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 29/173 (16%)

Query: 166 KLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHD 224
           KL  ++KLD               +G G    VY+G +   G+ VA+K++        H+
Sbjct: 3   KLETYKKLD--------------KLGEGSYATVYKGRSKLTGQLVALKEI-----RLEHE 43

Query: 225 NGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLK 280
            G       E   L  ++H NIV L      K+T  LV+EY+ +  L + +    G  L 
Sbjct: 44  EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMD-DCGGGLS 101

Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
                    +  +GL+Y H      ++HRD+K  N+L++   E  +ADFGLA+
Sbjct: 102 MHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 14/186 (7%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
           F ++D+    KD   IGRG  G V + +  P+G  +AVK++            L  ++  
Sbjct: 1   FTAEDL----KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR-LLMDLDV 55

Query: 234 LGKIRH-RNIVRLKAFCSNKETNLLVYEYMPNG--SLGEVLHGKRGSFLKWEMRLKIAIE 290
           + +      IV+       +    +  E M        + ++    S +  E+  KIA+ 
Sbjct: 56  VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115

Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
             K L+YL  +    IIHRDVK +NILL+ +    + DFG++  L D+ A    +  AG 
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGC 170

Query: 351 YGYIAP 356
             Y+AP
Sbjct: 171 RPYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 9/143 (6%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IG G  G+V      + G+QVAVKK+    +       L  E+  +    H N+V +   
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
               +   +V E++  G+L +++   R   +  E    + +   + LSYLH+     +IH
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 309 RDVKSNNILLNSDFEAHVADFGL 331
           RD+KS++ILL SD    ++DFG 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 55/178 (30%), Positives = 78/178 (43%), Gaps = 23/178 (12%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLGITKGSSHDN----GLSAEIR---TLGKIRHR 240
           V+GRG  G V+       GE  A+K L    KG          L  E R   T    RH 
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKAL---KKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLH 299
            +V L A    ++    V EY   G L  ++H     F   E R    A     GL YLH
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFS--EPRAVFYAACVVLGLQYLH 118

Query: 300 -HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +     I++RD+K +N+LL+++    +ADFGL K  +  G  +  S   G+  ++AP
Sbjct: 119 ENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAP 170

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 32/81 (39%), Positives = 47/81 (58%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           NN +G IP  +G+   L YL L QN LSGPIP  I  +  L  L++S N L+  +P+ + 
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305

Query: 64  NMKSLTSADFSHNNFSGEIPE 84
            +++L       NNF+G+IP 
Sbjct: 306 QLQNLEILHLFSNNFTGKIPV 326

Length = 968

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 25/175 (14%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
           IG+G +G VY  +    G++VA+K++    +       +  EI  + + +H NIV  L +
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA------KGLSYLHHD 301
           +    E   +V EY+  GSL +V+          E  +     AA      + L +LH  
Sbjct: 85  YLVGDEL-WVVMEYLAGGSLTDVVT---------ETCMDEGQIAAVCRECLQALEFLH-- 132

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            S  +IHRD+KS+NILL  D    + DFG     Q T      S + G+  ++AP
Sbjct: 133 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 29/167 (17%)

Query: 189 VIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRT----LGKIRHRNI 242
           VIGRG  G V R V     G   A+KKL    K    +    A +R     L +  +  +
Sbjct: 8   VIGRGAFGEV-RLVQKKDTGHIYAMKKLR---KSEMLEKEQVAHVRAERDILAEADNPWV 63

Query: 243 VRLKAFCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-----AIEAAKGL 295
           V+L  + S   E  L L+ EY+P G +  +L  K+ +F + E R  I     AI++   L
Sbjct: 64  VKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
            Y         IHRD+K +N+LL++     ++DFGL   L+ +  +E
Sbjct: 121 GY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 28/183 (15%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
           +G G  G V   +    GE+VA+KKL    +          E+  L  ++H N++ L   
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 248 FCSNKETN-----LLVYEYMP---NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           F S    +      LV  YM       +G  L   +  +L ++M          GL Y+H
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYIH 134

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--V 357
              S  IIHRD+K  N+ +N D E  + DFGLA++     A   M+    +  Y AP  +
Sbjct: 135 ---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVI 186

Query: 358 LGW 360
           L W
Sbjct: 187 LNW 189

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 18/158 (11%)

Query: 190 IGRGGAGVVYRGVTPNGE---QVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           +G G  G V  G     +   +VAVK + + I   S  ++ LS E   + +  H N++RL
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDHPNVMRL 65

Query: 246 KAFCSNKETN------LLVYEYMPNGSLGE-VLHGKRGS---FLKWEMRLKIAIEAAKGL 295
              C     +      +++  +M +G L   +L+ + G    +L  +M +K   + A G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            YL    S   IHRD+ + N +LN +    VADFGL+K
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 29/186 (15%)

Query: 178 DDILECVKDNNVIGR----GGAGVVYR----GVTPNGEQVAVKKLLGITKGSSHDNGLS- 228
           D   E  +D  V+G+    G  G V R    G+  +     V   + + K ++ D  L+ 
Sbjct: 4   DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD 63

Query: 229 --AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG-----SF-- 278
             +E+  +  I +H+NI+ L   C+ +    ++ EY   G+L E L  +R      +F  
Sbjct: 64  LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 279 -------LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
                  L ++  +  A + A+G+ YL    S   IHRD+ + N+L+  D    +ADFGL
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGL 180

Query: 332 AKYLQD 337
           A+ + D
Sbjct: 181 ARGVHD 186

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 25/164 (15%)

Query: 190 IGRGGAGVVYRG----VTPNGEQ--VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           +G G  G V+      ++P  ++  VAVK L   T  +  D    AE+ T   ++H +IV
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT--NLQHEHIV 70

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFL--------KWEM----RLKIAI 289
           +    C + +  ++V+EYM +G L + L  HG     L        K E+     L IA 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           + A G+ YL    S   +HRD+ + N L+ ++    + DFG+++
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 31/83 (37%), Positives = 48/83 (57%), Gaps = 5/83 (6%)

Query: 274 KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            +G  +  ++  KIA+   K L YLH   S  +IHRDVK +N+L+N + +  + DFG++ 
Sbjct: 95  DKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISG 152

Query: 334 YLQDTGASECMSAVAGSYGYIAP 356
           YL D+ A    +  AG   Y+AP
Sbjct: 153 YLVDSVAK---TIDAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 26/190 (13%)

Query: 174 DFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
           D  ++D LE + D   +G G  G V +        V  KK++ I   SS    +  E++ 
Sbjct: 1   DLRNED-LETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQI 56

Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
           + + R   IV       N+    +  E+M  GSL  +   K+G  +  E+  KIA+   +
Sbjct: 57  MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVE 114

Query: 294 GLSYL---HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA-- 348
           GL+YL   H      I+HRD+K +NIL+NS  +  + DFG+        + E ++++A  
Sbjct: 115 GLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGV--------SGELINSIADT 161

Query: 349 --GSYGYIAP 356
             G+  Y++P
Sbjct: 162 FVGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 12/156 (7%)

Query: 190 IGRGGAGVVYRGVTPNG---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           IG G  G V  G    G    +V VK+L            L  E++   ++ H N+++  
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ-EVQPYRELNHPNVLQCL 61

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL---KWEMRLKIAIEAAKGLSYLHHDCS 303
             C      LLV E+ P G L   L   RG      + ++  ++A E A GL +LH    
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLA--KYLQD 337
              IH D+   N  L +D    + D+GLA  +Y +D
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 23/162 (14%)

Query: 187 NNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-------------EIR 232
              +G G  G V +   T  G+ VA+KK+  I + S+                    E++
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 233 TLGKIRHRNIVRLKA-FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
            + +I+H NI+ L   +      NL V + M    L +V+  K    L       I ++ 
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINL-VMDIM-ASDLKKVVDRK--IRLTESQVKCILLQI 128

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             GL+ LH       +HRD+   NI +NS     +ADFGLA+
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 46/130 (35%), Positives = 63/130 (48%), Gaps = 14/130 (10%)

Query: 229 AEIRTLGKIRHRNIVRL-KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
            E R L  IRH  +V L  +F  +   NL LV EY+P G L      K G F +   R  
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDDS--NLYLVMEYVPGGELFS-HLRKSGRFPEPVARFY 106

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A +    L YLH      I++RD+K  N+LL+SD    + DFG AK ++    + C   
Sbjct: 107 AA-QVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--- 159

Query: 347 VAGSYGYIAP 356
             G+  Y+AP
Sbjct: 160 --GTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 21/144 (14%)

Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK +L      +  N    E++ L +++  NI+RL   C +++   ++ EYM NG L 
Sbjct: 49  VAVK-ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 269 EVLHGKR-----------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV 311
           + L                        + +   L +A++ A G+ YL    S   +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 312 KSNNILLNSDFEAHVADFGLAKYL 335
            + N L+  +    +ADFG+++ L
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 25/165 (15%)

Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETN--LLVYEY 261
            G+  A+K +    K     N L  EI+ L ++  H NI+RL     +++T    LV+E 
Sbjct: 23  TGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81

Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLK-IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           M + +L E++ G++      E R+K    +  K L ++H +    I HRD+K  NIL+  
Sbjct: 82  M-DMNLYELIKGRKRPLP--EKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD 135

Query: 321 DFEAHVADFGLAKYLQDTG------------ASECMSAVAGSYGY 353
           D    +ADFG  + +                A EC+    G YG 
Sbjct: 136 D-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL-LTDGYYGP 178

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 32/84 (38%), Positives = 46/84 (54%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N+ SG IP  +     L  L L  N+ +G IPV +T +  L  L +  N+ +  +PK
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
            +G   +LT  D S NN +GEIPE
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPE 374

Length = 968

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 54/151 (35%), Positives = 74/151 (49%), Gaps = 17/151 (11%)

Query: 190 IGRGGAGVVYRGVTPNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           I RG  G VY G   N  ++     VKK   I K   H   + AE   L   +   IV L
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ--VQAERDALALSKSPFIVHL 69

Query: 246 KAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDC 302
             + S +  N   LV EY+  G +  +LH   G F + EM +K   E A  L YLH H  
Sbjct: 70  --YYSLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDE-EMAVKYISEVALALDYLHRHG- 124

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
              IIHRD+K +N+L++++    + DFGL+K
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 44/144 (30%), Positives = 75/144 (52%), Gaps = 11/144 (7%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KA 247
           IG G  G+V       +G QVAVK ++ + K    +  L  E+  +   +H+N+V + K+
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRREL-LFNEVVIMRDYQHQNVVEMYKS 86

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           +   +E  +L+ E++  G+L +++   R   L  E    +     + L YLH   S  +I
Sbjct: 87  YLVGEELWVLM-EFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVI 139

Query: 308 HRDVKSNNILLNSDFEAHVADFGL 331
           HRD+KS++ILL  D    ++DFG 
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGF 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 39/101 (38%), Positives = 53/101 (52%), Gaps = 4/101 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
           +S  N SG I   I     +  ++LS N LSGPIP  I T    L YLN+S N    S+P
Sbjct: 76  LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135

Query: 60  KEMGNMKSLTSADFSHNNFSGEIP-EFGQYSFFNSTSFTGN 99
           +  G++ +L + D S+N  SGEIP + G +S        GN
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174

Length = 968

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 29/184 (15%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKA 247
           +G G  G V     T  G +VAVKKL    +   H      E+R L  ++H N++  L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 248 FC---SNKETN-LLVYEYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYL 298
           F    S +E N + +  ++    L  ++  ++ +     FL +++         +GL Y+
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYI 136

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-- 356
           H   S  IIHRD+K +N+ +N D E  + DFGLA++  D      M+    +  Y AP  
Sbjct: 137 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 188

Query: 357 VLGW 360
           +L W
Sbjct: 189 MLNW 192

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 27/177 (15%)

Query: 184 VKDNNVI-----GRGGAGVVYRG----VTPNGEQ--VAVKKLLGITKGSSHDNGLSAEIR 232
           +K +N++     G G  G V+      + P  ++  VAVK L   +  +  D    AE+ 
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSF---------LKW 281
           T   ++H +IV+    C   +  ++V+EYM +G L + L  HG              L  
Sbjct: 62  T--NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119

Query: 282 EMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
              L IA + A G+ YL    S   +HRD+ + N L+  +    + DFG+++ +  T
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 24/82 (29%), Positives = 41/82 (50%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           N+  G IP  +G C  L  + L  N  SG +P + T++ ++ +L++S N L   +     
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449

Query: 64  NMKSLTSADFSHNNFSGEIPEF 85
           +M SL     + N F G +P+ 
Sbjct: 450 DMPSLQMLSLARNKFFGGLPDS 471

Length = 968

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 51/172 (29%), Positives = 73/172 (42%), Gaps = 33/172 (19%)

Query: 189 VIGRGGAGVVYRGVTPNGEQV-AVKKLLGITKGSSHDNGLSAEIRT----LGKIRHRNIV 243
           VIGRG  G V+     +  QV A+K L    K         A +R     L       IV
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLR---KSDMIKRNQIAHVRAERDILADADSPWIV 64

Query: 244 RLKAFCSNKETNLL--VYEYMPNGSL------GEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
           +L  + S ++   L  V EYMP G L       +V   +   F   E+ L  A+++   L
Sbjct: 65  KL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL--ALDSVHKL 120

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMS 345
            +         IHRD+K +NIL+++D   H+  ADFGL K +      E   
Sbjct: 121 GF---------IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYL 161

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 8/167 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           +G G  G VY+    +  ++A  K++ +  G    + +  EI  + + +H NIV      
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
            ++E   +  EY   GSL ++ H   G   + ++   +  E  +GL+YLH   S   +HR
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAY-VCRETLQGLAYLH---SKGKMHR 130

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           D+K  NILL  + +  +ADFG+A  +  T A     +  G+  ++AP
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 25/143 (17%)

Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + D  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 47  VAVKML----KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102

Query: 265 GSLGEVLHGKRG-----SF---------LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R      SF         L ++  +  A + A+G+ YL    S   IHRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159

Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  D    +ADFGLA+
Sbjct: 160 LAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 13/169 (7%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
           IG+G +G VY  +    G++VA+K++    +       +  EI  + + ++ NIV  L +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           +    E   +V EY+  GSL +V+     + +       +  E  + L +LH   S  +I
Sbjct: 85  YLVGDEL-WVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLH---SNQVI 137

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+KS+NILL  D    + DFG     Q T      S + G+  ++AP
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 25/144 (17%)

Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 52  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107

Query: 264 NGSLGEVLHGKRGSFLKW----------EMRLK----IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   +++          ++  K     A + A+G+ YL    S   IHR
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHR 164

Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 7/150 (4%)

Query: 184 VKDNNVIGRGGAGVVYRGVT--PNGEQVAVK-KLLGITKGSSHDNGLSAEIRTLGKIRHR 240
           +K   ++G G  G + RG    P+  ++ V    L          G  AE  TLG+  H 
Sbjct: 7   IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHS 66

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           NIVRL+   +   T ++V EYM NG+L   L    G  +  ++ + +    A G+ YL  
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-MGMLPGLASGMKYL-- 123

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFG 330
                 +H+ + ++ +L+NSD    ++ F 
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 12/161 (7%)

Query: 174 DFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRT 233
           D   +++ E + +   +G G  G VY+        +A  K++  TK          EI  
Sbjct: 7   DLDPNEVWEIIGE---LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEI 62

Query: 234 LGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSLGEV-LHGKRGSFLKWEMRLKIAIEA 291
           L    H  IV+L  AF  + +  +++ E+ P G++  + L   RG  L       I  + 
Sbjct: 63  LATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRG--LTEPQIQVICRQM 119

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
            + L YLH   S  IIHRD+K+ N+LL  D +  +ADFG++
Sbjct: 120 LEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 8/167 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           IG G  G VY+    N  ++A  K++ +  G      +  EI  +   +H NIV      
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
             ++   +  E+   GSL ++ H   G   + ++   ++ E  +GL YLH       +HR
Sbjct: 76  LRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAY-VSRETLQGLYYLHSKGK---MHR 130

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           D+K  NILL  +    +ADFG++  +  T A     +  G+  ++AP
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 52/171 (30%), Positives = 74/171 (43%), Gaps = 10/171 (5%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           VIG+G  G V         +    K+L    I K     + ++     L  ++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                  +    V +Y+  G L   L  +R SF +   R   A E A  L YLH   S  
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           II+RD+K  NILL+S     + DFGL K  +    S+  S   G+  Y+AP
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)

Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           V+G+G  G V    +R    +G+Q  +KKL               E + L +++H NIV 
Sbjct: 7   VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
            +     ++  L +V  +   G L   L  ++G  L     ++  ++ A  L YLH    
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-- 121

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
             I+HRD+K+ N+ L       V D G+A+ L++    +  S + G+  Y++P L
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLIGTPYYMSPEL 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 20/175 (11%)

Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           +G+GG G V    V   G+  A KKL    L   KG   +     E + L K+  R IV 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVS 57

Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           L A+    + +L LV   M  G L   +   G+ G F +       A +   GL +LH  
Sbjct: 58  L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAA-QIICGLEHLHQR 114

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               I++RD+K  N+LL+      ++D GLA  L+     + +   AG+ GY+AP
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 10/171 (5%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG--ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           V+G+GG G V    V   G+  A K+L    I K       L+ E + L K+  + +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQFVVNL 65

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                 K+   LV   M  G L   ++       + E  L  A E   GL  LH +    
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--- 122

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            ++RD+K  NILL+      ++D GLA  + +    E +    G+ GY+AP
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 25/162 (15%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           +G G  G+V+  V +   ++VAVKK++ +T   S  + L  EI+ + ++ H NIV++   
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIV-LTDPQSVKHALR-EIKIIRRLDHDNIVKVYEV 70

Query: 249 CSNKETNL--------------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
                ++L              +V EYM    L  VL  ++G   +   RL    +  +G
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARL-FMYQLLRG 126

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYL 335
           L Y+H   S  ++HRD+K  N+ +N+ D    + DFGLA+ +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 27/180 (15%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNIV 243
           IG G  GVV+    P +G++VA+KK+  +       N +S      E++ L   +H N+ 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNV-----FQNLVSCKRVFRELKMLCFFKHDNV- 61

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL-----KIAI-EAAKGLSY 297
            L A    +  ++  +E +    + E++       +     L     K+ + +  +GL Y
Sbjct: 62  -LSALDILQPPHIDPFEEIY--VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA-VAGSYGYIAP 356
           LH   S  I+HRD+K  N+L+NS+    + DFGLA+ +++   S+ M+  V   Y Y AP
Sbjct: 119 LH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQY-YRAP 173

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 20/187 (10%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           VIG+G  G V+      +G   AVK L    I K    ++ ++     L  ++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                  E    V +Y+  G L   L  +R  FL+   R   A E A  + YLH   S  
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARF-YAAEVASAIGYLH---SLN 116

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--------- 356
           II+RD+K  NILL+S     + DFGL K  +     E  S   G+  Y+AP         
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 357 -VLGWYC 362
             + W+C
Sbjct: 175 RTVDWWC 181

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 13/148 (8%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
           +G G    V++G +   E +   K + +     H+ G       E+  L  ++H NIV L
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRL----EHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                 +    LV+EY+ +  L + L    G+ +          +  +GLSY H      
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK 333
           I+HRD+K  N+L+N   E  +ADFGLA+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.0 bits (129), Expect = 4e-08
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 13/169 (7%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
           IG+G +G VY  +    G++VA++++    +       +  EI  + + ++ NIV  L +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           +    E   +V EY+  GSL +V+     + +       +  E  + L +LH   S  +I
Sbjct: 86  YLVGDEL-WVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+KS+NILL  D    + DFG     Q T      S + G+  ++AP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 58/185 (31%), Positives = 86/185 (46%), Gaps = 32/185 (17%)

Query: 190 IGRGGAGVV---YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
           IG G  G+V   Y  V      VA+KKL    +  +H      E+  +  + H+NI+ L 
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 246 KAFCSNK-----ETNLLVYEYMPNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLS 296
             F   K     +   LV E M + +L +V    L  +R S+L ++M          G+ 
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIK 133

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +LH   S  IIHRD+K +NI++ SD    + DFGLA+     G S  M+    +  Y AP
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187

Query: 357 --VLG 359
             +LG
Sbjct: 188 EVILG 192

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 25/178 (14%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLG---ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           VIGRG  G V      + ++V   KLL    + K S  D+    E R +    +   V +
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWV-V 106

Query: 246 KAFCSNKETNLL--VYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEAAKGLSYL 298
           + FC+ ++   L  V EYMP G L  ++       K   F   E+ L +    + GL   
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL--- 163

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                   IHRDVK +N+LL+      +ADFG    + +TG   C +AV G+  YI+P
Sbjct: 164 --------IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 12/156 (7%)

Query: 190 IGRGGAGVVYRGVTPNG---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           IG G  G V  G   +G    QV VK+L  ++           E +    ++H N+++  
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRL--KIAIEAAKGLSYLHHDCS 303
             C+     LLV E+ P G L   L   R    +  +     ++A E A GL +LH +  
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLA--KYLQD 337
              IH D+   N LL +D    + D+GL+  KY +D
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 54/173 (31%), Positives = 77/173 (44%), Gaps = 14/173 (8%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG--ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           V+G+GG G V    V   G+  A KKL    I K       L+ E + L K+  R +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRFVVSL 65

Query: 246 KAFCSNKETNLLVYEYMPNGSLG-EVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLHHDCS 303
                 K+   LV   M  G L   + H     F   E R    A E   GL  LH +  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE--EGRAVFYAAEICCGLEDLHQE-- 121

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             I++RD+K  NILL+      ++D GLA ++ +    + +    G+ GY+AP
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 23/185 (12%)

Query: 185 KDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           K  N+IG G  GVVY  +     E+VA+KK+L   +   + N    E+  +  + H NI+
Sbjct: 69  KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQYKN---RELLIMKNLNHINII 122

Query: 244 RLKAF----CSNK-ETNL---LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKG 294
            LK +    C  K E N+   +V E++P      + H  R +       +K+ + +  + 
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEA-HVADFGLAKYLQDTGASECMSAVAGSYGY 353
           L+Y+H   S  I HRD+K  N+L++ +     + DFG AK L        +S +   + Y
Sbjct: 183 LAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSRF-Y 236

Query: 354 IAPVL 358
            AP L
Sbjct: 237 RAPEL 241

Length = 440

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 11/169 (6%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAF 248
           +G G  G VY+        +A  K++  TK          EI  L    H NIV+L  AF
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
               E NL ++ E+   G++  V+        + ++R+ +  +  + L+YLH +    II
Sbjct: 72  --YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+K+ NIL   D +  +ADFG++   ++T   +   +  G+  ++AP
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 13/169 (7%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
           IG+G +G V+  +    G++VA+K++  + K    +  ++ EI  + ++++ NIV  L +
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIIN-EILVMKELKNPNIVNFLDS 84

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           F    E   +V EY+  GSL +V+     + +       +  E  + L +LH +    +I
Sbjct: 85  FLVGDEL-FVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+KS+N+LL  D    + DFG     Q T      S + G+  ++AP
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 9/169 (5%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           +G+G  G VY+ +  P G  +A+K++  +    S  N +  E+  L K     IV     
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCSPLII 307
              +    +  EYM  GSL ++  G   +    E  L +I     KGL +L  + +  II
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRDVK  N+L+N + +  + DFG++  L  + A   +    G   Y+AP
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 9/143 (6%)

Query: 190 IGRGGAGVV-YRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IG G  G+V    V  +G+ VAVKK+    +       L  E+  +   +H N+V +   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH 308
               +   +V E++  G+L +++   R   +  E    + +   K LS LH   +  +IH
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQGVIH 139

Query: 309 RDVKSNNILLNSDFEAHVADFGL 331
           RD+KS++ILL  D    ++DFG 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 31/185 (16%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL--- 245
           +G G  G V     T   ++VAVKKL    +   H      E+R L  ++H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 246 ---KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSY 297
                   N     LV   M    L  ++  ++ S     FL +++         +GL Y
Sbjct: 83  FTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQL--------LRGLKY 133

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP- 356
           +H   S  IIHRD+K +N+ +N D E  + DFGLA+   D      M+    +  Y AP 
Sbjct: 134 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPE 185

Query: 357 -VLGW 360
            +L W
Sbjct: 186 IMLNW 190

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 17/171 (9%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            ++G G  G VY+       ++   K++ +         + +E+  L K     I+    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 248 --FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
             F  N+ +  +  E+M  GSL   ++ K    +   +  +IA+   KGL+YL    S  
Sbjct: 67  AFFVENRIS--ICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYL---WSLK 115

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           I+HRDVK +N+L+N+  +  + DFG++  L ++ A        G+  Y+AP
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----KTYVGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)

Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 50  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105

Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162

Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 163 LAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 56/183 (30%), Positives = 85/183 (46%), Gaps = 28/183 (15%)

Query: 190 IGRGGAGVVYRGVTPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKA 247
           IG G  G+V        E+ VA+KKL    +  +H      E+  +  + H+NI+  L  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 248 FCSNKETN-----LLVYEYMPNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           F   K         +V E M + +L +V    L  +R S+L ++M          G+ +L
Sbjct: 92  FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC--------GIKHL 142

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-- 356
           H   S  IIHRD+K +NI++ SD    + DFGLA+     G S  M+    +  Y AP  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEV 196

Query: 357 VLG 359
           +LG
Sbjct: 197 ILG 199

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 13/148 (8%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
           +G G    VY+G +   + +   K + +     H+ G       E+  L  ++H NIV L
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                 +++  LV+EY+ +  L + L     S     ++L +  +  +GL+Y H      
Sbjct: 70  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRR---K 124

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK 333
           ++HRD+K  N+L+N   E  +ADFGLA+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 24/173 (13%)

Query: 181 LECVKDNNVIGRGGAGVVYRG--VTPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTLG 235
           L  V+    +G    G +Y+G    P  +    VA+K L  I            E   + 
Sbjct: 4   LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMA 62

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-----HGKRG----------SFLK 280
           ++ H NIV L    + ++   +++EY+  G L E L     H   G          S L 
Sbjct: 63  ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122

Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
               L IAI+ A G+ YL    S   +H+D+ + NIL+       ++D GL++
Sbjct: 123 HGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 43/173 (24%), Positives = 70/173 (40%), Gaps = 32/173 (18%)

Query: 189 VIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            +G G  G V +              VAVK +L     SS    L +E   L ++ H ++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLH-------------GKRGSF---------LK 280
           ++L   CS     LL+ EY   GSL   L              G R S          L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
               +  A + ++G+ YL       ++HRD+ + N+L+    +  ++DFGL++
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N+FSG +P E     L+ +LD+S N+L G I  +   +  L  L+++ N+    LP 
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE-FGQYS 89
             G+ K L + D S N FSG +P   G  S
Sbjct: 471 SFGS-KRLENLDLSRNQFSGAVPRKLGSLS 499

Length = 968

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 10/171 (5%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG--ITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           V+G+GG G V    V   G+  A KKL    I K       L+ E R L K+  R +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSRFVVSL 65

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                 K+   LV   M  G L   ++         +  +  A E   GL  L  +    
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---R 122

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           I++RD+K  NILL+      ++D GLA  + +    E +    G+ GY+AP
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 5/71 (7%)

Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
           K+ +   K L YL       +IHRDVK +NILL++     + DFG++  L D+ A    +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172

Query: 346 AVAGSYGYIAP 356
             AG   Y+AP
Sbjct: 173 RSAGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 38/127 (29%), Positives = 53/127 (41%), Gaps = 7/127 (5%)

Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L   RH  +  LK     K+    V EY+  G L    H  R      +       
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA 102

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           E    L YLH   S  I++RD+K  N++L+ D    + DFGL K  +    +  M    G
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCG 157

Query: 350 SYGYIAP 356
           +  Y+AP
Sbjct: 158 TPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 49/170 (28%), Positives = 72/170 (42%), Gaps = 8/170 (4%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVRLK 246
           V+G+GG G V    V   G+  A KKL            ++  E + L K+  R +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
                K+   LV   M  G L   ++         E  +  A E   GL  LH      I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           ++RD+K  NILL+      ++D GLA  + +    E +    G+ GY+AP
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 59/180 (32%), Positives = 83/180 (46%), Gaps = 29/180 (16%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLG---ITKGSSHDNGLSAEIRTLGKIRHRN---I 242
           VIGRG  G V      + +QV   KLL    + K S  D+    E R +  + H N   I
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS--DSAFFWEERDI--MAHANSEWI 105

Query: 243 VRLK-AFCSNKETNLLVYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEAAKGLS 296
           V+L  AF  +K    +V EYMP G L  ++       K   F   E+ L  A++A   + 
Sbjct: 106 VQLHYAFQDDKYL-YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL--ALDAIHSMG 162

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +         IHRDVK +N+LL+      +ADFG    +   G   C +AV G+  YI+P
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISP 212

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 8/109 (7%)

Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           C    + L LV EY+  G L  + H +R   L  E     A E    L++LH      II
Sbjct: 64  CFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---II 118

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +RD+K +N+LL++D    + D+G+ K  +  G  +  S   G+  YIAP
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 54/187 (28%), Positives = 79/187 (42%), Gaps = 20/187 (10%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLL---GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           VIG+G  G V        E+    K+L    I K     + +S     L  ++H  +V L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                  +    V +Y+  G L   L  +R  FL+   R   A E A  L YLH   S  
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARF-YAAEIASALGYLH---SLN 116

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--------- 356
           I++RD+K  NILL+S     + DFGL K  ++   +   S   G+  Y+AP         
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 357 -VLGWYC 362
             + W+C
Sbjct: 175 RTVDWWC 181

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 27/162 (16%)

Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV----- 258
           P  E++  K++   ++ +     L  EI  LG++ H NI++++    ++    ++     
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ---LENEILALGRLNHENILKIEEILRSEANTYMITQKYD 246

Query: 259 ---YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
              Y +M + +        +   L  + R  I  +    + Y+H      +IHRD+K  N
Sbjct: 247 FDLYSFMYDEAFDW-----KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLEN 297

Query: 316 ILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPV 357
           I LN D +  + DFG A   +           A  YG++  V
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEK-------EREAFDYGWVGTV 332

Length = 501

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 26/167 (15%)

Query: 190 IGRGGAGVVYRGVTPN---GE---QVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHRN 241
           +G+G  G+VY G   +   GE   +VAVK    + + +S    +    E   +      +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKT---VNESASLRERIEFLNEASVMKGFTCHH 70

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIEA 291
           +VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAEI 128

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 13/148 (8%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRL 245
           +G G    V++G +   E +   K + +     H+ G       E+  L  ++H NIV L
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                  ++  LV+EY+ +  L + +    G+ +          +  +GL+Y H      
Sbjct: 70  HDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK 333
           ++HRD+K  N+L+N   E  +ADFGLA+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 38/116 (32%), Positives = 48/116 (41%), Gaps = 6/116 (5%)

Query: 217 ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG 276
           I K  +       EI  L  I HR I+ L      K T  +V   MP        +  R 
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRS 179

Query: 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             L  E  + I     + L+YLH      IIHRDVK+ NI L+    A + DFG A
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 41/173 (23%), Positives = 83/173 (47%), Gaps = 13/173 (7%)

Query: 190 IGRGGAGVVYRGVTP-NGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-L 245
           IGRG    VYR     + + VA+KK  +  +    +  + +  EI  L ++ H N+++ L
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNHPNVIKYL 68

Query: 246 KAFCSNKETNLLVYEYMPNGSLGE-VLHGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCS 303
            +F  + E N+ V E    G L + + + K+   L  E  + K  ++    + ++H   S
Sbjct: 69  DSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             ++HRD+K  N+ + +     + D GL ++   +  +    ++ G+  Y++P
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 42/175 (24%), Positives = 67/175 (38%), Gaps = 24/175 (13%)

Query: 190 IGRGGAGVVY--RGVTPNGEQVAVKKLLGITKGSSHDN-----GLSAEIRTLGKIRHR-N 241
           I +G  G VY  +  +  G+  A+K L    K S          + AE   +        
Sbjct: 4   ISKGAFGSVYLAKKRS-TGDYFAIKVL----KKSDMIAKNQVTNVKAERAIMMIQGESPY 58

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           + +L     +K+   LV EY+  G    ++    G    W    +   E   G+  LH  
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR 116

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               IIHRD+K  N+L++      + DFGL++               G+  Y+AP
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 20/182 (10%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVK--KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           V+G G  G V+      +GE  AVK   + G+++     N   AE+  L      +IV+ 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK--NRAQAEVCCLLNCDFFSIVKC 96

Query: 246 -KAFCSNKETN-------LLVYEYMPNGSLGEVLHGKRGS---FLKWEMRLKIAIEAAKG 294
            + F      N        LV +Y   G L + +  +  +   F + E  L + I+    
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-LFIQV--- 152

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI 354
           L  +HH  S  +IHRD+KS NILL S+    + DFG +K    T + +      G+  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 355 AP 356
           AP
Sbjct: 213 AP 214

Length = 496

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 53/179 (29%), Positives = 76/179 (42%), Gaps = 32/179 (17%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           +G+GG G V+     + GE VA+K     LL       H   +  E   L   +   +V+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH---VLTERDILTTTKSEWLVK 65

Query: 245 LKAFCSNKETNLLVYEYMPNG-------SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           L     + E   L  EY+P G       +LG VL      F   EM    A++A   L Y
Sbjct: 66  LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFE--AVDALHELGY 122

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                    IHRD+K  N L+++     + DFGL+K     G     ++V GS  Y+AP
Sbjct: 123 ---------IHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 39/128 (30%), Positives = 53/128 (41%), Gaps = 9/128 (7%)

Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIA 288
           E R L   RH  +  LK      +    V EY   G L    H  R   F +   R   A
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102

Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K  +       M    
Sbjct: 103 -EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156

Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 157 GTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 38/165 (23%), Positives = 74/165 (44%), Gaps = 22/165 (13%)

Query: 190 IGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHRN 241
           +G+G  G+VY G+           +VA+K    + + +S    +    E   + +    +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG--------SFLKWEMRLKIAIEAAK 293
           +VRL    S  +  L++ E M  G L   L   R         +    +  +++A E A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 7/100 (7%)

Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
            V EY+  G L  + H ++    K    +  A E + GL +LH      II+RD+K +N+
Sbjct: 78  FVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNV 132

Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +L+S+    +ADFG+ K     G         G+  YIAP
Sbjct: 133 MLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 39/127 (30%), Positives = 52/127 (40%), Gaps = 7/127 (5%)

Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L   RH  +  LK      +    V EY   G L    H  R      E       
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 102

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157

Query: 350 SYGYIAP 356
           +  Y+AP
Sbjct: 158 TPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 7/171 (4%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
           V+G G  GVV +       E VA+KK     +          E++ L  ++  NIV LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
               +    LV+EY+    L E+L          ++R  I  +  K + + H +    I+
Sbjct: 68  AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DIV 122

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           HRD+K  N+L++ +    + DFG A+ L +   +     VA  + Y +P L
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPEL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 17/115 (14%)

Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLHHDCSP 304
           FC+   KE    V EY+ NG  G+++   + S    E R +  A E   GL +LH     
Sbjct: 62  FCTFQTKEHLFFVMEYL-NG--GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KK 115

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK---YLQDTGASECMSAVAGSYGYIAP 356
            II+RD+K +N+LL+ D    +ADFG+ K     +   ++ C     G+  YIAP
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-----GTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 9/149 (6%)

Query: 190 IGRGGAGVVYRGVTPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           +G G  G V +GV    ++   VA+K L    + S  D  +  E   + ++ +  IVR+ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDE-MMREAEIMHQLDNPYIVRMI 61

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
             C   E  +LV E    G L + L GK+   +     +++  + + G+ YL        
Sbjct: 62  GVCE-AEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKN---F 116

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYL 335
           +HRD+ + N+LL +   A ++DFGL+K L
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 17/105 (16%)

Query: 257 LVYEYMPNGSLGEVLH-----GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV 311
           +V EYMP G L  ++       K   F   E+ L  A++A   + +         IHRDV
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL--ALDAIHSMGF---------IHRDV 168

Query: 312 KSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           K +N+LL+      +ADFG    +   G   C +AV G+  YI+P
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 20/124 (16%)

Query: 226 GLSAEIRTLGKIRHRNIVRLKA-FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
           G + E   L  I H +I++LK  F  NK T L++  Y  +  L   L  KR         
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKR--------N 178

Query: 285 LKI----AIEAA--KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           + I    AIE +  + + YLH +    IIHRD+K+ NI +N   +  + DFG A +  D 
Sbjct: 179 IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235

Query: 339 GASE 342
            A++
Sbjct: 236 NANK 239

Length = 391

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 9/120 (7%)

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           +H  + +L +    K+    V EY+  G L  + H +R            A E   GL +
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 298 LH-HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LH       II+RD+K +N+LL+S+    +ADFG+ K  +        S   G+  YIAP
Sbjct: 112 LHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 28/111 (25%), Positives = 46/111 (41%), Gaps = 25/111 (22%)

Query: 234 LGKIRHRNIVRLKAFCSNKETNLLV--------YEYMPNGSLGEVLHGKRGSFLKWEMRL 285
           L  + H +++R+K    +     +V        Y Y+   S                +  
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR------------PLPIDQ 158

Query: 286 KIAIEAA--KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
            + IE    +GL YLH   +  IIHRDVK+ NI +N   +  + D G A++
Sbjct: 159 ALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206

Length = 357

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 40/117 (34%), Positives = 61/117 (52%), Gaps = 11/117 (9%)

Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH- 299
           IV LK F    +++L LV +YM  G L   L  K G F +   +  IA E    L +LH 
Sbjct: 58  IVGLK-FSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLHK 114

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +D    I++RD+K  NILL++     + DFGL+K   +   ++  +   G+  Y+AP
Sbjct: 115 YD----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 55/177 (31%), Positives = 79/177 (44%), Gaps = 17/177 (9%)

Query: 190 IGRGGAGVVYR-GVTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           +G+GG G V    +   G+  A KKL    L   KG     G   E R L K+  R IV 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYE---GAMVEKRILAKVHSRFIVS 57

Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           L A+    +T+L LV   M  G L   ++   +               +   GL +LH  
Sbjct: 58  L-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
               II+RD+K  N+LL++D    ++D GLA  L+D          AG+ G++AP L
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYAGTPGFMAPEL 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 5/69 (7%)

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
           A E A GL +LH   S  II+RD+K +N++L+++    +ADFG+ K     G +      
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TF 161

Query: 348 AGSYGYIAP 356
            G+  YIAP
Sbjct: 162 CGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 57/187 (30%), Positives = 82/187 (43%), Gaps = 20/187 (10%)

Query: 189 VIGRGGAG-VVYRGVTPNGEQVAVKKLLG-ITKGSSHDNGLSAEIRTLGK-IRHRNIVRL 245
           VIG+G  G V+      +G+  AVK L   I         + AE   L K ++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                  E    V +++  G L   L  +R SF +   R   A E A  L YLH   S  
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAA-EIASALGYLH---SIN 116

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--------- 356
           I++RD+K  NILL+S     + DFGL K  +    S+  +   G+  Y+AP         
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 357 -VLGWYC 362
             + W+C
Sbjct: 175 NTVDWWC 181

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 56/173 (32%), Positives = 86/173 (49%), Gaps = 16/173 (9%)

Query: 190 IGRGGAG-VVYRGVTPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           +G+GG G V    V   G+  A KKL    + K S     L  E   L K+    IV L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMAL-LEKEILEKVNSPFIVNL- 58

Query: 247 AFCSNKETNL-LVYEYMPNGSLG-EVLH-GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           A+    +T+L LV   M  G L   + + G+RG  L+ E  +  + +   G+ +LH   S
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLH---S 113

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             I++RD+K  N+LL+      ++D GLA  L+D    + ++  AG+ GY+AP
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 38/164 (23%)

Query: 190 IGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR-H 239
           +G+G  G+V        +   E VA+KK+  +         + A     E++ L   R H
Sbjct: 8   LGQGAYGIVCSARNAETSE-EETVAIKKITNV-----FSKKILAKRALRELKLLRHFRGH 61

Query: 240 RNIVRL---KAFCSNKETNLLVYEYMPNGSLGEVLHGKR-------GSFLKWEMRLKIAI 289
           +NI  L             L +YE +    L +++   +        SF+   +      
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC----- 116

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
               GL Y+H   S  ++HRD+K  N+L+N+D E  + DFGLA+
Sbjct: 117 ----GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 4e-06
 Identities = 26/96 (27%), Positives = 52/96 (54%), Gaps = 6/96 (6%)

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           + N ++L    +  + ++L+ +Y+ +G L ++L  K G   + E++ KI  +  + L+ L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVK-KIIRQLVEALNDL 125

Query: 299 HHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAK 333
           H      IIH D+K  N+L + +    ++ D+GL K
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 17/139 (12%)

Query: 190 IGRGGAGVVYRGV-------TPNGEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIRHR 240
           +G+G    +Y+GV          G    V  +L +  GS H + L+       + ++ H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVL-GSDHRDSLAFFETASLMSQLSHK 61

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLH 299
           ++V+L   C   E N++V EY+  G L   LH ++ +  L W  +L +A + A  L YL 
Sbjct: 62  HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 300 HDCSPLIIHRDVKSNNILL 318
                 ++H +V   NIL+
Sbjct: 119 ---DKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 49/171 (28%), Positives = 73/171 (42%), Gaps = 40/171 (23%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNIV 243
           IG+GG G VY    P    +VA+KK   I +  S +N L       E +    + H  IV
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKK---IREDLS-ENPLLKKRFLREAKIAADLIHPGIV 65

Query: 244 RLKAFCSNKETNLLVYEYMP----------------NGSLGEVLHGKR--GSFLKWEMRL 285
            + + CS+ +    VY  MP                  SL + L  K   G+FL      
Sbjct: 66  PVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS----- 117

Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
            I  +    + Y+H   S  ++HRD+K +NILL    E  + D+G A + +
Sbjct: 118 -IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164

Length = 932

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 37/127 (29%), Positives = 53/127 (41%), Gaps = 6/127 (4%)

Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L   RH  +  LK      +    V EY   G L    H  R      +       
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           E    L YLH + +  +++RD+K  N++L+ D    + DFGL K     GA+  M    G
Sbjct: 103 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 158

Query: 350 SYGYIAP 356
           +  Y+AP
Sbjct: 159 TPEYLAP 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 8/109 (7%)

Query: 249 CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           C   E+ L  V E++  G L  + H +R   L  E     + E +  L++LH      II
Sbjct: 64  CFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGII 118

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +RD+K +N+LL+++    + D+G+ K  +     +  S   G+  YIAP
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 24/144 (16%)

Query: 227 LSAEIRTLGKIRHRNIVRL----KAFCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLK 280
              E     ++ H NIV L    +A        LL  V+EY+P  +L EVL       L 
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEA-----PPGLLFAVFEYVPGRTLREVLAAD--GALP 77

Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAH--VADFGLAKYLQD 337
                ++ ++    L+  H+     I+HRD+K  NI+++ +    H  V DFG+   L  
Sbjct: 78  AGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134

Query: 338 TGASECMSA-----VAGSYGYIAP 356
              ++  +      V G+  Y AP
Sbjct: 135 VRDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 21/156 (13%)

Query: 189 VIGRGGAGVVY--RGVT--PNGEQVAVKKLLGIT-----KGSSHDNGLSAEIRTLGKIRH 239
           V+G+GG G V+  R VT    G+  A+K L   T     K ++H     AE   L  ++H
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK---AERNILEAVKH 59

Query: 240 RNIVRLK-AFCSNKETNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSY 297
             IV L  AF +  +   L+ EY+  G L   +H +R G F++      ++ E +  L +
Sbjct: 60  PFIVDLIYAFQTGGKL-YLILEYLSGGEL--FMHLEREGIFMEDTACFYLS-EISLALEH 115

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           LH      II+RD+K  NILL++     + DFGL K
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 6/100 (6%)

Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           L+ +Y+  G L   L+ +R  F + E+R+ IA E    L +LH      II+RD+K  NI
Sbjct: 82  LILDYVNGGELFTHLY-QREHFTESEVRVYIA-EIVLALDHLHQLG---IIYRDIKLENI 136

Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LL+S+    + DFGL+K        E   +  G+  Y+AP
Sbjct: 137 LLDSEGHVVLTDFGLSKEFL-AEEEERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 8/109 (7%)

Query: 249 CSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           C   E+ L  V EY+  G L  + H +R   L  E     + E +  L+YLH      II
Sbjct: 64  CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 118

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +RD+K +N+LL+S+    + D+G+ K  +     +  S   G+  YIAP
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 21/158 (13%)

Query: 190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRN-IV 243
           IG G  G VY+    N G+ VA+KK    T+    + G+      EI  L  +     IV
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 244 RLKAFCSNKETN-----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLS 296
           RL      +E N      LV+EY+ +     +    RG       +       +  KG++
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEA-HVADFGLAK 333
           + H      ++HRD+K  N+L++       +AD GL +
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 44/173 (25%), Positives = 82/173 (47%), Gaps = 13/173 (7%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           IGRG    VYR     +G  VA+KK  +  +    +  + +  EI  L ++ H N+++  
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKYY 68

Query: 247 A-FCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCS 303
           A F  + E N+ V E    G L  ++ H K+   L  E  + K  ++    L ++H   S
Sbjct: 69  ASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---S 124

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             ++HRD+K  N+ + +     + D GL ++   +  +    ++ G+  Y++P
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 9/111 (8%)

Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           +C+   KE    V EY+  G L  + H +             A E   GL +LH   S  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKG 116

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           I++RD+K +NILL++D    +ADFG+ K      A  C     G+  YIAP
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC--TFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 36/205 (17%)

Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVV----YRGVTPNGEQVAVK-- 212
           + +++SWKL+ F+                  +G G  G V    ++G    GE  A+K  
Sbjct: 9   KPDTSSWKLSDFEM--------------GETLGTGSFGRVRIAKHKG---TGEYYAIKCL 51

Query: 213 KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMPNGSLGEVL 271
           K   I K     + ++ E   L ++ H  IV  + +F        L+ E++  G L   L
Sbjct: 52  KKREILKMKQVQH-VAQEKSILMELSHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHL 109

Query: 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
             K G F     +   A E      YLH   S  II+RD+K  N+LL++     V DFG 
Sbjct: 110 R-KAGRFPNDVAKFYHA-ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGF 164

Query: 332 AKYLQDTGASECMSAVAGSYGYIAP 356
           AK + D   + C     G+  Y+AP
Sbjct: 165 AKKVPDRTFTLC-----GTPEYLAP 184

Length = 329

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 37/139 (26%), Positives = 61/139 (43%), Gaps = 13/139 (9%)

Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN------LLV 258
           + ++VAVK L      SS       E   + +  H N+++L                +++
Sbjct: 26  SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85

Query: 259 YEYMPNGSLGEVLH----GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
             +M +G L   L     G+    L  +  ++  I+ A G+ YL    S   IHRD+ + 
Sbjct: 86  LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAAR 142

Query: 315 NILLNSDFEAHVADFGLAK 333
           N +LN +    VADFGL+K
Sbjct: 143 NCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 9/149 (6%)

Query: 190 IGRGGAGVVYRGV--TPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           +G G  G V +G+      E+ VAVK L       +  + L  E   + ++ +  IVR+ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
             C   E+ +LV E    G L + L   +   +  +   ++  + + G+ YL        
Sbjct: 63  GICE-AESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETN---F 116

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYL 335
           +HRD+ + N+LL +   A ++DFGL+K L
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 19/178 (10%)

Query: 189 VIGRGGAGVVY--RGVTPN--GEQVAVKKLLGIT-----KGSSHDNGLSAEIRTLGKIRH 239
           V+G G  G V+  R V+ +  G+  A+K L   T     K + H      E + L  IR 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR---TERQVLEHIRQ 63

Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
              +    +    +T L L+ +Y+  G L   L  +R  F + E+++    E    L +L
Sbjct: 64  SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSG-EIVLALEHL 121

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H      II+RD+K  NILL+S+    + DFGL+K        E   +  G+  Y+AP
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 13/176 (7%)

Query: 189 VIGRG---GAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           ++GR     A V  RG  P  + VA   +L   + +++     +E+  L    H  IV+ 
Sbjct: 74  LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYAR---SELHCLAACDHFGIVKH 130

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGK---RGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                + +  LL+ EY   G L + +  +      F ++E+ L +  +    L  +H   
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK 189

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
              ++HRD+KS NI L       + DFG +K   D+ + +  S+  G+  Y+AP L
Sbjct: 190 ---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL 242

Length = 478

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 15/174 (8%)

Query: 189 VIGRGGAGVVY--RGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           V+G+G  G V+  R +T    G+  A+K L   T           E   L ++ H  IV+
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 245 LK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           L  AF    E  L L+ +++  G L   L  K   F + +++  +A E A  L +LH   
Sbjct: 63  LHYAF--QTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELALALDHLH--- 115

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  II+RD+K  NILL+ +    + DFGL+K   D    +  S   G+  Y+AP
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYS-FCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 9/106 (8%)

Query: 252 KETNLLVYEYMPNGSLGEVLH-GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           KE    V E++  G L  + H   +G F  +      A E   GL +LH   S  II+RD
Sbjct: 68  KEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATF-YAAEIVCGLQFLH---SKGIIYRD 121

Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +K +N++L+ D    +ADFG+ K  ++       S   G+  YIAP
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 27/80 (33%), Positives = 40/80 (50%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           NNF+G IPV +     L  L L  N  SG IP  + + + L  L++S N L   +P+ + 
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377

Query: 64  NMKSLTSADFSHNNFSGEIP 83
           +  +L       N+  GEIP
Sbjct: 378 SSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 44/134 (32%), Positives = 62/134 (46%), Gaps = 15/134 (11%)

Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH--GKRGSFLKWEMRLK 286
           AE   L ++    IV LK    + E   LV  ++ NG  GE+ H   + G F     R  
Sbjct: 42  AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI-NG--GELFHHLQREGRFDLSRARFY 98

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA--DFGLAKYLQDTGASECM 344
            A E    L  LH      +I+RD+K  NILL  D++ H+A  DFGL K   +    +  
Sbjct: 99  TA-ELLCALENLH---KFNVIYRDLKPENILL--DYQGHIALCDFGLCKL--NMKDDDKT 150

Query: 345 SAVAGSYGYIAPVL 358
           +   G+  Y+AP L
Sbjct: 151 NTFCGTPEYLAPEL 164

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 33/103 (32%), Positives = 42/103 (40%), Gaps = 24/103 (23%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           N FSG IP  +G    LT LDLS N+L+G IP  +     L  L +  N L   +PK +G
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401

Query: 64  NMKSLTSA------------------------DFSHNNFSGEI 82
             +SL                           D S+NN  G I
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 25/70 (35%), Positives = 38/70 (54%), Gaps = 7/70 (10%)

Query: 288 AIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           A E    L +LH H     +I+RD+K +NILL+++    +ADFG+ K     G +   + 
Sbjct: 102 AAEVTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTT 155

Query: 347 VAGSYGYIAP 356
             G+  YIAP
Sbjct: 156 FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 38/204 (18%)

Query: 181 LECVKDNNVIGRGGAGVVYRGV---TPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTL 234
           L  V+    +G    G VY+G    T  GEQ   VA+K L    +G   +     E    
Sbjct: 4   LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE-FKHEAMMR 62

Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-----HGKRGSF---------LK 280
            +++H NIV L    + ++   +++ Y  +  L E L     H   GS          L+
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 281 WEMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL------A 332
               + I  + A G+ +L  HH     ++H+D+ + N+L+       ++D GL      A
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 333 KYLQDTGAS----ECMSAVAGSYG 352
            Y +  G S      MS  A  YG
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYG 201

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 35/143 (24%), Positives = 63/143 (44%), Gaps = 15/143 (10%)

Query: 190 IGRGGAGVVYRGV---------TPNGEQVAVKKLLGITKGSSHDNGLS--AEIRTLGKIR 238
           +GRG    +Y G+              +  +K +L +   S  D  L+       + ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           H++IV L   C     N++V E++  G L   +H ++   L    + K+A + A  LSYL
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121

Query: 299 HHDCSPLIIHRDVKSNNILLNSD 321
                  ++H +V + NILL  +
Sbjct: 122 E---DKDLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 32/89 (35%), Positives = 45/89 (50%), Gaps = 9/89 (10%)

Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM-RLKIAIEAAKGLSYLHHDCSP 304
           FCS   K    +V EY+  G    +L  K    L  +M R+  A E    L YLH   + 
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFA-ETVLALEYLH---NY 120

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
            I+HRD+K +N+L+ S     + DFGL+K
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 7/100 (7%)

Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
            V EY+  G L  +   ++    K    +  A E A GL +LH   S  II+RD+K +N+
Sbjct: 78  FVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNV 132

Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +L+S+    +ADFG+ K     G +       G+  YIAP
Sbjct: 133 MLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 28/83 (33%), Positives = 46/83 (55%), Gaps = 8/83 (9%)

Query: 274 KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           + G F + EMR   A E   GL ++H+     +++RD+K  NILL+      ++D GLA 
Sbjct: 90  QHGVFSEKEMRF-YATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA- 144

Query: 334 YLQDTGASECMSAVAGSYGYIAP 356
              D    +  ++V G++GY+AP
Sbjct: 145 --CDFSKKKPHASV-GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +V+L     +K+    V +Y+P G +  +L  + G F +   R  IA E    +  +H  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARFYIA-ELTCAIESVHKM 120

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
                IHRD+K +NIL++ D    + DFGL
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 24/160 (15%)

Query: 190 IGRGGAGVVYRGVTPNGE---QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
           +GRG  G VY+    +G+   + A+K++    +G+        EI  L +++H N++ L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF-------LKWEMRLKIAIEAAKGLSY 297
           K F S+ +  + L+++Y  +  L  ++   R S        L   M   +  +   G+ Y
Sbjct: 65  KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 298 LHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAK 333
           LH +    ++HRD+K  NIL+  +        +AD G A+
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 28/83 (33%), Positives = 46/83 (55%), Gaps = 8/83 (9%)

Query: 274 KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           + G F + EMR   A E   GL ++H+     +++RD+K  NILL+      ++D GLA 
Sbjct: 90  QHGVFSEAEMRF-YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA- 144

Query: 334 YLQDTGASECMSAVAGSYGYIAP 356
              D    +  ++V G++GY+AP
Sbjct: 145 --CDFSKKKPHASV-GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 5/69 (7%)

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
           A E    L +LH      II+RD+K +N+LL+ +    +ADFG+ K     G +   S  
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTF 156

Query: 348 AGSYGYIAP 356
            G+  YIAP
Sbjct: 157 CGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 43/185 (23%), Positives = 79/185 (42%), Gaps = 36/185 (19%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGL---SAEIRTLGKIRHRNIVRL 245
           +G+G  G VY         +  +K L  I  G  + N     + E + L K+ H  IV+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 246 KA-------------FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEA 291
            A             +C  ++ +  + E    G +L E          +W ++L +    
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE------NQVCEWFIQLLL---- 117

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
             G+ Y+H      I+HRD+K+ NI L ++    + DFG+++ L   G+ +  +   G+ 
Sbjct: 118 --GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTGTP 169

Query: 352 GYIAP 356
            Y++P
Sbjct: 170 YYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 21/178 (11%)

Query: 188 NVIGRGGAG---VVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IV 243
           +++GRG  G   VV    T  G+  A+K +      +        E R +  I +   I 
Sbjct: 7   SLVGRGHFGEVQVVREKAT--GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-----LKIAIEAAKGLSYL 298
           +L+    +K+   LV EY P G L  +L+     F +   +     L +AI +   + Y 
Sbjct: 65  QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY- 123

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                   +HRD+K  N+L++      +ADFG A  L           V G+  YIAP
Sbjct: 124 --------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 39/151 (25%), Positives = 62/151 (41%), Gaps = 11/151 (7%)

Query: 190 IGRGGAGVVYRG---VTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           IG G  G V            +V VK+L      S   N    +      ++H NI++  
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKA-NASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLSYLH-HDCS 303
             C      LLV+EY   G L   L  ++      ++ L  ++A E A G++++H H+  
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
              +H D+   N  L SD    V D+G+   
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.7 bits (93), Expect = 6e-04
 Identities = 29/144 (20%), Positives = 54/144 (37%), Gaps = 16/144 (11%)

Query: 193 GGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV--RLKAFCS 250
           G    VY  +    E   +K    I            E+  L  +  + +   ++ A   
Sbjct: 9   GLTNRVYL-LGTKDEDYVLK----INPSREKGADREREVAILQLLARKGLPVPKVLASGE 63

Query: 251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           +   + L+ E++   +L EV           E +  IA + A+ L+ LH     ++ H D
Sbjct: 64  SDGWSYLLMEWIEGETLDEVSE---------EEKEDIAEQLAELLAKLHQLPLLVLCHGD 114

Query: 311 VKSNNILLNSDFEAHVADFGLAKY 334
           +   NIL++      + D+  A Y
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 23/163 (14%)

Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           ++G+G  G V+    +G    G+  A+K   K   I +       +  E   L  + H  
Sbjct: 8   LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKR--VLTEQEILATLDHPF 62

Query: 242 IVRLKA-FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           +  L A F +  ET L LV +Y P G L  +L  + G  L  E+    A E    L YLH
Sbjct: 63  LPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGA 340
                 I++RD+K  NILL+     H+  +DF L+K       
Sbjct: 121 LLG---IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPP 158

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 4/80 (5%)

Query: 5   NFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGN 64
            + GI          +  +DLS  ++SG I   I ++  +  +N+S NQL+  +P ++  
Sbjct: 59  LWQGITCNNSSR---VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFT 115

Query: 65  M-KSLTSADFSHNNFSGEIP 83
              SL   + S+NNF+G IP
Sbjct: 116 TSSSLRYLNLSNNNFTGSIP 135

Length = 968

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 37/144 (25%), Positives = 73/144 (50%), Gaps = 12/144 (8%)

Query: 198 VYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVRLKAFCSNKETNL 256
           +Y+G+  N ++V ++      KG      ++  EI+ L +I   NI+++  F  +   +L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 257 ----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDV 311
               L+ EY   G L EVL  ++   L ++ +L +AI+  KGL  L+ +   P   ++++
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNL 149

Query: 312 KSNNILLNSDFEAHVADFGLAKYL 335
            S + L+  +++  +   GL K L
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKIL 173

Length = 283

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 8/101 (7%)

Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           L+ +Y+  G +   L+ +R +F + E+R     E    L +LH      I++RD+K  NI
Sbjct: 82  LILDYVSGGEMFTHLY-QRDNFSEDEVRFYSG-EIILALEHLH---KLGIVYRDIKLENI 136

Query: 317 LLNSDFEAHVADFGLAK-YLQDTGASECMSAVAGSYGYIAP 356
           LL+S+    + DFGL+K +L +    E   +  G+  Y+AP
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLSE--EKERTYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 15/110 (13%)

Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-- 284
           + AE   L +  +  +V+L     +K+    V +Y+P G +  +L  +   F +   R  
Sbjct: 48  VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMEVFPEVLARFY 106

Query: 285 ---LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
              L +AIE+   + +         IHRD+K +NIL++ D    + DFGL
Sbjct: 107 IAELTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 40.7 bits (95), Expect = 9e-04
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 4/100 (4%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N  S  +P EI     L  LDLS N +   +   ++ +  L+ L +S N+L   LP+
Sbjct: 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNP 100
            +GN+ +L + D S+N  S  I   G  +       +GN 
Sbjct: 250 SIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNS 288

Length = 394

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 5/86 (5%)

Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           L+ E++P G +  +L  K+ +  + E +  IA E    +  +H       IHRD+K +N+
Sbjct: 78  LIMEFLPGGDMMTLLM-KKDTLTEEETQFYIA-ETVLAIDSIHQLG---FIHRDIKPDNL 132

Query: 317 LLNSDFEAHVADFGLAKYLQDTGASE 342
           LL+S     ++DFGL   L+    +E
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTE 158

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 16/149 (10%)

Query: 189 VIGRG--GAGVVYRG-VTPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVR 244
           +IG+      +V+     P    VAVKK+  +   S  D   L  EI T  +++H NI+ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 245 -LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHH 300
            + +F  + E   +V   M  GS  ++L   +  F +    L IA    +    L Y+H 
Sbjct: 64  YVTSFIVDSEL-YVVSPLMAYGSCEDLL---KTHFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADF 329
                 IHR VK+++ILL+ D +  ++  
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 15/110 (13%)

Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLK-----W 281
           + AE   L +  +  +VRL     +K+    V +Y+P G +  +L  + G F +     +
Sbjct: 48  VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFPEDLARFY 106

Query: 282 EMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
              L  A+E+   + +         IHRD+K +NIL++ D    + DFGL
Sbjct: 107 IAELTCAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 37/113 (32%), Positives = 50/113 (44%), Gaps = 22/113 (19%)

Query: 253 ETNL-LVYEYMPNGSL-------GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           E NL LV +Y   G L        + L      F   EM L  AI++   L Y       
Sbjct: 73  ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL--AIDSVHQLGY------- 123

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA-GSYGYIAP 356
             +HRD+K +N+LL+ +    +ADFG    L   G     S VA G+  YI+P
Sbjct: 124 --VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 24/160 (15%)

Query: 190 IGRGGAGVVYRGVTPNGEQ---VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL- 245
           +GRG  G VY+    +G+     A+K++    +G+        EI  L +++H N++ L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF-------LKWEMRLKIAIEAAKGLSY 297
           K F S+ +  + L+++Y  +  L  ++   R S        L   M   +  +   G+ Y
Sbjct: 65  KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 298 LHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAK 333
           LH +    ++HRD+K  NIL+  +        +AD G A+
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 17/51 (33%), Positives = 30/51 (58%)

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IIHRD+K+ N+L+N   +  + DFG A + + + ++     +AG+    AP
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Length = 461

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 7/100 (7%)

Query: 245 LKAFCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           +K F S  +K    L+ E++P G +  +L  K+ +  +   +  IA E    +  +H   
Sbjct: 64  VKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQFYIA-ETVLAIDAIHQLG 121

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
               IHRD+K +N+LL++     ++DFGL   L+    +E
Sbjct: 122 ---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 19/49 (38%), Positives = 29/49 (59%), Gaps = 3/49 (6%)

Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           L+ + + A+G+ +L    S   IHRDV + N+LL     A + DFGLA+
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 24/70 (34%), Positives = 37/70 (52%), Gaps = 10/70 (14%)

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           IAI++   L Y         +HRD+K +NIL++ +    +ADFG    L + G  +   A
Sbjct: 113 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163

Query: 347 VAGSYGYIAP 356
           V G+  YI+P
Sbjct: 164 V-GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 11/100 (11%)

Query: 189 VIGRGGAGVVYR------GVTPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKI-RHR 240
            +GRG  G V +        + +   VAVK L  G T  +S    L  E++ L  I  H 
Sbjct: 14  PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHL 71

Query: 241 NIVRLKAFCSNKETNLLV-YEYMPNGSLGEVLHGKRGSFL 279
           N+V L   C+     L+V  EY   G+L   L  KR  F 
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFS 111

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 10/113 (8%)

Query: 178 DDILECVKDNNVIGRG-GAGVVYRGV--TPNG---EQVAVK---KLLGITKGSSHDNGLS 228
           D   E  +DN V+GR  G+G   R V  T +G    Q  +K   K+L  T  SS    L 
Sbjct: 29  DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALM 88

Query: 229 AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLK 280
           +E++ +  +  H NIV L   C+      ++ EY   G L + LH  + +FL+
Sbjct: 89  SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQ 141

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 20/162 (12%)

Query: 188 NVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHR 240
           +++  G  G ++ G+         E+V VK +      +S      L  E   L  + H+
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLLYGLSHQ 68

Query: 241 NIVRLKAFCS-NKETNLLVYEYMPNGSLGEVLHGKR------GSFLKWEMRLKIAIEAAK 293
           NI+ +   C  + E   ++Y YM  G+L   L   R         L  +  + +AI+ A 
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
           G+SYLH      +IH+D+ + N +++ + +  + D  L++ L
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 18/50 (36%), Positives = 29/50 (58%), Gaps = 1/50 (2%)

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRD+K +N+LL+ +    +ADFG    +   G  +   AV G+  YI+P
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 27/87 (31%)

Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEM------RLKIA-----IEAAKGLSYLHHDCSPL 305
           L+ E++P G L  +L       +K++       R  +A     IEA   L +        
Sbjct: 78  LIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMAECVLAIEAVHKLGF-------- 122

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLA 332
            IHRD+K +NIL++      ++DFGL+
Sbjct: 123 -IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 22/55 (40%), Positives = 30/55 (54%), Gaps = 3/55 (5%)

Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           L  E  L  + + AKG+S+L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	362
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.96
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.96
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.96
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.96
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.96
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.96
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
KOG0584	632	consensus Serine/threonine protein kinase [General	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.96
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.95
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.95
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.95
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.94
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.94
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.94
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.94
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.94
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.93
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.93
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.93
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.93
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
PHA02882	294	putative serine/threonine kinase; Provisional	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.92
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.92
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.9
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.9
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.88
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.88
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.86
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.8
PLN03150	623	hypothetical protein; Provisional	99.78
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.78
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.76
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
PLN00181	793	protein SPA1-RELATED; Provisional	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.63
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.5
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.4
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.4
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.34
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.31
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.31
PLN03150	623	hypothetical protein; Provisional	99.27
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.25
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.17
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.16
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.08
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.98
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.97
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.94
KOG1243	690	consensus Protein kinase [General function predict	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
PRK09902	216	hypothetical protein; Provisional	98.86
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.8
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.8
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.76
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.73
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.71
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.6
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.59
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.57
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.54
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.48
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.47
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.46
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.45
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.44
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.43
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.42
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.37
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.36
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.35
PLN02876	822	acyl-CoA dehydrogenase	98.35
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.34
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.34
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.28
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.25
PRK10593	297	hypothetical protein; Provisional	98.25
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.25
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.24
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.21
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.18
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.17
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.15
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.12
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.1
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.07
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.06
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.04
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.03
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.02

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-48  Score=410.32  Aligned_cols=332  Identities=34%  Similarity=0.577  Sum_probs=251.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++|.+|.++++|++|++|+|++|+++|.+|..+..+++|+.|||++|+++|.+|..+.++++|+.|++++|+++|
T Consensus       506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccCCccCCCCCCCCCC----CCCcCCCCCCcCCCCCCCCCCCCceeeehhhhhHHHhhhhheeeeeeee
Q 018036           81 EIPEFGQYSFFNSTSFTGNPHLCGSYL----NPCNYSSTTPIHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTR  156 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~~lc~~~l----~~c~~~~~~p~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~r  156 (362)
                      .+|..+++..+...++.||+.+|+...    .+|..          .+ ......+.++++++++++++++++.++++++
T Consensus       586 ~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~----------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  654 (968)
T PLN00113        586 SLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR----------VR-KTPSWWFYITCTLGAFLVLALVAFGFVFIRG  654 (968)
T ss_pred             eCCCcchhcccChhhhcCCccccCCccccCCCCCcc----------cc-ccceeeeehhHHHHHHHHHHHHHHHHHHHHh
Confidence            999998888888899999999998642    12311          00 1111112222222222222222211222222


Q ss_pred             cccc---C----CCCcccccccc---cCCChhhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchh
Q 018036          157 KFRK---N----SNSWKLTAFQK---LDFGSDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDN  225 (362)
Q Consensus       157 ~~~~---~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~  225 (362)
                      +++.   +    ...|....+..   ..+..+++.+.++..+.||+|+||.||+|+. .++..||||++.....      
T Consensus       655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------  728 (968)
T PLN00113        655 RNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------  728 (968)
T ss_pred             hhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------
Confidence            2111   1    11122221111   1234455667788889999999999999987 5789999998853221      


Q ss_pred             hHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018036          226 GLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL  305 (362)
Q Consensus       226 ~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~  305 (362)
                      ...+|++.+++++|||||+++++|.+.+..++||||+++|+|.++++.     ++|..+.+++.|+++||+|||..+.++
T Consensus       729 ~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~  803 (968)
T PLN00113        729 IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPA  803 (968)
T ss_pred             ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCC
Confidence            124568899999999999999999999999999999999999999952     899999999999999999999776678


Q ss_pred             eEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       306 ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+||||||+||+++.++.+++. ||.+.....      .....||+.|||||++.+
T Consensus       804 iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~  852 (968)
T PLN00113        804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRET  852 (968)
T ss_pred             eecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccC
Confidence            9999999999999999888875 666544321      122368999999998753

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=314.07  Aligned_cols=177  Identities=47%  Similarity=0.849  Sum_probs=153.6

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-eeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-TNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  259 (362)
                      .+.|...+.||+|+||.||+|...++..||||++.......  ..+|.+|++++.+++|||+|+|+|||.+.+ +.+|||
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            36788889999999999999999999999999875543322  344999999999999999999999999998 599999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|||+|+......
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence            99999999999986554378999999999999999999999888899999999999999999999999999997654311


Q ss_pred             Cceeeccc-cCccCccccccccc
Q 018036          340 ASECMSAV-AGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~-~Gt~~y~aPE~~~~  361 (362)
                      . . .... .||.+|+||||.++
T Consensus       232 ~-~-~~~~~~gt~gY~~PEy~~~  252 (361)
T KOG1187|consen  232 T-S-VSTTVMGTFGYLAPEYAST  252 (361)
T ss_pred             c-c-eeeecCCCCccCChhhhcc
Confidence            1 1 1222 89999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=301.82  Aligned_cols=174  Identities=31%  Similarity=0.436  Sum_probs=151.4

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ..+|...+.||+|+|++||+|+++ ++..||||.+....-.....+-+..|+.+|+.++|||||.++++++.++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356777778999999999999984 6789999999766544444556889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC------CceEEccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD------FEAHVADFGLAK  333 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~DFGla~  333 (362)
                      |||.||||.++++..  +.+++.++..++.|+|.||++||+.+   ||||||||.|||++..      -.+||+|||+|+
T Consensus        89 EyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999754  35999999999999999999999655   9999999999999764      458999999999


Q ss_pred             cccCCCCceeeccccCccCcccccccccC
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      .+...   ....+.||++.|||||+++.+
T Consensus       164 ~L~~~---~~a~tlcGSplYMAPEV~~~~  189 (429)
T KOG0595|consen  164 FLQPG---SMAETLCGSPLYMAPEVIMSQ  189 (429)
T ss_pred             hCCch---hHHHHhhCCccccCHHHHHhc
Confidence            98743   236788999999999998653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=290.14  Aligned_cols=175  Identities=37%  Similarity=0.579  Sum_probs=150.2

Q ss_pred             hccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-eeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-TNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  261 (362)
                      .+...+.||+|+||+||+|.++....||||++..........+.|.+|+.+|.+++|||||+++|+|.++. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            34455669999999999999976556999999766554444667999999999999999999999999887 78999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccccCCCC
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~~  340 (362)
                      |++|+|.++++..+...+++..+++||.|||+||.|||++. + ||||||||+|||++.++ .+||+|||+++...... 
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999998655677999999999999999999999542 2 99999999999999997 99999999999875432 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ...+...||+.|||||++.+
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~  218 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRG  218 (362)
T ss_pred             -ccccCCCCCccccChhhhcC
Confidence             22445789999999999863

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-38  Score=281.76  Aligned_cols=175  Identities=29%  Similarity=0.455  Sum_probs=150.5

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-----CchhhHHHHHHHHhcCccCcceeEEEEEecC
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK  252 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  252 (362)
                      .+.+.|...+.+|+|+||.|-+|.. ++|+.||||.+.......     ......++|+++|++++|||||+++++++.+
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3557788889999999999999986 579999999997643321     1223467999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC---CceEEccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADF  329 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DF  329 (362)
                      ++.||||||++||+|.+.+-.  .+.+.+..-..++.|++.|+.|||+++   |+||||||+|||+..+   ..+||+||
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             CceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999999954  345778888899999999999999666   9999999999999755   78999999


Q ss_pred             cccccccCCCCceeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|+...   ....+.++||||.|.|||++.+
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~  352 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLAS  352 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheec
Confidence            9999875   3455889999999999999854

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=277.45  Aligned_cols=171  Identities=28%  Similarity=0.393  Sum_probs=149.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-eeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-TNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  259 (362)
                      .+++..+.||+|..|+||++.++ +++.+|+|.+... ......+++.+|++++++++||+||.+||.|..++ ...|+|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            45566789999999999999985 5778899988433 23444556999999999999999999999999999 599999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |||++|||++++...  +.+++....+|+.+|++||.|||+.  ..||||||||+|||++..|++||||||.++.+.+. 
T Consensus       158 EYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999999643  5699999999999999999999962  34999999999999999999999999999988754 


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         ...+++||..|||||-+++
T Consensus       233 ---~a~tfvGT~~YMsPERi~g  251 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISG  251 (364)
T ss_pred             ---hcccccccccccChhhhcC
Confidence               3577899999999998875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=274.48  Aligned_cols=174  Identities=29%  Similarity=0.321  Sum_probs=151.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..++||+|+||+||.++.+ +++.+|+|.+++..-.. .+.+...+|..+|.+++||.||+++-.|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467888999999999999999864 57889999987654322 3445688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      +||+.||.|..+|.  +...+++..+.-++.+|+.||.|||+.+   ||||||||+|||+|++|.++|+|||+++.....
T Consensus       104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999995  4456999999999999999999999555   999999999999999999999999999965433


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        +..+.++|||+.|||||++.+
T Consensus       179 --~~~t~tfcGT~eYmAPEil~~  199 (357)
T KOG0598|consen  179 --GDATRTFCGTPEYMAPEILLG  199 (357)
T ss_pred             --CCccccccCCccccChHHHhc
Confidence              233667999999999999865

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-37  Score=286.77  Aligned_cols=172  Identities=31%  Similarity=0.437  Sum_probs=154.4

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ..|+.+++||+|+|+.||++++ .+|+.||+|++.+..- .....+.+.+|+++.+.++|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5689999999999999999998 7899999999966433 3334456999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |+|+.++|.++++  +.+.+++.++..+..||+.||.|||+.+   |+|||||..|+++++++++||+|||+|..+..++
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999996  4567999999999999999999999555   9999999999999999999999999999987543


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        +...+.||||.|+|||++.
T Consensus       173 --Erk~TlCGTPNYIAPEVl~  191 (592)
T KOG0575|consen  173 --ERKKTLCGTPNYIAPEVLN  191 (592)
T ss_pred             --cccceecCCCcccChhHhc
Confidence              3467899999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-38  Score=268.87  Aligned_cols=179  Identities=25%  Similarity=0.341  Sum_probs=152.6

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEE-EEecCCe-ee
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA-FCSNKET-NL  256 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~  256 (362)
                      .+.+|++.+.||+|.||+||++.. .+|..+|.|.+.-...+....+.+..|+.+|++++|||||++++ .+..++. .+
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            357788899999999999999985 68999999999755455556677999999999999999999998 4444444 78


Q ss_pred             EEEecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEeCCCCCceeeCCCCceEEcccccc
Q 018036          257 LVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL--IIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      ||||||++|+|.++++.  ...+.++++.+++++.|++.||.++|.. -++  |+||||||.||+++.+|.+||+|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999999999999964  3457899999999999999999999952 144  999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.+....  ......+|||.||+||.+..
T Consensus       176 r~l~s~~--tfA~S~VGTPyYMSPE~i~~  202 (375)
T KOG0591|consen  176 RFLSSKT--TFAHSLVGTPYYMSPERIHE  202 (375)
T ss_pred             hHhcchh--HHHHhhcCCCcccCHHHHhc
Confidence            9987532  23567899999999998753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-36  Score=275.52  Aligned_cols=175  Identities=27%  Similarity=0.410  Sum_probs=150.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  257 (362)
                      .+.|+..+.||+|.||.||+|++ .+|+.||+|+++..........-..+||.+|++++||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            46677788999999999999986 6799999999987665555555578999999999999999999998876  68999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |+|||+. ||.-++. ..+-.+++.++..++.|++.||+|+|..+   |+|||||.+|||||.+|.+||+|||+|+++..
T Consensus       196 VFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            9999975 8888885 34556999999999999999999999555   99999999999999999999999999998875


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .... ..+..+-|.+|.|||++.|
T Consensus       271 ~~~~-~~T~rVvTLWYRpPELLLG  293 (560)
T KOG0600|consen  271 SGSA-PYTSRVVTLWYRPPELLLG  293 (560)
T ss_pred             CCCc-ccccceEEeeccChHHhcC
Confidence            4433 3556677999999999876

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-35  Score=251.74  Aligned_cols=174  Identities=30%  Similarity=0.448  Sum_probs=151.2

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|...+.+|+|.||.||+|++ .+|+.||||+++.....+.......+|++.|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677788999999999999986 679999999998765554444558899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||+ .+|+..+++ +...++...+..++.++.+|++|||...   |+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus        82 fm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            995 599999974 4467889999999999999999999665   99999999999999999999999999999875443


Q ss_pred             ceeeccccCccCcccccccccC
Q 018036          341 SECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      ..  ...+-|.+|.|||++.|+
T Consensus       157 ~~--~~~V~TRWYRAPELLfGs  176 (318)
T KOG0659|consen  157 IQ--THQVVTRWYRAPELLFGS  176 (318)
T ss_pred             cc--ccceeeeeccChHHhccc
Confidence            32  233679999999999875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5e-36  Score=258.23  Aligned_cols=173  Identities=27%  Similarity=0.362  Sum_probs=147.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.|+....+|+|+||+||+|+++ +|+.||||++.....+....+-..+|+++|++++|+|+|.++++|..+...++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56777889999999999999985 68999999998766555555557899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||+. ++.+-|.... ..++...+.+++.|++.|+.|+|.+.   ++||||||+|||++.++.+||||||+|+.+..++ 
T Consensus        82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-  155 (396)
T ss_pred             ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence            9976 4445554333 34788899999999999999999555   9999999999999999999999999999987533 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ..-+..+.|.+|.|||++.|
T Consensus       156 -d~YTDYVATRWYRaPELLvG  175 (396)
T KOG0593|consen  156 -DNYTDYVATRWYRAPELLVG  175 (396)
T ss_pred             -chhhhhhhhhhccChhhhcc
Confidence             33566788999999998754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=268.96  Aligned_cols=171  Identities=30%  Similarity=0.443  Sum_probs=143.4

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhc--CccCcceeEEEEEecCC----ee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK--IRHRNIVRLKAFCSNKE----TN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~  255 (362)
                      ..++..++||+|+||.||||.+. ++.||||++....     .+.|++|-++.+.  ++|+||++++++-....    ++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            34455688999999999999984 5999999984322     2337777776665  58999999999876555    78


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC------SPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                      +||+||.+.|+|.++|...   .++|....+|+.-+++||+|||+..      .++|+|||||++|||+.+|+++.|+||
T Consensus       284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999999754   4899999999999999999999753      578999999999999999999999999


Q ss_pred             cccccccCCCCceeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|..+............+||.+|||||++.+
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEg  392 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEG  392 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence            99999875444444556789999999999865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=252.20  Aligned_cols=171  Identities=26%  Similarity=0.303  Sum_probs=149.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +++|+....||.|+||+|..++.+ +|..+|+|.+....--. .+.+...+|..+|+.+.||.++++++.+.+....+||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            467788899999999999999875 57889999886543221 2234578899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||.+||.|.++++.  .+.+++..+..+|.||+.||+|||..   .|++||+||+|||+|.+|.+||+|||+|+...+.
T Consensus       123 meyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999964  34699999999999999999999955   4999999999999999999999999999987642


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           +.+.||||.|+|||++++
T Consensus       198 -----T~TlCGTPeYLAPEii~s  215 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQS  215 (355)
T ss_pred             -----EEEecCCccccChHHhhc
Confidence                 678899999999999864

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-34  Score=251.96  Aligned_cols=175  Identities=29%  Similarity=0.342  Sum_probs=149.5

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  257 (362)
                      .+.|+..+.|++|+||.||+|+++ +++.||+|+++.........---.+||.+|.+++|||||.+..+....  +.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            467888899999999999999984 678899999987665444333368999999999999999999988654  57899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||||+. +|..++..-. +.+...++..++.|+++|++|||...   |+|||||++|+|+...|.+||+|||+|+.+.+
T Consensus       155 VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            9999975 9999997443 57888999999999999999999776   99999999999999999999999999999875


Q ss_pred             CCCceeeccccCccCcccccccccC
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      +.  ...+..+-|.+|.|||++.++
T Consensus       230 p~--k~~T~lVVTLWYRaPELLLG~  252 (419)
T KOG0663|consen  230 PL--KPYTPLVVTLWYRAPELLLGA  252 (419)
T ss_pred             Cc--ccCcceEEEeeecCHHHhcCC
Confidence            42  235666779999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-34  Score=265.50  Aligned_cols=174  Identities=28%  Similarity=0.367  Sum_probs=149.4

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC--CC-CchhhHHHHHHHHhcCc-cCcceeEEEEEecCCee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK--GS-SHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETN  255 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  255 (362)
                      ...|...+.||+|+||+|+.|.+ .+++.||+|.+.....  .. ...+.+.+|+.++++++ ||||+++++++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            46788899999999999999976 4679999996644311  11 23345778999999999 99999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEcccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKY  334 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~  334 (362)
                      ++||||+.+|+|.+++..  ...+.+..+.+++.|++.|++|+|..+   |+||||||+|||+|.+ +++||+|||++..
T Consensus        96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            999999999999999975  456888999999999999999999554   9999999999999999 9999999999998


Q ss_pred             ccCCCCceeeccccCccCccccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  .......+.+||+.|+|||++.+
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~  195 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSG  195 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCC
Confidence            74  22234678899999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=267.90  Aligned_cols=174  Identities=25%  Similarity=0.367  Sum_probs=152.6

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCC-e
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE-T  254 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~  254 (362)
                      ..++++|...+.||.|.||.||+|+. .++..||||+++..... .++..-.+|+..|+++. |||||++.+++.+.+ .
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            35678999999999999999999985 57889999998765432 33334578999999998 999999999998888 8


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||| ..+|+++++++ +..+++..+..|+.||++||+|+|++|   +.|||+||+|||+.....+||+|||+||.
T Consensus        85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            99999999 56999999866 788999999999999999999999776   99999999999999888999999999998


Q ss_pred             ccCCCCceeeccccCccCcccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +...   ...+..+.|.+|.|||++.
T Consensus       160 v~Sk---pPYTeYVSTRWYRAPEvLL  182 (538)
T KOG0661|consen  160 VRSK---PPYTEYVSTRWYRAPEVLL  182 (538)
T ss_pred             cccC---CCcchhhhcccccchHHhh
Confidence            8643   3356778999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=264.49  Aligned_cols=174  Identities=30%  Similarity=0.468  Sum_probs=148.2

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +.++..+.||+|.||+||.|.+.....||+|.++...   ...+.|.+|+++|++++|+|||+++++|..++.++|||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            4556678999999999999999888899999997653   2334489999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      |+.|+|.++|+...+..+...+.+.++.|||+||+||++++   +|||||.++|||++++..+||+|||+|+...+... 
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-  358 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-  358 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-
Confidence            99999999998767788999999999999999999999554   99999999999999999999999999996554322 


Q ss_pred             eeeccccCccCcccccccccC
Q 018036          342 ECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      .......-...|.|||.+..+
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~  379 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYG  379 (468)
T ss_pred             eecCCCCCCceecCHHHHhhC
Confidence            112222234579999988653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=252.05  Aligned_cols=173  Identities=33%  Similarity=0.493  Sum_probs=145.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC--eeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE--TNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  258 (362)
                      ..+...+.||+|+||.||++... +|...|||.+.....  ...+.+.+|+.+|.+++|||||+++|.....+  ..++.
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            34666789999999999999975 489999998865421  11445899999999999999999999865555  58899


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccccccccC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQD  337 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~  337 (362)
                      |||+++|+|.+++....+ .+++..+.++.+||++||+|||++   +||||||||+|||++. ++.+||+|||+++....
T Consensus        95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999986665 799999999999999999999955   4999999999999999 79999999999998763


Q ss_pred             -CCCceeeccccCccCcccccccc
Q 018036          338 -TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 -~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ...........||+.|||||++.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~  194 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIR  194 (313)
T ss_pred             ccccccccccccCCccccCchhhc
Confidence             11112244578999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.9e-34  Score=265.18  Aligned_cols=172  Identities=30%  Similarity=0.391  Sum_probs=150.9

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|...+.||+|+||+||||+.+ +.+.||+|.+.+..+...+...+.+|++++++++|||||.++++|++..+.|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56777789999999999999875 57789999987766666566669999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+.| +|..+|..  ...++++.+..++.|+..||.|||.   .+|+|||+||.|||++..|.+|+||||+|+.+...  
T Consensus        82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--  153 (808)
T ss_pred             hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence            9966 99999953  4569999999999999999999995   45999999999999999999999999999987642  


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....+...|||.|||||+..+
T Consensus       154 t~vltsikGtPlYmAPElv~e  174 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEE  174 (808)
T ss_pred             ceeeeeccCcccccCHHHHcC
Confidence            234667789999999998754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=252.44  Aligned_cols=175  Identities=31%  Similarity=0.404  Sum_probs=154.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||.|..++||+|+. +.++.||||++.-...... .+.+++|+..|+.++||||++++..|..+...|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            46788899999999999999986 5679999999865544333 466999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      .||.+||+.++++..-...+++..+..|.+++++||.|||++|   .||||||+.||||+++|.+||+|||.+..+.+.+
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999998765566999999999999999999999776   9999999999999999999999999998887655


Q ss_pred             Ccee--eccccCccCccccccc
Q 018036          340 ASEC--MSAVAGSYGYIAPVLG  359 (362)
Q Consensus       340 ~~~~--~~~~~Gt~~y~aPE~~  359 (362)
                      ....  ..+++||+.|||||++
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl  202 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVL  202 (516)
T ss_pred             ceeeEeeccccCcccccChHHh
Confidence            3322  2567899999999994

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-34  Score=261.14  Aligned_cols=175  Identities=29%  Similarity=0.358  Sum_probs=148.5

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+|..++.||+|+|++|++|+. .+++.+|||++.+.-- .....+...+|-.+|.+| .||.|++|+..|++....|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            5678899999999999999986 4688999998854321 122334477888999999 899999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      +||+++|+|.++|+..  +.+++..+..++.||+.||+|||.   .+||||||||+|||+|.+|++||+|||-|+.+.+.
T Consensus       153 Le~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            9999999999999644  569999999999999999999995   45999999999999999999999999999998643


Q ss_pred             CCc-----------eeeccccCccCccccccccc
Q 018036          339 GAS-----------ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~-----------~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...           .....++||..|++||++..
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~  261 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND  261 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcC
Confidence            222           11256899999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=260.82  Aligned_cols=172  Identities=30%  Similarity=0.383  Sum_probs=150.7

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +....|+....||+|+.|.||.|.. .+++.||||++........  +-+.+|+.+|+..+|+|||.+++.|...++.|+
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            4456788889999999999999975 5688999999865544333  338999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||||++|+|.|.+...   .+++.++..|++++++||+|||..+   |+|||||.+|||++.+|.+||+|||++..+..
T Consensus       348 VMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            99999999999998643   3899999999999999999999665   99999999999999999999999999998875


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ...+.+|||+|||||++.
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvt  442 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVT  442 (550)
T ss_pred             ccC--ccccccCCCCccchhhhh
Confidence            433  356788999999999874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-34  Score=253.47  Aligned_cols=174  Identities=23%  Similarity=0.356  Sum_probs=153.8

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +.-+|+..+.||+|.||.|-+|.. ..|+.||||.+++..- +......+.+|+++|+.++||||+.++++|+..+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            356788889999999999999986 6799999999876543 33344568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||..+|.|+|++..  .+.+++..+..+++||..|+.|+|.++   ++|||||.+|||+|.++++||+|||++..+.+
T Consensus       131 vMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999954  455999999999999999999999665   99999999999999999999999999998865


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .   ....++||+|-|.+||++.|
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG  226 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNG  226 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCC
Confidence            3   33678999999999998754

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.7e-33  Score=244.30  Aligned_cols=176  Identities=26%  Similarity=0.342  Sum_probs=147.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc-ceeEEEEEecCC-----
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKE-----  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----  253 (362)
                      ++.|+..+.||+|+||+||+|+. .+|+.||+|+++.....+.......+|+.++++++|+| ||++++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45667778899999999999986 47889999999866553333334789999999999999 999999998877     


Q ss_pred             -eeeEEEecCCCCChhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          254 -TNLLVYEYMPNGSLGEVLHGKRG--SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       254 -~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                       ..++|+||+ .-+|.+++.....  ..++...+..+++|++.||+|||+++   |+||||||.|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             788999999 5699999975543  35777889999999999999999655   9999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCcccccccccC
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      +|+...-+.  ...+..++|.+|.|||++.++
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs  195 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGS  195 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCC
Confidence            999765222  224566789999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=250.52  Aligned_cols=177  Identities=28%  Similarity=0.357  Sum_probs=145.4

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCC------------chhhHHHHHHHHhcCccCcceeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS------------HDNGLSAEIRTLGKIRHRNIVRL  245 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l  245 (362)
                      ..++.|+....||+|.||.|-+|+. .+++.||+|.+.+......            ..+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3468899999999999999999987 4688999999865432111            12468899999999999999999


Q ss_pred             EEEEecC--CeeeEEEecCCCCChhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC
Q 018036          246 KAFCSNK--ETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF  322 (362)
Q Consensus       246 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  322 (362)
                      +++..++  +..|||+|||..|.+...=   ..+. +++.++.++++++..||+|||.++   ||||||||+|+|++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            9999876  4789999999988875432   3334 899999999999999999999666   99999999999999999


Q ss_pred             ceEEccccccccccCC---CCceeeccccCccCccccccccc
Q 018036          323 EAHVADFGLAKYLQDT---GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~---~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++||+|||.+......   +........+|||.|||||+..+
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~  289 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG  289 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence            9999999999876321   12223445789999999998765

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.2e-33  Score=254.61  Aligned_cols=149  Identities=27%  Similarity=0.336  Sum_probs=132.4

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+....||+|+||.||.|+.+ +|..+|+|++++..... .+......|-.+|...++|+||+++..|++.++.||||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            67788899999999999999864 68999999997655422 23345888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ||++||++..+|.  +...+++..+..++.+++.|++-||+.+   +|||||||+|+|||..|++||+|||++.-+
T Consensus       221 EylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  221 EYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999995  4457999999999999999999999666   999999999999999999999999998643

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.6e-33  Score=234.17  Aligned_cols=174  Identities=28%  Similarity=0.370  Sum_probs=152.5

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+.++.||+|.||.||.|+.+ ++..||+|++.+..- .......+.+|+++-+.++||||+++++++.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            477899999999999999999864 577899999865432 222334589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      +||.++|++...|...+...+++.....++.|+|.||.|+|   .+.|+||||||+|+|++.++..||+|||.+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998777888999999999999999999999   5669999999999999999999999999997643  


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .....+.|||..|.|||...+
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~  196 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEG  196 (281)
T ss_pred             --CCCceeeecccccCCHhhcCC
Confidence              223567899999999998754

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=5.6e-33  Score=258.95  Aligned_cols=173  Identities=32%  Similarity=0.436  Sum_probs=150.5

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .+.+...+.||+|+||+||+|.|.  -.||||++......+...+.|.+|+.++++-+|.||+-+.|||..+.. .||+.
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            456677899999999999999984  359999998877777777889999999999999999999999998887 99999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      +|+|-+|+.+++..+ ..++..+..+||.|||+||.|||   .+.|||||||+.||++++++.+||+|||++..-.....
T Consensus       468 wCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             hccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            999999999998654 45888999999999999999999   45599999999999999999999999999976544333


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........|..-|||||+++
T Consensus       544 ~~q~~qp~gsilwmAPEvIR  563 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIR  563 (678)
T ss_pred             ccccCCCccchhhhcHHHHh
Confidence            33355567889999999874

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.98  E-value=1.1e-32  Score=243.87  Aligned_cols=167  Identities=33%  Similarity=0.409  Sum_probs=135.6

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----eee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNL  256 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  256 (362)
                      .|...+++|+|+||.||+|... +++.||||++....+.      -.+|+++|++++|||||++.-+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            4667789999999999999874 5689999998544332      357999999999999999988876432     234


Q ss_pred             EEEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~  333 (362)
                      +|||||+. +|.+.++..  .+..++.-.+.-+..|+.+||.|||..   +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999975 999998742  234577777788999999999999954   49999999999999966 999999999999


Q ss_pred             cccCCCCceeeccccCccCcccccccccC
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      .+.....   .....-|..|.|||++.||
T Consensus       175 ~L~~~ep---niSYicSRyYRaPELifga  200 (364)
T KOG0658|consen  175 VLVKGEP---NISYICSRYYRAPELIFGA  200 (364)
T ss_pred             eeccCCC---ceeEEEeccccCHHHHcCc
Confidence            9864322   3455668999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-32  Score=243.63  Aligned_cols=171  Identities=32%  Similarity=0.398  Sum_probs=140.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC--ccCcceeEEEEEecCC----e
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI--RHRNIVRLKAFCSNKE----T  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~  254 (362)
                      ..+....+.||+|.||+||+|.+ .|+.||||++....     ++.+.+|.++.+..  +|+||+.+++.-..++    .
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            35566678999999999999999 57899999985332     23366777777654  9999999998765443    5


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-----DCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                      .|||++|.|.|||+|+|..   ..++.+..++++..+|.||+|||.     ++.|.|.|||||+.|||+..++.+.|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            6899999999999999964   458899999999999999999994     56889999999999999999999999999


Q ss_pred             cccccccCCCC--ceeeccccCccCcccccccc
Q 018036          330 GLAKYLQDTGA--SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       330 Gla~~~~~~~~--~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+|........  .......+||.+|||||++-
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence            99987653321  12245678999999999873

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=256.64  Aligned_cols=173  Identities=29%  Similarity=0.340  Sum_probs=146.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      +++|....+||+|.||+|+.+..+ +++.+|||.+++..-- ..+-+....|.+++.-. +||.++.++..|+++++.|.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            467788899999999999999975 5789999999876542 22334467788877777 59999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+.||++..+.+   ...+++..+..+|..|+.||+|||+++   ||+||||.+|||+|.+|.+||+|||+++.--.
T Consensus       447 vmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence            999999999655543   345999999999999999999999666   99999999999999999999999999997542


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ....++++||||.|||||++++
T Consensus       521 --~g~~TsTfCGTpey~aPEil~e  542 (694)
T KOG0694|consen  521 --QGDRTSTFCGTPEFLAPEVLTE  542 (694)
T ss_pred             --CCCccccccCChhhcChhhhcc
Confidence              2345789999999999999864

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.1e-32  Score=234.42  Aligned_cols=175  Identities=29%  Similarity=0.458  Sum_probs=151.5

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCc------hhhHHHHHHHHhcC-ccCcceeEEEE
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSH------DNGLSAEIRTLGKI-RHRNIVRLKAF  248 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l-~h~niv~l~~~  248 (362)
                      .+++++.|...+.+|+|..++|.++.+ +++.+.|+|++.........      .++-.+|+.+|+++ .||+|+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            356778899999999999999999987 46889999998654432211      23456799999998 69999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       249 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                      |+++...++|+|.|+.|.|.|+|..  .-.++++...+|++|+.+|++|||...   ||||||||+|||+|++.++||+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            9999999999999999999999953  456899999999999999999999655   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ||+|..+..   ++.....||||+|.|||.+
T Consensus       167 FGFa~~l~~---GekLrelCGTPgYLAPEti  194 (411)
T KOG0599|consen  167 FGFACQLEP---GEKLRELCGTPGYLAPETI  194 (411)
T ss_pred             cceeeccCC---chhHHHhcCCCcccChhhe
Confidence            999998864   3447789999999999976

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.3e-32  Score=251.91  Aligned_cols=176  Identities=26%  Similarity=0.369  Sum_probs=156.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe-eeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET-NLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv  258 (362)
                      +++|...+.+|+|+||.++..+++ ++..+++|++.........++...+|+.++++++|||||.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            467788899999999999999874 57799999998766655555568999999999999999999999998887 8999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |+|++||+|.+.+...++..++++.+.+|+.|++.|+.|||+..   |+|||||+.||++..+..+||+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999999888889999999999999999999999555   999999999999999999999999999998754


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ....+.+||+.||+||++.+
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d  180 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSD  180 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCC
Confidence            3  23567899999999998764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-31  Score=252.70  Aligned_cols=171  Identities=30%  Similarity=0.398  Sum_probs=150.4

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      -|+.++.||.|+.|.|-.|++ .+|+.+|||.+..... .......+++|+-+|+-+.||||+++++++++..+.|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            456678999999999999987 5899999999976633 33344569999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|.|++++-  +.+.+++.++.++++||+.|+.|+|..+   |+|||+||+|+|+|..+++||+|||+|..-..   
T Consensus        93 yv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---  164 (786)
T KOG0588|consen   93 YVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP---  164 (786)
T ss_pred             ecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence            999999999995  3456899999999999999999999665   99999999999999999999999999986432   


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +....+-||+|.|.|||+++|
T Consensus       165 gklLeTSCGSPHYA~PEIV~G  185 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSG  185 (786)
T ss_pred             CccccccCCCcccCCchhhcC
Confidence            345678899999999999875

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=2.5e-31  Score=250.13  Aligned_cols=150  Identities=27%  Similarity=0.309  Sum_probs=130.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||+||+|... +++.||+|.+..... .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            35778899999999999999864 588999999865322 1222345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999964  345899999999999999999999555   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=3e-31  Score=247.14  Aligned_cols=175  Identities=27%  Similarity=0.396  Sum_probs=139.9

Q ss_pred             hhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC-
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE-  253 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  253 (362)
                      ++|+..+.||+|+||.||+|.+      .+++.||+|++.... .......+.+|+.++.++ +||||++++++|...+ 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            5788889999999999999974      235689999886432 222334588999999999 8999999999987654 


Q ss_pred             eeeEEEecCCCCChhhhhcCCC----------------------------------------------------------
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKR----------------------------------------------------------  275 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  275 (362)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999986422                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCc
Q 018036          276 --GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY  353 (362)
Q Consensus       276 --~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y  353 (362)
                        ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              124778888999999999999999554   999999999999999999999999999876432221122334567899


Q ss_pred             ccccccc
Q 018036          354 IAPVLGW  360 (362)
Q Consensus       354 ~aPE~~~  360 (362)
                      +|||++.
T Consensus       243 ~aPE~~~  249 (338)
T cd05102         243 MAPESIF  249 (338)
T ss_pred             cCcHHhh
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=3.7e-31  Score=249.24  Aligned_cols=173  Identities=25%  Similarity=0.271  Sum_probs=145.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||++... +++.+|+|.+..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            367888899999999999999875 578899998864322 122234578899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            9999999999999643   3788999999999999999999655   999999999999999999999999999876533


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .. ......+||+.|||||++.
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~  216 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLK  216 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHh
Confidence            22 1234567999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=2.7e-31  Score=247.43  Aligned_cols=170  Identities=24%  Similarity=0.266  Sum_probs=144.7

Q ss_pred             hhhccccceeeccCcccEEEEEcCC--CCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN--GEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|.+..  +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4678888999999999999998643  36899998864322 22233458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999643  45899999999999999999999555   99999999999999999999999999987643


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .     .....||+.|||||++.
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~  201 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILL  201 (340)
T ss_pred             C-----cceecCChhhcCHHHHh
Confidence            2     23467999999999874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=6.5e-31  Score=239.09  Aligned_cols=172  Identities=27%  Similarity=0.317  Sum_probs=144.6

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |+..+.||+|+||.||+|.. .+++.||+|.+...... ......+.+|+.++++++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            55678899999999999986 57899999988654322 22233478899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999998886544456899999999999999999999554   9999999999999999999999999998764321  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......||+.|||||++.+
T Consensus       157 -~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINN  175 (285)
T ss_pred             -eecCCCCCCCccCHhhhcC
Confidence             1344579999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=3.3e-31  Score=245.99  Aligned_cols=170  Identities=25%  Similarity=0.303  Sum_probs=145.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            467888899999999999999875 578999999865322 122334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...+.
T Consensus        97 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999999643  45888999999999999999999655   999999999999999999999999999876432


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                           .....||+.|+|||++.
T Consensus       172 -----~~~~~gt~~y~aPE~~~  188 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQ  188 (329)
T ss_pred             -----cceecCChhhcCHHHHc
Confidence                 23457999999999875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=5.8e-31  Score=243.70  Aligned_cols=166  Identities=26%  Similarity=0.298  Sum_probs=140.1

Q ss_pred             ceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          188 NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      +.||+|+||.||+|.. .+++.||+|.+..... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986 4688999999875332 1222345788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                      +|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~  153 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence            99999864  345899999999999999999999655   9999999999999999999999999998643221  2234


Q ss_pred             cccCccCcccccccc
Q 018036          346 AVAGSYGYIAPVLGW  360 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~  360 (362)
                      ..+||+.|+|||++.
T Consensus       154 ~~~gt~~y~aPE~~~  168 (323)
T cd05571         154 TFCGTPEYLAPEVLE  168 (323)
T ss_pred             ceecCccccChhhhc
Confidence            567999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=253.85  Aligned_cols=173  Identities=34%  Similarity=0.399  Sum_probs=147.2

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .+|....|.+.+.||.|+||.||-|++ .+.+.||||++.-..+.. ...+++.+|+..|.+++|||++.+.|+|.....
T Consensus        21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            345567788888999999999999997 467789999985443322 233569999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .||||||| -|+-.|++.-. .+++.+..+..|..+.+.||+|||   +.+.||||||+.|||+++.|.+||+|||.|..
T Consensus       101 aWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhh
Confidence            99999999 67888887532 356888899999999999999999   44599999999999999999999999999987


Q ss_pred             ccCCCCceeeccccCccCcccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...      ...++|||+|||||++.
T Consensus       176 ~~P------AnsFvGTPywMAPEVIL  195 (948)
T KOG0577|consen  176 MAP------ANSFVGTPYWMAPEVIL  195 (948)
T ss_pred             cCc------hhcccCCccccchhHhe
Confidence            653      45789999999999985

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.9e-31  Score=248.82  Aligned_cols=148  Identities=24%  Similarity=0.291  Sum_probs=128.7

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||++.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            577788999999999999986 4688999999864322 12233458889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          82 FLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999964  345889999999999999999999555   999999999999999999999999999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=237.23  Aligned_cols=174  Identities=30%  Similarity=0.443  Sum_probs=148.9

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-----CCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-----KETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~  255 (362)
                      ..|...+.||+|+||.|+.|.+ .+|+.||+|++..........++..+|+++|+.++|+||+.+.+.+..     -+..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4455568899999999999987 578999999998766666667779999999999999999999998865     3578


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      |+|+|+| +.+|.+.++..  +.++...+..++.|+++||.|+|+.+   |+|||+||+|++++.+..+||+|||+|+..
T Consensus       102 YiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             EEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence            9999999 67999999643  44899999999999999999999555   999999999999999999999999999988


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........++..+-|.+|.|||++..
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhc
Confidence            64322334677788999999998754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-31  Score=242.38  Aligned_cols=169  Identities=27%  Similarity=0.317  Sum_probs=144.1

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5677889999999999999875 688999999864322 11233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...+.  
T Consensus        82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          82 YVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999999999643  45889999999999999999999655   999999999999999999999999999876432  


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         .....||+.|+|||++.+
T Consensus       155 ---~~~~~gt~~y~aPE~~~~  172 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQS  172 (291)
T ss_pred             ---cccccCChhhcCHHHHcC
Confidence               234579999999998653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-31  Score=242.17  Aligned_cols=167  Identities=28%  Similarity=0.452  Sum_probs=146.4

Q ss_pred             cceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          187 NNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .+.||+|.||+||-|.+ ++|+.||||.+.+..-....+..+.+|+.+|++++||.||.+-..|++++..++|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            47999999999999987 57999999999776555555567999999999999999999999999999999999999 67


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC---CceEEccccccccccCCCCce
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~~~~~~~~~  342 (362)
                      +..+.+-..+...+++.....++.||+.||.|||..+   |+|+||||+|||+.+.   -++||||||+|+++.+.   .
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---s  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---S  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---h
Confidence            8888887777788999998999999999999999555   9999999999999643   46999999999998653   2


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      .....+|||.|.|||+++
T Consensus       722 FRrsVVGTPAYLaPEVLr  739 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLR  739 (888)
T ss_pred             hhhhhcCCccccCHHHHh
Confidence            356788999999999975

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.2e-31  Score=247.52  Aligned_cols=149  Identities=27%  Similarity=0.324  Sum_probs=130.1

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||+|... +++.||||++..... .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            5777899999999999999874 688999999865321 12223457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          82 YLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999643  45899999999999999999999655   9999999999999999999999999997653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=8.8e-31  Score=247.94  Aligned_cols=148  Identities=22%  Similarity=0.286  Sum_probs=128.3

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .|+..+.||+|+||+||+|.. .+++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            466778999999999999986 4678999999865332 22233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||..+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999998643  45888999999999999999999655   999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=243.24  Aligned_cols=175  Identities=30%  Similarity=0.413  Sum_probs=152.1

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCc-cCcceeEEEEEecCC
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE  253 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  253 (362)
                      .+++.+.|+..+.||+|.||.||+++.+. |+.+|+|.+.+..... ...+.+.+|+.+|+++. |||||.+++++++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            34556788889999999999999999864 9999999997655432 23455999999999998 999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC----CceEEccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAHVADF  329 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DF  329 (362)
                      ..++|||+++||.|.+.+...   .+++..+..++.|++.++.|||..   +|+|||+||+|+|+...    +.+|++||
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            999999999999999999755   399999999999999999999954   49999999999999643    57999999


Q ss_pred             cccccccCCCCceeeccccCccCcccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |++.....   .......+||+.|+|||++.
T Consensus       184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~  211 (382)
T KOG0032|consen  184 GLAKFIKP---GERLHTIVGTPEYVAPEVLG  211 (382)
T ss_pred             CCceEccC---CceEeeecCCccccCchhhc
Confidence            99998865   34477889999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=1.3e-30  Score=239.22  Aligned_cols=175  Identities=24%  Similarity=0.353  Sum_probs=142.1

Q ss_pred             hhccccceeeccCcccEEEEEcCC-----------------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCccee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-----------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR  244 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  244 (362)
                      ++|...+.||+|+||.||+|.+.+                 +..||+|.+..... .....++.+|++++.+++||||++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeE
Confidence            567888999999999999997532                 33699998764322 223345889999999999999999


Q ss_pred             EEEEEecCCeeeEEEecCCCCChhhhhcCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 018036          245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII  307 (362)
Q Consensus       245 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv  307 (362)
                      +++++...+..++||||+++|+|.+++....                 ...+++..+.+++.|++.||+|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999885321                 124788889999999999999999655   99


Q ss_pred             EeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       308 H~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||||||+|||++.++.+||+|||+++...............++..|||||++.
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  213 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL  213 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence            99999999999999999999999998764332222233445688999999764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=1.9e-30  Score=240.79  Aligned_cols=167  Identities=26%  Similarity=0.299  Sum_probs=140.4

Q ss_pred             ceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          188 NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      +.||+|+||.||++.. .+++.||+|.+..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999986 4688999999865432 2223345788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                      +|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  153 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK  153 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence            99998854  345899999999999999999999655   9999999999999999999999999998643221  1234


Q ss_pred             cccCccCccccccccc
Q 018036          346 AVAGSYGYIAPVLGWY  361 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~~  361 (362)
                      ..+||+.|+|||++.+
T Consensus       154 ~~~gt~~y~aPE~~~~  169 (328)
T cd05593         154 TFCGTPEYLAPEVLED  169 (328)
T ss_pred             cccCCcCccChhhhcC
Confidence            5679999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=1.6e-30  Score=240.70  Aligned_cols=167  Identities=26%  Similarity=0.302  Sum_probs=139.8

Q ss_pred             ceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          188 NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      +.||+|+||.||++.. .++..||+|.+..... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999986 4688999999865422 1222344778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                      +|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  153 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence            99998853  345899999999999999999999655   9999999999999999999999999987643221  1234


Q ss_pred             cccCccCccccccccc
Q 018036          346 AVAGSYGYIAPVLGWY  361 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~~  361 (362)
                      ...||+.|+|||++.+
T Consensus       154 ~~~gt~~y~aPE~~~~  169 (323)
T cd05595         154 TFCGTPEYLAPEVLED  169 (323)
T ss_pred             cccCCcCcCCcccccC
Confidence            5679999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=1.6e-30  Score=245.17  Aligned_cols=173  Identities=25%  Similarity=0.276  Sum_probs=145.0

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||++... +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467888899999999999999874 688999999864322 122233478899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999998643   3788889999999999999999554   999999999999999999999999999876432


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .. ......+||+.|+|||++.
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~  216 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLK  216 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhc
Confidence            21 1134567999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=242.83  Aligned_cols=169  Identities=25%  Similarity=0.319  Sum_probs=145.0

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||+|.+. +++.||+|++..... .......+.+|++++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5777889999999999999975 588999999865422 12233458889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....   
T Consensus        82 ~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          82 YVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999953  345889999999999999999999655   99999999999999999999999999986643   


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ......||+.|+|||++.+
T Consensus       154 --~~~~~~gt~~y~aPE~~~~  172 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRG  172 (333)
T ss_pred             --ccCCcccCccccChhHhcC
Confidence              1345679999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=1.5e-30  Score=245.98  Aligned_cols=147  Identities=23%  Similarity=0.293  Sum_probs=127.8

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+..... .......+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            5777899999999999999864 688999999854321 12233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|..
T Consensus        82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            99999999999643  45888888999999999999999655   99999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.4e-30  Score=246.75  Aligned_cols=147  Identities=23%  Similarity=0.287  Sum_probs=127.6

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+..... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            467788999999999999987 4678999999864322 12223458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999998643  45888999999999999999999655   99999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-31  Score=246.28  Aligned_cols=173  Identities=27%  Similarity=0.352  Sum_probs=140.2

Q ss_pred             hccccceeeccCcccEEEEEcCC--C---CEEEEEEeeccC-CCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPN--G---EQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +....+.||+|+||.||+|.+..  +   ..||||..+... .......+|.+|.++|++++|||||+++|++......+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34456899999999999998742  2   238999887532 23344567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +|||+|.||+|.++|....+ .++..++..++.+.|.||+|||..   .++||||.++|+|++.++.+||+|||+++.-.
T Consensus       238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999975443 689999999999999999999954   49999999999999999999999999988653


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......  ....-...|+|||.+.+
T Consensus       314 ~~~~~~--~~~klPirWLAPEtl~~  336 (474)
T KOG0194|consen  314 QYVMKK--FLKKLPIRWLAPETLNT  336 (474)
T ss_pred             ceeecc--ccccCcceecChhhhcc
Confidence            111110  01113468999998765

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=1.9e-30  Score=241.08  Aligned_cols=174  Identities=24%  Similarity=0.236  Sum_probs=144.9

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+..... .......+.+|..++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35778899999999999999874 578899998864321 1222344788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999643 245889999999999999999999555   9999999999999999999999999998765332


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .. ......||+.|+|||++.
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~  176 (331)
T cd05624         157 TV-QSSVAVGTPDYISPEILQ  176 (331)
T ss_pred             ce-eeccccCCcccCCHHHHh
Confidence            21 123457999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=238.97  Aligned_cols=165  Identities=26%  Similarity=0.260  Sum_probs=139.0

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      ||+|+||.||+|.+. +++.||+|.+..... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999875 578999999864322 222334578899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      .+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ......
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~  153 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF  153 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence            999964  345899999999999999999999555   9999999999999999999999999998643221  123456


Q ss_pred             cCccCccccccccc
Q 018036          348 AGSYGYIAPVLGWY  361 (362)
Q Consensus       348 ~Gt~~y~aPE~~~~  361 (362)
                      +||+.|+|||++.+
T Consensus       154 ~gt~~y~aPE~~~~  167 (312)
T cd05585         154 CGTPEYLAPELLLG  167 (312)
T ss_pred             cCCcccCCHHHHcC
Confidence            79999999998753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=3.6e-30  Score=238.58  Aligned_cols=168  Identities=26%  Similarity=0.294  Sum_probs=139.5

Q ss_pred             ceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          188 NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      +.||+|+||.||++.. .+++.||+|.+..... ......++.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986 4688999999865332 1222345778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                      +|.+++..  ...+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            99998853  34589999999999999999999951  349999999999999999999999999997643221  1234


Q ss_pred             cccCccCccccccccc
Q 018036          346 AVAGSYGYIAPVLGWY  361 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~~  361 (362)
                      ...||+.|+|||++.+
T Consensus       155 ~~~gt~~y~aPE~~~~  170 (325)
T cd05594         155 TFCGTPEYLAPEVLED  170 (325)
T ss_pred             cccCCcccCCHHHHcc
Confidence            5679999999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=2.2e-30  Score=244.10  Aligned_cols=173  Identities=25%  Similarity=0.252  Sum_probs=145.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||++.+. +++.+|+|.+..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367888999999999999999875 578899998864322 122234478899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       122 ~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         122 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            9999999999998643   3788888999999999999999555   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .. ......+||+.|||||++.
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~l~  216 (371)
T cd05622         196 GM-VRCDTAVGTPDYISPEVLK  216 (371)
T ss_pred             Cc-ccccCcccCccccCHHHHh
Confidence            21 1234567999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=240.95  Aligned_cols=174  Identities=25%  Similarity=0.259  Sum_probs=144.9

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            35778899999999999999864 588999999864221 1223345888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999642 345889999999999999999999655   9999999999999999999999999998765322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      . .......||+.|||||++.
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05597         157 T-VQSNVAVGTPDYISPEILQ  176 (331)
T ss_pred             C-ccccceeccccccCHHHHh
Confidence            2 1123356999999999874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=4.4e-30  Score=233.97  Aligned_cols=171  Identities=26%  Similarity=0.371  Sum_probs=142.3

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            56888899999999999999874 678999998864332 2223347899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |++ ++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          84 YLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            996 5999988633 345788999999999999999999555   9999999999999999999999999998654221 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......||+.|+|||++.
T Consensus       158 -~~~~~~~~~~~y~aPE~~~  176 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLL  176 (288)
T ss_pred             -ccccCceecccccChHHhc
Confidence             1133456899999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.8e-30  Score=232.55  Aligned_cols=152  Identities=25%  Similarity=0.253  Sum_probs=135.6

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      ++.|+..+.||+|.-|+||.+..++ +..+|+|++.+.... .....+.+.|-+||+.++||.++.||+.++.++..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            4667778899999999999999864 578999998654332 33345688899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ||||+||+|..+++.+.++.+++..+..++.+|+.||+|||..|   ||.|||||+|||+.++|.+.|+||.++...
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999999999999999999999999999999999666   999999999999999999999999987543

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=2.6e-30  Score=240.01  Aligned_cols=173  Identities=24%  Similarity=0.253  Sum_probs=146.1

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||++... +++.||+|.+..... .......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            5777889999999999999874 688999999875432 22233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          82 YQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999643 245899999999999999999999555   99999999999999999999999999987653322


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      . ......||+.|+|||++.
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             e-eeecccCCccccCHHHhc
Confidence            1 233457999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=6.1e-30  Score=234.72  Aligned_cols=172  Identities=28%  Similarity=0.361  Sum_probs=142.7

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            56888899999999999999975 6889999998644322 222347889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |++ ++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            995 6888887643 345888899999999999999999655   9999999999999999999999999997654221 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......||+.|+|||++.+
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~  177 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLG  177 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcC
Confidence             11344578999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=2.9e-30  Score=242.58  Aligned_cols=149  Identities=26%  Similarity=0.318  Sum_probs=129.5

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||++... +++.||+|.+..... .......+.+|+.++..++||+|+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5677889999999999999874 688999999864322 22233458889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          82 FLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             CCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            99999999999643  45899999999999999999999554   9999999999999999999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=246.05  Aligned_cols=162  Identities=33%  Similarity=0.531  Sum_probs=142.2

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++.+...+.||+|+.|.||+|+++ ++.||||+++..         -+.+|+-|++|+||||+.+.|+|....-+|||||
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            355566789999999999999994 689999987533         2467899999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||+.|.|.++|+.  +..++......|..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++...+.. 
T Consensus       193 fCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-  266 (904)
T KOG4721|consen  193 FCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-  266 (904)
T ss_pred             ccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-
Confidence            9999999999964  456888889999999999999999655   9999999999999999999999999999886542 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ....++||..|||||++.
T Consensus       267 --TkMSFaGTVaWMAPEvIr  284 (904)
T KOG4721|consen  267 --TKMSFAGTVAWMAPEVIR  284 (904)
T ss_pred             --hhhhhhhhHhhhCHHHhh
Confidence              256789999999999974

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=3.5e-30  Score=243.23  Aligned_cols=177  Identities=28%  Similarity=0.365  Sum_probs=143.3

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|++      .++..||||+++.... ....+.+.+|++++..+ +||||++++++|...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            45788899999999999999963      2456899998864332 22334588999999999 8999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCC----------------------------------------------------------
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKR----------------------------------------------------------  275 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  275 (362)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986422                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          276 ---------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       276 ---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                                     ...+++..+.+++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                           124788899999999999999999554   99999999999999999999999999987653322


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........++..|+|||++.+
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~  290 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFN  290 (375)
T ss_pred             ccccCCCCCCcceeChhHhcC
Confidence            111223345678999998754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=3.7e-30  Score=250.30  Aligned_cols=175  Identities=21%  Similarity=0.240  Sum_probs=144.4

Q ss_pred             hhccccceeeccCcccEEEEEcC-C-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-N-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ..|...+.||+|+||.||+|... + +..||+|++....  ......+.+|+.+++.++|||||++++++...+..++||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            34788899999999999999864 3 5678888764322  222345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999999999988532  2345889999999999999999999554   99999999999999999999999999997754


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..........+||+.|+|||++.+
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~  245 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWER  245 (478)
T ss_pred             ccccccccccCCCccccCHhHhCC
Confidence            332223455679999999998643

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=234.03  Aligned_cols=169  Identities=30%  Similarity=0.386  Sum_probs=147.4

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +-|+..+.||+|+||.||+|.++ +|..+|+|++..    ....+++.+|+.+|++++.|++|++||.|......|+|||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            44566788999999999999874 689999998742    3344569999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||..|+..++++ .+.+.+++..+..+.+..++||+|||...   -+|||||+.|||++.+|.+||+|||.|..+.+.-.
T Consensus       109 YCGAGSiSDI~R-~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  109 YCGAGSISDIMR-ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hcCCCcHHHHHH-HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            999999999997 45578999999999999999999999544   89999999999999999999999999998865432


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ...++.|||.|||||+++
T Consensus       185 --KRNTVIGTPFWMAPEVI~  202 (502)
T KOG0574|consen  185 --KRNTVIGTPFWMAPEVIE  202 (502)
T ss_pred             --hhCccccCcccccHHHHH
Confidence              245678999999999875

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=4.2e-30  Score=238.83  Aligned_cols=171  Identities=23%  Similarity=0.260  Sum_probs=142.3

Q ss_pred             ccccceeeccCcccEEEEEc----CCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          184 VKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      |+..+.||+|+||.||+++.    .+++.||+|.+.....  .....+.+.+|+.++..+ +|++|+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            66778999999999999875    3578999999864322  122234578899999999 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          82 LILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999999998643  45899999999999999999999655   9999999999999999999999999998654


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... .......||+.|||||++.
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~  179 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIR  179 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhc
Confidence            3221 1234567999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=3.9e-30  Score=237.67  Aligned_cols=166  Identities=27%  Similarity=0.302  Sum_probs=140.4

Q ss_pred             ceeeccCcccEEEEEc----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          188 NVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      +.||+|+||.||++..    .+++.+|+|.+............+.+|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    357899999987543333333457889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCcee
Q 018036          264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC  343 (362)
Q Consensus       264 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  343 (362)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++......  ..
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~  154 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK  154 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence            9999999853  345899999999999999999999655   9999999999999999999999999998654321  12


Q ss_pred             eccccCccCcccccccc
Q 018036          344 MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~  360 (362)
                      .....||+.|+|||++.
T Consensus       155 ~~~~~g~~~y~aPE~~~  171 (318)
T cd05582         155 AYSFCGTVEYMAPEVVN  171 (318)
T ss_pred             eecccCChhhcCHHHHc
Confidence            34567999999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=5.3e-30  Score=237.26  Aligned_cols=167  Identities=28%  Similarity=0.358  Sum_probs=138.9

Q ss_pred             ceeeccCcccEEEEEc----CCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          188 NVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +.||+|+||.||++..    .+++.||+|.+.....  .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    3578999999865321  122234478899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--  154 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence            999999999853  345788888999999999999999655   9999999999999999999999999997543222  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......||+.|+|||++.+
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~  174 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMR  174 (323)
T ss_pred             CcccccCCCccccChhhccC
Confidence            12344679999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-30  Score=242.34  Aligned_cols=174  Identities=30%  Similarity=0.328  Sum_probs=146.7

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|++++..++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            5777899999999999999975 6889999998754322 2334458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC-
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG-  339 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~-  339 (362)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||..+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999999999644  46899999999999999999999554   9999999999999999999999999998765432 


Q ss_pred             --------------------------CceeeccccCccCccccccccc
Q 018036          340 --------------------------ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 --------------------------~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                                                .........||+.|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG  204 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence                                      0011234579999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=229.11  Aligned_cols=172  Identities=28%  Similarity=0.394  Sum_probs=146.4

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .+.|+..+.||+|.|+.||++.+ .+|+.+|+|.+....-.....+++.+|+++-+.++|||||++++.+.+....|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46677888999999999999986 57889999988655444445566999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEEcccccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYLQ  336 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGla~~~~  336 (362)
                      |+|+|++|..-+-.+  ..+++..+...+.||++||.|+|.++   |||||+||+|+++.+   .--+||+|||+|..+.
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999997766432  45788888999999999999999665   999999999999953   3458999999999887


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                         .+.....++|||+|||||++.
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvr  185 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLK  185 (355)
T ss_pred             ---CccccccccCCCcccCHHHhh
Confidence               234567889999999999863

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-31  Score=250.18  Aligned_cols=173  Identities=30%  Similarity=0.478  Sum_probs=146.6

Q ss_pred             hhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ...++.++||.|.||+||+|+++    ....||||.++..... ..+.+|..|..+|.+++||||++|.|+.......+|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            44566799999999999999974    3458999999765433 334459999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |+|||++|+|+.+|+.+.++ +++-+...+.++||.||.||-+.+   +|||||.++|||++.+..+|++|||+++.+++
T Consensus       708 iTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999999866654 899999999999999999999665   99999999999999999999999999998875


Q ss_pred             CCCceeeccccC--ccCcccccccc
Q 018036          338 TGASECMSAVAG--SYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~G--t~~y~aPE~~~  360 (362)
                      .... ..++..|  ..+|.|||.+.
T Consensus       784 d~~~-~ytt~GGKIPiRWTAPEAIa  807 (996)
T KOG0196|consen  784 DPEA-AYTTLGGKIPIRWTAPEAIA  807 (996)
T ss_pred             CCCc-cccccCCccceeecChhHhh
Confidence            5422 2333333  35899999874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=5.2e-30  Score=233.11  Aligned_cols=173  Identities=24%  Similarity=0.317  Sum_probs=143.8

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||+|++. +++.+|+|++..........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            5777889999999999999985 578899999876544334445588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      ++++.+..+..  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            98877665543  2345889999999999999999999555   99999999999999999999999999987643221 


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......||+.|+|||++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~  175 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLG  175 (287)
T ss_pred             ccccccccccccCCcHHHcC
Confidence            12334579999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=4e-31  Score=256.15  Aligned_cols=177  Identities=26%  Similarity=0.423  Sum_probs=144.4

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      .+....+.||+|+||+||+|+..      +...||||.++..... ..+++|++|+++++.++|||||+++|+|..++..
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            34455678999999999999852      3568999999765443 2445699999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCC--------CC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc
Q 018036          256 LLVYEYMPNGSLGEVLHGKR--------GS----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE  323 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~--------~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  323 (362)
                      +||+|||..|||.++|....        +.    .++..+.+.||.|||.||+||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999996422        12    3888899999999999999999665   999999999999999999


Q ss_pred             eEEccccccccccCCCCceeeccccCccCcccccccccC
Q 018036          324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       324 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      +||+|||+++.+-..+.........=..+|||||-++++
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~  680 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG  680 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC
Confidence            999999999977543322211111225689999988763

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=6.4e-30  Score=237.61  Aligned_cols=174  Identities=25%  Similarity=0.247  Sum_probs=144.0

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||++... +++.+|+|.+..... .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            35777899999999999999875 467899998854221 1222334788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999642 345899999999999999999999555   9999999999999999999999999997654322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      . .......||+.|+|||++.
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         157 T-VQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             c-ceecccccCccccCHHHHh
Confidence            2 1233467999999999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=1e-29  Score=236.00  Aligned_cols=167  Identities=26%  Similarity=0.293  Sum_probs=138.7

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|... +++.+|+|.+...... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999874 5789999998754322 22334477888888777 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~  153 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT  153 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence            999988853  345899999999999999999999655   9999999999999999999999999998643221  123


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ....||+.|+|||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (329)
T cd05618         154 STFCGTPNYIAPEILRG  170 (329)
T ss_pred             ccccCCccccCHHHHcC
Confidence            45679999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=9e-30  Score=236.35  Aligned_cols=167  Identities=24%  Similarity=0.286  Sum_probs=139.4

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|.+. +++.||+|.++..... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999874 6789999998754322 22234578899999988 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTT  153 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccc
Confidence            9999988533  45899999999999999999999555   9999999999999999999999999997532211  123


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|+|||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (329)
T cd05588         154 STFCGTPNYIAPEILRG  170 (329)
T ss_pred             ccccCCccccCHHHHcC
Confidence            45689999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=1.7e-29  Score=230.04  Aligned_cols=171  Identities=27%  Similarity=0.354  Sum_probs=139.0

Q ss_pred             hccccceeeccCcccEEEEEcC--CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC---ccCcceeEEEEEec-----C
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSN-----K  252 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~  252 (362)
                      +|+..+.||+|+||.||+|.+.  +++.||+|.+............+.+|+.+++.+   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5777889999999999999863  467899998875543333333466777777665   69999999999853     3


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      ...++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence            46789999995 69999997655566899999999999999999999655   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.....   .......||+.|+|||++.
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~  182 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLL  182 (290)
T ss_pred             EeccCC---cccccccccccccChHHHh
Confidence            876432   2234567999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=6.3e-30  Score=241.30  Aligned_cols=176  Identities=27%  Similarity=0.392  Sum_probs=141.9

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|.+      .++..||+|++..... ....+.+.+|+++++.+ +|+|||+++++|...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            45788899999999999999874      2345799999864332 22234588999999999 8999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCC----------------------------------------------------------
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKR----------------------------------------------------------  275 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  275 (362)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885321                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          276 ----------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       276 ----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                                ...+++..+.+++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                      12478888999999999999999955   49999999999999999999999999998765332222222


Q ss_pred             cccCccCcccccccc
Q 018036          346 AVAGSYGYIAPVLGW  360 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~  360 (362)
                      ...++..|||||++.
T Consensus       273 ~~~~~~~y~aPE~~~  287 (374)
T cd05106         273 NARLPVKWMAPESIF  287 (374)
T ss_pred             CCCCccceeCHHHhc
Confidence            334567899999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=9e-30  Score=236.99  Aligned_cols=172  Identities=30%  Similarity=0.425  Sum_probs=140.0

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----Ceee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ETNL  256 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  256 (362)
                      +|+..+.||+|+||.||+|... ++..||+|++...........++.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            3677889999999999999864 689999999865433333334588999999999999999999988543     2479


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||++ ++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 7999988533  45899999999999999999999655   9999999999999999999999999998654


Q ss_pred             CCCC-ceeeccccCccCcccccccc
Q 018036          337 DTGA-SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~-~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... ........||+.|+|||++.
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~  179 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCG  179 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHh
Confidence            2221 11123467999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-29  Score=230.28  Aligned_cols=171  Identities=27%  Similarity=0.324  Sum_probs=143.8

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |+..+.||+|+||.||++... +++.||+|++...... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            566789999999999999864 6889999998653321 22233477899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|+|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            99999999886544456899999999999999999999655   9999999999999999999999999998764321  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ......||+.|+|||++.
T Consensus       157 -~~~~~~~~~~y~aPE~~~  174 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVK  174 (285)
T ss_pred             -ccccccCCCCccCcHHhc
Confidence             123457899999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-31  Score=238.61  Aligned_cols=171  Identities=29%  Similarity=0.359  Sum_probs=147.0

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|+..+.||+|+||.||+|.+ .+++.||+|.+.-.. .....+.+++|+.++..++++||.++|+.+..+...+++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            3456668999999999999997 467889999875433 33334558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||.+|++.+.++  .+..+++....-+++++..|+.|||.++   .+|||||+.|||+..+|.+|++|||++..+.....
T Consensus        92 y~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999995  3444578888889999999999999665   99999999999999999999999999998875433


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ...+++|||.|||||+++
T Consensus       167 --rr~tfvGTPfwMAPEVI~  184 (467)
T KOG0201|consen  167 --RRKTFVGTPFWMAPEVIK  184 (467)
T ss_pred             --ccccccccccccchhhhc
Confidence              247889999999999986

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.96  E-value=1.4e-29  Score=234.58  Aligned_cols=170  Identities=29%  Similarity=0.342  Sum_probs=138.9

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHH---hcCccCcceeEEEEEecCCeeeEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTL---GKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      |+..+.||+|+||.||+|.+. +++.||+|.+..... .....+.+.+|++++   ++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            455688999999999999864 688999999875432 122233466666554   567899999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|...+..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999988853   35899999999999999999999655   999999999999999999999999998754322


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ......+||+.|||||++.+
T Consensus       155 ~--~~~~~~~g~~~y~aPE~~~~  175 (324)
T cd05589         155 G--DRTSTFCGTPEFLAPEVLTE  175 (324)
T ss_pred             C--CcccccccCccccCHhHhcC
Confidence            1  22345679999999998643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.96  E-value=1.3e-29  Score=234.02  Aligned_cols=167  Identities=28%  Similarity=0.310  Sum_probs=136.4

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|... +++.||+|.++.... .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999874 578899999875432 122223356677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            9999998643  35899999999999999999999655   9999999999999999999999999998653222  223


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|+|||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (316)
T cd05592         154 STFCGTPDYIAPEILKG  170 (316)
T ss_pred             ccccCCccccCHHHHcC
Confidence            45679999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.96  E-value=1.3e-29  Score=234.59  Aligned_cols=167  Identities=29%  Similarity=0.329  Sum_probs=136.2

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHH-HHhcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||+||+|.+. +++.||+|.+..... .......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999974 688999999864322 1222233455544 56789999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT  153 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence            999999854  345889999999999999999999655   9999999999999999999999999997643221  223


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|+|||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (323)
T cd05575         154 STFCGTPEYLAPEVLRK  170 (323)
T ss_pred             ccccCChhhcChhhhcC
Confidence            45679999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=240.61  Aligned_cols=175  Identities=26%  Similarity=0.355  Sum_probs=147.8

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +.+...+.||+|.||+|..|....+..||||+++...... ...+|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            4455678999999999999999888999999998665432 345699999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      |++|+|.+++.........-....+|+.||+.||+||.   +..+||||+.++|+|+|.++++||+|||+++-+-.....
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999998765544556667889999999999999   666999999999999999999999999999976543333


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......+=..+|||||-+.
T Consensus       694 ~vqgr~vlpiRwmawEsil  712 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESIL  712 (807)
T ss_pred             eeecceeeeeeehhHHHHH
Confidence            3333444567999999653

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=1.2e-29  Score=237.86  Aligned_cols=167  Identities=28%  Similarity=0.475  Sum_probs=139.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|++. +++.||+|.+.... .......+.+|++++++++|+||+++++++...+..++||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            456777889999999999999864 68999999985432 1222345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+..      ..++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+....
T Consensus       152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999999986543      2567778899999999999999655   9999999999999999999999999998765321


Q ss_pred             CceeeccccCccCccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~  359 (362)
                        .......||..|+|||++
T Consensus       223 --~~~~~~~gt~~y~aPE~~  240 (353)
T PLN00034        223 --DPCNSSVGTIAYMSPERI  240 (353)
T ss_pred             --ccccccccCccccCcccc
Confidence              113445799999999986

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=6.5e-31  Score=227.44  Aligned_cols=179  Identities=28%  Similarity=0.405  Sum_probs=148.8

Q ss_pred             hHhhhccccceeeccCcccEEEEEcCC-----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-C
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-K  252 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~  252 (362)
                      +.+..|+....||+|.||.||+|...+     ...+|+|+++.............+|+..++.++|||++.+..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345778888999999999999996432     3478999998766555555568899999999999999999998877 7


Q ss_pred             CeeeEEEecCCCCChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC----CceE
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAH  325 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~k  325 (362)
                      ..+++++||.+. +|.++++..+   .+.++...+..|.+||+.|+.|||++.   |+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            788999999976 9999986433   357899999999999999999999776   9999999999999876    9999


Q ss_pred             EccccccccccCCCCce-eeccccCccCccccccccc
Q 018036          326 VADFGLAKYLQDTGASE-CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       326 l~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|||+++.+.++-..- ....++-|.+|.|||++.|
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG  213 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG  213 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence            99999999987543211 2334567999999999876

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.96  E-value=1.7e-29  Score=233.97  Aligned_cols=171  Identities=26%  Similarity=0.292  Sum_probs=140.4

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccC-cceeEEEEEecCCeeeEEEe
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHR-NIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e  260 (362)
                      |+..+.||+|+||.||+|... +++.||+|.+..... .....+.+..|.+++..++|+ +|+++++++...+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            567789999999999999875 567899999865322 222334578899999999764 58889999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          82 YVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            99999999998533  45889999999999999999999655   9999999999999999999999999987543211 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......+||+.|+|||++.+
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~  175 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAY  175 (324)
T ss_pred             -CceeeecCCccccChhhhcC
Confidence             12345679999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.96  E-value=1.3e-29  Score=234.34  Aligned_cols=166  Identities=27%  Similarity=0.307  Sum_probs=137.7

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|... +++.||+|.+..... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 578999999864321 222334467888888876 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~  153 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT  153 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence            9999988543  45899999999999999999999655   9999999999999999999999999988643221  123


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                      ....||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (320)
T cd05590         154 STFCGTPDYIAPEILQ  169 (320)
T ss_pred             cccccCccccCHHHHc
Confidence            4567999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.96  E-value=1.6e-29  Score=234.28  Aligned_cols=167  Identities=28%  Similarity=0.319  Sum_probs=136.1

Q ss_pred             ceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHH-HHhcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||+||+|.. .+++.+|+|.+..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3699999999999986 4688999999865322 1222233555554 46778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  153 (325)
T cd05604          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTT  153 (325)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCc
Confidence            999988853  345899999999999999999999655   9999999999999999999999999997543211  123


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|||||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (325)
T cd05604         154 TTFCGTPEYLAPEVIRK  170 (325)
T ss_pred             ccccCChhhCCHHHHcC
Confidence            45679999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=7.9e-30  Score=238.86  Aligned_cols=172  Identities=27%  Similarity=0.348  Sum_probs=151.1

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|.....||+|.|++|..|++ .++..||+|.+.+........+.+.+|+++|..++|||||+++.+...+...|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            4567788999999999999987 468999999987766555555558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+.+|.+++++...  ....+..+..++.|+.+|++|||..+   |||||||++|||++.++++||+|||++..+..   
T Consensus       136 ya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---  207 (596)
T KOG0586|consen  136 YASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY---  207 (596)
T ss_pred             eccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc---
Confidence            99999999999643  33556888899999999999999655   99999999999999999999999999998863   


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....+.+|++.|.|||++++
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g  228 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNG  228 (596)
T ss_pred             cccccccCCCCCccChHhhcC
Confidence            234678899999999999875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.6e-29  Score=239.68  Aligned_cols=165  Identities=25%  Similarity=0.304  Sum_probs=139.4

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|+..+.||+|+||.||+|.+ .+++.||+|...        ...+.+|++++++++||||+++++++......++|||
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            4688889999999999999987 467899999642        1237899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ++ .++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+...+...
T Consensus       164 ~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            99 47898888543  45889999999999999999999655   99999999999999999999999999976433221


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......||+.|+|||++.+
T Consensus       238 -~~~~~~~gt~~y~aPE~~~~  257 (391)
T PHA03212        238 -NKYYGWAGTIATNAPELLAR  257 (391)
T ss_pred             -cccccccCccCCCChhhhcC
Confidence             12345679999999998753

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=1.5e-29  Score=240.13  Aligned_cols=177  Identities=25%  Similarity=0.353  Sum_probs=142.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  253 (362)
                      .++|...+.||+|+||.||+|++.      .+..||||++..... ....+.+.+|+++++++. ||||++++++|...+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            357788899999999999999852      234799999864332 223345899999999996 999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCC----------------------------------------------------------
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKR----------------------------------------------------------  275 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  275 (362)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999885421                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC
Q 018036          276 ------------------------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN  319 (362)
Q Consensus       276 ------------------------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  319 (362)
                                                          ...+++..+..++.|++.||+|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124778888999999999999999655   99999999999999


Q ss_pred             CCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       320 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++.+||+|||+++...............+++.|+|||++.+
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  313 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD  313 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence            999999999999987643322222233457789999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.96  E-value=1.3e-29  Score=234.37  Aligned_cols=166  Identities=27%  Similarity=0.316  Sum_probs=137.6

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|+.. +++.||+|.+..... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999875 578999999865322 122233467888888866 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+.+...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT  153 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence            9999988533  45889999999999999999999655   9999999999999999999999999998643222  123


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                      ....||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (321)
T cd05591         154 TTFCGTPDYIAPEILQ  169 (321)
T ss_pred             cccccCccccCHHHHc
Confidence            4567999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.96  E-value=1.8e-29  Score=233.53  Aligned_cols=166  Identities=31%  Similarity=0.348  Sum_probs=135.1

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHH-HHhcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|++. +++.||+|.+..... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999874 678999999864322 1222233555554 57889999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      ++|.+.+..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT  153 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence            999988853  345788888999999999999999655   9999999999999999999999999988643221  123


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                      ....||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (321)
T cd05603         154 STFCGTPEYLAPEVLR  169 (321)
T ss_pred             ccccCCcccCCHHHhc
Confidence            4567999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.5e-29  Score=246.43  Aligned_cols=178  Identities=25%  Similarity=0.292  Sum_probs=147.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  253 (362)
                      .++|...+.||+|+||.||+|.. .+++.||||.+............+.+|+.++..++|+||+++++.+...+      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            46889999999999999999986 46899999998655433344456889999999999999999988775432      


Q ss_pred             --eeeEEEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          254 --TNLLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       254 --~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                        ..++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence              357999999999999998643  235689999999999999999999955   4999999999999999999999999


Q ss_pred             cccccccCCCCceeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+++..............+||+.|+|||++.+
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  219 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR  219 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCC
Confidence            99987654332333455789999999998753

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=2.3e-29  Score=228.35  Aligned_cols=167  Identities=30%  Similarity=0.324  Sum_probs=138.7

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      ||+|+||+||++.+. +++.+|+|++....... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999874 68899999986432211 1224477899999999999999999999999999999999999999


Q ss_pred             hhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          268 GEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       268 ~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                      .+++...  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            9887432  2356899999999999999999999554   99999999999999999999999999987643221  134


Q ss_pred             cccCccCccccccccc
Q 018036          346 AVAGSYGYIAPVLGWY  361 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~~  361 (362)
                      ...||+.|+|||++.+
T Consensus       156 ~~~g~~~y~aPE~~~~  171 (280)
T cd05608         156 GYAGTPGFMAPELLQG  171 (280)
T ss_pred             ccCCCcCccCHHHhcC
Confidence            4579999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=2.2e-29  Score=233.34  Aligned_cols=167  Identities=28%  Similarity=0.302  Sum_probs=134.5

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHH-HHHhcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEI-RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|.+. +++.||+|.+...... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999875 5678999998643221 12222344444 456788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~  153 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT  153 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence            999999964  345778888899999999999999655   9999999999999999999999999998643221  123


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|||||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (325)
T cd05602         154 STFCGTPEYLAPEVLHK  170 (325)
T ss_pred             ccccCCccccCHHHHcC
Confidence            45679999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.96  E-value=2.6e-29  Score=232.65  Aligned_cols=171  Identities=27%  Similarity=0.299  Sum_probs=140.3

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEe
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      |+..+.||+|+||.||+|... +++.||+|.+..... .......+..|..++..+ +|++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            566789999999999999875 577999999875432 122223466788888777 58999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+.+...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        82 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          82 YVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            99999999998533  45889999999999999999999655   9999999999999999999999999998643221 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......+||+.|+|||++.+
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             -CccccCCCChhhcCHHHhcC
Confidence             12345679999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=3.1e-29  Score=225.66  Aligned_cols=173  Identities=25%  Similarity=0.342  Sum_probs=141.7

Q ss_pred             hhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.++.... ......+.+|+.++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            56788899999999999999753    356899998864322 2223458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+|++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999998643 346899999999999999999999655   99999999999999999999999998775432


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ... .......++..|+|||++.
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~  181 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQ  181 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHh
Confidence            111 1122334567899999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=233.59  Aligned_cols=174  Identities=26%  Similarity=0.292  Sum_probs=149.7

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      +.|..-++||+|+||.||-++. .+|+.+|.|++.+... ....+....+|-.+|.++..+.||.+--.|++++..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            4566778999999999999986 4788999998854332 1122334788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ..|.||+|.-+|.......+++..+..+|.+|+.||++||+..   ||.||+||+|||+|+.|+++|+|.|+|..+.+. 
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-  340 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC-
Confidence            9999999999998766678999999999999999999999666   999999999999999999999999999988643 


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        +.....+||.+|||||+++.
T Consensus       341 --~~~~~rvGT~GYMAPEvl~n  360 (591)
T KOG0986|consen  341 --KPIRGRVGTVGYMAPEVLQN  360 (591)
T ss_pred             --CccccccCcccccCHHHHcC
Confidence              23455689999999999864

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=2.8e-29  Score=232.80  Aligned_cols=167  Identities=26%  Similarity=0.295  Sum_probs=139.1

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|... +++.+|+|.+...... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999874 5789999998754322 22334578899999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTT  153 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cce
Confidence            9999988533  45899999999999999999999655   9999999999999999999999999998543221  123


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|+|||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (327)
T cd05617         154 STFCGTPNYIAPEILRG  170 (327)
T ss_pred             ecccCCcccCCHHHHCC
Confidence            45679999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=4.2e-29  Score=232.04  Aligned_cols=171  Identities=27%  Similarity=0.335  Sum_probs=144.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||++.+. ++..+|+|.+.... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            57888899999999999999875 57788888876432 12223458999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++...+.. 
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            99999999999643  3588999999999999999999953  249999999999999999999999999998664321 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         .....||+.|+|||++.+
T Consensus       159 ---~~~~~g~~~y~aPE~~~~  176 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQG  176 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcC
Confidence               344579999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=243.37  Aligned_cols=170  Identities=32%  Similarity=0.430  Sum_probs=143.1

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC------eee
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------TNL  256 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  256 (362)
                      +...+.||+|+||.||+++. .+|+.||||.+.... .....++..+|+++|++++|+|||+++++-++..      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            34457899999999999995 689999999987644 3334456889999999999999999998866544      557


Q ss_pred             EEEecCCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC--CCCc--eEEccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN--SDFE--AHVADFGL  331 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~--~kl~DFGl  331 (362)
                      +|||||.+|||+..|.+..+ ..+++...+.+..+++.||.|||+++   |+||||||.||++-  .+|+  -||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999975443 56999999999999999999999776   99999999999984  3344  69999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+.+++..   ....+.||..|.+||+..
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E  196 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYE  196 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHh
Confidence            99987543   477889999999999864

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=3.6e-29  Score=231.00  Aligned_cols=167  Identities=28%  Similarity=0.299  Sum_probs=137.0

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|.+. +++.||+|.++.... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999875 678999999865322 122233466777777754 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA  153 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence            999999854  345889999999999999999999655   999999999999999999999999998754221  1224


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|+|||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (316)
T cd05620         154 STFCGTPDYIAPEILQG  170 (316)
T ss_pred             eccCCCcCccCHHHHcC
Confidence            45679999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.96  E-value=3e-29  Score=232.26  Aligned_cols=171  Identities=26%  Similarity=0.296  Sum_probs=140.3

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEe
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      |+..+.||+|+||.||+|... +++.||+|.+..... .....+.+..|..++..+. |++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            456789999999999999864 688999999865322 1222344778888888885 5778889999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 y~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          82 YVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            99999999998533  45899999999999999999999655   9999999999999999999999999998643221 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......||+.|+|||++.+
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             -ccccCccCCccccCHHHHcC
Confidence             12345679999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=4.4e-29  Score=230.42  Aligned_cols=167  Identities=26%  Similarity=0.307  Sum_probs=136.8

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||+||+|.+. +++.||+|.++.... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999875 578999999875422 122233466777788764 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence            9999998642  45889999999999999999999655   9999999999999999999999999987543211  123


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ....||+.|+|||++.+
T Consensus       154 ~~~~gt~~y~aPE~~~~  170 (316)
T cd05619         154 CTFCGTPDYIAPEILLG  170 (316)
T ss_pred             eeecCCccccCHHHHcC
Confidence            45679999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=5e-29  Score=231.72  Aligned_cols=171  Identities=27%  Similarity=0.351  Sum_probs=144.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||++.+. ++..+|+|.+.... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            67888899999999999999875 57788888775432 22223458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999964  34588899999999999999999953  249999999999999999999999999998654321 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         .....||..|+|||++.+
T Consensus       159 ---~~~~~~~~~y~aPE~~~~  176 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQG  176 (333)
T ss_pred             ---cccCCCCccccCHHHhcC
Confidence               234579999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=7.2e-29  Score=221.86  Aligned_cols=171  Identities=25%  Similarity=0.379  Sum_probs=142.8

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||++.++++..+|+|.+....   .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            4577788999999999999998888889999875322   2234588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|+|.++++... ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||.++....... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            99999999986433 35889999999999999999999655   99999999999999999999999999986643221 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......++..|+|||++.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~  174 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFN  174 (256)
T ss_pred             eccCCCCCchhhCChhhcc
Confidence            1122334567899999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=7.4e-29  Score=222.33  Aligned_cols=173  Identities=27%  Similarity=0.410  Sum_probs=146.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|...++..||+|.+....   ...+.+.+|+.++++++|+||+++++.+...+..+++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            46788889999999999999998888899999875422   223458999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||+++...+...
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999999997655667899999999999999999999655   99999999999999999999999999987653221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......++..|+|||+..
T Consensus       159 -~~~~~~~~~~~y~aPE~~~  177 (261)
T cd05072         159 -TAREGAKFPIKWTAPEAIN  177 (261)
T ss_pred             -eccCCCccceecCCHHHhc
Confidence             1122334677899999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=4.1e-29  Score=235.84  Aligned_cols=171  Identities=26%  Similarity=0.364  Sum_probs=141.2

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----eeeE
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNLL  257 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  257 (362)
                      |+..+.||+|+||.||++.+ .+++.||+|++..........+++.+|+++++.++|+||+++++++...+     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            56778999999999999986 47899999998644333333345889999999999999999999998776     7899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+. ++|.+.+..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 v~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          82 VTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             Eeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            999995 688888753  345899999999999999999999655   99999999999999999999999999987543


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ... .......+|+.|+|||++.+
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~  178 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMG  178 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcC
Confidence            221 12334568999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=8.9e-29  Score=224.09  Aligned_cols=166  Identities=28%  Similarity=0.311  Sum_probs=138.8

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      ||+|+||.||++..+ +++.+|+|.+...... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 6899999998643221 12223356799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      .+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            99886555556899999999999999999999554   9999999999999999999999999998765321   12345


Q ss_pred             cCccCccccccccc
Q 018036          348 AGSYGYIAPVLGWY  361 (362)
Q Consensus       348 ~Gt~~y~aPE~~~~  361 (362)
                      .||..|+|||++.+
T Consensus       155 ~~~~~y~aPE~~~~  168 (277)
T cd05607         155 AGTNGYMAPEILKE  168 (277)
T ss_pred             CCCCCccCHHHHcc
Confidence            68999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=9.7e-29  Score=224.78  Aligned_cols=172  Identities=26%  Similarity=0.311  Sum_probs=143.6

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |+..+.||+|+||+||+|.+ .+++.+|+|.+...... ......+.+|++++++++|+||+.+.+++...+..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45567899999999999987 46889999988653322 12233478899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999999886544456999999999999999999999554   9999999999999999999999999997654221  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......|+..|+|||++.+
T Consensus       157 -~~~~~~g~~~~~aPE~~~~  175 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNN  175 (285)
T ss_pred             -cccCCCCCcCccChHHhcC
Confidence             1234579999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=5.7e-29  Score=250.56  Aligned_cols=177  Identities=23%  Similarity=0.308  Sum_probs=144.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++...... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46788899999999999999874 5889999998643322 223456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          260 EYMPNGSLGEVLHGKR---------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      ||+++|+|.+++....         ....++..++.++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999985311         133567788999999999999999655   9999999999999999999999999


Q ss_pred             ccccccCCCC----------------ceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGA----------------SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~----------------~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++.......                .......+||+.|||||++.+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g  205 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG  205 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence            9987621110                001123579999999998754

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=7.3e-29  Score=228.93  Aligned_cols=173  Identities=25%  Similarity=0.398  Sum_probs=139.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.+.... .....+++.+|+.+++.++||||++++++|... ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            46788899999999999999863 333    48899875322 222345588999999999999999999999765 567


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          85 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999999743 345889999999999999999999554   9999999999999999999999999999775


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............++..|+|||++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~  184 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESIL  184 (316)
T ss_pred             CCCcceeccCCccceeecChHHhc
Confidence            432222122334567899999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.3e-28  Score=220.90  Aligned_cols=172  Identities=31%  Similarity=0.434  Sum_probs=144.7

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +.|+..+.||+|++|.||+|.+.+++.||+|.++...   ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            5678889999999999999998778889999875432   2234588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++....+..+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999997655567899999999999999999999655   999999999999999999999999999877532211


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      . ......+..|+|||++.
T Consensus       160 ~-~~~~~~~~~y~aPE~~~  177 (261)
T cd05068         160 A-REGAKFPIKWTAPEAAL  177 (261)
T ss_pred             c-cCCCcCceeccCccccc
Confidence            1 11222345799999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=8e-29  Score=238.21  Aligned_cols=167  Identities=22%  Similarity=0.261  Sum_probs=140.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|...+.||+|+||.||+|.+. .++.||||...        ...+.+|++++++++|+|||++++++...+..++|||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35778899999999999999975 57889999532        1226789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ++ .++|.+++... ...+++..+..|+.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       241 ~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            99 57999888643 346899999999999999999999655   99999999999999999999999999987653322


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........||+.|||||++.+
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~  336 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAG  336 (461)
T ss_pred             cccccccCCCcCCcCHHHHcC
Confidence            222334679999999998754

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=1e-28  Score=224.22  Aligned_cols=175  Identities=23%  Similarity=0.386  Sum_probs=143.1

Q ss_pred             hhccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|..     .++..+++|.+..... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            5677788999999999999974     3467899998864322 222345889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          257 LVYEYMPNGSLGEVLHGKR---------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      +||||+++++|.+++....               ...+++..+..++.|++.||+|||+.+   ++||||||+||+++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            9999999999999985221               234788899999999999999999655   9999999999999999


Q ss_pred             CceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.+||+|||+++...............++..|+|||++.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM  199 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhc
Confidence            999999999998765332222234445678899999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.7e-29  Score=230.60  Aligned_cols=164  Identities=26%  Similarity=0.256  Sum_probs=133.4

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC---ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      ||+|+||+||+|+.. +++.||+|.+..... ..........|..++.+.   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999874 688999999854321 111222345566666655   699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~  153 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT  153 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence            999999853  345899999999999999999999655   9999999999999999999999999997643221  123


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                      ...+||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (330)
T cd05586         154 NTFCGTTEYLAPEVLL  169 (330)
T ss_pred             cCccCCccccCHHHHc
Confidence            4567999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=1.5e-28  Score=223.63  Aligned_cols=172  Identities=27%  Similarity=0.318  Sum_probs=143.4

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |+..+.||+|+||.||++... +++.+|+|.+....... .....+.+|+.++++++|++|+.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            556688999999999999874 68899999886543222 2223477899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            9999999998654445689999999999999999999954   49999999999999999999999999997654221  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......||..|+|||++.+
T Consensus       157 -~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKN  175 (285)
T ss_pred             -cccCCCCCccccChHHHcC
Confidence             1234579999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=1.2e-28  Score=224.08  Aligned_cols=163  Identities=23%  Similarity=0.326  Sum_probs=137.3

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCc-hhhHHHHHHHHhcCccCcceeEEEEEec----CCeeeEEEecC
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH-DNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNLLVYEYM  262 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  262 (362)
                      ..|++|+++.||+|.+ +++.||||++......... .+.+.+|+.++.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6899999999999998 6889999998654332221 2457899999999999999999999876    34678999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++|+|.+++...  ..+++....+++.|++.||+|||+.  .+++||||||+||++++++.+||+|||+++.....    
T Consensus       105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----  176 (283)
T PHA02988        105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----  176 (283)
T ss_pred             CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence            999999999643  4588999999999999999999963  23789999999999999999999999999876432    


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                       .....||..|+|||++.
T Consensus       177 -~~~~~~~~~y~aPE~~~  193 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLN  193 (283)
T ss_pred             -cccccCcccccCHHHhh
Confidence             22346899999999874

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=1.7e-28  Score=225.76  Aligned_cols=171  Identities=25%  Similarity=0.352  Sum_probs=141.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+...... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            56888899999999999999875 5788999998654322 222347889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |++ ++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          85 YLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            996 5888888643 345788999999999999999999655   99999999999999999999999999986543221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ......+|+.|+|||++.
T Consensus       160 --~~~~~~~~~~y~aPE~~~  177 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLL  177 (309)
T ss_pred             --ccccccccccccCCHHHh
Confidence              123456899999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=7.9e-30  Score=239.24  Aligned_cols=168  Identities=30%  Similarity=0.465  Sum_probs=140.1

Q ss_pred             cccceeeccCcccEEEEEcC-CCCEEEEE--EeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe--eeEEE
Q 018036          185 KDNNVIGRGGAGVVYRGVTP-NGEQVAVK--KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET--NLLVY  259 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK--~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  259 (362)
                      +....||+|+|-+||+|.+. +|..||--  ++....+.+...++|..|+.+|+.|+|||||+++.++.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            33578999999999999874 56677643  233333444445779999999999999999999999987665  66899


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccccccccCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~  338 (362)
                      |.|..|+|..|+++.+  .++.+....|++||++||.|||.+ .|+|+|||||-+||+|+. .|.+||+|.|+|......
T Consensus       123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999996544  488889999999999999999987 789999999999999984 599999999999987643


Q ss_pred             CCceeeccccCccCccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      .    ....+|||.|||||+.
T Consensus       200 ~----aksvIGTPEFMAPEmY  216 (632)
T KOG0584|consen  200 H----AKSVIGTPEFMAPEMY  216 (632)
T ss_pred             c----cceeccCccccChHHH
Confidence            2    3347899999999975

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=2e-28  Score=220.22  Aligned_cols=174  Identities=29%  Similarity=0.411  Sum_probs=143.3

Q ss_pred             hhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||.||+|.+.    +...|++|.+.... ......++.+|+.++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            56788899999999999999874    24578999875432 22233458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++.... ..+++..+.+++.|++.||+|||+.+   |+||||||+||++++++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999996533 36899999999999999999999655   99999999999999999999999999998752


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...........++..|+|||.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~  181 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIA  181 (266)
T ss_pred             cccceeccCCCCCccccChhhhc
Confidence            22221122334567899999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=1.4e-28  Score=231.16  Aligned_cols=172  Identities=30%  Similarity=0.364  Sum_probs=141.1

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC----
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----  253 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  253 (362)
                      .+.++|+..+.||+|+||.||++.+. ++..||+|++...........++.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35688999999999999999999874 6889999998654333334455889999999999999999999986543    


Q ss_pred             --eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          254 --TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       254 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                        ..++||||++ ++|.+.+..    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          98 FQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             cceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence              4689999996 567776642    3788889999999999999999655   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.....   .......||+.|+|||++.+
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~  196 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILG  196 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccC
Confidence            9865322   12344578999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=4.6e-29  Score=223.75  Aligned_cols=172  Identities=37%  Similarity=0.518  Sum_probs=139.0

Q ss_pred             ccceeeccCcccEEEEEcC-----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          186 DNNVIGRGGAGVVYRGVTP-----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       186 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..+.||.|.||.||+|.+.     .+..|+||.+... ......+.+.+|++.+++++||||++++|++...+..++|||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence            4578999999999999875     2568999998542 222234669999999999999999999999998888999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++.......+++..+..|+.|+++||+|||+.+   ++|+||+++||++++++.+||+|||++........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999998765567999999999999999999999655   99999999999999999999999999987733222


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........+...|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~  179 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKD  179 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHH
T ss_pred             ccccccccccccccccccccc
Confidence            222334457789999998753

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=1.5e-28  Score=223.07  Aligned_cols=176  Identities=26%  Similarity=0.433  Sum_probs=143.4

Q ss_pred             hhhccccceeeccCcccEEEEEcCC------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|....      ...|++|.+..... .....++.+|++++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            3567888999999999999998632      25789998753321 2223458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRG--------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS  320 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~  320 (362)
                      .+++|||+++++|.+++.....              ..+++..+..++.|++.||+|||+.+   ++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcC
Confidence            9999999999999999864321              45788999999999999999999655   999999999999999


Q ss_pred             CCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       321 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.+||+|||+++...............+++.|+|||++.
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL  199 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhc
Confidence            9999999999998664332222233446788999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=1e-28  Score=228.22  Aligned_cols=167  Identities=29%  Similarity=0.344  Sum_probs=138.2

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|.+. +++.||+|.+..... .......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 578999999875422 222334467888888887 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (318)
T cd05570          81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT  153 (318)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence            9999988543  35899999999999999999999554   9999999999999999999999999997543221  123


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+||+.|+|||++.+
T Consensus       154 ~~~~g~~~y~aPE~~~~  170 (318)
T cd05570         154 STFCGTPDYIAPEILSY  170 (318)
T ss_pred             cceecCccccCHHHhcC
Confidence            44579999999998753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=254.09  Aligned_cols=174  Identities=26%  Similarity=0.250  Sum_probs=150.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|++.++||+|+||.|..++++ +++.+|+|++.+...- .....-|..|-.+|...+.+.||.++-.|++..+.|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            67788899999999999999985 5678889988653221 122334888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |||+||+|-.++....  .++++.+..++..|..||.-||+.|   +|||||||+|||+|..|++||+|||.+-.+...+
T Consensus       155 dY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             ecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            9999999999996544  6999999999999999999999555   9999999999999999999999999999987655


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .-. ....+|||.|++||++++
T Consensus       230 ~V~-s~~aVGTPDYISPEvLqs  250 (1317)
T KOG0612|consen  230 TVR-SSVAVGTPDYISPEVLQS  250 (1317)
T ss_pred             cEE-eccccCCCCccCHHHHHh
Confidence            443 567789999999999863

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=1.3e-28  Score=222.86  Aligned_cols=177  Identities=22%  Similarity=0.347  Sum_probs=142.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|.+.      .+..||+|++..... .....++.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            467888999999999999998753      346799998753221 1233458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                      .++||||+++++|.+++....        ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            999999999999999986432        124678889999999999999999554   999999999999999999999


Q ss_pred             ccccccccccCCCCceeeccccCccCccccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|||+++...............+++.|||||++.+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  195 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD  195 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhc
Confidence            99999986643222111223346788999998653

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=245.00  Aligned_cols=174  Identities=27%  Similarity=0.319  Sum_probs=141.4

Q ss_pred             hccccceeeccCcccEEEEEcCCC-CEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEE-ec------CC
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPNG-EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFC-SN------KE  253 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~-~~------~~  253 (362)
                      ++++.+.|.+|||+.||.|.+..+ ..+|+|++...  ++...+.+.+|+++|++|+ |+|||.+++.. ..      .-
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            345678999999999999998665 99999998655  3444456999999999997 99999999932 21      23


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      +++|.||||++|+|-|++..+....+++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            668999999999999999765556699999999999999999999976 7889999999999999999999999999987


Q ss_pred             cccCCCCc-ee------eccccCccCccccccc
Q 018036          334 YLQDTGAS-EC------MSAVAGSYGYIAPVLG  359 (362)
Q Consensus       334 ~~~~~~~~-~~------~~~~~Gt~~y~aPE~~  359 (362)
                      ........ +.      .-...-|+.|+|||.+
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI  227 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI  227 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence            54322111 00      0112369999999976

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=1.8e-28  Score=218.88  Aligned_cols=173  Identities=29%  Similarity=0.381  Sum_probs=147.9

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||+|... +++.|++|.+..........+++.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            566788999999999999874 6889999988654433444556899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.+.....  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--  156 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--  156 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc--
Confidence            9999999997655567899999999999999999999554   99999999999999999999999999987654321  


Q ss_pred             eeccccCccCccccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......|++.|+|||+..+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~  175 (256)
T cd08529         157 FANTIVGTPYYLSPELCED  175 (256)
T ss_pred             hhhccccCccccCHHHhcC
Confidence            2344578999999998653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=9.5e-29  Score=230.79  Aligned_cols=171  Identities=28%  Similarity=0.392  Sum_probs=141.6

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----  252 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  252 (362)
                      ++.++|+..+.||+|+||.||+|.+ .+++.||||++............+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457888999999999999999986 4678999999865433223334577899999999999999999887543     


Q ss_pred             -CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          253 -ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       253 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                       ...++++|++ +++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence             3468999998 7899988753   34899999999999999999999655   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.....     .....||+.|+|||++.+
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~  189 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcC
Confidence            9876432     334578999999998743

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=250.95  Aligned_cols=176  Identities=31%  Similarity=0.429  Sum_probs=142.9

Q ss_pred             hhccccceeeccCcccEEEEEcCC--C----CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN--G----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +..+..+.||+|+||.||+|...+  +    ..||+|.+..... ..+..+|.+|..+|++++|||||+++|+|.+....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            445567899999999999998642  3    3588998865543 33445699999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      +|++|||++|+|..+|++.+     ...++....+.++.|||+|+.||++.+   +|||||.++|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999998652     356888999999999999999999555   9999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|+.+-+...........=...|||||.++.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d  878 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKD  878 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhh
Confidence            9996543322211111111348999998864

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.96  E-value=2e-28  Score=220.64  Aligned_cols=168  Identities=27%  Similarity=0.307  Sum_probs=135.4

Q ss_pred             eeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .||+|+||.||+|...   .+..+++|+++.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            5899999999999754   345789998754432 222345888999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          266 SLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       266 sL~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      +|.+++....   ....++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432   234677788899999999999999554   9999999999999999999999999997654322111


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......|+..|+|||++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~  175 (269)
T cd05087         158 TPDQLWVPLRWIAPELVD  175 (269)
T ss_pred             cCCCcCCcccccCHhHhc
Confidence            123356788999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=2.5e-28  Score=218.56  Aligned_cols=171  Identities=24%  Similarity=0.358  Sum_probs=142.9

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||+|.+.++..+|+|.+....   ...+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            4677788999999999999988777789999875332   2234589999999999999999999999998899999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.... ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.++...+... 
T Consensus        81 ~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          81 MSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            99999999996433 36899999999999999999999554   99999999999999999999999999987643321 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......++..|+|||+..
T Consensus       156 ~~~~~~~~~~~y~~pe~~~  174 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLL  174 (256)
T ss_pred             eecCCCccChhhCCHHHHh
Confidence            1122234567899999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-28  Score=218.58  Aligned_cols=171  Identities=26%  Similarity=0.382  Sum_probs=141.6

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      .+|+..+.||+|+||.||++.++++..+|+|.+....   .....+.+|++++++++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            4567788999999999999998777789999875322   2234588899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.... ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...+....
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          81 MANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999996433 36899999999999999999999655   999999999999999999999999999876432111


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ......++..|+|||++.
T Consensus       157 -~~~~~~~~~~y~~Pe~~~  174 (256)
T cd05059         157 -SSQGTKFPVKWAPPEVFD  174 (256)
T ss_pred             -ccCCCCCCccccCHHHhc
Confidence             111223456799999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=3.5e-28  Score=221.16  Aligned_cols=171  Identities=30%  Similarity=0.418  Sum_probs=137.8

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC---ccCcceeEEEEEecC-----Ce
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSNK-----ET  254 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~~  254 (362)
                      |+..+.||+|+||.||+|.+. +++.||+|.+............+.+|+++++++   +||||+++++++...     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            667789999999999999875 688999998865433332233366777777665   699999999988642     45


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence            789999996 58999887555556899999999999999999999655   99999999999999999999999999987


Q ss_pred             ccCCCCceeeccccCccCccccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....   ......||..|+|||++.+
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~  181 (288)
T cd07863         158 YSCQM---ALTPVVVTLWYRAPEVLLQ  181 (288)
T ss_pred             ccCcc---cCCCccccccccCchHhhC
Confidence            64321   1234568999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=1.8e-28  Score=220.96  Aligned_cols=167  Identities=27%  Similarity=0.377  Sum_probs=132.6

Q ss_pred             eeeccCcccEEEEEcCC---CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAGVVYRGVTPN---GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .||+|+||.||+|...+   ...+++|.+.... .......+.+|++.++.++||||+++++++......++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            58999999999997533   3467777664322 2223345789999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          266 SLGEVLHGKRG---SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       266 sL~~~l~~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      +|.+++.....   ...++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999965432   33567888999999999999999655   9999999999999999999999999987643222111


Q ss_pred             eeccccCccCccccccc
Q 018036          343 CMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~  359 (362)
                      ......+++.|+|||+.
T Consensus       158 ~~~~~~~~~~y~aPE~~  174 (269)
T cd05042         158 TKDCHAVPLRWLAPELV  174 (269)
T ss_pred             ccCCCCCcccccCHHHH
Confidence            12334567789999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=5.1e-28  Score=219.63  Aligned_cols=171  Identities=26%  Similarity=0.382  Sum_probs=142.6

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||+|+.. ++..||+|++............+.+|+.++++++||||+++++++..++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            566789999999999999874 6889999998654433333455889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          263 PNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       263 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      + ++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  155 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--  155 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence            6 68988886433 356899999999999999999999655   9999999999999999999999999998654321  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......+++.|+|||++.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~  174 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLL  174 (285)
T ss_pred             ccccCCcccccccChHHhc
Confidence            1123346789999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=3.8e-28  Score=222.72  Aligned_cols=176  Identities=28%  Similarity=0.398  Sum_probs=144.8

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|...+.||+|+||.||++..      .++..+|+|.++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            46788899999999999999974      2345789998754322 22334588999999999 7999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++||||+++|+|.+++.......+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++++|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997555555899999999999999999999655   9999999999999999999999999998


Q ss_pred             cccCCCCceeeccccCccCcccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...............++..|+|||++.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~  216 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIF  216 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhc
Confidence            765332212222345678899999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=2e-28  Score=219.44  Aligned_cols=173  Identities=30%  Similarity=0.444  Sum_probs=147.6

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|...++..+++|.+.....  .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            356788899999999999999988889999998754332  223458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++....+..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||.+....+...
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999999998766667899999999999999999999655   99999999999999999999999999987653221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  .....++..|+|||+..
T Consensus       160 ~--~~~~~~~~~~~~PE~~~  177 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAAS  177 (261)
T ss_pred             c--ccCCCCceEecCHHHHc
Confidence            1  22344677899999764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=2.5e-28  Score=221.15  Aligned_cols=176  Identities=26%  Similarity=0.433  Sum_probs=143.5

Q ss_pred             hhccccceeeccCcccEEEEEcCC------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +.|...+.||+|+||.||+|...+      ++.||+|.+...... ...+.+.+|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            457778899999999999998633      478999988643322 1235689999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc
Q 018036          256 LLVYEYMPNGSLGEVLHGKR------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE  323 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  323 (362)
                      ++||||+++++|.+++....            ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999996432            235788999999999999999999554   999999999999999999


Q ss_pred             eEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       324 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +||+|||+++...............+++.|+|||++.+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY  198 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhcc
Confidence            99999999986543222122233456789999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=2.2e-28  Score=227.66  Aligned_cols=175  Identities=27%  Similarity=0.378  Sum_probs=139.8

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC-C
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK-E  253 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  253 (362)
                      ++|+..+.||+|+||.||+|...      +++.||+|++.... .....+.+.+|+.++.++ +|+||++++++|... .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            57888999999999999999642      34789999886432 222234577899999999 799999999988754 4


Q ss_pred             eeeEEEecCCCCChhhhhcCCCC---------------------------------------------------------
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRG---------------------------------------------------------  276 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  276 (362)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999853221                                                         


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCcc
Q 018036          277 --SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYI  354 (362)
Q Consensus       277 --~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~  354 (362)
                        ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              25789999999999999999999554   9999999999999999999999999998764322222233445678899


Q ss_pred             cccccc
Q 018036          355 APVLGW  360 (362)
Q Consensus       355 aPE~~~  360 (362)
                      |||++.
T Consensus       243 aPE~~~  248 (337)
T cd05054         243 APESIF  248 (337)
T ss_pred             CcHHhc
Confidence            999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=9.4e-29  Score=233.72  Aligned_cols=169  Identities=28%  Similarity=0.320  Sum_probs=144.9

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-c-----CcceeEEEEEecCCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-H-----RNIVRLKAFCSNKET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~  254 (362)
                      -+|++.+.||+|+||.|-+|.+ ++++.||||++++...   ...+...|+.+|..++ |     -|+|++++++...++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            4788899999999999999987 4689999999976543   2233678999999996 4     489999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC--CceEEcccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD--FEAHVADFGLA  332 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DFGla  332 (362)
                      .|||+|.+ .-+|+++++..+...++...+..++.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||.|
T Consensus       263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999 569999999888888999999999999999999999665   9999999999999643  46999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccccC
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      ......     ..+.+.+..|.|||++.|.
T Consensus       339 c~~~q~-----vytYiQSRfYRAPEVILGl  363 (586)
T KOG0667|consen  339 CFESQR-----VYTYIQSRFYRAPEVILGL  363 (586)
T ss_pred             cccCCc-----ceeeeeccccccchhhccC
Confidence            976532     2356788999999999763

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=5.7e-28  Score=215.89  Aligned_cols=173  Identities=25%  Similarity=0.328  Sum_probs=147.9

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||.+.. .+++.+++|++...........++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            367788999999999999886 4688999999865544444455688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++.++..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999997655566899999999999999999999655   99999999999999999999999999987643321 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ......|++.|+|||+..
T Consensus       157 -~~~~~~~~~~y~ape~~~  174 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQ  174 (256)
T ss_pred             -cccccCCCccccCHhhcC
Confidence             234457899999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=3.4e-28  Score=216.85  Aligned_cols=169  Identities=28%  Similarity=0.382  Sum_probs=136.1

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS  266 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  266 (362)
                      +.||+|+||.||+|.+. +++.+|+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            36899999999999874 68889999875322 12223458999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeecc
Q 018036          267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA  346 (362)
Q Consensus       267 L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  346 (362)
                      |.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....+.........
T Consensus        80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99998633 345889999999999999999999655   99999999999999999999999999986542211110111


Q ss_pred             ccCccCccccccccc
Q 018036          347 VAGSYGYIAPVLGWY  361 (362)
Q Consensus       347 ~~Gt~~y~aPE~~~~  361 (362)
                      ..++..|+|||++.+
T Consensus       156 ~~~~~~y~aPE~~~~  170 (252)
T cd05084         156 KQIPVKWTAPEALNY  170 (252)
T ss_pred             CCCceeecCchhhcC
Confidence            123457999998653

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=1.8e-28  Score=229.99  Aligned_cols=172  Identities=27%  Similarity=0.352  Sum_probs=141.4

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----  252 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  252 (362)
                      .+.++|+..+.||+|+||.||++.+. .++.||+|++............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35688999999999999999999874 578999999865443334445578899999999999999999988643     


Q ss_pred             -CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          253 -ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       253 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                       ...++||||++ ++|.+.+..    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             34689999996 577777642    3788899999999999999999655   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.....   .......||+.|+|||++.+
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~  192 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILG  192 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcC
Confidence            9865432   12344679999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.2e-28  Score=232.33  Aligned_cols=167  Identities=28%  Similarity=0.278  Sum_probs=140.2

Q ss_pred             hhccccceeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+|+..+.||+|+||.||+|...   .+..|++|.+...       ....+|++++++++||||+++++++...+..++|
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            46888899999999999999753   3568899876432       1267899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      ||++. ++|.+++.  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       165 ~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            99995 78988883  3356899999999999999999999655   999999999999999999999999999876543


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..........||+.|+|||++.+
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~  261 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLAL  261 (392)
T ss_pred             cccccccccccccCccCHhHhcC
Confidence            32222345679999999998753

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=3.2e-28  Score=231.01  Aligned_cols=176  Identities=23%  Similarity=0.361  Sum_probs=141.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  253 (362)
                      .++|...+.||+|+||.||+|++.      .+..||+|++...... ...+.+.+|++++.++. |||||++++++...+
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            356778899999999999999853      3468999998654322 22335889999999997 999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCC---------------------------------------------------------
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRG---------------------------------------------------------  276 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  276 (362)
                      ..++||||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999864321                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          277 ---------------------------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       277 ---------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                                                             ..+++..+.+++.|++.||+|||+.   +++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence                                                   2367778899999999999999954   4999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +++++.+||+|||+++...............++..|||||++.
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  314 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF  314 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence            9999999999999998754322111122345788999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=9.8e-29  Score=221.02  Aligned_cols=170  Identities=34%  Similarity=0.502  Sum_probs=143.0

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|+||+||++... +++.+|+|.+..............+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999975 4568999998755433333223456999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++.  ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||.+.....  ...
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE  153 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred             cccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccc
Confidence            9999999996  3345899999999999999999999665   99999999999999999999999999986421  122


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......+|..|+|||+..
T Consensus       154 ~~~~~~~~~~y~aPE~~~  171 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQ  171 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHT
T ss_pred             cccccccccccccccccc
Confidence            355677899999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.96  E-value=5e-28  Score=217.31  Aligned_cols=172  Identities=24%  Similarity=0.343  Sum_probs=143.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|+..+.||+|+||.||+|.+. .++.|++|.+...   .....++.+|++++++++|+||+++++++...+..+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            45677889999999999999874 5788999987532   2223458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999999997655566899999999999999999999655   99999999999999999999999999987653221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......++..|+|||++.
T Consensus       160 -~~~~~~~~~~~y~aPE~~~  178 (263)
T cd05052         160 -TAHAGAKFPIKWTAPESLA  178 (263)
T ss_pred             -eccCCCCCccccCCHHHhc
Confidence             1112223467899999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=4.2e-28  Score=223.82  Aligned_cols=167  Identities=25%  Similarity=0.392  Sum_probs=132.6

Q ss_pred             cceeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--CCeeeEEEec
Q 018036          187 NNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLLVYEY  261 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  261 (362)
                      +..||+|+||+||+|...   +++.+|+|.+....    ....+.+|++++++++||||+++++++..  ....+++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999864   46789999885332    12337889999999999999999998854  4567899999


Q ss_pred             CCCCChhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee----CCCCceEEcccc
Q 018036          262 MPNGSLGEVLHGKR-------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFG  330 (362)
Q Consensus       262 ~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFG  330 (362)
                      ++ ++|.+++....       ...+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            95 68888875321       235889999999999999999999655   9999999999999    456789999999


Q ss_pred             ccccccCCCCc-eeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++........ .......||+.|+|||++.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcC
Confidence            99876532211 12345678999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=4.1e-28  Score=217.90  Aligned_cols=171  Identities=30%  Similarity=0.477  Sum_probs=141.9

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||+|.+.++..||+|++....   ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            5688889999999999999998777789999886422   12345899999999999999999999875 4567899999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|+|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||.++.+..... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-  157 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  157 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence            99999999997655556899999999999999999999554   99999999999999999999999999987653221 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......++..|+|||+..
T Consensus       158 ~~~~~~~~~~~y~~PE~~~  176 (262)
T cd05071         158 TARQGAKFPIKWTAPEAAL  176 (262)
T ss_pred             ccccCCcccceecCHhHhc
Confidence            1122344677899999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-30  Score=239.68  Aligned_cols=171  Identities=23%  Similarity=0.334  Sum_probs=142.5

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEE-EEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQV-AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.|++...||.|+||.||+|..++.... |.|.+....  ....+.+.-||++|+.++||+||++++.|...+..||..|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            4456667899999999999998765544 456554332  2334558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||.||-.+.++-. -+..+++.++..++.|++.||.|||.+   .|||||||+.|||+.-+|.++|+|||.+.....  .
T Consensus       110 FC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t  183 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T  183 (1187)
T ss_pred             ecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--H
Confidence            9999999888753 346799999999999999999999954   499999999999999999999999999876542  2


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .+....+.|||+|||||+.+
T Consensus       184 ~qkRDsFIGTPYWMAPEVvm  203 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVM  203 (1187)
T ss_pred             HhhhccccCCcccccchhee
Confidence            33456789999999999874

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=3.3e-28  Score=234.15  Aligned_cols=167  Identities=28%  Similarity=0.381  Sum_probs=133.9

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--------
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--------  252 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  252 (362)
                      +.|+..+.||+|+||.||+|... +++.||||++....      ....+|+.++++++|||||++++++...        
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            46888899999999999999874 67899999874321      1256799999999999999999887432        


Q ss_pred             CeeeEEEecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADF  329 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DF  329 (362)
                      ...++||||++ ++|.+++..  .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            24568999996 578777642  23456899999999999999999999555   99999999999999664 6999999


Q ss_pred             cccccccCCCCceeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|+.+....   ......||+.|+|||++.+
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~  244 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLG  244 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcC
Confidence            9998764322   1334578999999998643

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=3.7e-28  Score=221.22  Aligned_cols=175  Identities=23%  Similarity=0.394  Sum_probs=142.0

Q ss_pred             hhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +.|...+.||+|+||.||++..      .++..+|+|.+....  ......+.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            5677889999999999999974      234568888875332  22234588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCce
Q 018036          256 LLVYEYMPNGSLGEVLHGKR-----------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA  324 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  324 (362)
                      ++||||+++++|.+++....           ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            99999999999999986332           134899999999999999999999655   9999999999999999999


Q ss_pred             EEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       325 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+|||+++...............++..|+|||++.+
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  196 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  196 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence            9999999987643322222233446788999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=4.8e-28  Score=222.20  Aligned_cols=176  Identities=24%  Similarity=0.369  Sum_probs=142.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC--------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  251 (362)
                      .++|+..+.||+|+||.||+|...        ++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            467888899999999999999741        24478888875332 222334588999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      ....++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+.+   ++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            999999999999999999986432              235788899999999999999999655   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +++++.+||+|||+++...............+++.|+|||++.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  212 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF  212 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc
Confidence            9999999999999998775432222233345678899999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=3.8e-28  Score=228.57  Aligned_cols=172  Identities=27%  Similarity=0.343  Sum_probs=141.5

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----  252 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  252 (362)
                      .+.++|+..+.||+|+||.||++.+. .++.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34678999999999999999999864 678999999865443334445588999999999999999999987543     


Q ss_pred             -CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          253 -ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       253 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                       ...++||||++ ++|.+.+..    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         101 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             cCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence             35699999995 578777742    3788899999999999999999554   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++......   ......||+.|+|||++.+
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~  199 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILG  199 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhC
Confidence            98764321   2344578999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.4e-28  Score=222.24  Aligned_cols=175  Identities=23%  Similarity=0.346  Sum_probs=141.0

Q ss_pred             hhccccceeeccCcccEEEEEcCC---------------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN---------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK  246 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~  246 (362)
                      ++|+..+.||+|+||.||++...+               ...||+|.+.... .....+.+.+|++++++++|+|+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            578888999999999999987632               2358899876432 222334588999999999999999999


Q ss_pred             EEEecCCeeeEEEecCCCCChhhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCce
Q 018036          247 AFCSNKETNLLVYEYMPNGSLGEVLHGKR----------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI  316 (362)
Q Consensus       247 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI  316 (362)
                      +++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999985432          124688999999999999999999655   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       317 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++++++.+||+|||++................++..|+|||+..
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  204 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL  204 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence            99999999999999998764332222223344577899999764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.95  E-value=6.4e-28  Score=216.98  Aligned_cols=170  Identities=28%  Similarity=0.331  Sum_probs=144.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|+. .+++.||+|++.....  .....+.+|+.++++++||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            46788899999999999999986 4678899998864322  22334788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++......
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          86 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999999998633  45889999999999999999999655   9999999999999999999999999998764321


Q ss_pred             CceeeccccCccCccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~  359 (362)
                        .......|++.|+|||.+
T Consensus       161 --~~~~~~~~~~~y~~PE~~  178 (267)
T cd06646         161 --AKRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             --cccCccccCccccCHhHc
Confidence              112345689999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.95  E-value=5.7e-28  Score=216.54  Aligned_cols=172  Identities=31%  Similarity=0.443  Sum_probs=143.0

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|...++..+|+|.+.....   ..+.+.+|+.++++++|+|++++++++. ....+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence            357888899999999999999988888899998864332   2345899999999999999999999885 456789999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            999999999997655556899999999999999999999655   99999999999999999999999999987643221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      . ......++..|+|||+..
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~  176 (260)
T cd05070         158 T-ARQGAKFPIKWTAPEAAL  176 (260)
T ss_pred             c-cccCCCCCccccChHHHh
Confidence            1 112234567899999764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=5.8e-28  Score=218.98  Aligned_cols=173  Identities=27%  Similarity=0.395  Sum_probs=137.3

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|.+. +++    .+++|.+.... ......++..|+..+++++||||+++++++.. ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            46777889999999999999863 344    46677664221 12223457788889999999999999998864 4567


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        85 ~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            899999999999999643 346899999999999999999999555   9999999999999999999999999998764


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............|+..|+|||++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~  184 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESIL  184 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhc
Confidence            332222233456788999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=3.8e-28  Score=227.92  Aligned_cols=164  Identities=24%  Similarity=0.283  Sum_probs=137.4

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|+..+.||+|+||.||+|... +++.||+|.....        ....|+.++++++||||+++++++...+..++|||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            35788899999999999999875 4678888863211        14579999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+ .++|.+++.. ....+++..+..|+.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       138 ~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        138 HY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             cc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            99 5689888864 3356899999999999999999999655   999999999999999999999999999854322  


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......||+.|+|||++.+
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~  230 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLAR  230 (357)
T ss_pred             -cccccccccccccCCeecCC
Confidence             11345679999999998754

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=8.2e-28  Score=216.73  Aligned_cols=174  Identities=25%  Similarity=0.336  Sum_probs=139.3

Q ss_pred             ccccceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe-----
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET-----  254 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  254 (362)
                      |+..+.||+|+||.||+|....    +..||+|+++...........+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            3567889999999999998632    3679999986543333334568999999999999999999998866554     


Q ss_pred             -eeEEEecCCCCChhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          255 -NLLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       255 -~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                       .+++|||+++|+|.+++....    ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             689999999999999985432    246899999999999999999999655   999999999999999999999999


Q ss_pred             cccccccCCCCceeeccccCccCcccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+++...............++..|+|||++.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  188 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA  188 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcc
Confidence            9998765332221122234567899999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=3.5e-28  Score=226.93  Aligned_cols=176  Identities=28%  Similarity=0.393  Sum_probs=139.4

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC-
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK-  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  252 (362)
                      .++|+..+.||+|+||.||+|.+      .+++.||||+++.... ......+.+|+.++.++ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            36788999999999999999973      3467899999864322 22234588999999999 689999999988654 


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCC--------------------------------------------------------
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRG--------------------------------------------------------  276 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  276 (362)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            457899999999999999864221                                                        


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          277 ---------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       277 ---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                               ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     23678888999999999999999554   999999999999999999999999999876432221112233


Q ss_pred             cCccCcccccccc
Q 018036          348 AGSYGYIAPVLGW  360 (362)
Q Consensus       348 ~Gt~~y~aPE~~~  360 (362)
                      .+++.|+|||++.
T Consensus       242 ~~~~~y~aPE~~~  254 (343)
T cd05103         242 RLPLKWMAPETIF  254 (343)
T ss_pred             CCCcceECcHHhc
Confidence            4677899999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=6e-28  Score=220.44  Aligned_cols=176  Identities=23%  Similarity=0.331  Sum_probs=143.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-----------------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcce
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-----------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV  243 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  243 (362)
                      .++|+..+.||+|+||.||+|...+                 +..||+|.+..... ....+.+.+|++++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence            3567888999999999999997642                 24578888754322 12334588999999999999999


Q ss_pred             eEEEEEecCCeeeEEEecCCCCChhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCC
Q 018036          244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR---------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN  314 (362)
Q Consensus       244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  314 (362)
                      ++++++...+..+++|||+++++|.+++....         ...+++..+..++.|++.||+|||+.+   ++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99999999999999999999999999986433         125899999999999999999999655   999999999


Q ss_pred             ceeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       315 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+++.++.++|+|||+++...............+++.|+|||++.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL  205 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence            9999999999999999998765433222233455788999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=3.1e-28  Score=221.02  Aligned_cols=175  Identities=20%  Similarity=0.309  Sum_probs=141.8

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      .+|+..+.||+|+||.||+|...      ++..||+|++..... ....+.+.+|+.++..++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            45667788999999999999863      246899998864332 12234588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          256 LLVYEYMPNGSLGEVLHGK--------------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      ++++||+++++|.+++...              ....+++..+..++.|++.||+|||+.+   |+||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            9999999999999998421              1234788889999999999999999555   9999999999999999


Q ss_pred             CceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.+||+|||+++...............+++.|+|||.+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM  199 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence            999999999998765332222233445678999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=7.2e-28  Score=219.68  Aligned_cols=176  Identities=24%  Similarity=0.383  Sum_probs=142.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||++...      ....+|+|.+..... .....++.+|++++.++ +|+||+++++++...+
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            367788899999999999999863      235788998764322 22234588999999999 8999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC
Q 018036          254 TNLLVYEYMPNGSLGEVLHGK--------------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN  319 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  319 (362)
                      ..+++|||+++|+|.+++...              ....+++..++.++.|++.||+|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998642              2346899999999999999999999554   99999999999999


Q ss_pred             CCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       320 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +++.+||+|||+++.+.............++..|+|||++.
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  207 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF  207 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc
Confidence            99999999999998765432222222334567899999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.95  E-value=9.9e-28  Score=215.05  Aligned_cols=171  Identities=29%  Similarity=0.450  Sum_probs=141.6

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|++|.||+|.+.++..+++|.+....   ...+.+.+|++++++++|+|++++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            5678888999999999999998777789999875322   22345889999999999999999999875 4567899999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            99999999997655566899999999999999999999655   99999999999999999999999999987643221 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......++..|+|||+..
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~  176 (260)
T cd05069         158 TARQGAKFPIKWTAPEAAL  176 (260)
T ss_pred             cccCCCccchhhCCHHHhc
Confidence            1122334677899999764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=5.9e-28  Score=217.57  Aligned_cols=168  Identities=24%  Similarity=0.311  Sum_probs=132.4

Q ss_pred             eeeccCcccEEEEEcCCCC---EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAGVVYRGVTPNGE---QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .||+|+||.||+|...++.   .+++|.+.... .....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            5899999999999754333   45566554322 1223456899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCcee
Q 018036          266 SLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC  343 (362)
Q Consensus       266 sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  343 (362)
                      +|.+++....  ....++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999996532  234667778899999999999999655   99999999999999999999999999865322111111


Q ss_pred             eccccCccCcccccccc
Q 018036          344 MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~  360 (362)
                      .....|+..|+|||++.
T Consensus       158 ~~~~~~~~~y~aPE~~~  174 (268)
T cd05086         158 EDDKCVPLRWLAPELVG  174 (268)
T ss_pred             ccCCcCcccccCchhcc
Confidence            23456889999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=9.8e-29  Score=198.55  Aligned_cols=172  Identities=27%  Similarity=0.382  Sum_probs=146.7

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      .|+..+.||+|.||+||+|+.+ +++.||+|+++-...++.......+|+.+++.++|.|||++++...+++..-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4555678999999999999864 678899999987666555555689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      | ..+|..+... -++.++.+.+..++.|+++||.|+|...   +.|||+||.|.|++.+|+.|++|||+++.+.-+.  
T Consensus        83 c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   83 C-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             h-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            9 4588888764 3456889999999999999999999555   9999999999999999999999999999875332  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+.+..+-|.+|.+|.++.|
T Consensus       156 rcysaevvtlwyrppdvlfg  175 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFG  175 (292)
T ss_pred             EeeeceeeeeeccCcceeee
Confidence            23455667999999998865

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=6e-28  Score=219.83  Aligned_cols=177  Identities=24%  Similarity=0.328  Sum_probs=140.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|..+      .+..||+|.+..... ......+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            467888999999999999999653      245789998753321 1223357889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                      .++||||+++|+|.+++....        ....++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996422        133567788899999999999999554   999999999999999999999


Q ss_pred             ccccccccccCCCCceeeccccCccCccccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|||+++...............++..|+|||.+.+
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  195 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD  195 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhcc
Confidence            99999986643222111223345778999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.95  E-value=1.1e-27  Score=213.92  Aligned_cols=171  Identities=26%  Similarity=0.357  Sum_probs=145.0

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|+||.||++... +++.+++|.+..... ....+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            566789999999999999874 688999998864332 223345888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            9999999987655566899999999999999999999655   99999999999999999999999999987643221  


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......|++.|+|||++.
T Consensus       156 ~~~~~~~~~~~~aPE~~~  173 (255)
T cd08219         156 YACTYVGTPYYVPPEIWE  173 (255)
T ss_pred             ccccccCCccccCHHHHc
Confidence            233457899999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.95  E-value=9.8e-28  Score=215.00  Aligned_cols=172  Identities=28%  Similarity=0.414  Sum_probs=143.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .+.|+..+.||+|+||.||+|..++++.||+|.+....   .....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            36778889999999999999998889999999885332   22345899999999999999999999874 456899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++....+..+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999999997666667899999999999999999999554   99999999999999999999999999987652211


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......++..|+|||++.
T Consensus       158 -~~~~~~~~~~~y~~pe~~~  176 (260)
T cd05067         158 -TAREGAKFPIKWTAPEAIN  176 (260)
T ss_pred             -ccccCCcccccccCHHHhc
Confidence             1122344678899999764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=5.1e-28  Score=217.62  Aligned_cols=170  Identities=26%  Similarity=0.332  Sum_probs=143.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.++....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            45778888999999999999986 4678999998864422  22234788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          86 EFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            999999999998543  35899999999999999999999665   9999999999999999999999999987664321


Q ss_pred             CceeeccccCccCccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~  359 (362)
                        .......||..|+|||++
T Consensus       161 --~~~~~~~~~~~y~aPE~~  178 (267)
T cd06645         161 --AKRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             --cccccccCcccccChhhh
Confidence              113455799999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=9.1e-28  Score=216.49  Aligned_cols=173  Identities=25%  Similarity=0.343  Sum_probs=135.8

Q ss_pred             cccceeeccCcccEEEEEcCCC-C--EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------Cee
Q 018036          185 KDNNVIGRGGAGVVYRGVTPNG-E--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ETN  255 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  255 (362)
                      ...+.||+|+||.||+|.+.+. .  .+|+|.++.........+.+.+|++++++++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            3467899999999999987543 2  588998765433333345688999999999999999999987532      246


Q ss_pred             eEEEecCCCCChhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGK----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                      +++|||+++|+|.+++...    ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887422    2245899999999999999999999654   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++...............+++.|+|||+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  187 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLA  187 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHcc
Confidence            98765332211122334677899999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=1e-27  Score=213.42  Aligned_cols=168  Identities=27%  Similarity=0.413  Sum_probs=138.1

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      +.||+|+||.||+|...++..+|+|.+..... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999988889999998754322 12233588999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      .+++.... ..+++..+..++.|++.||.|+|+.+   ++||||||+||++++++.+||+|||++........ ......
T Consensus        80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  154 (250)
T cd05085          80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK  154 (250)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence            99986433 45789999999999999999999555   99999999999999999999999999976542211 111223


Q ss_pred             cCccCccccccccc
Q 018036          348 AGSYGYIAPVLGWY  361 (362)
Q Consensus       348 ~Gt~~y~aPE~~~~  361 (362)
                      .++..|+|||+..+
T Consensus       155 ~~~~~y~aPE~~~~  168 (250)
T cd05085         155 QIPIKWTAPEALNY  168 (250)
T ss_pred             CCcccccCHHHhcc
Confidence            45678999998753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=1.5e-27  Score=216.52  Aligned_cols=172  Identities=28%  Similarity=0.370  Sum_probs=144.1

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+.++++++|+|++++++++......++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            5777889999999999999875 588999998865433333334578999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|..++..  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          82 CDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             cCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999888887643  235899999999999999999999655   99999999999999999999999999987754321 


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......++..|+|||++.+
T Consensus       156 -~~~~~~~~~~~~aPE~~~~  174 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVG  174 (286)
T ss_pred             -cccCcccccccCCHHHHhC
Confidence             1234568899999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=8.9e-28  Score=220.74  Aligned_cols=176  Identities=26%  Similarity=0.370  Sum_probs=141.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC--------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  251 (362)
                      .++|...+.||+|+||.||++.+.        +...+|+|.+.... .......+.+|++++.++ +||||+++++++..
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            367888999999999999999752        23468999876432 222234588899999999 79999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      .+..++||||+++|+|.+++....              ...+++.++++++.|++.||+|||+.+   ++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence            999999999999999999996532              135889999999999999999999655   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.++.+||+|||.++...............+++.|+|||++.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  215 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF  215 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc
Confidence            9999999999999998664322111122233457899999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=7.2e-28  Score=217.75  Aligned_cols=176  Identities=23%  Similarity=0.333  Sum_probs=143.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|...      ++..|++|.+..... ......+.+|+.++..++||||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            467888899999999999999864      236899998753321 1223458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                      .++||||+++++|.+++....        ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            999999999999999986432        234788999999999999999999554   999999999999999999999


Q ss_pred             ccccccccccCCCCceeeccccCccCcccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+++...............+|..|+|||.+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  194 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK  194 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHh
Confidence            9999998765433222233445788999999764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=9.9e-28  Score=215.67  Aligned_cols=174  Identities=19%  Similarity=0.309  Sum_probs=144.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+..... .......+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46778899999999999999874 688999998764332 2223345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||+++++|.+++...  ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988532  2345788999999999999999999655   99999999999999999999999999987653


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ......|++.|+|||++.
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~  179 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhc
Confidence            221  123456899999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=9.5e-28  Score=215.04  Aligned_cols=173  Identities=31%  Similarity=0.464  Sum_probs=146.3

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|..+++..+++|.+....   ...+++.+|+.++++++|+||+++++++......++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            46788889999999999999998878889999886432   223458999999999999999999999999899999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.......+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999997665567899999999999999999999665   99999999999999999999999999987653211


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......++..|+|||++.
T Consensus       159 -~~~~~~~~~~~y~~PE~~~  177 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAAN  177 (261)
T ss_pred             -hhhhccCCCccccCHHHhc
Confidence             1122233567899999765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=7.1e-28  Score=243.72  Aligned_cols=179  Identities=22%  Similarity=0.269  Sum_probs=144.1

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--CCee
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETN  255 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  255 (362)
                      ...++|+..+.||+|+||.||+|.+. ++..+|+|.+............+..|+.++++++|||||++++++..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34578899999999999999999875 46688888876543333344568899999999999999999998854  3568


Q ss_pred             eEEEecCCCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeEEeCCCCCceeeCC---------
Q 018036          256 LLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCS----PLIIHRDVKSNNILLNS---------  320 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~NIll~~---------  320 (362)
                      ||||||+++|+|.++|....  ...+++..++.|+.||+.||+|||..+.    .+||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999986422  2468999999999999999999996431    45999999999999964         


Q ss_pred             --------CCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          321 --------DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       321 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                              ...+||+|||++..+....   ......||+.|+|||++.
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~  214 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLL  214 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHh
Confidence                    2348999999998764321   133457999999999874

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=1.3e-27  Score=213.66  Aligned_cols=170  Identities=31%  Similarity=0.450  Sum_probs=143.5

Q ss_pred             ceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          188 NVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      +.||+|+||.||+|....    +..+++|.+....... ..+.+.+|++.+..++|+||+++++++......++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            468999999999998753    7889999986544332 34568999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          264 NGSLGEVLHGKR-------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       264 ~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +++|.+++....       ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            999999997542       356899999999999999999999655   9999999999999999999999999999876


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ............+++.|+|||.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~  181 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD  181 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc
Confidence            4332222344567899999997653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=1.4e-27  Score=216.50  Aligned_cols=164  Identities=25%  Similarity=0.339  Sum_probs=138.9

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||+|.+ .+++.||+|.+.... ......++.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            466778999999999999986 467899999885432 222334588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|..+.      .+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++......   
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            9999997553      3678888999999999999999655   999999999999999999999999999866432   


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ......||..|+|||++.
T Consensus       149 -~~~~~~~~~~y~aPE~~~  166 (279)
T cd06619         149 -IAKTYVGTNAYMAPERIS  166 (279)
T ss_pred             -cccCCCCChhhcCceeec
Confidence             134467999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=9.4e-28  Score=222.62  Aligned_cols=171  Identities=22%  Similarity=0.212  Sum_probs=139.1

Q ss_pred             cceeecc--CcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          187 NNVIGRG--GAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       187 ~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      .++||+|  +|++||++.. .+++.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  6889999987 478899999986543333334457889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce-
Q 018036          264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-  342 (362)
Q Consensus       264 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-  342 (362)
                      +|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+.+......+... 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999996544455899999999999999999999655   9999999999999999999999998765443221110 


Q ss_pred             ----eeccccCccCcccccccc
Q 018036          343 ----CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ----~~~~~~Gt~~y~aPE~~~  360 (362)
                          ......++..|+|||++.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~  181 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQ  181 (327)
T ss_pred             ccccccccccceecccChHHhh
Confidence                112235778899999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=1.3e-27  Score=219.87  Aligned_cols=170  Identities=28%  Similarity=0.345  Sum_probs=142.5

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||++.+. ++..+++|.+..... .....++.+|++++.+++||||+++++++..++..++||||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            5777889999999999999874 567788887753321 22234588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            9999999999643  4588999999999999999999952  249999999999999999999999999997654321  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .....|++.|+|||++.+
T Consensus       155 --~~~~~~~~~~~aPE~~~~  172 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQG  172 (308)
T ss_pred             --cccCCCCcCccChhHhcC
Confidence              244678999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=1.4e-27  Score=215.00  Aligned_cols=175  Identities=29%  Similarity=0.422  Sum_probs=141.9

Q ss_pred             hhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||.||+|.+.    ....+|+|.+.... .....+.+.+|+.++.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56788899999999999999863    23378888875432 22234568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||+++.+..
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999996433 45899999999999999999999655   99999999999999999999999999987754


Q ss_pred             CCCce-eeccccCccCccccccccc
Q 018036          338 TGASE-CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~-~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..... ......++..|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~  183 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAY  183 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhcc
Confidence            32211 1122234568999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.6e-27  Score=213.75  Aligned_cols=175  Identities=30%  Similarity=0.429  Sum_probs=144.2

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC---CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +.|+..+.||+|++|.||+|.. .+++.+++|.+.......   ...+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            3577889999999999999986 468899999886443211   123458889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999998643  35888999999999999999999655   99999999999999999999999999986643


Q ss_pred             CCCcee-eccccCccCccccccccc
Q 018036          338 TGASEC-MSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~-~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...... .....|+..|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~  181 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISG  181 (263)
T ss_pred             cccccccccCCCcCccccCcceecc
Confidence            211110 134568899999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=1.2e-27  Score=218.28  Aligned_cols=174  Identities=24%  Similarity=0.378  Sum_probs=141.5

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      .+|...+.||+|+||.||+|...      ++..+++|.+....  ....+.+.+|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            45677789999999999999742      34568888764322  22234588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          256 LLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      ++||||+++++|.+++....              ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence            99999999999999986432              234889999999999999999999655   9999999999999999


Q ss_pred             CceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.++|+|||+++...............|+..|+|||++.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  198 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM  198 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc
Confidence            999999999998765332222233455788999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=2e-27  Score=212.47  Aligned_cols=167  Identities=29%  Similarity=0.427  Sum_probs=143.4

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||+|... ++.|++|.+.....   ..+++.+|+.++++++|+||+++++++...+..++||||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            56778899999999999999874 78899999864432   345589999999999999999999999998999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||.++.....   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~---  155 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---  155 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence            99999999997655457899999999999999999999655   999999999999999999999999999876422   


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                        .....++..|+|||++.
T Consensus       156 --~~~~~~~~~~~ape~~~  172 (256)
T cd05039         156 --QDSGKLPVKWTAPEALR  172 (256)
T ss_pred             --cccCCCcccccCchhhc
Confidence              11233567899999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=1.7e-27  Score=214.04  Aligned_cols=172  Identities=30%  Similarity=0.486  Sum_probs=143.3

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCC----CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      |+..+.||+|+||.||+|...+++.+|+|.+.......    .....+.+|++++++++|+||+++++++.+.+..+++|
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            56778999999999999998888999999886543211    11245888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          82 EFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            999999999999643  35789999999999999999999655   9999999999999999999999999998653211


Q ss_pred             C----ceeeccccCccCcccccccc
Q 018036          340 A----SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~----~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .    ........|+..|+|||++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~  181 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVIN  181 (265)
T ss_pred             ccccccccccccCCCccccChhhhc
Confidence            1    11123456899999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=1.7e-27  Score=212.76  Aligned_cols=173  Identities=25%  Similarity=0.363  Sum_probs=144.5

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-CeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-ETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  261 (362)
                      |+..+.||+|++|.||++... +++.+++|++..........+.+.+|++++++++|+|++++++.+... ...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            667789999999999999864 578899999865443333445588999999999999999999987644 467899999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--  156 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--  156 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence            99999999997655566899999999999999999999655   9999999999999999999999999998764322  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......|++.|+|||+..+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~  176 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSN  176 (257)
T ss_pred             CccccccCCcCccChhHhcC
Confidence            12345578999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=2e-27  Score=213.54  Aligned_cols=174  Identities=21%  Similarity=0.335  Sum_probs=146.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||+|... +++.|++|.++..... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46778899999999999999986 7899999988643322 223456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||+++++|.+++...  ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998542  2355899999999999999999999655   99999999999999999999999999987643


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ......|++.|+|||++.
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~  179 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             CCc--ccceecCCccccCHHHhc
Confidence            221  123456899999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=1.2e-27  Score=218.08  Aligned_cols=168  Identities=28%  Similarity=0.323  Sum_probs=144.2

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||++.+. +++.+|+|.+..... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            5677889999999999999874 578999998864332 12233558899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.....  
T Consensus        82 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          82 YVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999999999643  46899999999999999999999655   999999999999999999999999999876533  


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                         .....|++.|+|||.+.
T Consensus       155 ---~~~~~~~~~y~aPE~~~  171 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIIL  171 (290)
T ss_pred             ---CCCCCCCccccChhhhc
Confidence               33457899999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=1.4e-27  Score=220.18  Aligned_cols=176  Identities=27%  Similarity=0.394  Sum_probs=140.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC--------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  251 (362)
                      .++|...+.||+|+||.||++...        ....+|+|.+..... ......+.+|+++++++ +||||+++++++..
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            367888999999999999999742        245688888753322 22234588899999999 69999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      .+..+++|||+++|+|.+++....              ...+++..+.+++.|++.||+|||+.+   ++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            999999999999999999996432              235889999999999999999999655   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +++++.+||+|||+++...............++..|||||++.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  209 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF  209 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc
Confidence            9999999999999998765322211122233456899999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=1.4e-27  Score=216.29  Aligned_cols=173  Identities=27%  Similarity=0.400  Sum_probs=138.6

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||+||+|.+ .+++    .||+|.+..... ......+.+|+.++..++||||+++++++... ..+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            5677889999999999999985 3444    478898754322 22334588999999999999999999999754 567


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ++|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999999643 345899999999999999999999554   9999999999999999999999999998775


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............+++.|+|||...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~  184 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESIL  184 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhc
Confidence            332221122234567899999864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=1.3e-27  Score=214.63  Aligned_cols=161  Identities=24%  Similarity=0.340  Sum_probs=131.1

Q ss_pred             ceeeccCcccEEEEEcCC-------------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          188 NVIGRGGAGVVYRGVTPN-------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      +.||+|+||.||+|+..+             ...|++|.+....  ......+.+|+.+++.++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999998532             2257888764432  2223458889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc-------eEEc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-------AHVA  327 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl~  327 (362)
                      .++||||+++++|..++... ...+++..+.+++.|++.||+|||+.   +|+||||||+|||++.++.       ++++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             CEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999999888643 34589999999999999999999955   4999999999999987654       8999


Q ss_pred             cccccccccCCCCceeeccccCccCcccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |||++.....      .....|+..|+|||++.
T Consensus       155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~  181 (262)
T cd05077         155 DPGIPITVLS------RQECVERIPWIAPECVE  181 (262)
T ss_pred             CCCCCccccC------cccccccccccChhhhc
Confidence            9999876532      22345788999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=1.8e-27  Score=218.01  Aligned_cols=172  Identities=26%  Similarity=0.365  Sum_probs=142.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            367888899999999999999875 5789999988644322 22234788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||++ ++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        84 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          84 EYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             eccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            9996 6999988643 345889999999999999999999554   9999999999999999999999999998654221


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  ......+++.|+|||++.
T Consensus       159 ~--~~~~~~~~~~y~~PE~~~  177 (301)
T cd07873         159 K--TYSNEVVTLWYRPPDILL  177 (301)
T ss_pred             C--cccccceeecccCcHHHh
Confidence            1  123446789999999764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=1.3e-27  Score=215.47  Aligned_cols=172  Identities=30%  Similarity=0.421  Sum_probs=143.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK------  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------  252 (362)
                      ...|+..+.||+|+||.||+|... +++.+|+|.+....   .....+.+|+.++.++ +|+||+++++++...      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            456777889999999999999864 57889999875432   2334588999999998 799999999998753      


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      ...++||||+++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            45789999999999999997655567899999999999999999999655   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......  .......|++.|+|||++.
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~  184 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIA  184 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhc
Confidence            8664321  1234567999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=1.7e-27  Score=213.01  Aligned_cols=160  Identities=23%  Similarity=0.346  Sum_probs=131.9

Q ss_pred             ceeeccCcccEEEEEcCCCC-----------EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          188 NVIGRGGAGVVYRGVTPNGE-----------QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +.||+|+||.||+|.+.+..           .+++|.+......   ...+.+|+.++++++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            36899999999999985433           4667765433221   4558999999999999999999999988 7789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-------ceEEccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-------EAHVADF  329 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~DF  329 (362)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++       .+||+||
T Consensus        77 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999999996433 26899999999999999999999554   99999999999999887       7999999


Q ss_pred             cccccccCCCCceeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |++.....      .....++..|+|||++.+
T Consensus       153 g~a~~~~~------~~~~~~~~~y~aPE~~~~  178 (259)
T cd05037         153 GIPITVLS------REERVERIPWIAPECIRN  178 (259)
T ss_pred             Cccccccc------ccccccCCCccChhhhcC
Confidence            99987543      223457788999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-29  Score=215.91  Aligned_cols=173  Identities=27%  Similarity=0.287  Sum_probs=147.4

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +++|+..++||+|.||+|..++- .+++.+|+|++++..--. .+...-..|-++|+..+||.+..+.-.++..+..|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46777789999999999999986 468899999987644322 2223356789999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||..||.|.-+|.  +...+++.....+..+|..||.|||+..   ||.||+|.+|.|+|.+|.+||.|||+++.-...
T Consensus       247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999998885  4456888888889999999999999554   999999999999999999999999999865432


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ...+.++||||.|.|||++.
T Consensus       322 --g~t~kTFCGTPEYLAPEVle  341 (516)
T KOG0690|consen  322 --GDTTKTFCGTPEYLAPEVLE  341 (516)
T ss_pred             --cceeccccCChhhcCchhhc
Confidence              34478999999999999874

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-28  Score=229.55  Aligned_cols=165  Identities=30%  Similarity=0.448  Sum_probs=140.4

Q ss_pred             ceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCC
Q 018036          188 NVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS  266 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  266 (362)
                      -++|+|.||+||.|++.+ ...+|||.+.....  ...+-+..|+..-++++|.|||+++|.+..++..-|.||-++||+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            479999999999999865 45789998854433  233338899999999999999999999999998899999999999


Q ss_pred             hhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCceEEccccccccccCCCCcee
Q 018036          267 LGEVLHGKRGSFL--KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQDTGASEC  343 (362)
Q Consensus       267 L~~~l~~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~~~~~~~  343 (362)
                      |.++|... -+++  .+.+.-.+..||++||.|||++.   |||||||-+|||++ -.|.+||+|||-++.+.  +....
T Consensus       659 LSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~  732 (1226)
T KOG4279|consen  659 LSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPC  732 (1226)
T ss_pred             HHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcc
Confidence            99999743 2344  66777888999999999999776   99999999999997 57999999999999875  33456


Q ss_pred             eccccCccCcccccccc
Q 018036          344 MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~  360 (362)
                      +.++.||..|||||++-
T Consensus       733 TETFTGTLQYMAPEvID  749 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVID  749 (1226)
T ss_pred             ccccccchhhhChHhhc
Confidence            78899999999999873

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=2.5e-27  Score=215.12  Aligned_cols=172  Identities=30%  Similarity=0.400  Sum_probs=145.7

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||+|.+. +++.|++|++............+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3667789999999999999874 688999999876543333345689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      + +++|.+++.... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999986433 56899999999999999999999655   99999999999999999999999999987754321 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......|+..|+|||++.
T Consensus       155 ~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07832         155 RLYSHQVATRWYRAPELLY  173 (286)
T ss_pred             CccccccCcccccCceeee
Confidence            1133456899999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.8e-27  Score=214.31  Aligned_cols=173  Identities=27%  Similarity=0.411  Sum_probs=139.0

Q ss_pred             hhccccceeeccCcccEEEEEcCC-CC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-GE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .+|+..+.||+|+||.||+|.+.+ +.    .+++|.+..... .....++.+|+.++++++||||+++++++.. ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            567788999999999999998642 32    578887653322 2233458899999999999999999999987 7889


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999997433 34899999999999999999999654   9999999999999999999999999998775


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............++..|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~  184 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESIL  184 (279)
T ss_pred             CcccceecCCCcccccccCHHHhh
Confidence            332211112223467899999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-27  Score=215.31  Aligned_cols=172  Identities=27%  Similarity=0.366  Sum_probs=142.0

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .+.|+..+.||+|++|.||+|..+ +++.||+|.+....... ....+.+|++++++++|+||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            367788899999999999999875 67899999986543222 2233778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          83 EYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             ecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9997 59999886433 36889999999999999999999655   9999999999999999999999999987653211


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  ......++..|+|||++.
T Consensus       158 ~--~~~~~~~~~~~~aPE~~~  176 (291)
T cd07844         158 K--TYSNEVVTLWYRPPDVLL  176 (291)
T ss_pred             c--cccccccccccCCcHHhh
Confidence            1  122335788999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=2.4e-27  Score=212.18  Aligned_cols=166  Identities=25%  Similarity=0.358  Sum_probs=134.7

Q ss_pred             eeeccCcccEEEEEc---CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .||+|+||.||+|.+   .++..+|+|.+..........+++.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999965   357889999886444333344568999999999999999999998864 5668999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce-ee
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-CM  344 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~  344 (362)
                      +|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999533  45899999999999999999999655   9999999999999999999999999998765332211 11


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                      ....++..|+|||.+.
T Consensus       156 ~~~~~~~~y~aPE~~~  171 (257)
T cd05116         156 THGKWPVKWYAPECMN  171 (257)
T ss_pred             CCCCCCccccCHhHhc
Confidence            2233467899999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=2.5e-27  Score=215.25  Aligned_cols=173  Identities=30%  Similarity=0.450  Sum_probs=141.1

Q ss_pred             hccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--Cee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETN  255 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  255 (362)
                      .|+..+.||+|+||.||.+..     .++..||+|.+..... ......+.+|++++++++||||+++++++...  ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            456778999999999999973     3578899999864432 22334589999999999999999999998775  567


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+
T Consensus        84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            8999999999999998643 235899999999999999999999655   999999999999999999999999999876


Q ss_pred             cCCCCc-eeeccccCccCcccccccc
Q 018036          336 QDTGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...... .......|+..|+|||++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhc
Confidence            532221 1123456778899999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=2.2e-27  Score=217.14  Aligned_cols=173  Identities=26%  Similarity=0.388  Sum_probs=146.6

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .+...+|+..+.||+|+||.||++.. .+++.||+|.+.....  ...+.+.+|+.+++.++|+||+++++++...+..+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            45567888999999999999999986 5789999998864332  23345889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++++|.+++..   ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            99999999999999853   34788999999999999999999654   9999999999999999999999999998664


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....  ......|++.|+|||++.
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~  188 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVVT  188 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHHc
Confidence            3221  123456899999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=2.2e-27  Score=217.06  Aligned_cols=170  Identities=31%  Similarity=0.425  Sum_probs=142.6

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC---CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG---SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      |+..+.||+|++|.||+|... +++.|++|++......   ......+..|++++++++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            566788999999999999874 6889999998755433   222344778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+ +++|.+++.... ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            999 899999996433 36899999999999999999999655   9999999999999999999999999998765432


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  ......+++.|+|||++.
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~  175 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLF  175 (298)
T ss_pred             c--cccccccceeeeCHHHHh
Confidence            1  123345788999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=1.9e-27  Score=217.47  Aligned_cols=172  Identities=26%  Similarity=0.382  Sum_probs=144.8

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +...+|+..+.||+|+||.||+|.. .+++.|++|.+......  ..+.+.+|+.+++.++|+||+++++.+......++
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            3446788889999999999999986 46889999988643322  23458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++..   ..+++.++..++.|++.||+|||..+   |+||||||+||+++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999999853   24789999999999999999999555   99999999999999999999999999886543


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ......|++.|+|||++.
T Consensus       169 ~~~--~~~~~~~~~~y~aPE~~~  189 (296)
T cd06654         169 EQS--KRSTMVGTPYWMAPEVVT  189 (296)
T ss_pred             ccc--ccCcccCCccccCHHHHc
Confidence            211  123457899999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-28  Score=222.75  Aligned_cols=175  Identities=25%  Similarity=0.317  Sum_probs=151.8

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +..-|+..+.||+|.|.+|-.|++ =+|..||||++.+...+......+.+|++.|+-++|||||++|++....-..|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            345577788999999999999986 3799999999976655554445588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCceEEccccccccccC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~  337 (362)
                      +|.-++|+|++++.... ..+.+..+.+++.||..|+.|+|+..   +|||||||+||.+- .-|-+||.|||++..+..
T Consensus        96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999997544 34889999999999999999999766   99999999998774 568999999999988764


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         ++...+.||+..|-|||++.|
T Consensus       172 ---G~kL~TsCGSLAYSAPEILLG  192 (864)
T KOG4717|consen  172 ---GKKLTTSCGSLAYSAPEILLG  192 (864)
T ss_pred             ---cchhhcccchhhccCchhhhc
Confidence               344778999999999999865

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=1.7e-27  Score=213.46  Aligned_cols=173  Identities=25%  Similarity=0.401  Sum_probs=144.1

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||++...++..+++|.+...   ....+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            4678888999999999999999877788999987532   2223458899999999999999999999887 77899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||.+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            999999999997655567899999999999999999999655   99999999999999999999999999987643221


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......++..|+|||++.+
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~  177 (260)
T cd05073         158 -TAREGAKFPIKWTAPEAINF  177 (260)
T ss_pred             -ccccCCcccccccCHhHhcc
Confidence             11223346678999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.95  E-value=2.7e-27  Score=214.43  Aligned_cols=176  Identities=23%  Similarity=0.305  Sum_probs=142.5

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-CCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  254 (362)
                      .++|+..+.||+|+||.||+|.+.+     +..|++|++.... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            3677888999999999999998755     6788888875332 22234558899999999999999999998876 467


Q ss_pred             eeEEEecCCCCChhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRG------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                      .++++||+++++|.+++.....      ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            8899999999999999864322      45899999999999999999999655   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCcccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+++.+.............++..|+|||++.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  192 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLV  192 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHh
Confidence            99998764322211122345677899999764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.95  E-value=3.7e-27  Score=210.78  Aligned_cols=167  Identities=30%  Similarity=0.413  Sum_probs=139.4

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEe-cCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS-NKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||++... +..+++|.+...    ...+.+.+|+.++++++|+|++++++++. ..+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            356788899999999999999774 778999987432    22345889999999999999999999764 456789999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..... 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc-
Confidence            9999999999997655556899999999999999999999655   999999999999999999999999999865432 


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                          .....++..|+|||++.
T Consensus       156 ----~~~~~~~~~y~aPE~~~  172 (256)
T cd05082         156 ----QDTGKLPVKWTAPEALR  172 (256)
T ss_pred             ----CCCCccceeecCHHHHc
Confidence                12334567899999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=2.3e-27  Score=215.40  Aligned_cols=174  Identities=32%  Similarity=0.410  Sum_probs=138.7

Q ss_pred             hhccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--Ce
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  254 (362)
                      ++|+..+.||+|+||.||++..     .++..|++|++....  ....+.+.+|++++++++||||+++++++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            4567788999999999999974     357899999875432  22234588999999999999999999987543  46


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            789999999999999996432 35899999999999999999999655   99999999999999999999999999997


Q ss_pred             ccCCCCce-eeccccCccCccccccccc
Q 018036          335 LQDTGASE-CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~-~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........ ......++..|+|||+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTE  185 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhcc
Confidence            65322211 1112234456999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=1.3e-27  Score=216.90  Aligned_cols=170  Identities=28%  Similarity=0.389  Sum_probs=141.4

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|+||.||+|.+. +|+.+++|.+............+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            566788999999999999874 6889999998654333333345788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      + ++|.+++... ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          82 D-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            6 5888887643 345899999999999999999999655   99999999999999999999999999986543211  


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......+++.|+|||++.
T Consensus       155 ~~~~~~~~~~y~aPE~~~  172 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLF  172 (284)
T ss_pred             CcCCCccccCCcChHHHh
Confidence            123456789999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=3.5e-27  Score=212.72  Aligned_cols=172  Identities=30%  Similarity=0.444  Sum_probs=142.3

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC--------chhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS--------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      |...+.||+|+||.||+|... +++.+|+|.+........        ..+.+.+|+.++++++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            566789999999999999864 688999998854322111        12347889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence            99999999999999999643  46889999999999999999999655   99999999999999999999999999987


Q ss_pred             ccCCCCceeeccccCccCcccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..............|+..|+|||++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~  183 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIH  183 (272)
T ss_pred             ccccccccccccccCCccccCHHHhc
Confidence            64322222233456899999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=3.3e-27  Score=217.73  Aligned_cols=167  Identities=24%  Similarity=0.389  Sum_probs=131.9

Q ss_pred             cceeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--CCeeeEEEec
Q 018036          187 NNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLLVYEY  261 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  261 (362)
                      +..||+|+||.||+|+..   ++..||+|.+....    ....+.+|++++++++||||+++++++..  ....++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            468999999999999864   45789999875332    12347889999999999999999998854  4577899999


Q ss_pred             CCCCChhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee----CCCCceEEcccc
Q 018036          262 MPNGSLGEVLHGK-------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFG  330 (362)
Q Consensus       262 ~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFG  330 (362)
                      ++ ++|.+++...       ....+++..+..++.|++.||+|||+.+   |+||||||+||++    +.++.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            95 5888877421       1235888999999999999999999555   9999999999999    566789999999


Q ss_pred             ccccccCCCCc-eeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++........ .......||+.|+|||++.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcC
Confidence            99876533211 12334578999999998753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.9e-27  Score=218.12  Aligned_cols=176  Identities=27%  Similarity=0.285  Sum_probs=146.3

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|++|.||+|... +++.+|+|.+....... ...+.+.+|++++..++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5777889999999999999875 48899999986543321 233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.......+++..+..++.|++.||+|||..+   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            999999999997655567899999999999999999999655   99999999999999999999999999876532111


Q ss_pred             c---------------------------eeeccccCccCccccccccc
Q 018036          341 S---------------------------ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~---------------------------~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .                           .......||..|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  206 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG  206 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC
Confidence            0                           01123468999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.95  E-value=2.9e-27  Score=213.06  Aligned_cols=175  Identities=30%  Similarity=0.477  Sum_probs=140.8

Q ss_pred             hhccccceeeccCcccEEEEEcCC-C---CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-G---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      .+|+..+.||+|+||.||+|.... +   ..|++|.+.... ......++..|+.++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            457788999999999999998642 2   369999875432 22233568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++... ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          83 ITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999998643 345899999999999999999999655   99999999999999999999999999987653


Q ss_pred             CCCcee-eccccC--ccCccccccccc
Q 018036          338 TGASEC-MSAVAG--SYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~-~~~~~G--t~~y~aPE~~~~  361 (362)
                      ...... .....|  +..|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY  185 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc
Confidence            222111 111122  457999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9e-29  Score=247.48  Aligned_cols=174  Identities=28%  Similarity=0.390  Sum_probs=145.4

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++..+..||.|.||.||.|.. .+|...|+|-++........-+...+|+.++..++|||+|+++|+-.+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            455678999999999999986 5688889998765443333334588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC-
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA-  340 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~-  340 (362)
                      |++|+|.+++..  +...++.....+..|++.|++|||+.+   ||||||||.||+++.+|.+|++|||.|..+..... 
T Consensus      1316 C~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             hccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            999999999953  344666666778899999999999776   99999999999999999999999999998864321 


Q ss_pred             -ceeeccccCccCccccccccc
Q 018036          341 -SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 -~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ........||+.|||||++.+
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcc
Confidence             111345689999999999865

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=2.3e-27  Score=215.11  Aligned_cols=175  Identities=25%  Similarity=0.380  Sum_probs=140.8

Q ss_pred             hhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +++...+.||+|+||.||++..      .++..+++|.+....  ....+.+.+|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            4567788999999999999963      235578888765332  22334589999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC
Q 018036          256 LLVYEYMPNGSLGEVLHGKRG-------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF  322 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  322 (362)
                      +++|||+++++|.+++.....             ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence            999999999999999864321             34789999999999999999999555   99999999999999999


Q ss_pred             ceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+||+|||+++...............+++.|+|||++.+
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  198 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence            999999999986543221111223345788999997643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.95  E-value=5.2e-27  Score=215.53  Aligned_cols=182  Identities=28%  Similarity=0.371  Sum_probs=145.8

Q ss_pred             CCChhhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC
Q 018036          174 DFGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK  252 (362)
Q Consensus       174 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  252 (362)
                      ++...+..++|+..+.||+|+||.||+|... +++.||+|.+............+.+|++++++++||||+++++++...
T Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            3444556788999999999999999999874 688999998865433333333467899999999999999999998765


Q ss_pred             C--------eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCce
Q 018036          253 E--------TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA  324 (362)
Q Consensus       253 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  324 (362)
                      +        ..++||||++ ++|.+.+... ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL  158 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence            4        3499999995 5888888543 345899999999999999999999665   9999999999999999999


Q ss_pred             EEccccccccccCCCCc--eeeccccCccCcccccccc
Q 018036          325 HVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       325 kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+|||++.........  .......++..|+|||++.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL  196 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhc
Confidence            99999999876532211  1123456788999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=1.3e-27  Score=216.09  Aligned_cols=160  Identities=20%  Similarity=0.258  Sum_probs=128.7

Q ss_pred             eeeccCcccEEEEEcCC-------------------------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcce
Q 018036          189 VIGRGGAGVVYRGVTPN-------------------------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV  243 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  243 (362)
                      .||+|+||.||+|....                         ...|++|.+....  .....++.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            58999999999997411                         1357888774322  12234578899999999999999


Q ss_pred             eEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-
Q 018036          244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-  322 (362)
Q Consensus       244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-  322 (362)
                      ++++++......++||||+++|+|.+++... ...+++..+..++.|+++||+|||+.+   |+||||||+||+++..+ 
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            9999999999999999999999999998643 346889999999999999999999554   99999999999997543 


Q ss_pred             ------ceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          323 ------EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       323 ------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                            .+|++|||++......      ....++..|+|||++.
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~  193 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVP  193 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhc
Confidence                  3799999998654321      2235788899999774

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=3e-27  Score=216.10  Aligned_cols=175  Identities=23%  Similarity=0.345  Sum_probs=140.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-----------------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCccee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-----------------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR  244 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  244 (362)
                      ++|+..+.||+|+||.||++...                 +...+|+|.+.... .....+.+.+|++++++++|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence            56888899999999999998532                 23468888875432 1222345889999999999999999


Q ss_pred             EEEEEecCCeeeEEEecCCCCChhhhhcCCCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCc
Q 018036          245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG---------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN  315 (362)
Q Consensus       245 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  315 (362)
                      +++++...+..++||||+++++|.+++.....         ..+++.++..++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999999864321         24778889999999999999999655   9999999999


Q ss_pred             eeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          316 ILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       316 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+++.++.++|+|||+++.+.............+++.|+|||+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  205 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL  205 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence            999999999999999998764332212122334567899999654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=3.1e-27  Score=214.40  Aligned_cols=170  Identities=25%  Similarity=0.309  Sum_probs=141.0

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      .|+..+.||+|+||.||+|... ++..+++|.+....  ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            3566788999999999999875 46677888774322  22334588899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--  157 (282)
T cd06643          84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  157 (282)
T ss_pred             cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence            9999999887542 346899999999999999999999655   9999999999999999999999999997654321  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......||+.|+|||++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~  176 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVM  176 (282)
T ss_pred             cccccccccccccCHhhcc
Confidence            1234457899999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=2.6e-27  Score=214.97  Aligned_cols=172  Identities=27%  Similarity=0.365  Sum_probs=144.0

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||+|+.. +++.|++|++............+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            567789999999999999874 6889999988654433333345889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      . ++|.+++.......+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++.......  
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--  155 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--  155 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--
Confidence            5 68999987655667899999999999999999999655   99999999999999999999999999986643211  


Q ss_pred             eeccccCccCccccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......+++.|+|||++.+
T Consensus       156 ~~~~~~~~~~y~aPE~~~~  174 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLG  174 (284)
T ss_pred             ccccccccccccCCeEEec
Confidence            1233457889999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=213.24  Aligned_cols=166  Identities=25%  Similarity=0.369  Sum_probs=138.1

Q ss_pred             cceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEecCCC
Q 018036          187 NNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      .+.||+|+|+.|-.++. .++.++|||++.+...  ..+.+..+|++++..++ |+||++++++|+++...|||||-|.|
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            46899999999999974 7899999999865532  23445899999999995 99999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC---CceEEccccccccccCCC--
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAKYLQDTG--  339 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~~~~~~--  339 (362)
                      |+|.++++.  .+.+++.++.++..+|+.||.|||..+   |.|||+||+|||-.+.   .-+|||||.+..-+....  
T Consensus       161 GplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  161 GPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             chHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999999964  456999999999999999999999555   9999999999999654   348999999876543211  


Q ss_pred             ---CceeeccccCccCccccccc
Q 018036          340 ---ASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       340 ---~~~~~~~~~Gt~~y~aPE~~  359 (362)
                         ......+.+|+..|||||+.
T Consensus       236 spastP~L~tPvGSAEfMAPEVV  258 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVV  258 (463)
T ss_pred             CCCCCccccCcccchhhcchhHH
Confidence               11224567899999999975

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=4.2e-27  Score=214.67  Aligned_cols=171  Identities=25%  Similarity=0.306  Sum_probs=143.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.|+..+.||+|+||.||+|... ++..+++|.+....  ....+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            56788889999999999999875 57889999875432  2233458889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          90 FCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999998887533 345899999999999999999999655   9999999999999999999999999987643221 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......|++.|+|||++.
T Consensus       165 -~~~~~~~~~~~y~aPE~~~  183 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVM  183 (292)
T ss_pred             -cccceecCCccccCceeec
Confidence             1123456899999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=5.4e-27  Score=210.78  Aligned_cols=174  Identities=29%  Similarity=0.395  Sum_probs=140.6

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC---CchhhHHHHHHHHhcCccCcceeEEEEEecC--Cee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  255 (362)
                      +.|+..+.||+|+||.||+|... ++..|++|.+.......   ...+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            35677899999999999999874 58899999886433221   1224588899999999999999999988764  467


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      +++|||+++++|.+++...  ..+++..+.+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999998643  34788889999999999999999655   999999999999999999999999999865


Q ss_pred             cCCCC-ceeeccccCccCcccccccc
Q 018036          336 QDTGA-SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~-~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..... ........||..|+|||++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVIS  182 (265)
T ss_pred             ccccccccccccCCCCccccChhhhc
Confidence            42111 11123456899999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=3.4e-27  Score=210.85  Aligned_cols=173  Identities=24%  Similarity=0.360  Sum_probs=146.2

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||++.. .+++.+++|.+..........+++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            367788999999999999986 4688999999865433333345689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++.++.+++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999997555556899999999999999999999655   9999999999999999999999999998764321  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......|++.|+|||+..
T Consensus       156 ~~~~~~~~~~~~~~pe~~~  174 (256)
T cd08218         156 ELARTCIGTPYYLSPEICE  174 (256)
T ss_pred             hhhhhccCCccccCHHHhC
Confidence            1123456899999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.95  E-value=4e-27  Score=213.17  Aligned_cols=176  Identities=28%  Similarity=0.361  Sum_probs=139.6

Q ss_pred             hhccccceeeccCcccEEEEEcCC------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +.|...+.||+|++|.||+|.+.+      +..|++|.+..... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            567888999999999999998743      46788887643321 22234588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC---ceEEc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRG-----SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHVA  327 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~  327 (362)
                      ++||||+++++|.+++.....     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865431     35899999999999999999999655   99999999999998654   59999


Q ss_pred             cccccccccCCCCceeeccccCccCccccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |||+++.+..............+..|+|||++.+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  195 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD  195 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhc
Confidence            9999987643221111122234568999998753

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=3.2e-27  Score=219.66  Aligned_cols=175  Identities=26%  Similarity=0.374  Sum_probs=140.1

Q ss_pred             hhccccceeeccCcccEEEEEcC--------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK  252 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  252 (362)
                      .+|+..+.||+|+||.||+|...        ....||+|.+.... .....+.+.+|+++++++ +||||+++++++...
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            46788899999999999999742        12368889775322 122234588999999999 799999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL  318 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  318 (362)
                      +..+++|||+++|+|.+++....              ...+++.++..++.|++.||+|||..+   ++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999986432              234788999999999999999999554   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       319 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.++.+||+|||+++...............++..|+|||++.
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  209 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF  209 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc
Confidence            999999999999998765322211122334567899999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=4.2e-27  Score=214.71  Aligned_cols=173  Identities=28%  Similarity=0.349  Sum_probs=143.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  257 (362)
                      .+.|+..+.||+|+||.||+|.+. +++.+++|.++...........+.+|+.++++++||||+++++++...  +..++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            356888899999999999999975 578999999875544333333467899999999999999999999877  88999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 v~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          84 VMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999996 59999886433 36899999999999999999999655   99999999999999999999999999987654


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ......+++.|+|||++.
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~  179 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLL  179 (293)
T ss_pred             Ccc--ccccccccccccCchhhc
Confidence            321  123345789999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=1.9e-27  Score=213.79  Aligned_cols=174  Identities=21%  Similarity=0.322  Sum_probs=145.1

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||++.. .+++.+++|.+...... .....++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4567788999999999999986 57899999987643322 223346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||+++++|.+++...  ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988632  2346899999999999999999999655   99999999999999999999999999887643


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ......|+..|+|||+..
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~  179 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhc
Confidence            221  123456899999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=2.5e-27  Score=217.42  Aligned_cols=172  Identities=28%  Similarity=0.425  Sum_probs=137.0

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC--EEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||.||+|.+. ++.  .+++|.+.... .......+.+|++++.++ +|+||+++++++...+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            56788899999999999999864 344  45677654322 122334588899999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc
Q 018036          258 VYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE  323 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  323 (362)
                      ||||+++++|.+++....              ...+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999996432              235789999999999999999999554   999999999999999999


Q ss_pred             eEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       324 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +||+|||+++......   ......++..|+|||++.
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  196 (303)
T cd05088         163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLN  196 (303)
T ss_pred             EEeCccccCcccchhh---hcccCCCcccccCHHHHh
Confidence            9999999987432111   112223467899999764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=5.3e-27  Score=210.08  Aligned_cols=166  Identities=27%  Similarity=0.376  Sum_probs=132.5

Q ss_pred             eeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .||+|+||.||+|.+.   ++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            3899999999999763   35578999875432 22233558999999999999999999998864 5678999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCcee-e
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-M  344 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~  344 (362)
                      +|.+++... ...+++..+.+++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.......... .
T Consensus        80 ~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          80 PLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999998643 346899999999999999999999655   99999999999999999999999999986643322111 1


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                      ....++..|+|||++.
T Consensus       156 ~~~~~~~~y~aPE~~~  171 (257)
T cd05115         156 SAGKWPLKWYAPECIN  171 (257)
T ss_pred             CCCCCCcccCCHHHHc
Confidence            1223457899999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=1.2e-27  Score=217.20  Aligned_cols=171  Identities=28%  Similarity=0.399  Sum_probs=143.8

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      .|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5677889999999999999975 588999998765433333344588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.++....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          82 VDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             CCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            9999998877532  34899999999999999999999655   9999999999999999999999999998764332  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......++..|+|||++.
T Consensus       155 ~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07846         155 EVYTDYVATRWYRAPELLV  173 (286)
T ss_pred             cccCcccceeeccCcHHhc
Confidence            2233456899999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=6.2e-27  Score=208.99  Aligned_cols=172  Identities=26%  Similarity=0.397  Sum_probs=145.1

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||++.. .+++.+++|.+............+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            366778999999999999986 4678999999865443334455689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEccccccccccCCCC
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~~~~~~~  340 (362)
                      +++++|.+++.......+++..+..++.|++.||+|||+.+   ++|+||||+||+++++ +.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997655566899999999999999999999655   9999999999999855 4689999999987653221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                         .....|+..|+|||.+.
T Consensus       158 ---~~~~~~~~~y~aPE~~~  174 (256)
T cd08220         158 ---AYTVVGTPCYISPELCE  174 (256)
T ss_pred             ---ccccccCCcccCchhcc
Confidence               23456899999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.95  E-value=3.3e-27  Score=211.07  Aligned_cols=168  Identities=28%  Similarity=0.366  Sum_probs=138.3

Q ss_pred             ceeeccCcccEEEEEcCC--C--CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          188 NVIGRGGAGVVYRGVTPN--G--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      +.||+|++|.||+|.+.+  +  ..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            368999999999998743  2  36899988654432 334568999999999999999999999988 88899999999


Q ss_pred             CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc-e
Q 018036          264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-E  342 (362)
Q Consensus       264 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~  342 (362)
                      +++|.+++.......+++..+..++.|++.||+|||..+   ++||||||+||+++.++.+||+|||+++.+...... .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999997544356899999999999999999999554   999999999999999999999999999877542211 1


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......++..|+|||++.
T Consensus       156 ~~~~~~~~~~y~~pE~~~  173 (257)
T cd05040         156 MEEHLKVPFAWCAPESLR  173 (257)
T ss_pred             cccCCCCCceecCHHHhc
Confidence            122345788999999764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=5.6e-27  Score=209.39  Aligned_cols=169  Identities=28%  Similarity=0.426  Sum_probs=143.6

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC---CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG---SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      |+..+.||+|++|.||+|... +++.|++|.+......   ....+.+.+|+.++++++|+||+++++++......+++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566789999999999999975 7899999988654322   123356889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          82 ELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999999643  35889999999999999999999655   9999999999999999999999999998764322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                         ......|+..|+|||.+.
T Consensus       157 ---~~~~~~~~~~y~~pe~~~  174 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIA  174 (258)
T ss_pred             ---cccccCCCcceeCHHHhc
Confidence               234566899999999764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=4.1e-27  Score=214.47  Aligned_cols=173  Identities=25%  Similarity=0.338  Sum_probs=138.0

Q ss_pred             ccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      |+..+.||+|+||.||+|...      ....+++|.+..... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            566789999999999999852      234677887653321 2223458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCc
Q 018036          258 VYEYMPNGSLGEVLHGKR----------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN  315 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  315 (362)
                      +|||+++++|.+++....                      ...+++..+..++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                      134788999999999999999999655   9999999999


Q ss_pred             eeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          316 ILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       316 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |++++++.+||+|||+++...............++..|+|||++.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  202 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF  202 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence            999999999999999998664332211123345677899999764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=7e-27  Score=210.14  Aligned_cols=173  Identities=30%  Similarity=0.452  Sum_probs=142.5

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC-------chhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS-------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      |.....||+|++|.||+|... +++.+++|.+........       ..+.+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            556789999999999999874 578999998865433221       114578899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999643  45888999999999999999999655   999999999999999999999999999877


Q ss_pred             cCCCCc----eeeccccCccCccccccccc
Q 018036          336 QDTGAS----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......    .......|+..|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~  186 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ  186 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhcc
Confidence            522111    11223568999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=5.9e-27  Score=208.67  Aligned_cols=169  Identities=28%  Similarity=0.398  Sum_probs=138.7

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      +.||+|+||.||++.+.+++.|++|.+...... .....+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            368999999999999877999999987644322 2334589999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      .+++... ...+++..+..++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..............
T Consensus        80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9998643 335789999999999999999999665   999999999999999999999999999865422111111223


Q ss_pred             cCccCccccccccc
Q 018036          348 AGSYGYIAPVLGWY  361 (362)
Q Consensus       348 ~Gt~~y~aPE~~~~  361 (362)
                      .++..|+|||++.+
T Consensus       156 ~~~~~y~~PE~~~~  169 (251)
T cd05041         156 QIPIKWTAPEALNY  169 (251)
T ss_pred             cceeccCChHhhcc
Confidence            34667999998653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.4e-27  Score=233.20  Aligned_cols=179  Identities=20%  Similarity=0.264  Sum_probs=134.9

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcCC--CCEEEEEEe--------------ec-cCCCCCchhhHHHHHHHHhcCccC
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTPN--GEQVAVKKL--------------LG-ITKGSSHDNGLSAEIRTLGKIRHR  240 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~--------------~~-~~~~~~~~~~~~~e~~~l~~l~h~  240 (362)
                      +.+.++|+..+.||+|+||+||+|..+.  +...+.|.+              .. ..........+.+|+.++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            4456889999999999999999987532  222222211              00 011112234578999999999999


Q ss_pred             cceeEEEEEecCCeeeEEEecCCCCChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       241 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      |||++++++...+..++|+|++ .++|.+++....   ........+..++.|++.||+|||+.+   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            9999999999999999999999 467887774322   112345667789999999999999554   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.++.+||+|||+++.+..... .......||+.|+|||++.+
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  342 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAG  342 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcC
Confidence            99999999999999987753322 11334679999999998754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.3e-27  Score=218.29  Aligned_cols=165  Identities=25%  Similarity=0.211  Sum_probs=127.4

Q ss_pred             HhhhccccceeeccCcccEEEEEcC--CCCEEEEEEeeccCC---CCCchhhHHHHHHHHhcCccCccee-EEEEEecCC
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP--NGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKE  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~  253 (362)
                      +.+.|+..+.||+|+||+||+|.+.  +++.+|||++.....   .......+.+|++++++++|+|+++ ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            3467899999999999999999864  567789998753211   1222345899999999999999985 4432    4


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCC-CCCceeeCCCCceEEcccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV-KSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DFGla  332 (362)
                      ..++||||+++++|... . ..    .   ...++.|+++||+|||+.+   |+|||| ||+|||++.++.+||+|||+|
T Consensus        92 ~~~LVmE~~~G~~L~~~-~-~~----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-R-PH----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CcEEEEEccCCCCHHHh-C-cc----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            57999999999999632 1 11    1   1467889999999999655   999999 999999999999999999999


Q ss_pred             ccccCCCCcee------eccccCccCcccccccc
Q 018036          333 KYLQDTGASEC------MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~------~~~~~Gt~~y~aPE~~~  360 (362)
                      +.+........      .....+++.|+|||++.
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            98765432222      24567899999999863

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.3e-27  Score=214.90  Aligned_cols=172  Identities=24%  Similarity=0.285  Sum_probs=144.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||++.+. ++..+++|.+....  ....+.+.+|++++++++||||+++++++..+...++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            356788889999999999999874 67899999885432  222345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++... ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            999999999998643 345899999999999999999999665   9999999999999999999999999987654322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        .......||+.|+|||++.
T Consensus       158 --~~~~~~~~~~~y~~PE~~~  176 (280)
T cd06611         158 --QKRDTFIGTPYWMAPEVVA  176 (280)
T ss_pred             --cccceeecchhhcCHHHHh
Confidence              1233456899999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=4.4e-27  Score=213.74  Aligned_cols=173  Identities=29%  Similarity=0.348  Sum_probs=144.4

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||+|.+. +++.|++|.+..........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5777889999999999999875 578999998865444344445689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      ++++.+..+...  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.........
T Consensus        82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          82 VERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            988777665532  244899999999999999999999665   999999999999999999999999999877543221


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......++..|+|||++.+
T Consensus       157 -~~~~~~~~~~~~~PE~~~~  175 (288)
T cd07833         157 -PLTDYVATRWYRAPELLVG  175 (288)
T ss_pred             -cccCcccccCCcCCchhcC
Confidence             2344678999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=3.4e-27  Score=214.48  Aligned_cols=171  Identities=26%  Similarity=0.347  Sum_probs=143.3

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||++... ++..+|+|.+.... .......+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            5677889999999999999875 68899999885432 222234588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          262 MPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       262 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            99999999886432 23689999999999999999999953  249999999999999999999999999998664321 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                         .....|++.|+|||++.
T Consensus       158 ---~~~~~~~~~y~aPE~~~  174 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIK  174 (286)
T ss_pred             ---cccCCCccCccCcchhc
Confidence               23456889999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=8e-27  Score=212.97  Aligned_cols=173  Identities=25%  Similarity=0.355  Sum_probs=141.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46778899999999999999875 68899999886543333333458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccccccccCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~  339 (362)
                      |++ ++|.+++........++..+..++.|++.||+|||+.+   ++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 68888886544445688888999999999999999654   999999999999985 5679999999998654321


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  ......|++.|+|||++.
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~  176 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILL  176 (294)
T ss_pred             c--ccccCceeecccCHHHHh
Confidence            1  123346789999999764

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=9.6e-27  Score=208.95  Aligned_cols=174  Identities=29%  Similarity=0.411  Sum_probs=146.4

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||+||+|... ++..+++|++....... ..+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            5778899999999999999864 67889999885433222 445689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          262 MPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      +++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965432 56899999999999999999999655   99999999999999999999999999987764332


Q ss_pred             ce--eeccccCccCcccccccc
Q 018036          341 SE--CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~--~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..  ......|+..|+|||++.
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~  179 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVME  179 (267)
T ss_pred             ccccccccccCChhhcChHHHc
Confidence            21  223456899999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=8.4e-27  Score=208.30  Aligned_cols=172  Identities=23%  Similarity=0.428  Sum_probs=142.1

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      .+|+..+.||+|+||.||++.+.++..+++|.+....   .....+.+|++++++++|||++++++++......++||||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            3567778999999999999988778899999875322   2234589999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.... ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          81 MEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            99999999986433 35789999999999999999999665   99999999999999999999999999986543211 


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......++.+|+|||++.+
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~  175 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSF  175 (256)
T ss_pred             cccCCCccchhhcCHhHhcc
Confidence            11122335678999998753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=1.1e-26  Score=208.99  Aligned_cols=174  Identities=28%  Similarity=0.412  Sum_probs=140.8

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC---CchhhHHHHHHHHhcCccCcceeEEEEEec--CCeee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNL  256 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  256 (362)
                      .|+..+.||+|+||.||+|... ++..|++|++.......   .....+.+|+.++++++||||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            4677899999999999999874 58899999886443221   122458889999999999999999998875  35678


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ++|||+++++|.+++...  ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            999999999999999643  34889999999999999999999555   9999999999999999999999999998664


Q ss_pred             CCCC-ceeeccccCccCccccccccc
Q 018036          337 DTGA-SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~-~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .... ........|+..|+|||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISG  183 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCC
Confidence            2111 111233568999999998653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-27  Score=226.67  Aligned_cols=171  Identities=28%  Similarity=0.413  Sum_probs=146.9

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec-----CCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN-----KET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~  254 (362)
                      +.+++.+.||.|.+|.||+++. ++++..|+|++...   ...+++++.|.++++.. .|||++.++|++..     ++.
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            5677789999999999999986 46788888876443   33344588899999888 69999999999853     468


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .|||||||.+||.-|+++...+..+.|..+..|++.++.|+.+||+..   ++|||||-.|||++.++.+|++|||++..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence            899999999999999998777888999999999999999999999665   99999999999999999999999999998


Q ss_pred             ccCCCCceeeccccCccCcccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +....  ....+.+|||.|||||++.
T Consensus       173 ldsT~--grRnT~iGtP~WMAPEVia  196 (953)
T KOG0587|consen  173 LDSTV--GRRNTFIGTPYWMAPEVIA  196 (953)
T ss_pred             eeccc--ccccCcCCCcccccceeee
Confidence            86432  2355678999999999873

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=1.5e-26  Score=210.84  Aligned_cols=171  Identities=28%  Similarity=0.346  Sum_probs=140.1

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.|...+.||+|+||.||+|.. .+++.|++|.+..... ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            5677889999999999999986 4688999999864432 2222347889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+. ++|.+.+.... ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            995 78877775332 45788888899999999999999655   99999999999999999999999999986543221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ......+++.|+|||++.
T Consensus       159 --~~~~~~~~~~y~aPE~~~  176 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLL  176 (291)
T ss_pred             --CCCCccccccccCCceee
Confidence              123345789999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=5.5e-27  Score=211.81  Aligned_cols=174  Identities=22%  Similarity=0.360  Sum_probs=141.8

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ++|+....||+|+||.||+|+.+      +.+.+++|.+.... .....+++.+|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            56778889999999999999863      24578888764322 122335589999999999999999999999998999


Q ss_pred             eEEEecCCCCChhhhhcCCCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRG-------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                      ++||||+++++|.+++.....       ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            999999999999999975442       25899999999999999999999655   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCcccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+++....... .......++..|+|||.+.
T Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~  191 (275)
T cd05046         161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQ  191 (275)
T ss_pred             cccccccCcccc-cccCCceeEEeecChhhhc
Confidence            999876532211 1123445678899999764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=6.8e-27  Score=212.01  Aligned_cols=171  Identities=26%  Similarity=0.357  Sum_probs=137.4

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHH-HhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRT-LGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||++.+. +++.||+|++....... ....+..|+.. ++..+||||+++++++..++..+++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            5677789999999999999875 68999999886543222 22335556664 566689999999999999999999999


Q ss_pred             cCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          261 YMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       261 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |++ |+|.+++...  ....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 7888887532  235689999999999999999999964  24999999999999999999999999999876432


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .   ......|+..|+|||++.
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~  176 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERIN  176 (283)
T ss_pred             c---ccccccCCccccChhhcC
Confidence            1   123356899999999764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=1.2e-26  Score=207.11  Aligned_cols=166  Identities=27%  Similarity=0.396  Sum_probs=138.8

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||++.. +++.+|+|.+...    ...+.+.+|+.++++++|||++++++++... ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            6688899999999999999975 6788999987532    1234588999999999999999999998754 47899999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999999997655556899999999999999999999655   999999999999999999999999999765321   


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ......+..|+|||++.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~  171 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKH  171 (254)
T ss_pred             --CCCCCCCceecCHHHhcc
Confidence              122334678999998653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=5.3e-27  Score=213.50  Aligned_cols=176  Identities=26%  Similarity=0.395  Sum_probs=141.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|...      ++..+|+|.+..... ......+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            356788899999999999999853      467899998753321 2223458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCC
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR--------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN  314 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  314 (362)
                      .++||||+++++|.+++....                    ...+++..++.++.|++.||+|||+.+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999986321                    124788889999999999999999655   999999999


Q ss_pred             ceeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       315 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||++++++.++|+|||+++...............++..|+|||++.
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF  205 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence            9999999999999999998654322111122234567899999764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=6.7e-27  Score=235.39  Aligned_cols=172  Identities=28%  Similarity=0.338  Sum_probs=145.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +++|...+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.++..++||||+++++++...+..++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357888899999999999999975 6889999998653322 22234588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++...  ..+++..+..++.||+.||+|||..+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~  157 (669)
T cd05610          83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR  157 (669)
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence            9999999999999643  45888999999999999999999654   999999999999999999999999999976532


Q ss_pred             CCceeeccccCccCccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      .  .......+|+.|+|||..
T Consensus       158 ~--~~~~~~~~t~~~~~pe~~  176 (669)
T cd05610         158 E--LNMMDILTTPSMAKPKND  176 (669)
T ss_pred             c--ccccccccCccccCcccc
Confidence            2  123456799999999853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=7.6e-27  Score=213.55  Aligned_cols=172  Identities=28%  Similarity=0.420  Sum_probs=136.6

Q ss_pred             hhccccceeeccCcccEEEEEcCC-CC--EEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-GE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||.||+|...+ +.  .+++|.++.... ....+.+.+|++++.++ +||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            467788899999999999998743 32  467887653221 22234588999999999 79999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc
Q 018036          258 VYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE  323 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  323 (362)
                      ||||+++++|.+++....              ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            999999999999996432              135889999999999999999999654   999999999999999999


Q ss_pred             eEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       324 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +||+|||++......   ........+..|+|||+..
T Consensus       158 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~  191 (297)
T cd05089         158 SKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLN  191 (297)
T ss_pred             EEECCcCCCccccce---eccCCCCcCccccCchhhc
Confidence            999999998743211   1111223356799999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-26  Score=207.03  Aligned_cols=171  Identities=31%  Similarity=0.355  Sum_probs=145.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||+|... +++.+++|.+......  ..+.+.+|++++++++||||+++++++...+..+++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            56778899999999999999874 5778999988644322  34558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            99999999998643 245889999999999999999999655   9999999999999999999999999998765321 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......|+..|+|||++.
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~  174 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAA  174 (262)
T ss_pred             -hccccccCCccccCchhhc
Confidence             1234457899999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=1.2e-26  Score=207.97  Aligned_cols=174  Identities=28%  Similarity=0.427  Sum_probs=145.9

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||.||+|... +++.+++|.+..........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            3667789999999999999864 688999999875544333455689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999643  45788999999999999999999655   999999999999999999999999999877543221


Q ss_pred             ee--eccccCccCccccccccc
Q 018036          342 EC--MSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~--~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  .....+++.|+|||++.+
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~  177 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITG  177 (264)
T ss_pred             ccccccCCcCCcCccChhhccC
Confidence            10  123568899999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.94  E-value=1.1e-26  Score=212.34  Aligned_cols=169  Identities=25%  Similarity=0.413  Sum_probs=143.6

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .+|+..+.||.|++|.||+|.. .+++.|++|.+.....  ...+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            5678888999999999999986 5788999998864322  233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++..   ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             ecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999998853   24899999999999999999999554   99999999999999999999999999887643221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ......|+..|+|||.+.
T Consensus       171 --~~~~~~~~~~y~aPE~~~  188 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVT  188 (296)
T ss_pred             --cCCCcCCCccccCcchhc
Confidence              123456899999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.94  E-value=6.7e-27  Score=212.49  Aligned_cols=172  Identities=31%  Similarity=0.410  Sum_probs=140.4

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEe-----cC
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCS-----NK  252 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~  252 (362)
                      ..++|+..+.||+|+||.||++... +++.+++|.+....   .....+.+|+.+++++ +||||+++++++.     ..
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            4577888899999999999999874 57889999875322   2234488899999999 6999999999884     34


Q ss_pred             CeeeEEEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      +..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCC
Confidence            5689999999999999987532  2346888999999999999999999554   9999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      +++.......  ......|++.|+|||++
T Consensus       170 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~  196 (286)
T cd06638         170 VSAQLTSTRL--RRNTSVGTPFWMAPEVI  196 (286)
T ss_pred             ceeecccCCC--ccccccCCCcccChhhh
Confidence            9987643221  12345699999999986

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=1.4e-26  Score=206.70  Aligned_cols=171  Identities=29%  Similarity=0.439  Sum_probs=141.2

Q ss_pred             cccceeeccCcccEEEEEcCC-----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          185 KDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      +..+.||+|+||.||++.+.+     +..||+|.+...... .....+..|++++..++|+||+++++++.+.+..+++|
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            456789999999999998753     478999988543221 13456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++.......+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999997544333899999999999999999999655   9999999999999999999999999998775432


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ... .....+++.|+|||.+.
T Consensus       158 ~~~-~~~~~~~~~y~~Pe~~~  177 (258)
T smart00219      158 YYK-KKGGKLPIRWMAPESLK  177 (258)
T ss_pred             ccc-cccCCCcccccChHHhc
Confidence            211 11233788999999763

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=1.2e-26  Score=208.86  Aligned_cols=174  Identities=29%  Similarity=0.446  Sum_probs=140.3

Q ss_pred             hhccccceeeccCcccEEEEEcC-CC---CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NG---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||.||+|... ++   ..+++|++..... ....+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            46777899999999999999874 23   3688888754321 2223458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++.... ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999996433 45899999999999999999999655   99999999999999999999999999987653


Q ss_pred             CCCceee-ccccCccCcccccccc
Q 018036          338 TGASECM-SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~-~~~~Gt~~y~aPE~~~  360 (362)
                      ....... .....+..|+|||++.
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~  183 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIA  183 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhh
Confidence            2221111 1122355799999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=1.1e-26  Score=210.93  Aligned_cols=169  Identities=32%  Similarity=0.407  Sum_probs=136.2

Q ss_pred             cccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeE
Q 018036          185 KDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL  257 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  257 (362)
                      +..+.||+|+||+||++..     .++..||+|.+..... ......+.+|++++++++||||+++++++...  ...++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            7778999999999988652     3577899998864322 22334588999999999999999999988654  45789


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++...   .+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999998643   4899999999999999999999655   99999999999999999999999999987653


Q ss_pred             CCCce-eeccccCccCcccccccc
Q 018036          338 TGASE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..... ......++..|+|||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhc
Confidence            22111 112234567799999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=2e-27  Score=212.81  Aligned_cols=162  Identities=18%  Similarity=0.319  Sum_probs=132.0

Q ss_pred             ceeeccCcccEEEEEcCC--------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      +.||+|+||.||+|....        ...+++|.+....  ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            368999999999998632        2247777664221  222345888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc--------eEEccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--------AHVADFGL  331 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~DFGl  331 (362)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.        ++++|||+
T Consensus        79 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          79 EYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             ecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999999997433 35899999999999999999999554   999999999999987765        69999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....      .....++..|+|||++.+
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~  178 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIEN  178 (258)
T ss_pred             ccccCC------chhccccCCccCchhccC
Confidence            876532      234568899999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=1.2e-26  Score=211.40  Aligned_cols=171  Identities=26%  Similarity=0.297  Sum_probs=141.8

Q ss_pred             ccccceeeccCcccEEEEEc----CCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          184 VKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      |+..+.||+|+||.||++..    .++..||+|.+.....  .....+.+.+|++++.++ +|+||+++++.+......+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            56678999999999999986    3688999999865332  122334578899999999 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          82 LILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            999999999999998643  45788999999999999999999655   9999999999999999999999999998764


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... .......|+..|+|||++.
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~  179 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVR  179 (290)
T ss_pred             cccc-cccccccCCcccCChhhcc
Confidence            3221 1123456899999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=7.5e-27  Score=214.24  Aligned_cols=173  Identities=28%  Similarity=0.438  Sum_probs=136.9

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|.+. ++.    .+|+|.+.... ......++.+|+.++++++||||+++++++... ..+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            45677789999999999999863 343    46778765332 222233588999999999999999999998764 467


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            999999999999998643 335889999999999999999999655   9999999999999999999999999998765


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............++..|+|||++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~  184 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIH  184 (303)
T ss_pred             CcccccccCCCccccccCCHHHhc
Confidence            322211122344677899999864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=7e-28  Score=239.97  Aligned_cols=176  Identities=27%  Similarity=0.439  Sum_probs=138.6

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-------
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-------  251 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  251 (362)
                      ...+|+..+.||+||||.||+++.+ ||+.+|||++.... .......+.+|+..+++++|||||+++..+..       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4567788899999999999999975 89999999997655 33334458899999999999999999864200       


Q ss_pred             ------------------------------------------------C-------------------------------
Q 018036          252 ------------------------------------------------K-------------------------------  252 (362)
Q Consensus       252 ------------------------------------------------~-------------------------------  252 (362)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ---------------------------------CeeeEEEecCCCCChhhhhcCCCCCCC-CHHHHHHHHHHHHHHHHHH
Q 018036          253 ---------------------------------ETNLLVYEYMPNGSLGEVLHGKRGSFL-KWEMRLKIAIEAAKGLSYL  298 (362)
Q Consensus       253 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~i~~~i~~~L~~L  298 (362)
                                                       -..||-||||+...+.++++...  .. .....++++++|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHHHHHHHHHHHHH
Confidence                                             11378899999888888875432  22 4567789999999999999


Q ss_pred             hcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc------C---------CC-CceeeccccCccCccccccccc
Q 018036          299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ------D---------TG-ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       299 H~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~------~---------~~-~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+++   ||||||||.||++|++..+||+|||+|....      +         .+ .....+..+||.-|+|||++.+
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9766   9999999999999999999999999998721      0         00 1112456789999999998753

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=1.7e-26  Score=209.31  Aligned_cols=175  Identities=31%  Similarity=0.415  Sum_probs=141.9

Q ss_pred             hhccccceeeccCcccEEEEEcC-----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--CCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  254 (362)
                      +.|+..+.||+|+||.||++.+.     ++..+|+|.+...... ...+.+.+|++++++++|+||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            45667789999999999999853     3678999998644332 234569999999999999999999999887  557


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||.+..
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            899999999999999996433 35899999999999999999999655   99999999999999999999999999987


Q ss_pred             ccCCCCc-eeeccccCccCccccccccc
Q 018036          335 LQDTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....... .......++..|+|||+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~  186 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRT  186 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHcc
Confidence            7532211 11122345667999997654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=1.5e-26  Score=213.14  Aligned_cols=174  Identities=25%  Similarity=0.375  Sum_probs=139.8

Q ss_pred             ccccceeeccCcccEEEEEcC---CCCEEEEEEeeccC-CCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL  257 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  257 (362)
                      |+..+.||+|+||.||+|...   +++.||+|.+.... ......+.+.+|+.++++++||||+++++++...  +..++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            566788999999999999974   47899999987543 1122234578899999999999999999999988  78999


Q ss_pred             EEecCCCCChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC----CCceEEcccc
Q 018036          258 VYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS----DFEAHVADFG  330 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~DFG  330 (362)
                      ||||++ ++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999996 47777764322   236889999999999999999999555   999999999999999    8999999999


Q ss_pred             ccccccCCCC-ceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGA-SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++....... ........+|+.|+|||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  189 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG  189 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhC
Confidence            9987653322 111234568999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2e-27  Score=220.62  Aligned_cols=171  Identities=22%  Similarity=0.295  Sum_probs=143.1

Q ss_pred             hhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCC--C----CCchhhHHHHHHHHhcCc---cCcceeEEEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITK--G----SSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSN  251 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  251 (362)
                      ..|+..+.+|+|+||.|+.|.++. ...|++|.+.+..-  +    +...-..-.|+++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            346677899999999999999864 56788888754321  1    111122667999999997   9999999999999


Q ss_pred             CCeeeEEEecC-CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          252 KETNLLVYEYM-PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       252 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      +++.||+||-. ++.+|.+++...  ..+++..+..|++||+.|+++||.++   |||||||-+|+.+|.+|-+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence            99999999975 677999999644  45999999999999999999999666   9999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .|.....    .+...++||.+|.|||++.|
T Consensus       716 saa~~ks----gpfd~f~gtv~~aapevl~g  742 (772)
T KOG1152|consen  716 SAAYTKS----GPFDVFVGTVDYAAPEVLGG  742 (772)
T ss_pred             chhhhcC----CCcceeeeeccccchhhhCC
Confidence            9987653    23678899999999999864

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.94  E-value=1.4e-26  Score=208.49  Aligned_cols=169  Identities=28%  Similarity=0.431  Sum_probs=138.1

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      +.....||+|+||.||+|.+. ++..|++|.+.....  ...+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            344568999999999999864 577899998754322  23345889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccccccccCCC
Q 018036          263 PNGSLGEVLHGKRGSFL--KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~  339 (362)
                      ++++|.+++.... ..+  ++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|||++.......
T Consensus        88 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          88 PGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            9999999997432 224  78888899999999999999554   999999999999986 6789999999998664221


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        .......|++.|+|||++.
T Consensus       164 --~~~~~~~~~~~~~aPE~~~  182 (268)
T cd06624         164 --PCTETFTGTLQYMAPEVID  182 (268)
T ss_pred             --CccccCCCCccccChhhhc
Confidence              1133446899999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=1.4e-26  Score=211.21  Aligned_cols=172  Identities=25%  Similarity=0.290  Sum_probs=139.4

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCe-----e
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKET-----N  255 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~  255 (362)
                      +|+..+.||+|+||.||+|.+. +++.||+|.+............+.+|+.++++++ ||||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5777889999999999999874 6889999987654433333345888999999995 6999999999887665     7


Q ss_pred             eEEEecCCCCChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGL  331 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGl  331 (362)
                      ++||||+++ +|.+++....   ...+++..+..++.||+.||+|||..+   ++||||||+||+++. ++.+||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999975 8988886432   246899999999999999999999655   999999999999998 88999999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++........  .....+++.|+|||++.
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~  184 (295)
T cd07837         158 GRAFSIPVKS--YTHEIVTLWYRAPEVLL  184 (295)
T ss_pred             ceecCCCccc--cCCcccccCCCChHHhh
Confidence            9865432111  22335788999999764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=6.8e-27  Score=227.07  Aligned_cols=168  Identities=19%  Similarity=0.266  Sum_probs=132.5

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc------CcceeEEEEEecC-
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH------RNIVRLKAFCSNK-  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~-  252 (362)
                      .++|+..+.||+|+||+||+|.+. +++.||||+++....   ....+..|++++++++|      .+++.+++++... 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            367888899999999999999874 578899999864321   12235667777776654      4588999988765 


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC----------
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----------  322 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----------  322 (362)
                      ...++|||++ +++|.+++...  ..+++..+..|+.|++.||+|||.+  .+||||||||+|||++.++          
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence            4788999998 78999988543  4589999999999999999999952  2499999999999998765          


Q ss_pred             ------ceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          323 ------EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 ------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                            .+||+|||.+.....     .....+||+.|||||++.+
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~  319 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLG  319 (467)
T ss_pred             cCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhc
Confidence                  499999998864321     1345689999999998754

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=5.7e-27  Score=214.44  Aligned_cols=170  Identities=25%  Similarity=0.356  Sum_probs=141.7

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|+....||+|+||.||++... +++.|++|.+.....  ...+.+.+|+.++..++||||+++++++...+..++|||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            34444567999999999999864 688999999854332  233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++..   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999999998753   34889999999999999999999655   99999999999999999999999999976543221


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ......|+..|+|||++.+
T Consensus       173 --~~~~~~~~~~y~aPE~~~~  191 (297)
T cd06659         173 --KRKSLVGTPYWMAPEVISR  191 (297)
T ss_pred             --cccceecCccccCHHHHcc
Confidence              1334578999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.7e-26  Score=206.55  Aligned_cols=167  Identities=28%  Similarity=0.395  Sum_probs=133.8

Q ss_pred             ceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          188 NVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      +.||+|+||.||+|.+..    +..+|+|.+...... ...+++.+|+.++++++|+||+++++++.. +..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            468999999999997532    268999987644332 334568999999999999999999998764 46799999999


Q ss_pred             CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce-
Q 018036          264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-  342 (362)
Q Consensus       264 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-  342 (362)
                      +++|.+++....  .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......... 
T Consensus        79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          79 LGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999996433  6899999999999999999999655   9999999999999999999999999998765322211 


Q ss_pred             eeccccCccCccccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......++..|+|||...+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~  172 (257)
T cd05060         154 ATTAGRWPLKWYAPECINY  172 (257)
T ss_pred             cccCccccccccCHHHhcC
Confidence            1112224568999997653

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=1.3e-26  Score=209.71  Aligned_cols=166  Identities=28%  Similarity=0.305  Sum_probs=138.9

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      ||+|+||+||+|... +++.+++|.+..... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999864 688999998864322 122234467899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      .+++.......+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99997555456899999999999999999999655   999999999999999999999999999876431   113345


Q ss_pred             cCccCccccccccc
Q 018036          348 AGSYGYIAPVLGWY  361 (362)
Q Consensus       348 ~Gt~~y~aPE~~~~  361 (362)
                      .++..|+|||+..+
T Consensus       155 ~~~~~y~~PE~~~~  168 (277)
T cd05577         155 AGTPGYMAPEVLQG  168 (277)
T ss_pred             cCCCCcCCHHHhcC
Confidence            68899999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=2e-26  Score=211.79  Aligned_cols=172  Identities=33%  Similarity=0.400  Sum_probs=143.3

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      .+..+.|+..+.||+|+||.||+|... +++.|++|.+....... ...+++.+|+++++.++||||+++++++...+..
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            344567888899999999999999874 68899999885433222 2234588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||++ |++.+++... ...+++..+..++.|++.||.|||..+   ++||||+|+||++++++.+||+|||++...
T Consensus        91 ~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          91 WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence            99999996 6887777532 345899999999999999999999655   999999999999999999999999999765


Q ss_pred             cCCCCceeeccccCccCcccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..      .....|++.|+|||++.
T Consensus       166 ~~------~~~~~~~~~y~aPE~~~  184 (307)
T cd06607         166 SP------ANSFVGTPYWMAPEVIL  184 (307)
T ss_pred             CC------CCCccCCccccCceeee
Confidence            42      23456889999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=4.3e-27  Score=214.70  Aligned_cols=171  Identities=26%  Similarity=0.374  Sum_probs=141.9

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      ..+.|.....||+|+||.||++.. .++..||+|++....  ....+.+.+|+..+++++|+||+++++.+...+..++|
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv   97 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV   97 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence            345555567899999999999986 467899999875432  22334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++......
T Consensus        98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999999999998853   24789999999999999999999655   999999999999999999999999999765432


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  .......|+..|+|||+..
T Consensus       172 ~--~~~~~~~~~~~y~aPE~~~  191 (292)
T cd06658         172 V--PKRKSLVGTPYWMAPEVIS  191 (292)
T ss_pred             c--ccCceeecCccccCHHHHc
Confidence            2  1123456899999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.94  E-value=1e-26  Score=216.52  Aligned_cols=175  Identities=31%  Similarity=0.467  Sum_probs=143.2

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC--Ce
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK--ET  254 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~  254 (362)
                      .+.++|+..+.||+|+||.||+|.+. +++.+++|++............+.+|+.+++++ +||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            45678889999999999999999875 578999998864333333334577899999999 999999999998654  36


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||++ ++|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            799999996 6999988643   5889999999999999999999554   99999999999999999999999999987


Q ss_pred             ccCCCCc---eeeccccCccCcccccccc
Q 018036          335 LQDTGAS---ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~---~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......   .......||..|+|||++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILL  185 (337)
T ss_pred             cccccccccCcchhcccccccccCceeee
Confidence            6533221   2234457899999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=1.4e-26  Score=206.64  Aligned_cols=170  Identities=31%  Similarity=0.384  Sum_probs=145.3

Q ss_pred             hhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||+|...+ ++.+++|.+.....    .+.+.+|++++++++||||+++++++......++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            467788899999999999999864 78999998854322    4569999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.. ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++........
T Consensus        79 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          79 YCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             cCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999999863 2356899999999999999999999655   99999999999999999999999999987754321


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ......|+..|+|||++.+
T Consensus       155 --~~~~~~~~~~y~~PE~~~~  173 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQE  173 (256)
T ss_pred             --ccccccCCccccCHHHHhc
Confidence              1234558999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-26  Score=208.68  Aligned_cols=170  Identities=26%  Similarity=0.322  Sum_probs=144.6

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||.|++|.||+|.+. +++.+++|.+.... .......+.+|+++++.++|+||+++++++......++|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            5677788999999999999874 67899999875432 222334588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++...   .+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||+++......  
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  152 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--  152 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence            9999999999643   6899999999999999999999655   9999999999999999999999999998875432  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......|++.|+|||++.+
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~  172 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQ  172 (274)
T ss_pred             cccccccCCccccChhhhcc
Confidence            12344578999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=1.9e-26  Score=208.00  Aligned_cols=166  Identities=28%  Similarity=0.437  Sum_probs=131.7

Q ss_pred             ceeeccCcccEEEEEcCC-CC--EEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecCC
Q 018036          188 NVIGRGGAGVVYRGVTPN-GE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      +.||+|+||.||+|.+.+ +.  .+++|.+.... .....+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999998743 33  46777765322 122234588999999999 79999999999999999999999999


Q ss_pred             CCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          264 NGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       264 ~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                      +|+|.+++....              ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            999999986432              134789999999999999999999554   999999999999999999999999


Q ss_pred             cccccccCCCCceeeccccCccCcccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |++.......   .......+..|+|||++.
T Consensus       157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~  184 (270)
T cd05047         157 GLSRGQEVYV---KKTMGRLPVRWMAIESLN  184 (270)
T ss_pred             CCccccchhh---hccCCCCccccCChHHHc
Confidence            9986432111   111223466799999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=214.36  Aligned_cols=176  Identities=28%  Similarity=0.349  Sum_probs=143.0

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC--CC---CchhhHHHHHHHHhcCccCcceeEEEEEec-CCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK--GS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  254 (362)
                      ++|-..++||+|+|++||+|.+- ..+.||||+-.....  +.   ...+...+|.++-+.++||.||++|+++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45555689999999999999864 466788886432221  11   112346789999999999999999999964 456


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC---CCCceEEccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGL  331 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGl  331 (362)
                      .|-|+|||+|-+|+-+|+.  .+.++++.+..|+.||..||.||.+. +++|||-||||.|||+.   ..|.+||.|||+
T Consensus       543 FCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             ceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7899999999999999964  45699999999999999999999976 78999999999999995   458899999999


Q ss_pred             cccccCCCCc-----eeeccccCccCcccccccc
Q 018036          332 AKYLQDTGAS-----ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.+++....     +.++..+||.+|++||.+-
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv  653 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV  653 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceee
Confidence            9999754433     3466789999999999764

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=1.9e-26  Score=209.13  Aligned_cols=171  Identities=27%  Similarity=0.361  Sum_probs=142.3

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||+|.+. ++..|++|++............+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            455678999999999999864 7899999998654433333345888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      + ++|.+++.......+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            4 69999987555456899999999999999999999654   99999999999999999999999999986542211  


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......++..|+|||++.
T Consensus       155 ~~~~~~~~~~~~aPE~~~  172 (283)
T cd07835         155 TYTHEVVTLWYRAPEILL  172 (283)
T ss_pred             ccCccccccCCCCCceee
Confidence            122335789999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=1.8e-26  Score=211.91  Aligned_cols=173  Identities=25%  Similarity=0.263  Sum_probs=140.8

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +|+..+.||+|+||.||++... +++.|++|.+...... ....+.+.+|+++++.++||||+++++.+...+..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            4677789999999999999874 5789999988654321 1223458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC-
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG-  339 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~-  339 (362)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          82 YVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999999543  45899999999999999999999655   9999999999999999999999999987421100 


Q ss_pred             ------------CceeeccccCccCcccccccc
Q 018036          340 ------------ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ------------~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                                  .........|+..|+|||++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL  189 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhcc
Confidence                        000112346788999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.7e-26  Score=206.22  Aligned_cols=175  Identities=29%  Similarity=0.410  Sum_probs=141.4

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC---CCCchhhHHHHHHHHhcCccCcceeEEEEEecC--Cee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  255 (362)
                      +.|+..+.||+|+||.||+|.+ .++..|++|.+.....   .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3577889999999999999986 4688999998753221   122234688999999999999999999998764  457


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      +++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            8999999999999998633  34788999999999999999999655   999999999999999999999999999876


Q ss_pred             cCCCC-ceeeccccCccCccccccccc
Q 018036          336 QDTGA-SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~-~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..... ........|+..|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISG  183 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcC
Confidence            42111 111234568999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=1.3e-26  Score=208.43  Aligned_cols=172  Identities=29%  Similarity=0.444  Sum_probs=142.0

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCC----chhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS----HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      |+..+.||+|++|.||++.. .+++.+|+|.+........    ..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            66778999999999999986 5688999998864332111    234688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccccC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQD  337 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~  337 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++ .+||+|||.+.....
T Consensus        82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          82 VEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            9999999999999643  35889999999999999999999655   99999999999998775 599999999987753


Q ss_pred             CCCc--eeeccccCccCcccccccc
Q 018036          338 TGAS--ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~--~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....  .......||..|+|||++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~  181 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLR  181 (268)
T ss_pred             ccccCCccccccccccceeCHhHhc
Confidence            3211  1123456899999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=7.6e-27  Score=211.26  Aligned_cols=172  Identities=29%  Similarity=0.362  Sum_probs=143.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .+.|+..+.||+|+||.||+|.+. ++..||+|.+..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            355677788999999999999864 577899998753322 223345899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++..   ..+++..+..++.|+++|+.|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999999999853   35889999999999999999999655   9999999999999999999999999998765322


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ......|+..|+|||++.+
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~  175 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQ  175 (277)
T ss_pred             h--hhhcccCcccccCHHHhCc
Confidence            1  1234568999999998753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=1.2e-26  Score=207.17  Aligned_cols=172  Identities=27%  Similarity=0.398  Sum_probs=144.2

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|+||.||++... ++..+|+|.+..........+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            567789999999999999875 5788999988654333334455889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccccCCCCc
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~~~  341 (362)
                      ++++|.+++.......+++..+..++.|++.||+|||+.+   ++|+||||+||++++++ .+||+|||.+.......  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--  156 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--  156 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc--
Confidence            9999999997655556899999999999999999999655   99999999999999875 46999999998765322  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......|++.|+|||+..
T Consensus       157 ~~~~~~~~~~~~~ape~~~  175 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQ  175 (257)
T ss_pred             ccccccCCCccccCHHHHc
Confidence            1123346899999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=6.5e-27  Score=209.37  Aligned_cols=169  Identities=27%  Similarity=0.313  Sum_probs=144.4

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |+..+.||+|+||.||+|.+. ++..+++|.+....... ...+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            667789999999999999875 58899999986543222 3345689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++...  ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  
T Consensus        82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            9999999999643  46889999999999999999999655   9999999999999999999999999998765322  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ......|+..|+|||++.
T Consensus       155 -~~~~~~~~~~y~~PE~~~  172 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLC  172 (258)
T ss_pred             -cccccCCChhhcCHHHHc
Confidence             133456889999999864

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.94  E-value=6.5e-27  Score=210.58  Aligned_cols=170  Identities=27%  Similarity=0.380  Sum_probs=136.0

Q ss_pred             ceeeccCcccEEEEEcCC-------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          188 NVIGRGGAGVVYRGVTPN-------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.||+|+||.||+|+..+       +..+++|.+..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998642       25788888753321 2233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-----ceEEcccc
Q 018036          261 YMPNGSLGEVLHGK-----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-----EAHVADFG  330 (362)
Q Consensus       261 ~~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DFG  330 (362)
                      |+++++|.+++...     ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999643     2234789999999999999999999554   99999999999999877     89999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++...............++..|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  187 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLD  187 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHcc
Confidence            9987643222222223346788999998753

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=2.9e-26  Score=210.85  Aligned_cols=173  Identities=32%  Similarity=0.403  Sum_probs=141.5

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+............+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467888899999999999999874 688999999865443333233467899999999999999999998765  56799


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999996 5898888643 256899999999999999999999655   99999999999999999999999999987653


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ......+++.|+|||++.
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~  181 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLL  181 (309)
T ss_pred             ccC--CCCcccccccccChhhhc
Confidence            321  122334688899999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=1.8e-26  Score=207.93  Aligned_cols=172  Identities=27%  Similarity=0.334  Sum_probs=137.8

Q ss_pred             hhccccceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|...+.||+|+||.||+|.+.+    ...|++|....... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            457778999999999999998643    24688887753321 2233468999999999999999999999875 45789


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999999643 235899999999999999999999655   99999999999999999999999999987653


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ... .......++..|+|||++.
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~  181 (270)
T cd05056         160 ESY-YKASKGKLPIKWMAPESIN  181 (270)
T ss_pred             ccc-eecCCCCccccccChhhhc
Confidence            321 1122333557899999764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=1.8e-26  Score=206.81  Aligned_cols=168  Identities=27%  Similarity=0.386  Sum_probs=131.6

Q ss_pred             ceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-CCeeeEEEecC
Q 018036          188 NVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLVYEYM  262 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  262 (362)
                      +.||+|+||.||+|.+.    +...+|+|++.... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            36899999999999853    23578999874322 12223458889999999999999999998764 45678999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++.... ...++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...+.....
T Consensus        80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          80 KHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999996432 34677888899999999999999655   9999999999999999999999999998664322111


Q ss_pred             --eeccccCccCcccccccc
Q 018036          343 --CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 --~~~~~~Gt~~y~aPE~~~  360 (362)
                        ......++..|+|||+..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~  175 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQ  175 (262)
T ss_pred             ecccccCcCCccccChhHhc
Confidence              112345677899999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=3e-26  Score=207.94  Aligned_cols=171  Identities=27%  Similarity=0.389  Sum_probs=141.4

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||+|+.. ++..||+|.+...... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            667789999999999999975 6889999988654332 22334778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          263 PNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       263 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      + ++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++....... 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            7 58988886433 246899999999999999999999655   99999999999999999999999999986543211 


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......+|..|+|||++.+
T Consensus       156 -~~~~~~~~~~y~~PE~~~~  174 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLG  174 (284)
T ss_pred             -ccccccccccccChHHhcC
Confidence             1233457899999998643

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=2.3e-26  Score=208.55  Aligned_cols=163  Identities=26%  Similarity=0.281  Sum_probs=131.0

Q ss_pred             eeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC-chhhHHHHHHHHh---cCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          189 VIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS-HDNGLSAEIRTLG---KIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      .||+|+||.||++... +++.+|+|.+........ ....+.+|..++.   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999874 588999998865433222 1222444443333   3479999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCcee
Q 018036          264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC  343 (362)
Q Consensus       264 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  343 (362)
                      +++|.+++...  ..+++..+..++.|++.||+|||..+   |+||||||+||++++++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            99999998633  45899999999999999999999555   9999999999999999999999999997654321    


Q ss_pred             eccccCccCcccccccc
Q 018036          344 MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~  360 (362)
                      .....||+.|+|||...
T Consensus       152 ~~~~~~~~~y~aPE~~~  168 (279)
T cd05633         152 PHASVGTHGYMAPEVLQ  168 (279)
T ss_pred             ccCcCCCcCccCHHHhc
Confidence            23346999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.6e-26  Score=209.90  Aligned_cols=171  Identities=27%  Similarity=0.344  Sum_probs=143.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||+||++... +++.+|+|.+..... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            56777889999999999999874 578899998754322 2234558899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++..  ...+++..+..++.+++.||.|||+.  .+++||||||+||++++++.++|+|||++....... 
T Consensus        84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            9999999999854  34589999999999999999999952  249999999999999999999999999987653221 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         .....||..|+|||++.+
T Consensus       159 ---~~~~~~~~~~~aPE~~~~  176 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQG  176 (284)
T ss_pred             ---cCccccCcccCCHHHHcc
Confidence               234578999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=3.4e-26  Score=209.49  Aligned_cols=175  Identities=30%  Similarity=0.398  Sum_probs=142.8

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  253 (362)
                      ..++|+..+.||+|+||.||+|... +++.|++|.+............+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3577888999999999999999975 5789999998755433333345788999999999999999999987655     


Q ss_pred             -----eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          254 -----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       254 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                           ..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCc
Confidence                 78999999975 777777543 346899999999999999999999655   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCcccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||++........ .......++..|+|||.+.
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~  190 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLL  190 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhc
Confidence            999987653321 1122345688899999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=2.8e-26  Score=206.86  Aligned_cols=174  Identities=24%  Similarity=0.300  Sum_probs=137.0

Q ss_pred             ccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC------
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------  253 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  253 (362)
                      |+..+.||+|+||.||+|.+.    +++.||+|.+..........+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999853    4678999998654444444556889999999999999999999886542      


Q ss_pred             eeeEEEecCCCCChhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                      ..++++||+++|+|.+++....    ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999998874321    124788999999999999999999554   999999999999999999999999


Q ss_pred             cccccccCCCCceeeccccCccCcccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+++...............+++.|++||.+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  188 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLA  188 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHh
Confidence            9998764322111122344667899999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.8e-26  Score=207.43  Aligned_cols=169  Identities=27%  Similarity=0.391  Sum_probs=142.2

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc---cCcceeEEEEEecCCeeeEE
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  258 (362)
                      .|+..+.||+|+||.||+|.+ .+++.+++|.+..... .....++.+|+.++++++   |||++++++++......++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            356678899999999999996 5688999998754322 223345888999999996   99999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          81 MEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999998542   5899999999999999999999655   999999999999999999999999999877543


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..  ......|+..|+|||++.
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~  174 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVIT  174 (277)
T ss_pred             cc--ccccccCCcceeCHHHhc
Confidence            21  233457899999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=4.8e-26  Score=206.33  Aligned_cols=163  Identities=25%  Similarity=0.272  Sum_probs=131.5

Q ss_pred             eeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHH---HHHhcCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          189 VIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEI---RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      .||+|+||.||+|... +++.||+|.+....... .....+..|.   ..++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999874 57899999886543221 1112233343   34445579999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCcee
Q 018036          264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC  343 (362)
Q Consensus       264 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  343 (362)
                      +++|.+++..  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......    
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            9999998853  346899999999999999999999655   9999999999999999999999999998654321    


Q ss_pred             eccccCccCcccccccc
Q 018036          344 MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~  360 (362)
                      .....||..|+|||++.
T Consensus       152 ~~~~~~~~~y~aPE~~~  168 (278)
T cd05606         152 PHASVGTHGYMAPEVLQ  168 (278)
T ss_pred             CcCcCCCcCCcCcHHhc
Confidence            23457999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.94  E-value=2.8e-26  Score=214.95  Aligned_cols=171  Identities=28%  Similarity=0.379  Sum_probs=140.4

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------  252 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  252 (362)
                      +.++|+..+.||+|+||.||+|... +++.||+|.+............+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578888999999999999999874 688999998854333333334577899999999999999999988644      


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      ...++||||++ ++|.+.+...    +++..+..++.|++.||+|||..+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            34689999995 5888887532    788999999999999999999655   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +......   ......||+.|+|||++.+
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~  191 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILG  191 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhC
Confidence            8764321   1334568999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=9.9e-27  Score=208.83  Aligned_cols=171  Identities=30%  Similarity=0.379  Sum_probs=143.9

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|++|.||++.+. +++.+++|.+..... .....++.+|++++++++||||+++++++...+..++++||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            4566788999999999999875 578899998865432 23345588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++.... ..+++..+..++.|++.||+|||.  ..+++|+||||+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  155 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--  155 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence            99999999996443 568899999999999999999995  0459999999999999999999999999988664321  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .....|+..|+|||++.+
T Consensus       156 --~~~~~~~~~y~~PE~~~~  173 (265)
T cd06605         156 --AKTFVGTSSYMAPERIQG  173 (265)
T ss_pred             --hhcccCChhccCHHHHcC
Confidence              112678999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=3.2e-26  Score=205.07  Aligned_cols=176  Identities=24%  Similarity=0.349  Sum_probs=143.5

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--CCeeeEEEe
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLLVYE  260 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  260 (362)
                      |+..+.||+|+||.||++.. .++..+++|.+..........+++..|++++++++||||+++++++..  ....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            56678899999999999986 467889999886544333444568899999999999999999998764  456789999


Q ss_pred             cCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          261 YMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       261 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      |+++++|.+++...  ....+++..++.++.|++.||+|||..+  ..+++|+||||+||++++++.+||+|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            99999999998643  2356899999999999999999999332  3449999999999999999999999999998775


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....  ......|++.|+|||++.+
T Consensus       162 ~~~~--~~~~~~~~~~~~~pE~~~~  184 (265)
T cd08217         162 HDSS--FAKTYVGTPYYMSPEQLNH  184 (265)
T ss_pred             CCcc--cccccccCCCccChhhhcC
Confidence            4321  1234568999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=6.4e-26  Score=205.26  Aligned_cols=171  Identities=27%  Similarity=0.352  Sum_probs=143.2

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .+.|+..+.||+|+||.||+|.. .++..+|+|.+..... ......+.+|+.++++++||||+++++++...+..++||
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            45677788999999999999986 4678999998743321 223345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++..   ..+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++..+....
T Consensus        82 e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          82 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999999853   34889999999999999999999655   9999999999999999999999999998764321


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  ......|+..|+|||++.
T Consensus       156 ~--~~~~~~~~~~y~~PE~~~  174 (277)
T cd06641         156 I--KRNTFVGTPFWMAPEVIK  174 (277)
T ss_pred             h--hhccccCCccccChhhhc
Confidence            1  123456899999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=205.14  Aligned_cols=168  Identities=27%  Similarity=0.316  Sum_probs=138.6

Q ss_pred             hHhhhcccc-ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec----
Q 018036          179 DILECVKDN-NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN----  251 (362)
Q Consensus       179 ~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----  251 (362)
                      .+.++|... ++||-|-.|.|-.+.++ +++.+|+|.+....+       ..+|++.--.. .|||||+++++|..    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-------ARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-------ARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-------HHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            345666654 78999999999999874 688999998753322       56777765555 69999999998864    


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEEcc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVAD  328 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D  328 (362)
                      .....+|||.|+||.|.+.+.++....+++.++..|+.||+.|+.|||..   .|.||||||+|+|...   +..+||+|
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            34567999999999999999988888899999999999999999999954   4999999999999964   56689999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ||+|+.-...   ....+.+-||+|.|||++
T Consensus       208 fGFAK~t~~~---~~L~TPc~TPyYvaPevl  235 (400)
T KOG0604|consen  208 FGFAKETQEP---GDLMTPCFTPYYVAPEVL  235 (400)
T ss_pred             cccccccCCC---ccccCCcccccccCHHHh
Confidence            9999976532   236677889999999986

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=6.7e-27  Score=216.26  Aligned_cols=173  Identities=23%  Similarity=0.320  Sum_probs=150.7

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|+..+.||+||.+.||++...+.+.+|+|++.....+....+.|.+|+..|.+++ |.+||++++|-..++..|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            457778999999999999999988899999998766666666677999999999995 9999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |- ..+|..+|.........| .+..+..|++.|+.++|+++   |||.||||.|+|+- .|.+||+|||+|..+.....
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            87 579999998665554555 66788899999999999877   99999999999987 46899999999999987666


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +-.....+||+.||+||.+.
T Consensus       515 sI~kdsQvGT~NYMsPEAl~  534 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALT  534 (677)
T ss_pred             ceeeccccCcccccCHHHHh
Confidence            66667789999999999764

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.94  E-value=5.5e-26  Score=202.61  Aligned_cols=172  Identities=27%  Similarity=0.393  Sum_probs=147.2

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|+||.||++.+. ++..+++|++............+.+|++++++++|+|++++++.+...+..++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            566788999999999999974 5889999998655444444556899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          263 PNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       263 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ++++|.+++....  ...+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  157 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-  157 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence            9999999997543  467899999999999999999999655   9999999999999999999999999998765432 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......|++.|+|||...
T Consensus       158 -~~~~~~~~~~~y~~pe~~~  176 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQ  176 (258)
T ss_pred             -ceecceeeeecccChhHhc
Confidence             2234457899999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.2e-26  Score=205.53  Aligned_cols=172  Identities=32%  Similarity=0.428  Sum_probs=143.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC-----
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE-----  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----  253 (362)
                      .++|+..+.||+|++|.||+|... +++.+++|.+.....   ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            367888999999999999999974 577899998754322   334589999999999 6999999999997644     


Q ss_pred             -eeeEEEecCCCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          254 -TNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       254 -~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                       ..++||||+++++|.+++....  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999999986433  456899999999999999999999555   9999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCcccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.......  .......|+..|+|||++.
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  186 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIA  186 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhc
Confidence            998764322  1233456899999999764

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=5.4e-26  Score=203.71  Aligned_cols=172  Identities=31%  Similarity=0.421  Sum_probs=145.3

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|++|.||+|+.. +++.|++|++...... .....+.+|+..+.+++|+|++++++++...+..++||||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            4677789999999999999886 5899999988654322 3345699999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++...  ..+++..+..++.|+++|++|||.  ..+++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999643  558999999999999999999995  044999999999999999999999999999877532221


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .....++..|+|||.+.+
T Consensus       157 --~~~~~~~~~y~~pE~~~~  174 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQG  174 (264)
T ss_pred             --ccceeecccccCHhhhCC
Confidence              224568899999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.94  E-value=5.8e-26  Score=206.05  Aligned_cols=171  Identities=32%  Similarity=0.416  Sum_probs=141.7

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeEEEe
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYE  260 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  260 (362)
                      |+..+.||+|+||.||+|... +++.+++|++............+.+|++++++++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            455678999999999999875 578999999976543333344588999999999999999999999988  88999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |++ ++|.+++... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            997 5899888643 246899999999999999999999665   99999999999999999999999999987754321


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......++..|+|||.+.
T Consensus       156 -~~~~~~~~~~~y~~PE~~~  174 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLL  174 (287)
T ss_pred             -ccccccccccccCCceeeE
Confidence             1123345788999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.2e-26  Score=201.61  Aligned_cols=170  Identities=30%  Similarity=0.458  Sum_probs=145.3

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||++... +++.+++|.+..........+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            567789999999999999875 5789999998765443334456899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++...  ..+++..+..++.|++.||.|||..+   ++||||||+||+++.++.++|+|||.+......... 
T Consensus        82 ~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          82 ENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            999999998643  46899999999999999999999554   999999999999999999999999999877543221 


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                       .....|+..|+|||+..
T Consensus       156 -~~~~~~~~~y~~pe~~~  172 (254)
T cd06627         156 -DASVVGTPYWMAPEVIE  172 (254)
T ss_pred             -ccccccchhhcCHhhhc
Confidence             23456899999999764

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=4.3e-26  Score=208.23  Aligned_cols=170  Identities=26%  Similarity=0.394  Sum_probs=143.3

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ..+|+..+.||+|+||.||++.. .++..|++|.+....  ....+.+.+|+.++++++||||+++++++...+..++|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            46788889999999999999986 467889999875322  222345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999999998642   4788999999999999999999655   9999999999999999999999999987664322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  ......|++.|+|||++.
T Consensus       170 ~--~~~~~~~~~~y~~PE~~~  188 (293)
T cd06647         170 S--KRSTMVGTPYWMAPEVVT  188 (293)
T ss_pred             c--ccccccCChhhcCchhhc
Confidence            1  123456899999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.3e-26  Score=213.69  Aligned_cols=169  Identities=28%  Similarity=0.417  Sum_probs=140.1

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  253 (362)
                      +.++|+..+.||+|+||.||++.. .++..||||++............+.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456788899999999999999985 47889999988543322223345789999999999999999999987653     


Q ss_pred             -eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       254 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                       ..++||||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence             358999999 7899988853   34899999999999999999999655   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......     .....+++.|+|||++.
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~  188 (343)
T cd07880         166 RQTDSE-----MTGYVVTRWYRAPEVIL  188 (343)
T ss_pred             cccccC-----ccccccCCcccCHHHHh
Confidence            865432     23446789999999764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.94  E-value=5e-26  Score=204.08  Aligned_cols=163  Identities=25%  Similarity=0.305  Sum_probs=138.8

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      ||+|++|.||+|+.. +++.+++|.+...... ....+.+.+|+.++++++||||+++++++.+....+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 4889999998654322 23345689999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      .+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            9999643  34889999999999999999999655   9999999999999999999999999998775332   12345


Q ss_pred             cCccCcccccccc
Q 018036          348 AGSYGYIAPVLGW  360 (362)
Q Consensus       348 ~Gt~~y~aPE~~~  360 (362)
                      .|++.|+|||++.
T Consensus       153 ~~~~~~~~PE~~~  165 (262)
T cd05572         153 CGTPEYVAPEIIL  165 (262)
T ss_pred             cCCcCccChhHhc
Confidence            7899999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=8.4e-26  Score=208.62  Aligned_cols=170  Identities=32%  Similarity=0.399  Sum_probs=141.6

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +..+.|+..+.||+|+||.||++.. .++..+|+|.+....... .....+.+|++++++++|||++++++++...+..+
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence            3445677888999999999999986 467899999886433222 22345888999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||++ |+|.+.+... ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++....
T Consensus       102 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         102 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             EEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            9999996 5888877533 345899999999999999999999655   9999999999999999999999999987653


Q ss_pred             CCCCceeeccccCccCccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      .      .....|++.|+|||++
T Consensus       177 ~------~~~~~~~~~y~aPE~~  193 (317)
T cd06635         177 P------ANSFVGTPYWMAPEVI  193 (317)
T ss_pred             C------cccccCCccccChhhh
Confidence            2      2345689999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=7.4e-26  Score=204.83  Aligned_cols=172  Identities=26%  Similarity=0.338  Sum_probs=143.5

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .+.|+..+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            345677788999999999999874 57889999875332 1223345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++..   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999999999853   34788999999999999999999554   9999999999999999999999999998764322


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ......++..|+|||++.+
T Consensus       156 ~--~~~~~~~~~~y~apE~~~~  175 (277)
T cd06640         156 I--KRNTFVGTPFWMAPEVIQQ  175 (277)
T ss_pred             c--ccccccCcccccCHhHhcc
Confidence            1  1234568899999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.94  E-value=7.7e-26  Score=201.59  Aligned_cols=172  Identities=34%  Similarity=0.452  Sum_probs=146.3

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeEEEe
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYE  260 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  260 (362)
                      |+..+.||+|++|.||+|... +++.|++|.+..........+.+.+|+.++++++|+||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            566789999999999999975 688999999865543334456689999999999999999999999988  88999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++....  .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          82 YVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             ecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999999996443  6899999999999999999999655   99999999999999999999999999987764332


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........++..|+|||+..
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~  176 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIR  176 (260)
T ss_pred             cccccCCCCCccccCHhhhc
Confidence            11134456899999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-27  Score=199.58  Aligned_cols=175  Identities=25%  Similarity=0.289  Sum_probs=144.6

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----Cee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  255 (362)
                      ++|++.+.+|+|||+-||.++. .++..+|+|++.....  ...+...+|++..++++|||+++++++...+     ...
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            6788899999999999999984 6788999999976552  3344589999999999999999998876443     458


Q ss_pred             eEEEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ||+++|...|+|.+.+...  ++..+++.+.+.|+.++++||++||+. .+++.||||||.|||+.+++.+++.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999998643  345799999999999999999999976 4579999999999999999999999999988


Q ss_pred             cccCCCCc-------eeeccccCccCccccccc
Q 018036          334 YLQDTGAS-------ECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       334 ~~~~~~~~-------~~~~~~~Gt~~y~aPE~~  359 (362)
                      ...-.-.+       +.......|..|.|||++
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf  210 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELF  210 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchhe
Confidence            75411110       112234568999999986

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-26  Score=216.56  Aligned_cols=171  Identities=29%  Similarity=0.418  Sum_probs=140.6

Q ss_pred             hhccccceeeccCcccEEEEEcC---CCC--EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP---NGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +..+..+.||.|.||.||+|...   .|+  .||||..+..... ...+.|..|..+|++++|||||+++|+|.+ ...|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence            44556789999999999999863   233  5788887654433 335569999999999999999999999975 4679


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ||||.++.|.|..+|+.. ...++......++.|++.||+|||   +.+.|||||.++|||+.....+|++|||+++.+.
T Consensus       467 ivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            999999999999999744 456888999999999999999999   6679999999999999999999999999999998


Q ss_pred             CCCCceeeccccCccCccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      +..... .+...=...|||||-+
T Consensus       543 d~~yYk-aS~~kLPIKWmaPESI  564 (974)
T KOG4257|consen  543 DDAYYK-ASRGKLPIKWMAPESI  564 (974)
T ss_pred             ccchhh-ccccccceeecCcccc
Confidence            654332 2223335689999965

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=3.5e-26  Score=212.69  Aligned_cols=173  Identities=27%  Similarity=0.409  Sum_probs=141.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec----CCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|... ++..|++|++............+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            57788899999999999999864 68899999987543333334557889999999999999999988753    34679


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||++ ++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++....
T Consensus        85 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            9999995 6999998533  44899999999999999999999655   9999999999999999999999999998764


Q ss_pred             CCCCc--eeeccccCccCcccccccc
Q 018036          337 DTGAS--ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~--~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .....  .......|+..|+|||++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLL  184 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhc
Confidence            32211  1123457899999999763

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.94  E-value=6.7e-26  Score=206.54  Aligned_cols=172  Identities=32%  Similarity=0.400  Sum_probs=141.3

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC-----C
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK-----E  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~  253 (362)
                      .++|+..+.||+|+||.||++.. .+++.+|+|.+....   .....+.+|+.++.++ +|||++++++++...     +
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            46788889999999999999987 467899999875332   2234578899999999 799999999998754     3


Q ss_pred             eeeEEEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                      ..++||||+++++|.++++..  ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeeccc
Confidence            578999999999999988532  3356899999999999999999999654   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +........  ......|+..|+|||++.
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~  201 (291)
T cd06639         175 SAQLTSTRL--RRNTSVGTPFWMAPEVIA  201 (291)
T ss_pred             chhcccccc--cccCccCCccccChhhhc
Confidence            987643221  123456899999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=6.1e-26  Score=205.83  Aligned_cols=172  Identities=28%  Similarity=0.414  Sum_probs=141.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec------C
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN------K  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~  252 (362)
                      ...|+..+.||+|+||.||+|.+ .+++.+|+|.+....   .....+..|+.++.++ +|+||+++++++..      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            46778889999999999999987 457889999874322   2234488899999998 69999999999853      4


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      +..+++|||+++|+|.+++.......+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcch
Confidence            57799999999999999997655566888999999999999999999655   999999999999999999999999998


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........  ......|++.|+|||++.
T Consensus       169 ~~~~~~~~--~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         169 AQLDRTVG--RRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             hhhhcccc--CCCcccccccccCHhhcC
Confidence            86542211  134457899999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.93  E-value=1.2e-25  Score=204.48  Aligned_cols=169  Identities=27%  Similarity=0.391  Sum_probs=141.9

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|...+.||+|++|.||++.. .+++.+++|++.....  ...+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4566678999999999999986 4678999998753322  223448899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++..   ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            9999999999864   34889999999999999999999655   99999999999999999999999999876543211


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ......|++.|+|||+..
T Consensus       171 --~~~~~~~~~~y~aPE~~~  188 (285)
T cd06648         171 --RRKSLVGTPYWMAPEVIS  188 (285)
T ss_pred             --ccccccCCccccCHHHhc
Confidence              123456899999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=1.1e-25  Score=204.63  Aligned_cols=173  Identities=31%  Similarity=0.424  Sum_probs=146.3

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +..+.|+..+.||+|++|.||++.+. ++..+++|.+.....   ..+.+.+|++++++++|+|++++++++...+..++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            34566777889999999999999986 688999999864433   34458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |+||+++++|.+++.... ..+++..+..++.|++.||+|||..+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999999997543 36899999999999999999999554   99999999999999999999999999876643


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  ......++..|+|||++.
T Consensus       169 ~~~--~~~~~~~~~~y~~PE~~~  189 (286)
T cd06614         169 EKS--KRNSVVGTPYWMAPEVIK  189 (286)
T ss_pred             chh--hhccccCCcccCCHhHhc
Confidence            221  123445889999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=6e-26  Score=211.33  Aligned_cols=172  Identities=24%  Similarity=0.396  Sum_probs=138.8

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----Ce
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  254 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|.+..... .....++.+|+.++++++|+||+++++++...     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            36788899999999999999986 4688999998854322 22334578899999999999999999987654     35


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++|+||++ ++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            789999996 588888753   35899999999999999999999655   99999999999999999999999999987


Q ss_pred             ccCCCCc-eeeccccCccCcccccccc
Q 018036          335 LQDTGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....... .......||+.|+|||++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIML  182 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhh
Confidence            6432211 1123457899999999753

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=1.2e-25  Score=202.33  Aligned_cols=173  Identities=26%  Similarity=0.388  Sum_probs=140.5

Q ss_pred             ccccceeeccCcccEEEEEcCC--CCEEEEEEeeccCCC--------CCchhhHHHHHHHHhc-CccCcceeEEEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPN--GEQVAVKKLLGITKG--------SSHDNGLSAEIRTLGK-IRHRNIVRLKAFCSNK  252 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~  252 (362)
                      |+..+.||+|+||.||+|.+..  ++.+|+|.+......        .....++.+|+.++.+ ++||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5667889999999999999754  678999987543221        1122346778887865 7999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      +..+++|||+++++|.+++..  .....+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence            999999999999999998743  2334689999999999999999999952  249999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.......   ......|+..|+|||++.+
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~  187 (269)
T cd08528         160 LAKQKQPES---KLTSVVGTILYSCPEIVKN  187 (269)
T ss_pred             ceeeccccc---ccccccCcccCcChhhhcC
Confidence            998765332   2345678999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.93  E-value=1e-26  Score=190.76  Aligned_cols=170  Identities=28%  Similarity=0.384  Sum_probs=140.4

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +.....||+|++|.|-+-++ .+|...|+|++..... .+.+.+..+|+.+..+. ..|.+|.++|.+......|+.||.
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            34456799999999988876 5789999999865433 34445678888877666 699999999999999999999999


Q ss_pred             CCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          262 MPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       262 ~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      | ..||+.+...  ..+..+++...-+||..|..||.|||++  ..++|||+||+|||++.+|++|+||||.+..+.++-
T Consensus       127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            9 5688777643  3467799999999999999999999974  359999999999999999999999999999887542


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .   .+.-+|...|||||.+.
T Consensus       204 A---kt~daGCkpYmaPEri~  221 (282)
T KOG0984|consen  204 A---KTMDAGCKPYMAPERIN  221 (282)
T ss_pred             H---HHHhcCCCccCChhhcC
Confidence            2   33457899999999763

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.93  E-value=4.5e-26  Score=207.33  Aligned_cols=172  Identities=30%  Similarity=0.350  Sum_probs=138.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||++.+. +++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..++..+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            45566788999999999999874 5789999988643322 33445889999999996 999999999999999999999


Q ss_pred             ecCCCCChhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          260 EYMPNGSLGEVL---HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       260 e~~~~gsL~~~l---~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ||++ +++.++.   .......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++...
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9985 4655543   223345689999999999999999999963  249999999999999999999999999998764


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....   .....||+.|+|||++.
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         160 DSIA---KTRDAGCRPYMAPERID  180 (288)
T ss_pred             cCCc---cccccCccCccCHHHhc
Confidence            3221   23346899999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=6.1e-26  Score=211.34  Aligned_cols=172  Identities=27%  Similarity=0.421  Sum_probs=141.1

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----Ce
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  254 (362)
                      .++|...+.||+|+||.||+|.. .++..||+|.+............+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35678888999999999999986 4688999999865433333334578899999999999999999988654     34


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||+. ++|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999995 799998853  345899999999999999999999655   99999999999999999999999999987


Q ss_pred             ccCCCCceeeccccCccCcccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .....  .......||..|+|||++.
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~  181 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLL  181 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHh
Confidence            65322  2234456899999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=8.6e-26  Score=211.03  Aligned_cols=168  Identities=29%  Similarity=0.405  Sum_probs=138.5

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------C
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------E  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  253 (362)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+.++.+++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            47788889999999999999986 5688999998865433333344578899999999999999999988643      3


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..+++++++ +++|.+++...   .+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccc
Confidence            467888887 78999888532   4899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCCceeeccccCccCcccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .....     .....||..|+|||+..
T Consensus       169 ~~~~~-----~~~~~~~~~y~aPE~~~  190 (345)
T cd07877         169 HTDDE-----MTGYVATRWYRAPEIML  190 (345)
T ss_pred             ccccc-----ccccccCCCccCHHHHh
Confidence            65321     23456899999999763

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=7.7e-26  Score=209.87  Aligned_cols=169  Identities=23%  Similarity=0.260  Sum_probs=135.5

Q ss_pred             eeecc--CcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRG--GAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .||+|  +||+||++.+ .+++.||+|.+..........+.+.+|+.+++.++||||+++++++...+..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  8999999987 47899999988644333333456889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCcee--
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC--  343 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~--  343 (362)
                      +|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+...........  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999987554456899999999999999999999554   99999999999999999999999986544322111100  


Q ss_pred             ---eccccCccCcccccccc
Q 018036          344 ---MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       344 ---~~~~~Gt~~y~aPE~~~  360 (362)
                         .....++..|+|||++.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~  181 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLR  181 (328)
T ss_pred             ccccccccCccCccChhhhc
Confidence               11123567799999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=2.6e-25  Score=197.38  Aligned_cols=168  Identities=35%  Similarity=0.490  Sum_probs=144.3

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||++... ++..+++|++.....  .....+.+|++.+++++|+|++++++++...+..++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            566789999999999999975 688999999865433  23455899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++.... ..+++..+..++.|++.||+|||..+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999999986542 46899999999999999999999654   99999999999999999999999999987654321  


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                       .....|+..|+|||++.
T Consensus       154 -~~~~~~~~~~~~PE~~~  170 (253)
T cd05122         154 -RNTMVGTPYWMAPEVIN  170 (253)
T ss_pred             -ccceecCCcccCHHHHc
Confidence             34557899999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=2.1e-25  Score=202.52  Aligned_cols=170  Identities=31%  Similarity=0.386  Sum_probs=138.1

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC---ccCcceeEEEEEecCCe-----
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSNKET-----  254 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  254 (362)
                      |+..+.||+|+||.||+|.+. +++.+|+|.+............+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456788999999999999986 488999999865443333333466787777665   69999999999988776     


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .+++|||+. ++|.+++.......+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 58999886544446899999999999999999999655   99999999999999999999999999987


Q ss_pred             ccCCCCceeeccccCccCcccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......   .....++..|+|||++.
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~  179 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLL  179 (287)
T ss_pred             ccCCcc---cccccccccccChHHhc
Confidence            643221   23345789999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.93  E-value=1e-25  Score=207.51  Aligned_cols=169  Identities=20%  Similarity=0.155  Sum_probs=136.3

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      +.+|.|+++.||++.. +++.||+|++..........+.+.+|+++++.++|+||+++++++...+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445555555555555 689999999876533334445699999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc-----e
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-----E  342 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-----~  342 (362)
                      .+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+.........     .
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            99997655556889999999999999999999655   999999999999999999999999998765432211     1


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......++..|+|||++.
T Consensus       164 ~~~~~~~~~~y~aPE~~~  181 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQ  181 (314)
T ss_pred             ccccccccccccCHHHhc
Confidence            123345788999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=2.3e-25  Score=201.78  Aligned_cols=167  Identities=26%  Similarity=0.298  Sum_probs=135.8

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecC--CeeeEEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNK--ETNLLVY  259 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  259 (362)
                      |+..+.||+|+||.||+|... +++.+|+|+++....... .....+|+.++.++. |+|++++++++.+.  +..++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            345678999999999999864 688999998865432222 223557888999885 99999999999987  8899999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||++ ++|.+.+.... ..+++..+..++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        80 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          80 ELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             ecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9996 68888886432 46899999999999999999999655   999999999999999 999999999998765322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .   .....++..|+|||++.
T Consensus       154 ~---~~~~~~~~~y~aPE~~~  171 (282)
T cd07831         154 P---YTEYISTRWYRAPECLL  171 (282)
T ss_pred             C---cCCCCCCcccCChhHhh
Confidence            2   23356899999999753

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.93  E-value=7.3e-26  Score=202.76  Aligned_cols=166  Identities=28%  Similarity=0.386  Sum_probs=138.0

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      ||+|+||.||++.+. +++.+++|.+..... .....+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999986 489999998854332 122345588999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC------c
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA------S  341 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~------~  341 (362)
                      .+++....  .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........      .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99996433  5899999999999999999999655   99999999999999999999999999886543211      0


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......++..|+|||+..
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~  174 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVIL  174 (265)
T ss_pred             ccccCcccCccccCHHHhc
Confidence            1233456889999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.93  E-value=1.2e-25  Score=204.68  Aligned_cols=171  Identities=25%  Similarity=0.271  Sum_probs=140.5

Q ss_pred             ccccceeeccCcccEEEEEc----CCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          184 VKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      |+..+.||+|++|.||++..    .+++.||+|.++....  .....+.+.+|++++.++ +||||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            56678899999999999974    3568899998864322  122234588999999999 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++++|.+++...  ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||+++...
T Consensus        82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          82 LILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999999998532  45889999999999999999999554   9999999999999999999999999998764


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..... ......|+..|+|||...
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~  179 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIR  179 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhc
Confidence            33211 123456899999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=9.8e-26  Score=204.40  Aligned_cols=169  Identities=28%  Similarity=0.421  Sum_probs=141.0

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |+..+.||+|++|.||+|... +++.|++|++...... .......+|+..+.+++ |+||+++++++..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            456678999999999999975 4788999988644322 22233567999999999 99999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      + +|+|.+++.......+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence            9 889999987655457899999999999999999999655   99999999999999999999999999987653221 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                        .....|+..|+|||++.
T Consensus       155 --~~~~~~~~~~~aPE~~~  171 (283)
T cd07830         155 --YTDYVSTRWYRAPEILL  171 (283)
T ss_pred             --cCCCCCcccccCceeee
Confidence              23456889999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=4.5e-25  Score=203.38  Aligned_cols=171  Identities=31%  Similarity=0.388  Sum_probs=140.9

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +..+.|...+.||+|+||.||+|+. .++..|++|++....... .....+.+|++++++++|||++++++++.+.+..+
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            3345567778899999999999986 467899999886443322 22245788999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+. +++.+++... ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        98 lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          98 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            9999995 6888877533 345899999999999999999999655   9999999999999999999999999986532


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .      .....|+..|+|||++.
T Consensus       173 ~------~~~~~~~~~y~aPE~~~  190 (313)
T cd06633         173 P------ANSFVGTPYWMAPEVIL  190 (313)
T ss_pred             C------CCCccccccccChhhcc
Confidence            2      23457899999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.93  E-value=1.5e-25  Score=205.94  Aligned_cols=175  Identities=27%  Similarity=0.366  Sum_probs=139.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  253 (362)
                      .++|+..+.||+|+||.||+|... +++.+++|++............+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888999999999999999874 6789999998654433333334788999999999999999999875433      


Q ss_pred             --eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          254 --TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       254 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                        ..++||||++ ++|.+.+.. ....+++..+..++.|+++||+|||..+   ++||||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence              4689999996 578777753 2346999999999999999999999555   99999999999999999999999999


Q ss_pred             cccccCCCCc---------eeeccccCccCcccccccc
Q 018036          332 AKYLQDTGAS---------ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~---------~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++........         .......|++.|+|||++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL  199 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence            9876432211         1122346788999999764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=1.3e-25  Score=205.06  Aligned_cols=167  Identities=26%  Similarity=0.369  Sum_probs=139.5

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+....||+|+||.||++.. .+++.||+|++....  ......+.+|+.++++++|+||+++++++...+..++||||+
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            33446799999999999987 468899999875332  223445889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++..   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .
T Consensus       100 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~  171 (292)
T cd06657         100 EGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  171 (292)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--c
Confidence            99999998753   24789999999999999999999655   9999999999999999999999999987664321  1


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......||+.|+|||+..
T Consensus       172 ~~~~~~~~~~y~~pE~~~  189 (292)
T cd06657         172 RRKSLVGTPYWMAPELIS  189 (292)
T ss_pred             cccccccCccccCHHHhc
Confidence            123456899999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=1.8e-25  Score=207.81  Aligned_cols=171  Identities=25%  Similarity=0.353  Sum_probs=136.0

Q ss_pred             ccccceeeccCcccEEEEEcC-C--CCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC----Cee
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-N--GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK----ETN  255 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~  255 (362)
                      |+..+.||+|+||.||++... +  +..||+|++..........+.+.+|++++.++ +||||+++++.+...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            566788999999999999974 3  67899998864333333344578899999999 599999999875432    456


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++++||++ ++|.+++..  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        82 ~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          82 YLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            89999995 699998853  345899999999999999999999655   999999999999999999999999999876


Q ss_pred             cCCCC--ceeeccccCccCcccccccc
Q 018036          336 QDTGA--SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~--~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .....  ........||+.|+|||+..
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~  182 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIML  182 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHh
Confidence            43221  11123457899999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5e-28  Score=206.28  Aligned_cols=171  Identities=27%  Similarity=0.387  Sum_probs=141.6

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----eeeE
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNLL  257 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  257 (362)
                      .+..+.||-|+||.||..++ ++|+.|+.|++......-...+++.+|++++...+|.|++..++..+-..     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            45567899999999999987 57999999998665444334456899999999999999999998876553     5678


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ++|.| ..+|..++-  ....++.+.+.-+..||++||.|||..+   |.||||||.|.|++++..+||||||+|+.-+.
T Consensus       135 ~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            99999 569988884  3456888888889999999999999555   99999999999999999999999999997654


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ... ..++..+-|.+|.|||+++|
T Consensus       209 d~~-~hMTqEVVTQYYRAPEiLMG  231 (449)
T KOG0664|consen  209 RDR-LNMTHEVVTQYYRAPELLMG  231 (449)
T ss_pred             hhh-hhhHHHHHHHHhccHHHhhc
Confidence            332 23555667999999999987

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=2.2e-25  Score=202.80  Aligned_cols=170  Identities=27%  Similarity=0.348  Sum_probs=139.6

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeEEE
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVY  259 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  259 (362)
                      +|+..+.||+|++|.||++.+. +++.+|+|.+..... .....++.+|++++++++||||+++++++...  +..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4667789999999999999974 578899998764322 23345589999999999999999999998654  4679999


Q ss_pred             ecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||+++++|.+++..  .....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988753  22355888999999999999999999655   99999999999999999999999999876543


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..    .....++..|+|||.+.
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~  176 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQ  176 (287)
T ss_pred             cc----cccccCCccccCHHHhc
Confidence            21    22456788999999764

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=6.2e-26  Score=205.09  Aligned_cols=173  Identities=28%  Similarity=0.378  Sum_probs=144.3

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEE
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  259 (362)
                      +|...+.||+|+||.||++... ++..|++|.+..... .....+.+.+|.+++.+++ ||||+++++++...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            5677889999999999999874 688999998865322 2223355888999999998 999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||++.......
T Consensus        82 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          82 EYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            999999999999643  36999999999999999999999655   9999999999999999999999999998765332


Q ss_pred             Cc------------------eeeccccCccCcccccccc
Q 018036          340 AS------------------ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~------------------~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..                  .......|+..|+|||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  195 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN  195 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhC
Confidence            11                  1223456889999999764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=2.8e-25  Score=206.14  Aligned_cols=169  Identities=26%  Similarity=0.398  Sum_probs=139.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-CCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.. .+..+++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            467888899999999999999864 78899999886443333334558899999999999999999999876 4578899


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.+......
T Consensus        89 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          89 TELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             eehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            9999 6799988853   24788888899999999999999555   999999999999999999999999999865321


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           .....++..|+|||++.+
T Consensus       162 -----~~~~~~~~~y~aPE~~~~  179 (328)
T cd07856         162 -----MTGYVSTRYYRAPEIMLT  179 (328)
T ss_pred             -----cCCCcccccccCceeeec
Confidence                 234467889999998643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=2.7e-25  Score=206.81  Aligned_cols=175  Identities=27%  Similarity=0.293  Sum_probs=139.7

Q ss_pred             hhhcc-ccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC------------chhhHHHHHHHHhcCccCcceeEE
Q 018036          181 LECVK-DNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS------------HDNGLSAEIRTLGKIRHRNIVRLK  246 (362)
Q Consensus       181 ~~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~  246 (362)
                      .++|. ..+.||+|+||.||+|.+. +++.||+|++........            ....+.+|++++++++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34554 3578999999999999864 688999998865432210            012377899999999999999999


Q ss_pred             EEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       247 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                      +++...+..++||||++ ++|.+++..  ...+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            99999999999999996 699999853  345889999999999999999999554   999999999999999999999


Q ss_pred             ccccccccccCCC------------CceeeccccCccCccccccccc
Q 018036          327 ADFGLAKYLQDTG------------ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       327 ~DFGla~~~~~~~------------~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|||+++......            .........+++.|+|||++.+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  207 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG  207 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhccc
Confidence            9999998664111            0111223457889999998753

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=5e-28  Score=204.02  Aligned_cols=178  Identities=28%  Similarity=0.398  Sum_probs=142.0

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----  252 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  252 (362)
                      +....|+....||+|.||+||+|+.+ +++.||+|++....+.........+|+++|..++|+|++.+++.|...     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            33466777889999999999999875 577889887654333333334478999999999999999999888543     


Q ss_pred             ---CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          253 ---ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       253 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                         ...|+||++|+. +|.-+|. .....++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+||
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhc-CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence               346899999965 8988885 33456899999999999999999999554   999999999999999999999999


Q ss_pred             cccccccCCCCc--eeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGAS--ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+++.+......  ...+..+-|.+|.+||++.|
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG  202 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG  202 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence            999877533322  12234456999999998865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.6e-25  Score=215.70  Aligned_cols=176  Identities=22%  Similarity=0.286  Sum_probs=130.6

Q ss_pred             hhhccccceeeccCcccEEEEEc-----------------CCCCEEEEEEeeccCCCC------------CchhhHHHHH
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-----------------PNGEQVAVKKLLGITKGS------------SHDNGLSAEI  231 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e~  231 (362)
                      .++|+..++||+|+||.||+|..                 .+++.||||++.......            ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            46788899999999999999963                 235689999986432211            0112244577


Q ss_pred             HHHhcCccCcc-----eeEEEEEec--------CCeeeEEEecCCCCChhhhhcCCCC----------------------
Q 018036          232 RTLGKIRHRNI-----VRLKAFCSN--------KETNLLVYEYMPNGSLGEVLHGKRG----------------------  276 (362)
Q Consensus       232 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~----------------------  276 (362)
                      .++.+++|.++     ++++++|..        .+..++||||+++++|.++++...+                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77888876554     677777753        3567999999999999999864211                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCcccc
Q 018036          277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP  356 (362)
Q Consensus       277 ~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aP  356 (362)
                      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....... .......+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            12467788899999999999999655   99999999999999999999999999976542211 111223458999999


Q ss_pred             cccc
Q 018036          357 VLGW  360 (362)
Q Consensus       357 E~~~  360 (362)
                      |.+.
T Consensus       380 E~l~  383 (507)
T PLN03224        380 EELV  383 (507)
T ss_pred             hhhc
Confidence            9763

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.93  E-value=6.8e-25  Score=197.61  Aligned_cols=163  Identities=21%  Similarity=0.242  Sum_probs=130.2

Q ss_pred             hhhcccccee--eccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVI--GRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      .+.|+..+.+  |+|+||.||++..+ ++..+|+|.+.......     .  |+.....+ +||||+++++.+...+..+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----I--EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----h--hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            3455555555  99999999999864 67788888875432111     1  22222222 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYL  335 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~  335 (362)
                      +||||+++++|.+++...  ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++ .++|+|||+++..
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999643  36899999999999999999999655   99999999999999988 9999999999866


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...      ....|+..|+|||++.+
T Consensus       161 ~~~------~~~~~~~~y~aPE~~~~  180 (267)
T PHA03390        161 GTP------SCYDGTLDYFSPEKIKG  180 (267)
T ss_pred             CCC------ccCCCCCcccChhhhcC
Confidence            432      23468999999998753

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.93  E-value=1.8e-27  Score=202.10  Aligned_cols=171  Identities=28%  Similarity=0.355  Sum_probs=139.5

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++++...||.|+||+|+|-.+ +.|+..|||+++.... ..++.++..|.+...+- +.||||+++|.+..++..|+.||
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            345567899999999999987 4789999999976543 34455688888766555 68999999999999999999999


Q ss_pred             cCCCCChhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          261 YMPNGSLGEVLH---GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       261 ~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      .| ..||+.+.+   ..+...+++...-.|..-..+||.||-+.  ..|+|||+||+|||+|..|.+||||||++..+.+
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            99 567766653   23345688888889999999999999864  3599999999999999999999999999998865


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +-   ..+.-+|...|||||-+.
T Consensus       221 Si---AkT~daGCrpYmAPERi~  240 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERID  240 (361)
T ss_pred             HH---HhhhccCCccccChhccC
Confidence            32   245567999999999763

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=1.4e-25  Score=200.18  Aligned_cols=170  Identities=27%  Similarity=0.393  Sum_probs=143.6

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|+||.||++... +++.+++|.+............+.+|++++++++|+||+++++++......++||||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            567789999999999999764 6789999998654433334455888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          263 PNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       263 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ++++|.+++...  ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN--  156 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence            999999998642  1346899999999999999999999554   999999999999999999999999999877543  


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        ......|++.|+|||+..
T Consensus       157 --~~~~~~~~~~~~~Pe~~~  174 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWK  174 (256)
T ss_pred             --CcccccCCccccCHHHHC
Confidence              123356889999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.6e-25  Score=207.75  Aligned_cols=173  Identities=29%  Similarity=0.391  Sum_probs=143.3

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----eee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----TNL  256 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  256 (362)
                      +|+..+.||+|++|.||+|... ++..+++|++..........+.+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3667789999999999999975 4889999998765433344456899999999999999999999988775     789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ++|||++ ++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 5899988643  36899999999999999999999655   9999999999999999999999999999775


Q ss_pred             CCCCc-eeeccccCccCccccccccc
Q 018036          337 DTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..... .......+|..|+|||++.+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~  180 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLS  180 (330)
T ss_pred             ccccccccccccccccCcCCceeeec
Confidence            43210 11334568999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.3e-25  Score=207.87  Aligned_cols=168  Identities=27%  Similarity=0.374  Sum_probs=137.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  253 (362)
                      .++|...+.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            35678889999999999999986 46899999988654322333345789999999999999999999987543      


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++|+||+. .+|.++..    ..+++..+..++.|++.||+|||..+   ++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4589999995 47777652    24889999999999999999999655   9999999999999999999999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....     .....||..|+|||++.+
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcC
Confidence            65321     234567899999998653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=4.3e-25  Score=197.80  Aligned_cols=163  Identities=24%  Similarity=0.306  Sum_probs=131.5

Q ss_pred             ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHH-hcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTL-GKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|... +++.||+|.+....... .....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999874 57899999885432211 1112244554444 445899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      ++|.+++...  ..+++..+..++.|++.||.|||..+   ++||||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            9999999643  35889999999999999999999654   99999999999999999999999999876532      2


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                      ....|+..|+|||.+.+
T Consensus       151 ~~~~~~~~y~~pe~~~~  167 (260)
T cd05611         151 KKFVGTPDYLAPETILG  167 (260)
T ss_pred             ccCCCCcCccChhhhcC
Confidence            34568899999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.93  E-value=5.8e-25  Score=200.89  Aligned_cols=173  Identities=20%  Similarity=0.221  Sum_probs=123.7

Q ss_pred             hhccccceeeccCcccEEEEEcCCC----CEEEEEEeeccCCCCCch---------hhHHHHHHHHhcCccCcceeEEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNG----EQVAVKKLLGITKGSSHD---------NGLSAEIRTLGKIRHRNIVRLKAF  248 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~l~~~  248 (362)
                      ++|+..+.||+|+||.||+|...++    ..+++|...........+         .....+...+..++|++++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788899999999999999987543    345555432111110000         112233445667789999999987


Q ss_pred             EecCC----eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCce
Q 018036          249 CSNKE----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA  324 (362)
Q Consensus       249 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  324 (362)
                      +....    ..++++|++ ..++.+.+...  ...++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence            65543    447888887 34777766432  23578888999999999999999554   9999999999999999999


Q ss_pred             EEccccccccccCCCCc-----eeeccccCccCcccccccc
Q 018036          325 HVADFGLAKYLQDTGAS-----ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       325 kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|+|||+|+.+......     .......||+.|+|||+..
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~  206 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN  206 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence            99999999876432111     1123457999999999764

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=5.6e-25  Score=202.29  Aligned_cols=170  Identities=31%  Similarity=0.391  Sum_probs=140.4

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ..+.|+..+.||+|+||.||+|... ++..+++|.+...... .....++.+|+++++.++|+|++++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            3455777788999999999999874 5788999988643222 2223457889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+. |++.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        93 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          93 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            999996 6888877533 345789999999999999999999655   99999999999999999999999999876542


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                            .....|++.|+|||++.
T Consensus       168 ------~~~~~~~~~y~aPE~~~  184 (308)
T cd06634         168 ------ANXFVGTPYWMAPEVIL  184 (308)
T ss_pred             ------cccccCCccccCHHHHh
Confidence                  23456899999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-26  Score=205.58  Aligned_cols=173  Identities=27%  Similarity=0.276  Sum_probs=140.6

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+|....+||+|+||.|..|..+ +.+.+|||++++..--. ...+--..|-++|+-. +-|.+++++..+++-+..|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            45666789999999999999875 45678999987654322 1112234566777666 578999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+.||+|--.+++  -..+.+..+..+|.+||-||-|||+.+   |+.||||.+|||+|.+|.+||+|||+++.-.-.
T Consensus       429 MEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence            999999999888853  345788889999999999999999554   999999999999999999999999999865422


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ...+.++||||.|+|||++.+
T Consensus       504 --~~TTkTFCGTPdYiAPEIi~Y  524 (683)
T KOG0696|consen  504 --GVTTKTFCGTPDYIAPEIIAY  524 (683)
T ss_pred             --CcceeeecCCCcccccceEEe
Confidence              233678999999999998754

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=5.4e-25  Score=201.17  Aligned_cols=172  Identities=26%  Similarity=0.359  Sum_probs=138.8

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+.|+..+.||+|+||.||+|.+.+ ++.||||.+...... ....++.+|+.++.+.. ||||+++++++.+....+++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            4667888999999999999999864 889999998644322 22334667777776664 99999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||++ +++.+++... ...+++..+..++.|++.||+|||+.  .+|+||||+|+||++++++.+||+|||++..+...
T Consensus        93 ~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99984 5777776543 24689999999999999999999952  24999999999999999999999999999876432


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..   .....++..|+|||++.
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~  187 (296)
T cd06618         169 KA---KTRSAGCAAYMAPERID  187 (296)
T ss_pred             Cc---ccCCCCCccccCHhhcC
Confidence            21   22345788999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=4.3e-25  Score=199.99  Aligned_cols=170  Identities=28%  Similarity=0.390  Sum_probs=141.9

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||+|... +++.+++|.+............+.+|++++++++|+||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            345678999999999999874 6889999988655443334456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++ +|.+++.... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            64 8988886433 46899999999999999999999655   9999999999999999999999999998775432  1


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......++..|+|||.+.
T Consensus       154 ~~~~~~~~~~~~~PE~~~  171 (283)
T cd05118         154 PYTHYVVTRWYRAPELLL  171 (283)
T ss_pred             cccCccCcccccCcHHHh
Confidence            123346888999999764

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-26  Score=213.22  Aligned_cols=167  Identities=28%  Similarity=0.396  Sum_probs=143.1

Q ss_pred             ccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      +...+.||-|.||.||.|.|+. .-.||||.++..   ....++|.+|..+|+.++|||+|+++|+|......|||+|||
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            4456899999999999999964 568999988543   345566999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      .+|+|.++|++.....++.-..+.+|.||+.||+||....   +|||||.++|.|+.++..+||+|||+++.+..+.   
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT---  419 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT---  419 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc---
Confidence            9999999998777677888888999999999999999544   9999999999999999999999999999986432   


Q ss_pred             eeccccC---ccCcccccccc
Q 018036          343 CMSAVAG---SYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~G---t~~y~aPE~~~  360 (362)
                       .+..+|   ...|.|||-+.
T Consensus       420 -YTAHAGAKFPIKWTAPEsLA  439 (1157)
T KOG4278|consen  420 -YTAHAGAKFPIKWTAPESLA  439 (1157)
T ss_pred             -eecccCccCcccccCccccc
Confidence             222333   45799999664

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=7.6e-26  Score=214.07  Aligned_cols=174  Identities=28%  Similarity=0.403  Sum_probs=143.9

Q ss_pred             hhccccceeeccCcccEEEEEcC--CC--CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP--NG--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +.++..++||+|.||.|++|.|.  +|  -.||||.++...... ..+.|.+|+.+|.+|+|+|+++|||+..+ ....|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            45566789999999999999984  33  478999998766543 44569999999999999999999999987 67789


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||+++.|+|.+.|++.....+.......++.|||.||+||.   ++++|||||.++|+|+-..-.+||+|||+.+.+..
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999998755667888888999999999999999   55599999999999999999999999999998864


Q ss_pred             CCCceeecc-ccCccCcccccccc
Q 018036          338 TGASECMSA-VAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~-~~Gt~~y~aPE~~~  360 (362)
                      ......+.. ..-...|.|||.+.
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLr  288 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLR  288 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhc
Confidence            433222221 22346799999764

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.92  E-value=7.7e-26  Score=192.92  Aligned_cols=170  Identities=24%  Similarity=0.335  Sum_probs=138.7

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++++....||.|..|.|++++.+ +|..+|||.+..... ..+.+++...+.++.+.. .|.||+.+|+|..+...++.|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            44555677999999999999875 578899999865432 233455788888777764 899999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |.| ..-++.+++ .-..++++..+-++..-+..||.||-+.+  +|+|||+||+|||+|+.|++|+||||++..+.+..
T Consensus       171 elM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  171 ELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            999 445555554 33456898888999999999999998743  69999999999999999999999999999987654


Q ss_pred             CceeeccccCccCccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      .   .+.-+|.+.|||||-+
T Consensus       247 A---htrsAGC~~YMaPERi  263 (391)
T KOG0983|consen  247 A---HTRSAGCAAYMAPERI  263 (391)
T ss_pred             c---cccccCCccccCcccc
Confidence            3   4456799999999965

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=4.3e-25  Score=199.90  Aligned_cols=170  Identities=30%  Similarity=0.381  Sum_probs=141.7

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||+|+.. +++.+++|.+..........+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            345678999999999999975 5889999998765433333455888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      + ++|.+++.... ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            7 59999997542 45899999999999999999999665   99999999999999999999999999987653221  


Q ss_pred             eeccccCccCcccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......++..|+|||++.
T Consensus       154 ~~~~~~~~~~~~aPE~~~  171 (282)
T cd07829         154 TYTHEVVTLWYRAPEILL  171 (282)
T ss_pred             ccCccccCcCcCChHHhc
Confidence            123345678899999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-26  Score=218.22  Aligned_cols=172  Identities=28%  Similarity=0.366  Sum_probs=147.0

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +..++|+....+|+|.||.|||+++ .+++..|+|.++-...+.-  .-++.|+-+++.++|||||.++|.+...+..|+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~--~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF--SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc--cccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            3456788889999999999999997 4688889998865443322  237889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      .||||.+|+|.+..+  ....+++.++..+.+...+||+|||..+   -+|||||-.||++++.|.+|++|||.+..+..
T Consensus        90 cMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence            999999999999885  3456899999999999999999999554   89999999999999999999999999987754


Q ss_pred             CCCceeeccccCccCccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      .-  .....+.||++|||||+.
T Consensus       165 ti--~KrksfiGtpywmapEva  184 (829)
T KOG0576|consen  165 TI--AKRKSFIGTPYWMAPEVA  184 (829)
T ss_pred             hh--hhhhcccCCccccchhHH
Confidence            32  235678999999999975

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.2e-27  Score=214.36  Aligned_cols=171  Identities=23%  Similarity=0.235  Sum_probs=145.4

Q ss_pred             hhccccceeeccCcccEEEEEcCCCC-EEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGE-QVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++++....||-|+||.|-.+...... .+|+|.+++..- +..+++....|-.+|..++.|.||++|..|.+..+.|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            44555678999999999998765433 478887765443 2334455888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |-|-||.|+..|.+  .+.++..++..++..+.+|++|||.   ++||.|||||+|.++|.+|.+||.|||+|+.+..  
T Consensus       500 EaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--  572 (732)
T KOG0614|consen  500 EACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--  572 (732)
T ss_pred             HhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence            99999999999964  3568889999999999999999994   4599999999999999999999999999999864  


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       +..+-++||||.|.|||++.
T Consensus       573 -g~KTwTFcGTpEYVAPEIIL  592 (732)
T KOG0614|consen  573 -GRKTWTFCGTPEYVAPEIIL  592 (732)
T ss_pred             -CCceeeecCCcccccchhhh
Confidence             34477899999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.4e-25  Score=210.29  Aligned_cols=147  Identities=24%  Similarity=0.306  Sum_probs=124.8

Q ss_pred             ccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |...+.||-|+||+|..+..- +...+|.|.+++... ..........|-.||+..+.+.||+|+-.|++++..|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            444578999999999999754 456788888865432 122223477899999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||++-.+|-  +...+++..+..++.+++.|+++.|..|   +|||||||+|||||.+|.+||.|||++.-+
T Consensus       711 IPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  711 IPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             cCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            99999999985  3456889999999999999999999655   999999999999999999999999998643

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.92  E-value=9.5e-25  Score=194.13  Aligned_cols=164  Identities=32%  Similarity=0.370  Sum_probs=138.8

Q ss_pred             eeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCCh
Q 018036          190 IGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL  267 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  267 (362)
                      ||+|+||.||++... +++.+++|.+...... ....+.+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875 5889999988654322 22334588999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccc
Q 018036          268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       268 ~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      .+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            9999643  35899999999999999999999655   9999999999999999999999999998765321  123456


Q ss_pred             cCccCcccccccc
Q 018036          348 AGSYGYIAPVLGW  360 (362)
Q Consensus       348 ~Gt~~y~aPE~~~  360 (362)
                      .|+..|+|||...
T Consensus       154 ~~~~~~~~Pe~~~  166 (250)
T cd05123         154 CGTPEYLAPEVLL  166 (250)
T ss_pred             cCCccccChHHhC
Confidence            7899999999864

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=3.7e-25  Score=206.63  Aligned_cols=169  Identities=28%  Similarity=0.418  Sum_probs=140.6

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe----
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET----  254 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  254 (362)
                      +.++|+..+.||+|++|.||+|... ++..||+|++..........+.+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4567888899999999999999875 57899999876433223333457789999999999999999988766554    


Q ss_pred             --eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          255 --NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       255 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                        .++|+||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence              89999999 6799999864   35899999999999999999999655   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......     .....+|..|+|||++.
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~  188 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIML  188 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHh
Confidence            876432     23456889999999763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1e-25  Score=216.48  Aligned_cols=170  Identities=29%  Similarity=0.440  Sum_probs=136.6

Q ss_pred             ccccceeeccCcccEEEEEc-CCC----CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNG----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+..++||+|+||+||+|.+ +.|    .+||+|.+..... .....++..|+-+|.+++|||+++++++|.... ..||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            45568999999999999986 334    3788888765432 333456999999999999999999999998776 7899


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      ++||+.|+|.++++..+ ..+-.+..+.|..|||+||.|||++.   +|||||.++|||+.+-..+||.|||+|+.+...
T Consensus       776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999998654 45777888999999999999999665   999999999999999999999999999988754


Q ss_pred             CCceeeccccCccCccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ..........-.+.|||=|.+
T Consensus       852 ~~ey~~~~gK~pikwmale~i  872 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESI  872 (1177)
T ss_pred             cccccccccccCcHHHHHHHh
Confidence            433222222224456665543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=2.2e-24  Score=190.82  Aligned_cols=151  Identities=23%  Similarity=0.212  Sum_probs=126.0

Q ss_pred             cCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCChhhhh
Q 018036          193 GGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL  271 (362)
Q Consensus       193 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  271 (362)
                      |.+|.||++.+. +++.+|+|++.....       +.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            889999999874 678999999854321       344555556667999999999999999999999999999999998


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCcc
Q 018036          272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY  351 (362)
Q Consensus       272 ~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~  351 (362)
                      ...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+......     .....++.
T Consensus        77 ~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~  146 (237)
T cd05576          77 SKF--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN  146 (237)
T ss_pred             HHh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence            643  34899999999999999999999655   999999999999999999999999988765432     23345678


Q ss_pred             Ccccccccc
Q 018036          352 GYIAPVLGW  360 (362)
Q Consensus       352 ~y~aPE~~~  360 (362)
                      .|+|||...
T Consensus       147 ~y~aPE~~~  155 (237)
T cd05576         147 MYCAPEVGG  155 (237)
T ss_pred             cccCCcccC
Confidence            899999764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.1e-25  Score=192.34  Aligned_cols=174  Identities=23%  Similarity=0.253  Sum_probs=147.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      +++|+...+||+|+|.+|..+++. +.+.+|+|++++... .....+..+.|-.+.... +||.+|-++..+++....++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467788899999999999999875 567788888865433 333445678888888777 79999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |.||++||+|--++..+  ..++++.+..+..+|+.||.|||+.+   |+.||||.+|+|+|.+|.+|+.|+|+++.-..
T Consensus       329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999998777543  45899999999999999999999665   99999999999999999999999999987543


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +  ...++++||||.|+|||++.+
T Consensus       404 ~--gd~tstfcgtpnyiapeilrg  425 (593)
T KOG0695|consen  404 P--GDTTSTFCGTPNYIAPEILRG  425 (593)
T ss_pred             C--CcccccccCCCcccchhhhcc
Confidence            3  344788999999999998864

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.91  E-value=1.7e-24  Score=201.99  Aligned_cols=171  Identities=27%  Similarity=0.389  Sum_probs=136.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-------  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  252 (362)
                      ..+|+..+.||+|+||.||+|.. .++..||+|++.....  ...+.+.+|++++++++||||+++++++...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            36788889999999999999987 4688999998865433  2334488999999999999999999776543       


Q ss_pred             -------CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCce
Q 018036          253 -------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEA  324 (362)
Q Consensus       253 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~  324 (362)
                             ...++||||++ ++|.+++..   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++ +++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~  154 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence                   35789999996 699888853   24889999999999999999999665   99999999999997 45678


Q ss_pred             EEccccccccccCCCCce-eeccccCccCcccccccc
Q 018036          325 HVADFGLAKYLQDTGASE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       325 kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+|||.++......... ......|+..|+|||++.
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  191 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL  191 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHh
Confidence            999999998764321111 122345789999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=1.4e-24  Score=194.52  Aligned_cols=172  Identities=23%  Similarity=0.328  Sum_probs=136.8

Q ss_pred             hccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCC---CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +|...+.||+|+||.||++.+.. +..+++|.++....   .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36677899999999999998743 34455555543322   222333477899999999999999999999998999999


Q ss_pred             EecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          259 YEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      |||+++++|.+++..  .....+++..+..++.|++.||.|||+.+   ++|+||||+||++++ +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998853  23356899999999999999999999655   999999999999975 569999999998764


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...  .......|++.|+|||+..
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~  178 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALK  178 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHc
Confidence            322  1233456899999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=4.2e-24  Score=181.92  Aligned_cols=143  Identities=18%  Similarity=0.220  Sum_probs=109.3

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCc-------h-----------------hhHHHHHHHHhcCccCcc
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH-------D-----------------NGLSAEIRTLGKIRHRNI  242 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------~-----------------~~~~~e~~~l~~l~h~ni  242 (362)
                      ...||+|+||.||+|...+|+.||||+++........       .                 ....+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999999754321111       0                 122459999999988877


Q ss_pred             eeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEeCCCCCceeeCCC
Q 018036          243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL-HHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       243 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      .....+..  ...+|||||++++++.....  ....+++..+..++.|++.+|+|+ |+.+   |+||||||+|||++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence            54433322  22389999998877765432  124588899999999999999999 6555   99999999999998 4


Q ss_pred             CceEEccccccccccC
Q 018036          322 FEAHVADFGLAKYLQD  337 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~  337 (362)
                      +.++|+|||+|.....
T Consensus       154 ~~v~LiDFG~a~~~~~  169 (190)
T cd05147         154 GKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CcEEEEEccccccCCC
Confidence            7899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.91  E-value=3.6e-24  Score=210.91  Aligned_cols=169  Identities=20%  Similarity=0.179  Sum_probs=118.0

Q ss_pred             hhhccccceeeccCcccEEEEEcC-C----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEE------E
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-N----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF------C  249 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~  249 (362)
                      .++|+..+.||+|+||.||+|++. +    +..||+|++.....    .+....|  .+....+.+++.+...      +
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            467888999999999999999975 4    68999998753211    1111111  1122222222222111      2


Q ss_pred             ecCCeeeEEEecCCCCChhhhhcCCCCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCC
Q 018036          250 SNKETNLLVYEYMPNGSLGEVLHGKRGS------------------FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV  311 (362)
Q Consensus       250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  311 (362)
                      ......++||||+++++|.+++......                  ......+..++.|++.||+|||+.+   |+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence            4566789999999999999998643210                  1123345679999999999999654   999999


Q ss_pred             CCCceeeCC-CCceEEccccccccccCCCCceeeccccCccCccccccc
Q 018036          312 KSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       312 k~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ||+|||+++ ++.+||+|||+|+.+.... ........||+.|||||.+
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~  329 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQY  329 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHh
Confidence            999999985 5899999999998764322 2224567899999999954

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-23  Score=208.41  Aligned_cols=174  Identities=30%  Similarity=0.417  Sum_probs=141.3

Q ss_pred             hhccccceeeccCcccEEEEEcC----C----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecC
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP----N----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNK  252 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  252 (362)
                      +.....+.+|+|.||.|++|...    .    ...||||.++..... .+.+.+..|+++|..+ +|+||+.++|+|..+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            34455669999999999999742    1    457999998766544 5556799999999999 699999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCCC------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKR------------G--SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL  318 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  318 (362)
                      +..++|+||++.|+|.++++..+            .  ..++....+.++.|||.|++||+   +.++|||||.++|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence            99999999999999999997655            0  13888899999999999999999   5559999999999999


Q ss_pred             CCCCceEEccccccccccCCCCceeeccccC--ccCcccccccc
Q 018036          319 NSDFEAHVADFGLAKYLQDTGASECMSAVAG--SYGYIAPVLGW  360 (362)
Q Consensus       319 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G--t~~y~aPE~~~  360 (362)
                      ..+..+||+|||+|+......... ...-.|  ...|||||.+.
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~  494 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLF  494 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhc
Confidence            999999999999999765433221 122223  23599999765

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-24  Score=207.65  Aligned_cols=166  Identities=31%  Similarity=0.442  Sum_probs=130.1

Q ss_pred             cccceeeccCccc-EEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEecC
Q 018036          185 KDNNVIGRGGAGV-VYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       185 ~~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      ...+++|.|+.|+ ||+|.. +++.||||++-...     .+..++|+..|+.- +|||||++++.-.++...||..|.|
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            3357789998864 799998 57899999874322     23378999999988 5999999999999999999999999


Q ss_pred             CCCChhhhhcCC-CC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---C--CceEEccccccccc
Q 018036          263 PNGSLGEVLHGK-RG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---D--FEAHVADFGLAKYL  335 (362)
Q Consensus       263 ~~gsL~~~l~~~-~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DFGla~~~  335 (362)
                       ..+|.+++... .. .....-....+..|++.||++||   +.+||||||||.||||+.   +  .+++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             56999999763 11 11111234677899999999999   556999999999999975   3  57999999999998


Q ss_pred             cCCCCc-eeeccccCccCcccccccc
Q 018036          336 QDTGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .....+ .......||-+|+|||.+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~  687 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLR  687 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHh
Confidence            743322 2345678999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.90  E-value=6.3e-24  Score=188.97  Aligned_cols=171  Identities=22%  Similarity=0.265  Sum_probs=143.0

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc--C----cceeEEEEEec
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--R----NIVRLKAFCSN  251 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~  251 (362)
                      .+..+|.....+|+|.||.|-++.+. .+..||+|+++...+.   .++..-|+++++++.+  |    -+|.+.+|+..
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY---reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY---REAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH---hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            34688999999999999999999874 4689999998765432   2336779999999942  2    37888999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-----------
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-----------  320 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----------  320 (362)
                      .++.|||+|.+ |.|+.+++..+.-.+++...+..|+.|++++++|||+..   ++|-||||+|||+.+           
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence            99999999999 779999998877788999999999999999999999555   999999999999832           


Q ss_pred             ---------CCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          321 ---------DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       321 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                               +..+||+|||.|....+.     .+..+.|..|.|||++++
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLg  283 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILG  283 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheec
Confidence                     235899999999876432     356778999999999976

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=6.5e-23  Score=175.10  Aligned_cols=142  Identities=23%  Similarity=0.240  Sum_probs=111.2

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCc------------------------hhhHHHHHHHHhcCccCcc
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH------------------------DNGLSAEIRTLGKIRHRNI  242 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni  242 (362)
                      ...||+|++|.||+|.+.+|+.||||.+.........                        ...+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999888999999998765321100                        1124678999999999988


Q ss_pred             eeEEEEEecCCeeeEEEecCCCCChhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEeCCCCCceeeCC
Q 018036          243 VRLKAFCSNKETNLLVYEYMPNGSLGEV-LHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNS  320 (362)
Q Consensus       243 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~  320 (362)
                      .....+...  ..++||||++++++... +.   ...++......++.|++.++.++|+ .+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            655444333  24899999988755433 32   2346778889999999999999996 55   99999999999999 


Q ss_pred             CCceEEccccccccccC
Q 018036          321 DFEAHVADFGLAKYLQD  337 (362)
Q Consensus       321 ~~~~kl~DFGla~~~~~  337 (362)
                      ++.++|+|||+++....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            78999999999987754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.89  E-value=2e-22  Score=175.87  Aligned_cols=170  Identities=35%  Similarity=0.456  Sum_probs=142.1

Q ss_pred             ccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      |+..+.||+|++|.||++...+ ++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            3456789999999999999865 889999998654322 13456899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      ++++|.+++...... +++..+..++.+++.++.|||+.+   ++|+|++|+||+++.++.++|+|||.+........ .
T Consensus        80 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       80 EGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            999999999643321 789999999999999999999654   99999999999999999999999999987754321 1


Q ss_pred             eeccccCccCccccccc
Q 018036          343 CMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~  359 (362)
                      ......++..|++||..
T Consensus       155 ~~~~~~~~~~~~~pe~~  171 (225)
T smart00221      155 LLKTVKGTPFYLAPEVL  171 (225)
T ss_pred             cccceeccCCcCCHhHh
Confidence            23445688899999975

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.88  E-value=9.8e-22  Score=168.87  Aligned_cols=164  Identities=36%  Similarity=0.557  Sum_probs=137.6

Q ss_pred             eeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCChh
Q 018036          190 IGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG  268 (362)
Q Consensus       190 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  268 (362)
                      ||+|++|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            6899999999999854 8899999986443321 2345899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccccccccCCCCceeeccc
Q 018036          269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAV  347 (362)
Q Consensus       269 ~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  347 (362)
                      +++.... ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            9986432 35889999999999999999999655   999999999999999 89999999999987653321  12335


Q ss_pred             cCccCcccccccc
Q 018036          348 AGSYGYIAPVLGW  360 (362)
Q Consensus       348 ~Gt~~y~aPE~~~  360 (362)
                      .++..|++||...
T Consensus       154 ~~~~~~~~pe~~~  166 (215)
T cd00180         154 VGTPAYMAPEVLL  166 (215)
T ss_pred             cCCCCccChhHhc
Confidence            5788999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.88  E-value=1.7e-23  Score=174.52  Aligned_cols=162  Identities=27%  Similarity=0.404  Sum_probs=134.0

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCC--eeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE--TNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l  257 (362)
                      ++|+..+.+|+|.|++||.|.. .+.+.++||.+++...     +.+.+|+.+|..+. ||||+++++...++.  ...+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            6778889999999999999985 5678999999875543     33899999999997 999999999998765  4579


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEcccccccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQ  336 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~~~  336 (362)
                      |+||+.+.+...+..     .++...+..++.+++.||.|+|   +.||+|||+||.|+++|.. -.++|+|+|+|-+.-
T Consensus       113 iFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             HhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            999999988877763     2666778889999999999999   5559999999999999954 569999999999876


Q ss_pred             CCCCceeeccccCccCccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ....   -...+.+..|.-||++
T Consensus       185 p~~e---YnVRVASRyfKGPELL  204 (338)
T KOG0668|consen  185 PGKE---YNVRVASRYFKGPELL  204 (338)
T ss_pred             CCce---eeeeeehhhcCCchhe
Confidence            4322   2344567888999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.87  E-value=6e-22  Score=174.44  Aligned_cols=158  Identities=34%  Similarity=0.472  Sum_probs=134.6

Q ss_pred             CcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCChhhhhc
Q 018036          194 GAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH  272 (362)
Q Consensus       194 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~  272 (362)
                      +||.||+|... +++.+++|.+........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999986 488999999865443221 4569999999999999999999999999999999999999999999986


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccC
Q 018036          273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG  352 (362)
Q Consensus       273 ~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~  352 (362)
                      ....  +++..+..++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        80 ~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       80 KRGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             hccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            4332  889999999999999999999665   9999999999999999999999999998775432   2345568999


Q ss_pred             cccccccc
Q 018036          353 YIAPVLGW  360 (362)
Q Consensus       353 y~aPE~~~  360 (362)
                      |+|||...
T Consensus       152 ~~~pE~~~  159 (244)
T smart00220      152 YMAPEVLL  159 (244)
T ss_pred             CCCHHHHc
Confidence            99999764

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5e-22  Score=187.59  Aligned_cols=163  Identities=25%  Similarity=0.299  Sum_probs=133.4

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+.|+....+|.|+|+.|-++.+ .+++..+||.+.....      ...+|+.++... +||||+++++.+.+..+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            46677778899999999999987 4678899998854421      145677666666 699999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee-CCCCceEEccccccccccC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL-NSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DFGla~~~~~  337 (362)
                      ||++.++-+.+.+...+.  .. ..+..|+++++.|+.|||.++   +|||||||+|||+ ++.++++|+|||.++....
T Consensus       395 ~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             ehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999988887754332  22 667789999999999999665   9999999999999 5889999999999998764


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .     ..+.+=|..|.|||++.
T Consensus       469 ~-----~~tp~~t~~y~APEvl~  486 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLA  486 (612)
T ss_pred             h-----hcccchhhcccChhhhc
Confidence            3     33446688999999874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.86  E-value=3.4e-22  Score=174.20  Aligned_cols=168  Identities=29%  Similarity=0.354  Sum_probs=136.2

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------Ce
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  254 (362)
                      .+|.....+|.|.- .|..|.+ -.++.||+|++..........++..+|..++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666677888877 5555544 3578999999866554455556689999999999999999999998543      35


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .|+||||| ..+|.+.+.    ..++-.+...|..|++.|++|||..+   |+||||||+||++..+..+||.|||+|+.
T Consensus        96 ~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence            68999999 579999886    23777888999999999999999555   99999999999999999999999999986


Q ss_pred             ccCCCCceeeccccCccCccccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      -...   -.++..+.|..|.|||++.+
T Consensus       168 e~~~---~~mtpyVvtRyyrapevil~  191 (369)
T KOG0665|consen  168 EDTD---FMMTPYVVTRYYRAPEVILG  191 (369)
T ss_pred             cCcc---cccCchhheeeccCchheec
Confidence            5432   23667789999999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.86  E-value=7e-22  Score=178.09  Aligned_cols=144  Identities=26%  Similarity=0.372  Sum_probs=124.4

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecC
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNK  252 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  252 (362)
                      ..+.+.|...+.||+|.|++||++.+.    ..+.||+|.+....    ...++.+|+++|..+. +.||+++.+++...
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            345678888999999999999999863    46789999885433    2334899999999994 99999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGL  331 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGl  331 (362)
                      +...+|+||++.-+..+++..     ++...+..+++.+..||+++|..+   ||||||||+|+|.+. .+.-.|.|||+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            999999999999999998853     667888899999999999999655   999999999999985 46789999999


Q ss_pred             cc
Q 018036          332 AK  333 (362)
Q Consensus       332 a~  333 (362)
                      |.
T Consensus       180 A~  181 (418)
T KOG1167|consen  180 AQ  181 (418)
T ss_pred             HH
Confidence            97

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=4.1e-21  Score=165.17  Aligned_cols=139  Identities=18%  Similarity=0.276  Sum_probs=105.6

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-----ccCcceeEEEEEecCC---ee
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-----RHRNIVRLKAFCSNKE---TN  255 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~  255 (362)
                      +...+.||+|+||.||.  +++....+||++.....  ...+.+.+|+.+++.+     +||||++++|+++++.   ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            35567899999999996  44333346888754322  2334589999999999     5799999999998874   43


Q ss_pred             e-EEEec--CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEEeCCCCCceeeCC----CCceEEc
Q 018036          256 L-LVYEY--MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL-SYLHHDCSPLIIHRDVKSNNILLNS----DFEAHVA  327 (362)
Q Consensus       256 ~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~  327 (362)
                      + +|+||  +++|+|.+++...   .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +..++|+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence            4 78999  5579999999642   25555  35678888887 9999666   999999999999974    3479999


Q ss_pred             c-cccccc
Q 018036          328 D-FGLAKY  334 (362)
Q Consensus       328 D-FGla~~  334 (362)
                      | ||....
T Consensus       152 Dg~G~~~~  159 (210)
T PRK10345        152 DNIGESTF  159 (210)
T ss_pred             ECCCCcce
Confidence            9 554444

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=7.1e-22  Score=168.61  Aligned_cols=170  Identities=19%  Similarity=0.304  Sum_probs=132.6

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEE-EEecCC
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKA-FCSNKE  253 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~  253 (362)
                      .-++.+.|++.+.+|+|.||.+-.+.++. ...+++|.+...   .....+|.+|...--.+ .|.||+.-++ .|++.+
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            34566889999999999999999999864 557777876432   22334599998766666 5899998776 467778


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee-C-CCCceEEccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL-N-SDFEAHVADFGL  331 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~-~~~~~kl~DFGl  331 (362)
                      ..++++||++.|+|.+-+..   ..+-+....+++.|++.|++|+|   ++.+||||||.+|||| + +..++|+||||+
T Consensus        96 ~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccc
Confidence            88899999999999988754   34778888999999999999999   5559999999999999 3 345799999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .+.....     ....--+..|.|||+..
T Consensus       170 t~k~g~t-----V~~~~~~~~y~~pe~~~  193 (378)
T KOG1345|consen  170 TRKVGTT-----VKYLEYVNNYHAPELCD  193 (378)
T ss_pred             ccccCce-----ehhhhhhcccCCcHHHh
Confidence            9875432     22233466788998753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.2e-20  Score=158.67  Aligned_cols=166  Identities=25%  Similarity=0.356  Sum_probs=134.3

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc-CcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  259 (362)
                      ..|...+.||+|+||.+|.|.. .+|..||+|.-......+    .+..|..+...+++ ..|..+..+..+..+-.+||
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            5677889999999999999985 679999999754433332    37889999998875 67888888888888999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC---CCCceEEcccccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~~~~  336 (362)
                      |.+ |.||.+++.- ....++.++++-+|-|++.-++|+|..+   .+||||||+|+|..   ....+.++|||+|+.+.
T Consensus        91 dLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999 8999998852 3456899999999999999999999766   99999999999985   34568999999999887


Q ss_pred             CCCCce-----eeccccCccCcccc
Q 018036          337 DTGASE-----CMSAVAGSYGYIAP  356 (362)
Q Consensus       337 ~~~~~~-----~~~~~~Gt~~y~aP  356 (362)
                      +..+..     ......||.+|.+=
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             cccccccCccccCCccceeeeehhh
Confidence            543321     13346789998763

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=2.5e-20  Score=163.39  Aligned_cols=165  Identities=25%  Similarity=0.369  Sum_probs=135.4

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .|+.++.||+|+||+++.|+. -+++.||||.-....    +...+..|.+..+.|. -++|...+-+.....+-.||+|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            578889999999999999984 578999999643222    2233778888888774 6899999888888888899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-----CCceEEccccccccc
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-----DFEAHVADFGLAKYL  335 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DFGla~~~  335 (362)
                      .+ |.||.|++. -.+..++.+++..+|.|++.-++|+|+..   +|.|||||+|+||..     ...+.|+|||+|+.+
T Consensus       105 LL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  105 LL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            99 889999885 45667999999999999999999999665   999999999999964     345899999999999


Q ss_pred             cCCCCce-----eeccccCccCcccc
Q 018036          336 QDTGASE-----CMSAVAGSYGYIAP  356 (362)
Q Consensus       336 ~~~~~~~-----~~~~~~Gt~~y~aP  356 (362)
                      .++.+..     -.....||.+||+=
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             cCccccccCccccccccccceeeeEe
Confidence            8765432     13456799999973

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=5e-20  Score=170.24  Aligned_cols=173  Identities=24%  Similarity=0.286  Sum_probs=134.6

Q ss_pred             hccccceeeccCcccEEEEEcCCC--CEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc----CcceeEEEEE-ecCCee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPNG--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH----RNIVRLKAFC-SNKETN  255 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~  255 (362)
                      +|+..+.||+|+||.||.+.....  ..+|+|...........  .+..|..++..+..    +++..+++.. ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            688899999999999999997553  46777765433222211  37889998988863    6899999988 577788


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-----CceEEcccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-----FEAHVADFG  330 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~DFG  330 (362)
                      ++||+.+ |.+|.++......+.++..++.+|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            9999998 889999886555678999999999999999999999555   9999999999999754     468999999


Q ss_pred             ccc--cccCCCCc----e-e-eccccCccCccccccccc
Q 018036          331 LAK--YLQDTGAS----E-C-MSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~--~~~~~~~~----~-~-~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++  ........    . . ...+.||..|+++....+
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~  211 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG  211 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence            999  33222111    1 1 234669999999886543

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.1e-19  Score=159.96  Aligned_cols=145  Identities=19%  Similarity=0.184  Sum_probs=110.4

Q ss_pred             ccccceeeccCcccEEEEE--cCCCCEEEEEEeeccCCCCC----------------------chhhHHHHHHHHhcCcc
Q 018036          184 VKDNNVIGRGGAGVVYRGV--TPNGEQVAVKKLLGITKGSS----------------------HDNGLSAEIRTLGKIRH  239 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h  239 (362)
                      |...+.||+|++|.||+|.  ..+|+.||+|.++.......                      ....+.+|++.+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5567899999999999998  56899999999875431100                      01235689999999976


Q ss_pred             Cc--ceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEEeCCCCCce
Q 018036          240 RN--IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL-IIHRDVKSNNI  316 (362)
Q Consensus       240 ~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~NI  316 (362)
                      ..  +.+++++    ...++||||+++.+|......  ...........++.|++.++++||   ..+ ++||||||+||
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            33  3444443    234899999999888765422  223555667889999999999999   556 99999999999


Q ss_pred             eeCCCCceEEccccccccccCC
Q 018036          317 LLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       317 ll~~~~~~kl~DFGla~~~~~~  338 (362)
                      +++ ++.++|+|||.+.....+
T Consensus       181 li~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCCc
Confidence            999 889999999999876543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.1e-19  Score=157.83  Aligned_cols=138  Identities=22%  Similarity=0.364  Sum_probs=113.8

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC------chhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +.||+|++|.||+|.+ .+..+++|+.........      ...++.+|++++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 677899997654322111      123478899999999999998888887777888999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ++|++|.+++...     .+ .+..++.+++.+|.++|+.+   ++|||++|+||+++ ++.++|+|||.++...
T Consensus        81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            9999999998532     12 77889999999999999655   99999999999999 7889999999998643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.5e-19  Score=151.66  Aligned_cols=134  Identities=19%  Similarity=0.099  Sum_probs=105.4

Q ss_pred             ccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC--chhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEecC
Q 018036          186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      ....|++|+||+||.+.. ++.+++.+.+........  ....+.+|+++|+++. |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            356899999999998766 677888777654433211  1224789999999995 5889999886    3468999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCC-CCCceeeCCCCceEEcccccccccc
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDV-KSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +|.+|.+.+..        . ...++.|++.+|+++|+.+   |+|||| ||+|||++.++.++|+|||+|....
T Consensus        81 ~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         81 AGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             cCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            99998765421        1 1357789999999999665   999999 7999999999999999999998654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=2.4e-19  Score=176.61  Aligned_cols=140  Identities=21%  Similarity=0.337  Sum_probs=112.0

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccC-CCC-----CchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGIT-KGS-----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ..|...+.||+|+||.||++.+.+.. +++|+..... ...     ...+++.+|++++..++|++++....++...+..
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34456789999999999999875443 4444432211 111     1124588999999999999999888888887788


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||+++++|.+++.          ....++.+++++|.|||+.+   ++|||+||+|||+ +++.++|+|||+++..
T Consensus       412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999999884          34678999999999999655   9999999999999 5779999999999875


Q ss_pred             c
Q 018036          336 Q  336 (362)
Q Consensus       336 ~  336 (362)
                      .
T Consensus       478 ~  478 (535)
T PRK09605        478 D  478 (535)
T ss_pred             C
Confidence            4

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=2.4e-19  Score=154.17  Aligned_cols=139  Identities=21%  Similarity=0.185  Sum_probs=107.7

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC--------------------chhhHHHHHHHHhcCccCc--
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS--------------------HDNGLSAEIRTLGKIRHRN--  241 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~h~n--  241 (362)
                      |...+.||+|+||.||++..++|+.||||++........                    ....+..|+.++.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            555788999999999999988899999998754321000                    0112577888999988874  


Q ss_pred             ceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       242 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      ++..++.    ...++||||+++++|.++...        .....++.+++.++.++|+.+   ++||||||+||+++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence            4444432    345899999999999776421        234578899999999999655   9999999999999999


Q ss_pred             CceEEccccccccccC
Q 018036          322 FEAHVADFGLAKYLQD  337 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~  337 (362)
                      +.++|+|||.+.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999976653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1.8e-19  Score=155.68  Aligned_cols=141  Identities=13%  Similarity=0.152  Sum_probs=113.5

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCc-------hhhHHHHHHHHhcCccCcceeEEEEEecC-
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH-------DNGLSAEIRTLGKIRHRNIVRLKAFCSNK-  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  252 (362)
                      ..+|+..+++|+|+||.||.+.. ++..+|+|.+.........       .+.+++|+..+.+++|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            46788889999999999999766 5778999998654432211       11268999999999999999999886543 


Q ss_pred             -------CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceE
Q 018036          253 -------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH  325 (362)
Q Consensus       253 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  325 (362)
                             ...++||||++|.+|.++..      ++.    ....+++.++..+|+.+   ++|||+||+||+++.++ ++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EE
Confidence                   35789999999999988742      222    34569999999999665   99999999999999988 99


Q ss_pred             Ecccccccccc
Q 018036          326 VADFGLAKYLQ  336 (362)
Q Consensus       326 l~DFGla~~~~  336 (362)
                      |+|||..+...
T Consensus       175 liDfg~~~~~~  185 (232)
T PRK10359        175 IIDLSGKRCTA  185 (232)
T ss_pred             EEECCCccccc
Confidence            99999987664

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=2.6e-19  Score=153.98  Aligned_cols=134  Identities=22%  Similarity=0.384  Sum_probs=107.4

Q ss_pred             eeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC------chhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      .||+|+||.||+|.+ ++..+++|..........      ...++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 568899998654322111      1245778999999999887766666666667779999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ++++|.+++....         ..++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||+++...
T Consensus        80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            9999999874321         078899999999999555   99999999999999 7899999999988754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.80  E-value=1.3e-18  Score=159.42  Aligned_cols=173  Identities=35%  Similarity=0.461  Sum_probs=142.3

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC-chhhHHHHHHHHhcCccC-cceeEEEEEecCCeeeEEEec
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS-HDNGLSAEIRTLGKIRHR-NIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  261 (362)
                      |.....||.|+|+.||++.+.  ..+++|.+........ ....+.+|+..++.+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455678999999999999886  7889998876554433 455699999999999988 799999999877788999999


Q ss_pred             CCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccccCCC
Q 018036          262 MPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDTG  339 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~  339 (362)
                      +.++++.+++..... ..++......++.|++.+++|+|..+   ++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977753321 25888899999999999999999665   99999999999999988 79999999998665332


Q ss_pred             Cce----eeccccCccCccccccccc
Q 018036          340 ASE----CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~----~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...    ......||..|+|||.+.+
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~  182 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLG  182 (384)
T ss_pred             ccccccccccccccccccCCHHHhcC
Confidence            211    2466789999999998764

>PLN03150 hypothetical protein; Provisional

Probab=99.78  E-value=3.8e-19  Score=177.26  Aligned_cols=111  Identities=31%  Similarity=0.533  Sum_probs=98.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.|+|.+|.++++|++|+.|+|++|+|+|.+|..++++++|+.|||++|+|+|.+|.+++++++|+.|+|++|+|+|
T Consensus       425 L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g  504 (623)
T PLN03150        425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG  504 (623)
T ss_pred             CCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCc--ccccccCCccCCCCCCCCCC-CCCc
Q 018036           81 EIPEFGQ--YSFFNSTSFTGNPHLCGSYL-NPCN  111 (362)
Q Consensus        81 ~~p~~~~--~~~~~~~~~~~n~~lc~~~l-~~c~  111 (362)
                      .+|....  ........+.+|+.+|+.+. ..|.
T Consensus       505 ~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        505 RVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             cCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            9997422  12334567889999998653 4453

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.78  E-value=1.6e-19  Score=166.48  Aligned_cols=169  Identities=24%  Similarity=0.231  Sum_probs=136.0

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc------cCcceeEEEEEecCCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR------HRNIVRLKAFCSNKET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~  254 (362)
                      .+|......|+|-|+.|.+|.+. .|..||||++......   .+.=.+|+++|.+|+      -.|+++++..|...++
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            56777778899999999999874 5789999999754321   122467999999994      3589999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEcccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLA  332 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla  332 (362)
                      .|||+|-+ .-+|.++|+... ...+....+..++.|+..||..|-..   +|+|.||||.|||+++. ..+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccc
Confidence            99999988 579999997543 34588888999999999999999944   59999999999999865 55799999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....+..    .+...-+..|.|||++.|
T Consensus       585 ~~~~ene----itPYLVSRFYRaPEIiLG  609 (752)
T KOG0670|consen  585 SFASENE----ITPYLVSRFYRAPEIILG  609 (752)
T ss_pred             ccccccc----ccHHHHHHhccCcceeec
Confidence            8876432    222334567999999876

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.76  E-value=3.6e-18  Score=139.50  Aligned_cols=135  Identities=22%  Similarity=0.205  Sum_probs=112.7

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc--CcceeEEEEEecCCeeeEEEecCCC
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      .+.||+|.++.||++...+ ..+++|.......    ...+.+|+..+..++|  ..+++++++....+..+++|||+++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            4679999999999999854 7889998744322    3448999999999976  5899999998888889999999988


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      +++..+         +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++..
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            777543         45666788999999999999754456999999999999999899999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.76  E-value=9.7e-19  Score=156.43  Aligned_cols=175  Identities=18%  Similarity=0.181  Sum_probs=135.6

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-CCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  254 (362)
                      ++++...++-+|.||+||+|.+.      +.+.|.+|.++.... ..+-..+..|-..+..+.|||+.++.+++.. ...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            44555678889999999999764      345677777654332 2233458889999999999999999998865 456


Q ss_pred             eeEEEecCCCCChhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          255 NLLVYEYMPNGSLGEVLHGK------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                      .+.++.++.-|+|..+|..-      ..+.++-.+...++.|++.|++|||..+   +||.||.++|.+||+..++||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence            78999999999999999621      2245777788899999999999999665   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCcccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      =.+++.+-..+..-..........||+||.++
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~  471 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQ  471 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHh
Confidence            99999876443322222233456899999764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=8e-18  Score=143.23  Aligned_cols=140  Identities=21%  Similarity=0.260  Sum_probs=98.6

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhh----------------------HHHHHHHHhcCccCc--c
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNG----------------------LSAEIRTLGKIRHRN--I  242 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~n--i  242 (362)
                      .+.||+|+||+||+|.+.+++.||||.+............                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999888999999988654321111111                      135666666664433  4


Q ss_pred             eeEEEEEecCCeeeEEEecCCCCChhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          243 VRLKAFCSNKETNLLVYEYMPNGSLGEV-LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       243 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      .+.++.    ...++||||++++++... +....   .. .....++.+++.++.++|.  ..+|+||||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-C
Confidence            444443    235899999998544321 11100   11 5567899999999999996  14599999999999999 8


Q ss_pred             CceEEccccccccccC
Q 018036          322 FEAHVADFGLAKYLQD  337 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~  337 (362)
                      +.++++|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            8999999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=3.2e-18  Score=172.43  Aligned_cols=171  Identities=20%  Similarity=0.220  Sum_probs=134.4

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc---cCcceeEEEEEecCCeeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  258 (362)
                      +.|.+.+.||+|+||.||+|...+++.||+|.=+.....+     |.--.+++.+|+   -+-|..+...+...+..++|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            5567788999999999999999889999999865443322     333344555665   23455555566667788999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-------CCCceEEccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-------SDFEAHVADFGL  331 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-------~~~~~kl~DFGl  331 (362)
                      +||.+.|+|.+++.  ..+.++|..++.++.|+++-+++||..+   |||+||||+|.||.       +..-++|+|||.
T Consensus       773 ~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            99999999999995  5567999999999999999999999666   99999999999993       234589999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccccC
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWYC  362 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~  362 (362)
                      +-.+.--.........++|-.+-.+|...||
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~gr  878 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGR  878 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence            9877533333456777889999999987664

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.6e-17  Score=152.38  Aligned_cols=134  Identities=25%  Similarity=0.338  Sum_probs=112.0

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-----c---CcceeEEEEEecC
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----H---RNIVRLKAFCSNK  252 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~  252 (362)
                      .+|-..+.||=|.|++||.|.+. +.+.||+|+.+...   ...+....||++|++++     |   ..||+|++.|...
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            57888899999999999999874 56788999875332   22344778999999883     3   3699999999653


Q ss_pred             ----CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          253 ----ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       253 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                          .+++||+|++ |-+|..+|....-+.++...+.+|+.||+.||.|||+.+  +|||-||||+|||+...
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence                5889999999 789999998777778999999999999999999999866  69999999999999543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.6e-16  Score=140.08  Aligned_cols=140  Identities=21%  Similarity=0.224  Sum_probs=106.6

Q ss_pred             ccceee-ccCcccEEEEEcCCCCEEEEEEeeccC------C-----CCCchhhHHHHHHHHhcCccCcc--eeEEEEEec
Q 018036          186 DNNVIG-RGGAGVVYRGVTPNGEQVAVKKLLGIT------K-----GSSHDNGLSAEIRTLGKIRHRNI--VRLKAFCSN  251 (362)
Q Consensus       186 ~~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~  251 (362)
                      ....|| .|+.|+||++... +..+++|.+....      .     ......++.+|++++.+++|++|  +..+++...
T Consensus        35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            356788 8999999999874 6788998875311      1     11223458889999999998875  667776543


Q ss_pred             CC----eeeEEEecCCC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          252 KE----TNLLVYEYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       252 ~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                      ..    ..++||||+++ .+|.+++...   .++..    .+.+++.++.+||+.+   |+||||||.|||++.++.++|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            32    23599999997 6999888532   24433    3578999999999665   999999999999999889999


Q ss_pred             cccccccccc
Q 018036          327 ADFGLAKYLQ  336 (362)
Q Consensus       327 ~DFGla~~~~  336 (362)
                      +|||.+....
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999988754

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.70  E-value=9e-18  Score=173.13  Aligned_cols=121  Identities=12%  Similarity=0.063  Sum_probs=87.9

Q ss_pred             cCcc-CcceeEEEEE-------ecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 018036          236 KIRH-RNIVRLKAFC-------SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII  307 (362)
Q Consensus       236 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv  307 (362)
                      .++| +||+++++++       ...+..+.++||+ +++|.+++... ...+++..++.++.||++||+|||+.+   |+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            3455 5788888877       2233566788988 67999999643 355899999999999999999999555   99


Q ss_pred             EeCCCCCceeeCC-------------------CCceEEccccccccccCCCC--------------ceeeccccCccCcc
Q 018036          308 HRDVKSNNILLNS-------------------DFEAHVADFGLAKYLQDTGA--------------SECMSAVAGSYGYI  354 (362)
Q Consensus       308 H~Dlk~~NIll~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y~  354 (362)
                      ||||||+|||++.                   ++.+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   45567777777764321000              00011246899999


Q ss_pred             ccccccc
Q 018036          355 APVLGWY  361 (362)
Q Consensus       355 aPE~~~~  361 (362)
                      |||++.+
T Consensus       183 APE~~~~  189 (793)
T PLN00181        183 SPEEDNG  189 (793)
T ss_pred             Chhhhcc
Confidence            9998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=4.5e-17  Score=160.55  Aligned_cols=170  Identities=22%  Similarity=0.253  Sum_probs=127.4

Q ss_pred             cccceeeccCcccEEEEEcC-CCCEEEEEEeeccC-CCCCc---hhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          185 KDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGIT-KGSSH---DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .....+|.|++|.|+..... .....+.|...... .....   ...+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988877653 33334444332110 11111   112556777778889999988877776666666669


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |||++ +|..++...  ..+....+-.++.|+..|++|+|..+   |.|||+|++|+++...|.+||+|||.+....-..
T Consensus       401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 999999643  35777888899999999999999655   9999999999999999999999999998776443


Q ss_pred             Cc--eeeccccCccCcccccccc
Q 018036          340 AS--ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~--~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..  .....++|+..|+|||++.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~  497 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLT  497 (601)
T ss_pred             chhhhhhcCcccCCcCcCccccc
Confidence            33  3456788999999999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.66  E-value=2e-17  Score=141.62  Aligned_cols=166  Identities=21%  Similarity=0.334  Sum_probs=131.6

Q ss_pred             ccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      ....|.+...|+.|+|++. |..+++|.+............|..|.-.|+-+.||||..+++.|.++....++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3456788889999999994 566777877655544444456999999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                      +|+..++...+-..+..++.+++.++|+|++|||.. .+-|.---+.+..+++|++.+++|+- +-+++--      ...
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf------qe~  344 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QEV  344 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee------ecc
Confidence            999999988887888899999999999999999975 23344457889999999999988752 2122111      012


Q ss_pred             cccCccCcccccccc
Q 018036          346 AVAGSYGYIAPVLGW  360 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~  360 (362)
                      ...-.|.||+||.++
T Consensus       345 gr~y~pawmspealq  359 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQ  359 (448)
T ss_pred             ccccCcccCCHHHHh
Confidence            234478999999875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.63  E-value=1.3e-15  Score=145.64  Aligned_cols=152  Identities=19%  Similarity=0.230  Sum_probs=104.0

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC----------------------------------
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS----------------------------------  222 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------  222 (362)
                      .++++..|+ .+.||.|++|+||+|+.++|+.||||+.++.....-                                  
T Consensus       113 ~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~  191 (437)
T TIGR01982       113 LEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE  191 (437)
T ss_pred             HHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence            344555555 368999999999999999999999999865321000                                  


Q ss_pred             ----chhhHHHHHHHHhcCc----cCcceeEEEEE-ecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 018036          223 ----HDNGLSAEIRTLGKIR----HRNIVRLKAFC-SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK  293 (362)
Q Consensus       223 ----~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~  293 (362)
                          .+-.+.+|.+.+.+++    |.+-+.+-.++ ......+|||||++|++|.++...... ..+   +..++.+++.
T Consensus       192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~  267 (437)
T TIGR01982       192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLAR  267 (437)
T ss_pred             HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHH
Confidence                0012455666555552    22223322222 234457899999999999887642211 122   3456666665


Q ss_pred             -HHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          294 -GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       294 -~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                       .+..+|..+   ++|+|++|.||+++++++++++|||++..+.
T Consensus       268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             467888655   9999999999999999999999999998775

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.61  E-value=8.3e-17  Score=152.51  Aligned_cols=160  Identities=24%  Similarity=0.240  Sum_probs=130.5

Q ss_pred             eeccCcccEEEEEc----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEecCCC
Q 018036          190 IGRGGAGVVYRGVT----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       190 ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +|+|+||.|+.+..    +.+..+|.|.+++.............|..++..++ ||.+|+++..++.+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            68999999997753    34667888877655433322224667888888887 99999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|...+...  ..+++.....+...++-+++++|..+   |+|||+|++||+++.+|.+++.|||+++...+..     
T Consensus        82 g~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   82 GDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             chhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence            9998888533  34666677777889999999999555   9999999999999999999999999999876432     


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                       ..|||..|||||++.
T Consensus       152 -~~cgt~eymApEI~~  166 (612)
T KOG0603|consen  152 -IACGTYEYRAPEIIN  166 (612)
T ss_pred             -hcccchhhhhhHhhh
Confidence             228999999999875

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.50  E-value=1.3e-14  Score=140.59  Aligned_cols=151  Identities=17%  Similarity=0.176  Sum_probs=98.3

Q ss_pred             ChhhHhhhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCC-----------------------C---------C
Q 018036          176 GSDDILECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKG-----------------------S---------S  222 (362)
Q Consensus       176 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----------------------~---------~  222 (362)
                      +.++++..|+. +.||+|++|+||+|++++ |+.||||+.++....                       .         .
T Consensus       114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e  192 (537)
T PRK04750        114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE  192 (537)
T ss_pred             CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence            34566677776 789999999999999877 999999998754210                       0         0


Q ss_pred             ch------hhHHHHHHHHhcCc----cCcceeEEEEEec-CCeeeEEEecCCCCChhhhhcC-CCCC---CCCHHHHHHH
Q 018036          223 HD------NGLSAEIRTLGKIR----HRNIVRLKAFCSN-KETNLLVYEYMPNGSLGEVLHG-KRGS---FLKWEMRLKI  287 (362)
Q Consensus       223 ~~------~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~-~~~~---~~~~~~~~~i  287 (362)
                      ..      -++.+|...+.+++    +...+.+-.++.+ ....+|||||++|+++.++-.- ..+.   .+....+..+
T Consensus       193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~  272 (537)
T PRK04750        193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF  272 (537)
T ss_pred             HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence            00      12445555555542    3334443333332 4456899999999999875211 1110   1222222233


Q ss_pred             HHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC----ceEEccccccccccC
Q 018036          288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVADFGLAKYLQD  337 (362)
Q Consensus       288 ~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFGla~~~~~  337 (362)
                      +.|       +...+   ++|+|+||.||+++.++    +++++|||++..+..
T Consensus       273 ~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            333       33344   99999999999999888    999999999987753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=4.3e-14  Score=127.32  Aligned_cols=116  Identities=28%  Similarity=0.379  Sum_probs=85.0

Q ss_pred             ccCcceeEEEEEec---------------------------CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHH
Q 018036          238 RHRNIVRLKAFCSN---------------------------KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIE  290 (362)
Q Consensus       238 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~  290 (362)
                      +|||||++.++|.+                           +...|+||..++ .+|.+++..+.   .+...+.-+..|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence            69999999887633                           234589999884 59999996543   455666778899


Q ss_pred             HHHHHHHHhcCCCCCeEEeCCCCCceee--CCCC--ceEEccccccccccCCCCc----eeeccccCccCcccccccc
Q 018036          291 AAKGLSYLHHDCSPLIIHRDVKSNNILL--NSDF--EAHVADFGLAKYLQDTGAS----ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       291 i~~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~--~~kl~DFGla~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +++|+.|||+++   |.|||+|++|||+  |+|+  ...|+|||++-..+..+-.    .-.-...|...-||||+..
T Consensus       350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            999999999776   9999999999998  4443  3689999998644321110    1112345777889999864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=2e-13  Score=114.03  Aligned_cols=131  Identities=21%  Similarity=0.130  Sum_probs=95.7

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcce-eEEEEEecCCeeeEEEecCCCCC
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEYMPNGS  266 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs  266 (362)
                      +.++.|.++.||++... +..+++|.......   ....+.+|+.++..+.+.+++ +++.+.  ....++||||+++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            46789999999999874 77899998643321   122368899999988765544 455443  234579999999988


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       267 L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      +.+.-       ..   ...++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+...
T Consensus        78 l~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          78 LLTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             ccccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            76430       11   1245678999999999654  12359999999999999 668999999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.44  E-value=1.4e-13  Score=145.57  Aligned_cols=103  Identities=36%  Similarity=0.544  Sum_probs=91.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++|.+|..+.++++|+.|+|++|+++|.+|..++++++|+.|+|++|.++|.+|..+..+++|+.|+|++|+++|
T Consensus       482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  561 (968)
T PLN00113        482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG  561 (968)
T ss_pred             CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCC-CcccccccCCccCCCCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNPHLC  103 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~~lc  103 (362)
                      .+|.. ..+..+....+.+|+..+
T Consensus       562 ~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        562 EIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             cCChhHhcCcccCEEeccCCccee
Confidence            99863 445556666777776554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=3e-12  Score=108.38  Aligned_cols=138  Identities=14%  Similarity=0.173  Sum_probs=98.4

Q ss_pred             ceeeccCcccEEEEEcCC-------CCEEEEEEeeccCC----------CC----------CchhhH----HHHHHHHhc
Q 018036          188 NVIGRGGAGVVYRGVTPN-------GEQVAVKKLLGITK----------GS----------SHDNGL----SAEIRTLGK  236 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------~~----------~~~~~~----~~e~~~l~~  236 (362)
                      ..||.|.=+.||.|...+       +..+|||..+....          ++          .....+    ++|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653       47999998754211          00          011122    389999999


Q ss_pred             Ccc--CcceeEEEEEecCCeeeEEEecCCCCChhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEeCCC
Q 018036          237 IRH--RNIVRLKAFCSNKETNLLVYEYMPNGSLGE-VLHGKRGSFLKWEMRLKIAIEAAKGLSYL-HHDCSPLIIHRDVK  312 (362)
Q Consensus       237 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk  312 (362)
                      +..  -++..++++    ...++||||+.+..+.. .++.   ..++......+..+++.+|..+ |+.+   +||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            853  456666654    45689999997643322 2221   1244556677889999999999 7554   9999999


Q ss_pred             CCceeeCCCCceEEcccccccccc
Q 018036          313 SNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       313 ~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +.||+++ ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4689999999987664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=6.7e-14  Score=138.19  Aligned_cols=176  Identities=26%  Similarity=0.281  Sum_probs=137.2

Q ss_pred             hccccceeeccCcccEEEEEcCC--CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEE
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPN--GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .|...+.||+|+|+.|-......  ...+|+|.+...............|..+-..+. |+|++.+++.....+..++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            45556679999999998887633  345666665444322233333555777777776 999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~  337 (362)
                      ||.+++++.+.+........+...+..+..|+..++.|+| +.+   +.|||+||+|.+++..+ ..+++|||+|.....
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999883222224566667789999999999999 666   99999999999999999 999999999998876


Q ss_pred             -CCCceeeccccC-ccCccccccccc
Q 018036          338 -TGASECMSAVAG-SYGYIAPVLGWY  361 (362)
Q Consensus       338 -~~~~~~~~~~~G-t~~y~aPE~~~~  361 (362)
                       .+........+| ++.|+|||...+
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~  203 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSG  203 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccc
Confidence             455555666788 999999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.40  E-value=8.2e-13  Score=117.81  Aligned_cols=168  Identities=20%  Similarity=0.312  Sum_probs=103.7

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCc----------cCcceeEEEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIR----------HRNIVRLKAFCS  250 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~  250 (362)
                      .+..++.||.|+++.||.+++. +++++|+|........ ....+.+.+|.-....+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456789999999999999984 5899999988655432 223345666664444432          222332223221


Q ss_pred             ---------cC---C-----eeeEEEecCCCCChhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 018036          251 ---------NK---E-----TNLLVYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIH  308 (362)
Q Consensus       251 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  308 (362)
                               ..   .     ..+++|+-+ .+||.+++..     .....+....++.+..|+.+.+++||..+   +||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                     11   1     225788888 5788887642     11122344455677799999999999666   999


Q ss_pred             eCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccc
Q 018036          309 RDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       309 ~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      +||||+|++++.+|.+.|+||+......+.     ......+..|.+||+.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~  214 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELE  214 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhh
Confidence            999999999999999999999887765421     1113345789999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.37  E-value=8.2e-12  Score=108.89  Aligned_cols=144  Identities=21%  Similarity=0.245  Sum_probs=110.1

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc--CcceeEEEEEecCC---eeeEEEecC
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKE---TNLLVYEYM  262 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~  262 (362)
                      +.|+.|..+.||++...+|+.+++|........ .....+.+|.++++.+++  ..+.+++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998877788999986543221 123348899999999975  34677777776542   568999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC----------------------------------------  302 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  302 (362)
                      ++.++.+.+..   ..++......++.+++++|..||+..                                        
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99888776531   24677777888889999999998521                                        


Q ss_pred             -------------CCCeEEeCCCCCceeeCC--CCceEEccccccccc
Q 018036          303 -------------SPLIIHRDVKSNNILLNS--DFEAHVADFGLAKYL  335 (362)
Q Consensus       303 -------------~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~~~  335 (362)
                                   ...++|+|+.+.||+++.  ++.+.|+||+.+..-
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         234799999999999998  666899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=9.5e-12  Score=102.10  Aligned_cols=134  Identities=22%  Similarity=0.349  Sum_probs=101.7

Q ss_pred             eeeccCcccEEEEEcCCCCEEEEEEeeccC-CCCC-----chhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGIT-KGSS-----HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      .+++|+-+.+|.+.+.+ ..+++|.=.++. ..+.     ...+..+|.+++.+++--.|....=+..+++...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            57899999999997743 345555322222 2222     1245678999999998777776666777888889999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +|..|.+.+...         ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++|||++..-.
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999998888543         2466777888888899666   99999999999998764 9999999998644

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.34  E-value=1.9e-12  Score=108.75  Aligned_cols=78  Identities=24%  Similarity=0.220  Sum_probs=65.4

Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM  344 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  344 (362)
                      |+|.+++... +..+++..+..++.|++.||+|||+.+         ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence            6899999642 456999999999999999999999543         999999999999999  9999876432      


Q ss_pred             ccccCccCccccccccc
Q 018036          345 SAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~~  361 (362)
                       ...||+.|||||++.+
T Consensus        63 -~~~g~~~y~aPE~~~~   78 (176)
T smart00750       63 -QSRVDPYFMAPEVIQG   78 (176)
T ss_pred             -cCCCcccccChHHhcC
Confidence             1268999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.33  E-value=2.6e-13  Score=135.71  Aligned_cols=169  Identities=23%  Similarity=0.205  Sum_probs=123.6

Q ss_pred             hccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC-ch-hhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS-HD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .+...+.+|++.|=+|.+|+++.|. |+||++.+....-. .. .+...|++ ...++|||++++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4555688999999999999998887 88998865543221 11 12233444 455689999999888777778889999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc--CC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ--DT  338 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~--~~  338 (362)
                      |. .-+|+|.+.  ....+..-+.+-|+.|++.||.-+|+.+   |+|||||.+|||+..-.-+.|+||.-=+..-  .+
T Consensus       102 yv-khnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YV-KHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HH-hhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            98 459999995  3456777778889999999999999665   9999999999999999899999997654321  11


Q ss_pred             CCce---eeccccCccCccccccc
Q 018036          339 GASE---CMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       339 ~~~~---~~~~~~Gt~~y~aPE~~  359 (362)
                      ....   ...+-..-..|+|||-+
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERF  199 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERF  199 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhh
Confidence            1111   11112223469999965

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.31  E-value=1.8e-11  Score=100.05  Aligned_cols=147  Identities=22%  Similarity=0.275  Sum_probs=107.5

Q ss_pred             ccceeeccCcccEEEEEcCCCCEEEEEEeecc-CCCCC-----chhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGI-TKGSS-----HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ....+-||+-+.|+++.+ .|+...||.=... -+.+.     ...+..+|++.+.+++--.|....=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            356788999999999988 5677777643222 22221     1245788999999998667766666777777788999


Q ss_pred             ecCCC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC---ceEEccccccccc
Q 018036          260 EYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGLAKYL  335 (362)
Q Consensus       260 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~~~  335 (362)
                      ||+++ .++.+++...............++.++-+.+.-||.++   |+|+||..+||++..++   .+.++|||++..-
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99976 47888876443333333333688899999999999665   99999999999996554   3589999998754


Q ss_pred             c
Q 018036          336 Q  336 (362)
Q Consensus       336 ~  336 (362)
                      .
T Consensus       167 ~  167 (229)
T KOG3087|consen  167 R  167 (229)
T ss_pred             c
Confidence            3

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.31  E-value=3e-12  Score=121.47  Aligned_cols=125  Identities=28%  Similarity=0.459  Sum_probs=101.2

Q ss_pred             HhcCccCcceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCC
Q 018036          234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS  313 (362)
Q Consensus       234 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  313 (362)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....++|.-...++++++.||+|||.  ++-..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            4568899999999999999999999999999999999974 44568999999999999999999995  33339999999


Q ss_pred             CceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          314 NNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       314 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|.++|..+.+||+|||+.....+...........-..-|.|||++..
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~  125 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG  125 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence            999999999999999999987753111111111223456899998753

>PLN03150 hypothetical protein; Provisional

Probab=99.27  E-value=7.2e-12  Score=125.30  Aligned_cols=84  Identities=33%  Similarity=0.478  Sum_probs=75.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCC-CCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNM-KSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~-~~l~~l~ls~n~l~   79 (362)
                      |++|+|+|.+|.+++.|++|+.|||++|+|+|.+|+.+++|++|+.|||++|+|+|.+|..++.+ .++..+++++|...
T Consensus       449 Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l  528 (623)
T PLN03150        449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL  528 (623)
T ss_pred             CCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence            68999999999999999999999999999999999999999999999999999999999998764 46789999999654


Q ss_pred             CCCCC
Q 018036           80 GEIPE   84 (362)
Q Consensus        80 g~~p~   84 (362)
                      ..+|.
T Consensus       529 c~~p~  533 (623)
T PLN03150        529 CGIPG  533 (623)
T ss_pred             cCCCC
Confidence            43443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.25  E-value=8.4e-13  Score=106.23  Aligned_cols=77  Identities=32%  Similarity=0.571  Sum_probs=71.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ||+|.++ .+|+.|..|.+|+.|++++|+++ .+|.+|++|++|+.|+++.|+|. .+|..||.++.|+.|||++|+|+.
T Consensus        40 LSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e  116 (264)
T KOG0617|consen   40 LSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNE  116 (264)
T ss_pred             cccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccc
Confidence            6899998 89999999999999999999999 89999999999999999999997 799999999999999999999874

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.17  E-value=3.4e-10  Score=101.13  Aligned_cols=143  Identities=19%  Similarity=0.150  Sum_probs=100.3

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCC---------CchhhHHHHHHHHhcCccCcc--eeEEEEEec-----
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGS---------SHDNGLSAEIRTLGKIRHRNI--VRLKAFCSN-----  251 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----  251 (362)
                      +.+-.-....|++... +|+.+.||.........         .....+.+|...+.++...+|  +.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455444555777766 56789999764322110         111137789999988854333  344555543     


Q ss_pred             CCeeeEEEecCCCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-------CCc
Q 018036          252 KETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-------DFE  323 (362)
Q Consensus       252 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~  323 (362)
                      ....++|||++++. +|.+++........+...+..++.+++..+.-||..+   |+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            23568999999876 8999885322233556677789999999999999666   999999999999975       467


Q ss_pred             eEEcccccccc
Q 018036          324 AHVADFGLAKY  334 (362)
Q Consensus       324 ~kl~DFGla~~  334 (362)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.16  E-value=2.6e-11  Score=121.47  Aligned_cols=135  Identities=27%  Similarity=0.311  Sum_probs=88.6

Q ss_pred             hhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .+|+..+.|..|+||.||..+++. .+.+|.| +.+...       +.+-  ++.....|.+|                 
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee-----------------
Confidence            456778899999999999998864 4567773 321110       1111  23333344433                 


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                          |+-...++..  +.++.        +++.+++|||   +.+|+|||+||+|.+|..-|.+|+.|||+++..-....
T Consensus       136 ----gDc~tllk~~--g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ----GDCATLLKNI--GPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ----chhhhhcccC--CCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence                3444444321  22332        2277899999   55599999999999999999999999999876431110


Q ss_pred             ------------ce-eeccccCccCcccccccc
Q 018036          341 ------------SE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ------------~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                                  .+ .....+||+.|+||||+.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence                        01 134568999999999873

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=9.5e-11  Score=111.49  Aligned_cols=176  Identities=25%  Similarity=0.211  Sum_probs=136.1

Q ss_pred             hhhccccceeec--cCcccEEEEEc---CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGR--GGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  254 (362)
                      .+.+.....+|.  |.+|.||.+..   .++..+|+|+-+..........+=.+|+....+++ |+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            355666788999  99999999976   46788999885444433333333456777777774 9999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADF  329 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DF  329 (362)
                      .++-+|++ +.+|.++.+. ....++....+....+...    ||.++|   +..++|-|+||.||+...+ ...+++||
T Consensus       193 lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             ceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence            99999999 5788888763 3345777888888888888    999999   5559999999999999988 88999999


Q ss_pred             cccccccCCCCc---eeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGAS---ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+...+.+..-.   .......|...|++||+..+
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~  302 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG  302 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc
Confidence            999988654321   11222257788999998754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=6.3e-10  Score=93.90  Aligned_cols=128  Identities=25%  Similarity=0.318  Sum_probs=82.5

Q ss_pred             cEEEEEcCCCCEEEEEEeeccCC-----------CCC-------------chhhHHHHHHHHhcCccC--cceeEEEEEe
Q 018036          197 VVYRGVTPNGEQVAVKKLLGITK-----------GSS-------------HDNGLSAEIRTLGKIRHR--NIVRLKAFCS  250 (362)
Q Consensus       197 ~Vy~~~~~~~~~vavK~~~~~~~-----------~~~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~  250 (362)
                      .||.|...++..+|+|..+....           ...             ......+|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999988999999998754211           000             013467899999999765  466666542 


Q ss_pred             cCCeeeEEEecCC--CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEEeCCCCCceeeCCCCceEEc
Q 018036          251 NKETNLLVYEYMP--NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY-LHHDCSPLIIHRDVKSNNILLNSDFEAHVA  327 (362)
Q Consensus       251 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  327 (362)
                         ..++||||++  +..+..+....    ++......++.+++..+.. +|..+   |+|+|+.+.||+++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence               3479999998  55554443211    1133445677788886665 56544   9999999999999987 99999


Q ss_pred             ccccccccc
Q 018036          328 DFGLAKYLQ  336 (362)
Q Consensus       328 DFGla~~~~  336 (362)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.08  E-value=1.8e-11  Score=114.47  Aligned_cols=101  Identities=23%  Similarity=0.348  Sum_probs=83.9

Q ss_pred             eeeEEEecCCCCChhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      +.++.|++|+..+|.+++... .....++...+.++.|++.|++|   .+   .+|||+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            568999999999999999643 34567888889999999999999   44   899999999999999999999999999


Q ss_pred             ccccCCC----CceeeccccCccCcccccccc
Q 018036          333 KYLQDTG----ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~----~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......    .....+.-.||..||+||-+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~  435 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIR  435 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHh
Confidence            8776433    122345567999999999664

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.00  E-value=8.2e-11  Score=111.92  Aligned_cols=96  Identities=29%  Similarity=0.439  Sum_probs=81.7

Q ss_pred             CCcc-cccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCcccC
Q 018036            3 RNNF-SGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         3 ~n~~-~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~g   80 (362)
                      .|+| ...||++|-+|..|+.||||+|+|. ..|..+....++..|+||+|++. +||.. +-++..|-+||||+|+|.-
T Consensus        87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~  164 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEM  164 (1255)
T ss_pred             ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhh
Confidence            4555 4579999999999999999999999 89999999999999999999996 89986 5688889999999999999


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      .+|....+..+..+.+.+||
T Consensus       165 LPPQ~RRL~~LqtL~Ls~NP  184 (1255)
T KOG0444|consen  165 LPPQIRRLSMLQTLKLSNNP  184 (1255)
T ss_pred             cCHHHHHHhhhhhhhcCCCh
Confidence            99987777666666666665

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.00  E-value=1.6e-10  Score=104.72  Aligned_cols=99  Identities=30%  Similarity=0.535  Sum_probs=81.0

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccc----------------------cCcc
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN----------------------ASLP   59 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~----------------------g~~p   59 (362)
                      ++|.+ +-+|.+++.+++|..|+|++|-|. .+|.+++.+..|+.||+|+|+|.                      |.+|
T Consensus       420 snn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd  497 (565)
T KOG0472|consen  420 SNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVD  497 (565)
T ss_pred             hcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccC
Confidence            34444 488888889999999999988888 89999999999999999988886                      3444


Q ss_pred             hh-hcCCCCCCEEEccCCcccCCCCCCCcccccccCCccCCCCC
Q 018036           60 KE-MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL  102 (362)
Q Consensus        60 ~~-~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~l  102 (362)
                      ++ +.+|.+|.+|||.+|.+.-.+|..+...++......|||..
T Consensus       498 ~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  498 PSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            44 77788999999999999988888888888888888888743

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.98  E-value=8.1e-11  Score=106.52  Aligned_cols=92  Identities=26%  Similarity=0.388  Sum_probs=74.4

Q ss_pred             ccCCcccccccCCCEEECcCCcccc---------------------cCchhhh-cccccCeeeccccccccCcchhhcCC
Q 018036            8 GIIPVEIGHCLLLTYLDLSQNHLSG---------------------PIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNM   65 (362)
Q Consensus         8 g~ip~~~~~l~~l~~l~l~~n~l~g---------------------~ip~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~   65 (362)
                      ++||+++|.+.+|..|+|..|++.-                     .+|.+.. .+++|..|||..|++. ++|+++..+
T Consensus       196 ~tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL  274 (565)
T KOG0472|consen  196 ETLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL  274 (565)
T ss_pred             hcCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence            4777777777777666666666650                     3445444 6888999999999998 899999999


Q ss_pred             CCCCEEEccCCcccCCCCCCCcccccccCCccCCCC
Q 018036           66 KSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPH  101 (362)
Q Consensus        66 ~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~~  101 (362)
                      .+|.+||+|+|.+++.+|+.+.+ .+......|||-
T Consensus       275 rsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  275 RSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             hhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence            99999999999999999999887 677778889973

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.97  E-value=4.6e-10  Score=76.83  Aligned_cols=60  Identities=35%  Similarity=0.477  Sum_probs=52.9

Q ss_pred             cCCCEEECcCCcccccCc-hhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcc
Q 018036           18 LLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus        18 ~~l~~l~l~~n~l~g~ip-~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l   78 (362)
                      ++|++|+|++|+|+ .|| ..+..+++|++|++++|+++.--|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57899999999999 566 5889999999999999999854445789999999999999986

...

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.94  E-value=5.3e-11  Score=95.94  Aligned_cols=101  Identities=26%  Similarity=0.391  Sum_probs=88.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeecccccccc-CcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g-~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      +++|+++ .+|.+++.++.|+.|+++-|+|. .+|..+++++.|+.|||..|+|+. .+|-.|.-+..|+.|+|+.|.|.
T Consensus        63 ~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe  140 (264)
T KOG0617|consen   63 LSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE  140 (264)
T ss_pred             cccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc
Confidence            4689998 99999999999999999999999 899999999999999999999984 57877877888899999999999


Q ss_pred             CCCCCCCcccccccCCccCCCCCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGNPHLC  103 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n~~lc  103 (362)
                      =.+|+.+++..+..++...|..+.
T Consensus       141 ~lp~dvg~lt~lqil~lrdndll~  164 (264)
T KOG0617|consen  141 ILPPDVGKLTNLQILSLRDNDLLS  164 (264)
T ss_pred             cCChhhhhhcceeEEeeccCchhh
Confidence            888888888887777777765443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.92  E-value=5.3e-09  Score=100.96  Aligned_cols=123  Identities=21%  Similarity=0.237  Sum_probs=99.7

Q ss_pred             cCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHH
Q 018036          203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWE  282 (362)
Q Consensus       203 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  282 (362)
                      ..++.+|.|...+....  ...+...+-++.|+.+|||||+++++.++..+..|+|+|-+.  .|..++...     ...
T Consensus        34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHH
Confidence            34678888888765443  233346778899999999999999999999999999999983  677777532     244


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       283 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ...--+.||+.||.|||+.+  .++|++|..+.|++++.|+.||++|-++....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            55566789999999999754  59999999999999999999999998886654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=6.7e-09  Score=90.51  Aligned_cols=137  Identities=23%  Similarity=0.217  Sum_probs=95.8

Q ss_pred             ccceeeccCcccEEEEEcCCCCEEEEEEeeccC----------C------CCC----chhhHHHHHHHHhcCccC--cce
Q 018036          186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGIT----------K------GSS----HDNGLSAEIRTLGKIRHR--NIV  243 (362)
Q Consensus       186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~------~~~----~~~~~~~e~~~l~~l~h~--niv  243 (362)
                      .++.||-|.-+.||.|..+.|.++|||.=+...          .      ...    .....++|.+.|.++...  .+.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            458899999999999999999999999532110          0      000    112467899999998644  676


Q ss_pred             eEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc
Q 018036          244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE  323 (362)
Q Consensus       244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  323 (362)
                      +.+++    +...+||||++|-.|...--       +....-.++..|++-+.-+-+.+   +||+|+.+=||+++++|.
T Consensus       175 ~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~  240 (304)
T COG0478         175 KPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             Ccccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence            66654    45679999998876654321       22223344444555455444344   999999999999999999


Q ss_pred             eEEcccccccccc
Q 018036          324 AHVADFGLAKYLQ  336 (362)
Q Consensus       324 ~kl~DFGla~~~~  336 (362)
                      +.++||--+....
T Consensus       241 ~~vIDwPQ~v~~~  253 (304)
T COG0478         241 IVVIDWPQAVPIS  253 (304)
T ss_pred             EEEEeCcccccCC
Confidence            9999996665443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=1.6e-08  Score=87.38  Aligned_cols=107  Identities=21%  Similarity=0.308  Sum_probs=83.3

Q ss_pred             hhHHHHHHHHhcCccC--cceeEEEEEecCC----eeeEEEecCCCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018036          225 NGLSAEIRTLGKIRHR--NIVRLKAFCSNKE----TNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY  297 (362)
Q Consensus       225 ~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~  297 (362)
                      .+..+|...+..+...  .+.+.+++.....    ..++|+|++++. +|.+++.....  .+......++.+++..++-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            3478898888888533  3455666665532    457999999874 89999864222  5566678899999999999


Q ss_pred             HhcCCCCCeEEeCCCCCceeeCCCC---ceEEcccccccccc
Q 018036          298 LHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGLAKYLQ  336 (362)
Q Consensus       298 LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~~~~  336 (362)
                      ||+.+   |+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99766   99999999999999886   79999999887643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.86  E-value=5.8e-08  Score=82.65  Aligned_cols=140  Identities=17%  Similarity=0.107  Sum_probs=102.3

Q ss_pred             eccCcccEEEEEcCCCCEEEEEEeeccCCC----CCchhhHHHHHHHHhcCccC--cceeEEEEEe-cC----CeeeEEE
Q 018036          191 GRGGAGVVYRGVTPNGEQVAVKKLLGITKG----SSHDNGLSAEIRTLGKIRHR--NIVRLKAFCS-NK----ETNLLVY  259 (362)
Q Consensus       191 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv~  259 (362)
                      |+||-+-|++-... |..+.+|+-...-..    +.....|.+|+..+.++..-  .+.++. ++. ..    ...+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            67888999998764 447889986532211    33345699999999998532  244444 332 11    2357999


Q ss_pred             ecCCC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc--eEEccccccccc
Q 018036          260 EYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVADFGLAKYL  335 (362)
Q Consensus       260 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla~~~  335 (362)
                      |-+++ -||.+++....-...+...+..+..+++..++-||+.+   +.|+|+.+.||+++.++.  ++++||.-++..
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            97753 58998886544445677778899999999999999666   999999999999986667  999999877653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.82  E-value=1.8e-08  Score=97.53  Aligned_cols=153  Identities=20%  Similarity=0.251  Sum_probs=98.4

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC------------------------c---------
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS------------------------H---------  223 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~---------  223 (362)
                      .++.+..|+. +.|+.++-|+||+|++++|+.||||+.++.-...-                        .         
T Consensus       121 iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~  199 (517)
T COG0661         121 IEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE  199 (517)
T ss_pred             HHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence            3445555543 68999999999999999999999998764321100                        0         


Q ss_pred             -----hhhHHHHHHHHhcCc-----cCcceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 018036          224 -----DNGLSAEIRTLGKIR-----HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK  293 (362)
Q Consensus       224 -----~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~  293 (362)
                           +-.+.+|...+.+++     .+++.-..=|++-.....|+|||++|-.+.+...-.. ...+.+.   ++..+++
T Consensus       200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~  275 (517)
T COG0661         200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVR  275 (517)
T ss_pred             HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHH
Confidence                 002344555555442     3443322223334566789999999998888842222 2345333   3322222


Q ss_pred             H-HHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          294 G-LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       294 ~-L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      + +.-+-..+   ++|.|..|.||+++.++++.+.|||+...+.+
T Consensus       276 ~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         276 AFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2 22233234   99999999999999999999999999987753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.80  E-value=4.8e-08  Score=91.79  Aligned_cols=139  Identities=17%  Similarity=0.291  Sum_probs=108.5

Q ss_pred             CcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec----CCeeeEEEecCCC-CCh
Q 018036          194 GAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNLLVYEYMPN-GSL  267 (362)
Q Consensus       194 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL  267 (362)
                      .-.+.|++.. .||..++.|+++........  ....-+++++++.|+|+|++.+++..    +...++||+|+++ ++|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN--KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc--cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            3457889875 58999999999543322211  14556788999999999999998863    4567899999985 688


Q ss_pred             hhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          268 GEVLHGK-------------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       268 ~~~l~~~-------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++....             .+...++...+.++.|++.||.++|+.|   +.-+-|.+.+|+++.+.+++|+..|....
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceee
Confidence            8776422             1234778899999999999999999655   88899999999999999999999888776


Q ss_pred             ccC
Q 018036          335 LQD  337 (362)
Q Consensus       335 ~~~  337 (362)
                      +..
T Consensus       443 l~~  445 (655)
T KOG3741|consen  443 LQE  445 (655)
T ss_pred             ecC
Confidence            654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.80  E-value=2.7e-09  Score=88.76  Aligned_cols=94  Identities=27%  Similarity=0.399  Sum_probs=36.5

Q ss_pred             CCCCcccccCCcccc-cccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhh-cCCCCCCEEEccCCcc
Q 018036            1 MSRNNFSGIIPVEIG-HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n~~~g~ip~~~~-~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~-~~~~~l~~l~ls~n~l   78 (362)
                      |++|.++ .|. .++ .+.+|+.||||+|+++ .|+ .+..++.|+.|+|++|+++ .++..+ ..+++|+.|++++|++
T Consensus        26 L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I  100 (175)
T PF14580_consen   26 LRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKI  100 (175)
T ss_dssp             ------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS--
T ss_pred             ccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcC
Confidence            4567776 553 566 5889999999999999 676 5888999999999999998 687655 4689999999999999


Q ss_pred             cCCCCCC---CcccccccCCccCCC
Q 018036           79 SGEIPEF---GQYSFFNSTSFTGNP  100 (362)
Q Consensus        79 ~g~~p~~---~~~~~~~~~~~~~n~  100 (362)
                      ... -+.   ..+..+..++..|||
T Consensus       101 ~~l-~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen  101 SDL-NELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             -SC-CCCGGGGG-TT--EEE-TT-G
T ss_pred             CCh-HHhHHHHcCCCcceeeccCCc
Confidence            752 222   233444455666775

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.76  E-value=4.2e-09  Score=100.44  Aligned_cols=148  Identities=23%  Similarity=0.231  Sum_probs=115.3

Q ss_pred             hhccccceeeccCcccEEEEEc--CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT--PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+|.....||.|.|+.|++...  .++..+++|.+.........+..-..|+.+...+ -|.+++..+..+......++-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            3455667899999999999864  3577888888765544433333344566666666 488899888777777777899


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEcccccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKY  334 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~  334 (362)
                      -||++++++....  .....+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +..+++|||++..
T Consensus       345 ~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  345 LEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             hhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            9999999887655  23345788888999999999999999   5669999999999999876 7889999999864

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.74  E-value=1.7e-09  Score=107.16  Aligned_cols=98  Identities=30%  Similarity=0.413  Sum_probs=77.3

Q ss_pred             CCCCcccccCCcc-cccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVE-IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~-~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|+|. ++|.. +.+|..|+.|+||+|+|+ .||..+.++..|++|...+|++. .+| ++.++++|+++|+|.|+|+
T Consensus       390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence            5778886 77764 677888888888888888 88888888888888888888887 678 7889999999999999997


Q ss_pred             C-CCCCCCcccccccCCccCCCCC
Q 018036           80 G-EIPEFGQYSFFNSTSFTGNPHL  102 (362)
Q Consensus        80 g-~~p~~~~~~~~~~~~~~~n~~l  102 (362)
                      - .+|.......+..+.++||..+
T Consensus       466 ~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  466 EVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhhhhhhCCCcccceeeccCCccc
Confidence            4 4454333345566678888753

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.73  E-value=2.4e-07  Score=81.04  Aligned_cols=139  Identities=14%  Similarity=0.185  Sum_probs=84.4

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc--ceeEEEEEecCCeeeEEEecCCCC
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN--IVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      ..||+|..+.||+.   .+..+++|......    ......+|.++++.+..-.  +.+.+++....+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999984   24567778754211    2234788999999886443  466788887777888999999886


Q ss_pred             C-hhhhh---------------------cCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhc-CCCCCeEEeC
Q 018036          266 S-LGEVL---------------------HGKRGSFLKWEMRL-KIAI----------EAAK-GLSYLHH-DCSPLIIHRD  310 (362)
Q Consensus       266 s-L~~~l---------------------~~~~~~~~~~~~~~-~i~~----------~i~~-~L~~LH~-~~~~~ivH~D  310 (362)
                      + +.+.+                     |............. .+-.          .+.. ..++|.. .....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 22111                     11100001111000 0000          0000 1112211 1134578999


Q ss_pred             CCCCceeeCCCCceEEcccccccc
Q 018036          311 VKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       311 lk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      +.|.||++++++ +.|+||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.71  E-value=7.6e-09  Score=91.80  Aligned_cols=129  Identities=22%  Similarity=0.338  Sum_probs=94.2

Q ss_pred             HHHHhcCccCcceeEEEEEecCC-----eeeEEEecCCCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 018036          231 IRTLGKIRHRNIVRLKAFCSNKE-----TNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCS  303 (362)
Q Consensus       231 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~  303 (362)
                      ..-+-.+.|.|||+++.|+.+..     ...++.|||+-|++.++|++..  ...+......+|+.||..||.|||.. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            44455668999999999987654     4678999999999999997532  34567777789999999999999965 7


Q ss_pred             CCeEEeCCCCCceeeCCCCceEEcccccccccc--CCCCceeeccccCccCcccccccc
Q 018036          304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ--DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       304 ~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~--~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+|+|+++..+-|++..+|-+||.--.-.....  ............|-++|.|||+-.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~  255 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT  255 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc
Confidence            999999999999999999988875321111000  000001123345778999999753

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.60  E-value=4.7e-09  Score=100.22  Aligned_cols=104  Identities=21%  Similarity=0.283  Sum_probs=81.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCccc-ccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS-GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~-g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      ||.|+|+ .+|..+++|+.|+.|.+.+|+|+ .-||+.||.|..|+.+..++|+|. -+|..+..+..|+.|.|+.|+|-
T Consensus       275 lSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi  352 (1255)
T KOG0444|consen  275 LSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI  352 (1255)
T ss_pred             cccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee
Confidence            5788888 88888888888888888888875 248888888888888888888886 78888888888888888888887


Q ss_pred             CCCCCCCcccccccCCccCCCCCCCCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGNPHLCGSY  106 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n~~lc~~~  106 (362)
                      ..+-.+.-+.-+..+....||.+.-+|
T Consensus       353 TLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  353 TLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             echhhhhhcCCcceeeccCCcCccCCC
Confidence            554444444555556777888877654

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.59  E-value=4.1e-08  Score=61.95  Aligned_cols=36  Identities=33%  Similarity=0.511  Sum_probs=21.6

Q ss_pred             CCCEEECcCCcccccCchhhhcccccCeeeccccccc
Q 018036           19 LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN   55 (362)
Q Consensus        19 ~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~   55 (362)
                      +|++|+|++|+++ .||+.|++|++|+.|+|++|+++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            5666666666666 56666666666666666666665

...

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.57  E-value=6.6e-09  Score=98.17  Aligned_cols=75  Identities=37%  Similarity=0.565  Sum_probs=49.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      +++|+++ .+|.+++.+..|..||.|.|.+. .+|+.++.+.+|+.|++..|++. .+|.+++.|+ |..||+|.|+++
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis  224 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS  224 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee
Confidence            3577776 88888887788888888888887 77777777776665555555554 4555554332 455555555554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.54  E-value=8.3e-07  Score=76.80  Aligned_cols=140  Identities=24%  Similarity=0.227  Sum_probs=93.9

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCc----------------------hhhHHHHHHHHhcCc--cCcce
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH----------------------DNGLSAEIRTLGKIR--HRNIV  243 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~--h~niv  243 (362)
                      ..|++|.-+.||+|...++..+|||+.+.....-..                      .....+|+.-|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            367788889999999888999999998653221110                      012355777777764  33444


Q ss_pred             eEEEEEecCCeeeEEEecCCCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC
Q 018036          244 RLKAFCSNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF  322 (362)
Q Consensus       244 ~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  322 (362)
                      +.+++..    ..|||||+... .-.-.|+.   ..+.......+..++++.+.-|-..  .++||+||..=|||+. ++
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence            4454432    36999999542 11112211   1233335667778888888888751  3499999999999999 88


Q ss_pred             ceEEccccccccccC
Q 018036          323 EAHVADFGLAKYLQD  337 (362)
Q Consensus       323 ~~kl~DFGla~~~~~  337 (362)
                      .+.|+|||-|.....
T Consensus       204 ~p~iID~~QaV~~~h  218 (268)
T COG1718         204 EPYIIDVSQAVTIDH  218 (268)
T ss_pred             eEEEEECccccccCC
Confidence            999999999887653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.48  E-value=9.1e-08  Score=65.34  Aligned_cols=53  Identities=34%  Similarity=0.457  Sum_probs=46.2

Q ss_pred             CCCCcccccCC-cccccccCCCEEECcCCcccccCchhhhcccccCeeecccccc
Q 018036            1 MSRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL   54 (362)
Q Consensus         1 l~~n~~~g~ip-~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l   54 (362)
                      |++|+++ .|| ..+..+++|++|++++|+++.--|..+..+++|++|+|++|+|
T Consensus         8 l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    8 LSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4789999 666 5678999999999999999965556889999999999999985

...

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.47  E-value=7.3e-07  Score=86.25  Aligned_cols=152  Identities=19%  Similarity=0.169  Sum_probs=93.7

Q ss_pred             ChhhHhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCc--------------------------------
Q 018036          176 GSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH--------------------------------  223 (362)
Q Consensus       176 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------------------------  223 (362)
                      +.++++..|+ .+.|+.-+.|.||+|+.++|+.||||+-++.-+....                                
T Consensus       156 ~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~  234 (538)
T KOG1235|consen  156 PIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKS  234 (538)
T ss_pred             CHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhh
Confidence            3445555554 3689999999999999999999999976543221100                                


Q ss_pred             ---hhhHHHHHHHHhcC----ccCc------ceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHH
Q 018036          224 ---DNGLSAEIRTLGKI----RHRN------IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIE  290 (362)
Q Consensus       224 ---~~~~~~e~~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~  290 (362)
                         +-+|.+|.+-..++    +|-+      |.+++-  .......|+||||+|..+.|.-.- ....++...+..-+.+
T Consensus       235 L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~  311 (538)
T KOG1235|consen  235 LPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVE  311 (538)
T ss_pred             hHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHH
Confidence               01234454444333    3444      333322  223456899999999877765321 1222554443333333


Q ss_pred             HHHHHHHHhcCCCCCeEEeCCCCCceeeCC----CCceEEcccccccccc
Q 018036          291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNS----DFEAHVADFGLAKYLQ  336 (362)
Q Consensus       291 i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~DFGla~~~~  336 (362)
                      +..-+-+     ..+.+|+|-.|.||+++.    ++++.+-|||+...+.
T Consensus       312 ~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  312 AYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            2222222     223899999999999983    6789999999988765

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.46  E-value=2.5e-08  Score=99.16  Aligned_cols=81  Identities=32%  Similarity=0.478  Sum_probs=73.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ||+|+++ ..|..+..+.+|+.|+++.|.+. ..|.+++++.+|++|+|.+|.+. .+|.++..+++|+.|++|+|+|.-
T Consensus        52 lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~  128 (1081)
T KOG0618|consen   52 LSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGP  128 (1081)
T ss_pred             ccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCC
Confidence            4666665 99999999999999999999999 89999999999999999999997 899999999999999999999975


Q ss_pred             CCCC
Q 018036           81 EIPE   84 (362)
Q Consensus        81 ~~p~   84 (362)
                      .++-
T Consensus       129 ~Pl~  132 (1081)
T KOG0618|consen  129 IPLV  132 (1081)
T ss_pred             Cchh
Confidence            5443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.45  E-value=1.2e-07  Score=95.76  Aligned_cols=60  Identities=30%  Similarity=0.340  Sum_probs=32.3

Q ss_pred             CCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCCCC
Q 018036           20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE   84 (362)
Q Consensus        20 l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~p~   84 (362)
                      |+.|+|++|+|+ .||..+   .+|+.|+|++|+|+ .||.+++++++|..|+|++|+|+|.+|.
T Consensus       404 L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        404 LKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            444444444444 244321   23455566666665 5666666666666666666666665553

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=3.2e-06  Score=74.90  Aligned_cols=141  Identities=16%  Similarity=0.122  Sum_probs=84.9

Q ss_pred             eeeccCc-ccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEecCCCCC
Q 018036          189 VIGRGGA-GVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPNGS  266 (362)
Q Consensus       189 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  266 (362)
                      .|..|.+ ..||+.... +..+.+|......     ...+.+|++++..+. +--+.+++++....+..++|||+++|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            3445555 788999764 4678888754322     223778998888874 4446677887776667899999999887


Q ss_pred             hhhhh-------------------cCCCC--CCCCHH--HHHHHHH--------------------HHHHHHHHHhc---
Q 018036          267 LGEVL-------------------HGKRG--SFLKWE--MRLKIAI--------------------EAAKGLSYLHH---  300 (362)
Q Consensus       267 L~~~l-------------------~~~~~--~~~~~~--~~~~i~~--------------------~i~~~L~~LH~---  300 (362)
                      +.+..                   +....  ..+...  .......                    .+....+.|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            76442                   11110  011100  0000000                    01111222211   


Q ss_pred             -CCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          301 -DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       301 -~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                       ...+.++|+|+.|.|||++++....|+||+.+..-
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence             11345899999999999999877889999988643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.44  E-value=2.3e-07  Score=77.24  Aligned_cols=76  Identities=22%  Similarity=0.295  Sum_probs=38.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhh-hcccccCeeeccccccccCcc--hhhcCCCCCCEEEccCCc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP--KEMGNMKSLTSADFSHNN   77 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~-~~l~~l~~l~l~~n~l~g~~p--~~~~~~~~l~~l~ls~n~   77 (362)
                      ||+|.++ .|+ .+..++.|++|+|++|+++ .+++.+ ..+++|+.|+|++|++. .+-  ..+..+++|+.|++.+|.
T Consensus        49 Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen   49 LSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             -TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-TT-G
T ss_pred             CCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeeccCCc
Confidence            6789998 676 5778999999999999999 687666 46999999999999997 343  357789999999999999


Q ss_pred             ccC
Q 018036           78 FSG   80 (362)
Q Consensus        78 l~g   80 (362)
                      ++.
T Consensus       125 v~~  127 (175)
T PF14580_consen  125 VCE  127 (175)
T ss_dssp             GGG
T ss_pred             ccc
Confidence            874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.43  E-value=2.9e-08  Score=94.25  Aligned_cols=83  Identities=25%  Similarity=0.245  Sum_probs=65.0

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~   79 (362)
                      ||.|++..--++.+..+.+|++||||+|+++--=|.++.-|..|+.|+|++|.++ .|-+ .|..+++|+.|||++|.++
T Consensus       300 lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls  378 (873)
T KOG4194|consen  300 LSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELS  378 (873)
T ss_pred             cchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEE
Confidence            5778887666777888888888888888888444457777888888888888886 4544 4667888899999999998


Q ss_pred             CCCCC
Q 018036           80 GEIPE   84 (362)
Q Consensus        80 g~~p~   84 (362)
                      +.|.+
T Consensus       379 ~~IED  383 (873)
T KOG4194|consen  379 WCIED  383 (873)
T ss_pred             EEEec
Confidence            88765

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.42  E-value=2.1e-07  Score=58.67  Aligned_cols=38  Identities=34%  Similarity=0.524  Sum_probs=33.6

Q ss_pred             cccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036           42 HILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        42 ~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|++|+|++|+++ .||+++++|++|+.|++++|+++.
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            47999999999998 799999999999999999999984

...

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=2e-06  Score=75.27  Aligned_cols=143  Identities=24%  Similarity=0.249  Sum_probs=83.2

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccC--cceeEEEEEec---CCeeeEEEecC
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR--NIVRLKAFCSN---KETNLLVYEYM  262 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~  262 (362)
                      +.++.|..+.||+....+ ..+++|.....    .....+.+|..+++.+...  .+.+++.+...   ....+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            568999999999999877 68999986432    2334578899888888533  35566665433   33568999999


Q ss_pred             CCCChhh----------------hh---cCC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHh
Q 018036          263 PNGSLGE----------------VL---HGK--RGSFLKWEM---------RLKI------------AIEAAK-GLSYLH  299 (362)
Q Consensus       263 ~~gsL~~----------------~l---~~~--~~~~~~~~~---------~~~i------------~~~i~~-~L~~LH  299 (362)
                      ++.++..                .+   +..  ......+..         ....            ...+.. .++.++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988777                11   111  111111110         0000            011222 233333


Q ss_pred             c----CCCCCeEEeCCCCCceeeC-CCCceEEccccccccc
Q 018036          300 H----DCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYL  335 (362)
Q Consensus       300 ~----~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~  335 (362)
                      +    .....++|+|+.|.||+++ +++.+.|+||+.+...
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence            1    1245699999999999999 6666789999887653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.37  E-value=1.8e-06  Score=73.21  Aligned_cols=104  Identities=24%  Similarity=0.242  Sum_probs=81.1

Q ss_pred             HHHHHHHhcCcc-CcceeEEEEEecCCeeeEEEecCCCCChhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018036          228 SAEIRTLGKIRH-RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL  305 (362)
Q Consensus       228 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~  305 (362)
                      ..|.-+++.+++ +++++++|+|-    .++|.||...+++...... ..-...+|..+.+||.++++.++++++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888865 69999999994    3689999987766422100 01123689999999999999999999754445


Q ss_pred             eEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          306 IIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       306 ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            778999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.36  E-value=1.1e-05  Score=68.86  Aligned_cols=138  Identities=20%  Similarity=0.247  Sum_probs=92.7

Q ss_pred             cccceeeccCcccEEEEEcCCCCEEEEEEeeccCC--------------CCCchhhHHHHHHHHhcCc------cCccee
Q 018036          185 KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITK--------------GSSHDNGLSAEIRTLGKIR------HRNIVR  244 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~e~~~l~~l~------h~niv~  244 (362)
                      +....||+|+.-.||.  +++.....||+......              ......+..+|+.....+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3457899999999996  45556678888765540              0112234677776666555      889999


Q ss_pred             EEEEEecCCeeeEEEecCCC------CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee
Q 018036          245 LKAFCSNKETNLLVYEYMPN------GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL  318 (362)
Q Consensus       245 l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  318 (362)
                      ++|+.+++....+|+|.+.+      .+|.+++...   .++. ...+.+.+.   .+||-+..   |+.+|++|.||++
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence            99999999999999997643      3677887432   2454 333333444   44555444   9999999999999


Q ss_pred             CCC--C--ceEEcc-cccccc
Q 018036          319 NSD--F--EAHVAD-FGLAKY  334 (362)
Q Consensus       319 ~~~--~--~~kl~D-FGla~~  334 (362)
                      ...  +  .+.|+| ||-...
T Consensus       152 ~~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             EecCCCceEEEEEeCCCCccc
Confidence            532  2  577787 555443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.35  E-value=1.9e-06  Score=73.82  Aligned_cols=136  Identities=16%  Similarity=0.173  Sum_probs=81.8

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCch-------hhHHHHHHHHhcCccCc---ceeEEEEEe---
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD-------NGLSAEIRTLGKIRHRN---IVRLKAFCS---  250 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~h~n---iv~l~~~~~---  250 (362)
                      |+..+++-......|.+-.. ++..+++|..+......++.       ....+++..+.+++...   ...++.+..   
T Consensus        33 ~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~  111 (229)
T PF06176_consen   33 YKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI  111 (229)
T ss_pred             ceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence            44444555555555555544 56778888765433211110       11234444444443222   222222222   


Q ss_pred             --cCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          251 --NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       251 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                        -....+++|||++|..|.+...      +++    .++..+.+++.-+|..|   ++|+|..|.|++++++ .++++|
T Consensus       112 ~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  112 FRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             ccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEE
Confidence              2234568999999988876542      232    24456777899999666   9999999999999965 499999


Q ss_pred             cccccc
Q 018036          329 FGLAKY  334 (362)
Q Consensus       329 FGla~~  334 (362)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN02876 acyl-CoA dehydrogenase

Probab=98.35  E-value=7.5e-06  Score=85.09  Aligned_cols=80  Identities=15%  Similarity=0.298  Sum_probs=56.2

Q ss_pred             cceeeccCcccEEEEEcCCC---CEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcc--eeEEEEEecC---CeeeE
Q 018036          187 NNVIGRGGAGVVYRGVTPNG---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNI--VRLKAFCSNK---ETNLL  257 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~l  257 (362)
                      .+.++.|.+..+|+....++   ..+++|+...... ......+.+|.++++.+. |.++  .+++.+|.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            45688999999999876543   3677776532221 112234889999999995 6665  7778888764   46789


Q ss_pred             EEecCCCCCh
Q 018036          258 VYEYMPNGSL  267 (362)
Q Consensus       258 v~e~~~~gsL  267 (362)
                      ||||+++..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999987643

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.34  E-value=4.2e-08  Score=76.46  Aligned_cols=82  Identities=22%  Similarity=0.286  Sum_probs=63.0

Q ss_pred             cCCcccccc---cCCCEEECcCCcccccCchhhhccc-ccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCCCC
Q 018036            9 IIPVEIGHC---LLLTYLDLSQNHLSGPIPVQITQIH-ILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE   84 (362)
Q Consensus         9 ~ip~~~~~l---~~l~~l~l~~n~l~g~ip~~~~~l~-~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~p~   84 (362)
                      .||..+.++   ..|...+|++|.|. .+|+.+.... .++.|||++|.++ .+|.++..++.|+.+|+++|.|...+-.
T Consensus        41 ~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~v  118 (177)
T KOG4579|consen   41 YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRV  118 (177)
T ss_pred             HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHH
Confidence            355544444   44555699999998 8888887754 8999999999998 7999999999999999999999877655


Q ss_pred             CCcccccc
Q 018036           85 FGQYSFFN   92 (362)
Q Consensus        85 ~~~~~~~~   92 (362)
                      +.++..+.
T Consensus       119 i~~L~~l~  126 (177)
T KOG4579|consen  119 IAPLIKLD  126 (177)
T ss_pred             HHHHHhHH
Confidence            44444443

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.34  E-value=3.9e-08  Score=76.63  Aligned_cols=80  Identities=28%  Similarity=0.403  Sum_probs=70.0

Q ss_pred             CCCCcccccCCccccc-ccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGH-CLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~-l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.|- .+|+.+.. .+.++.|+|++|.++ .+|.++..++.|+.||++.|.|+ ..|.-+..+.+|..||...|.+.
T Consensus        60 ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen   60 LSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            6789997 88888765 458999999999999 99999999999999999999998 68888888999999999888775


Q ss_pred             CCCCC
Q 018036           80 GEIPE   84 (362)
Q Consensus        80 g~~p~   84 (362)
                       +||.
T Consensus       137 -eid~  140 (177)
T KOG4579|consen  137 -EIDV  140 (177)
T ss_pred             -cCcH
Confidence             4443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.28  E-value=8.2e-08  Score=90.92  Aligned_cols=81  Identities=32%  Similarity=0.443  Sum_probs=43.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |+.|+|+ ++|.+.+.+-.|+.|.|..|.+. .||..+.+|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++-
T Consensus        82 lsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~  157 (722)
T KOG0532|consen   82 LSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTS  157 (722)
T ss_pred             ccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcccc
Confidence            3455555 55555555555555555555555 55555555555555555555554 4555555443 5555555555554


Q ss_pred             CCCCC
Q 018036           81 EIPEF   85 (362)
Q Consensus        81 ~~p~~   85 (362)
                      .++..
T Consensus       158 lp~~i  162 (722)
T KOG0532|consen  158 LPEEI  162 (722)
T ss_pred             CCccc
Confidence            44443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.25  E-value=1.1e-06  Score=89.32  Aligned_cols=73  Identities=19%  Similarity=0.340  Sum_probs=38.0

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhc-------------------ccccCeeeccccccccCcchh
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQ-------------------IHILNYLNVSWNQLNASLPKE   61 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~-------------------l~~l~~l~l~~n~l~g~~p~~   61 (362)
                      |++|+++ .+|..+.  ++|++|+|++|+|+ .||..+..                   ..+|+.|+|++|+|+ .+|..
T Consensus       206 Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~~LP~~l~s~L~~L~Ls~N~L~-~LP~~  280 (754)
T PRK15370        206 LDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSINRITELPERLPSALQSLDLFHNKIS-CLPEN  280 (754)
T ss_pred             ecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCCccCcCChhHhCCCCEEECcCCccC-ccccc
Confidence            3566666 5665443  35666666666665 45543321                   124555555555554 35544


Q ss_pred             hcCCCCCCEEEccCCcccC
Q 018036           62 MGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        62 ~~~~~~l~~l~ls~n~l~g   80 (362)
                      +.  ++|+.|++++|+|++
T Consensus       281 l~--~sL~~L~Ls~N~Lt~  297 (754)
T PRK15370        281 LP--EELRYLSVYDNSIRT  297 (754)
T ss_pred             cC--CCCcEEECCCCcccc
Confidence            42  355555555555554

>PRK10593 hypothetical protein; Provisional

Probab=98.25  E-value=2.2e-05  Score=71.65  Aligned_cols=79  Identities=10%  Similarity=0.062  Sum_probs=56.4

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc---CcceeEEEEEec---CCeeeE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH---RNIVRLKAFCSN---KETNLL  257 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~l  257 (362)
                      ....+.||.|..+.||+....+++ +.+|..+.    ......+.+|.+.++.+.-   -.+.++++++..   .+..++
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQGN-PMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCCC-EEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            344578999999999999776654 56665322    1112348999999988853   357788888754   356899


Q ss_pred             EEecCCCCCh
Q 018036          258 VYEYMPNGSL  267 (362)
Q Consensus       258 v~e~~~~gsL  267 (362)
                      |||+++++++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998765

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.25  E-value=1.5e-06  Score=88.25  Aligned_cols=70  Identities=24%  Similarity=0.357  Sum_probs=54.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |+++.++ ++|..+.  +.|+.|+|++|+|+ .+|..+.  .+|+.|+|++|+|+ .||..+.  ++|+.|+|++|+++
T Consensus       185 L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~  254 (754)
T PRK15370        185 LKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT  254 (754)
T ss_pred             eCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC
Confidence            4567788 7887764  58999999999999 7998775  58999999999998 6887653  35666666666665

>PLN03210 Resistant to P

Probab=98.24  E-value=2e-06  Score=92.44  Aligned_cols=51  Identities=20%  Similarity=0.156  Sum_probs=35.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeecccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWN   52 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n   52 (362)
                      |++|...+.+|.++++|++|+.|+|++|...+.+|..+ ++++|+.|+|++|
T Consensus       785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c  835 (1153)
T PLN03210        785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGC  835 (1153)
T ss_pred             CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence            35666677888888888889999988876555788665 4555555555443

syringae 6; Provisional

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.21  E-value=5.5e-07  Score=85.76  Aligned_cols=96  Identities=32%  Similarity=0.485  Sum_probs=73.0

Q ss_pred             CCCCcccccCCccccccc-CCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~-~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      +.+|+++ .||+..+.++ +|+.|++++|++. .+|..+..++.|+.|++++|+++ .+|...+.+++|..|++++|+++
T Consensus       123 l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~  199 (394)
T COG4886         123 LDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS  199 (394)
T ss_pred             cCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc
Confidence            3467777 8888888885 8888888888888 88888888888888888888887 78887778888888888888888


Q ss_pred             CCCCCCCcccccccCCccCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n   99 (362)
                      -.++.......+......+|
T Consensus       200 ~l~~~~~~~~~L~~l~~~~N  219 (394)
T COG4886         200 DLPPEIELLSALEELDLSNN  219 (394)
T ss_pred             cCchhhhhhhhhhhhhhcCC
Confidence            66554333333444445555

>PLN03210 Resistant to P

Probab=98.18  E-value=3.2e-06  Score=91.00  Aligned_cols=96  Identities=16%  Similarity=0.108  Sum_probs=58.8

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE   81 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~   81 (362)
                      ++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|.+++++++|+.|++++|..-+.
T Consensus       619 ~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~  696 (1153)
T PLN03210        619 QGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEI  696 (1153)
T ss_pred             cCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCc
Confidence            445554 5666666677777777776655556663 66677777777777655567777777777777777777644445


Q ss_pred             CCCCCcccccccCCccCC
Q 018036           82 IPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        82 ~p~~~~~~~~~~~~~~~n   99 (362)
                      +|....+..+..+.+.|+
T Consensus       697 Lp~~i~l~sL~~L~Lsgc  714 (1153)
T PLN03210        697 LPTGINLKSLYRLNLSGC  714 (1153)
T ss_pred             cCCcCCCCCCCEEeCCCC
Confidence            554333333333344443

syringae 6; Provisional

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.17  E-value=3.6e-07  Score=80.35  Aligned_cols=74  Identities=24%  Similarity=0.250  Sum_probs=58.4

Q ss_pred             ccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCC
Q 018036            6 FSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEI   82 (362)
Q Consensus         6 ~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~   82 (362)
                      .+|..-.++..+..|++||||+|.++ .|-++..-++.++.|+||+|.+. ++-. +..+++|+.||||+|.|+...
T Consensus       272 ~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~  345 (490)
T KOG1259|consen  272 SNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECV  345 (490)
T ss_pred             cCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhh
Confidence            34555556667788889999999888 78888888889999999999887 4544 788888999999999887543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.15  E-value=6.5e-07  Score=78.79  Aligned_cols=75  Identities=20%  Similarity=0.210  Sum_probs=61.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      ||+|.++ .|-++..-++.++.|+||+|.+. .+-. +..|.+|+.||||+|.|+ .+--+-.++.+.++|+|+.|.+.
T Consensus       291 LS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE  365 (490)
T KOG1259|consen  291 LSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE  365 (490)
T ss_pred             ccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh
Confidence            6788888 88888988999999999999998 5554 888999999999999997 56666666777777777777664

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.12  E-value=1.5e-06  Score=87.99  Aligned_cols=67  Identities=30%  Similarity=0.236  Sum_probs=32.6

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|+|+ .+|...   ++|+.|++++|+|+ .||..+   .+|+.|+|++|+|+ .+|...   ++|+.|++|+|+|++
T Consensus       350 S~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss  416 (788)
T PRK15387        350 SDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS  416 (788)
T ss_pred             CCCccC-CCCCCC---cccceehhhccccc-cCcccc---cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC
Confidence            455555 344321   23344444444444 244321   34566666666665 355432   345566666666654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.10  E-value=1.2e-06  Score=84.60  Aligned_cols=154  Identities=18%  Similarity=0.103  Sum_probs=108.3

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc-ceeEEEEEecCCeeeEEEecCCCC-
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKETNLLVYEYMPNG-  265 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-  265 (362)
                      +-.++++++++||.+....+....+.+...       ....-++++|.+++||| .+..++-++.+...+++++++..+ 
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            446889999999987654444445544211       22566889999999999 777777777788889999999776 


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeec
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS  345 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  345 (362)
                      +-..... .....+...+...+.+.-+++++++|..   .-+|||    ||+..+ +..|..||+....+....   ...
T Consensus       321 s~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~  388 (829)
T KOG0576|consen  321 SSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR  388 (829)
T ss_pred             cccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence            2222211 1112233444456667778899999953   258999    777665 578999999998876432   245


Q ss_pred             cccCccCcccccccc
Q 018036          346 AVAGSYGYIAPVLGW  360 (362)
Q Consensus       346 ~~~Gt~~y~aPE~~~  360 (362)
                      ...+|+.|+|||+.+
T Consensus       389 t~~~~~~~~~pev~~  403 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQ  403 (829)
T ss_pred             cCCCCCCCCCchhhc
Confidence            678999999999765

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.07  E-value=1.5e-07  Score=91.65  Aligned_cols=99  Identities=25%  Similarity=0.361  Sum_probs=57.5

Q ss_pred             CCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcch----------------------
Q 018036            3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK----------------------   60 (362)
Q Consensus         3 ~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~----------------------   60 (362)
                      .|+|. .+-.++.-++.|+.||||+|+|+ ..- .|..|++|++||||.|.|. .+|.                      
T Consensus       173 yN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL~  248 (1096)
T KOG1859|consen  173 YNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTLR  248 (1096)
T ss_pred             hhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhhh
Confidence            34444 44444555555666666666655 232 4555556666666666654 3442                      


Q ss_pred             hhcCCCCCCEEEccCCcccCCC--CCCCcccccccCCccCCCCCCCC
Q 018036           61 EMGNMKSLTSADFSHNNFSGEI--PEFGQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        61 ~~~~~~~l~~l~ls~n~l~g~~--p~~~~~~~~~~~~~~~n~~lc~~  105 (362)
                      .+.++++|..||||+|-|.+--  -....++.+..+.+.|||--|.+
T Consensus       249 gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  249 GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            2456778888888888777521  11223345556678899977754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.06  E-value=4.9e-05  Score=64.39  Aligned_cols=127  Identities=20%  Similarity=0.333  Sum_probs=88.7

Q ss_pred             hhccccceeeccCc-ccEEEEEcCCCCEEEEEEeeccCC---------CC----------CchhhHHHHHHHHhcCc---
Q 018036          182 ECVKDNNVIGRGGA-GVVYRGVTPNGEQVAVKKLLGITK---------GS----------SHDNGLSAEIRTLGKIR---  238 (362)
Q Consensus       182 ~~~~~~~~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~---------~~----------~~~~~~~~e~~~l~~l~---  238 (362)
                      ..++..+.||.|.- |.||+++. +|+.+|+|..+....         ..          ....-|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            45667789999999 99999998 567999998322110         00          11124788999888885   


Q ss_pred             cCcc--eeEEEEEecC------------------CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018036          239 HRNI--VRLKAFCSNK------------------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL  298 (362)
Q Consensus       239 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~L  298 (362)
                      +.++  |+.+||..-.                  ....||.||++...           .+.    .+-+.+|.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence            4455  8999987322                  11257888775432           122    23356777888899


Q ss_pred             hcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       299 H~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      |..+   |+-+|+++.|..     .-||+|||.+
T Consensus       181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCC---eeeccCcccccc-----CCEEEecccC
Confidence            9555   999999999986     5689999864

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.04  E-value=1.8e-06  Score=78.69  Aligned_cols=92  Identities=16%  Similarity=0.181  Sum_probs=77.1

Q ss_pred             ccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCcccCCCCCC-Ccccc
Q 018036           13 EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFSGEIPEF-GQYSF   90 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~   90 (362)
                      .+..|++|++|+|++|++++.=+.++..+..|+.|.|..|++. .+-. .|..++.|++|+|.+|+++-.-|.. ....+
T Consensus       269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~  347 (498)
T KOG4237|consen  269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS  347 (498)
T ss_pred             HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence            3788999999999999999888899999999999999999997 4443 5788999999999999999877753 33345


Q ss_pred             cccCCccCCCCCCCC
Q 018036           91 FNSTSFTGNPHLCGS  105 (362)
Q Consensus        91 ~~~~~~~~n~~lc~~  105 (362)
                      +..+...+||..|..
T Consensus       348 l~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  348 LSTLNLLSNPFNCNC  362 (498)
T ss_pred             eeeeehccCcccCcc
Confidence            556677899988864

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.04  E-value=1.8e-06  Score=82.33  Aligned_cols=78  Identities=26%  Similarity=0.249  Sum_probs=48.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      ||+|.|+-.=+..+-++++|+.++|.+|.|+ .||...+...+|+.|+|.+|.++..=.+++.-++.|+.||||.|.++
T Consensus        85 lsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is  162 (873)
T KOG4194|consen   85 LSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS  162 (873)
T ss_pred             ccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh
Confidence            4667777555556677777777777777777 67765555555666666666665322334555566666666666655

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.03  E-value=0.00011  Score=64.73  Aligned_cols=141  Identities=21%  Similarity=0.208  Sum_probs=80.4

Q ss_pred             ceeeccCcccEEEEEcCC--CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc-ceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTPN--GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.|..|-...+|+....+  +..+++|.......   ......+|+.++..+...+ .+++++...    ..++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence            456778888999998764  67888886543211   1112457888888885333 344444332    2489999998


Q ss_pred             CChhhh-----------------hcCCCC---------CCC-CHHHHHHHHH----------------------HHH---
Q 018036          265 GSLGEV-----------------LHGKRG---------SFL-KWEMRLKIAI----------------------EAA---  292 (362)
Q Consensus       265 gsL~~~-----------------l~~~~~---------~~~-~~~~~~~i~~----------------------~i~---  292 (362)
                      .++...                 +|....         ... .+.....+..                      .+.   
T Consensus        77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  156 (235)
T cd05157          77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI  156 (235)
T ss_pred             CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence            765321                 111110         011 1122111111                      111   


Q ss_pred             HHHH-HHhcC-CCCCeEEeCCCCCceeeCC-CCceEEccccccccc
Q 018036          293 KGLS-YLHHD-CSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYL  335 (362)
Q Consensus       293 ~~L~-~LH~~-~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~  335 (362)
                      ..+. .+-.. ....++|+|+.+.|||++. ++.+.++||..|..-
T Consensus       157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~  202 (235)
T cd05157         157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN  202 (235)
T ss_pred             HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence            1111 11111 1345899999999999997 578999999887653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.02  E-value=5.8e-05  Score=66.50  Aligned_cols=73  Identities=15%  Similarity=0.216  Sum_probs=43.9

Q ss_pred             ceeeccCcc-cEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccC---cceeEEEEEecCC---eeeEEEe
Q 018036          188 NVIGRGGAG-VVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR---NIVRLKAFCSNKE---TNLLVYE  260 (362)
Q Consensus       188 ~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e  260 (362)
                      +.|+.|+.. .||+.    +..+++|....    ......+.+|.+++..+...   -+.++++.....+   ..+++||
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            456766665 58876    23466775332    11223488999999877532   3444454443322   3488999


Q ss_pred             cCCCCChh
Q 018036          261 YMPNGSLG  268 (362)
Q Consensus       261 ~~~~gsL~  268 (362)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	362
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-28
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-22
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-20
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-19
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-18
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-08
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-05
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
3soa_A	444	Full-Length Human Camkii Length = 444		1e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-04
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 68/154 (44%), Positives = 89/154 (57%), Gaps = 4/154 (2%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G  VAVK+L    +    +     E+  +    HRN++RL+ FC      LLVY YM N
Sbjct: 61  DGTLVAVKRL-KEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 119
Query: 265 GSLGEVLHGKRGSF--LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           GS+   L  +  S   L W  R +IA+ +A+GL+YLH  C P IIHRDVK+ NILL+ +F
Sbjct: 120 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 179
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           EA V DFGLAK L D        AV G+ G+IAP
Sbjct: 180 EAVVGDFGLAK-LMDYKDXHVXXAVRGTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/154 (44%), Positives = 88/154 (57%), Gaps = 4/154 (2%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G  VAVK+L    +    +     E+  +    HRN++RL+ FC      LLVY YM N
Sbjct: 53  DGXLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 265 GSLGEVLHGKRGSF--LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           GS+   L  +  S   L W  R +IA+ +A+GL+YLH  C P IIHRDVK+ NILL+ +F
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           EA V DFGLAK L D        AV G  G+IAP
Sbjct: 172 EAVVGDFGLAK-LMDYKDXHVXXAVRGXIGHIAP 204

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/155 (40%), Positives = 88/155 (56%), Gaps = 6/155 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           N   VAVKKL  +   ++ +       EI+ + K +H N+V L  F S+ +   LVY YM
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 263 PNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
           PNGSL + L    G+  L W MR KIA  AA G+++LH +     IHRD+KS NILL+  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEA 169
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           F A ++DFGLA+  +    +   S + G+  Y+AP
Sbjct: 170 FTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/155 (39%), Positives = 87/155 (56%), Gaps = 6/155 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           N   VAVKKL  +   ++ +       EI+ + K +H N+V L  F S+ +   LVY YM
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 263 PNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
           PNGSL + L    G+  L W MR KIA  AA G+++LH +     IHRD+KS NILL+  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEA 169
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           F A ++DFGLA+  +    +     + G+  Y+AP
Sbjct: 170 FTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/155 (39%), Positives = 86/155 (55%), Gaps = 6/155 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           N   VAVKKL  +   ++ +       EI+ + K +H N+V L  F S+ +   LVY YM
Sbjct: 47  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 106
Query: 263 PNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
           PNGSL + L    G+  L W MR KIA  AA G+++LH +     IHRD+KS NILL+  
Sbjct: 107 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEA 163
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           F A ++DFGLA+  +          + G+  Y+AP
Sbjct: 164 FTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/121 (42%), Positives = 72/121 (59%), Gaps = 5/121 (4%)
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGL 295
           RH ++V L  FC  +   +L+Y+YM NG+L   L+G       + WE RL+I I AA+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
            YLH   +  IIHRDVKS NILL+ +F   + DFG++K   + G +     V G+ GYI 
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 356 P 356
           P
Sbjct: 210 P 210

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/155 (38%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           N   VAVKKL  +   ++ +       EI+   K +H N+V L  F S+ +   LVY Y 
Sbjct: 44  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYX 103
Query: 263 PNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
           PNGSL + L    G+  L W  R KIA  AA G+++LH +     IHRD+KS NILL+  
Sbjct: 104 PNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEA 160
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           F A ++DFGLA+  +        S + G+  Y AP
Sbjct: 161 FTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 51/121 (42%), Positives = 71/121 (58%), Gaps = 5/121 (4%)
Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGL 295
           RH ++V L  FC  +   +L+Y+YM NG+L   L+G       + WE RL+I I AA+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
            YLH   +  IIHRDVKS NILL+ +F   + DFG++K   +   +     V G+ GYI 
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 356 P 356
           P
Sbjct: 210 P 210

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/113 (43%), Positives = 64/113 (56%)
Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MS N  SG IP EIG    L  L+L  N +SG IP ++  +  LN L++S N+L+  +P+
Sbjct: 636 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 695
Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS 113
            M  +  LT  D S+NN SG IPE GQ+  F    F  NP LCG  L  C+ S
Sbjct: 696 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 748

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/113 (43%), Positives = 64/113 (56%)
Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MS N  SG IP EIG    L  L+L  N +SG IP ++  +  LN L++S N+L+  +P+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS 113
            M  +  LT  D S+NN SG IPE GQ+  F    F  NP LCG  L  C+ S
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/134 (36%), Positives = 74/134 (55%), Gaps = 7/134 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN--LLVYEYM 262
            GEQVAVK L     G +H   L  EI  L  + H NIV+ K  C+    N   L+ E++
Sbjct: 49  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P+GSL E L  K  + +  + +LK A++  KG+ YL    S   +HRD+ + N+L+ S+ 
Sbjct: 108 PSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEH 163
Query: 323 EAHVADFGLAKYLQ 336
           +  + DFGL K ++
Sbjct: 164 QVKIGDFGLTKAIE 177

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/134 (36%), Positives = 74/134 (55%), Gaps = 7/134 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN--LLVYEYM 262
            GEQVAVK L     G +H   L  EI  L  + H NIV+ K  C+    N   L+ E++
Sbjct: 37  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 95
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P+GSL E L  K  + +  + +LK A++  KG+ YL    S   +HRD+ + N+L+ S+ 
Sbjct: 96  PSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEH 151
Query: 323 EAHVADFGLAKYLQ 336
           +  + DFGL K ++
Sbjct: 152 QVKIGDFGLTKAIE 165

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           G  VAVK L+     +   N    E+  + ++RH NIV      +      +V EY+  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 266 SLGEVLH--GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
           SL  +LH  G R   L    RL +A + AKG++YLH+  +P I+HR++KS N+L++  + 
Sbjct: 120 SLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYT 177
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             V DFGL++    T  S    + AG+  ++AP
Sbjct: 178 VKVCDFGLSRLKASTFLSS--KSAAGTPEWMAP 208

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           G  VAVK L+     +   N    E+  + ++RH NIV      +      +V EY+  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 266 SLGEVLH--GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
           SL  +LH  G R   L    RL +A + AKG++YLH+  +P I+HRD+KS N+L++  + 
Sbjct: 120 SLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYT 177
Query: 324 AHVADFGLAKYLQDTGASECMSA--VAGSYGYIAP 356
             V DFGL++      AS  + +   AG+  ++AP
Sbjct: 178 VKVCDFGLSRL----KASXFLXSKXAAGTPEWMAP 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 86/169 (50%), Gaps = 33/169 (19%)
Query: 206 GEQVAVKKLLGITKGSSHD---------NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL 256
           G++VAVK        + HD           +  E +    ++H NI+ L+  C  KE NL
Sbjct: 30  GDEVAVK-------AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-KEPNL 81
Query: 257 -LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
            LV E+   G L  VL GKR   +  ++ +  A++ A+G++YLH +    IIHRD+KS+N
Sbjct: 82  CLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138
Query: 316 ILLNSDFE--------AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IL+    E          + DFGLA+    T     MSA AG+Y ++AP
Sbjct: 139 ILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSA-AGAYAWMAP 183

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + KIRH  +V+L A  S +E   +V EYM  GSL
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 34  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIXIVTEYMSKGSL 89
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 90  LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 146
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 147 DFGLARLIED 156

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVIEYMSKGSL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 33  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 88
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 89  LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 145
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 146 DFGLARLIED 155

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVIEYMSKGSL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 210 RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 265
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 322
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 323 DFGLARLIED 332

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 35  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 90
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 91  LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 147
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 148 DFGLARLIED 157

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 210 RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 265
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 322
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 323 DFGLARLIED 332

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 37  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 92
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 93  LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 149
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 150 DFGLARLIED 159

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 293 RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 348
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 406 DFGLARLIED 415

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVCEYMSKGSL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 7/133 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N ++VA+K    I +GS  ++    E   + K+ H  +V+L   C  +    LV+E+M +
Sbjct: 50  NKDKVAIKT---IKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 106
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L + L  +RG F   E  L + ++  +G++YL   C   +IHRD+ + N L+  +   
Sbjct: 107 GCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 162
Query: 325 HVADFGLAKYLQD 337
            V+DFG+ +++ D
Sbjct: 163 KVSDFGMTRFVLD 175

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 210 RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVGEYMSKGSL 265
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 322
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 323 DFGLARLIED 332

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+ + NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLAAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  G L
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVMEYMSKGCL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  G L
Sbjct: 44  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGCL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 41  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMNKGSL 96
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + ++ + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 153
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 154 DFGLARLIED 163

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 72/130 (55%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 41  RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMNKGSL 96
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + ++ + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 153
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 154 DFGLARLIED 163

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N ++VA+K    I +G+  +     E   + K+ H  +V+L   C  +    LV+E+M +
Sbjct: 28  NKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L + L  +RG F   E  L + ++  +G++YL   C   +IHRD+ + N L+  +   
Sbjct: 85  GCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 140
Query: 325 HVADFGLAKYLQD 337
            V+DFG+ +++ D
Sbjct: 141 KVSDFGMTRFVLD 153

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N ++VA+K    I +G+  +     E   + K+ H  +V+L   C  +    LV+E+M +
Sbjct: 30  NKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L + L  +RG F   E  L + ++  +G++YL   C   +IHRD+ + N L+  +   
Sbjct: 87  GCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 142
Query: 325 HVADFGLAKYLQD 337
            V+DFG+ +++ D
Sbjct: 143 KVSDFGMTRFVLD 155

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N ++VA+K    I +G+  +     E   + K+ H  +V+L   C  +    LV+E+M +
Sbjct: 33  NKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L + L  +RG F   E  L + ++  +G++YL   C   +IHRD+ + N L+  +   
Sbjct: 90  GCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 145
Query: 325 HVADFGLAKYLQD 337
            V+DFG+ +++ D
Sbjct: 146 KVSDFGMTRFVLD 158

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K+RH  +V+L A  S +E   +V EYM  GSL
Sbjct: 211 RVAIKTL---KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 266
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L G+ G +L+    + +A + A G++Y+        +HRD+++ NIL+  +    VA
Sbjct: 267 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 323
Query: 328 DFGLAKYLQD 337
           DFGL + ++D
Sbjct: 324 DFGLGRLIED 333

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 45  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 100
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 101 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 157
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 158 DFGLARLIED 167

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 48  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 103
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 104 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 160
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 161 DFGLARLIED 170

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 47  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 102
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 103 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 159
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 160 DFGLARLIED 169

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 49  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 104
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 105 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 161
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 162 DFGLARLIED 171

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 39  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 152 DFGLARLIED 161

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 73/131 (55%), Gaps = 7/131 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 39  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151
Query: 328 DFGLAKYLQDT 338
           DFGLA+ ++D 
Sbjct: 152 DFGLARLIEDA 162

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 41  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 96
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 97  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 153
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 154 DFGLARLIED 163

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 45  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 100
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 101 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 157
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 158 DFGLARLIED 167

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 40  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 95
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 96  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 152
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 153 DFGLARLIED 162

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 34  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 89
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 90  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 146
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 147 DFGLARLIED 156

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 39  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 152 DFGLARLIED 161

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 44  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 99
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 100 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 156
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 157 DFGLARLIED 166

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 39  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHRD+++ NIL++      +A
Sbjct: 95  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 152 DFGLARLIED 161

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 7/133 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N ++VA+K    I +G+  +     E   + K+ H  +V+L   C  +    LV E+M +
Sbjct: 31  NKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L + L  +RG F   E  L + ++  +G++YL   C   +IHRD+ + N L+  +   
Sbjct: 88  GCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 143
Query: 325 HVADFGLAKYLQD 337
            V+DFG+ +++ D
Sbjct: 144 KVSDFGMTRFVLD 156

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L  +            E+  L K RH NI+    + + K+   +V ++    SL 
Sbjct: 61  VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLY 119
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + LH +   F  +++ + IA + A+G+ YLH   +  IIHRD+KSNNI L+      + D
Sbjct: 120 KHLHVQETKFQMFQL-IDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGD 175
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S+ +    GS  ++AP
Sbjct: 176 FGLATVKSRWSGSQQVEQPTGSVLWMAP 203

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK L    +GS   +   AE   + +++H+ +VRL A  + +E   ++ EYM NGSL
Sbjct: 35  KVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 90
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  L     L +A + A+G++++        IHR++++ NIL++      +A
Sbjct: 91  VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRNLRAANILVSDTLSCKIA 147
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 148 DFGLARLIED 157

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 95
Query: 269 EVLHGKRGSFLKWEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
             LH    S  K+EM+  + IA + A+G+ YLH      IIHRD+KSNNI L+ D    +
Sbjct: 96  HHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKI 149
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            DFGLA        S     ++GS  ++AP
Sbjct: 150 GDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 42  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 99
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 100 YGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 70/133 (52%), Gaps = 7/133 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N ++VA+K    I +G+  +     E   + K+ H  +V+L   C  +    LV+E+M +
Sbjct: 30  NKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L + L  +RG F   E  L + ++  +G++YL       +IHRD+ + N L+  +   
Sbjct: 87  GCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAS---VIHRDLAARNCLVGENQVI 142
Query: 325 HVADFGLAKYLQD 337
            V+DFG+ +++ D
Sbjct: 143 KVSDFGMTRFVLD 155

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 107
Query: 269 EVLHGKRGSFLKWEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
             LH    S  K+EM+  + IA + A+G+ YLH      IIHRD+KSNNI L+ D    +
Sbjct: 108 HHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKI 161
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            DFGLA        S     ++GS  ++AP
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGLA+ L+D
Sbjct: 190 DFGLARVLED 199

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 70  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 128 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 181
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 182 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 38  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 95
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 96  YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 149
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 150 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 37  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 94
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 95  YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 148
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 149 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 57  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 114
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 115 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 168
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 39  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 96
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 97  YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 71/130 (54%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T+    D     E   +G+  H NI+RL+   S  +  +++ EYM NG+L
Sbjct: 76  VAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L  K G F   ++ + +    A G+ YL +      +HRD+ + NIL+NS+    V+
Sbjct: 134 DKFLREKDGEFSVLQL-VGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 39  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 96
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 97  YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 42  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 99
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 100 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ E++P
Sbjct: 42  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLP 99
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL E L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 100 YGSLREYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 43  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 100
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 101 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 154
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 155 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 44  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 101
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 102 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 155
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 156 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 46  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 103
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 104 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 157
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 158 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 45  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 102
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 103 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 156
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 157 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 57  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 114
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 115 YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 168
Query: 322 FEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
               + DFGL K L QD    +          + AP
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/134 (38%), Positives = 70/134 (52%), Gaps = 12/134 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 39  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 96
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHRD+ + NIL+ ++
Sbjct: 97  YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 322 FEAHVADFGLAKYL 335
               + DFGL K L
Sbjct: 151 NRVKIGDFGLTKVL 164

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/131 (38%), Positives = 73/131 (55%), Gaps = 9/131 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-ETNL-LVYEYM 262
            GE VAVK L     G  H +G   EI  L  + H +I++ K  C ++ E +L LV EY+
Sbjct: 42  TGEMVAVKALKADC-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P GSL + L   R S    ++ L  A +  +G++YLH   S   IHR++ + N+LL++D 
Sbjct: 101 PLGSLRDYL--PRHSIGLAQLLL-FAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDR 154
Query: 323 EAHVADFGLAK 333
              + DFGLAK
Sbjct: 155 LVKIGDFGLAK 165

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/131 (36%), Positives = 70/131 (53%), Gaps = 9/131 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYEYM 262
            GE VAVK L     G  H +G   EI  L  + H +I++ K  C +    +  LV EY+
Sbjct: 59  TGEMVAVKALKA-DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P GSL + L   R S    ++ L  A +  +G++YLH   +   IHRD+ + N+LL++D 
Sbjct: 118 PLGSLRDYL--PRHSIGLAQLLL-FAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDR 171
Query: 323 EAHVADFGLAK 333
              + DFGLAK
Sbjct: 172 LVKIGDFGLAK 182

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 64  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 121
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 122 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 177
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 178 DFGLSRVLED 187

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 93
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 94  HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 149
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 150 FGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 91
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 92  HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 96
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 97  HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 152
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 153 FGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 47  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 104
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 105 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 160
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 161 DFGLSRVLED 170

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 96
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 97  HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 152
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 153 FGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 74  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 131
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 132 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 187
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 188 DFGLSRVLED 197

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + +  +   +V ++    SL 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLY 107
Query: 269 EVLHGKRGSFLKWEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
             LH    S  K+EM+  + IA + A+G+ YLH      IIHRD+KSNNI L+ D    +
Sbjct: 108 HHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKI 161
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            DFGLA        S     ++GS  ++AP
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/131 (37%), Positives = 73/131 (55%), Gaps = 9/131 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-ETNL-LVYEYM 262
            GE VAVK L     G  H +G   EI  L  + H +I++ K  C ++ E +L LV EY+
Sbjct: 42  TGEMVAVKALKADC-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P GSL + L   R S    ++ L  A +  +G++YLH   +   IHR++ + N+LL++D 
Sbjct: 101 PLGSLRDYL--PRHSIGLAQLLL-FAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDR 154
Query: 323 EAHVADFGLAK 333
              + DFGLAK
Sbjct: 155 LVKIGDFGLAK 165

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 91
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 92  HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 148 FGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 118
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 119 HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 174
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 175 FGLATVKSRWSGSHQFEQLSGSILWMAP 202

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V EYM NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL + L+D
Sbjct: 190 DFGLGRVLED 199

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 119
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 120 HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 175
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 176 FGLATVKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 6/133 (4%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N  +VAVK L     G+        E   +  ++H  +VRL A  + +E   ++ EYM  
Sbjct: 36  NSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAK 92
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           GSL + L    G  +     +  + + A+G++Y+        IHRD+++ N+L++     
Sbjct: 93  GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMC 149
Query: 325 HVADFGLAKYLQD 337
            +ADFGLA+ ++D
Sbjct: 150 KIADFGLARVIED 162

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 72/141 (51%), Gaps = 5/141 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K L G          LS E   +G+  H NI+RL+   +N    +++ E+M NG+L 
Sbjct: 45  VAIKTLKGGYTERQRREFLS-EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALD 103
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L    G F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+D
Sbjct: 104 SFLRLNDGQFTVIQL-VGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSD 159
Query: 329 FGLAKYLQDTGASECMSAVAG 349
           FGL+++L++  +    ++  G
Sbjct: 160 FGLSRFLEENSSDPTYTSSLG 180

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 111
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 112 HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 167
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 168 FGLATEKSRWSGSHQFEQLSGSILWMAP 195

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VA+K L     G+        E + + K++H  +V+L A  S +E   +V EYM  GSL
Sbjct: 35  KVAIKTL---KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS-EEPIYIVTEYMNKGSL 90
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    G  LK    + +A + A G++Y+        IHRD++S NIL+ +     +A
Sbjct: 91  LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGNGLICKIA 147
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 148 DFGLARLIED 157

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + S K    +V ++    SL 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLY 119
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 120 HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 175
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 176 FGLATEKSRWSGSHQFEQLSGSILWMAP 203

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K L G          LS E   +G+  H NI+RL+   +N    +++ E+M NG+L 
Sbjct: 47  VAIKTLKGGYTERQRREFLS-EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALD 105
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L    G F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+D
Sbjct: 106 SFLRLNDGQFTVIQL-VGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSD 161
Query: 329 FGLAKYLQD 337
           FGL+++L++
Sbjct: 162 FGLSRFLEE 170

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/134 (37%), Positives = 70/134 (52%), Gaps = 12/134 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNL-LVYEYMP 263
           GE VAVKKL   T+   H      EI  L  ++H NIV+ K  C S    NL L+ EY+P
Sbjct: 40  GEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 97
Query: 264 NGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
            GSL + L  H +R   +K    L+   +  KG+ YL    +   IHR++ + NIL+ ++
Sbjct: 98  YGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRNLATRNILVENE 151
Query: 322 FEAHVADFGLAKYL 335
               + DFGL K L
Sbjct: 152 NRVKIGDFGLTKVL 165

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 68/148 (45%), Gaps = 5/148 (3%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L               E+  L K RH NI+    + +  +  + V ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLY 91
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             LH     F   ++ + IA + A+G+ YLH      IIHRD+KSNNI L+ D    + D
Sbjct: 92  HHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA        S     ++GS  ++AP
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 6/133 (4%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N  +VAVK L     G+        E   +  ++H  +VRL A  + +E   ++ E+M  
Sbjct: 35  NSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAK 91
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           GSL + L    G  +     +  + + A+G++Y+        IHRD+++ N+L++     
Sbjct: 92  GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMC 148
Query: 325 HVADFGLAKYLQD 337
            +ADFGLA+ ++D
Sbjct: 149 KIADFGLARVIED 161

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 72/139 (51%), Gaps = 11/139 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMP 263
            G +VAVK +    K  +      AE   + ++RH N+V+L      ++  L +V EYM 
Sbjct: 215 RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL + L  +  S L  +  LK +++  + + YL  +     +HRD+ + N+L++ D  
Sbjct: 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNV 327
Query: 324 AHVADFGLAKY---LQDTG 339
           A V+DFGL K     QDTG
Sbjct: 328 AKVSDFGLTKEASSTQDTG 346

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 209 VAVKKLL-GITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T+    D    +E   +G+  H N++ L+   +     +++ E+M NGSL
Sbjct: 64  VAIKTLKSGYTEKQRRD--FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 121
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +    A G+ YL  D +   +HRD+ + NIL+NS+    V+
Sbjct: 122 DSFLRQNDGQFTVIQL-VGMLRGIAAGMKYLA-DMN--YVHRDLAARNILVNSNLVCKVS 177
Query: 328 DFGLAKYLQDTGASECMSAVAG 349
           DFGL+++L+D  +    ++  G
Sbjct: 178 DFGLSRFLEDDTSDPTYTSALG 199

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 19/158 (12%)
Query: 209 VAVKKL-LGITKGSSHD----NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           VA+K L LG ++G +           E+  +  + H NIV+L     N     +V E++P
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            G L   L  K    +KW ++L++ ++ A G+ Y+ +  +P I+HRD++S NI L S  E
Sbjct: 105 CGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDE 162
Query: 324 -----AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                A VADFGL++      +   +S + G++ ++AP
Sbjct: 163 NAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAP 195

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMP 263
            G +VAVK      K  +      AE   + ++RH N+V+L      ++  L +V EYM 
Sbjct: 34  RGNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 89
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL + L  +  S L  +  LK +++  + + YL  +     +HRD+ + N+L++ D  
Sbjct: 90  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNV 146
Query: 324 AHVADFGLAKY---LQDTG 339
           A V+DFGL K     QDTG
Sbjct: 147 AKVSDFGLTKEASSTQDTG 165

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V E M NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL    +   +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMP 263
            G +VAVK      K  +      AE   + ++RH N+V+L      ++  L +V EYM 
Sbjct: 28  RGNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL + L  +  S L  +  LK +++  + + YL  +     +HRD+ + N+L++ D  
Sbjct: 84  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNV 140
Query: 324 AHVADFGLAKY---LQDTG 339
           A V+DFGL K     QDTG
Sbjct: 141 AKVSDFGLTKEASSTQDTG 159

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 11/139 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMP 263
            G +VAVK      K  +      AE   + ++RH N+V+L      ++  L +V EYM 
Sbjct: 43  RGNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL + L  +  S L  +  LK +++  + + YL  +     +HRD+ + N+L++ D  
Sbjct: 99  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNV 155
Query: 324 AHVADFGLAKY---LQDTG 339
           A V+DFGL K     QDTG
Sbjct: 156 AKVSDFGLTKEASSTQDTG 174

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T+    D    +E   +G+  H NI+RL+   +     ++V EYM NGSL
Sbjct: 80  VAIKALKAGYTERQRRD--FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +      G+ YL  D     +HRD+ + N+L++S+    V+
Sbjct: 138 DTFLRTHDGQFTIMQL-VGMLRGVGAGMRYL-SDLG--YVHRDLAARNVLVDSNLVCKVS 193
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 194 DFGLSRVLED 203

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T+    D    +E   +G+  H NI+RL+   +     ++V EYM NGSL
Sbjct: 80  VAIKALKAGYTERQRRD--FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +      G+ YL  D     +HRD+ + N+L++S+    V+
Sbjct: 138 DTFLRTHDGQFTIMQL-VGMLRGVGAGMRYL-SDLG--YVHRDLAARNVLVDSNLVCKVS 193
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 194 DFGLSRVLED 203

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+ L+   +  +  ++V EYM NGSL
Sbjct: 53  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 110
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +    + G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 111 DTFLKKNDGQFTVIQL-VGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 166
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 167 DFGLSRVLED 176

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           T +G Q  +K++  I++ SS +   S  E+  L  ++H NIV+ +       +  +V +Y
Sbjct: 46  TEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
              G L + ++ ++G   + +  L   ++    L ++H      I+HRD+KS NI L  D
Sbjct: 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKD 161
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               + DFG+A+ L  T   E   A  G+  Y++P
Sbjct: 162 GTVQLGDFGIARVLNST--VELARACIGTPYYLSP 194

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 230 EIRTLGKIRHRNIVRLKAF---CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRL 285
           EI +   ++H N+++  A     SN E  L L+  +   GSL + L   +G+ + W    
Sbjct: 59  EIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELC 115
Query: 286 KIAIEAAKGLSYLHHDC--------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
            +A   ++GLSYLH D          P I HRD KS N+LL SD  A +ADFGLA   + 
Sbjct: 116 HVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEP 175
Query: 338 TGASECMSAVAGSYGYIAP 356
                      G+  Y+AP
Sbjct: 176 GKPPGDTHGQVGTRRYMAP 194

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
            G +VAVK +L   K  S D    +  EI+ L   RH +I++L    S      +V EY+
Sbjct: 40  TGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
             G L + +  K G   + E R ++  +   G+ Y H     +++HRD+K  N+LL++  
Sbjct: 99  SGGELFDYI-CKNGRLDEKESR-RLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHM 153
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            A +ADFGL+  + D    E +    GS  Y AP
Sbjct: 154 NAKIADFGLSNMMSD---GEFLRXSCGSPNYAAP 184

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V E M NGSL
Sbjct: 47  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 104
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 105 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 160
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 161 DFGLSRVLED 170

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D     E   +G+  H NI+RL+   +  +  ++V E M NGSL
Sbjct: 76  VAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L      F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 134 DSFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189
Query: 328 DFGLAKYLQD 337
           DFGL++ L+D
Sbjct: 190 DFGLSRVLED 199

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 8/135 (5%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSA---EIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260
           P GE + +   + + +  S      A    +  +G + H +IVRL   C      L V +
Sbjct: 36  PEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQ 94
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           Y+P GSL + +   RG+ L  ++ L   ++ AKG+ YL       ++HR++ + N+LL S
Sbjct: 95  YLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKS 150
Query: 321 DFEAHVADFGLAKYL 335
             +  VADFG+A  L
Sbjct: 151 PSQVQVADFGVADLL 165

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 204 PNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260
           P GE + +    K++    G      ++  +  +G + H +IVRL   C      L V +
Sbjct: 54  PEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQ 112
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           Y+P GSL + +   RG+ L  ++ L   ++ AKG+ YL       ++HR++ + N+LL S
Sbjct: 113 YLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKS 168
Query: 321 DFEAHVADFGLAKYL 335
             +  VADFG+A  L
Sbjct: 169 PSQVQVADFGVADLL 183

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G++VAVK +      SS    L  E+R +  + H NIV+L      ++T  LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 98  GEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCHQK---FIVHRDLKAENLLLDADMNI 152
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +    +      + A  G+  Y AP L
Sbjct: 153 KIADFGFS---NEFTFGNKLDAFCGAPPYAAPEL 183

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK    I +GS  ++    E +T+ K+ H  +V+    CS +    +V EY+ NG L 
Sbjct: 35  VAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L    G  L+    L++  +  +G+++L    S   IHRD+ + N L++ D    V+D
Sbjct: 92  NYLRS-HGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSD 147
Query: 329 FGLAKYLQD 337
           FG+ +Y+ D
Sbjct: 148 FGMTRYVLD 156

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL----KAFCSNKETNLLVYEYM 262
           E VAVK +  I    S  N    E+ +L  ++H NI++     K   S      L+  + 
Sbjct: 48  EYVAVK-IFPIQDKQSWQN--EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-------SPLIIHRDVKSNN 315
             GSL + L   + + + W     IA   A+GL+YLH D         P I HRD+KS N
Sbjct: 105 EKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161
Query: 316 ILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +LL ++  A +ADFGLA   +   ++       G+  Y+AP
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 19/158 (12%)
Query: 209 VAVKKL-LGITKGSSHD----NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           VA+K L LG ++G +           E+  +  + H NIV+L     N     +V E++P
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            G L   L  K    +KW ++L++ ++ A G+ Y+ +  +P I+HRD++S NI L S  E
Sbjct: 105 CGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDE 162
Query: 324 -----AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                A VADFG ++      +   +S + G++ ++AP
Sbjct: 163 NAPVCAKVADFGTSQQ-----SVHSVSGLLGNFQWMAP 195

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 13/154 (8%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
             + VA+K++    +  S       E+R L ++ H NIV+L   C N     LV EY   
Sbjct: 31  RAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEG 84
Query: 265 GSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
           GSL  VLHG     +      +   ++ ++G++YLH      +IHRD+K  N+LL +   
Sbjct: 85  GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 144
Query: 324 A-HVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              + DFG A  +Q       M+   GS  ++AP
Sbjct: 145 VLKICDFGTACDIQTH-----MTNNKGSAAWMAP 173

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G++VAVK +      SS    L  E+R +  + H NIV+L      ++T  LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 98  GEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCHQK---FIVHRDLKAENLLLDADMNI 152
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +    +      +    GS  Y AP L
Sbjct: 153 KIADFGFS---NEFTFGNKLDTFCGSPPYAAPEL 183

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G++VAVK +      SS    L  E+R +  + H NIV+L      ++T  LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 98  GEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCHQK---FIVHRDLKAENLLLDADMNI 152
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +    +      +    GS  Y AP L
Sbjct: 153 KIADFGFS---NEFTFGNKLDTFCGSPPYAAPEL 183

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 13/154 (8%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
             + VA+K++    +  S       E+R L ++ H NIV+L   C N     LV EY   
Sbjct: 30  RAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEG 83
Query: 265 GSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
           GSL  VLHG     +      +   ++ ++G++YLH      +IHRD+K  N+LL +   
Sbjct: 84  GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143
Query: 324 A-HVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              + DFG A  +Q       M+   GS  ++AP
Sbjct: 144 VLKICDFGTACDIQTH-----MTNNKGSAAWMAP 172

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 19/158 (12%)
Query: 209 VAVKKL-LGITKGSSHD----NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           VA+K L LG ++G +           E+  +  + H NIV+L     N     +V E++P
Sbjct: 47  VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            G L   L  K    +KW ++L++ ++ A G+ Y+ +  +P I+HRD++S NI L S  E
Sbjct: 105 CGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDE 162
Query: 324 -----AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                A VADF L++      +   +S + G++ ++AP
Sbjct: 163 NAPVCAKVADFSLSQQ-----SVHSVSGLLGNFQWMAP 195

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K    I +GS  ++    E + +  + H  +V+L   C+ +    ++ EYM NG L 
Sbjct: 31  VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L   R  F   ++ L++  +  + + YL    S   +HRD+ + N L+N      V+D
Sbjct: 88  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 143
Query: 329 FGLAKYLQD 337
           FGL++Y+ D
Sbjct: 144 FGLSRYVLD 152

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K    I +GS  ++    E + +  + H  +V+L   C+ +    ++ EYM NG L 
Sbjct: 35  VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 91
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L   R  F   ++ L++  +  + + YL    S   +HRD+ + N L+N      V+D
Sbjct: 92  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 147
Query: 329 FGLAKYLQD 337
           FGL++Y+ D
Sbjct: 148 FGLSRYVLD 156

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K    I +GS  ++    E + +  + H  +V+L   C+ +    ++ EYM NG L 
Sbjct: 36  VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L   R  F   ++ L++  +  + + YL    S   +HRD+ + N L+N      V+D
Sbjct: 93  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 148
Query: 329 FGLAKYLQD 337
           FGL++Y+ D
Sbjct: 149 FGLSRYVLD 157

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K    I +GS  ++    E + +  + H  +V+L   C+ +    ++ EYM NG L 
Sbjct: 51  VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L   R  F   ++ L++  +  + + YL    S   +HRD+ + N L+N      V+D
Sbjct: 108 NYLREMRHRFQTQQL-LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 163
Query: 329 FGLAKYLQD 337
           FGL++Y+ D
Sbjct: 164 FGLSRYVLD 172

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K    I +GS  ++    E + +  + H  +V+L   C+ +    ++ EYM NG L 
Sbjct: 36  VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L   R  F   ++ L++  +  + + YL    S   +HRD+ + N L+N      V+D
Sbjct: 93  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 148
Query: 329 FGLAKYLQD 337
           FGL++Y+ D
Sbjct: 149 FGLSRYVLD 157

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K    I +GS  ++    E + +  + H  +V+L   C+ +    ++ EYM NG L 
Sbjct: 51  VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L   R  F   ++ L++  +  + + YL    S   +HRD+ + N L+N      V+D
Sbjct: 108 NYLREMRHRFQTQQL-LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 163
Query: 329 FGLAKYLQD 337
           FGL++Y+ D
Sbjct: 164 FGLSRYVLD 172

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
            G +VAVK +L   K  S D    +  EI+ L   RH +I++L    S      +V EY+
Sbjct: 35  TGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
             G L + +  K G   + E R ++  +    + Y H     +++HRD+K  N+LL++  
Sbjct: 94  SGGELFDYI-CKHGRVEEMEAR-RLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHM 148
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            A +ADFGL+  + D    E +    GS  Y AP
Sbjct: 149 NAKIADFGLSNMMSD---GEFLRTSCGSPNYAAP 179

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K    I +GS  ++    E + +  + H  +V+L   C+ +    ++ EYM NG L 
Sbjct: 42  VAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 98
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L   R  F   ++ L++  +  + + YL    S   +HRD+ + N L+N      V+D
Sbjct: 99  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 154
Query: 329 FGLAKYLQD 337
           FGL++Y+ D
Sbjct: 155 FGLSRYVLD 163

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T     D    +E   +G+  H NI+ L+   +  +  +++ EYM NGSL
Sbjct: 60  VAIKTLKAGYTDKQRRD--FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 117
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +      G+ YL    +   +HRD+ + NIL+NS+    V+
Sbjct: 118 DAFLRKNDGRFTVIQL-VGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVS 173
Query: 328 DFGLAKYLQD 337
           DFG+++ L+D
Sbjct: 174 DFGMSRVLED 183

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 69/130 (53%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L +G T+    D    A I  +G+  H N+V L+   +  +  ++V E+M NG+L
Sbjct: 74  VAIKTLKVGYTEKQRRDFLCEASI--MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGAL 131
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +    A G+ YL        +HRD+ + NIL+NS+    V+
Sbjct: 132 DAFLRKHDGQFTVIQL-VGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVS 187
Query: 328 DFGLAKYLQD 337
           DFGL++ ++D
Sbjct: 188 DFGLSRVIED 197

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK +     GS       AE   +  ++H  +V+L A  + KE   ++ E+M  GSL
Sbjct: 41  KVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 96
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    GS       +  + + A+G++++        IHRD+++ NIL+++     +A
Sbjct: 97  LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIA 153
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 154 DFGLARVIED 163

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G++VAV+ +      SS    L  E+R +  + H NIV+L      ++T  LV EY   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 98  GEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCHQK---FIVHRDLKAENLLLDADMNI 152
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +    +      +    GS  Y AP L
Sbjct: 153 KIADFGFS---NEFTFGNKLDTFCGSPPYAAPEL 183

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T     D    +E   +G+  H NI+ L+   +  +  +++ EYM NGSL
Sbjct: 39  VAIKTLKAGYTDKQRRD--FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 96
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +      G+ YL  D S   +HRD+ + NIL+NS+    V+
Sbjct: 97  DAFLRKNDGRFTVIQL-VGMLRGIGSGMKYLS-DMS--YVHRDLAARNILVNSNLVCKVS 152
Query: 328 DFGLAKYLQD 337
           DFG+++ L+D
Sbjct: 153 DFGMSRVLED 162

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 36  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 94
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 95  DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 150
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D  A+E      G+  Y++P
Sbjct: 151 DFGVSGQLIDEMANE----FVGTRSYMSP 175

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK +     GS       AE   +  ++H  +V+L A  + KE   ++ E+M  GSL
Sbjct: 214 KVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    GS       +  + + A+G++++        IHRD+++ NIL+++     +A
Sbjct: 270 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIA 326
Query: 328 DFGLAKYLQD 337
           DFGLA+ ++D
Sbjct: 327 DFGLARVIED 336

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T     D    +E   +G+  H NI+ L+   +  +  +++ EYM NGSL
Sbjct: 45  VAIKTLKAGYTDKQRRD--FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 102
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +      G+ YL  D S   +HRD+ + NIL+NS+    V+
Sbjct: 103 DAFLRKNDGRFTVIQL-VGMLRGIGSGMKYLS-DMS--YVHRDLAARNILVNSNLVCKVS 158
Query: 328 DFGLAKYLQD 337
           DFG+++ L+D
Sbjct: 159 DFGMSRVLED 168

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G++VAVK +      SS    L  E+R +  + H NIV+L      ++T  LV EY   
Sbjct: 31  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 90
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 91  GEVFDYLVA-HGWMKEKEARAKFR-QIVSAVQYCHQK---FIVHRDLKAENLLLDADMNI 145
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +    +      +    GS  Y AP L
Sbjct: 146 KIADFGFS---NEFTFGNKLDTFCGSPPYAAPEL 176

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G++VAV+ +      SS    L  E+R +  + H NIV+L      ++T  LV EY   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 98  GEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCHQK---FIVHRDLKAENLLLDADMNI 152
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +    +      +    GS  Y AP L
Sbjct: 153 KIADFGFS---NEFTFGNKLDEFCGSPPYAAPEL 183

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 209 VAVKKLL-GITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G T+    D    +E   +G+  H N++ L+   +     +++ E+M NGSL
Sbjct: 38  VAIKTLKSGYTEKQRRD--FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 95
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
              L    G F   ++ + +    A G+ YL  D +   +HR + + NIL+NS+    V+
Sbjct: 96  DSFLRQNDGQFTVIQL-VGMLRGIAAGMKYLA-DMN--YVHRALAARNILVNSNLVCKVS 151
Query: 328 DFGLAKYLQDTGASECMSAVAG 349
           DFGL+++L+D  +    ++  G
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALG 173

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHD--NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
            G +VAVK +L   K  S D    +  EI+ L   RH +I++L    S      +V EY+
Sbjct: 35  TGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
             G L + +  K G   + E R ++  +    + Y H     +++HRD+K  N+LL++  
Sbjct: 94  SGGELFDYI-CKHGRVEEMEAR-RLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHM 148
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            A +ADFGL+  + D    E +    GS  Y AP
Sbjct: 149 NAKIADFGLSNMMSD---GEFLRDSCGSPNYAAP 179

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + H+++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 86  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 144
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +   G  YLH +    +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    
Sbjct: 145 LR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKV 198
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 199 LCGTPNYIAP 208

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 80/149 (53%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           +  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 43  IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 101
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K    +  E+  K++I   +GL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 102 DQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLC 157
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y+AP
Sbjct: 158 DFGVSGQLIDSMA----NSFVGTRSYMAP 182

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + H+++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 68  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 126
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +   G  YLH +    +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    
Sbjct: 127 LR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKT 180
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 181 LCGTPNYIAP 190

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + H+++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 122
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +   G  YLH +    +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    
Sbjct: 123 LR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKT 176
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 177 LCGTPNYIAP 186

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + H+++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 146
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +   G  YLH +    +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    
Sbjct: 147 LR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKV 200
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 201 LCGTPNYIAP 210

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + H+++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 122
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +   G  YLH +    +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    
Sbjct: 123 LR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKT 176
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 177 LCGTPNYIAP 186

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + H+++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 120
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +   G  YLH +    +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    
Sbjct: 121 LR-QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKV 174
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 175 LCGTPNYIAP 184

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 91
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 92  DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 147
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 148 DFGVSGQLIDSMA----NSFVGTRSYMSP 172

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 95  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 153
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 154 DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 209
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 210 DFGVSGQLIDSMA----NSFVGTRSYMSP 234

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 91
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 92  DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 147
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 148 DFGVSGQLIDSMA----NSFVGTRSYMSP 172

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMP 263
           N  ++A+K++    + S +   L  EI     ++H+NIV+ L +F  N    + + E +P
Sbjct: 46  NQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVP 102
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKI-AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-D 321
            GSL  +L  K G     E  +     +  +GL YLH +    I+HRD+K +N+L+N+  
Sbjct: 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYS 159
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               ++DFG +K L   G + C     G+  Y+AP
Sbjct: 160 GVLKISDFGTSKRL--AGINPCTETFTGTLQYMAP 192

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMP 263
           N  ++A+K++    + S +   L  EI     ++H+NIV+ L +F  N    + + E +P
Sbjct: 32  NQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVP 88
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-D 321
            GSL  +L  K G     E  +     +  +GL YLH +    I+HRD+K +N+L+N+  
Sbjct: 89  GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYS 145
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               ++DFG +K L   G + C     G+  Y+AP
Sbjct: 146 GVLKISDFGTSKRL--AGINPCTETFTGTLQYMAP 178

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 91
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 92  DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 147
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 148 DFGVSGQLIDSMA----NSFVGTRSYMSP 172

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 91
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 92  DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 147
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 148 DFGVSGQLIDSMA----NSFVGTRSYMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 91
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 92  DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 147
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 148 DFGVSGQLIDSMA----NSFVGTRSYMSP 172

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 8/137 (5%)
Query: 203 TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
            P GE V +    K+L  T G   +     E   +  + H ++VRL   C +  T  LV 
Sbjct: 37  VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 95
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           + MP+G L E +H  + + +  ++ L   ++ AKG+ YL       ++HRD+ + N+L+ 
Sbjct: 96  QLMPHGCLLEYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVK 151
Query: 320 SDFEAHVADFGLAKYLQ 336
           S     + DFGLA+ L+
Sbjct: 152 SPNHVKITDFGLARLLE 168

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G++VAVK +      SS    L  E+R    + H NIV+L      ++T  LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 265 GSLGE--VLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           G + +  V HG+     + E R K   +    + Y H      I+HRD+K+ N+LL++D 
Sbjct: 98  GEVFDYLVAHGRXK---EKEARAKFR-QIVSAVQYCHQK---FIVHRDLKAENLLLDADX 150
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
              +ADFG +    +      + A  G+  Y AP L
Sbjct: 151 NIKIADFGFS---NEFTFGNKLDAFCGAPPYAAPEL 183

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 8/137 (5%)
Query: 203 TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
            P GE V +    K+L  T G   +     E   +  + H ++VRL   C +  T  LV 
Sbjct: 60  VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 118
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           + MP+G L E +H  + + +  ++ L   ++ AKG+ YL       ++HRD+ + N+L+ 
Sbjct: 119 QLMPHGCLLEYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVK 174
Query: 320 SDFEAHVADFGLAKYLQ 336
           S     + DFGLA+ L+
Sbjct: 175 SPNHVKITDFGLARLLE 191

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 60  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 118
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 119 DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 174
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 175 DFGVSGQLIDSMA----NSFVGTRSYMSP 199

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYEYM 262
            GE VAVK L     G    +G   EI  L  + H +IV+ K  C ++  ++  LV EY+
Sbjct: 36  TGEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P GSL + L        +    L  A +  +G++YLH   +   IHR + + N+LL++D 
Sbjct: 95  PLGSLRDYLPRHCVGLAQL---LLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDR 148
Query: 323 EAHVADFGLAK 333
              + DFGLAK
Sbjct: 149 LVKIGDFGLAK 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLVYEYM 262
            GE VAVK L     G    +G   EI  L  + H +IV+ K  C ++  ++  LV EY+
Sbjct: 37  TGEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P GSL + L        +    L  A +  +G++YLH   +   IHR + + N+LL++D 
Sbjct: 96  PLGSLRDYLPRHCVGLAQL---LLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDR 149
Query: 323 EAHVADFGLAK 333
              + DFGLAK
Sbjct: 150 LVKIGDFGLAK 160

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 7/154 (4%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G  VA+KK L              EI+ L ++RH N+V L   C  K+   LV+E++ +
Sbjct: 49  TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L ++     G  L +++  K   +   G+ + H   S  IIHRD+K  NIL++     
Sbjct: 109 TILDDLELFPNG--LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVV 163
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            + DFG A+ L   G  E       +  Y AP L
Sbjct: 164 KLCDFGFARTLAAPG--EVYDDEVATRWYRAPEL 195

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
            P  E+VA+K++  + K  +  + L  EI+ + +  H NIV        K+   LV + +
Sbjct: 32  APKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 90
Query: 263 PNGSLGEVLH------GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
             GS+ +++         +   L       I  E  +GL YLH +     IHRDVK+ NI
Sbjct: 91  SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNI 147
Query: 317 LLNSDFEAHVADFGLAKYLQ---DTGASECMSAVAGSYGYIAP 356
           LL  D    +ADFG++ +L    D   ++      G+  ++AP
Sbjct: 148 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
            P  E+VA+K++  + K  +  + L  EI+ + +  H NIV        K+   LV + +
Sbjct: 37  APKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95
Query: 263 PNGSLGEVLH------GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
             GS+ +++         +   L       I  E  +GL YLH +     IHRDVK+ NI
Sbjct: 96  SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNI 152
Query: 317 LLNSDFEAHVADFGLAKYLQ---DTGASECMSAVAGSYGYIAP 356
           LL  D    +ADFG++ +L    D   ++      G+  ++AP
Sbjct: 153 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMPNGSL 267
           V  +KL+ +    +  N +  E++ L +     IV    AF S+ E ++ + E+M  GSL
Sbjct: 52  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL 110
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            +VL  K+   +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + 
Sbjct: 111 DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 166
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG++  L D+ A    ++  G+  Y++P
Sbjct: 167 DFGVSGQLIDSMA----NSFVGTRSYMSP 191

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G+ VA+KK L              EIR L +++H N+V L      K    LV+EY  +
Sbjct: 27  TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDFE 323
             L E+   +RG  +   +   I  +  + +++ H H+C    IHRDVK  NIL+     
Sbjct: 87  TVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHNC----IHRDVKPENILITKHSV 140
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
             + DFG A+ L  TG S+       +  Y +P L
Sbjct: 141 IKLCDFGFARLL--TGPSDYYDDEVATRWYRSPEL 173

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 66/136 (48%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 111
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 112 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 164
Query: 343 CMSAVAGSYGYIAPVL 358
             +A+ G+  Y+ P +
Sbjct: 165 RRAALCGTLDYLPPEM 180

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 109 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 161
Query: 343 CMSAVAGSYGYIAP 356
             +A+ G+  Y+ P
Sbjct: 162 RRAALCGTLDYLPP 175

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK--AFCSNKETNLLVYEYM 262
            G  VAVK+L     G         EI+ L  +    IV+ +  ++   +++  LV EY+
Sbjct: 39  TGALVAVKQLQ--HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 96
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P+G L + L   R   L     L  + +  KG+ YL    S   +HRD+ + NIL+ S+ 
Sbjct: 97  PSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEA 152
Query: 323 EAHVADFGLAKYL 335
              +ADFGLAK L
Sbjct: 153 HVKIADFGLAKLL 165

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G +VAVK +       +    L  E+R +  + H NIV+L      ++T  LV EY   
Sbjct: 39  TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASG 98
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL+ D   
Sbjct: 99  GEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCHQK---YIVHRDLKAENLLLDGDMNI 153
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +    +      +    GS  Y AP L
Sbjct: 154 KIADFGFS---NEFTVGNKLDTFCGSPPYAAPEL 184

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G + + L  K   F   E 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ-KLSKFD--EQ 113
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 114 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 166
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 167 RRTTLCGTLDYLPPEM 182

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G +VA+K +       +    L  E+R +  + H NIV+L      ++T  L+ EY   
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 99  GEVFDYLVA-HGRMKEKEARSKFR-QIVSAVQYCHQK---RIVHRDLKAENLLLDADMNI 153
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +      G    + A  G+  Y AP L
Sbjct: 154 KIADFGFSNEFTVGGK---LDAFCGAPPYAAPEL 184

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 109 RTATYITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 161
Query: 343 CMSAVAGSYGYIAP 356
             +A+ G+  Y+ P
Sbjct: 162 RRAALCGTLDYLPP 175

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK--AFCSNKETNLLVYEYM 262
            G  VAVK+L     G         EI+ L  +    IV+ +  ++   +++  LV EY+
Sbjct: 51  TGALVAVKQLQ--HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P+G L + L   R   L     L  + +  KG+ YL    S   +HRD+ + NIL+ S+ 
Sbjct: 109 PSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEA 164
Query: 323 EAHVADFGLAKYL 335
              +ADFGLAK L
Sbjct: 165 HVKIADFGLAKLL 177

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK--AFCSNKETNLLVYEYM 262
            G  VAVK+L     G         EI+ L  +    IV+ +  ++   +++  LV EY+
Sbjct: 38  TGALVAVKQLQ--HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 95
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P+G L + L   R   L     L  + +  KG+ YL    S   +HRD+ + NIL+ S+ 
Sbjct: 96  PSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEA 151
Query: 323 EAHVADFGLAKYL 335
              +ADFGLAK L
Sbjct: 152 HVKIADFGLAKLL 164

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 205 NGEQVAVKKLLGI-TKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
            G++ AVK +     K  +    L  E++ L ++ H NI++L  F  +K    LV E   
Sbjct: 56  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 115
Query: 264 NGSL-GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-- 320
            G L  E++  KR S +      +I  +   G++Y+H +    I+HRD+K  N+LL S  
Sbjct: 116 GGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKS 169
Query: 321 -DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            D    + DFGL+ + +   AS+ M    G+  YIAP
Sbjct: 170 KDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAP 203

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 205 NGEQVAVKKLLG-ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
            G++ AVK +     K  +    L  E++ L ++ H NI++L  F  +K    LV E   
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109
Query: 264 NGSL-GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-- 320
            G L  E++  KR S +      +I  +   G++Y+H +    I+HRD+K  N+LL S  
Sbjct: 110 GGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKS 163
Query: 321 -DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            D    + DFGL+ + +   AS+ M    G+  YIAP
Sbjct: 164 KDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAP 197

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 9/133 (6%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  ++ S    + 
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQR 113
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
                 E A  LSY H   S  +IHRD+K  N+LL S+ E  +ADFG + +      S  
Sbjct: 114 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVH----APSSR 166
Query: 344 MSAVAGSYGYIAP 356
            + + G+  Y+ P
Sbjct: 167 RTTLCGTLDYLPP 179

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 134
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 135 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 187
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 188 RRTTLCGTLDYLPPEM 203

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 69  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 125
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 126 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 178
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 179 RRTTLCGTLDYLPPEM 194

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +   +  +E
Sbjct: 109 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTE 165
Query: 343 CMSAVAGSYGYIAPVL 358
               + G+  Y+ P +
Sbjct: 166 ----LCGTLDYLPPEM 177

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 8/154 (5%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G +VA+K +       +    L  E+R +  + H NIV+L      ++T  L+ EY   
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 95
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G + + L    G   + E R K   +    + Y H      I+HRD+K+ N+LL++D   
Sbjct: 96  GEVFDYLVA-HGRMKEKEARSKFR-QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNI 150
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            +ADFG +      G    +    GS  Y AP L
Sbjct: 151 KIADFGFSNEFTVGGK---LDTFCGSPPYAAPEL 181

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 7/126 (5%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +VAVK +     GS       AE   +  ++H  +V+L A  + KE   ++ E+M  GSL
Sbjct: 208 KVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 263
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L    GS       +  + + A+G++++        IHRD+++ NIL+++     +A
Sbjct: 264 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIA 320
Query: 328 DFGLAK 333
           DFGLA+
Sbjct: 321 DFGLAR 326

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 109 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 161
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 162 RRTTLCGTLDYLPPEM 177

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 113
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 114 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 166
Query: 343 CMSAVAGSYGYIAP 356
             + + G+  Y+ P
Sbjct: 167 RRTTLCGTLDYLPP 180

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 109
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 110 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCH----APSS 162
Query: 343 CMSAVAGSYGYIAPVL 358
             + ++G+  Y+ P +
Sbjct: 163 RRTTLSGTLDYLPPEM 178

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 111
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 112 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 164
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 165 RRTTLCGTLDYLPPEM 180

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G + + L  K   F   E 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ-KLSKFD--EQ 113
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 114 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 166
Query: 343 CMSAVAGSYGYIAPVL 358
               + G+  Y+ P +
Sbjct: 167 RRXXLXGTLDYLPPEM 182

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 9/133 (6%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  ++ S    + 
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQR 113
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
                 E A  LSY H   S  +IHRD+K  N+LL S+ E  +ADFG + +      S  
Sbjct: 114 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVH----APSSR 166
Query: 344 MSAVAGSYGYIAP 356
              + G+  Y+ P
Sbjct: 167 RDTLCGTLDYLPP 179

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 59/132 (44%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 135
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         +A
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANA 191
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 192 FVGTAQYVSPEL 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 205 NGEQVAVKKLLG-ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
            G++ AVK +     K  +    L  E++ L ++ H NI++L  F  +K    LV E   
Sbjct: 74  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 133
Query: 264 NGSL-GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-- 320
            G L  E++  KR S +      +I  +   G++Y+H +    I+HRD+K  N+LL S  
Sbjct: 134 GGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKS 187
Query: 321 -DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            D    + DFGL+ + +   AS+ M    G+  YIAP
Sbjct: 188 KDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAP 221

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 51  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 107
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 108 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 160
Query: 343 CMSAVAGSYGYIAP 356
             + + G+  Y+ P
Sbjct: 161 RRTTLCGTLDYLPP 174

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 66/133 (49%), Gaps = 6/133 (4%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE + +K+L+   + +        E++ +  + H N+++        +    + EY+  
Sbjct: 34  TGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L  ++      +  W  R+  A + A G++YLH   S  IIHRD+ S+N L+  +   
Sbjct: 92  GTLRGIIKSMDSQY-PWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNV 147
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 148 VVADFGLARLMVD 160

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 205 NGEQVAVKKLLG-ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
            G++ AVK +     K  +    L  E++ L ++ H NI++L  F  +K    LV E   
Sbjct: 73  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 132
Query: 264 NGSL-GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-- 320
            G L  E++  KR S +      +I  +   G++Y+H +    I+HRD+K  N+LL S  
Sbjct: 133 GGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKS 186
Query: 321 -DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            D    + DFGL+ + +   AS+ M    G+  YIAP
Sbjct: 187 KDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAP 220

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 113
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 114 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 166
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 167 RRTTLCGTLDYLPPEM 182

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 12/137 (8%)
Query: 223 HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWE 282
            D+ L  EI  L KI+H NIV L+    +     LV + +  G L + +  +RG + + +
Sbjct: 49  RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL-ERGVYTEKD 107
Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADFGLAKYLQDTG 339
             L I  +    + YLH +    I+HRD+K  N+L  +  E     + DFGL+K  Q+  
Sbjct: 108 ASLVIQ-QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162
Query: 340 ASECMSAVAGSYGYIAP 356
               MS   G+ GY+AP
Sbjct: 163 ---IMSTACGTPGYVAP 176

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 49  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 105
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 106 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 158
Query: 343 CMSAVAGSYGYIAP 356
             + + G+  Y+ P
Sbjct: 159 RRTTLCGTLDYLPP 172

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 112
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 113 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 165
Query: 343 CMSAVAGSYGYIAP 356
             + + G+  Y+ P
Sbjct: 166 RRTTLCGTLDYLPP 179

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 111
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 112 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 164
Query: 343 CMSAVAGSYGYIAP 356
             + + G+  Y+ P
Sbjct: 165 RRTTLCGTLDYLPP 178

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRL-KAFCSNKETNL-----LVYE 260
           Q+A  K++ +T     +  +  EI  L K   HRNI     AF       +     LV E
Sbjct: 50  QLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +   GS+ +++   +G+ LK E    I  E  +GLS+LH      +IHRD+K  N+LL  
Sbjct: 108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE 164
Query: 321 DFEAHVADFGLAKYLQDT 338
           + E  + DFG++  L  T
Sbjct: 165 NAEVKLVDFGVSAQLDRT 182

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 109
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 110 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 162
Query: 343 CMSAVAGSYGYIAPVL 358
               + G+  Y+ P +
Sbjct: 163 RRDTLCGTLDYLPPEM 178

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 109 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 161
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 162 RRTDLCGTLDYLPPEM 177

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 109
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 110 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 162
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 163 RRTDLCGTLDYLPPEM 178

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 19/136 (13%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-----LL 257
            PNGE+       G+   +  +  L   +R L    H N+VRL   C+   T+      L
Sbjct: 39  VPNGEE-------GLPISTVREVAL---LRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 88
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
           V+E++ +  L   L       L  E    +  +  +GL +LH +C   I+HRD+K  NIL
Sbjct: 89  VFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 144
Query: 318 LNSDFEAHVADFGLAK 333
           + S     +ADFGLA+
Sbjct: 145 VTSGGTVKLADFGLAR 160

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 19/136 (13%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-----LL 257
            PNGE+       G+   +  +  L   +R L    H N+VRL   C+   T+      L
Sbjct: 39  VPNGEE-------GLPISTVREVAL---LRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 88
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
           V+E++ +  L   L       L  E    +  +  +GL +LH +C   I+HRD+K  NIL
Sbjct: 89  VFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 144
Query: 318 LNSDFEAHVADFGLAK 333
           + S     +ADFGLA+
Sbjct: 145 VTSGGTVKLADFGLAR 160

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 19/136 (13%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-----LL 257
            PNGE+       G+   +  +  L   +R L    H N+VRL   C+   T+      L
Sbjct: 39  VPNGEE-------GLPISTVREVAL---LRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 88
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
           V+E++ +  L   L       L  E    +  +  +GL +LH +C   I+HRD+K  NIL
Sbjct: 89  VFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 144
Query: 318 LNSDFEAHVADFGLAK 333
           + S     +ADFGLA+
Sbjct: 145 VTSGGTVKLADFGLAR 160

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 113
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 114 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 166
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 167 RRTDLCGTLDYLPPEM 182

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 109 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 161
Query: 343 CMSAVAGSYGYIAP 356
             + + G+  Y+ P
Sbjct: 162 RRTXLCGTLDYLPP 175

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 24/166 (14%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET------NLLV 258
            G +VA+KKL    +          E+R L  +RH N++ L    +  ET        LV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 259 YEYMPNGSLGEVL-HGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNI 316
             +M    LG+++ H K G     E R++  + +  KGL Y+H   +  IIHRD+K  N+
Sbjct: 109 MPFM-GTDLGKLMKHEKLG-----EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNL 159
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N D E  + DFGLA+       SE    V   + Y AP  +L W
Sbjct: 160 AVNEDCELKILDFGLAR----QADSEMXGXVVTRW-YRAPEVILNW 200

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 134
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 135 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 187
Query: 343 CMSAVAGSYGYIAPVL 358
               + G+  Y+ P +
Sbjct: 188 RRDDLCGTLDYLPPEM 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L +  H NIVRL   C+ K+   +V E +  G     L  + G+ L+ +  L++  
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVG 220
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           +AA G+ YL   C    IHRD+ + N L+       ++DFG+++   D
Sbjct: 221 DAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEAD 265

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L +  H NIVRL   C+ K+   +V E +  G     L  + G+ L+ +  L++  
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVG 220
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           +AA G+ YL   C    IHRD+ + N L+       ++DFG+++   D
Sbjct: 221 DAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEAD 265

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
            A+K++        H +  + E+  L K+  H NI+ L   C ++    L  EY P+G+L
Sbjct: 45  AAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 103
Query: 268 GEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
            + L   R               S L  +  L  A + A+G+ YL        IHRD+ +
Sbjct: 104 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAA 160
Query: 314 NNILLNSDFEAHVADFGLAK 333
            NIL+  ++ A +ADFGL++
Sbjct: 161 RNILVGENYVAKIADFGLSR 180

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 109 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 161
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 162 RRTDLCGTLDYLPPEM 177

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
            A+K++        H +  + E+  L K+  H NI+ L   C ++    L  EY P+G+L
Sbjct: 55  AAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 113
Query: 268 GEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
            + L   R               S L  +  L  A + A+G+ YL        IHRD+ +
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAA 170
Query: 314 NNILLNSDFEAHVADFGLAK 333
            NIL+  ++ A +ADFGL++
Sbjct: 171 RNILVGENYVAKIADFGLSR 190

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 110
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 111 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 163
Query: 343 CMSAVAGSYGYIAPVL 358
               + G+  Y+ P +
Sbjct: 164 RRXXLCGTLDYLPPEM 179

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK--AFCSNKETNLLVYEYM 262
            G  VAVK+L     G         EI+ L  +    IV+ +  ++   +    LV EY+
Sbjct: 35  TGALVAVKQLQ--HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYL 92
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P+G L + L   R   L     L  + +  KG+ YL    S   +HRD+ + NIL+ S+ 
Sbjct: 93  PSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEA 148
Query: 323 EAHVADFGLAKYL 335
              +ADFGLAK L
Sbjct: 149 HVKIADFGLAKLL 161

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 59/132 (44%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 138
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         ++
Sbjct: 139 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 194
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 195 FVGTAQYVSPEL 206

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 9/110 (8%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETN-----LLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           A +R L    H N+VRL   C+   T+      LV+E++ +  L   L       L  E 
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAET 121
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
              +  +  +GL +LH +C   I+HRD+K  NIL+ S     +ADFGLA+
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 111
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 112 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 164
Query: 343 CMSAVAGSYGYIAP 356
               + G+  Y+ P
Sbjct: 165 RRXXLCGTLDYLPP 178

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 60/133 (45%), Gaps = 7/133 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV-YEYMPNGSLGEVLHGKRGSFLKWEMRL 285
           ++ E   + ++ H   V+L  FC   +  L     Y  NG L + +  K GSF +   R 
Sbjct: 84  VTRERDVMSRLDHPFFVKL-YFCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRF 141
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
             A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         +
Sbjct: 142 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 197
Query: 346 AVAGSYGYIAPVL 358
              G+  Y++P L
Sbjct: 198 XFVGTAQYVSPEL 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 111
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 112 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 164
Query: 343 CMSAVAGSYGYIAPVL 358
               + G+  Y+ P +
Sbjct: 165 RRDDLCGTLDYLPPEM 180

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 108
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +ADFG + +      S 
Sbjct: 109 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSS 161
Query: 343 CMSAVAGSYGYIAP 356
               + G+  Y+ P
Sbjct: 162 RRXXLCGTLDYLPP 175

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 59/132 (44%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 134
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         ++
Sbjct: 135 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 190
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 191 FVGTAQYVSPEL 202

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + + ++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +  +G+ YLH++    +IHRD+K  N+ LN D +  + DFGLA  ++  G  E    
Sbjct: 148 MR-QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKT 201
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 202 LCGTPNYIAP 211

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 57  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 115
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 116 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 171
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 172 FVGTAQYVSPEL 183

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 50  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 109
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 166
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 167 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 203

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 59/132 (44%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFY 137
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         ++
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 193
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 194 FVGTAQYVSPEL 205

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 197

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 197

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 138
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 139 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 194
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 195 FVGTAQYVSPEL 206

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 40  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 100 LVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 156
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 157 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 193

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 135
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 192 FVGTAQYVSPEL 203

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 137
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 194 FVGTAQYVSPEL 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 56  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 114
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 115 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 170
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 171 FVGTAQYVSPEL 182

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 82  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 140
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 141 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 196
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 197 FVGTAQYVSPEL 208

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 40  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 156
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 157 DCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNW 193

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 18/143 (12%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L   ++ +  D    AE+ T+  ++H++IVR    C+     L+V+EYM +G L 
Sbjct: 74  VAVKALKEASESARQDFQREAELLTM--LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 269 EVL--HGKRGSFLK-----------WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
             L  HG     L                L +A + A G+ YL        +HRD+ + N
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 188
Query: 316 ILLNSDFEAHVADFGLAKYLQDT 338
            L+       + DFG+++ +  T
Sbjct: 189 CLVGQGLVVKIGDFGMSRDIYST 211

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 135
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 192 FVGTAQYVSPEL 203

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 137
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 194 FVGTAQYVSPEL 205

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 24/133 (18%)
Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV------QITQIHI----------- 43
           +SRN  +G IP    + L L ++DLS+N L G   V         +IH+           
Sbjct: 181 ISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 44  ------LNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
                 LN L++  N++  +LP+ +  +K L S + S NN  GEIP+ G    F+ +++ 
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299
Query: 98  GNPHLCGSYLNPC 110
            N  LCGS L  C
Sbjct: 300 NNKCLCGSPLPAC 312

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + + ++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +  +G+ YLH++    +IHRD+K  N+ LN D +  + DFGLA  ++  G  E    
Sbjct: 148 MR-QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKX 201
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 202 LCGTPNYIAP 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 113
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 114 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 169
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 170 FVGTAQYVSPEL 181

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 135
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 192 FVGTAQYVSPEL 203

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 40  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 156
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 157 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 193

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 19/144 (13%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L   T  +  D    AE+ T   ++H +IV+    C + +  ++V+EYM +G L 
Sbjct: 48  VAVKALKDPTLAARKDFQREAELLT--NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 269 EVL--HGKRGSFL--------KWEM----RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + L  HG     L        K E+     L IA + A G+ YL    S   +HRD+ + 
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATR 162
Query: 315 NILLNSDFEAHVADFGLAKYLQDT 338
           N L+ ++    + DFG+++ +  T
Sbjct: 163 NCLVGANLLVKIGDFGMSRDVYST 186

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 54  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 112
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 113 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 168
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 169 FVGTAQYVSPEL 180

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 137
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 194 FVGTAQYVSPEL 205

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 54  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 113
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 114 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 170
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 171 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 137
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 194 FVGTAQYVSPEL 205

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 137
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 138 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 194 FVGTAQYVSPEL 205

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 61  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 119
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 120 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 175
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 176 FVGTAQYVSPEL 187

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + + ++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 73  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 131
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +  +G+ YLH++    +IHRD+K  N+ LN D +  + DFGLA  ++  G  E    
Sbjct: 132 MR-QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKD 185
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 186 LCGTPNYIAP 195

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 5/132 (3%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ E   + ++ H   V+L     + E       Y  NG L + +  K GSF +   R  
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 134
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            A E    L YLH      IIHRD+K  NILLN D    + DFG AK L         + 
Sbjct: 135 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 190
Query: 347 VAGSYGYIAPVL 358
             G+  Y++P L
Sbjct: 191 FVGTAQYVSPEL 202

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           +    +G  L+   K        ++  I  +  +GL Y+H   S  IIHRD+K +N+ +N
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVN 159
Query: 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 160 EDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +S EI     + + ++V    F  + +   +V E     SL E LH +R +  + E R  
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           +  +  +G+ YLH++    +IHRD+K  N+ LN D +  + DFGLA  ++  G  E    
Sbjct: 148 MR-QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKD 201
Query: 347 VAGSYGYIAP 356
           + G+  YIAP
Sbjct: 202 LCGTPNYIAP 211

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 63  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 122
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 179
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 180 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 64  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 123
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 180
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 181 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 110
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +A+FG + +      S 
Sbjct: 111 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVH----APSS 163
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 164 RRTTLCGTLDYLPPEM 179

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 49  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 108
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 157
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 158 PSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 202

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 49  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 108
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 157
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 158 PSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 202

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  E+     +RH NI+RL  +  +     L+ EY P G++   L  K   F   E 
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFD--EQ 111
Query: 284 RLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           R    I E A  LSY H   S  +IHRD+K  N+LL S  E  +A+FG + +      S 
Sbjct: 112 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVH----APSS 164
Query: 343 CMSAVAGSYGYIAPVL 358
             + + G+  Y+ P +
Sbjct: 165 RRTTLCGTLDYLPPEM 180

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 18/143 (12%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L   ++ +  D    AE+ T+  ++H++IVR    C+     L+V+EYM +G L 
Sbjct: 45  VAVKALKEASESARQDFQREAELLTM--LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 269 EVL--HGKRGSFLK-----------WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
             L  HG     L                L +A + A G+ YL        +HRD+ + N
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 159
Query: 316 ILLNSDFEAHVADFGLAKYLQDT 338
            L+       + DFG+++ +  T
Sbjct: 160 CLVGQGLVVKIGDFGMSRDIYST 182

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 10/129 (7%)
Query: 230 EIRTLGKIRHRNIVRLKAFCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
           EI  L K+ H N+V+L       N++   +V+E +  G + EV   K  S  +     + 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQD 145
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
            I   KG+ YLH+     IIHRD+K +N+L+  D    +ADFG++   +  G+   +S  
Sbjct: 146 LI---KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--GSDALLSNT 197
Query: 348 AGSYGYIAP 356
            G+  ++AP
Sbjct: 198 VGTPAFMAP 206

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 18/143 (12%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L   ++ +  D    AE+ T+  ++H++IVR    C+     L+V+EYM +G L 
Sbjct: 51  VAVKALKEASESARQDFQREAELLTM--LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 269 EVL--HGKRGSFLK-----------WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
             L  HG     L                L +A + A G+ YL        +HRD+ + N
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 165
Query: 316 ILLNSDFEAHVADFGLAKYLQDT 338
            L+       + DFG+++ +  T
Sbjct: 166 CLVGQGLVVKIGDFGMSRDIYST 188

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 28/166 (16%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEYMPNG 265
           ++VAVKKL    +   H      E+R L  ++H N++  L  F            Y+   
Sbjct: 46  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 266 SLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
            +G         + L  +   FL +++         +GL Y+H   S  IIHRD+K +N+
Sbjct: 106 LMGADLNNIVKCQALSDEHVQFLVYQL--------LRGLKYIH---SAGIIHRDLKPSNV 154
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N D E  + DFGLA+      A E M+    +  Y AP  +L W
Sbjct: 155 AVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 195

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEYMPNG 265
           ++VAVKKL    +   H      E+R L  ++H N++  L  F            Y+   
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 266 SLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
            +G  L+   +   L  E    +  +  +GL Y+H   S  IIHRD+K +N+ +N D E 
Sbjct: 114 LMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSEL 170
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            + DFGLA+      A E M+    +  Y AP  +L W
Sbjct: 171 RILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 203

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAF--CSNKETNLLVYEYM 262
           GE VAVKK+    + S+       EI  L ++  H NIV L       N     LV++YM
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93
Query: 263 PNGSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
                   LH   R + L+   +  +  +  K + YLH   S  ++HRD+K +NILLN++
Sbjct: 94  ETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAE 145
Query: 322 FEAHVADFGLAK 333
               VADFGL++
Sbjct: 146 CHVKVADFGLSR 157

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/140 (35%), Positives = 69/140 (49%), Gaps = 21/140 (15%)
Query: 205 NGEQVAVKKLLGITKGSSHDNG---LSAEIRTLGKIRHRNIVRLKA---FCSNKETNL-L 257
           +GE VAVK        SS D        EI     +RH NI+   A      N  T L L
Sbjct: 30  HGESVAVKIF------SSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWL 83
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVK 312
           +  Y  +GSL + L  +    L+  + L++A+ AA GL++LH +       P I HRD K
Sbjct: 84  ITHYHEHGSLYDFLQRQT---LEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFK 140
Query: 313 SNNILLNSDFEAHVADFGLA 332
           S N+L+ S+ +  +AD GLA
Sbjct: 141 SRNVLVKSNLQCCIADLGLA 160

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           +    +G  L+   K        ++  I  +  +GL Y+H   S  IIHRD+K +N+ +N
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVN 159
Query: 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 160 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 50  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 109
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 166
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 167 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 203

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 55  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 114
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 163
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 164 PSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 208

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIMLNW 197

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 49  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 108
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 165
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 166 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 202

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 43  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 102
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 103 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 159
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 160 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 196

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 205 NGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           N E VA+KK+    K S+     +  E+R L K+RH N ++ +     + T  LV EY  
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC- 136
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GS  ++L   +    + E+   +   A +GL+YLH   S  +IHRDVK+ NILL+    
Sbjct: 137 LGSASDLLEVHKKPLQEVEI-AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192
Query: 324 AHVADFGLAKYL 335
             + DFG A  +
Sbjct: 193 VKLGDFGSASIM 204

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 69/132 (52%), Gaps = 13/132 (9%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           GE  A+KK+    +    D G+ +    EI  L +++H NIV+L      K+  +LV+E+
Sbjct: 26  GETFALKKI----RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
           + +  L ++L    G       +    ++   G++Y H      ++HRD+K  N+L+N +
Sbjct: 82  L-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINRE 136
Query: 322 FEAHVADFGLAK 333
            E  +ADFGLA+
Sbjct: 137 GELKIADFGLAR 148

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 49  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 108
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 165
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 166 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 202

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 69/132 (52%), Gaps = 13/132 (9%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           GE  A+KK+    +    D G+ +    EI  L +++H NIV+L      K+  +LV+E+
Sbjct: 26  GETFALKKI----RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
           + +  L ++L    G       +    ++   G++Y H      ++HRD+K  N+L+N +
Sbjct: 82  L-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINRE 136
Query: 322 FEAHVADFGLAK 333
            E  +ADFGLA+
Sbjct: 137 GELKIADFGLAR 148

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 28/166 (16%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEYMPNG 265
           ++VAVKKL    +   H      E+R L  ++H N++  L  F            Y+   
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 266 SLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
            +G         + L  +   FL +++         +GL Y+H   S  IIHRD+K +N+
Sbjct: 114 LMGADLNNIVKCQALSDEHVQFLVYQL--------LRGLKYIH---SAGIIHRDLKPSNV 162
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N D E  + DFGLA+      A E M+    +  Y AP  +L W
Sbjct: 163 AVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 203

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 41  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 100
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 157
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 158 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 194

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 46  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 105
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 162
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 163 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 51  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 159
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 204

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 46  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 105
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 162
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 163 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 40  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 156
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 157 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 193

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 50  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 109
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 158
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 159 PSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 203

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 50  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 109
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 158
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 159 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 203

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 103 KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 158
Query: 264 NGSLGEVLHGKRGSFLKWEMR--------------LKIAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++                 +  A + A+G+ YL    S   IHR
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 215
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 216 DLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 46  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 105
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 162
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 163 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 64  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 123
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 180
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M     +  Y AP  +L W
Sbjct: 181 DCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIMLNW 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 41  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 100
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 157
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 158 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 194

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 69/132 (52%), Gaps = 13/132 (9%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           GE  A+KK+    +    D G+ +    EI  L +++H NIV+L      K+  +LV+E+
Sbjct: 26  GETFALKKI----RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
           + +  L ++L    G       +    ++   G++Y H      ++HRD+K  N+L+N +
Sbjct: 82  L-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINRE 136
Query: 322 FEAHVADFGLAK 333
            E  +ADFGLA+
Sbjct: 137 GELKIADFGLAR 148

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 42  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 101
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 102 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 158
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 159 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 195

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 70/144 (48%), Gaps = 16/144 (11%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF---CSNKETNL-LVYE 260
            GE+VAVK      + S        EI     +RH NI+   A     +   T L L+ +
Sbjct: 59  RGEKVAVKVFFTTEEASWFRE---TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSNN 315
           Y  NGSL + L   + + L  +  LK+A  +  GL +LH +       P I HRD+KS N
Sbjct: 116 YHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 316 ILLNSDFEAHVADFGLA-KYLQDT 338
           IL+  +    +AD GLA K++ DT
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDT 196

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 56  TKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 115
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 172
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 173 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 209

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 252 KETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           K T+L +V EY   GS+ +++  +  +  + E+   I     KGL YLH       IHRD
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI-ATILQSTLKGLEYLHFMRK---IHRD 150
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +K+ NILLN++  A +ADFG+A  L D  A    + V G+  ++AP
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTPFWMAP 194

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 55  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 114
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 171
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 172 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 208

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 64  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 123
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 180
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 181 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 217

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 205 NGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           N E VA+KK+    K S+     +  E+R L K+RH N ++ +     + T  LV EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC- 97
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GS  ++L   +    + E+   +   A +GL+YLH   S  +IHRDVK+ NILL+    
Sbjct: 98  LGSASDLLEVHKKPLQEVEI-AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 153
Query: 324 AHVADFGLAKYL 335
             + DFG A  +
Sbjct: 154 VKLGDFGSASIM 165

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 63  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 122
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 179
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 180 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 67  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 126
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 183
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 184 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 56  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 115
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 172
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 173 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 209

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 46  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 105
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 154
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 155 PSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 199

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+    S    +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGL ++  D      M+    +  Y AP  +L W
Sbjct: 161 DSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 56  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 115
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 172
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 173 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 209

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 51  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 159
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNW 204

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 51  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 159
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNW 204

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
            A+K++        H +  + E+  L K+  H NI+ L   C ++    L  EY P+G+L
Sbjct: 52  AAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 110
Query: 268 GEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
            + L   R               S L  +  L  A + A+G+ YL        IHR++ +
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAA 167
Query: 314 NNILLNSDFEAHVADFGLAK 333
            NIL+  ++ A +ADFGL++
Sbjct: 168 RNILVGENYVAKIADFGLSR 187

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 16/141 (11%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L   +  +  D    AE+  L  ++H +IV+    C   +  ++V+EYM +G L 
Sbjct: 46  VAVKTLKDASDNARKDFHREAEL--LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 269 EVL--HGKRGSF---------LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
           + L  HG              L     L IA + A G+ YL    S   +HRD+ + N L
Sbjct: 104 KFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCL 160
Query: 318 LNSDFEAHVADFGLAKYLQDT 338
           +  +    + DFG+++ +  T
Sbjct: 161 VGENLLVKIGDFGMSRDVYST 181

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLXQVIQMELDHERMSYLLYQM--------LXGIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 51  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 159
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNW 204

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           +V  K+++   K   H N    E   L  + H  I+R+     + +   ++ +Y+  G L
Sbjct: 37  KVLKKEIVVRLKQVEHTND---ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL 93
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
             +L  K   F     +   A E    L YLH   S  II+RD+K  NILL+ +    + 
Sbjct: 94  FSLLR-KSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 148
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFG AKY+ D     C     G+  YIAP
Sbjct: 149 DFGFAKYVPDVTYXLC-----GTPDYIAP 172

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 62  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 264 NGSLGEVLHGKRGSFLKW--------EMRLK------IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++        E +L        A + A+G+ YL    S   IHR
Sbjct: 118 KGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 174
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 175 DLAARNVLVTEDNVMKIADFGLAR 198

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 55  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 110
Query: 264 NGSLGEVLHGKRGSFLKW--------EMRLK------IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++        E +L        A + A+G+ YL    S   IHR
Sbjct: 111 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 167
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 168 DLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 51  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 106
Query: 264 NGSLGEVLHGKRGSFLKW--------EMRLK------IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++        E +L        A + A+G+ YL    S   IHR
Sbjct: 107 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 163
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 164 DLAARNVLVTEDNVMKIADFGLAR 187

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 54  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 109
Query: 264 NGSLGEVLHGKRGSFLKW--------EMRLK------IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++        E +L        A + A+G+ YL    S   IHR
Sbjct: 110 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 166
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 167 DLAARNVLVTEDNVMKIADFGLAR 190

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 47  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 102
Query: 264 NGSLGEVLHGKRGSFLKW--------EMRLK------IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++        E +L        A + A+G+ YL    S   IHR
Sbjct: 103 KGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 159
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 160 DLAARNVLVTEDNVMKIADFGLAR 183

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 62  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 264 NGSLGEVLHGKRGSFLKW--------EMRLK------IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++        E +L        A + A+G+ YL    S   IHR
Sbjct: 118 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 174
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 175 DLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 67  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 126
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 183
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + DFGLA++  D      M     +  Y AP  +L W
Sbjct: 184 DCELKILDFGLARHTDDE-----MXGYVATRWYRAPEIMLNW 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 62  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 264 NGSLGEVLHGKRGSFLKWEMR--------------LKIAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +R   L++                 +  A + A+G+ YL    S   IHR
Sbjct: 118 KGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 174
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 175 DLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 65/139 (46%), Gaps = 24/139 (17%)
Query: 237 IRHRNIVRL-----KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
           + H NI R      +     +   LLV EY PNGSL + L         W    ++A   
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD---WVSSCRLAHSV 120
Query: 292 AKGLSYLHHDC------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG------ 339
            +GL+YLH +        P I HRD+ S N+L+ +D    ++DFGL+  L  TG      
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL--TGNRLVRP 178
Query: 340 ASECMSAVA--GSYGYIAP 356
             E  +A++  G+  Y+AP
Sbjct: 179 GEEDNAAISEVGTIRYMAP 197

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +N+ +N D E  + DFGLA++  D      M+    +  Y AP
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 203 TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           T  G++VA+K +   +   S     +  EI  L  +RH +I++L     +K+  ++V EY
Sbjct: 36  TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 95
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
             N     ++  +R    + E R +   +    + Y H      I+HRD+K  N+LL+  
Sbjct: 96  AGNELFDYIV--QRDKMSEQEAR-RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEH 149
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               +ADFGL+  + D      +    GS  Y AP
Sbjct: 150 LNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAP 181

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 203 TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           T  G++VA+K +   +   S     +  EI  L  +RH +I++L     +K+  ++V EY
Sbjct: 30  TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 89
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
             N     ++  +R    + E R +   +    + Y H      I+HRD+K  N+LL+  
Sbjct: 90  AGNELFDYIV--QRDKMSEQEAR-RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEH 143
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               +ADFGL+  + D      +    GS  Y AP
Sbjct: 144 LNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAP 175

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 203 TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           T  G++VA+K +   +   S     +  EI  L  +RH +I++L     +K+  ++V EY
Sbjct: 26  TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 85
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
             N     ++  +R    + E R +   +    + Y H      I+HRD+K  N+LL+  
Sbjct: 86  AGNELFDYIV--QRDKMSEQEAR-RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEH 139
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               +ADFGL+  + D      +    GS  Y AP
Sbjct: 140 LNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAP 171

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 203 TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           T  G++VA+K +   +   S     +  EI  L  +RH +I++L     +K+  ++V EY
Sbjct: 35  TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
             N     ++  +R    + E R +   +    + Y H      I+HRD+K  N+LL+  
Sbjct: 95  AGNELFDYIV--QRDKMSEQEAR-RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEH 148
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               +ADFGL+  + D      +    GS  Y AP
Sbjct: 149 LNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAP 180

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + D+GLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 13/133 (9%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260
            G  VA+K++    +  + D G+ +    EI  L ++ H NIV L     ++    LV+E
Sbjct: 44  QGRIVALKRI----RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +M    L +VL   +      ++++ +  +  +G+++ H      I+HRD+K  N+L+NS
Sbjct: 100 FM-EKDLKKVLDENKTGLQDSQIKIYLY-QLLRGVAHCHQH---RILHRDLKPQNLLINS 154
Query: 321 DFEAHVADFGLAK 333
           D    +ADFGLA+
Sbjct: 155 DGALKLADFGLAR 167

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 13/133 (9%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260
            G  VA+K++    +  + D G+ +    EI  L ++ H NIV L     ++    LV+E
Sbjct: 44  QGRIVALKRI----RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +M    L +VL   +      ++++ +  +  +G+++ H      I+HRD+K  N+L+NS
Sbjct: 100 FM-EKDLKKVLDENKTGLQDSQIKIYLY-QLLRGVAHCHQH---RILHRDLKPQNLLINS 154
Query: 321 DFEAHVADFGLAK 333
           D    +ADFGLA+
Sbjct: 155 DGALKLADFGLAR 167

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLXQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 28/168 (16%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-----KAFCSNKETNLLVY 259
           +G ++AVKKL    +   H      E+R L  ++H N++ L      A    +  ++ + 
Sbjct: 75  SGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLV 134
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
            ++    L  ++  ++ +     FL +++         +GL Y+H   S  IIHRD+K +
Sbjct: 135 THLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLKPS 183
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           N+ +N D E  + DFGLA++  D      M+    +  Y AP  +L W
Sbjct: 184 NLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 48/82 (58%), Gaps = 5/82 (6%)
Query: 275 RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
           +G  +  ++  KIA+   K L +LH   S  +IHRDVK +N+L+N+  +  + DFG++ Y
Sbjct: 146 KGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY 203
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           L D+ A    +  AG   Y+AP
Sbjct: 204 LVDSVAK---TIDAGCKPYMAP 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 105 -DANLXQVIQMELDHERMSYLLYQM--------LXGIKHLH---SAGIIHRDLKPSNIVV 152
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 153 KSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 192

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLXQVIQMELDHERMSYLLYQM--------LXGIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            G+QVAVKK+    +       L  E+  +    H N+V + +     +   +V E++  
Sbjct: 69  TGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEG 126
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L +++   R   +  E    + +   + LSYLH+     +IHRD+KS++ILL SD   
Sbjct: 127 GALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRI 180
Query: 325 HVADFGL 331
            ++DFG 
Sbjct: 181 KLSDFGF 187

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           E VA+K++    +    D G+ +    EI  L +++H+NIVRL     + +   LV+E+ 
Sbjct: 28  EIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
            +  L +      G  L  E+      +  KGL + H   S  ++HRD+K  N+L+N + 
Sbjct: 84  -DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNG 138
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           E  +ADFGLA+         C SA   +  Y  P
Sbjct: 139 ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPP 170

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 26/148 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           QVAVK +L     SS    L +E++ + ++  H NIV L   C+      L++EY   G 
Sbjct: 77  QVAVK-MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 267 LGEVLHGKRGSF---------------------LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           L   L  KR  F                     L +E  L  A + AKG+ +L       
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC-- 193
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK 333
            +HRD+ + N+L+       + DFGLA+
Sbjct: 194 -VHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GLS+ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 14/157 (8%)
Query: 205 NGEQVAVKKLLG-ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
            G++ AVK +     K  +    L  E++ L ++ H NI +L  F  +K    LV E   
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYT 109
Query: 264 NGSL-GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-- 320
            G L  E++  KR S +      +I  +   G++Y H +    I+HRD+K  N+LL S  
Sbjct: 110 GGELFDEIISRKRFSEVD---AARIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKS 163
Query: 321 -DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            D    + DFGL+ + +   AS+      G+  YIAP
Sbjct: 164 KDANIRIIDFGLSTHFE---ASKKXKDKIGTAYYIAP 197

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 69/138 (50%), Gaps = 22/138 (15%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVY 259
           G  VAVKKL    +  +H      E+  L  + H+NI+ L   F   K     +   LV 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 260 EYMPNGSLGEVLHGK----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
           E M + +L +V+H +    R S+L ++M          G+ +LH   S  IIHRD+K +N
Sbjct: 109 ELM-DANLCQVIHMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSN 156
Query: 316 ILLNSDFEAHVADFGLAK 333
           I++ SD    + DFGLA+
Sbjct: 157 IVVKSDCTLKILDFGLAR 174

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 19/141 (13%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           +VAVK +L  T  +     L +E++ +  + +H NIV L   C++    L++ EY   G 
Sbjct: 78  KVAVK-MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 267 LGEVLHGKRGSFLKWEMR--------------LKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           L   L  KR   L++                 L  + + A+G+++L    S   IHRDV 
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVA 193
Query: 313 SNNILLNSDFEAHVADFGLAK 333
           + N+LL +   A + DFGLA+
Sbjct: 194 ARNVLLTNGHVAKIGDFGLAR 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 221 SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL-GEVLHGKRGSFL 279
           +S+   L  E+  L ++ H NI++L  F  +K    LV E    G L  E++  ++ S +
Sbjct: 62  TSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV 121
Query: 280 KWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYL 335
              + +K   +   G +YLH H+    I+HRD+K  N+LL S   D    + DFGL+ + 
Sbjct: 122 DAAVIMK---QVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 174
Query: 336 QDTGASECMSAVAGSYGYIAP 356
           +  G    M    G+  YIAP
Sbjct: 175 EVGGK---MKERLGTAYYIAP 192

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 13/135 (9%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           +VAVK +L  T  +     L +E++ +  + +H NIV L   C++    L++ EY   G 
Sbjct: 70  KVAVK-MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 267 LGEVLHGKRGSFLK------WEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
           L   L  K  + L        E+R  L  + + A+G+++L    S   IHRDV + N+LL
Sbjct: 129 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 185
Query: 319 NSDFEAHVADFGLAK 333
            +   A + DFGLA+
Sbjct: 186 TNGHVAKIGDFGLAR 200

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL-G 268
           A+K +   +  +S ++ L  E+  L  + H NI++L  F  +K    LV E    G L  
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNS---DFEA 324
           E++H  R  F + +  + I  +   G++YLH H+    I+HRD+K  N+LL S   D   
Sbjct: 126 EIIH--RMKFNEVDAAV-IIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALI 178
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            + DFGL+   ++    + M    G+  YIAP
Sbjct: 179 KIVDFGLSAVFEN---QKKMKERLGTAYYIAP 207

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 203 TPNGEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
            P+G+ V+V     K   +++  + D+ +  E+  +  + HRN++RL          + V
Sbjct: 35  APSGKTVSVAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPPMKM-V 92
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E  P GSL + L   +G FL   +  + A++ A+G+ YL    S   IHRD+ + N+LL
Sbjct: 93  TELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 148
Query: 319 NSDFEAHVADFGLAKYL 335
            +     + DFGL + L
Sbjct: 149 ATRDLVKIGDFGLMRAL 165

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNL-LVY 259
            GE+VAVK      + S       AEI     +RH NI+   A   NK+    T L LV 
Sbjct: 64  RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIA-ADNKDNGTWTQLWLVS 119
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSN 314
           +Y  +GSL + L+    +    E  +K+A+  A GL++LH +       P I HRD+KS 
Sbjct: 120 DYHEHGSLFDYLNRYTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAV----AGSYGYIAP 356
           NIL+  +    +AD GLA  ++   A++ +        G+  Y+AP
Sbjct: 177 NILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAP 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNL-LVY 259
            GE+VAVK      + S       AEI     +RH NI+   A   NK+    T L LV 
Sbjct: 51  RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIA-ADNKDNGTWTQLWLVS 106
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSN 314
           +Y  +GSL + L+    +    E  +K+A+  A GL++LH +       P I HRD+KS 
Sbjct: 107 DYHEHGSLFDYLNRYTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 163
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAV----AGSYGYIAP 356
           NIL+  +    +AD GLA  ++   A++ +        G+  Y+AP
Sbjct: 164 NILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAP 207

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 13/135 (9%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           +VAVK +L  T  +     L +E++ +  + +H NIV L   C++    L++ EY   G 
Sbjct: 78  KVAVK-MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 267 LGEVLHGKRGSFLK------WEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
           L   L  K  + L        E+R  L  + + A+G+++L    S   IHRDV + N+LL
Sbjct: 137 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 193
Query: 319 NSDFEAHVADFGLAK 333
            +   A + DFGLA+
Sbjct: 194 TNGHVAKIGDFGLAR 208

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 203 TPNGEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
            P+G+ V+V     K   +++  + D+ +  E+  +  + HRN++RL          + V
Sbjct: 31  APSGKTVSVAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPPMKM-V 88
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E  P GSL + L   +G FL   +  + A++ A+G+ YL    S   IHRD+ + N+LL
Sbjct: 89  TELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 144
Query: 319 NSDFEAHVADFGLAKYL 335
            +     + DFGL + L
Sbjct: 145 ATRDLVKIGDFGLMRAL 161

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  EI     +RH NI+R+  +  +++   L+ E+ P G L + L  K G F + + 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDE-QR 115
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
                 E A  L Y H      +IHRD+K  N+L+    E  +ADFG + +      S  
Sbjct: 116 SATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH----APSLR 168
Query: 344 MSAVAGSYGYIAPVL 358
              + G+  Y+ P +
Sbjct: 169 RRXMCGTLDYLPPEM 183

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 208 QVAVKKLLGITKGSSHDNGL--SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++  K+   I      D  L    EI  L K+ H  I+++K F  + E   +V E M  G
Sbjct: 180 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 238
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAI------EAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
            L + + G +        RLK A       +    + YLH +    IIHRD+K  N+LL+
Sbjct: 239 ELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 287
Query: 320 SDFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  E     + DFG +K L   G +  M  + G+  Y+AP
Sbjct: 288 SQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 324

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 208 QVAVKKLLGITKGSSHDNGL--SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++  K+   I      D  L    EI  L K+ H  I+++K F  + E   +V E M  G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 224
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAI------EAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
            L + + G +        RLK A       +    + YLH +    IIHRD+K  N+LL+
Sbjct: 225 ELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 273
Query: 320 SDFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  E     + DFG +K L   G +  M  + G+  Y+AP
Sbjct: 274 SQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 310

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  EI     +RH NI+R+  +  +++   L+ E+ P G L + L  K G F + + 
Sbjct: 59  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDE-QR 116
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
                 E A  L Y H      +IHRD+K  N+L+    E  +ADFG + +      S  
Sbjct: 117 SATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH----APSLR 169
Query: 344 MSAVAGSYGYIAPVL 358
              + G+  Y+ P +
Sbjct: 170 RRXMCGTLDYLPPEM 184

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 203 TPNGEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
            P+G+ V+V     K   +++  + D+ +  E+  +  + HRN++RL          + V
Sbjct: 31  APSGKTVSVAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPPMKM-V 88
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E  P GSL + L   +G FL   +  + A++ A+G+ YL    S   IHRD+ + N+LL
Sbjct: 89  TELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 144
Query: 319 NSDFEAHVADFGLAKYL 335
            +     + DFGL + L
Sbjct: 145 ATRDLVKIGDFGLMRAL 161

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 203 TPNGEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
            P+G+ V+V     K   +++  + D+ +  E+  +  + HRN++RL          + V
Sbjct: 31  APSGKTVSVAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPPMKM-V 88
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E  P GSL + L   +G FL   +  + A++ A+G+ YL    S   IHRD+ + N+LL
Sbjct: 89  TELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 144
Query: 319 NSDFEAHVADFGLAKYL 335
            +     + DFGL + L
Sbjct: 145 ATRDLVKIGDFGLMRAL 161

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 203 TPNGEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
            P+G+ V+V     K   +++  + D+ +  E+  +  + HRN++RL          + V
Sbjct: 41  APSGKTVSVAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPPMKM-V 98
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E  P GSL + L   +G FL   +  + A++ A+G+ YL    S   IHRD+ + N+LL
Sbjct: 99  TELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 154
Query: 319 NSDFEAHVADFGLAKYL 335
            +     + DFGL + L
Sbjct: 155 ATRDLVKIGDFGLMRAL 171

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 203 TPNGEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
            P+G+ V+V     K   +++  + D+ +  E+  +  + HRN++RL          + V
Sbjct: 41  APSGKTVSVAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPPMKM-V 98
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E  P GSL + L   +G FL   +  + A++ A+G+ YL    S   IHRD+ + N+LL
Sbjct: 99  TELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 154
Query: 319 NSDFEAHVADFGLAKYL 335
            +     + DFGL + L
Sbjct: 155 ATRDLVKIGDFGLMRAL 171

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 203 TPNGEQVAVK----KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
            P+G+ V+V     K   +++  + D+ +  E+  +  + HRN++RL          + V
Sbjct: 35  APSGKTVSVAVKCLKPDVLSQPEAMDDFIR-EVNAMHSLDHRNLIRLYGVVLTPPMKM-V 92
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E  P GSL + L   +G FL   +  + A++ A+G+ YL    S   IHRD+ + N+LL
Sbjct: 93  TELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 148
Query: 319 NSDFEAHVADFGLAKYL 335
            +     + DFGL + L
Sbjct: 149 ATRDLVKIGDFGLMRAL 165

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 69/138 (50%), Gaps = 22/138 (15%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVY 259
           G  VAVKKL    +  +H      E+  L  + H+NI+ L   F   K     +   LV 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 260 EYMPNGSLGEVLHGK----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
           E M + +L +V+H +    R S+L ++M          G+ +LH   S  IIHRD+K +N
Sbjct: 107 ELM-DANLCQVIHMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSN 154
Query: 316 ILLNSDFEAHVADFGLAK 333
           I++ SD    + DFGLA+
Sbjct: 155 IVVKSDCTLKILDFGLAR 172

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 221 SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL-GEVLHGKRGSFL 279
           +S+   L  E+  L ++ H NI++L  F  +K    LV E    G L  E++  ++ S +
Sbjct: 45  TSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV 104
Query: 280 KWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYL 335
              + +K   +   G +YLH H+    I+HRD+K  N+LL S   D    + DFGL+ + 
Sbjct: 105 DAAVIMK---QVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 157
Query: 336 QDTGASECMSAVAGSYGYIAP 356
           +  G    M    G+  YIAP
Sbjct: 158 EVGGK---MKERLGTAYYIAP 175

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + DF LA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNL-LVY 259
            GE+VAVK      + S       AEI     +RH NI+   A   NK+    T L LV 
Sbjct: 25  RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIA-ADNKDNGTWTQLWLVS 80
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSN 314
           +Y  +GSL + L+    +    E  +K+A+  A GL++LH +       P I HRD+KS 
Sbjct: 81  DYHEHGSLFDYLNRYTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAV----AGSYGYIAP 356
           NIL+  +    +AD GLA  ++   A++ +        G+  Y+AP
Sbjct: 138 NILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAP 181

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNL-LVY 259
            GE+VAVK      + S       AEI     +RH NI+   A   NK+    T L LV 
Sbjct: 28  RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIA-ADNKDNGTWTQLWLVS 83
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSN 314
           +Y  +GSL + L+    +    E  +K+A+  A GL++LH +       P I HRD+KS 
Sbjct: 84  DYHEHGSLFDYLNRYTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 140
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAV----AGSYGYIAP 356
           NIL+  +    +AD GLA  ++   A++ +        G+  Y+AP
Sbjct: 141 NILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAP 184

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNL-LVY 259
            GE+VAVK      + S       AEI     +RH NI+   A   NK+    T L LV 
Sbjct: 26  RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIA-ADNKDNGTWTQLWLVS 81
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSN 314
           +Y  +GSL + L+    +    E  +K+A+  A GL++LH +       P I HRD+KS 
Sbjct: 82  DYHEHGSLFDYLNRYTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 138
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAV----AGSYGYIAP 356
           NIL+  +    +AD GLA  ++   A++ +        G+  Y+AP
Sbjct: 139 NILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAP 182

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 12/133 (9%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCS----NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           A +R L    H N+VRL   C+    ++ET L LV+E++ +  L   L       +  E 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
              +  +  +GL +LH   S  ++HRD+K  NIL+ S  +  +ADFGLA+      A   
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--- 175
Query: 344 MSAVAGSYGYIAP 356
           +++V  +  Y AP
Sbjct: 176 LTSVVVTLWYRAP 188

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 88
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 89  MDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 145
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 146 KLADFGLAR 154

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNL-LVY 259
            GE+VAVK      + S       AEI     +RH NI+   A   NK+    T L LV 
Sbjct: 31  RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIA-ADNKDNGTWTQLWLVS 86
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSN 314
           +Y  +GSL + L+    +    E  +K+A+  A GL++LH +       P I HRD+KS 
Sbjct: 87  DYHEHGSLFDYLNRYTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 143
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASECMSAV----AGSYGYIAP 356
           NIL+  +    +AD GLA  ++   A++ +        G+  Y+AP
Sbjct: 144 NILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAP 187

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M +        G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M +        G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M +        G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 87
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 88  MDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 144
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 145 KLADFGLAR 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 141
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 142 KLADFGLAR 150

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 26/151 (17%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG--------SLGEVLHGKRGSFLKW 281
           EI  + +++H NIVRL      +    LV+E+M N         ++G    G   + +K+
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 282 EMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL---QDT 338
                   +  +GL++ H +    I+HRD+K  N+L+N   +  + DFGLA+      +T
Sbjct: 113 -----FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164
Query: 339 GASECMS-------AVAGSYGYIAPVLGWYC 362
            +SE ++        + GS  Y   +  W C
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC 195

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 208 QVAVKKLLGITKGSSHDNGL--SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++  K+   I      D  L    EI  L K+ H  I+++K F  + E   +V E M  G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG 99
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAI------EAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
            L + + G +        RLK A       +    + YLH +    IIHRD+K  N+LL+
Sbjct: 100 ELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 148
Query: 320 SDFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  E     + DFG +K L   G +  M  + G+  Y+AP
Sbjct: 149 SQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 185

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 143
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 144 KLADFGLAR 152

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 87
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 88  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 144
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 145 KLADFGLAR 153

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIR--TLGKIR-------HRNIVRLKAFCSNKET 254
           P  ++ AVK ++ +T G S       E+R  TL ++        H NI++LK        
Sbjct: 40  PTCKEYAVK-IIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98
Query: 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
             LV++ M  G L + L  ++ +  + E R  ++  +E    L  L+      I+HRD+K
Sbjct: 99  FFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLK 151
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             NILL+ D    + DFG +  L D G  E + +V G+  Y+AP
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQL-DPG--EKLRSVCGTPSYLAP 192

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 34  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 92
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 93  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 149
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 150 KLADFGLAR 158

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 31  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 89
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 90  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 146
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 147 KLADFGLAR 155

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 88
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 89  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 145
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 146 KLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 87
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 88  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 144
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 145 KLADFGLAR 153

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 31  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 89
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 90  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 146
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 147 KLADFGLAR 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 88
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 89  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 145
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 146 KLADFGLAR 154

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 141
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 142 KLADFGLAR 150

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 141
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 142 KLADFGLAR 150

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 141
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 142 KLADFGLAR 150

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 208 QVAVKKLLGITKGSSHDNGL--SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++  K+   I      D  L    EI  L K+ H  I+++K F  + E   +V E M  G
Sbjct: 40  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 98
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAI------EAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
            L + + G +        RLK A       +    + YLH +    IIHRD+K  N+LL+
Sbjct: 99  ELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 147
Query: 320 SDFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  E     + DFG +K L   G +  M  + G+  Y+AP
Sbjct: 148 SQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 184

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 208 QVAVKKLLGITKGSSHDNGL--SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++  K+   I      D  L    EI  L K+ H  I+++K F  + E   +V E M  G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAI------EAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
            L + + G +        RLK A       +    + YLH +    IIHRD+K  N+LL+
Sbjct: 100 ELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 148
Query: 320 SDFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  E     + DFG +K L   G +  M  + G+  Y+AP
Sbjct: 149 SQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 185

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 143
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 144 KLADFGLAR 152

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 34  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 92
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 93  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 149
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 150 KLADFGLAR 158

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 25/144 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMP 263
           +VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY  
Sbjct: 62  KVAVKML----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 264 NGSLGEVLHGKRGSFLKW--------EMRLK------IAIEAAKGLSYLHHDCSPLIIHR 309
            G+L E L  +    L++        E +L        A + A+G+ YL    S   IHR
Sbjct: 118 KGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHR 174
Query: 310 DVKSNNILLNSDFEAHVADFGLAK 333
           D+ + N+L+  D    +ADFGLA+
Sbjct: 175 DLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 87
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 88  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAI 144
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 145 KLADFGLAR 153

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           +  +  EI  L KI+H NIV L     +     L+ + +  G L + +  K   F     
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 117
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL---LNSDFEAHVADFGLAKYLQDTGA 340
             ++  +    + YL HD    I+HRD+K  N+L   L+ D +  ++DFGL+K ++D G+
Sbjct: 118 ASRLIFQVLDAVKYL-HDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS 173
Query: 341 SECMSAVAGSYGYIAP 356
              +S   G+ GY+AP
Sbjct: 174 --VLSTACGTPGYVAP 187

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 275 RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
           +G  +  ++  KIA+   K L +LH   S  +IHRDVK +N+L+N+  +  + DFG++ Y
Sbjct: 102 KGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY 159
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           L D  A +     AG   Y+AP
Sbjct: 160 LVDDVAKDI---DAGCKPYMAP 178

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 208 QVAVKKLLGITKGSSHDNGL--SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++  K+   I      D  L    EI  L K+ H  I+++K F  + E   +V E M  G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAI------EAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
            L + + G +        RLK A       +    + YLH +    IIHRD+K  N+LL+
Sbjct: 100 ELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 148
Query: 320 SDFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  E     + DFG +K L   G +  M  + G+  Y+AP
Sbjct: 149 SQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 185

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 14/162 (8%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ETNLLV 258
            G+QVA+KK+       ++      E++ L   +H NI+ +K            ++  +V
Sbjct: 79  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 138
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + M    L +++H  +   L  E       +  +GL Y+H   S  +IHRD+K +N+L+
Sbjct: 139 LDLM-ESDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLV 192
Query: 319 NSDFEAHVADFGLAKYLQDTGASE--CMSAVAGSYGYIAPVL 358
           N + E  + DFG+A+ L  + A     M+    +  Y AP L
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-------- 256
            G++VA+KK+L   +          EI+ L  ++H N+V L   C  K +          
Sbjct: 42  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 101
Query: 257 LVYEYMPN---GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
           LV+++  +   G L  VL     S +K  M++ +      GL Y+H +    I+HRD+K+
Sbjct: 102 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-----NGLYYIHRNK---ILHRDMKA 153
Query: 314 NNILLNSDFEAHVADFGLAK 333
            N+L+  D    +ADFGLA+
Sbjct: 154 ANVLITRDGVLKLADFGLAR 173

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 208 QVAVKKLLGITKGSSHDNGL--SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++  K+   I      D  L    EI  L K+ H  I+++K F  + E   +V E M  G
Sbjct: 47  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG 105
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAI------EAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
            L + + G +        RLK A       +    + YLH +    IIHRD+K  N+LL+
Sbjct: 106 ELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 154
Query: 320 SDFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  E     + DFG +K L   G +  M  + G+  Y+AP
Sbjct: 155 SQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAP 191

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 143
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 144 KLADFGLAR 152

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 203 TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           TP  E  A  K++   K S+ D   L  E R    ++H NIVRL    S +  + LV++ 
Sbjct: 54  TPTQEYAA--KIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDL 111
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNS 320
           +  G L E +   R  + + +    I  +  + ++++H HD    I+HRD+K  N+LL S
Sbjct: 112 VTGGELFEDIVA-REYYSEADASHCIH-QILESVNHIHQHD----IVHRDLKPENLLLAS 165
Query: 321 DFE---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             +     +ADFGLA  +Q  G  +     AG+ GY++P
Sbjct: 166 KCKGAAVKLADFGLAIEVQ--GEQQAWFGFAGTPGYLSP 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 88
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 89  MDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAI 145
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 146 KLADFGLAR 154

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    +V EYMP G+L 
Sbjct: 60  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLL 116
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 117 DYLRECNREEVTAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVAD 173
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 174 FGLSRLM 180

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+   +L +++H +    +  +  +++  +A + L++ H +    IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 317 LLNSDFEAHVADFGLAKYLQDTGAS-ECMSAVAGSYGYIAP 356
           L+++     V DFG+A+ + D+G S    +AV G+  Y++P
Sbjct: 148 LISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 12/133 (9%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCS----NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           A +R L    H N+VRL   C+    ++ET L LV+E++ +  L   L       +  E 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
              +  +  +GL +LH   S  ++HRD+K  NIL+ S  +  +ADFGLA+      A   
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--- 175
Query: 344 MSAVAGSYGYIAP 356
           +++V  +  Y AP
Sbjct: 176 LTSVVVTLWYRAP 188

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 87  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAI 143
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 144 KLADFGLAR 152

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 12/133 (9%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCS----NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           A +R L    H N+VRL   C+    ++ET L LV+E++ +  L   L       +  E 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
              +  +  +GL +LH   S  ++HRD+K  NIL+ S  +  +ADFGLA+      A   
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--- 175
Query: 344 MSAVAGSYGYIAP 356
           +++V  +  Y AP
Sbjct: 176 LTSVVVTLWYRAP 188

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           +  +  EI  L KI+H NIV L     +     L+ + +  G L + +  K   F     
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 117
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL---LNSDFEAHVADFGLAKYLQDTGA 340
             ++  +    + YL HD    I+HRD+K  N+L   L+ D +  ++DFGL+K ++D G+
Sbjct: 118 ASRLIFQVLDAVKYL-HDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS 173
Query: 341 SECMSAVAGSYGYIAP 356
              +S   G+ GY+AP
Sbjct: 174 --VLSTACGTPGYVAP 187

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 150 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 197
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 198 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 237

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-S 86
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 87  MDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAI 143
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 144 KLADFGLAR 152

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 105 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 152
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 153 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 192

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 113 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 160
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 161 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 200

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 110
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 111 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 158
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 159 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 198

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           E+   G+L + +  +RG  L   + L++  +  KG+ Y+H   S  +IHRD+K +NI L 
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLV 170
Query: 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              +  + DFGL   L++ G     +   G+  Y++P
Sbjct: 171 DTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSP 204

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 106 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 153
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 154 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 193

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIR--TLGKIR-------HRNIVRLKAFCSNKET 254
           P  ++ AVK ++ +T G S       E+R  TL ++        H NI++LK        
Sbjct: 27  PTCKEYAVK-IIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 85
Query: 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
             LV++ M  G L + L  ++ +  + E R  ++  +E    L  L+      I+HRD+K
Sbjct: 86  FFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLK 138
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             NILL+ D    + DFG +  L D G  E +  V G+  Y+AP
Sbjct: 139 PENILLDDDMNIKLTDFGFSCQL-DPG--EKLREVCGTPSYLAP 179

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 14/162 (8%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ETNLLV 258
            G+QVA+KK+       ++      E++ L   +H NI+ +K            ++  +V
Sbjct: 78  TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + M    L +++H  +   L  E       +  +GL Y+H   S  +IHRD+K +N+L+
Sbjct: 138 LDLM-ESDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLV 191
Query: 319 NSDFEAHVADFGLAKYLQDTGASE--CMSAVAGSYGYIAPVL 358
           N + E  + DFG+A+ L  + A     M+    +  Y AP L
Sbjct: 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 150 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 197
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 198 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 237

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           +  +  EI  L KI+H NIV L     +     L+ + +  G L + +  K   F     
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 117
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL---LNSDFEAHVADFGLAKYLQDTGA 340
             ++  +    + YL HD    I+HRD+K  N+L   L+ D +  ++DFGL+K ++D G+
Sbjct: 118 ASRLIFQVLDAVKYL-HDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS 173
Query: 341 SECMSAVAGSYGYIAP 356
              +S   G+ GY+AP
Sbjct: 174 --VLSTACGTPGYVAP 187

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           +  +  EI  L KI+H NIV L     +     L+ + +  G L + +  K   F     
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 117
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL---LNSDFEAHVADFGLAKYLQDTGA 340
             ++  +    + YL HD    I+HRD+K  N+L   L+ D +  ++DFGL+K ++D G+
Sbjct: 118 ASRLIFQVLDAVKYL-HDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS 173
Query: 341 SECMSAVAGSYGYIAP 356
              +S   G+ GY+AP
Sbjct: 174 --VLSTACGTPGYVAP 187

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 106 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 153
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 154 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 193

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-------- 256
            G++VA+KK+L   +          EI+ L  ++H N+V L   C  K +          
Sbjct: 42  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 101
Query: 257 LVYEYMPN---GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
           LV+++  +   G L  VL     S +K  M++ +      GL Y+H +    I+HRD+K+
Sbjct: 102 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-----NGLYYIHRNK---ILHRDMKA 153
Query: 314 NNILLNSDFEAHVADFGLAK 333
            N+L+  D    +ADFGLA+
Sbjct: 154 ANVLITRDGVLKLADFGLAR 173

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-------- 256
            G++VA+KK+L   +          EI+ L  ++H N+V L   C  K +          
Sbjct: 41  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100
Query: 257 LVYEYMPN---GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
           LV+++  +   G L  VL     S +K  M++ +      GL Y+H +    I+HRD+K+
Sbjct: 101 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-----NGLYYIHRNK---ILHRDMKA 152
Query: 314 NNILLNSDFEAHVADFGLAK 333
            N+L+  D    +ADFGLA+
Sbjct: 153 ANVLITRDGVLKLADFGLAR 172

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  +  FGLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILGFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-------- 256
            G++VA+KK+L   +          EI+ L  ++H N+V L   C  K +          
Sbjct: 42  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIY 101
Query: 257 LVYEYMPN---GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS 313
           LV+++  +   G L  VL     S +K  M++ +      GL Y+H +    I+HRD+K+
Sbjct: 102 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-----NGLYYIHRNK---ILHRDMKA 153
Query: 314 NNILLNSDFEAHVADFGLAK 333
            N+L+  D    +ADFGLA+
Sbjct: 154 ANVLITRDGVLKLADFGLAR 173

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIR--TLGKIR-------HRNIVRLKAFCSNKET 254
           P  ++ AVK ++ +T G S       E+R  TL ++        H NI++LK        
Sbjct: 40  PTCKEYAVK-IIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98
Query: 255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMR--LKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
             LV++ M  G L + L  ++ +  + E R  ++  +E    L  L+      I+HRD+K
Sbjct: 99  FFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLK 151
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             NILL+ D    + DFG +  L D G  E +  V G+  Y+AP
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQL-DPG--EKLREVCGTPSYLAP 192

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+ L   F   K     +   LV E M
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 113 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 160
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 161 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 65/129 (50%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 88
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L   +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 89  QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 145
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 146 KLADFGLAR 154

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +G +  N    E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 44  SGELVAIKKVL---QGKAFKN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 155 LDPDTAVLKLCDFGSAKQL 173

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +G +  N    E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 44  SGELVAIKKVL---QGKAFKN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 155 LDPDTAVLKLCDFGSAKQL 173

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 213 KLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271
           K++   K S+ D   L  E R   K++H NIVRL      +  + LV++ +  G L E +
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119
Query: 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVAD 328
             +   F           +  + ++Y H +    I+HR++K  N+LL S  +     +AD
Sbjct: 120 VAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA  + D   SE     AG+ GY++P
Sbjct: 175 FGLAIEVND---SEAWHGFAGTPGYLSP 199

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 213 KLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271
           K++   K S+ D   L  E R   K++H NIVRL      +  + LV++ +  G L E +
Sbjct: 37  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 96
Query: 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVAD 328
             +   F           +  + ++Y H   S  I+HR++K  N+LL S  +     +AD
Sbjct: 97  VAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA  + D   SE     AG+ GY++P
Sbjct: 152 FGLAIEVND---SEAWHGFAGTPGYLSP 176

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 80  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 134
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 135 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 190
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 191 KVADFGLARDMYD 203

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + D GLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 10/159 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL--KAFCSNKETNLLVYEYM 262
           +G+ +  K+L   +   +    L +E+  L +++H NIVR   +       T  +V EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 263 PNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHH--DCSPLIIHRDVKSNNILL 318
             G L  V+    K   +L  E  L++  +    L   H   D    ++HRD+K  N+ L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 319 NSDFEAHVADFGLAKYL-QDTGASECMSAVAGSYGYIAP 356
           +      + DFGLA+ L  DT  ++   A  G+  Y++P
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAK---AFVGTPYYMSP 185

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 28/170 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLG---------EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
           +    +G         + L      FL +++         +GL Y+H   S  IIHRD+K
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIH---SADIIHRDLK 152
Query: 313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
            +N+ +N D E  + D GLA++  D      M+    +  Y AP  +L W
Sbjct: 153 PSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 213 KLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271
           K++   K S+ D   L  E R   K++H NIVRL      +  + LV++ +  G L E +
Sbjct: 36  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 95
Query: 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVAD 328
             +   F           +  + ++Y H   S  I+HR++K  N+LL S  +     +AD
Sbjct: 96  VAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 150
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA  + D   SE     AG+ GY++P
Sbjct: 151 FGLAIEVND---SEAWHGFAGTPGYLSP 175

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 217 ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGE------V 270
           I+  S +D+    E++ +  I++   +  +   +N +   ++YEYM N S+ +      V
Sbjct: 81  ISIKSKYDD-FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 271 LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330
           L      F+  ++   I        SY+H++ +  I HRDVK +NIL++ +    ++DFG
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197
Query: 331 LAKYLQDTGASECMSAVAGSYGYIAP 356
            ++Y+ D      +    G+Y ++ P
Sbjct: 198 ESEYMVDKK----IKGSRGTYEFMPP 219

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-D 88
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 89  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 145
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 146 KLADFGLAR 154

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 81  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 135
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 136 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 191
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 192 KVADFGLARDMYD 204

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 62  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 116
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 117 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 173 KVADFGLARDMYD 185

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 61  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 115
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 116 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 171
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 172 KVADFGLARDMYD 184

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 63/129 (48%), Gaps = 10/129 (7%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKI 287
           E+    ++ H+NIV +       +   LV EY+   +L E +  HG     L  +  +  
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINF 116
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAV 347
             +   G+ + H      I+HRD+K  NIL++S+    + DFG+AK L +T  ++  + V
Sbjct: 117 TNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHV 172
Query: 348 AGSYGYIAP 356
            G+  Y +P
Sbjct: 173 LGTVQYFSP 181

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 213 KLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL 271
           K++   K S+ D   L  E R   K++H NIVRL      +  + LV++ +  G L E +
Sbjct: 37  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 96
Query: 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVAD 328
             +   F           +  + ++Y H   S  I+HR++K  N+LL S  +     +AD
Sbjct: 97  VAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGLA  + D   SE     AG+ GY++P
Sbjct: 152 FGLAIEVND---SEAWHGFAGTPGYLSP 176

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 62  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 116
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 117 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 173 KVADFGLARDMYD 185

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+   +L +++H +    +  +  +++  +A + L++ H +    IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMS-AVAGSYGYIAP 356
           ++++     V DFG+A+ + D+G S   + AV G+  Y++P
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 61  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 115
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 116 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 171
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 172 KVADFGLARDMYD 184

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+   +L +++H +    +  +  +++  +A + L++ H +    IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMS-AVAGSYGYIAP 356
           ++++     V DFG+A+ + D+G S   + AV G+  Y++P
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+   +L +++H +    +  +  +++  +A + L++ H +    IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMS-AVAGSYGYIAP 356
           ++++     V DFG+A+ + D+G S   + AV G+  Y++P
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 60  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 114
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 115 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 170
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 171 KVADFGLARDMYD 183

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 54  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 108
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 109 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 164
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 165 KVADFGLARDMYD 177

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           ++ EY+  GS  ++L    G F ++++   +  E  KGL YLH +     IHRD+K+ N+
Sbjct: 98  IIMEYLGGGSALDLLRA--GPFDEFQIATMLK-EILKGLDYLHSEKK---IHRDIKAANV 151
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LL+   +  +ADFG+A  L DT      +   G+  ++AP
Sbjct: 152 LLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 189

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+   +L +++H +    +  +  +++  +A + L++ H +    IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMS-AVAGSYGYIAP 356
           ++++     V DFG+A+ + D+G S   + AV G+  Y++P
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLSQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 57  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 111
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 112 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 167
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 168 KVADFGLARDMYD 180

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 59  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 113
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ YL    S   +HRD+ + N +L+  F  
Sbjct: 114 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 169
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 170 KVADFGLARDMYD 182

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 20/145 (13%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 54  TATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW----------EMRLKIAIEAAKGLSYLHHDCSPLIIH 308
            E+   G+L   L  KR  F+ +          E  +  + + AKG+ +L    S   IH
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIH 167
Query: 309 RDVKSNNILLNSDFEAHVADFGLAK 333
           RD+ + NILL+      + DFGLA+
Sbjct: 168 RDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+   +L +++H +    +  +  +++  +A + L++ H +    IIHRDVK  NI
Sbjct: 110 IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMS-AVAGSYGYIAP 356
           ++++     V DFG+A+ + D+G S   + AV G+  Y++P
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 205

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           E VA+K++    +    D G+ +    EI  L +++H+NIVRL     + +   LV+E+ 
Sbjct: 28  EIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
            +  L +      G  L  E+      +  KGL + H   S  ++HRD+K  N+L+N + 
Sbjct: 84  -DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNG 138
Query: 323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           E  +A+FGLA+         C SA   +  Y  P
Sbjct: 139 ELKLANFGLARAF--GIPVRCYSAEVVTLWYRPP 170

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMRIADFGLAR 205

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +G +  N    E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 44  SGELVAIKKVL---QGKAFKN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 98  LDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 155 LDPDTAVLKLCDFGSAKQL 173

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNKETNLLVYEY 261
           T  G +VAVKKL    +   H      E+R L  ++H N++  L  F   +        Y
Sbjct: 44  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +    +G  L+         +  ++  I +  +GL Y+H   S  IIHRD+K +N+ +N 
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 160
Query: 321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
           D E  + D GLA++  D      M+    +  Y AP  +L W
Sbjct: 161 DCELKILDGGLARHTDDE-----MTGYVATRWYRAPEIMLNW 197

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ +  EI  L KI+H NIV L+    +     LV + +  G L + +  ++G + + + 
Sbjct: 64  ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI-VEKGFYTEKDA 122
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGA 340
              I  +    + YLH      I+HRD+K  N+L  S  E     ++DFGL+K     G 
Sbjct: 123 STLIR-QVLDAVYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGK 175
Query: 341 SECMSAVAGSYGYIAP 356
            + MS   G+ GY+AP
Sbjct: 176 GDVMSTACGTPGYVAP 191

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 22/143 (15%)
Query: 230 EIRTLGKIRHRNIVRL----KAFCSNKETN------------LLVYEYMPNGSLGEVLHG 273
           E++ L K+ H NIV        F  + ET+             +  E+   G+L + +  
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 274 KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           +RG  L   + L++  +  KG+ Y+H   S  +I+RD+K +NI L    +  + DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 334 YLQDTGASECMSAVAGSYGYIAP 356
            L++ G         G+  Y++P
Sbjct: 171 SLKNDGKR---XRSKGTLRYMSP 190

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 70  VAVKML----KDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 62  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 117
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 118 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 174
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 175 LAARNVLVTENNVMKIADFGLAR 197

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 116 VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 228
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 229 LAARNVLVTENNVMKIADFGLAR 251

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 59  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 114
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 115 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 171
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 172 LAARNVLVTENNVMKIADFGLAR 194

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 57  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 112
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 113 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 169
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 170 LTARNVLVTENNVMKIADFGLAR 192

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLSQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLSQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 275 RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
           +G  +  ++  KIA+   K L +LH   S  +IHRDVK +N+L+N+  +    DFG++ Y
Sbjct: 129 KGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGY 186
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           L D  A +     AG   Y AP
Sbjct: 187 LVDDVAKDID---AGCKPYXAP 205

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 26/136 (19%)
Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEA 291
           +  RN V+       K T  +  EY  NG+L +++H      +R  +  W +  +I    
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY--WRLFRQIL--- 126
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT------------G 339
            + LSY+H   S  IIHRD+K  NI ++      + DFGLAK +  +            G
Sbjct: 127 -EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 340 ASECMSAVAGSYGYIA 355
           +S+ +++  G+  Y+A
Sbjct: 183 SSDNLTSAIGTAMYVA 198

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE-YMP 263
           +GE+VA+KKL    +          E+  L  ++H N++ L    +   +    Y+ Y+ 
Sbjct: 66  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
              +   L    G     E    +  +  KGL Y+H   S  ++HRD+K  N+ +N D E
Sbjct: 126 MPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCE 182
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
             + DFGLA++     A   M+    +  Y AP  +L W
Sbjct: 183 LKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILSW 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 27/149 (18%)
Query: 209 VAVKKLLGITKGSSH---DNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K S+H      L +E++ L  +  H NIV L   C+     L++ EY   
Sbjct: 79  VAVKML----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 134
Query: 265 GSLGEVLHGKRGSFLKWEMRLKI----------------AIEAAKGLSYLHHDCSPLIIH 308
           G L   L  KR SF+  +    I                + + AKG+++L    S   IH
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIH 191
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           RD+ + NILL       + DFGLA+++++
Sbjct: 192 RDLAARNILLTHGRITKICDFGLARHIKN 220

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 65/129 (50%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+KK+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-H 84
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L   +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 85  QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 141
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 142 KLADFGLAR 150

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 15/155 (9%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           ++ AVK +   +  +   + +  E+  L K+ H NI++L     +  +  +V E    G 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 267 L-GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNS---D 321
           L  E++  KR S        +I  +   G++Y+H H+    I+HRD+K  NILL S   D
Sbjct: 108 LFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKD 160
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +  + DFGL+   Q       M    G+  YIAP
Sbjct: 161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAP 192

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 15/155 (9%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           ++ AVK +   +  +   + +  E+  L K+ H NI++L     +  +  +V E    G 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 267 L-GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNS---D 321
           L  E++  KR S        +I  +   G++Y+H H+    I+HRD+K  NILL S   D
Sbjct: 108 LFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKD 160
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +  + DFGL+   Q       M    G+  YIAP
Sbjct: 161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAP 192

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 106 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 153
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 154 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 193

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK    I +G   D  +  EI     +RH NIVR K          +V EY   G 
Sbjct: 45  ELVAVKY---IERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH- 325
           L E +    G F + E R     +   G+SY H   +  + HRD+K  N LL+       
Sbjct: 102 LFERICNA-GRFSEDEARFFFQ-QLISGVSYAH---AMQVAHRDLKLENTLLDGSPAPRL 156
Query: 326 -VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +ADFG +K       S+  SAV G+  YIAP
Sbjct: 157 KIADFGYSK--ASVLHSQPKSAV-GTPAYIAP 185

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 121 AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 175
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ +L    S   +HRD+ + N +L+  F  
Sbjct: 176 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 231
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 232 KVADFGLARDMYD 244

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 20/145 (13%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 54  TATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW----------EMRLKIAIEAAKGLSYLHHDCSPLIIH 308
            E+   G+L   L  KR  F+ +          E  +  + + AKG+ +L    S   IH
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIH 167
Query: 309 RDVKSNNILLNSDFEAHVADFGLAK 333
           RD+ + NILL+      + DFGLA+
Sbjct: 168 RDLAARNILLSEKNVVKICDFGLAR 192

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 57/119 (47%), Gaps = 19/119 (15%)
Query: 245 LKAFCSNKETNLL--VYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEAAKGLSY 297
           ++ FC+ ++   L  V EYMP G L  ++       K   F   E+ L +    + GL  
Sbjct: 138 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL-- 195
Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                    IHRDVK +N+LL+      +ADFG    + +TG   C +AV G+  YI+P
Sbjct: 196 ---------IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISP 244

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 22/147 (14%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 56  TATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 112
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW------------EMRLKIAIEAAKGLSYLHHDCSPLI 306
            E+   G+L   L  KR  F+ +            E  +  + + AKG+ +L    S   
Sbjct: 113 VEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKX 169
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAK 333
           IHRD+ + NILL+      + DFGLA+
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 67  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 121
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ +L    S   +HRD+ + N +L+  F  
Sbjct: 122 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 177
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 178 KVADFGLARDMYD 190

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 217 ITKGSSHDNGLSA---EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL-GEVLH 272
           I K S+ +   S    E+  L K+ H NI++L     +  +  +V E    G L  E++ 
Sbjct: 55  INKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNS---DFEAHVAD 328
            KR S        +I  +   G++Y+H H+    I+HRD+K  NILL S   D +  + D
Sbjct: 115 RKRFS---EHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIID 167
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP 356
           FGL+   Q       M    G+  YIAP
Sbjct: 168 FGLSTCFQQNTK---MKDRIGTAYYIAP 192

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE-YMP 263
           +GE+VA+KKL    +          E+  L  ++H N++ L    +   +    Y+ Y+ 
Sbjct: 48  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
              +   L    G     E    +  +  KGL Y+H   S  ++HRD+K  N+ +N D E
Sbjct: 108 MPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCE 164
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLGW 360
             + DFGLA++     A   M+    +  Y AP  +L W
Sbjct: 165 LKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILSW 198

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 62  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 116
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ +L    S   +HRD+ + N +L+  F  
Sbjct: 117 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 173 KVADFGLARDMYD 185

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 62  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 116
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ +L    S   +HRD+ + N +L+  F  
Sbjct: 117 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 172
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 173 KVADFGLARDMYD 185

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+ K+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 27  TGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 85
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 86  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 142
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 143 KLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 4/129 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
            GE VA+ K+   T+     +    EI  L ++ H NIV+L      +    LV+E++ +
Sbjct: 26  TGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-H 84
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
             L + +     + +   +      +  +GL++ H   S  ++HRD+K  N+L+N++   
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAI 141
Query: 325 HVADFGLAK 333
            +ADFGLA+
Sbjct: 142 KLADFGLAR 150

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 11/145 (7%)
Query: 215 LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGK 274
           L + K +     +  EI  L ++ H NI++LK          LV E +  G L + +  +
Sbjct: 83  LKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-E 141
Query: 275 RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGL 331
           +G + + +    +  +  + ++YLH +    I+HRD+K  N+L  +   D    +ADFGL
Sbjct: 142 KGYYSERDAADAVK-QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197
Query: 332 AKYLQDTGASECMSAVAGSYGYIAP 356
           +K ++       M  V G+ GY AP
Sbjct: 198 SKIVEH---QVLMKTVCGTPGYCAP 219

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 60  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 114
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ +L    S   +HRD+ + N +L+  F  
Sbjct: 115 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 170
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 171 KVADFGLARDMYD 183

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 63  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 117
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ +L    S   +HRD+ + N +L+  F  
Sbjct: 118 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 173
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 174 KVADFGLARDMYD 186

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           +VAVK +L  T  +     L +E++ +  + +H NIV L   C++    L++ EY   G 
Sbjct: 78  KVAVK-MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 267 LGEVLHGKR------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           L   L  K              S L     L  + + A+G+++L    S   IHRDV + 
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAAR 193
Query: 315 NILLNSDFEAHVADFGLAK 333
           N+LL +   A + DFGLA+
Sbjct: 194 NVLLTNGHVAKIGDFGLAR 212

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 10/137 (7%)
Query: 227 LSAEIRTLGKIRHRNIVRL--KAFCSNKETNLLVYEYMPNGSLGEVLHG--KRGSFLKWE 282
           L +E+  L +++H NIVR   +       T  +V EY   G L  V+    K   +L  E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 283 MRLKIAIEAAKGLSYLHH--DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL-QDTG 339
             L++  +    L   H   D    ++HRD+K  N+ L+      + DFGLA+ L  DT 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 340 ASECMSAVAGSYGYIAP 356
            ++      G+  Y++P
Sbjct: 172 FAK---TFVGTPYYMSP 185

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 117 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 164
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 165 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 204

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 210 AVKKLLGITKGSSHDNGLSAEIRTLGKIR----HRNIVRLKAFCSNKE-TNLLVYEYMPN 264
           AVK L  IT     D G  ++  T G I     H N++ L   C   E + L+V  YM +
Sbjct: 63  AVKSLNRIT-----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 117
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G L   +  +  +    ++ +   ++ AKG+ +L    S   +HRD+ + N +L+  F  
Sbjct: 118 GDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTV 173
Query: 325 HVADFGLAKYLQD 337
            VADFGLA+ + D
Sbjct: 174 KVADFGLARDMLD 186

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYRAPEVILG 199

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 204 PNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           P G++ A K ++   K S+ D   L  E R    ++H NIVRL    S +  + LV++ +
Sbjct: 27  PTGQEYAAK-IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLV 85
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
             G L E +  +     ++      +    + L  ++H     I+HRD+K  N+LL S  
Sbjct: 86  TGGELFEDIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKS 140
Query: 323 E---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +     +ADFGLA  +Q  G  +     AG+ GY++P
Sbjct: 141 KGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSP 175

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      E      
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC 166
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 167 GTPEYLAP 174

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 113 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 160
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M+    +  Y AP  +LG
Sbjct: 161 KSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 200

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK    I +G++ D  +  EI     +RH NIVR K          ++ EY   G 
Sbjct: 46  ELVAVKY---IERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH- 325
           L E +    G F + E R     +   G+SY H   S  I HRD+K  N LL+       
Sbjct: 103 LYERICNA-GRFSEDEARFFFQ-QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRL 157
Query: 326 -VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            + DFG +K       S+  S V G+  YIAP
Sbjct: 158 KICDFGYSK--SSVLHSQPKSTV-GTPAYIAP 186

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 204 PNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           P G++ A K ++   K S+ D   L  E R    ++H NIVRL    S +  + LV++ +
Sbjct: 27  PTGQEYAAK-IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLV 85
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
             G L E +  +     ++      +    + L  ++H     I+HRD+K  N+LL S  
Sbjct: 86  TGGELFEDIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKS 140
Query: 323 E---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +     +ADFGLA  +Q  G  +     AG+ GY++P
Sbjct: 141 KGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSP 175

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF--CSNKETNL----LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F   S ++ ++    LV
Sbjct: 44  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLV 97
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 155 LDPDTAVLKLCDFGSAKQL 173

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 206 GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY 261
           G +VA+K    I K + +  G+      E++   +++H +I+ L  +  +     LV E 
Sbjct: 36  GLEVAIKM---IDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92
Query: 262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
             NG +   L  +   F + E R     +   G+ YLH   S  I+HRD+  +N+LL  +
Sbjct: 93  CHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRN 148
Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLG 359
               +ADFGLA  L+     E    + G+  YI+P + 
Sbjct: 149 MNIKIADFGLATQLK--MPHEKHYTLCGTPNYISPEIA 184

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV------RLKAFCSNKETNLL 257
           P GE VA+KK+    K       L  EI+ L   +H NI+      R  +F +  E   +
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEV-YI 91
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
           + E M    L  V+  +  S    +  +   + A K L    H  +  +IHRD+K +N+L
Sbjct: 92  IQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL----HGSN--VIHRDLKPSNLL 144
Query: 318 LNSDFEAHVADFGLAKYLQDTGA--SECMSAVAGSYGYIAPVLGWY 361
           +NS+ +  V DFGLA+ + ++ A  SE     +G   Y+A    WY
Sbjct: 145 INSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA--TRWY 188

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      E      
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC 166
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 167 GTPEYLAP 174

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      E      
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 114
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 115 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC 169
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 170 GTPEYLAP 177

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      E      
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFC 166
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 167 GTPEYLAP 174

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           +VAVK +L  T  +     L +E++ +  + +H NIV L   C++    L++ EY   G 
Sbjct: 63  KVAVK-MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 121
Query: 267 LGEVLHGKRGSFL-------------------KWEMR--LKIAIEAAKGLSYLHHDCSPL 305
           L   L  K  + L                     E+R  L  + + A+G+++L    S  
Sbjct: 122 LLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKN 178
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK 333
            IHRDV + N+LL +   A + DFGLA+
Sbjct: 179 CIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      E      
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFC 166
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 167 GTPEYLAP 174

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           +VAVK +L  T  +     L +E++ +  + +H NIV L   C++    L++ EY   G 
Sbjct: 78  KVAVK-MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 267 LGEVLHGKRGSFLKWEMRLKIA-------------IEAAKGLSYLHHDCSPLIIHRDVKS 313
           L   L  ++   L+ +    IA              + A+G+++L    S   IHRDV +
Sbjct: 137 LLNFLR-RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192
Query: 314 NNILLNSDFEAHVADFGLAK 333
            N+LL +   A + DFGLA+
Sbjct: 193 RNVLLTNGHVAKIGDFGLAR 212

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 44  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 155 LDPDTAVLKLCDFGSAKQL 173

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 72  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 125
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 126 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 182
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 183 LDPDTAVLKLCDFGSAKQL 201

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 57  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 110
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 111 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 167
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 168 LDPDTAVLKLCDFGSAKQL 186

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M     +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPEVILG 199

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 45  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 98
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 99  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 155
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 156 LDPDTAVLKLCDFGSAKQL 174

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 44  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 155 LDPDTAVLKLCDFGSAKQL 173

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 55  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 111
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW-------------EMRLKIAIEAAKGLSYLHHDCSPL 305
            E+   G+L   L  KR  F+ +             E  +  + + AKG+ +L    S  
Sbjct: 112 VEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 168
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK 333
            IHRD+ + NILL+      + DFGLA+
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      E      
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFC 166
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 167 GTPEYLAP 174

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      E      
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 116
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH   S  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 117 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFC 171
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 172 GTPEYLAP 179

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 78  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 188
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 189 LDPDTAVLKLCDFGSAKQL 207

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 44  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 154
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 155 LDPDTAVLKLCDFGSAKQL 173

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 52  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 105
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 106 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 162
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 163 LDPDTAVLKLCDFGSAKQL 181

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 63  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 116
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 117 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 173
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 174 LDPDTAVLKLCDFGSAKQL 192

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 112 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 159
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M     +  Y AP  +LG
Sbjct: 160 KSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPEVILG 199

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 49  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 102
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 103 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 159
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 160 LDPDTAVLKLCDFGSAKQL 178

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 27/149 (18%)
Query: 209 VAVKKLLGITKGSSH---DNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K S+H      L +E++ L  +  H NIV L   C+     L++ EY   
Sbjct: 56  VAVKML----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 111
Query: 265 GSLGEVLHGKRGSFLKWEMRLKI----------------AIEAAKGLSYLHHDCSPLIIH 308
           G L   L  KR SF+  +    I                + + AKG+++L    S   IH
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIH 168
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           RD+ + NILL       + DFGLA+ +++
Sbjct: 169 RDLAARNILLTHGRITKICDFGLARDIKN 197

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 78  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 188
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 189 LDPDTAVLKLCDFGSAKQL 207

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 80  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 133
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 134 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 190
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 191 LDPDTAVLKLCDFGSAKQL 209

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 56  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 109
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 110 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 166
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 167 LDPDTAVLKLCDFGSAKQL 185

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 48  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 101
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 102 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 158
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 159 LDPDTAVLKLCDFGSAKQL 177

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++ EY   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   ++           +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 123 SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 176
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 177 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 233
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 234 LDPDTAVLKLCDFGSAKQL 252

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 252 KETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           K+T L ++ EY+  GS  ++L  + G   + ++   I  E  KGL YLH +     IHRD
Sbjct: 96  KDTKLWIIMEYLGGGSALDLL--EPGPLDETQIA-TILREILKGLDYLHSEKK---IHRD 149
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +K+ N+LL+   E  +ADFG+A  L DT      +   G+  ++AP
Sbjct: 150 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 193

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 56  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 109
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 110 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 166
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 167 LDPDTAVLKLCDFGSAKQL 185

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-----SNKETNL-LV 258
           +GE VA+KK+L   +  +       E++ + K+ H NIVRL+ F         E  L LV
Sbjct: 82  SGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 135
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            +Y+P        H  R       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 136 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 192
Query: 318 LNSDFEA-HVADFGLAKYL 335
           L+ D     + DFG AK L
Sbjct: 193 LDPDTAVLKLCDFGSAKQL 211

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 27/149 (18%)
Query: 209 VAVKKLLGITKGSSH---DNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K S+H      L +E++ L  +  H NIV L   C+     L++ EY   
Sbjct: 72  VAVKML----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 127
Query: 265 GSLGEVLHGKRGSFLKWEMRLKI----------------AIEAAKGLSYLHHDCSPLIIH 308
           G L   L  KR SF+  +    I                + + AKG+++L    S   IH
Sbjct: 128 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIH 184
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           RD+ + NILL       + DFGLA+ +++
Sbjct: 185 RDLAARNILLTHGRITKICDFGLARDIKN 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 27/149 (18%)
Query: 209 VAVKKLLGITKGSSH---DNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K S+H      L +E++ L  +  H NIV L   C+     L++ EY   
Sbjct: 79  VAVKML----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 134
Query: 265 GSLGEVLHGKRGSFLKWEMRLKI----------------AIEAAKGLSYLHHDCSPLIIH 308
           G L   L  KR SF+  +    I                + + AKG+++L    S   IH
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIH 191
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           RD+ + NILL       + DFGLA+ +++
Sbjct: 192 RDLAARNILLTHGRITKICDFGLARDIKN 220

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 27/149 (18%)
Query: 209 VAVKKLLGITKGSSH---DNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K S+H      L +E++ L  +  H NIV L   C+     L++ EY   
Sbjct: 74  VAVKML----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 129
Query: 265 GSLGEVLHGKRGSFLKWEMRLKI----------------AIEAAKGLSYLHHDCSPLIIH 308
           G L   L  KR SF+  +    I                + + AKG+++L    S   IH
Sbjct: 130 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIH 186
Query: 309 RDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           RD+ + NILL       + DFGLA+ +++
Sbjct: 187 RDLAARNILLTHGRITKICDFGLARDIKN 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 6/115 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRL--KAFCSNKETNLLVYEYMPNGSLGEVLHG--KRGSFLKWE 282
           L +E+  L +++H NIVR   +       T  +V EY   G L  V+    K   +L  E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 283 MRLKIAIEAAKGLSYLHH--DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
             L++  +    L   H   D    ++HRD+K  N+ L+      + DFGLA+ L
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV-RLKAFCSNK-----ETNLLVYEYM 262
           VA+KKL    +  +H      E+  +  + H+NI+  L  F   K     +   +V E M
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 263 PNGSLGEV----LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            + +L +V    L  +R S+L ++M          G+ +LH   S  IIHRD+K +NI++
Sbjct: 114 -DANLCQVIQMELDHERMSYLLYQMLC--------GIKHLH---SAGIIHRDLKPSNIVV 161
Query: 319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP--VLG 359
            SD    + DFGLA+     G S  M     +  Y AP  +LG
Sbjct: 162 KSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYRAPEVILG 201

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 9/133 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260
           N  Q+   K + +   S   +G++     EI+ L ++ H NI+ L     +K    LV++
Sbjct: 33  NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 92
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
           +M      EV+       L         +   +GL YLH      I+HRD+K NN+LL+ 
Sbjct: 93  FMETDL--EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDE 147
Query: 321 DFEAHVADFGLAK 333
           +    +ADFGLAK
Sbjct: 148 NGVLKLADFGLAK 160

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 71/128 (55%), Gaps = 12/128 (9%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNLLVYEYMP 263
           +G QVAVK ++ + K    +  L  E+  +   +H N+V + K++   +E  +L+ E++ 
Sbjct: 69  SGRQVAVK-MMDLRKQQRREL-LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM-EFLQ 125
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAA-KGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
            G+L +++   R +    E ++    EA  + L+YLH      +IHRD+KS++ILL  D 
Sbjct: 126 GGALTDIVSQVRLN----EEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDG 178
Query: 323 EAHVADFG 330
              ++DFG
Sbjct: 179 RVKLSDFG 186

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 17/164 (10%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           V V +   I K     + +S     L  ++H  +V L       +    V +Y+  G L 
Sbjct: 68  VKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF 127
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  +R  FL+   R   A E A  L YLH   S  I++RD+K  NILL+S     + D
Sbjct: 128 YHLQRER-CFLEPRARF-YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTD 182
Query: 329 FGLAKYLQDTGASECMSAVAGSYGYIAP----------VLGWYC 362
           FGL K  ++   +   S   G+  Y+AP           + W+C
Sbjct: 183 FGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 39  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 96
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 97  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 147
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 148 NVLVKTPQHVKITDFGLAKLL---GAEE 172

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 252 KETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           K+T L ++ EY+  GS  ++L    G   + ++   I  E  KGL YLH +     IHRD
Sbjct: 76  KDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLHSEKK---IHRD 129
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +K+ N+LL+   E  +ADFG+A  L DT      +   G+  ++AP
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 173

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 41  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 98
Query: 260 EYMPNGSLGEVLHGKR---GS--FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   +   GS   L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 99  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 149
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 150 NVLVKTPQHVKITDFGLAKLL---GAEE 174

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 42  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 99
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 100 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 150
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 151 NVLVKTPQHVKITDFGLAKLL---GAEE 175

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 54  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 39  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 96
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 97  QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 147
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 148 NVLVKTPQHVKITDFGLAKLL---GAEE 172

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 56  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 112
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 113 VEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 169
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 170 KCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVY 259
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 45  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 260 -EYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 102 TEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 54  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 91  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 204
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 205 KCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 54  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 63/135 (46%), Gaps = 8/135 (5%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNG---LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE 260
           P+GE V +   + + + ++       +  E   +  +    + RL   C    T  LV +
Sbjct: 40  PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTS-TVQLVTQ 98
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            MP G L + +   RG     ++ L   ++ AKG+SYL       ++HRD+ + N+L+ S
Sbjct: 99  LMPYGCLLDHVRENRGRLGSQDL-LNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKS 154
Query: 321 DFEAHVADFGLAKYL 335
                + DFGLA+ L
Sbjct: 155 PNHVKITDFGLARLL 169

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 38  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 95
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 96  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 146
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 147 NVLVKTPQHVKITDFGLAKLL---GAEE 171

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 40  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 97
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 98  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 148
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 149 NVLVKTPQHVKITDFGLAKLL---GAEE 173

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV- 258
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 45  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 259 YEYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 102 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 63  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 120
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           + MP G L + +   + + +  +  L   ++ AKG++YL       ++HRD+ + N+L+ 
Sbjct: 121 QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVK 176
Query: 320 SDFEAHVADFGLAKYLQDTGASE 342
           +     + DFGLAK L   GA E
Sbjct: 177 TPQHVKITDFGLAKLL---GAEE 196

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 45  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 102
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 103 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 153
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 154 NVLVKTPQHVKITDFGLAKLL---GAEE 178

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 252 KETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           K+T L ++ EY+  GS  ++L    G   + ++   I  E  KGL YLH +     IHRD
Sbjct: 91  KDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLHSEKK---IHRD 144
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +K+ N+LL+   E  +ADFG+A  L DT      +   G+  ++AP
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAP 188

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVY 259
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 45  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 260 -EYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 102 TEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 38  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 95
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 96  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 146
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 147 NVLVKTPQHVKITDFGLAKLL---GAEE 171

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV------RLKAFCSNKETNLL 257
           P GE VA+KK+    K       L  EI+ L   +H NI+      R  +F +  E   +
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEV-YI 91
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
           + E M    L  V+  +  S    +  +   + A K L    H  +  +IHRD+K +N+L
Sbjct: 92  IQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL----HGSN--VIHRDLKPSNLL 144
Query: 318 LNSDFEAHVADFGLAKYLQDTGA--SECMSAVAGSYGYIAPVLGWY 361
           +NS+ +  V DFGLA+ + ++ A  SE     +G   ++A    WY
Sbjct: 145 INSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA--TRWY 188

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 24/149 (16%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVY 259
           T     VAVK L    +G++H     L +E++ L  I  H N+V L   C+     L+V 
Sbjct: 45  TATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 101
Query: 260 -EYMPNGSLGEVLHGKRGSFLKW--------------EMRLKIAIEAAKGLSYLHHDCSP 304
            E+   G+L   L  KR  F+ +              E  +  + + AKG+ +L    S 
Sbjct: 102 TEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAK 333
             IHRD+ + NILL+      + DFGLA+
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 252 KETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           K+T L ++ EY+  GS  ++L    G   + ++   I  E  KGL YLH +     IHRD
Sbjct: 76  KDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLHSEKK---IHRD 129
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +K+ N+LL+   E  +ADFG+A  L DT      +   G+  ++AP
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAP 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 38  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 95
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 96  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 146
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 147 NVLVKTPQHVKITDFGLAKLL---GAEE 171

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E+  L  ++H NIV L      +++  LV+EY+ +  L + L    G+ +          
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNIINMHNVKLFLF 107
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK 333
           +  +GL+Y H      ++HRD+K  N+L+N   E  +ADFGLA+
Sbjct: 108 QLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 38  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 95
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 96  QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 146
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 147 NVLVKTPQHVKITDFGLAKLL---GAEE 171

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 44  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 101
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           + MP G L + +   + + +  +  L   ++ AKG++YL       ++HRD+ + N+L+ 
Sbjct: 102 QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVK 157
Query: 320 SDFEAHVADFGLAKYLQDTGASE 342
           +     + DFGLAK L   GA E
Sbjct: 158 TPQHVKITDFGLAKLL---GAEE 177

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 41  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 98
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 99  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 149
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 150 NVLVKTPQHVKITDFGLAKLL---GAEE 174

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++  Y   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 48  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 105
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 106 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 156
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 157 NVLVKTPQHVKITDFGLAKLL---GAEE 181

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 32  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 89
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 90  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 140
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 141 NVLVKTPQHVKITDFGLAKLL---GAEE 165

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 41  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 98
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 99  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 149
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 150 NVLVKTPQHVKITDFGLAKLL---GAEE 174

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 45  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 102
Query: 260 EYMPNGSLGEVLHGKR---GS--FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   +   GS   L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 103 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 153
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 154 NVLVKTPQHVKITDFGLAKLL---GAEE 178

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 41  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 98
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 99  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 149
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 150 NVLVKTPQHVKITDFGLAKLL---GAEE 174

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 40  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 97
Query: 260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
           + MP G L + +   + + +  +  L   ++ AKG++YL       ++HRD+ + N+L+ 
Sbjct: 98  QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVK 153
Query: 320 SDFEAHVADFGLAKYLQDTGASE 342
           +     + DFGLAK L   GA E
Sbjct: 154 TPQHVKITDFGLAKLL---GAEE 173

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 45  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 102
Query: 260 EYMPNGSLGEVLHGKR---GS--FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   +   GS   L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 103 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 153
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 154 NVLVKTPQHVKITDFGLAKLL---GAEE 178

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 38  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLT-STVQLIT 95
Query: 260 EYMPNGSLGEVLHGKR---GS--FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   +   GS   L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 96  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 146
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 147 NVLVKTPQHVKITDFGLAKLL---GAEE 171

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 11/112 (9%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +  E +  GSLG+++  K    L  +  L    +A +GL YLH   S  I+H DVK++N+
Sbjct: 162 IFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDVKADNV 216
Query: 317 LLNSD-FEAHVADFGLAKYLQDTGASECM---SAVAGSYGYIAP--VLGWYC 362
           LL+SD   A + DFG A  LQ  G  + +     + G+  ++AP  VLG  C
Sbjct: 217 LLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 8/129 (6%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E++ +  + H  +V L     ++E   +V + +  G L    H ++    K E       
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFIC 122
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           E    L YL +     IIHRD+K +NILL+     H+ DF +A  L        ++ +AG
Sbjct: 123 ELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAG 176
Query: 350 SYGYIAPVL 358
           +  Y+AP +
Sbjct: 177 TKPYMAPEM 185

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 26/136 (19%)
Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEA 291
           +  RN V+       K T  +  EY  N +L +++H      +R  +  W +  +I    
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY--WRLFRQIL--- 126
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT------------G 339
            + LSY+H   S  IIHRD+K  NI ++      + DFGLAK +  +            G
Sbjct: 127 -EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 340 ASECMSAVAGSYGYIA 355
           +S+ +++  G+  Y+A
Sbjct: 183 SSDNLTSAIGTAMYVA 198

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 206 GEQVAVKKLLGITKGSSHDN-GLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           G++ A K ++   K S+ D+  L  E R    ++H NIVRL    S +  + L+++ +  
Sbjct: 47  GQEYAAK-IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 105
Query: 265 GSLGE-VLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL-IIHRDVKSNNILLNSDF 322
           G L E ++  +  S       ++  +EA      LH  C  + ++HRD+K  N+LL S  
Sbjct: 106 GELFEDIVAREYYSEADASHCIQQILEAV-----LH--CHQMGVVHRDLKPENLLLASKL 158
Query: 323 E---AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +     +ADFGLA  ++  G  +     AG+ GY++P
Sbjct: 159 KGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSP 193

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 252 KETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRD 310
           K T L ++ EY+  GS  ++L  K G  L+      I  E  KGL YLH +     IHRD
Sbjct: 88  KSTKLWIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLHSERK---IHRD 141
Query: 311 VKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +K+ N+LL+   +  +ADFG+A  L DT      +   G+  ++AP
Sbjct: 142 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAP 185

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 46  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 102
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 159
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 160 FGLSRLM 166

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 213 KLLGITKGSSHDN-GLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGE-V 270
           K++   K S+ D+  L  E R    ++H NIVRL    S +  + LV++ +  G L E +
Sbjct: 35  KIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 271 LHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL-IIHRDVKSNNILLNSDFE---AHV 326
           +  +  S       ++  +EA      LH  C  + ++HRD+K  N+LL S  +     +
Sbjct: 95  VAREYYSEADASHCIQQILEAV-----LH--CHQMGVVHRDLKPENLLLASKCKGAAVKL 147
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           ADFGLA  +Q  G  +     AG+ GY++P
Sbjct: 148 ADFGLAIEVQ--GDQQAWFGFAGTPGYLSP 175

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 25/143 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLS---AEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPN 264
           VAVK L    K  + +  LS   +E+  +  I +H+NI+ L   C+      ++  Y   
Sbjct: 70  VAVKML----KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASK 125
Query: 265 GSLGEVLHGKRGSFLKW----------EMRLKIAI----EAAKGLSYLHHDCSPLIIHRD 310
           G+L E L  +R   +++          +M  K  +    + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 311 VKSNNILLNSDFEAHVADFGLAK 333
           + + N+L+  +    +ADFGLA+
Sbjct: 183 LAARNVLVTENNVMKIADFGLAR 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 39  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 95
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 96  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 152
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 153 FGLSRLM 159

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 31  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 90  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 144
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 46  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 159
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 160 FGLSRLM 166

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 41  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 155 FGLSRLM 161

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 46  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 159
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 160 FGLSRLM 166

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 24/144 (16%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL---------- 256
           ++VA+KK++ +T   S  + L  EI+ + ++ H NIV++        + L          
Sbjct: 37  KRVAIKKIV-LTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94
Query: 257 ----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK 312
               +V EYM    L  VL  ++G  L+   RL    +  +GL Y+H   S  ++HRD+K
Sbjct: 95  NSVYIVQEYM-ETDLANVL--EQGPLLEEHARL-FMYQLLRGLKYIH---SANVLHRDLK 147
Query: 313 SNNILLNS-DFEAHVADFGLAKYL 335
             N+ +N+ D    + DFGLA+ +
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIM 171

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 8/118 (6%)
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           H +I+ L     +     LV++ M  G L + L  ++ +  + E R  I     + +S+L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETR-SIMRSLLEAVSFL 216
Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H +    I+HRD+K  NILL+ + +  ++DFG + +L+     E +  + G+ GY+AP
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRELCGTPGYLAP 268

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 42  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 98
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 99  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 155
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 156 FGLSRLM 162

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 9/145 (6%)
Query: 217 ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG 276
           +T   S    +  EI+T+  +RH  +V L     +    +++YE+M  G L E +  +  
Sbjct: 85  MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 144
Query: 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF--EAHVADFGLAKY 334
              + E  ++   +  KGL ++H +     +H D+K  NI+  +    E  + DFGL  +
Sbjct: 145 KMSEDEA-VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 200
Query: 335 LQDTGASECMSAVAGSYGYIAPVLG 359
           L      + +    G+  + AP + 
Sbjct: 201 LD---PKQSVKVTTGTAEFAAPEVA 222

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 41  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 98  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 155 FGLSRLM 161

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 209 VAVKKLLGITKGSSHDNG--LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           VAVK      K  + DN     +E   +  + H +IV+L      +E   ++ E  P G 
Sbjct: 55  VAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGE 110
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAH 325
           LG  L   + S LK    +  +++  K ++YL   +C    +HRD+   NIL+ S     
Sbjct: 111 LGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVK 165
Query: 326 VADFGLAKYLQD 337
           + DFGL++Y++D
Sbjct: 166 LGDFGLSRYIED 177

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 66/152 (43%), Gaps = 13/152 (8%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK    I +G   D  +  EI     +RH NIVR K          +V EY   G 
Sbjct: 44  ELVAVKY---IERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 100
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH- 325
           L E +    G F + E R     +   G+SY H   +  + HRD+K  N LL+       
Sbjct: 101 LFERI-CNAGRFSEDEARFFFQ-QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 155
Query: 326 -VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            + DFG +K       S+  S V G+  YIAP
Sbjct: 156 KICDFGYSK--SSVLHSQPKSTV-GTPAYIAP 184

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 41  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 155 FGLSRLM 161

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 45  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 102 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 158
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 159 FGLSRLM 165

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 33  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 209 VAVKKLLGITKGSSHDNG--LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           VAVK      K  + DN     +E   +  + H +IV+L      +E   ++ E  P G 
Sbjct: 43  VAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGE 98
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAH 325
           LG  L   + S LK    +  +++  K ++YL   +C    +HRD+   NIL+ S     
Sbjct: 99  LGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVK 153
Query: 326 VADFGLAKYLQD 337
           + DFGL++Y++D
Sbjct: 154 LGDFGLSRYIED 165

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 46  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 103 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 159
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 160 FGLSRLM 166

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 138
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 139 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 46  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 159
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 160 FGLSRLM 166

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 41  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 155 FGLSRLM 161

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 209 VAVKKLLGITKGSSHDNG--LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           VAVK      K  + DN     +E   +  + H +IV+L      +E   ++ E  P G 
Sbjct: 39  VAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGE 94
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAH 325
           LG  L   + S LK    +  +++  K ++YL   +C    +HRD+   NIL+ S     
Sbjct: 95  LGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVK 149
Query: 326 VADFGLAKYLQD 337
           + DFGL++Y++D
Sbjct: 150 LGDFGLSRYIED 161

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 42  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 98
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 99  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 155
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 156 FGLSRLM 162

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 138
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 139 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 41  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 98  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 155 FGLSRLM 161

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 43  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 100 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 156
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 157 FGLSRLM 163

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 135
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 136 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 180

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 41  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 155 FGLSRLM 161

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 9/145 (6%)
Query: 217 ITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG 276
           +T   S    +  EI+T+  +RH  +V L     +    +++YE+M  G L E +  +  
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF--EAHVADFGLAKY 334
              + E  ++   +  KGL ++H +     +H D+K  NI+  +    E  + DFGL  +
Sbjct: 251 KMSEDEA-VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306
Query: 335 LQDTGASECMSAVAGSYGYIAPVLG 359
           L      + +    G+  + AP + 
Sbjct: 307 LD---PKQSVKVTTGTAEFAAPEVA 328

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 54  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 110
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 111 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 167
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 168 FGLSRLM 174

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 11/112 (9%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +  E +  GSLG+++  K    L  +  L    +A +GL YLH   S  I+H DVK++N+
Sbjct: 143 IFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDVKADNV 197
Query: 317 LLNSD-FEAHVADFGLAKYLQDTGASECM---SAVAGSYGYIAP--VLGWYC 362
           LL+SD   A + DFG A  LQ  G  + +     + G+  ++AP  VLG  C
Sbjct: 198 LLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 6/152 (3%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK ++ + +       +  EI     + H N+V+            L  EY   G 
Sbjct: 32  EAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV 326
           L + +    G       R    + A  G+ YLH      I HRD+K  N+LL+      +
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHRDIKPENLLLDERDNLKI 145
Query: 327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +DFGLA   +       ++ + G+  Y+AP L
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 43  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 100 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 156
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 157 FGLSRLM 163

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 39  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 96  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 152
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 153 FGLSRLM 159

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 39  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 96  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 152
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 153 FGLSRLM 159

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK L    + +        E   + +I+H N+V+L   C+ +    ++ E+M  G+L 
Sbjct: 43  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
           + L       +   + L +A + +  + YL        IHRD+ + N L+  +    VAD
Sbjct: 100 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 156
Query: 329 FGLAKYL 335
           FGL++ +
Sbjct: 157 FGLSRLM 163

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 55/109 (50%), Gaps = 15/109 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 138
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
            A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T 
Sbjct: 139 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA 184

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 35  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 92
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ A+G++YL       ++HRD+ + 
Sbjct: 93  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYLEDR---RLVHRDLAAR 143
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 144 NVLVKTPQHVKITDFGLAKLL---GAEE 168

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV------RLKAFCSNKETNLL 257
           P GE VA+KK+    K       L  EI+ L   +H NI+      R  +F +  E   +
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEV-YI 91
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
           + E M    L  V+  +  S    +  +   + A K L    H  +  +IHRD+K +N+L
Sbjct: 92  IQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL----HGSN--VIHRDLKPSNLL 144
Query: 318 LNSDFEAHVADFGLAKYLQD--------TGASECMSAVAGSYGYIAP 356
           +NS+ +  V DFGLA+ + +        TG    M+    +  Y AP
Sbjct: 145 INSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAP 191

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 57/138 (41%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K+ H+NIVR            ++ E M 
Sbjct: 73  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMA 131
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 132 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 188
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 189 TCPGPGRVAKIGDFGMAR 206

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 58/144 (40%), Gaps = 12/144 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 99  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 157
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 214
Query: 319 NSDFEAHVA---DFGLAKYLQDTG 339
                  VA   DFG+A+ +   G
Sbjct: 215 TCPGPGRVAKIGDFGMARDIYRAG 238

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 63/136 (46%), Gaps = 26/136 (19%)
Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHG-----KRGSFLKWEMRLKIAIEA 291
           +  RN V+       K T  +  EY  N +L +++H      +R  +  W +  +I    
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY--WRLFRQIL--- 126
Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT------------G 339
            + LSY+H   S  IIHR++K  NI ++      + DFGLAK +  +            G
Sbjct: 127 -EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 340 ASECMSAVAGSYGYIA 355
           +S+ +++  G+  Y+A
Sbjct: 183 SSDNLTSAIGTAXYVA 198

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 137
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 138 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 182

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 138
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 139 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 183

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 57/138 (41%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K+ H+NIVR            ++ E M 
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMA 117
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 118 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 174
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 175 TCPGPGRVAKIGDFGMAR 192

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 6/128 (4%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      +      
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 114
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH + +  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 115 AEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFC 170
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 171 GTPEYLAP 178

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 8/109 (7%)
Query: 249 CSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           C   E+ L  V EY+  G L  + H +R   L  E     + E +  L+YLH      II
Sbjct: 121 CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 175
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +RD+K +N+LL+S+    + D+G+ K  +     +  S   G+  YIAP
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 6/128 (4%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      +      
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 116
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH + +  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 117 AEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFC 172
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 173 GTPEYLAP 180

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 6/128 (4%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      +      
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 254
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH + +  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 255 AEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFC 310
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 311 GTPEYLAP 318

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 6/128 (4%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      +      
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 257
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH + +  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 258 AEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFC 313
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 314 GTPEYLAP 321

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 9/133 (6%)
Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           ++ L  EI     + H NI+RL  +  ++    L+ EY P G L + L  ++      + 
Sbjct: 67  EHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQR 124
Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC 343
              I  E A  L Y H      +IHRD+K  N+LL    E  +ADFG + +      S  
Sbjct: 125 TATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVH----APSLR 177
Query: 344 MSAVAGSYGYIAP 356
              + G+  Y+ P
Sbjct: 178 RKTMCGTLDYLPP 190

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 58/144 (40%), Gaps = 12/144 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 76  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 134
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 135 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 191
Query: 319 NSDFEAHVA---DFGLAKYLQDTG 339
                  VA   DFG+A+ +   G
Sbjct: 192 TCPGPGRVAKIGDFGMARDIYRAG 215

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N  +VA+KK+      +     L  EI+ L + RH NI+ +           +   Y+  
Sbjct: 67  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT 125
Query: 265 GSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
             +G  L+   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+  +
Sbjct: 126 HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXD 182
Query: 324 AHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             + DFGLA+    D   +  ++    +  Y AP
Sbjct: 183 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 42  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 99
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 100 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 150
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFG AK L   GA E
Sbjct: 151 NVLVKTPQHVKITDFGRAKLL---GAEE 175

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 6/128 (4%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E R L   RH  +  LK      +    V EY   G L    H  R      +      
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 115
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E    L YLH + +  +++RD+K  N++L+ D    + DFGL K     GA+  M    
Sbjct: 116 AEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFC 171
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 172 GTPEYLAP 179

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 60/147 (40%), Gaps = 26/147 (17%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK +L     +        E   + +  + NIV+L   C+  +   L++EYM  G L 
Sbjct: 80  VAVK-MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 269 EVLHG---------------KRGSF-------LKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
           E L                  R          L    +L IA + A G++YL        
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAK 333
           +HRD+ + N L+  +    +ADFGL++
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 40  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 97
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 98  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 148
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFG AK L   GA E
Sbjct: 149 NVLVKTPQHVKITDFGRAKLL---GAEE 173

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 49/105 (46%), Gaps = 11/105 (10%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL--------KWEMRLKIAIEAAK 293
           +VRL    S  +  L++ E M  G L   L   R +               +++A E A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 150 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 8/109 (7%)
Query: 249 CSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           C   E+ L  V EY+  G L  + H +R   L  E     + E +  L+YLH      II
Sbjct: 78  CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 132
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +RD+K +N+LL+S+    + D+G+ K  +     +  S   G+  YIAP
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 179

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 49/105 (46%), Gaps = 11/105 (10%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL--------KWEMRLKIAIEAAK 293
           +VRL    S  +  L++ E M  G L   L   R +               +++A E A 
Sbjct: 80  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 140 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 181

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 3/146 (2%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN--LLVYEYM 262
            G  + VK L      +      + E   L    H N++ +   C +       L+  +M
Sbjct: 32  QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P GSL  VLH      +     +K A++ A+G+++L H   PLI    + S +++++ D 
Sbjct: 92  PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL-HTLEPLIPRHALNSRSVMIDEDM 150
Query: 323 EAHVADFGLAKYLQDTGASECMSAVA 348
            A ++   +    Q  G     + VA
Sbjct: 151 TARISMADVKFSFQSPGRMYAPAWVA 176

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+ +L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 72  PEGEKVKIPVAIMELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 129
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 130 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 180
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFGLAK L   GA E
Sbjct: 181 NVLVKTPQHVKITDFGLAKLL---GAEE 205

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 8/109 (7%)
Query: 249 CSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           C   E+ L  V EY+  G L  + H +R   L  E     + E +  L+YLH      II
Sbjct: 74  CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 128
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +RD+K +N+LL+S+    + D+G+ K  +     +  S   G+  YIAP
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 175

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 40  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIM 97
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 98  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 148
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFG AK L   GA E
Sbjct: 149 NVLVKTPQHVKITDFGRAKLL---GAEE 173

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 63/140 (45%), Gaps = 18/140 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           N  Q A+K L  IT+    +  L   +   G + H N++ L          +L  E +P+
Sbjct: 48  NRIQCAIKSLSRITEMQQVEAFLREGLLMRG-LNHPNVLALIGI-------MLPPEGLPH 99
Query: 265 GSLGEVLHGKRGSFLKWEMR-------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
             L  + HG    F++   R       +   ++ A+G+ YL        +HRD+ + N +
Sbjct: 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCM 156
Query: 318 LNSDFEAHVADFGLAKYLQD 337
           L+  F   VADFGLA+ + D
Sbjct: 157 LDESFTVKVADFGLARDILD 176

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 73  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMA 131
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 132 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 188
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 189 TCPGPGRVAKIGDFGMAR 206

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 61/112 (54%), Gaps = 11/112 (9%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +  E +  GSLG+++  K+   L  +  L    +A +GL YLH   +  I+H DVK++N+
Sbjct: 141 IFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 195
Query: 317 LLNSD-FEAHVADFGLAKYLQDTGASECM---SAVAGSYGYIAP--VLGWYC 362
           LL+SD   A + DFG A  LQ  G  + +     + G+  ++AP  V+G  C
Sbjct: 196 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 51  NKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 110 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 163
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 164 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 50  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 108
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 109 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 165
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 166 TCPGPGRVAKIGDFGMAR 183

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 12/140 (8%)
Query: 222 SHDNGLSAEIRTLGKIRHRNIVRL----KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS 277
           S       E   L  ++H NIVR     ++    K+  +LV E   +G+L   L  KR  
Sbjct: 67  SERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYL--KRFK 124
Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQ 336
             K ++      +  KGL +LH   +P IIHRD+K +NI +        + D GLA   +
Sbjct: 125 VXKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 337 DTGASECMSAVAGSYGYIAP 356
            + A     AV G+  + AP
Sbjct: 184 ASFA----KAVIGTPEFXAP 199

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 48/100 (48%), Gaps = 7/100 (7%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EYMP G L  ++        KW  R   A E    L  +H   S   IHRDVK +N+
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVP-EKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNM 199
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LL+      +ADFG    +   G   C +AV G+  YI+P
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 138
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 139 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 61/112 (54%), Gaps = 11/112 (9%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +  E +  GSLG+++  K+   L  +  L    +A +GL YLH   +  I+H DVK++N+
Sbjct: 127 IFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 181
Query: 317 LLNSD-FEAHVADFGLAKYLQDTGASECM---SAVAGSYGYIAP--VLGWYC 362
           LL+SD   A + DFG A  LQ  G  + +     + G+  ++AP  V+G  C
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 8/109 (7%)
Query: 249 CSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           C   E+ L  V EY+  G L  + H +R   L  E     + E +  L+YLH      II
Sbjct: 89  CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 143
Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +RD+K +N+LL+S+    + D+G+ K  +     +  S   G+  YIAP
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 190

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 58  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMA 116
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 173
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 174 TCPGPGRVAKIGDFGMAR 191

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 38  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 95
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 96  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 146
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFG AK L   GA E
Sbjct: 147 NVLVKTPQHVKITDFGRAKLL---GAEE 171

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 48/100 (48%), Gaps = 7/100 (7%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EYMP G L  ++        KW  R   A E    L  +H   S   IHRDVK +N+
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVP-EKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNM 204
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LL+      +ADFG    +   G   C +AV G+  YI+P
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 243

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 58  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 116
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 173
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 174 TCPGPGRVAKIGDFGMAR 191

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 117
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 118 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 174
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 175 TCPGPGRVAKIGDFGMAR 192

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 53/113 (46%), Gaps = 13/113 (11%)
Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           FC+   KE    V EY+  G L  + H +             A E   GL +LH   S  
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKG 139
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGASECMSAVAGSYGYIAP 356
           I++RD+K +NILL+ D    +ADFG+ K   L D   +E      G+  YIAP
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE----FCGTPDYIAP 188

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 75  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 129
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 130 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 176

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 61/112 (54%), Gaps = 11/112 (9%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +  E +  GSLG+++  K+   L  +  L    +A +GL YLH   +  I+H DVK++N+
Sbjct: 143 IFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 197
Query: 317 LLNSD-FEAHVADFGLAKYLQDTGASECM---SAVAGSYGYIAP--VLGWYC 362
           LL+SD   A + DFG A  LQ  G  + +     + G+  ++AP  V+G  C
Sbjct: 198 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 75  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 133
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 134 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 190
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 191 TCPGPGRVAKIGDFGMAR 208

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 45  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 102
Query: 260 EYMPNGSLGEVLHGKR---GS--FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   +   GS   L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 103 QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 153
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFG AK L   GA E
Sbjct: 154 NVLVKTPQHVKITDFGRAKLL---GAEE 178

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 48/100 (48%), Gaps = 7/100 (7%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EYMP G L  ++        KW  R   A E    L  +H   S   IHRDVK +N+
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVP-EKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNM 204
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LL+      +ADFG    +   G   C +AV G+  YI+P
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 243

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 204 PNGEQV----AVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY 259
           P GE+V    A+K+L   T   ++   L  E   +  + + ++ RL   C    T  L+ 
Sbjct: 40  PEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVCRLLGICLTS-TVQLIT 97
Query: 260 EYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSN 314
           + MP G L + +   + +      L W       ++ AKG++YL       ++HRD+ + 
Sbjct: 98  QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAAR 148
Query: 315 NILLNSDFEAHVADFGLAKYLQDTGASE 342
           N+L+ +     + DFG AK L   GA E
Sbjct: 149 NVLVKTPQHVKITDFGRAKLL---GAEE 173

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 65  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 123
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 124 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 180
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 181 TCPGPGRVAKIGDFGMAR 198

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 10/151 (6%)
Query: 207 EQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG 265
           ++VA+K +   + K S     +  EI  L  +RH +I++L    +     ++V EY    
Sbjct: 35  QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGE 94
Query: 266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH 325
               ++  KR +  +     +  I A   + Y H      I+HRD+K  N+LL+ +    
Sbjct: 95  LFDYIVEKKRMTEDEGRRFFQQIICA---IEYCHRHK---IVHRDLKPENLLLDDNLNVK 148
Query: 326 VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +ADFGL+  + D      +    GS  Y AP
Sbjct: 149 IADFGLSNIMTD---GNFLKTSCGSPNYAAP 176

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 73  PSPLQVAVKTLPEVYSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 131
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 132 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 188
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 189 TCPGPGRVAKIGDFGMAR 206

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 117
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 118 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 174
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 175 TCPGPGRVAKIGDFGMAQ 192

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 218 TKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNL-LVYEYMPNGSLGEVLHGKR 275
           TK          EI  L    H NIV+L  AF    E NL ++ E+   G++  V+    
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELE 129
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
               + ++++ +  +    L+YLH +    IIHRD+K+ NIL   D +  +ADFG++   
Sbjct: 130 RPLTESQIQV-VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA-- 183
Query: 336 QDTGASECMSAVAGSYGYIAP 356
           ++T   +   +  G+  ++AP
Sbjct: 184 KNTRTIQRRDSFIGTPYWMAP 204

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G+ VAVKK+    +       L  E+  +   +H N+V +       +   +V E++  
Sbjct: 44  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L +++   R   +  E    + +   + LS LH      +IHRD+KS++ILL  D   
Sbjct: 102 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 155
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            ++DFG     Q +        + G+  ++AP L
Sbjct: 156 KLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPEL 187

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G+ VAVKK+    +       L  E+  +   +H N+V +       +   +V E++  
Sbjct: 55  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 112
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L +++   R   +  E    + +   + LS LH      +IHRD+KS++ILL  D   
Sbjct: 113 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 166
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            ++DFG     Q +        + G+  ++AP L
Sbjct: 167 KLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPEL 198

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 131
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 132 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 178

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G+ VAVKK+    +       L  E+  +   +H N+V +       +   +V E++  
Sbjct: 48  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 105
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L +++   R   +  E    + +   + LS LH      +IHRD+KS++ILL  D   
Sbjct: 106 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 159
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            ++DFG     Q +        + G+  ++AP L
Sbjct: 160 KLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPEL 191

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 138
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 139 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 185

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 51  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 110 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 163
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 164 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E   + +I+H N+V+L   C+ +    ++ E+M  G+L + L       +   + L +A 
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
           + +  + YL        IHR++ + N L+  +    VADFGL++ +
Sbjct: 326 QISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 135
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 136 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 182

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EYMP G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      VADFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 12/138 (8%)
Query: 204 PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP 263
           P+  QVAVK L  +       + L  E   + K  H+NIVR            ++ E M 
Sbjct: 85  PSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 143
Query: 264 NGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            G L   L   R      S L     L +A + A G  YL  +     IHRD+ + N LL
Sbjct: 144 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLL 200
Query: 319 NSDFEAHVA---DFGLAK 333
                  VA   DFG+A+
Sbjct: 201 TCPGPGRVAKIGDFGMAR 218

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 47  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 105
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 106 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 159
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 160 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G+ VAVKK+    +       L  E+  +   +H N+V +       +   +V E++  
Sbjct: 53  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 110
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L +++   R   +  E    + +   + LS LH      +IHRD+KS++ILL  D   
Sbjct: 111 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 164
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            ++DFG     Q +        + G+  ++AP L
Sbjct: 165 KLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPEL 196

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 403 ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 461
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 462 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 516
Query: 333 KYLQ 336
           K L+
Sbjct: 517 KALR 520

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 62/138 (44%), Gaps = 18/138 (13%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
           +  EI+ L ++RH+N+++L     N+E     +V EY   G + E+L          E R
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP------EKR 105
Query: 285 LKIA------IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
             +        +   GL YLH   S  I+H+D+K  N+LL +     ++  G+A+ L   
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 339 GASECMSAVAGSYGYIAP 356
            A +      GS  +  P
Sbjct: 163 AADDTCRTSQGSPAFQPP 180

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 69/141 (48%), Gaps = 10/141 (7%)
Query: 218 TKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNL-LVYEYMPNGSLGEVLHGKR 275
           TK          EI  L    H NIV+L  AF    E NL ++ E+   G++  V+    
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELE 129
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
               + ++++ +  +    L+YLH +    IIHRD+K+ NIL   D +  +ADFG++   
Sbjct: 130 RPLTESQIQV-VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA-- 183
Query: 336 QDTGASECMSAVAGSYGYIAP 356
           ++T   +   +  G+  ++AP
Sbjct: 184 KNTRXIQRRDSFIGTPYWMAP 204

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 137
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 138 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EYMP G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      VADFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 144
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 145 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 69  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 126
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 127 SFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 182
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 183 FGLSRYMEDS 192

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 61/131 (46%), Gaps = 13/131 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           EI  L  + H NI++L     +K+   LV E+   G L E +   R  F + +    I  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDA-ANIMK 153
Query: 290 EAAKGLSYLH-HDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKYLQDTGASECMS 345
           +   G+ YLH H+    I+HRD+K  NILL   NS     + DFGL+ +         + 
Sbjct: 154 QILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LR 206
Query: 346 AVAGSYGYIAP 356
              G+  YIAP
Sbjct: 207 DRLGTAYYIAP 217

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 404 ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 462
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 463 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 517
Query: 333 KYLQ 336
           K L+
Sbjct: 518 KALR 521

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 9/111 (8%)
Query: 248 FCS--NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           FC+   KE    V EY+  G L  + H +             A E   GL +LH   S  
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKG 138
Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           I++RD+K +NILL+ D    +ADFG+ K  ++       +   G+  YIAP
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAP 187

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E   + +I+H N+V+L   C+ +    ++ E+M  G+L + L       +   + L +A 
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
           + +  + YL        IHR++ + N L+  +    VADFGL++ +
Sbjct: 365 QISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 407

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G+ VAVKK+    +       L  E+  +   +H N+V +       +   +V E++  
Sbjct: 98  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L +++   R   +  E    + +   + LS LH      +IHRD+KS++ILL  D   
Sbjct: 156 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 209
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            ++DFG     Q +        + G+  ++AP L
Sbjct: 210 KLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPEL 241

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 137
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 138 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 47  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 105
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 106 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 159
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 160 TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 166
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 167 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 213

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 47  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 105
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 106 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 159
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 160 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 49  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 107
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 108 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 161
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 162 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 47  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 105
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 106 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 159
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 160 TXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 98
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 99  SFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 154
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 155 FGLSRYMEDS 164

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 52  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 110
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 111 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 164
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 165 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 53  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 111
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 112 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 165
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 166 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 44  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 102
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 103 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 156
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 157 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 98
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 99  SFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 154
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 155 FGLSRYMEDS 164

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 51  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 110 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 163
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 61  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 119
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 120 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 333 KYLQ 336
           K L+
Sbjct: 175 KALR 178

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 61  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 119
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 120 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 333 KYLQ 336
           K L+
Sbjct: 175 KALR 178

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 13/136 (9%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMR 284
           + AEI  L  + H NI+++     +     +V E    G L E  V    RG  L     
Sbjct: 67  IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQDTGA 340
            ++  +    L+Y H   S  ++H+D+K  NIL   D   H    + DFGLA+  +   +
Sbjct: 127 AELMKQMMNALAYFH---SQHVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFK---S 179
Query: 341 SECMSAVAGSYGYIAP 356
            E  +  AG+  Y+AP
Sbjct: 180 DEHSTNAAGTALYMAP 195

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 38  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 95
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 96  SFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 151
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 152 FGLSRYMEDS 161

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 98
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 99  SFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 154
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 155 FGLSRYMEDS 164

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 55  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 113
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 114 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 167
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 168 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 47  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 105
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 106 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 159
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 160 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 46  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 103
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 104 SFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 159
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 160 FGLSRYMEDS 169

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 45  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 103
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 104 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 157
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 158 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN 264
           +G+ VAVKK+    +       L  E+  +   +H N+V +       +   +V E++  
Sbjct: 175 SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           G+L +++   R   +  E    + +   + LS LH      +IHRD+KS++ILL  D   
Sbjct: 233 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 286
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
            ++DFG     Q +        + G+  ++AP L
Sbjct: 287 KLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPEL 318

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 44  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 101
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 102 SFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 157
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 158 FGLSRYMEDS 167

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 45  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 103
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 104 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 157
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 158 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 59  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 117
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 118 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 172
Query: 333 KYLQ 336
           K L+
Sbjct: 173 KALR 176

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 45  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 103
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 104 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 158
Query: 333 KYLQ 336
           K L+
Sbjct: 159 KALR 162

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 64/140 (45%), Gaps = 21/140 (15%)
Query: 205 NGEQVAVKKLLGITKGSSHDNG---LSAEIRTLGKIRHRNIVRLKA---FCSNKETNL-L 257
            GE VAVK        SS D        E+     +RH NI+   A      +  T L L
Sbjct: 59  QGENVAVKIF------SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 112
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVK 312
           +  Y   GSL + L   + + L     L+I +  A GL++LH +       P I HRD+K
Sbjct: 113 ITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 169
Query: 313 SNNILLNSDFEAHVADFGLA 332
           S NIL+  + +  +AD GLA
Sbjct: 170 SKNILVKKNGQCCIADLGLA 189

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 218 TKGSSHDNGLSAEIRTLGKIRHRNIVRL-KAFCSNKETNL-LVYEYMPNGSLGEVLHGKR 275
           TK          EI  L    H NIV+L  AF    E NL ++ E+   G++  V+    
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELE 129
Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
               + ++++ +  +    L+YLH +    IIHRD+K+ NIL   D +  +ADFG++   
Sbjct: 130 RPLTESQIQV-VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA-- 183
Query: 336 QDTGASECMSAVAGSYGYIAP 356
           ++T   +      G+  ++AP
Sbjct: 184 KNTRXIQRRDXFIGTPYWMAP 204

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 67  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 125
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 126 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 179
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 180 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMP 263
            G++VA++++    +       +  EI  + + ++ NIV  L ++    E   +V EY+ 
Sbjct: 44  TGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLA 100
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL +V+     + +       +  E  + L +LH   S  +IHRD+KS+NILL  D  
Sbjct: 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGS 154
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             + DFG     Q T      S + G+  ++AP
Sbjct: 155 VKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 185

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 45  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 103
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 104 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 158
Query: 333 KYLQ 336
           K L+
Sbjct: 159 KALR 162

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 58/128 (45%), Gaps = 8/128 (6%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG-EVLHGKRGSFLKWEMRLKIA 288
           E + L K+  R +V L      K+   LV   M  G L   + H  +  F +       A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YA 292
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E   GL  LH +    I++RD+K  NILL+      ++D GLA ++ +    + +    
Sbjct: 293 AEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRV 346
Query: 349 GSYGYIAP 356
           G+ GY+AP
Sbjct: 347 GTVGYMAP 354

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 58/128 (45%), Gaps = 8/128 (6%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG-EVLHGKRGSFLKWEMRLKIA 288
           E + L K+  R +V L      K+   LV   M  G L   + H  +  F +       A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YA 292
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E   GL  LH +    I++RD+K  NILL+      ++D GLA ++ +    + +    
Sbjct: 293 AEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRV 346
Query: 349 GSYGYIAP 356
           G+ GY+AP
Sbjct: 347 GTVGYMAP 354

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 41  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 99
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 100 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 154
Query: 333 KYLQ 336
           K L+
Sbjct: 155 KALR 158

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 43  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 100
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 101 SFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 156
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 157 FGLSRYMEDS 166

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 51  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 109
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 110 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 333 KYLQ 336
           K L+
Sbjct: 165 KALR 168

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 217 ITKGSSHDNGLS----AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH 272
           I K  ++D  L     AE   + ++ +  IVR+   C   E+ +LV E    G L + L 
Sbjct: 39  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ 97
Query: 273 GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             R   +K +  +++  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+
Sbjct: 98  QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 152
Query: 333 KYLQ 336
           K L+
Sbjct: 153 KALR 156

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 51  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 110 DLMETDLYKLL---KCQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 163
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMP 263
            G++VA++++    +       +  EI  + + ++ NIV  L ++    E   +V EY+ 
Sbjct: 44  TGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLA 100
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL +V+     + +       +  E  + L +LH   S  +IHRD+KS+NILL  D  
Sbjct: 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGS 154
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             + DFG     Q T      S + G+  ++AP
Sbjct: 155 VKLTDFGFCA--QITPEQSKRSEMVGTPYWMAP 185

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVYEYMP 263
            G++VA++++    +       +  EI  + + ++ NIV  L ++    E   +V EY+ 
Sbjct: 44  TGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL-WVVMEYLA 100
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
            GSL +V+     + +       +  E  + L +LH   S  +IHRD+KS+NILL  D  
Sbjct: 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGS 154
Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             + DFG     Q T      S + G+  ++AP
Sbjct: 155 VKLTDFGFCA--QITPEQSKRSXMVGTPYWMAP 185

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 421 VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 478
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L++S+    + D
Sbjct: 479 SFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 534
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 535 FGLSRYMEDS 544

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 64/140 (45%), Gaps = 21/140 (15%)
Query: 205 NGEQVAVKKLLGITKGSSHDNG---LSAEIRTLGKIRHRNIVRLKA---FCSNKETNL-L 257
            GE VAVK        SS D        E+     +RH NI+   A      +  T L L
Sbjct: 30  QGENVAVKIF------SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVK 312
           +  Y   GSL + L   + + L     L+I +  A GL++LH +       P I HRD+K
Sbjct: 84  ITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 313 SNNILLNSDFEAHVADFGLA 332
           S NIL+  + +  +AD GLA
Sbjct: 141 SKNILVKKNGQCCIADLGLA 160

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 63/140 (45%), Gaps = 21/140 (15%)
Query: 205 NGEQVAVKKLLGITKGSSHDNG---LSAEIRTLGKIRHRNIVRLKA---FCSNKETNL-L 257
            GE VAVK        SS D        E+     +RH NI+   A      +  T L L
Sbjct: 30  QGENVAVKIF------SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVK 312
           +  Y   GSL + L     + L     L+I +  A GL++LH +       P I HRD+K
Sbjct: 84  ITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 313 SNNILLNSDFEAHVADFGLA 332
           S NIL+  + +  +AD GLA
Sbjct: 141 SKNILVKKNGQCCIADLGLA 160

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 51  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 110 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 163
Query: 321 DFEAHVADFGLAK 333
             +  + DFGLA+
Sbjct: 164 TCDLKICDFGLAR 176

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 52  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 110
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 111 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 164
Query: 321 DFEAHVADFGLAK 333
             +  + DFGLA+
Sbjct: 165 TCDLKICDFGLAR 177

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+  GSL +V+     + +       +  E  + L +LH   S  +IHRD+KS+NI
Sbjct: 95  VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNI 148
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LL  D    + DFG     Q T      S + G+  ++AP
Sbjct: 149 LLGMDGSVKLTDFGFCA--QITPEQSKRSXMVGTPYWMAP 186

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 139
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G++YL+   +   +HR++ + N ++  DF   + DFG+ + + +T
Sbjct: 140 IADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 184

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH----------GKRGSFLKWEMRLKIAIE 290
           ++VRL    S  +  L+V E M +G L   L           G+    L+ EM +++A E
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EM-IQMAAE 138
Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            A G++YL+   +   +HR++ + N ++  DF   + DFG+ + + +T
Sbjct: 139 IADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 183

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 65/152 (42%), Gaps = 13/152 (8%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK    I +G   D  +  EI     +RH NIVR K          +V EY   G 
Sbjct: 45  ELVAVKY---IERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH- 325
           L E +    G F + E R     +   G+SY H   +  + HRD+K  N LL+       
Sbjct: 102 LFERICNA-GRFSEDEARFFFQ-QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 156
Query: 326 -VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +  FG +K       S+  S V G+  YIAP
Sbjct: 157 KICAFGYSK--SSVLHSQPKSTV-GTPAYIAP 185

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA++K+      +     L  EI+ L + RH NI+     ++A    +  ++ + +
Sbjct: 51  NKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 110 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 163
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 68/172 (39%), Gaps = 45/172 (26%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL--------------- 271
           +  E+R + K+ H NI RL     +++   LV E    G L + L               
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 272 --------------------HGKRGS--FLKWEMRLK-IAIEAAKGLSYLHHDCSPLIIH 308
                               HG R S  F++ E  +  I  +    L YLH+     I H
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICH 191
Query: 309 RDVKSNNILL--NSDFEAHVADFGLAK--YLQDTGASECMSAVAGSYGYIAP 356
           RD+K  N L   N  FE  + DFGL+K  Y  + G    M+  AG+  ++AP
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-------LKAFCSNKETNLL 257
            GEQVA+K+        + +     EI+ + K+ H N+V        L+    N +  LL
Sbjct: 39  TGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN-DLPLL 96
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNI 316
             EY   G L + L+         E  ++  + + +  L YLH +    IIHRD+K  NI
Sbjct: 97  AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENI 153
Query: 317 LLNSDFEA---HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +L    +     + D G AK L D G  E  +   G+  Y+AP L
Sbjct: 154 VLQPGPQRLIHKIIDLGYAKEL-DQG--ELCTEFVGTLQYLAPEL 195

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-------LKAFCSNKETNLL 257
            GEQVA+K+        + +     EI+ + K+ H N+V        L+    N +  LL
Sbjct: 38  TGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN-DLPLL 95
Query: 258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNI 316
             EY   G L + L+         E  ++  + + +  L YLH +    IIHRD+K  NI
Sbjct: 96  AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENI 152
Query: 317 LLNSDFEA---HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +L    +     + D G AK L D G  E  +   G+  Y+AP L
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKEL-DQG--ELCTEFVGTLQYLAPEL 194

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 8/110 (7%)
Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
            F +N +   +  E M  G+  E L  +    +   +  K+ +   K L YL       +
Sbjct: 92  TFITNTDV-FIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--V 146
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IHRDVK +NILL+   +  + DFG++  L D  A +     AG   Y+AP
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD---RSAGCAAYMAP 193

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 19/130 (14%)
Query: 239 HRNIVRLKAFCSNKETNLLVYEYMP----NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
           H N++R   FC+ K+     ++Y+       +L E +  K  + L  E  + +  +   G
Sbjct: 77  HPNVIRY--FCTEKDRQ---FQYIAIELCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSG 130
Query: 295 LSYLHHDCSPLIIHRDVKSNNILL-----NSDFEAHVADFGLAKYLQDTGAS-ECMSAVA 348
           L++LH   S  I+HRD+K +NIL+     +   +A ++DFGL K L     S    S V 
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 349 GSYGYIAPVL 358
           G+ G+IAP +
Sbjct: 188 GTEGWIAPEM 197

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 21/110 (19%)
Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------------LKIA 288
           +VRL    S  +  L++ E M  G L   L       L+ EM              +++A
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----LRPEMENNPVLAPPSLSKMIQMA 131
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            E A G++YL+ +     +HRD+ + N  +  DF   + DFG+ + + +T
Sbjct: 132 GEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYET 178

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 7/130 (5%)
Query: 227 LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           ++ EI  L ++ H NI+++     N+    LV E   +G L       R   L   +   
Sbjct: 76  VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASY 134
Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           I  +    + YL       IIHRD+K  NI++  DF   + DFG A YL+     +    
Sbjct: 135 IFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYT 188
Query: 347 VAGSYGYIAP 356
             G+  Y AP
Sbjct: 189 FCGTIEYCAP 198

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           +  ++L    +G S +  +  E+  L +IRH NI+ L     NK   +L+ E +  G L 
Sbjct: 59  IKKRRLXSSRRGVSREE-IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 117
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS----DFEA 324
           + L  K    L  +   +   +   G+ YLH   S  I H D+K  NI+L      +   
Sbjct: 118 DFLAEKES--LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRI 172
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            + DFG+A  ++   A      + G+  ++AP
Sbjct: 173 KLIDFGIAHKIE---AGNEFKNIFGTPEFVAP 201

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 15/149 (10%)
Query: 214 LLGITKGSSHDN-GLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGE-VL 271
           ++   K S+ D+  L  E R    ++H NIVRL    S +  + L+++ +  G L E ++
Sbjct: 43  IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV 102
Query: 272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL-IIHRDVKSNNILLNSDFE---AHVA 327
             +  S       ++  +EA      LH  C  + ++HR++K  N+LL S  +     +A
Sbjct: 103 AREYYSEADASHCIQQILEAV-----LH--CHQMGVVHRNLKPENLLLASKLKGAAVKLA 155
Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFGLA  ++  G  +     AG+ GY++P
Sbjct: 156 DFGLA--IEVEGEQQAWFGFAGTPGYLSP 182

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E   L  + H  +V+L      +    L+ +++  G L   L  K   F + +++  +A 
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA- 137
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           E A GL +LH   S  II+RD+K  NILL+ +    + DFGL+K   D    +   +  G
Sbjct: 138 ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID--HEKKAYSFCG 192
Query: 350 SYGYIAP 356
           +  Y+AP
Sbjct: 193 TVEYMAP 199

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 65/152 (42%), Gaps = 13/152 (8%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK    I +G      +  EI     +RH NIVR K          +V EY   G 
Sbjct: 45  ELVAVKY---IERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH- 325
           L E +    G F + E R     +   G+SY H   +  + HRD+K  N LL+       
Sbjct: 102 LFERICNA-GRFSEDEARFFFQ-QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 156
Query: 326 -VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            + DFG +K       S+  S V G+  YIAP
Sbjct: 157 KICDFGYSK--SSVLHSQPKSTV-GTPAYIAP 185

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L   RH NI+     ++A    +  ++ + +
Sbjct: 49  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQ 107
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 108 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 161
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 162 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
            V EY+  G L  + H ++    K    +  A E + GL +LH      II+RD+K +N+
Sbjct: 97  FVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNV 151
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY 361
           +L+S+    +ADFG+ K     G +       G+  YIAP +  Y
Sbjct: 152 MLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDYIAPEIIAY 194

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 61/128 (47%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      VADFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 62/130 (47%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 98
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L+++     + D
Sbjct: 99  SFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGD 154
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 155 FGLSRYMEDS 164

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           +  ++L    +G S +  +  E+  L +IRH NI+ L     NK   +L+ E +  G L 
Sbjct: 45  IKKRRLSSSRRGVSREE-IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 103
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS----DFEA 324
           + L  K    L  +   +   +   G+ YLH   S  I H D+K  NI+L      +   
Sbjct: 104 DFLAEKES--LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRI 158
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY 361
            + DFG+A  ++   A      + G+  ++AP +  Y
Sbjct: 159 KLIDFGIAHKIE---AGNEFKNIFGTPEFVAPEIVNY 192

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 84  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YA 140
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 141 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 192
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 193 GTPEYLAP 200

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 12/135 (8%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-----LLVYEYM 262
           +VAVK +              +E   +    H N++RL   C    +      +++  +M
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 263 PNGSLGEVLHGKR----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
             G L   L   R       +  +  LK  ++ A G+ YL +      +HRD+ + N +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML 180
Query: 319 NSDFEAHVADFGLAK 333
             D    VADFGL+K
Sbjct: 181 RDDMTVCVADFGLSK 195

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 92  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 148
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++    + C     
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----- 200
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 201 GTPEYLAP 208

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYE 260
           N  +VA+KK+      +     L  EI+ L   RH NI+     ++A    +  ++ + +
Sbjct: 49  NKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQ 107
Query: 261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS 320
            +    L ++L   +   L  +       +  +GL Y+H   S  ++HRD+K +N+LLN+
Sbjct: 108 DLMETDLYKLL---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 161
Query: 321 DFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+    D   +  ++    +  Y AP
Sbjct: 162 TSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 77  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 133
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++    + C     
Sbjct: 134 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----- 185
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 186 GTPEYLAP 193

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           +  ++L    +G S +  +  E+  L +IRH NI+ L     NK   +L+ E +  G L 
Sbjct: 38  IKKRRLSSSRRGVSREE-IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS----DFEA 324
           + L  K    L  +   +   +   G+ YLH   S  I H D+K  NI+L      +   
Sbjct: 97  DFLAEKES--LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRI 151
Query: 325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY 361
            + DFG+A  ++   A      + G+  ++AP +  Y
Sbjct: 152 KLIDFGIAHKIE---AGNEFKNIFGTPEFVAPEIVNY 185

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 92  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YA 148
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 200
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 201 GTPEYLAP 208

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 225 NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH-----GKRGSFL 279
            G   E + L K+  R IV L A+    +T+L +   + NG  G++ +      +     
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNG--GDIRYHIYNVDEDNPGF 286
Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
           +    +    +   GL +LH      II+RD+K  N+LL+ D    ++D GLA  L+  G
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AG 342
Query: 340 ASECMSAVAGSYGYIAPVL 358
            ++     AG+ G++AP L
Sbjct: 343 QTKT-KGYAGTPGFMAPEL 360

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 62/130 (47%), Gaps = 6/130 (4%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VA+K     T  S  +  L  E  T+ +  H +IV+L    +      ++ E    G L 
Sbjct: 421 VAIKTCKNCTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELR 478
Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
             L  ++ S L     +  A + +  L+YL    S   +HRD+ + N+L+++     + D
Sbjct: 479 SFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGD 534
Query: 329 FGLAKYLQDT 338
           FGL++Y++D+
Sbjct: 535 FGLSRYMEDS 544

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G  K  + +    A+I  + ++ +  IVRL   C   E  +LV E    G L
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQI--MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPL 96
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L GKR       +  ++  + + G+ YL        +HRD+ + N+LL +   A ++
Sbjct: 97  HKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKIS 152
Query: 328 DFGLAKYL 335
           DFGL+K L
Sbjct: 153 DFGLSKAL 160

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 64/152 (42%), Gaps = 13/152 (8%)
Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
           E VAVK    I +G   D  +  EI     +RH NIVR K          +V EY   G 
Sbjct: 45  ELVAVKY---IERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH- 325
           L E +    G F + E R     +   G+SY H   +  + HRD+K  N LL+       
Sbjct: 102 LFERICNA-GRFSEDEARFFFQ-QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRL 156
Query: 326 -VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +  FG +K       S+    V G+  YIAP
Sbjct: 157 KICAFGYSK--SSVLHSQPKDTV-GTPAYIAP 185

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 225 NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH-----GKRGSFL 279
            G   E + L K+  R IV L A+    +T+L +   + NG  G++ +      +     
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNG--GDIRYHIYNVDEDNPGF 286
Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
           +    +    +   GL +LH      II+RD+K  N+LL+ D    ++D GLA  L+  G
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AG 342
Query: 340 ASECMSAVAGSYGYIAPVL 358
            ++     AG+ G++AP L
Sbjct: 343 QTKT-KGYAGTPGFMAPEL 360

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 9/130 (6%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
            E + L  IR    +    +    ET L L+ +Y+  G L   L  +R  F + E+++ +
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQIYV 165
Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK-YLQDTGASECMSA 346
             E    L +LH      II+RD+K  NILL+S+    + DFGL+K ++ D   +E    
Sbjct: 166 G-EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD--ETERAYD 219
Query: 347 VAGSYGYIAP 356
             G+  Y+AP
Sbjct: 220 FCGTIEYMAP 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 225 NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH-----GKRGSFL 279
            G   E + L K+  R IV L A+    +T+L +   + NG  G++ +      +     
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNG--GDIRYHIYNVDEDNPGF 286
Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
           +    +    +   GL +LH      II+RD+K  N+LL+ D    ++D GLA  L+  G
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AG 342
Query: 340 ASECMSAVAGSYGYIAPVL 358
            ++     AG+ G++AP L
Sbjct: 343 QTKT-KGYAGTPGFMAPEL 360

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 84  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 140
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 141 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 192
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 193 GTPEYLAP 200

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 225 NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLH-----GKRGSFL 279
            G   E + L K+  R IV L A+    +T+L +   + NG  G++ +      +     
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNG--GDIRYHIYNVDEDNPGF 286
Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
           +    +    +   GL +LH      II+RD+K  N+LL+ D    ++D GLA  L+  G
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AG 342
Query: 340 ASECMSAVAGSYGYIAPVL 358
            ++     AG+ G++AP L
Sbjct: 343 QTKT-KGYAGTPGFMAPEL 360

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 92  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 148
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 200
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 201 GTPEYLAP 208

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 56/128 (43%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           AE   L +++H  IV L           L+ EY+  G L   L  + G F++      +A
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLA 128
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E +  L +LH      II+RD+K  NI+LN      + DFGL K     G         
Sbjct: 129 -EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFC 182
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 183 GTIEYMAP 190

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 92  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 148
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 200
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 201 GTPEYLAP 208

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 92  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 148
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 200
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 201 GTPEYLAP 208

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
           +V EY+  GSL +V+     + +       +  E  + L +LH   S  +IHR++KS+NI
Sbjct: 95  VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRNIKSDNI 148
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LL  D    + DFG     Q T      S + G+  ++AP
Sbjct: 149 LLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAP 186

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 203 TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM 262
           T  G ++A K +   T+G      +  EI  + ++ H N+++L     +K   +LV EY+
Sbjct: 111 TATGLKLAAKIIK--TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL-LNSD 321
             G L + +  +  +  + +  L +  +  +G+ ++H      I+H D+K  NIL +N D
Sbjct: 169 DGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQ---MYILHLDLKPENILCVNRD 224
Query: 322 F-EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             +  + DFGLA+  +     E +    G+  ++AP
Sbjct: 225 AKQIKIIDFGLARRYK---PREKLKVNFGTPEFLAP 257

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/71 (36%), Positives = 39/71 (54%), Gaps = 5/71 (7%)
Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
           KI +   K L++L  +    IIHRD+K +NILL+      + DFG++  L D+ A    +
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---T 183
Query: 346 AVAGSYGYIAP 356
             AG   Y+AP
Sbjct: 184 RDAGCRPYMAP 194

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 92  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 148
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 200
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 201 GTPEYLAP 208

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC---SNKETNL---LV 258
             ++VA+KK+L   +  +       E++ +  ++H N+V LKAF     +K+  +   LV
Sbjct: 63  ESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNIL 317
            EY+P        H  +       + +K+ + +  + L+Y+H   S  I HRD+K  N+L
Sbjct: 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLL 173
Query: 318 LNSDFEA-HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           L+       + DFG AK L        +S +   Y Y AP L
Sbjct: 174 LDPPSGVLKLIDFGSAKIL--IAGEPNVSXICSRY-YRAPEL 212

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 56/128 (43%), Gaps = 7/128 (5%)
Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           AE   L +++H  IV L           L+ EY+  G L   L  + G F++      +A
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLA 128
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            E +  L +LH      II+RD+K  NI+LN      + DFGL K     G         
Sbjct: 129 -EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFC 182
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 183 GTIEYMAP 190

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L  +    +V+L+    +     +V EY+P G +   L  + G F +   R   A 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAA 148
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----G 200
Query: 350 SYGYIAP 356
           +  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L  +    +V+L+    +     +V EY+P G +   L  + G F +   R   A 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAA 148
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----G 200
Query: 350 SYGYIAP 356
           +  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY+P G +   L  + G F +   R   A
Sbjct: 112 EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YA 168
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     
Sbjct: 169 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----- 220
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 221 GTPEYLAP 228

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 205 NGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA-FCSNKETNLLVYEY 261
           +G  VA+KK  +  +    +  + +  EI  L ++ H N+++  A F  + E N+ V E 
Sbjct: 56  DGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKYYASFIEDNELNI-VLEL 113
Query: 262 MPNGSLGEVL-HGKRGSFLKWEMRL-KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN 319
              G L  ++ H K+   L  E  + K  ++    L ++H   S  ++HRD+K  N+ + 
Sbjct: 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFIT 170
Query: 320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +     + D GL ++   +  +    ++ G+  Y++P
Sbjct: 171 ATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 205

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N++++      V DFGLAK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
            V EY+  G L  + H ++    K    +  A E A GL +L    S  II+RD+K +N+
Sbjct: 419 FVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNV 473
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY 361
           +L+S+    +ADFG+ K  ++           G+  YIAP +  Y
Sbjct: 474 MLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAY 516

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E R L  +    +V+L+    +     +V EY+P G +   L  + G F +   R   A 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAA 148
Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
           +      YLH   S  +I+RD+K  N+L++      V DFG AK ++      C     G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----G 200
Query: 350 SYGYIAP 356
           +  Y+AP
Sbjct: 201 TPEYLAP 207

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 53  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 109
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 110 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 167 I-DFGNE--FKNIFGTPEFVAP 185

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPAFVAP 186

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 28/154 (18%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK +L      S    L +E   L ++ H ++++L   CS     LL+ EY   GSL 
Sbjct: 56  VAVK-MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 269 EVLHGKRG----------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
             L   R                         L     +  A + ++G+ YL       +
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---L 171
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAK--YLQDT 338
           +HRD+ + NIL+    +  ++DFGL++  Y +D+
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 53  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 109
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 110 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 167 I-DFGNE--FKNIFGTPEFVAP 185

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 65/130 (50%), Gaps = 11/130 (8%)
Query: 208 QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV----RLKAFCSNKETNLLVYEYMP 263
           +VA+KK+      +     L  EI+ L + RH N++     L+A       ++ + + + 
Sbjct: 70  RVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLM 128
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
              L ++L  ++   L  +       +  +GL Y+H   S  ++HRD+K +N+L+N+  +
Sbjct: 129 ETDLYKLLKSQQ---LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCD 182
Query: 324 AHVADFGLAK 333
             + DFGLA+
Sbjct: 183 LKICDFGLAR 192

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 3/146 (2%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN--LLVYEYM 262
            G  + VK L      +      + E   L    H N++ +   C +       L+  + 
Sbjct: 32  QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWX 91
Query: 263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF 322
           P GSL  VLH      +     +K A++ A+G ++L H   PLI    + S ++ ++ D 
Sbjct: 92  PYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL-HTLEPLIPRHALNSRSVXIDEDX 150
Query: 323 EAHVADFGLAKYLQDTGASECMSAVA 348
            A ++   +    Q  G     + VA
Sbjct: 151 TARISXADVKFSFQSPGRXYAPAWVA 176

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 7/105 (6%)
Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI 316
            V EY+  G L  + H ++    K    +  A E A GL +L    S  II+RD+K +N+
Sbjct: 98  FVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNV 152
Query: 317 LLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY 361
           +L+S+    +ADFG+ K  ++           G+  YIAP +  Y
Sbjct: 153 MLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAY 195

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 209 VAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL 267
           VA+K L  G  K  + +    A+I  + ++ +  IVRL   C   E  +LV E    G L
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQI--MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPL 422
Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA 327
            + L GKR       +  ++  + + G+ YL        +HR++ + N+LL +   A ++
Sbjct: 423 HKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKIS 478
Query: 328 DFGLAKYL 335
           DFGL+K L
Sbjct: 479 DFGLSKAL 486

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 24/143 (16%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCS-----NKETNLLV 258
           +G + A+K+LL  +     +  +  E+  + K+  H NIV+   FCS      +E++   
Sbjct: 52  SGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQ---FCSAASIGKEESDTGQ 106
Query: 259 YEYMPNGSLGEVLHGKRGSFLK-WEMR--------LKIAIEAAKGLSYLHHDCSPLIIHR 309
            E++    L E+  G+   FLK  E R        LKI  +  + + ++H    P IIHR
Sbjct: 107 AEFL---LLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHR 162
Query: 310 DVKSNNILLNSDFEAHVADFGLA 332
           D+K  N+LL++     + DFG A
Sbjct: 163 DLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 28/154 (18%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK +L      S    L +E   L ++ H ++++L   CS     LL+ EY   GSL 
Sbjct: 56  VAVK-MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 269 EVLHGKRG----------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
             L   R                         L     +  A + ++G+ YL       +
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKL 171
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAK--YLQDT 338
           +HRD+ + NIL+    +  ++DFGL++  Y +D+
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N++++      V DFGLAK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 28/154 (18%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           VAVK +L      S    L +E   L ++ H ++++L   CS     LL+ EY   GSL 
Sbjct: 56  VAVK-MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 269 EVLHGKRG----------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
             L   R                         L     +  A + ++G+ YL       +
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKL 171
Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAK--YLQDT 338
           +HRD+ + NIL+    +  ++DFGL++  Y +D+
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 70/156 (44%), Gaps = 10/156 (6%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKETNLLVYEYMP 263
            G++ A K L    +G      +  EI  L   +    ++ L     N    +L+ EY  
Sbjct: 53  TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
Query: 264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF- 322
            G +  +   +    +     +++  +  +G+ YLH +    I+H D+K  NILL+S + 
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169
Query: 323 --EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             +  + DFG+++ +   G +  +  + G+  Y+AP
Sbjct: 170 LGDIKIVDFGMSRKI---GHACELREIMGTPEYLAP 202

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
           L ++ H  IV+L      +    L+ +++  G L   L  K   F + +++  +A E A 
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELAL 137
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
            L +LH   S  II+RD+K  NILL+ +    + DFGL+K  +     +   +  G+  Y
Sbjct: 138 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEY 192
Query: 354 IAP 356
           +AP
Sbjct: 193 MAP 195

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 11/130 (8%)
Query: 209 VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN----LLVYEYMPN 264
           VA+KK+L + +       +  EI  L ++ H ++V++      K+      L V   + +
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD 140
Query: 265 GSLGEVLHGKRGSFLKWEMRLKIAI-EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE 323
               ++    R      E+ +K  +     G+ Y+H   S  I+HRD+K  N L+N D  
Sbjct: 141 SDFKKLF---RTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCS 194
Query: 324 AHVADFGLAK 333
             V DFGLA+
Sbjct: 195 VKVCDFGLAR 204

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAPVLGWY 361
           + D G       + G+  ++AP +  Y
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAPEIVNY 191

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
           L ++ H  IV+L      +    L+ +++  G L   L  K   F + +++  +A E A 
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELAL 138
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
            L +LH   S  II+RD+K  NILL+ +    + DFGL+K  +     +   +  G+  Y
Sbjct: 139 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEY 193
Query: 354 IAP 356
           +AP
Sbjct: 194 MAP 196

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
           L ++ H  IV+L      +    L+ +++  G L   L  K   F + +++  +A E A 
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELAL 137
Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
            L +LH   S  II+RD+K  NILL+ +    + DFGL+K  +     +   +  G+  Y
Sbjct: 138 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEY 192
Query: 354 IAP 356
           +AP
Sbjct: 193 MAP 195

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF 278
           +G S ++ +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    
Sbjct: 54  RGVSRED-IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-- 110
Query: 279 LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI-LLNSDF---EAHVADFGLAKY 334
           L  E   +   +   G+ YLH   S  I H D+K  NI LL+ +       + DFGLA  
Sbjct: 111 LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 335 LQDTGASECMSAVAGSYGYIAP 356
           + D G       + G+  ++AP
Sbjct: 168 I-DFGNE--FKNIFGTPEFVAP 186

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 218 TKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS 277
           TK          EI  L    H  IV+L     +     ++ E+ P G++  ++      
Sbjct: 46  TKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG 105
Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
             + ++++ +  +  + L++LH   S  IIHRD+K+ N+L+  + +  +ADFG++
Sbjct: 106 LTEPQIQV-VCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 12/128 (9%)
Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
           E R L  +    +V+L+ F     +NL +V EY P G +   L  + G F +   R   A
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFXEPHARF-YA 147
Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            +      YLH   S  +I+RD+K  N++++      V DFG AK ++      C     
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----- 199
Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 200 GTPEYLAP 207

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 205 NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC----SNKETNLLVYE 260
           +G   A+K++L   +    +    A++  L    H NI+RL A+C      K    L+  
Sbjct: 53  DGHFYALKRILCHEQQDREEAQREADMHRL--FNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 261 YMPNGSL-GEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
           +   G+L  E+   K +G+FL  +  L + +   +GL  +H   +    HRD+K  NILL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILL 167
Query: 319 NSDFEAHVADFG-------------LAKYLQDTGASECMSAVAGSYGYIAPVL 358
             + +  + D G              A  LQD  A  C      +  Y AP L
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC------TISYRAPEL 214

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	362
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-74
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-69
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-66
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-58
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-50
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-44
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-43
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-09
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-41
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-36
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-24
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-30
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-27
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-24
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-04
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  232 bits (594), Expect = 2e-74
 Identities = 77/173 (44%), Positives = 104/173 (60%), Gaps = 4/173 (2%)

Query: 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           + N++GRGG G VY+G   +G  VAVK+L    +    +     E+  +    HRN++RL
Sbjct: 34  NKNILGRGGFGKVYKGRLADGTLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRL 92

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGS--FLKWEMRLKIAIEAAKGLSYLHHDCS 303
           + FC      LLVY YM NGS+   L  +  S   L W  R +IA+ +A+GL+YLH  C 
Sbjct: 93  RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           P IIHRDVK+ NILL+ +FEA V DFGLAK L D   +   +AV G+ G+IAP
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAP 204

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  219 bits (560), Expect = 2e-69
 Identities = 71/176 (40%), Positives = 98/176 (55%), Gaps = 13/176 (7%)

Query: 186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLS---AEIRTLGKIRHRNI 242
              +IG G  G VY+GV  +G +VA+K+    T  SS   G+     EI TL   RH ++
Sbjct: 43  HKFLIGHGVFGKVYKGVLRDGAKVALKRR---TPESSQ--GIEEFETEIETLSFCRHPHL 97

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF--LKWEMRLKIAIEAAKGLSYLHH 300
           V L  FC  +   +L+Y+YM NG+L   L+G       + WE RL+I I AA+GL YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                IIHRDVKS NILL+ +F   + DFG++K   +   +   + V G+ GYI P
Sbjct: 158 RA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  211 bits (540), Expect = 1e-66
 Identities = 71/174 (40%), Positives = 98/174 (56%), Gaps = 9/174 (5%)

Query: 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLS---AEIRTLGKIRHRNIV 243
            N +G GG GVVY+G   N   VAVKKL  +   ++          EI+ + K +H N+V
Sbjct: 36  GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE-ELKQQFDQEIKVMAKCQHENLV 93

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDC 302
            L  F S+ +   LVY YMPNGSL + L    G+  L W MR KIA  AA G+++LH + 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               IHRD+KS NILL+  F A ++DFGLA+  +    +   S + G+  Y+AP
Sbjct: 154 ---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  190 bits (485), Expect = 3e-58
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 25/200 (12%)

Query: 173 LDFGSDDI---LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA 229
           +D G++++      ++   V  RG  G V++      E VAVK                 
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKA-QLLNEYVAVKIFP-----IQDKQSWQN 65

Query: 230 E--IRTLGKIRHRNIVRLKAFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
           E  + +L  ++H NI++         +      L+  +   GSL + L       + W  
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNE 122

Query: 284 RLKIAIEAAKGLSYLHHD-------CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
              IA   A+GL+YLH D         P I HRD+KS N+LL ++  A +ADFGLA   +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 337 DTGASECMSAVAGSYGYIAP 356
              ++       G+  Y+AP
Sbjct: 183 AGKSAGDTHGQVGTRRYMAP 202

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  175 bits (447), Expect = 1e-52
 Identities = 56/170 (32%), Positives = 87/170 (51%), Gaps = 5/170 (2%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             IG G  G V+R    +G  VAVK L+     +   N    E+  + ++RH NIV    
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
             +      +V EY+  GSL  +LH       L    RL +A + AKG++YLH+  +P I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HR++KS N+L++  +   V DFGL++    T  S    + AG+  ++AP
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAP 208

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  167 bits (425), Expect = 6e-50
 Identities = 35/171 (20%), Positives = 69/171 (40%), Gaps = 11/171 (6%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             +    +G +++G    G  + VK L      +      + E   L    H N++ +  
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 248 FCSNKETNLL--VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
            C +        +  +MP GSL  VLH      +     +K A++ A+G+++LH    PL
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           I    + S +++++ D  A ++   +    Q  G          +  ++AP
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAP 177

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  168 bits (427), Expect = 7e-50
 Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 14/171 (8%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            V+GRG  GVV +      + VA+K++    +  S       E+R L ++ H NIV+L  
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
            C N     LV EY   GSL  VLHG     +      +   ++ ++G++YLH      +
Sbjct: 69  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 307 IHRDVKSNNILLNSDFE-AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IHRD+K  N+LL +      + DFG A  +Q       M+   GS  ++AP
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAP 172

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  167 bits (425), Expect = 1e-49
 Identities = 54/180 (30%), Positives = 93/180 (51%), Gaps = 20/180 (11%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLL-----GITKGSSHDNGLSAEIRTLGKIRHRN 241
             IG+GG G+V++G    +   VA+K L+     G T+          E+  +  + H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           IV+L     N     +V E++P G L   L  K    +KW ++L++ ++ A G+ Y+ + 
Sbjct: 85  IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN- 140

Query: 302 CSPLIIHRDVKSNNILL-----NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +P I+HRD++S NI L     N+   A VADFGL++    +     +S + G++ ++AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAP 195

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  166 bits (422), Expect = 2e-49
 Identities = 58/179 (32%), Positives = 88/179 (49%), Gaps = 18/179 (10%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
            +IG GG G VYR     G++VAVK          S     +  E +    ++H NI+ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           +  C  +    LV E+   G L  VL GKR   +  ++ +  A++ A+G++YLH +    
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 306 IIHRDVKSNNILLNSDFEAH--------VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IIHRD+KS+NIL+    E          + DFGLA+    T       + AG+Y ++AP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAP 183

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  159 bits (404), Expect = 1e-46
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 7/167 (4%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC 249
           IG G  G VY+G   +G+ VAVK L               E+  L K RH NI+    + 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           +      +V ++    SL   LH       + +  + IA + A+G+ YLH   +  IIHR
Sbjct: 90  T-APQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSIIHR 144

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           D+KSNNI L+ D    + DFGLA        S     ++GS  ++AP
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  159 bits (404), Expect = 4e-46
 Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 28/188 (14%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAE--IRTLGKIRHRNIVRL 245
            +IGRG  G VY+G + +   VAVK         ++      E  I  +  + H NI R 
Sbjct: 19  ELIGRGRYGAVYKG-SLDERPVAVKVFS-----FANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 246 KAFC----SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
                   ++      LV EY PNGSL + L         W    ++A    +GL+YLH 
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHT 129

Query: 301 D------CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE------CMSAVA 348
           +        P I HRD+ S N+L+ +D    ++DFGL+  L                +  
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 190 GTIRYMAP 197

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  153 bits (389), Expect = 2e-44
 Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 18/180 (10%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             +G+G  G V+RG +  GE VAVK      + S        E+     +RH NI+   A
Sbjct: 14  ECVGKGRYGEVWRG-SWQGENVAVKIFSSRDEKSWF---RETELYNTVMLRHENILGFIA 69

Query: 248 FC---SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-- 301
                 +  T L L+  Y   GSL + L       L     L+I +  A GL++LH +  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 302 ---CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE--CMSAVAGSYGYIAP 356
                P I HRD+KS NIL+  + +  +AD GLA     +        +   G+  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  153 bits (389), Expect = 4e-44
 Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 10/172 (5%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +IG+G  G VY G   +GE VA++ +               E+    + RH N+V    
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
            C +     ++       +L  V+   +   L      +IA E  KG+ YLH   +  I+
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLH---AKGIL 152

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAK---YLQDTGASECMSAVAGSYGYIAP 356
           H+D+KS N+  + + +  + DFGL      LQ     + +    G   ++AP
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  152 bits (387), Expect = 1e-43
 Identities = 56/188 (29%), Positives = 80/188 (42%), Gaps = 18/188 (9%)

Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
           I + ++    IG+G  G V+ G    GE+VAVK      + S        EI     +RH
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF---RETEIYQTVLMRH 90

Query: 240 RNIVRLKAFC---SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
            NI+   A     +   T L L+ +Y  NGSL + L       L  +  LK+A  +  GL
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGL 147

Query: 296 SYLH-----HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE--CMSAVA 348
            +LH         P I HRD+KS NIL+  +    +AD GLA              +   
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 349 GSYGYIAP 356
           G+  Y+ P
Sbjct: 208 GTKRYMPP 215

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  151 bits (383), Expect = 5e-43
 Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 18/188 (9%)

Query: 180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH 239
           I   +     IG+G  G V+RG    GE+VAVK      + S       AEI     +RH
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRH 95

Query: 240 RNIVRLKAFC---SNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
            NI+   A     +   T L LV +Y  +GSL + L+      +  E  +K+A+  A GL
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGL 152

Query: 296 SYLHHD-----CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC--MSAVA 348
           ++LH +       P I HRD+KS NIL+  +    +AD GLA        +     +   
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 349 GSYGYIAP 356
           G+  Y+AP
Sbjct: 213 GTKRYMAP 220

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  155 bits (394), Expect = 4e-42
 Identities = 51/127 (40%), Positives = 69/127 (54%), Gaps = 2/127 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           MS N  SG IP EIG    L  L+L  N +SG IP ++  +  LN L++S N+L+  +P+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
            M  +  LT  D S+NN SG IPE GQ+  F    F  NP LCG  L  C+ S+      
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADG--Y 756

Query: 121 QNGNKSH 127
            +  +SH
Sbjct: 757 AHHQRSH 763

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  100 bits (251), Expect = 3e-23
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N F+G IP  + +C  L  L LS N+LSG IP  +  +  L  L +  N L   +P+
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
           E+  +K+L +     N+ +GEIP        N T+
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPS----GLSNCTN 491

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 98.8 bits (247), Expect = 1e-22
 Identities = 34/130 (26%), Positives = 57/130 (43%), Gaps = 4/130 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N+ +G IP  + +C  L ++ LS N L+G IP  I ++  L  L +S N  + ++P 
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
           E+G+ +SL   D + N F+G IP     + F  +       + G               +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPA----AMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 121 QNGNKSHVPG 130
             GN     G
Sbjct: 589 GAGNLLEFQG 598

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 28/85 (32%), Positives = 42/85 (49%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N  SG IP  +G    L  L L  N L G IP ++  +  L  L + +N L   +P 
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEF 85
            + N  +L     S+N  +GEIP++
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKW 509

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 29/84 (34%), Positives = 47/84 (55%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N   G IP E+ +   L  L L  N L+G IP  ++    LN++++S N+L   +PK
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
            +G +++L     S+N+FSG IP 
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 6/97 (6%)

Query: 1   MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           +S NNFSG I   +       L  L L  N  +G IP  ++    L  L++S+N L+ ++
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
           P  +G++  L       N   GEIP+          +
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQ----ELMYVKT 467

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIHILNYLNVSWNQLNASLP 59
           +S N+F G +P   G C LL  L LS N+ SG +P+  + ++  L  L++S+N+ +  LP
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 60  KEMGNMK-SLTSADFSHNNFSGEIP-EFGQYSFFN 92
           + + N+  SL + D S NNFSG I     Q     
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 36/96 (37%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 2   SRNNFSGIIPVEI-GHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           + N F+G IP  + G C  LT LDLS NH  G +P       +L  L +S N  +  LP 
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 61  EM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
           +    M+ L   D S N FSGE+PE    S  N ++
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPE----SLTNLSA 368

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 35/85 (41%), Positives = 46/85 (54%), Gaps = 3/85 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S NNFS  IP  +G C  L +LD+S N LSG     I+    L  LN+S NQ    +P 
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEF 85
               +KSL     + N F+GEIP+F
Sbjct: 266 L--PLKSLQYLSLAENKFTGEIPDF 288

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 3/90 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQN--HLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           ++ N  +G   V I +  +      + N     G    Q+ ++   N  N++        
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIP-EFGQ 87
                N  S+   D S+N  SG IP E G 
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.8 bits (208), Expect = 8e-18
 Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPK 60
           S N F G IP        L YL L++N  +G IP  ++     L  L++S N    ++P 
Sbjct: 255 SSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
             G+   L S   S NNFSGE+P 
Sbjct: 313 FFGSCSLLESLALSSNNFSGELPM 336

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 81.1 bits (201), Expect = 6e-17
 Identities = 28/90 (31%), Positives = 37/90 (41%), Gaps = 6/90 (6%)

Query: 2   SRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQ---IHILNYLNVSWNQLNAS 57
           S N       V  G  L  L  LDLS N +SG   V          L +L +S N+++  
Sbjct: 134 SSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGD 193

Query: 58  LPKEMGNMKSLTSADFSHNNFSGEIPEFGQ 87
           +   +    +L   D S NNFS  IP  G 
Sbjct: 194 VD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 4/87 (4%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP--VQITQIHILNYLNVSWNQLNASL 58
           +S ++ +G +         LT LDLS+N LSGP+     +     L +LNVS N L+   
Sbjct: 84  LSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142

Query: 59  PKEMG-NMKSLTSADFSHNNFSGEIPE 84
               G  + SL   D S N+ SG    
Sbjct: 143 KVSGGLKLNSLEVLDLSANSISGANVV 169

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 6/89 (6%)

Query: 1   MSRNNFSGIIP--VEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNAS 57
           +SRN+ SG +     +G C  L +L++S N L  P  V    +++ L  L++S N ++ +
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 58  LPKEM---GNMKSLTSADFSHNNFSGEIP 83
                        L     S N  SG++ 
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD 195

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 16/82 (19%), Positives = 29/82 (35%), Gaps = 3/82 (3%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP--KE 61
           N     +   +     L  L LS +H++G +         L  L++S N L+  +     
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121

Query: 62  MGNMKSLTSADFSHNNFSGEIP 83
           +G+   L   + S N       
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGK 143

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)

Query: 20  LTYLDLSQNHLS---GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN 76
           +T +DLS   L+     +   +  +  L  L +S + +N S+        SLTS D S N
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110

Query: 77  NFSGEIPEFGQ 87
           + SG +     
Sbjct: 111 SLSGPVTTLTS 121

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  145 bits (369), Expect = 3e-41
 Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 19/188 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR 240
             +    V+G+G  G   +      GE + +K+L+   + +        E++ +  + H 
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHP 67

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           N+++        +    + EY+  G+L  ++     S   W  R+  A + A G++YLH 
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLH- 125

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS------------ECMSAVA 348
             S  IIHRD+ S+N L+  +    VADFGLA+ + D                +    V 
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 349 GSYGYIAP 356
           G+  ++AP
Sbjct: 184 GNPYWMAP 191

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  133 bits (338), Expect = 1e-36
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 1/110 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +SRN   G   V  G       + L++N L+  +  ++     LN L++  N++  +LP+
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQ 262

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPC 110
            +  +K L S + S NN  GEIP+ G    F+ +++  N  LCGS L  C
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  101 bits (254), Expect = 9e-25
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 4/94 (4%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
             NN  G IP  I     L YL ++  ++SG IP  ++QI  L  L+ S+N L+ +LP  
Sbjct: 85  GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
           + ++ +L    F  N  SG IP+    S+ + + 
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPD----SYGSFSK 174

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  101 bits (253), Expect = 2e-24
 Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 2/92 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++  N SG IP  +     L  LD S N LSG +P  I+ +  L  +    N+++ ++P 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 61  EMGNMKSLTSA-DFSHNNFSGEIP-EFGQYSF 90
             G+   L ++   S N  +G+IP  F   + 
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNL 199

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 76.8 bits (190), Expect = 5e-16
 Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 3/87 (3%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVS-WNQLNASL 58
               + G++         +  LDLS  +L    PIP  +  +  LN+L +   N L   +
Sbjct: 34  CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPEF 85
           P  +  +  L     +H N SG IP+F
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDF 120

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  122 bits (309), Expect = 5e-32
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 12/161 (7%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA---EIRTLGKI 237
           E +     IGRG  G V+ G    +   VAVK      + +   +  +    E R L + 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARILKQY 169

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
            H NIVRL   C+ K+   +V E +  G     L    G+ L+ +  L++  +AA G+ Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEY 228

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           L    S   IHRD+ + N L+       ++DFG+++   D 
Sbjct: 229 LE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  119 bits (301), Expect = 1e-31
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 13/178 (7%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           K +  IGRG    VY+G+ T    +VA  +L       S       E   L  ++H NIV
Sbjct: 29  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 244 R-LKAFCSNKETNLLVY---EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           R   ++ S  +    +    E M +G+L   L  KR   +K ++      +  KGL +LH
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 300 HDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              +P IIHRD+K +NI +        + D GLA   + + A      V G+  ++AP
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAP 199

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  118 bits (299), Expect = 2e-31
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 11/162 (6%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           + +K    IG+G  G V  G    G +VAVK +    K  +      AE   + ++RH N
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 75

Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           +V+L      ++  L +V EYM  GSL + L  +  S L  +  LK +++  + + YL  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 134

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGA 340
                 +HRD+ + N+L++ D  A V+DFGL K         
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  118 bits (299), Expect = 2e-31
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 7/157 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E +K    +G G  G V+ G      +VAVK L    +GS   +   AE   + +++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +VRL A  + +E   ++ EYM NGSL + L    G  L     L +A + A+G++++   
Sbjct: 70  LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
                IHRD+++ NIL++      +ADFGLA+ ++D 
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  118 bits (297), Expect = 4e-31
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
             +     IG G  G+V+ G   N ++VA+K +    +G+  +     E   + K+ H  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPK 64

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--H 299
           +V+L   C  +    LV E+M +G L + L  +RG F    + L + ++  +G++YL   
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEA 123

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                 +IHRD+ + N L+  +    V+DFG+ +++ D
Sbjct: 124 C-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  118 bits (297), Expect = 4e-31
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 7/157 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR 240
             +   + +G G  G VY GV       VAVK L    + +        E   + +I+H 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 69

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           N+V+L   C+ +    ++ E+M  G+L + L       +   + L +A + +  + YL  
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 128

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                 IHRD+ + N L+  +    VADFGL++ +  
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  118 bits (297), Expect = 5e-31
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 11/159 (6%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           + +     +G G  GVV  G       VA+K +    +GS  ++    E + +  + H  
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEK 80

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--H 299
           +V+L   C+ +    ++ EYM NG L   L   R  F   ++ L++  +  + + YL   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESK 139

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
                  +HRD+ + N L+N      V+DFGL++Y+ D 
Sbjct: 140 Q-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  121 bits (306), Expect = 5e-31
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 7/157 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ-VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR 240
             +   + +G G  G VY GV       VAVK L    + +        E   + +I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 276

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           N+V+L   C+ +    ++ E+M  G+L + L       +   + L +A + +  + YL  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                 IHR++ + N L+  +    VADFGL++ +  
Sbjct: 336 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  120 bits (303), Expect = 1e-30
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 7/157 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E +K    +G G  G V+        +VAVK +     GS       AE   +  ++H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDK 244

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +V+L A  + KE   ++ E+M  GSL + L    GS       +  + + A+G++++   
Sbjct: 245 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 301

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
                IHRD+++ NIL+++     +ADFGLA+ ++D 
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  120 bits (302), Expect = 1e-30
 Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 7/156 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E ++    +G+G  G V+ G      +VA+K L     G+        E + + K+RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +V+L A  S +E   +V EYM  GSL + L G+ G +L+    + +A + A G++Y+   
Sbjct: 241 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 297

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                +HRD+++ NIL+  +    VADFGLA+ ++D
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  115 bits (291), Expect = 2e-30
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 7/157 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E +     +G G  GVV  G       VAVK +    +GS  ++    E +T+ K+ H  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPK 64

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +V+    CS +    +V EY+ NG L   L          ++ L++  +  +G+++L   
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-LEMCYDVCEGMAFLE-- 121

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            S   IHRD+ + N L++ D    V+DFG+ +Y+ D 
Sbjct: 122 -SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  119 bits (300), Expect = 2e-30
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 13/163 (7%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           + +K    IG+G  G V  G    G +VAVK +    K  +      AE   + ++RH N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 247

Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL-H 299
           +V+L      ++  L +V EYM  GSL + L  +  S L  +  LK +++  + + YL  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK--YLQDTGA 340
           ++     +HRD+ + N+L++ D  A V+DFGL K         
Sbjct: 308 NNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  119 bits (300), Expect = 5e-30
 Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 7/156 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E ++    +G+G  G V+ G      +VA+K L     G+        E + + K+RH  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 323

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +V+L A  S +E   +V EYM  GSL + L G+ G +L+    + +A + A G++Y+   
Sbjct: 324 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 380

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                +HRD+++ NIL+  +    VADFGLA+ ++D
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (289), Expect = 8e-30
 Identities = 51/174 (29%), Positives = 87/174 (50%), Gaps = 16/174 (9%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
           V+G+G  G+VY G    N  ++A+K+   I +  S     L  EI     ++H+NIV+  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKE---IPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 247 AFCSNKETNLLVY-EYMPNGSLGEVLHGKRGSFLKWEMRLK-IAIEAAKGLSYLHHDCSP 304
               ++   + ++ E +P GSL  +L  K G     E  +     +  +GL YLH +   
Sbjct: 86  G-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142

Query: 305 LIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            I+HRD+K +N+L+N+ +   +  +DFG +K L     + C     G+  Y+AP
Sbjct: 143 -IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAP 192

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  114 bits (288), Expect = 9e-30
 Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 14/163 (8%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
           E V  N ++G G  G VY GV     GE   VAVK         + +  +S E   +  +
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS-EAVIMKNL 70

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
            H +IV+L      +E   ++ E  P G LG  L   + S     + +  +++  K ++Y
Sbjct: 71  DHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAY 128

Query: 298 L--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           L   +      +HRD+   NIL+ S     + DFGL++Y++D 
Sbjct: 129 LESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  114 bits (288), Expect = 1e-29
 Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 12/163 (7%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
             +K    +G G  G V            GEQVAVK L   + G +H   L  EI  L  
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRN 79

Query: 237 IRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
           + H NIV+ K  C+    N   L+ E++P+GSL E L   +      +  LK A++  KG
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-LKYAVQICKG 138

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           + YL    S   +HRD+ + N+L+ S+ +  + DFGL K ++ 
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  115 bits (289), Expect = 2e-29
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 18/165 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGEQ---VAVKKLLGITKGSSHDNGLS--AEIRTL 234
            CV    VIG G  G VY+G+  T +G++   VA+K L     G +    +    E   +
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIM 100

Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
           G+  H NI+RL+   S  +  +++ EYM NG+L + L  K G F   ++ + +    A G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAG 159

Query: 295 LSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           + YL   +      +HRD+ + NIL+NS+    V+DFGL++ L+D
Sbjct: 160 MKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  112 bits (283), Expect = 4e-29
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 13/153 (8%)

Query: 190 IGRGGAGVVYRGV--TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           +G G  G V +GV      +  VA+K L   T+ +  +  +  E + + ++ +  IVRL 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQLDNPYIVRLI 76

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--HHDCSP 304
             C   E  +LV E    G L + L GKR       +  ++  + + G+ YL   +    
Sbjct: 77  GVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN---- 130

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
             +HRD+ + N+LL +   A ++DFGL+K L  
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (285), Expect = 5e-29
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 13/162 (8%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV---TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
             +    +IG G +G V  G        +  VA+K L          + LS E   +G+ 
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS-EASIMGQF 107

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
            H NI+RL+   +     ++V EYM NGSL   L    G F   ++ + +      G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-VGMLRGVGAGMRY 166

Query: 298 L--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           L          +HRD+ + N+L++S+    V+DFGL++ L+D
Sbjct: 167 LSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  113 bits (286), Expect = 8e-29
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 17/164 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLS--AEIRTLG 235
             +  + V+G G  G V  G    P+ +   VA+K L     G +         E   +G
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMG 101

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
           +  H NI+RL+   +  +  ++V EYM NGSL   L      F   ++ + +    A G+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-VGMLRGIASGM 160

Query: 296 SYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
            YL          +HRD+ + NIL+NS+    V+DFGL + L+D
Sbjct: 161 KYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  111 bits (280), Expect = 1e-28
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 12/162 (7%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
           E ++    IG G  G V++G+  +P      VA+K     T  S  +  L  E  T+ + 
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ-EALTMRQF 73

Query: 238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
            H +IV+L    + +    ++ E    G L   L  ++ S     + +  A + +  L+Y
Sbjct: 74  DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYAYQLSTALAY 131

Query: 298 L-HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           L         +HRD+ + N+L++S+    + DFGL++Y++D+
Sbjct: 132 LESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  112 bits (282), Expect = 1e-28
 Identities = 47/163 (28%), Positives = 69/163 (42%), Gaps = 13/163 (7%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
             +K  + +G+G  G V            G  VAVK+L     G         EI+ L  
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKA 80

Query: 237 IRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
           +    IV+ +            LV EY+P+G L + L   R       + L  + +  KG
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-LLYSSQICKG 139

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           + YL    S   +HRD+ + NIL+ S+    +ADFGLAK L  
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  111 bits (280), Expect = 1e-28
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 14/163 (8%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKL-LGITKGSSHDNGLSAEIRTLGK 236
           + ++    +G G  GVV RG    P+G+   VAVK L   +       +    E+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           + HRN++RL           +V E  P GSL + L   +G FL   +  + A++ A+G+ 
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMG 135

Query: 297 YL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           YL          IHRD+ + N+LL +     + DFGL + L  
Sbjct: 136 YLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  112 bits (282), Expect = 1e-28
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 15/157 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            V+G G  G VY+G+  P GE     VA+K+L   T   ++   L  E   +  + + ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHV 79

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--HH 300
            RL   C    T  L+ + MP G L + +   + + +  +  L   ++ AKG++YL    
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                ++HRD+ + N+L+ +     + DFGLAK L  
Sbjct: 138 -----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (280), Expect = 2e-28
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 17/165 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITK--GSSHDNGLSAEIRTL 234
             +K    +G+G  G V            GE VAVKKL    +     H      EI  L
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEIL 65

Query: 235 GKIRHRNIVRLKAFC--SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
             ++H NIV+ K  C  + +    L+ EY+P GSL + L   +   +     L+   +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQIC 124

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           KG+ YL    +   IHRD+ + NIL+ ++    + DFGL K L  
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (281), Expect = 2e-28
 Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 19/202 (9%)

Query: 161 NSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITK 219
           N         + +D+   + +  +     +GRG  G V+R      G Q AVKK+     
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV----- 91

Query: 220 GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFL 279
               +     E+     +    IV L           +  E +  GSLG+++  + G   
Sbjct: 92  --RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLP 148

Query: 280 KWEMRLK-IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQD 337
             E R      +A +GL YLH      I+H DVK++N+LL+SD   A + DFG A  LQ 
Sbjct: 149 --EDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203

Query: 338 TGASECMSA---VAGSYGYIAP 356
            G  + +     + G+  ++AP
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAP 225

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  111 bits (279), Expect = 3e-28
 Identities = 40/175 (22%), Positives = 71/175 (40%), Gaps = 17/175 (9%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD---NGLSAEIRTLGKIRHRN--I 242
             IG GG+  V++ +    +  A+K    +    + +   +    EI  L K++  +  I
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKY---VNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
           +RL  +    +   +V E   N  L   L  K+ S   WE +        + +  +H H 
Sbjct: 91  IRLYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERK-SYWKNMLEAVHTIHQHG 147

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               I+H D+K  N L+       + DFG+A  +Q    S    +  G+  Y+ P
Sbjct: 148 ----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  111 bits (279), Expect = 4e-28
 Identities = 40/172 (23%), Positives = 69/172 (40%), Gaps = 11/172 (6%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRL 245
             IG GG+  V++ +    +  A+K +      +   +    EI  L K++     I+RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSP 304
             +    +   +V E   N  L   L  K+ S   WE +        + +  +H H    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 128

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            I+H D+K  N L+       + DFG+A  +Q    S    +  G+  Y+ P
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 6e-28
 Identities = 49/165 (29%), Positives = 72/165 (43%), Gaps = 17/165 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITK--GSSHDNGLSAEIRTL 234
             +K    +G+G  G V            GE VAVKKL    +     H      EI  L
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEIL 96

Query: 235 GKIRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
             ++H NIV+ K  C +       L+ EY+P GSL + L   +   +     L+   +  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQIC 155

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           KG+ YL    +   IHRD+ + NIL+ ++    + DFGL K L  
Sbjct: 156 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  109 bits (274), Expect = 9e-28
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 15/155 (9%)

Query: 189 VIGRGGAGVVYRGV--TPNGE-QVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
            +G G  G V +G          VAVK L       +  D  L+ E   + ++ +  IVR
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVR 82

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--HHDC 302
           +   C   E+ +LV E    G L + L  ++   +K +  +++  + + G+ YL   +  
Sbjct: 83  MIGICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
               +HRD+ + N+LL +   A ++DFGL+K L+ 
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (278), Expect = 1e-27
 Identities = 41/172 (23%), Positives = 70/172 (40%), Gaps = 11/172 (6%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRL 245
             IG GG+  V++ +    +  A+K +      +   +    EI  L K++     I+RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSP 304
             +    +   +V E   N  L   L  K+ S   WE +        + +  +H H    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            I+H D+K  N L+  D    + DFG+A  +Q    S    +  G+  Y+ P
Sbjct: 176 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  113 bits (283), Expect = 1e-27
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 13/161 (8%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKIR 238
             +  +  +G G  G V +GV      +  VA+K L   T+ +  +  +  E + + ++ 
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQLD 394

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           +  IVRL   C   E  +LV E    G L + L GKR       +  ++  + + G+ YL
Sbjct: 395 NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL 452

Query: 299 --HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
              +      +HR++ + N+LL +   A ++DFGL+K L  
Sbjct: 453 EEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  110 bits (276), Expect = 1e-27
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 10/171 (5%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
            IG G  G       T +G Q  +K+  +  ++     +     E+  L  ++H NIV+ 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE--SRREVAVLANMKHPNIVQY 88

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           +       +  +V +Y   G L + ++ ++G   + +  L   ++    L ++H      
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           I+HRD+KS NI L  D    + DFG+A+ L  T   E   A  G+  Y++P
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSP 194

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (274), Expect = 1e-27
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 15/166 (9%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
           VIG G   VV      P  E+VA+K++  + K  +  + L  EI+ + +  H NIV    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--SY 78

Query: 248 FCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK---IAI---EAAKGLSYLH 299
           + S   +  L LV + +  GS+ +++             L    IA    E  +GL YLH
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
            +     IHRDVK+ NILL  D    +ADFG++ +L   G      
Sbjct: 139 KNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  109 bits (275), Expect = 1e-27
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 15/163 (9%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-TPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
             ++   V+G G  G V++GV  P GE     V +K +   +   S        +  +G 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-HMLAIGS 71

Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           + H +IVRL   C    +  LV +Y+P GSL + +   RG+ L  ++ L   ++ AKG+ 
Sbjct: 72  LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMY 129

Query: 297 YL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           YL  H      ++HR++ + N+LL S  +  VADFG+A  L  
Sbjct: 130 YLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (274), Expect = 2e-27
 Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 20/166 (12%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV-----TPNGEQVAVKKLLGITKGSSHDNGLSA---EIRT 233
             +K    +G G  G V            GE VAVK L    K  +     S    EI  
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL----KADAGPQHRSGWKQEIDI 86

Query: 234 LGKIRHRNIVRLKAFCSNKETN--LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
           L  + H +I++ K  C +       LV EY+P GSL + L       +     L  A + 
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQI 143

Query: 292 AKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
            +G++YLH   +   IHRD+ + N+LL++D    + DFGLAK + +
Sbjct: 144 CEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  108 bits (272), Expect = 2e-27
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 29/186 (15%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
            +IG GG G V++     +G+   +K+   +   +  +     E++ L K+ H NIV   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN--EKAER-EVKALAKLDHVNIVHYN 70

Query: 247 AF---------------CSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIE 290
                              +K   L +  E+   G+L + +  +RG  L   + L++  +
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130

Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
             KG+ Y+H   S  +I+RD+K +NI L    +  + DFGL   L++ G     +   G+
Sbjct: 131 ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGT 184

Query: 351 YGYIAP 356
             Y++P
Sbjct: 185 LRYMSP 190

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  108 bits (273), Expect = 3e-27
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 15/157 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            V+G G  G VY+G+  P GE     VA+K+L   T   ++   L  E   +  + + ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHV 79

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL--HH 300
            RL   C    T  L+ + MP G L + +   + + +  +  L   ++ AKG++YL    
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
                ++HRD+ + N+L+ +     + DFGLAK L  
Sbjct: 138 -----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  107 bits (270), Expect = 4e-27
 Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 10/162 (6%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
             V  N VIGRG  G VY G     +G+    AVK L  IT        L+ E   +   
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDF 83

Query: 238 RHRNIVRLKAFCSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
            H N++ L   C   E + L V  YM +G L   +  +  +    ++ +   ++ AKG+ 
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 142

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           YL    S   +HRD+ + N +L+  F   VADFGLA+ + D 
Sbjct: 143 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  107 bits (270), Expect = 4e-27
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 14/164 (8%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV---TPNGE-QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
                + VIG+G  GVVY G          Q A+K L  IT+    +  L  E   +  +
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR-EGLLMRGL 79

Query: 238 RHRNIVRLKAFCSNKE-TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
            H N++ L       E    ++  YM +G L + +   + +    ++ +   ++ A+G+ 
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGME 138

Query: 297 YL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           YL          +HRD+ + N +L+  F   VADFGLA+ + D 
Sbjct: 139 YLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  107 bits (270), Expect = 5e-27
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 11/173 (6%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKK--LLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
            IGRG    VYR     +G  VA+KK  +  +    +  + +  EI  L ++ H N+++ 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKY 97

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
            A         +V E    G L  ++    K+   +      K  ++    L ++H   S
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             ++HRD+K  N+ + +     + D GL ++      +    ++ G+  Y++P
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSP 205

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (270), Expect = 6e-27
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 19/178 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
           ++G+G    V+RG     G+  A+K        S          E   L K+ H+NIV+L
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKV---FNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 246 KAFCSNKETNL--LVYEYMPNGSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
            A      T    L+ E+ P GSL  VL        L     L +  +   G+++L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129

Query: 303 SPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              I+HR++K  NI+     +      + DFG A+ L+D    E   ++ G+  Y+ P
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHP 184

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  106 bits (267), Expect = 7e-27
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 9/175 (5%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK- 246
            IG G  G   +     +G+ +  K+L   +   +    L +E+  L +++H NIVR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 247 AFCSNKETNL-LVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLH--HD 301
                  T L +V EY   G L  V+    K   +L  E  L++  +    L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               ++HRD+K  N+ L+      + DFGLA+ L     +       G+  Y++P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSP 185

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  107 bits (268), Expect = 7e-27
 Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 28/192 (14%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK- 246
            +GRGG GVV+      +    A+K++  +         +  E++ L K+ H  IVR   
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 247 AF--------CSNKETNLLVY---EYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKG 294
           A+               + +Y   +     +L + ++G+      +  + L I ++ A+ 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG----------ASECM 344
           + +LH   S  ++HRD+K +NI    D    V DFGL   +              A    
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 345 SAVAGSYGYIAP 356
           +   G+  Y++P
Sbjct: 188 TGQVGTKLYMSP 199

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  106 bits (267), Expect = 1e-26
 Identities = 35/177 (19%), Positives = 74/177 (41%), Gaps = 30/177 (16%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLS--AEI 231
           E +  N  +G+G    +++GV          +  +V +K L      +  +   S     
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL----DKAHRNYSESFFEAA 63

Query: 232 RTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
             + K+ H+++V     C   + N+LV E++  GSL   L   +   +    +L++A + 
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQL 122

Query: 292 AKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAH--------VADFGLAKYLQDT 338
           A  + +L  +      +IH +V + NILL  + +          ++D G++  +   
Sbjct: 123 AAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  106 bits (267), Expect = 1e-26
 Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 33/194 (17%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
           V+G+G  G V +     +    A+KK   I       + + +E+  L  + H+ +VR  A
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKK---IRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 248 F----------CSNKETNLLVY---EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
                       +  +    ++   EY  NG+L +++H       + +   ++  +  + 
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEA 128

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT------------GASE 342
           LSY+H   S  IIHRD+K  NI ++      + DFGLAK +  +            G+S+
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 343 CMSAVAGSYGYIAP 356
            +++  G+  Y+A 
Sbjct: 186 NLTSAIGTAMYVAT 199

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  109 bits (274), Expect = 2e-26
 Identities = 40/165 (24%), Positives = 77/165 (46%), Gaps = 18/165 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGEQ--VAVKKLLGITKGSSHDNGLS---AEIRTL 234
           E ++    IG G  G V++G+  +P      VA+K      K  + D+       E  T+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQEALTM 445

Query: 235 GKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
            +  H +IV+L    + +    ++ E    G L   L  ++ S     + +  A + +  
Sbjct: 446 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASL-ILYAYQLSTA 503

Query: 295 LSYLH-HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           L+YL         +HRD+ + N+L++S+    + DFGL++Y++D+
Sbjct: 504 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  107 bits (269), Expect = 2e-26
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 21/179 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
           ++G+G    V+RG     G+  A+K        S          E   L K+ H+NIV+L
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKV---FNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 246 KAFCSNKETNL--LVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
            A      T    L+ E+ P GSL  VL          + E    +  +   G+++L   
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLR-- 129

Query: 302 CSPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               I+HR++K  NI+     +      + DFG A+ L+D    E   ++ G+  Y+ P
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHP 184

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  107 bits (270), Expect = 3e-26
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)

Query: 187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRL 245
            +V+G G  G +      +   VAVK++L         +    E++ L +   H N++R 
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPNVIRY 83

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                +++   +  E     +L E +  K  + L  E    +  +   GL++LH   S  
Sbjct: 84  FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLN 138

Query: 306 IIHRDVKSNNILL-----NSDFEAHVADFGLAKYLQDTGAS-ECMSAVAGSYGYIAP 356
           I+HRD+K +NIL+     +   +A ++DFGL K L     S    S V G+ G+IAP
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  106 bits (266), Expect = 4e-26
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 10/162 (6%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--TPNGE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
             V  N VIGRG  G VY G     +G+    AVK L  IT        L+ E   +   
Sbjct: 89  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDF 147

Query: 238 RHRNIVRLKAFCSNKETNLL-VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
            H N++ L   C   E + L V  YM +G L   +  +  +    ++ +   ++ AKG+ 
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMK 206

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           +L    S   +HRD+ + N +L+  F   VADFGLA+ + D 
Sbjct: 207 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 6e-26
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 20/161 (12%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVR-- 244
           ++G G  G VY+G     G+  A+K    +      +  +  EI  L K   HRNI    
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKV---MDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 245 ---LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSY 297
              +K      +  L LV E+   GS+ +++   +G+ LK E    IA    E  +GLS+
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE---WIAYICREILRGLSH 144

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           LH      +IHRD+K  N+LL  + E  + DFG++  L  T
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  103 bits (259), Expect = 1e-25
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 18/185 (9%)

Query: 162 SNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKG 220
           ++S   +    +     D  E       IG+G  G V++G+     + VA+K +  + + 
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEA 60

Query: 221 SSHDNGLSAEIRTLGKIRHRNIVRLKAFCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSF 278
                 +  EI  L +     +   K + S  K+T L ++ EY+  GS  ++L  + G  
Sbjct: 61  EDEIEDIQQEITVLSQCDSPYVT--KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPL 116

Query: 279 LKWEMRLKIAI---EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
                  +IA    E  KGL YLH +     IHRD+K+ N+LL+   E  +ADFG+A  L
Sbjct: 117 ----DETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169

Query: 336 QDTGA 340
            DT  
Sbjct: 170 TDTQI 174

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (265), Expect = 3e-25
 Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 30/179 (16%)

Query: 189 VIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
            I  GG G +Y  +    NG  V +K L+      S D    A    E + L ++ H +I
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLV-----HSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 243 VRLKAF-----CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           V++  F             +V EY+   SL      K    L     +   +E    LSY
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSY 197

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           LH      +++ D+K  NI+L  + +  + D G    +   G       + G+ G+ AP
Sbjct: 198 LHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYGTPGFQAP 246

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (260), Expect = 3e-25
 Identities = 38/161 (23%), Positives = 64/161 (39%), Gaps = 16/161 (9%)

Query: 188 NVIGRGGA--GVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
            VIG+G      V      P GE V V+++      +     L  E+       H NIV 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV- 89

Query: 245 LKAFCS-NKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLH 299
                +   +  L +V  +M  GS  +++       +  E  L IA       K L Y+H
Sbjct: 90  -PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-E--LAIAYILQGVLKALDYIH 145

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340
           H      +HR VK+++IL++ D + +++       +   G 
Sbjct: 146 HMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (264), Expect = 3e-25
 Identities = 53/181 (29%), Positives = 76/181 (41%), Gaps = 22/181 (12%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
            +G GG G V R +    GEQVA+K+     +  S  N      EI+ + K+ H N+V  
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQ---CRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 246 KAF------CSNKETNLLVYEYMPNGSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYL 298
           +         +  +  LL  EY   G L + L+       LK      +  + +  L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIA 355
           H      IIHRD+K  NI+L    +     + D G AK L       C   V G+  Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFV-GTLQYLA 191

Query: 356 P 356
           P
Sbjct: 192 P 192

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (257), Expect = 4e-25
 Identities = 46/176 (26%), Positives = 62/176 (35%), Gaps = 28/176 (15%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLS---AEIR 232
           + +     +G G  G VY G            QVAVK L         +        E  
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL----PEVCSEQDELDFLMEAL 85

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKI 287
            + K  H+NIVR            ++ E M  G L   L   R      S L     L +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 288 AIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHV---ADFGLAKYLQDT 338
           A + A G  YL  +H      IHRD+ + N LL       V    DFG+A+ +   
Sbjct: 146 ARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (254), Expect = 6e-25
 Identities = 36/182 (19%), Positives = 68/182 (37%), Gaps = 34/182 (18%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSA---EIR 232
             V+    +G    G VY+G             VA+K L    K  +          E  
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL----KDKAEGPLREEFRHEAM 64

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSF 278
              +++H N+V L    +  +   +++ Y  +G L E L  +                S 
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 279 LKWEMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
           L+    + +  + A G+ YL  HH     ++H+D+ + N+L+       ++D GL + + 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 337 DT 338
             
Sbjct: 180 AA 181

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  101 bits (255), Expect = 6e-25
 Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 20/172 (11%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
             +    ++G G  G V  G     +    +VAVK +              +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 238 RHRNIVRLKAFCSNKETN-----LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIA 288
            H N++RL   C    +      +++  +M  G L   L   R       +  +  LK  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 289 IEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           ++ A G+ YL   +      +HRD+ + N +L  D    VADFGL+K +   
Sbjct: 154 VDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (255), Expect = 6e-25
 Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 29/179 (16%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSAEIRTLG 235
             +     +G G  G V+     N         VAVK L   T  +  D     E   L 
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLT 72

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKW 281
            ++H +IV+    C + +  ++V+EYM +G L + L                     L  
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 282 EMRLKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
              L IA + A G+ YL   H      +HRD+ + N L+ ++    + DFG+++ +  T
Sbjct: 133 SQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  101 bits (255), Expect = 7e-25
 Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 18/171 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSAEIRTLG 235
           E +  +  +G+G  G+VY GV           +VA+K +            L+ E   + 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASVMK 83

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR--------LKI 287
           +    ++VRL    S  +  L++ E M  G L   L   R +     +         +++
Sbjct: 84  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           A E A G++YL+   +   +HRD+ + N ++  DF   + DFG+ + + +T
Sbjct: 144 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (255), Expect = 9e-25
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 32/184 (17%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ---VAVKKLLGITKGSSHDNGLSA---EIRTLG 235
             +K  +VIG G  G V +            A+K++    K  +  +       E+  L 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYASKDDHRDFAGELEVLC 80

Query: 236 KI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR--------------GSFLK 280
           K+  H NI+ L   C ++    L  EY P+G+L + L   R               S L 
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK----YLQ 336
            +  L  A + A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++    Y++
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197

Query: 337 DTGA 340
            T  
Sbjct: 198 KTMG 201

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  101 bits (254), Expect = 9e-25
 Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 17/187 (9%)

Query: 157 KFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLL 215
             +  +   +       D  +    E       +G G  G VY+ +    G+ VA+K++ 
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV- 62

Query: 216 GITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGK 274
                 S    +  EI  + +    ++V+       K T+L +V EY   GS+ +++  +
Sbjct: 63  ---PVESDLQEIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLR 118

Query: 275 RGSFLKWEMRLKIAI---EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL 331
             +  + E    IA       KGL YLH       IHRD+K+ NILLN++  A +ADFG+
Sbjct: 119 NKTLTEDE----IATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 332 AKYLQDT 338
           A  L DT
Sbjct: 172 AGQLTDT 178

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  101 bits (254), Expect = 1e-24
 Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 21/183 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
            +G GG   V       +G   A+K+   I      D      E        H NI+RL 
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKR---ILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           A+C  +        L+  +   G+L   +     +G+FL  +  L + +   +GL  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT--GASECMS-----AVAGSYGY 353
             +    HRD+K  NILL  + +  + D G          G+ + ++     A   +  Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 354 IAP 356
            AP
Sbjct: 210 RAP 212

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (254), Expect = 1e-24
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 20/201 (9%)

Query: 167 LTAFQKLDFGSDDILECVKDN----NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGS 221
           + +  KL    +   +   ++      IGRG  G V + V  P+G+ +AVK++   T   
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDE 61

Query: 222 SHDNGLSAEIRTLGK-IRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF 278
                L  ++  + +      IV+   A    +E +  +  E M + S  +         
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDCWICMELM-STSFDKFYKYVYSVL 118

Query: 279 LKW--EMRL-KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
                E  L KI +   K L++L  +    IIHRD+K +NILL+      + DFG++  L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

Query: 336 QDTGASECMSAVAGSYGYIAP 356
            D+ A    +  AG   Y+AP
Sbjct: 177 VDSIA---KTRDAGCRPYMAP 194

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  101 bits (253), Expect = 1e-24
 Identities = 37/173 (21%), Positives = 65/173 (37%), Gaps = 21/173 (12%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKI 237
           +      ++G+G  G V        +     VAVK L      SS       E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 238 RHRNIVRLKAFCSNKETN------LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKI 287
            H ++ +L                +++  +M +G L   L   R       L  +  ++ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 288 AIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
            ++ A G+ YL   +      IHRD+ + N +L  D    VADFGL++ +   
Sbjct: 143 MVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  101 bits (253), Expect = 1e-24
 Identities = 42/178 (23%), Positives = 68/178 (38%), Gaps = 28/178 (15%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSAEIRTLG 235
             +     +G G  G V+     N         VAVK L   ++ +  D     E   L 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLT 98

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR----------- 284
            ++H++IVR    C+     L+V+EYM +G L   L                        
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 285 --LKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
             L +A + A G+ YL   H      +HRD+ + N L+       + DFG+++ +  T
Sbjct: 159 QLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  102 bits (255), Expect = 2e-24
 Identities = 46/176 (26%), Positives = 62/176 (35%), Gaps = 28/176 (15%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLS---AEIR 232
           + +     +G G  G VY G            QVAVK L         +        E  
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL----PEVCSEQDELDFLMEAL 126

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKI 287
            + K  H+NIVR            ++ E M  G L   L   R      S L     L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 288 AIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHV---ADFGLAKYLQDT 338
           A + A G  YL  +H      IHRD+ + N LL       V    DFG+A+ +   
Sbjct: 187 ARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 15/156 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             +G G  G VY+      G   A K +   ++    D     EI  L    H  IV+L 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLL 82

Query: 247 AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHHDC 302
                 +  L ++ E+ P G++  ++        + +    I +   +  + L++LH   
Sbjct: 83  G-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ----IQVVCRQMLEALNFLH--- 134

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           S  IIHRD+K+ N+L+  + +  +ADFG++     T
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  100 bits (250), Expect = 5e-24
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGI 217
           ++      LT  QK+    DD  E +     +G G  GVV++    P+G  +A K +  +
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKIS---ELGAGNGGVVFKVSHKPSGLVMARKLIH-L 68

Query: 218 TKGSSHDNGLSAEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKR 275
               +  N +  E++ L +     IV    AF    +  + +  E+M  GSL +VL  K+
Sbjct: 69  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL--KK 124

Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
              +  ++  K++I   KGL+YL       I+HRDVK +NIL+NS  E  + DFG++  L
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182

Query: 336 QDTGASECMSAVAGSYGYIAP 356
            D+ A    ++  G+  Y++P
Sbjct: 183 IDSMA----NSFVGTRSYMSP 199

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 99.3 bits (248), Expect = 9e-24
 Identities = 46/172 (26%), Positives = 71/172 (41%), Gaps = 15/172 (8%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G+GG    +        E  A K    + K              EI     + H+++V 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKI---VPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
              F  + +   +V E     SL E+   +R +  + E R     +   G  YLH +   
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEAR-YYLRQIVLGCQYLHRNR-- 161

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    + G+  YIAP
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAP 210

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 29/179 (16%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
             ++    +G G  G V               +VAVK L    K ++H +   A   E++
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEKEALMSELK 101

Query: 233 TLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR------------GSFL 279
            +  + +H NIV L   C++    L++ EY   G L   L  K              S  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
                L  + + A+G+++L    S   IHRDV + N+LL +   A + DFGLA+ + + 
Sbjct: 162 STRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 15/172 (8%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G+GG    +        E  A K    + K              EI     + H+++V 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKI---VPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
              F  + +   +V E     SL E+   +R +  + E R     +   G  YLH     
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEAR-YYLRQIVLGCQYLH---RN 134

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +IHRD+K  N+ LN D E  + DFGLA  ++  G  E    + G+  YIAP
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAP 184

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 99.5 bits (248), Expect = 2e-23
 Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 34/204 (16%)

Query: 176 GSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
               +   V    ++G G +G V    +  G  VAVK++L         +    EI+ L 
Sbjct: 9   FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLT 63

Query: 236 KI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK- 293
           +   H N++R     +      +  E   N +L +++  K  +     ++L+        
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESK--NVSDENLKLQKEYNPISL 120

Query: 294 ------GLSYLHHDCSPLIIHRDVKSNNILLNS-------------DFEAHVADFGLAKY 334
                 G+++LH   S  IIHRD+K  NIL+++             +    ++DFGL K 
Sbjct: 121 LRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 335 LQDTGASEC--MSAVAGSYGYIAP 356
           L    +S    ++  +G+ G+ AP
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAP 201

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 13/152 (8%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
           IG+G +G VY  +    G++VA++++    +       +  EI  + + ++ NIV  L +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 248 FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
           +       L +V EY+  GSL +V+       +       +  E  + L +LH   S  +
Sbjct: 86  YL--VGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQV 137

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           IHRD+KS+NILL  D    + DFG    +   
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.4 bits (243), Expect = 5e-23
 Identities = 43/190 (22%), Positives = 71/190 (37%), Gaps = 42/190 (22%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSA---EIR 232
             ++    IG G  G V++   P          VAVK L    K  +  +  +    E  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAA 102

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------- 284
            + +  + NIV+L   C+  +   L++EYM  G L E L       +             
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 285 --------------LKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
                         L IA + A G++YL          +HRD+ + N L+  +    +AD
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIAD 217

Query: 329 FGLAKYLQDT 338
           FGL++ +   
Sbjct: 218 FGLSRNIYSA 227

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.1 bits (242), Expect = 6e-23
 Identities = 52/151 (34%), Positives = 73/151 (48%), Gaps = 15/151 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
             IG G  G VY      N E VA+KK+     + +     +  E+R L K+RH N ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 246 KAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI---EAAKGLSYLHHD 301
           +  C  +E    LV EY   GS  ++L   +    + E    IA     A +GL+YLH  
Sbjct: 120 RG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE----IAAVTHGALQGLAYLH-- 171

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
            S  +IHRDVK+ NILL+      + DFG A
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.7 bits (241), Expect = 7e-23
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 13/152 (8%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKA 247
           IG G  G+V       +G QVAVK +    +       L  E+  +   +H N+V   K+
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 248 FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
           +       L ++ E++  G+L +++   R   L  E    +     + L+YLH   +  +
Sbjct: 111 YL--VGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH---AQGV 162

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDT 338
           IHRD+KS++ILL  D    ++DFG    +   
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.5 bits (241), Expect = 7e-23
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 13/151 (8%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
             +G G  GVVY+     G  VA+K++    +  + D G+ +    EI  L ++ H NIV
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRI----RLDAEDEGIPSTAIREISLLKELHHPNIV 82

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
            L     ++    LV+E+M    L +VL   +      +++     +  +G+++ H    
Sbjct: 83  SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK-IYLYQLLRGVAHCHQHR- 139

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
             I+HRD+K  N+L+NSD    +ADFGLA+ 
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARA 168

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.2 bits (240), Expect = 7e-23
 Identities = 50/184 (27%), Positives = 74/184 (40%), Gaps = 33/184 (17%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
             +     +G G  G V          +     VAVK L    K S+H     A   E++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML----KPSAHLTEREALMSELK 78

Query: 233 TLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------- 284
            L  +  H NIV L   C+     L++ EY   G L   L  KR SF+  +         
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 285 ---------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
                    L  + + AKG+++L    S   IHRD+ + NILL       + DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 336 QDTG 339
           ++  
Sbjct: 196 KNDS 199

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.4 bits (242), Expect = 7e-23
 Identities = 18/202 (8%), Positives = 42/202 (20%), Gaps = 40/202 (19%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
            +  G   VV+        E  A+K      + S  +   L        ++   +    +
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 247 AFC-------------------------SNKETNLLVYEYMPNGSLGEVL-----HGKRG 276
                                            N L+     +  L  +           
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 277 SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
                     +  +  +  + L       ++H     +N+ +  D    + D      + 
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 337 DTGASECMSAVAGSYGYIAPVL 358
             G +           Y     
Sbjct: 246 TRGPASS-----VPVTYAPREF 262

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 95.3 bits (238), Expect = 9e-23
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 14/172 (8%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G+G    VYR      G +VA+K    I K + +  G+      E++   +++H +I+ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKM---IDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           L  +  +     LV E   NG +   L  +   F + E R  +  +   G+ YLH   S 
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH---SH 131

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            I+HRD+  +N+LL  +    +ADFGLA  L+     E    + G+  YI+P
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISP 181

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 40/190 (21%), Positives = 74/190 (38%), Gaps = 42/190 (22%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGE------QVAVKKLLGITKGSSHDNGLSA---EIR 232
           + +     +G G  G V +    + +       VAVK L    K ++  + L     E  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRDLLSEFN 78

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-------- 284
            L ++ H ++++L   CS     LL+ EY   GSL   L   R     +           
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 285 --------------LKIAIEAAKGLSYL--HHDCSPLIIHRDVKSNNILLNSDFEAHVAD 328
                         +  A + ++G+ YL         ++HRD+ + NIL+    +  ++D
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISD 193

Query: 329 FGLAKYLQDT 338
           FGL++ + + 
Sbjct: 194 FGLSRDVYEE 203

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 31/188 (16%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           VIG+G   VV R +    G+Q AVK        +        L  E      ++H +IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
           L    S+     +V+E+M    L    V     G     E        A+         L
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-EA------VASHYMRQILEAL 143

Query: 296 SYLH-HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSY 351
            Y H ++    IIHRDVK + +LL S   +    +  FG+A  L ++G         G+ 
Sbjct: 144 RYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTP 197

Query: 352 GYIAP-VL 358
            ++AP V+
Sbjct: 198 HFMAPEVV 205

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 32/183 (17%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
           + +K    +GRG  G V          T     VAVK L    K  +  +   A   E++
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEHRALMSELK 82

Query: 233 TLGKI-RHRNIVRLKAFCSNKET-NLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------ 284
            L  I  H N+V L   C+      +++ E+   G+L   L  KR  F+ +++       
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 285 --------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ 336
                   +  + + AKG+ +L    S   IHRD+ + NILL+      + DFGLA+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199

Query: 337 DTG 339
              
Sbjct: 200 KDP 202

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 18/190 (9%)

Query: 171 QKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAE 230
           Q+     +D+    ++   +G G  G V++        V   K +  +     +  +  +
Sbjct: 18  QRYQAEINDL----ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73

Query: 231 IRTLGK-IRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRL-K 286
           +  + K      IV+    F     T++ +  E M      ++    +G     E  L K
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFI--TNTDVFIAMELM-GTCAEKLKKRMQGPIP--ERILGK 128

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           + +   K L YL       +IHRDVK +NILL+   +  + DFG++  L D  A      
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDR 183

Query: 347 VAGSYGYIAP 356
            AG   Y+AP
Sbjct: 184 SAGCAAYMAP 193

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 33/184 (17%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLSA---E 230
           + +     +G G  G V                  VAVK L    K  + +  LS    E
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDLSDLVSE 90

Query: 231 IRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-------------- 275
           +  +  I +H+NI+ L   C+      ++ EY   G+L E L  +R              
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
              + ++  +    + A+G+ YL    S   IHRD+ + N+L+  +    +ADFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 336 QDTG 339
            +  
Sbjct: 208 NNID 211

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 21/191 (10%)

Query: 173 LDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEI 231
           ++  +DD LE +     +GRG  GVV +    P+G+ +AVK++   T  S     L  ++
Sbjct: 2   MEVKADD-LEPIM---ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDL 56

Query: 232 RTLGK-IRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHG--KRGSFLKWEMRL- 285
               + +     V    A    +E ++ +  E M + SL +       +G  +  E  L 
Sbjct: 57  DISMRTVDCPFTVTFYGALF--REGDVWICMELM-DTSLDKFYKQVIDKGQTIP-EDILG 112

Query: 286 KIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
           KIA+   K L +LH   S  +IHRDVK +N+L+N+  +  + DFG++ YL D  A     
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KD 167

Query: 346 AVAGSYGYIAP 356
             AG   Y+AP
Sbjct: 168 IDAGCKPYMAP 178

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.1 bits (235), Expect = 3e-22
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
             IG G  GVVY+     GE  A+KK+    +    D G+ +    EI  L +++H NIV
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKI----RLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           +L      K+  +LV+E++    L ++L    G       +    ++   G++Y H    
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDRR- 120

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
             ++HRD+K  N+L+N + E  +ADFGLA+ 
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARA 149

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 94.1 bits (235), Expect = 3e-22
 Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
             IG G  GVVY+      GE VA+KK+    +  +   G+ +    EI  L ++ H NI
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELNHPNI 64

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           V+L      +    LV+E++    L + +     + +   +      +  +GL++ H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
              ++HRD+K  N+L+N++    +ADFGLA+ 
Sbjct: 124 ---VLHRDLKPQNLLINTEGAIKLADFGLARA 152

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 95.5 bits (237), Expect = 4e-22
 Identities = 25/201 (12%), Positives = 55/201 (27%), Gaps = 37/201 (18%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-------- 238
           V+G+              GE   V       +  S+    +  E+  L  +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 239 -----------------HRNIVRLKAFCSNKE-TNLLVYEYMPNGSLGEVL-----HGKR 275
                             + ++R++    +    +          +L         H   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
              L    RL++ ++  + L+ LHH     ++H  ++  +I+L+      +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 336 QDTGASECMSAVAGSYGYIAP 356
             +  S             A 
Sbjct: 262 GASAVSPIGRGF-APPETTAE 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 33/184 (17%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLSA---E 230
           + +     +G G  G V                  VAVK L    K  + +  LS    E
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDLSDLVSE 136

Query: 231 IRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR-------------- 275
           +  +  I +H+NI+ L   C+      ++ EY   G+L E L  +R              
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
              + ++  +    + A+G+ YL    S   IHRD+ + N+L+  +    +ADFGLA+ +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 336 QDTG 339
            +  
Sbjct: 254 NNID 257

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 37/204 (18%)

Query: 166 KLTAFQKLDFGSDDILE----CVKDNNVIGRGGAGVVYRGV--------TPNGEQVAVKK 213
            L    + +   D   E     +     +G G  G V                 +VAVK 
Sbjct: 49  MLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 108

Query: 214 LLGITKGSSHDNGLSA---EIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGE 269
           L    K  + +  LS    E+  +  I +H+NI+ L   C+      ++ EY   G+L E
Sbjct: 109 L----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164

Query: 270 VLHGKRGSFLKWEMR--------------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNN 315
            L  +R   L++                 +  A + A+G+ YL    S   IHRD+ + N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221

Query: 316 ILLNSDFEAHVADFGLAKYLQDTG 339
           +L+  D    +ADFGLA+ +    
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHID 245

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.4 bits (233), Expect = 6e-22
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 14/152 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
             IG G  G V++       E VA+K++    +    D G+ +    EI  L +++H+NI
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           VRL     + +   LV+E+     L +      G      ++     +  KGL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGFCHSRN 121

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
              ++HRD+K  N+L+N + E  +A+FGLA+ 
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARA 150

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 36/190 (18%), Positives = 77/190 (40%), Gaps = 30/190 (15%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKL----LGITKGSSHDNGLSA-----------EIRT 233
            + +G    +      + +  A+KK     L   +  +  N               E++ 
Sbjct: 38  TLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 234 LGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSL-------GEVLHGKRGSFLKWEMRLK 286
           +  I++   +  +   +N +   ++YEYM N S+         +            ++  
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-C 155

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           I        SY+H++ +  I HRDVK +NIL++ +    ++DFG ++Y+ D    + +  
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKG 209

Query: 347 VAGSYGYIAP 356
             G+Y ++ P
Sbjct: 210 SRGTYEFMPP 219

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 93.5 bits (233), Expect = 7e-22
 Identities = 43/170 (25%), Positives = 64/170 (37%), Gaps = 10/170 (5%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
            +G G  G V++     +G   AVK+ +   +G        AE+ +  K+ +H   VRL+
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
                     L  E     SL +      G+ L          +    L++LH   S  +
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLH---SQGL 178

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +H DVK  NI L       + DFGL   L   G         G   Y+AP
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAP 225

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 93.0 bits (232), Expect = 7e-22
 Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 19/178 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVR 244
            +G+G   VV R V    G + A K    I      +     L  E R   K++H NIVR
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKI---INTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           L      +  + LV++ +  G L E +   R  + + +       +  + ++Y H   S 
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADAS-HCIQQILESIAYCH---SN 124

Query: 305 LIIHRDVKSNNILLNSDFE-AHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
            I+HR++K  N+LL S  + A V  ADFGLA  + D   SE     AG+ GY++P VL
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVL 179

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 94.3 bits (234), Expect = 9e-22
 Identities = 26/190 (13%), Positives = 63/190 (33%), Gaps = 27/190 (14%)

Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHR 240
           +++G G    VY           N ++  +K        +  +    +  +  L      
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV---QKPANPWEFYIGTQLMERLKPSMQH 127

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKR---GSFLKWEMRLKIAIEAAKGLSY 297
             ++  +    +  ++LV E    G+L   ++  +      +   + +  A+     +  
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAH-----------VADFGLAKYLQDTGASECMSA 346
           +H      IIH D+K +N +L + F              + D G +  ++        +A
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 347 VAGSYGYIAP 356
              + G+   
Sbjct: 245 KCETSGFQCV 254

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 14/173 (8%)

Query: 189 VIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
           ++GRGG G VY          VA+K +   ++  S D         E RT G+++  ++V
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLM---SETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
            +  F        +    +    L  +L  ++G  L     + I  +    L   H    
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGP-LAPPRAVAIVRQIGSALDAAHAAG- 154

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               HRDVK  NIL+++D  A++ DFG+A    D   ++ +    G+  Y+AP
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAP 204

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 14/153 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
            ++G G  G+V +      G  VA+KK       S  D  +      EI+ L ++RH N+
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           V L   C  K+   LV+E++ + ++ + L           ++ K   +   G+ + H   
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCHSHN 144

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
              IIHRD+K  NIL++      + DFG A+ L
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 48/189 (25%), Positives = 74/189 (39%), Gaps = 38/189 (20%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSA---EIR 232
           E ++   V+G G  G V          T    QVAVK L    K  +  +   A   E++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML----KEKADSSEREALMSELK 100

Query: 233 TLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------- 284
            + ++  H NIV L   C+      L++EY   G L   L  KR  F + E+        
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 285 --------------LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG 330
                         L  A + AKG+ +L        +HRD+ + N+L+       + DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 217

Query: 331 LAKYLQDTG 339
           LA+ +    
Sbjct: 218 LARDIMSDS 226

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 18/180 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHD--NGLSAEIRTLGKI-RH 239
           ++GRG + VV R +  P  ++ AVK          +     +       E+  L K+  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
            NI++LK          LV++ M  G L + L  ++ +  + E R KI     + +  LH
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETR-KIMRALLEVICALH 141

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
                 I+HRD+K  NILL+ D    + DFG +  L      E +  V G+  Y+AP ++
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEII 195

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 15/173 (8%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
             +G+G  G VY      +   +A+K L    + K       L  E+     +RH NI+R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           L  +  +     L+ EY P G++   L  K   F +         E A  LSY H   S 
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTA-TYITELANALSYCH---SK 128

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-CMSAVAGSYGYIAP 356
            +IHRD+K  N+LL S  E  +ADFG + +   +  ++ C     G+  Y+ P
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPP 176

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 29/183 (15%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
            +G+G   VV R V    G + A K +    K S+ D   L  E R   K++H NIVRL 
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
                +  + LV++ +  G L E +   R  +   E       +A+         ++Y H
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIV-AREFYS--EA------DASHCIQQILESIAYCH 145

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              S  I+HR++K  N+LL S  +     +ADFGLA  + D   SE     AG+ GY++P
Sbjct: 146 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSP 199

Query: 357 -VL 358
            VL
Sbjct: 200 EVL 202

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 14/176 (7%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN-GLSAEIRTLGKIRHRNIVRLK 246
            +G+G   VV R V    G++ A   +    K S+ D+  L  E R    ++H NIVRL 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIIN-TKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
              S +  + L+++ +  G L E +   R  + + +       +  + + + H      +
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIV-AREYYSEADAS-HCIQQILEAVLHCH---QMGV 131

Query: 307 IHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
           +HR++K  N+LL S  +     +ADFGLA  ++     +     AG+ GY++P VL
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVL 185

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 14/150 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
             IG G  GVV++      G+ VA+KK       S  D  +      EIR L +++H N+
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           V L      K    LV+EY  + ++   L   +    +  ++  I  +  + +++ H   
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFCHKHN 122

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
               IHRDVK  NIL+       + DFG A
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFA 149

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 19/178 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITK---GSSHDNGLSAEIRTLGKIRHRNIVR 244
           ++G+G  G V +       ++ AVK    I K    +   + +  E+  L K+ H NI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKV---INKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           L     +  +  +V E    G L + +  KR  F + +   +I  +   G++Y+H     
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAA-RIIKQVFSGITYMH---KH 140

Query: 305 LIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
            I+HRD+K  NILL S  +     + DFGL+   Q       M    G+  YIAP VL
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVL 195

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 20/213 (9%)

Query: 156 RKFRKNSNSWKLTAFQKLDFGSDDILECVKDN--------NVIGRGGAGVVYRGV-TPNG 206
                +S    L     L       +   K +          +G G  G V         
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62

Query: 207 EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGS 266
            + A+K +   +  +S ++ L  E+  L  + H NI++L  F  +K    LV E    G 
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 267 LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFE 323
           L + +   R  F + +    I  +   G++YLH      I+HRD+K  N+LL S   D  
Sbjct: 123 LFDEII-HRMKFNEVDAA-VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177

Query: 324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             + DFGL+   ++    + M    G+  YIAP
Sbjct: 178 IKIVDFGLSAVFEN---QKKMKERLGTAYYIAP 207

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 42/175 (24%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
           +   + G+G  G V  G     G  VA+KK++         +          ++ L  + 
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--------QDPRFRNRELQIMQDLAVLH 77

Query: 239 HRNIVRLK-AFCSNKETNL------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEA 291
           H NIV+L+  F +  E +       +V EY+P     + LH       +   R ++A   
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLH----RCCRNYYRRQVAPPP 128

Query: 292 A----------KGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYL 335
                      + +  LH   S  + HRD+K +N+L+N +D    + DFG AK L
Sbjct: 129 ILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 46/216 (21%), Positives = 73/216 (33%), Gaps = 53/216 (24%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            IG+G  GVV   +        A+K     K+  I         +  E+R + K+ H NI
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER--IKTEVRLMKKLHHPNI 90

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI------------- 289
            RL     +++   LV E    G L + L+              +               
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 290 ------------------EAAK-------GLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
                               +         L YLH   +  I HRD+K  N L +++   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207

Query: 325 HV--ADFGLAKYLQ--DTGASECMSAVAGSYGYIAP 356
            +   DFGL+K     + G    M+  AG+  ++AP
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.4 bits (225), Expect = 7e-21
 Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 14/172 (8%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G GG   VY    T    +VA+K +                   E+    ++ H+NIV 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           +       +   LV EY+   +L E +    G  L  +  +    +   G+ + H     
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP-LSVDTAINFTNQILDGIKHAHDMR-- 131

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            I+HRD+K  NIL++S+    + DFG+AK L +T  ++  + V G+  Y +P
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSP 181

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 92.1 bits (229), Expect = 8e-21
 Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 20/181 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDN-GLSAEIRTLGKIRHRN 241
            +G G  G V         ++VA++     K    +   +     +  EI  L K+ H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           I+++K F   ++  + V E M  G L + +        +   +     +    + YLH  
Sbjct: 202 IIKIKNFFDAEDYYI-VLELMEGGELFDKV-VGNKRLKEATCK-LYFYQMLLAVQYLH-- 256

Query: 302 CSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP-V 357
               IIHRD+K  N+LL+S  E     + DFG +K L +T     M  + G+  Y+AP V
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEV 312

Query: 358 L 358
           L
Sbjct: 313 L 313

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 17/179 (9%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK----KLLGITKGSSHD--NGLSAEIRTLGKIR-HR 240
           VIGRG + VV R V    G + AVK        ++     +       E   L ++  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           +I+ L     +     LV++ M  G L + L  ++ +  + E R  I     + +S+LH 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLT-EKVALSEKETR-SIMRSLLEAVSFLH- 217

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
             +  I+HRD+K  NILL+ + +  ++DFG + +L+     E +  + G+ GY+AP +L
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEIL 271

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 11/152 (7%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNI 242
           + +G G    VY+       + VA+KK+  +   S   +G+  +A  EI+ L ++ H NI
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNI 74

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           + L     +K    LV+++M    L  ++           ++    +   +GL YLH   
Sbjct: 75  IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK-AYMLMTLQGLEYLHQHW 132

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
              I+HRD+K NN+LL+ +    +ADFGLAK 
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 18/176 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
           V+G G    V+       G+  A+K    I K  +   + L  EI  L KI+H NIV L+
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKC---IKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               +     LV + +  G L + +  +RG + + +    +  +    + YLH      I
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRIL-ERGVYTEKDAS-LVIQQVLSAVKYLH---ENGI 127

Query: 307 IHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
           +HRD+K  N+L  +  E     + DFGL+K  Q+      MS   G+ GY+AP VL
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVL 179

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 17/176 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
            V+G+G  G V        G++ AVK   K     K       L  E++ L ++ H NI+
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--LLREVQLLKQLDHPNIM 89

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           +L  F  +K    LV E    G L + +   R  F + +   +I  +   G++Y+H +  
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAA-RIIRQVLSGITYMHKNK- 146

Query: 304 PLIIHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             I+HRD+K  N+LL S   D    + DFGL+ + +    S+ M    G+  YIAP
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAP 197

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 53/174 (30%), Positives = 76/174 (43%), Gaps = 46/174 (26%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
            D  VIG G  GVVY+     +GE VA+KK+L                   E++ + K+ 
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----------QDKRFKNRELQIMRKLD 105

Query: 239 HRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
           H NIVRL+  F S+ E        LV +Y+P     E ++       +   R K  +   
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVY----RVARHYSRAKQTLPVI 156

Query: 293 ----------KGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYL 335
                     + L+Y+H   S  I HRD+K  N+LL+ D     + DFG AK L
Sbjct: 157 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 20/157 (12%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGL--SA--EIRTLGKIRHRN 241
             +G G    VY+G+    G  VA+K++ L        + G   +A  EI  + +++H N
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREISLMKELKHEN 64

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL----KIAIEAAKGLSY 297
           IVRL      +    LV+E+M N  L + +  +        + L        +  +GL++
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
            H +    I+HRD+K  N+L+N   +  + DFGLA+ 
Sbjct: 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 16/159 (10%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSA--EI---RTLGKIRHR 240
             IG G  G VY+     +G  VA+K + +    G      +S   E+   R L    H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 241 NIVRLKAFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
           N+VRL   C+   T+      LV+E++    L   L       L  E    +  +  +GL
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
            +LH +C   I+HRD+K  NIL+ S     +ADFGLA+ 
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 20/178 (11%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGS-SHDNGLSA----EIRTLGKIRHRNIV 243
           +G GG   V+      +   VAVK L    +   + D         E +    + H  IV
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVL----RADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 244 RL----KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
            +    +A         +V EY+   +L +++H   G  +  +  +++  +A + L++ H
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGP-MTPKRAIEVIADACQALNFSH 133

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM-SAVAGSYGYIAP 356
            +    IIHRDVK  NI++++     V DFG+A+ + D+G S    +AV G+  Y++P
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 22/214 (10%)

Query: 151 AIIKTRKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQV 209
             + +       + WK    Q ++   D +L+    +  +G G  GVV+R      G   
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185

Query: 210 AVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLG 268
           A K    +      D   +  EI+T+  +RH  +V L     +    +++YE+M  G L 
Sbjct: 186 AAKF---VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242

Query: 269 EVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDCSPLIIHRDVKSNNILLNSDFEA 324
           E +  +       E     A+E  +    GL ++H       +H D+K  NI+  +    
Sbjct: 243 EKVADEHNKMS--E---DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSN 294

Query: 325 HV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            +   DFGL  +L      + +    G+  + AP
Sbjct: 295 ELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAP 325

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 88.4 bits (220), Expect = 3e-20
 Identities = 48/176 (27%), Positives = 71/176 (40%), Gaps = 17/176 (9%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNIVRLK 246
            IGRG  G V   V      + A KK   I K    D +    EI  +  + H NI+RL 
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               +     LV E    G L E +   +  F + +   +I  +    ++Y H      +
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAA-RIMKDVLSAVAYCH---KLNV 127

Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
            HRD+K  N L  +   D    + DFGLA   +     + M    G+  Y++P VL
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVL 180

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 20/157 (12%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNI 242
             +G G  G VY+ + T   E VA+K++    +    + G+      E+  L +++HRNI
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           + LK+   +     L++EY  N  L + +  K        ++     +   G+++ H   
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYMD-KNPDVSMRVIK-SFLYQLINGVNFCH--- 149

Query: 303 SPLIIHRDVKSNNILLNSDFEAH-----VADFGLAKY 334
           S   +HRD+K  N+LL+    +      + DFGLA+ 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 51/224 (22%), Positives = 82/224 (36%), Gaps = 32/224 (14%)

Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDN--------NVIGRGGAGVVYRGV-TPNGEQV 209
             +S+  +   FQ +       +   +            +G G  G V          + 
Sbjct: 5   HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64

Query: 210 AVK-----KLLGITKGSSHDNG------LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV 258
           A+K     +         + N       +  EI  L  + H NI++L     +K+   LV
Sbjct: 65  AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124

Query: 259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL 318
            E+   G L E +   R  F + +    I  +   G+ YLH      I+HRD+K  NILL
Sbjct: 125 TEFYEGGELFEQII-NRHKFDECDAA-NIMKQILSGICYLHKHN---IVHRDIKPENILL 179

Query: 319 NS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
            +        + DFGL+ +         +    G+  YIAP VL
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVL 220

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 24/183 (13%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNG-LSAEIRTLGKIRHRN 241
            +G G  G V         ++VA+K     K    +   +     +  EI  L K+ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           I+++K F   ++  + V E M  G L +  V         +   +     +    + YLH
Sbjct: 77  IIKIKNFFDAEDYYI-VLELMEGGELFDKVV---GNKRLKEATCK-LYFYQMLLAVQYLH 131

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                 IIHRD+K  N+LL+S  E     + DFG +K L +T     M  + G+  Y+AP
Sbjct: 132 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAP 185

Query: 357 -VL 358
            VL
Sbjct: 186 EVL 188

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 18/176 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLK 246
            +G G   +  + V   + +  AVK    I+K    +     EI  L     H NIV+L 
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEAN--TQKEITALKLCEGHPNIVKLH 72

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               ++    LV E +  G L E +  K+  F + E    I  +    +S++H      +
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIK-KKKHFSETEAS-YIMRKLVSAVSHMH---DVGV 127

Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
           +HRD+K  N+L      + E  + DFG A+        + +     +  Y AP +L
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELL 181

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 49/176 (27%), Positives = 83/176 (47%), Gaps = 13/176 (7%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
            ++G+G  G V +       ++ AVK +   +  +   + +  E+  L K+ H NI++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               +  +  +V E    G L + +  KR  F + +   +I  +   G++Y+H      I
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAA-RIIKQVFSGITYMHKHN---I 142

Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
           +HRD+K  NILL S   D +  + DFGL+   Q    +  M    G+  YIAP VL
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVL 195

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 43/158 (27%), Positives = 62/158 (39%), Gaps = 19/158 (12%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH----DNGLSA-----EIRTLGKIRH 239
            I  G  G V  GV   G  VA+K++              +         EIR L    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 240 RNIVRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
            NI+ L+  F   +E  +    LV E M    L +V+H +R       ++         G
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY-FMYHILLG 146

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           L  LH      ++HRD+   NILL  + +  + DF LA
Sbjct: 147 LHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLA 181

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 87.7 bits (218), Expect = 9e-20
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 20/182 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-HRNIVRL 245
           V+G G    V   +     ++ AVK    I K   H  + +  E+  L + + HRN++ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKI---IEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
             F   ++   LV+E M  GS+   +H KR  F + E    +  + A  L +LH   +  
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEAS-VVVQDVASALDFLH---NKG 131

Query: 306 IIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTG-----ASECMSAVAGSYGYIAP- 356
           I HRD+K  NIL     +     + DF L   ++  G     ++  +    GS  Y+AP 
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 357 VL 358
           V+
Sbjct: 192 VV 193

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 15/152 (9%)

Query: 188 NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNI 242
           + +G G    VY+G +      VA+K++        H+ G   +A  E+  L  ++H NI
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIR-----LEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           V L      +++  LV+EY+    L + L           ++     +  +GL+Y H   
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-LFLFQLLRGLAYCHRQK 120

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
              ++HRD+K  N+L+N   E  +ADFGLA+ 
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARA 149

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 22/161 (13%)

Query: 188 NVIGRGGAGVVYRG--VTPNGEQVAVKKLLGITKGSSHDNGL--SA--EI---RTLGKIR 238
             IG G  G V++   +   G  VA+K++    +  + + G+  S   E+   R L    
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 239 HRNIVRLK----AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
           H N+VRL        +++ET L LV+E++    L   L       +  E    +  +  +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY 334
           GL +LH      ++HRD+K  NIL+ S  +  +ADFGLA+ 
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 20/178 (11%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK-IRHRNIVRL 245
             IG G   V  R +      + AVK    I K S  D   + EI  L +  +H NI+ L
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKI---IDK-SKRDP--TEEIEILLRYGQHPNIITL 81

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           K    + +   +V E M  G L + +  ++  F + E    +     K + YLH   +  
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREAS-AVLFTITKTVEYLH---AQG 136

Query: 306 IIHRDVKSNNILLNSDFEAH----VADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
           ++HRD+K +NIL   +        + DFG AK L+       +     +  ++AP VL
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVL 192

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 27/201 (13%), Positives = 57/201 (28%), Gaps = 42/201 (20%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-------- 238
           V+G+              GE   V       +  S+    +  E+  L  +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 239 -----------------HRNIVRLKA-FCSNKETNLLVYEYMPNGSLGEVL-----HGKR 275
                             + ++R++         +          +L         H   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL 335
              L    RL++ ++  + L+ LHH     ++H  ++  +I+L+      +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 336 QDTGASECMSAVAGSYGYIAP 356
                S      + S G+  P
Sbjct: 257 GARVVS------SVSRGFEPP 271

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 20/180 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDN--GLSAEIRTLGKIRHRNIVRL 245
            +G G  G V+      +G +  +K    I K  S      + AEI  L  + H NI+++
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85

Query: 246 KAFCSNKETNLLVYEYMPNGSLGE---VLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                +     +V E    G L E       +  +  +  +  ++  +    L+Y H   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFH--- 141

Query: 303 SPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
           S  ++H+D+K  NIL           + DFGLA+  +     E  +  AG+  Y+AP V 
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPEVF 198

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 15/172 (8%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
            +G+G  G VY      N   +A+K L    + K       L  EI     +RH NI+R+
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
             +  +++   L+ E+ P G L + L  K G F +      +  E A  L Y H      
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFME-ELADALHYCH---ERK 134

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-ECMSAVAGSYGYIAP 356
           +IHRD+K  N+L+    E  +ADFG + +         C     G+  Y+ P
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPP 181

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 38/192 (19%), Positives = 75/192 (39%), Gaps = 34/192 (17%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
            IG G  G V++ V   +G   A+K+      GS  +     E+     + +H ++VR  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 247 AFCSNKETNLLVY-EYMPNGSLGEVL--HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           +    ++ ++L+  EY   GSL + +  + +  S+ K      + ++  +GL Y+H   S
Sbjct: 78  S-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133

Query: 304 PLIIHRDVKSNNILLNSDFEAHV-------------------ADFGLAKYLQDTGASECM 344
             ++H D+K +NI ++     +                     D G    +      E  
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191

Query: 345 SAVAGSYGYIAP 356
               G   ++A 
Sbjct: 192 ----GDSRFLAN 199

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 42/189 (22%), Positives = 69/189 (36%), Gaps = 25/189 (13%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIR-HRNIVRL 245
           V+  GG   VY      +G + A+K+   +          +  E+  + K+  H NIV+ 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKR---LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 246 KAFCS-------NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR-LKIAIEAAKGLSY 297
            +  S         +   L+   +  G L E L              LKI  +  + + +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL----------QDTGASECMSAV 347
           +H    P IIHRD+K  N+LL++     + DFG A  +          Q     E     
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 348 AGSYGYIAP 356
             +  Y  P
Sbjct: 211 NTTPMYRTP 219

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 85.3 bits (212), Expect = 4e-19
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 28/185 (15%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            +G G   +V +      G++ A K     +L    +G S +  +  E+  L +IRH NI
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-IEREVNILREIRHPNI 70

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
           + L     NK   +L+ E +  G L + L  ++ S    E     A +  K    G+ YL
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLA-EKESLT--E---DEATQFLKQILDGVHYL 124

Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
           H   S  I H D+K  NI+L + +       + DFG+A  ++          + G+  ++
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPEFV 178

Query: 355 AP-VL 358
           AP ++
Sbjct: 179 APEIV 183

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 39/178 (21%), Positives = 73/178 (41%), Gaps = 22/178 (12%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +GRG  G+V+R V T + +    K    +    +    +  EI  L   RHRNI+ L  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKF---VKVKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDCS 303
              + E  ++++E++    + E ++         E   +  +         L +LH   S
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELN--E---REIVSYVHQVCEALQFLH---S 120

Query: 304 PLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
             I H D++  NI+  +   + +   +FG A+ L+     +    +  +  Y AP V 
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVH 175

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 84.6 bits (210), Expect = 6e-19
 Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 25/177 (14%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           +G G  G V   V     E VAVK ++ + +       +  EI     + H N+V+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
                   L  EY   G L +                 +    +A +       G+ YLH
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP-DAQRFFHQLMAGVVYLH 122

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                 I HRD+K  N+LL+      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.5 bits (212), Expect = 7e-19
 Identities = 43/185 (23%), Positives = 79/185 (42%), Gaps = 28/185 (15%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            +G G   +V +      G + A K     +     +G   +  +  E+  L ++ H NI
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-IEREVSILRQVLHPNI 77

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
           + L     N+   +L+ E +  G L + L  ++ S    E   + A    K    G++YL
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLS--E---EEATSFIKQILDGVNYL 131

Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
           H   +  I H D+K  NI+L + +       + DFGLA  ++D         + G+  ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFV 185

Query: 355 AP-VL 358
           AP ++
Sbjct: 186 APEIV 190

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.0 bits (211), Expect = 8e-19
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 13/170 (7%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IG+G    V        G +VA+K +       +    L  E+R +  + H NIV+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
              ++T  L+ EY   G + +  V HG+    +K +       +    + Y H      I
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQKR---I 135

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRD+K+ N+LL++D    +ADFG +           + A  G+  Y AP
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGAPPYAAP 182

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 27/182 (14%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            +G G   +V +      G + A K     +     +G S +  +  E+  L ++ H N+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-IEREVSILRQVLHHNV 77

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
           + L     N+   +L+ E +  G L + L  ++ S    E   + A    K    G++YL
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLS--E---EEATSFIKQILDGVNYL 131

Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
           H   +  I H D+K  NI+L + +       + DFGLA  ++D         + G+  ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFV 185

Query: 355 AP 356
           AP
Sbjct: 186 AP 187

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 31/182 (17%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +GRG   +VYR       +  A+K    + K +     +  EI  L ++ H NI++LK 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKV---LKK-TVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLHH 300
                    LV E +  G L + +  ++G +   E       +AA         ++YLH 
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIV-EKGYYS--ER------DAADAVKQILEAVAYLH- 165

Query: 301 DCSPLIIHRDVKSNNILLNS-DFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP- 356
                I+HRD+K  N+L  +   +A +  ADFGL+K ++       M  V G+ GY AP 
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPE 220

Query: 357 VL 358
           +L
Sbjct: 221 IL 222

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 44/209 (21%), Positives = 76/209 (36%), Gaps = 28/209 (13%)

Query: 159 RKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGI 217
           +   + WK    Q ++     + +       +G G  GVV+R V    G     K    I
Sbjct: 28  KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF---I 84

Query: 218 TKGSSHD-NGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRG 276
                 D   +  EI  + ++ H  ++ L     +K   +L+ E++  G L + +  +  
Sbjct: 85  NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144

Query: 277 SFLKWEMRLKIAIEAAK-------GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--A 327
                E       E          GL ++H      I+H D+K  NI+  +   + V   
Sbjct: 145 KMS--EA------EVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193

Query: 328 DFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           DFGLA  L      E +     +  + AP
Sbjct: 194 DFGLATKLNP---DEIVKVTTATAEFAAP 219

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 45/173 (26%)

Query: 185 KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRH 239
            +  VIG G  GVV++      ++VA+KK+L                   E++ +  ++H
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-----------QDKRFKNRELQIMRIVKH 91

Query: 240 RNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA- 292
            N+V LK  F SN +        LV EY+P     E ++       +   +LK  +    
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVY----RASRHYAKLKQTMPMLL 142

Query: 293 ---------KGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYL 335
                    + L+Y+H   S  I HRD+K  N+LL+       + DFG AK L
Sbjct: 143 IKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 24/179 (13%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNG-LSAEIRTLGKIRHRNI 242
           +G G  G V+  V     ++V VK     K+L          G ++ EI  L ++ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGE-----VLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           +++     N+    LV E   +G   +       H +    L   +   I  +    + Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPR----LDEPLASYIFRQLVSAVGY 145

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           L       IIHRD+K  NI++  DF   + DFG A YL+     +      G+  Y AP
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFYTFCGTIEYCAP 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 22/158 (13%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGL--SA--EIRTLGKIRHRNI 242
             IG+G  G V++      G++VA+KK+       +   G   +A  EI+ L  ++H N+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENV 78

Query: 243 VRLKAFCSNKETNL--------LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKG 294
           V L   C  K +          LV+++  +  L  +L      F   E++ ++      G
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNG 136

Query: 295 LSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           L Y+H +    I+HRD+K+ N+L+  D    +ADFGLA
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 25/177 (14%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           +G G  G V   V     E VAVK ++ + +       +  EI     + H N+V+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
                   L  EY   G L +                 +    +A +       G+ YLH
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP-DAQRFFHQLMAGVVYLH 122

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                 I HRD+K  N+LL+      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 21/157 (13%), Positives = 45/157 (28%), Gaps = 18/157 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIV 243
             G       ++ + T    QVA+  +          + +          L +I    + 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDP---QGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           R+      +   L+V E++  GSL EV              ++     A      H    
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG- 149

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340
             +       + + ++ D +  +A       + D   
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPA---TMPDANP 181

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 43/180 (23%), Positives = 75/180 (41%), Gaps = 20/180 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR-NIVRLK 246
            +GRG   VV + +    G++ A K L    +G      +  EI  L   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYLHHDC 302
               N    +L+ EY   G +  +   +    +  E      I   K    G+ YLH   
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVS-E---NDVIRLIKQILEGVYYLH--- 148

Query: 303 SPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYIAP-VL 358
              I+H D+K  NILL+S +      + DFG+++ +     +  +  + G+  Y+AP +L
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEIL 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 28/185 (15%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            +G G   VV +      G Q A K     +     +G S ++ +  E+  L +I+H N+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQHPNV 76

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSYL 298
           + L     NK   +L+ E +  G L + L  ++ S    E   + A E  K    G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLA-EKESLT--E---EEATEFLKQILNGVYYL 130

Query: 299 HHDCSPLIIHRDVKSNNILL-NSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYGYI 354
           H   S  I H D+K  NI+L + +       + DFGLA  +           + G+  ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFV 184

Query: 355 AP-VL 358
           AP ++
Sbjct: 185 APEIV 189

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 33/170 (19%)

Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
            +L+  ++   IG G  G+V           VA+KKL          N   A     E+ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-----FQNQTHAKRAYRELV 76

Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGK----RGSFLKWE 282
            +  + H+NI+ L   F   K         +V E M   +L +V+  +    R S+L ++
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135

Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           M          G+ +LH   S  IIHRD+K +NI++ SD    + DFGLA
Sbjct: 136 M--------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 42/201 (20%)

Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
           ++ +       +G G  G V   +   +GE+VA+KKL          + + A     E+ 
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-----FQSEIFAKRAYRELL 75

Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGK----RGSFLKWE 282
            L  ++H N++ L   F             LV  +M    L +++  K    +  +L ++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQ 134

Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           M         KGL Y+H   S  ++HRD+K  N+ +N D E  + DFGLA+      A  
Sbjct: 135 M--------LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADA 178

Query: 343 CMSA-VAGSYGYIAP--VLGW 360
            M+  V   + Y AP  +L W
Sbjct: 179 EMTGYVVTRW-YRAPEVILSW 198

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 29/183 (15%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           ++G G  G V   + +    + AVK L    + +  + +  +  EI+ L ++RH+N+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 246 KAFCSNKETN--LLVYEYMPNGS---LGEVLHGKRGSFLKWEMRLKIAIEAAK------- 293
                N+E     +V EY   G    L  V             R  +  +A         
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------RFPVC-QAHGYFCQLID 120

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
           GL YLH   S  I+H+D+K  N+LL +     ++  G+A+ L    A +      GS  +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 354 IAP 356
             P
Sbjct: 178 QPP 180

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 38/176 (21%), Positives = 74/176 (42%), Gaps = 38/176 (21%)

Query: 185 KDNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKI 237
            +   +GRG  G VY+       + +  A+K++           G+S     EI  L ++
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLREL 75

Query: 238 RHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA--- 292
           +H N++ L+  F S+ +  + L+++Y  +  L  ++   R S      +  + +      
Sbjct: 76  KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK---ANKKPVQLPRGMVK 131

Query: 293 -------KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH----VADFGLAKYLQD 337
                   G+ YLH +    ++HRD+K  NIL+  +        +AD G A+    
Sbjct: 132 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 54/181 (29%), Positives = 67/181 (37%), Gaps = 36/181 (19%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
           IG G  GV          E VAVK    I +G++ D  +  EI     +RH NIVR K  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKY---IERGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 249 CSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GLSYLH 299
                   ++ EY   G L E     G          R     EA         G+SY H
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAG----------RFSED-EARFFFQQLLSGVSYCH 133

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAH--VADFGLAKYLQDTGA--SECMSAVAGSYGYIA 355
              S  I HRD+K  N LL+        + DFG +K         S       G+  YIA
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIA 185

Query: 356 P 356
           P
Sbjct: 186 P 186

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 23/184 (12%)

Query: 184 VKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRN 241
           V    ++G G  G V++   T  G ++A K    I      D   +  EI  + ++ H N
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKI---IKTRGMKDKEEVKNEISVMNQLDHAN 147

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK----GLSY 297
           +++L     +K   +LV EY+  G L + +  +  +  + +      I   K    G+ +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD-----TILFMKQICEGIRH 202

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIA 355
           +H      I+H D+K  NIL  +     +   DFGLA+  +     E +    G+  ++A
Sbjct: 203 MH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLA 256

Query: 356 P-VL 358
           P V+
Sbjct: 257 PEVV 260

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 24/171 (14%)

Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
           ++    +D   +G G  G V   V    G +VA+KKL          + L A     E+R
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-----FQSELFAKRAYRELR 76

Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
            L  +RH N++ L   F  ++  +      LV  +M    LG+++  ++   L  +    
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---LGEDRIQF 132

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
           +  +  KGL Y+H   +  IIHRD+K  N+ +N D E  + DFGLA+    
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 29/188 (15%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRN 241
           + IG G  G+V       N  +VA+KK+      S  ++         EI+ L + RH N
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIKILLRFRHEN 86

Query: 242 IVRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           I+ +     +     +    +V + M    L ++L  +    L  +       +  +GL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH---LSNDHICYFLYQILRGLK 142

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK-YLQDTGASECMSA-VAGSYGYI 354
           Y+H   S  ++HRD+K +N+LLN+  +  + DFGLA+    D   +  ++  VA  + Y 
Sbjct: 143 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW-YR 198

Query: 355 AP--VLGW 360
           AP  +L  
Sbjct: 199 APEIMLNS 206

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 22/155 (14%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
           +IG G  G V           VA+KK+L +      ++ +       EI  L ++ H ++
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-----EDLIDCKRILREIAILNRLNHDHV 114

Query: 243 VRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           V++                +V E   +    ++   +   +L       +      G+ Y
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTELHIKTLLYNLLVGVKY 171

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           +H   S  I+HRD+K  N L+N D    V DFGLA
Sbjct: 172 VH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 38/183 (20%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G G  G V  G     G +VAVK    + +       +      EI+ L   RH +I++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKI---LNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
           L    S      +V EY+  G L +    HG          R++   EA +        +
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEM-EARRLFQQILSAV 124

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGY 353
            Y H     +++HRD+K  N+LL++   A +ADFGL+  + D     + C     GS  Y
Sbjct: 125 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNY 176

Query: 354 IAP 356
            AP
Sbjct: 177 AAP 179

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 36/185 (19%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
           ++G G  GVV      P GE VA+KK+         D  L A     EI+ L   +H NI
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKI------EPFDKPLFALRTLREIKILKHFKHENI 71

Query: 243 VRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGS-----FLKWEMRLKIAIEAA 292
           + +      +   N     ++ E M    L  V+  +  S     +  ++          
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT--------L 122

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY- 351
           + +  LH      +IHRD+K +N+L+NS+ +  V DFGLA+ + ++ A         S  
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 352 -GYIA 355
             ++A
Sbjct: 180 VEFVA 184

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 38/181 (20%), Positives = 75/181 (41%), Gaps = 26/181 (14%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHR--N 241
           ++G GG G VY G+   +   VA+K +    +       +   +  E+  L K+      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGE-----VLHGKRGSFLKWEMRLKIAIEAAKGLS 296
           ++RL  +    ++ +L+ E        +        G     L+ E+      +  + + 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGA----LQEELARSFFWQVLEAVR 163

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
           + H   +  ++HRD+K  NIL++ +  E  + DFG    L+DT  ++      G+  Y  
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSP 216

Query: 356 P 356
           P
Sbjct: 217 P 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 30/184 (16%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIRTLGKIR---- 238
           ++G+GG G V+ G    +  QVA+K     ++LG +  S        E+  L K+     
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKVGAGGG 96

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGE-----VLHGKRGSFLKWEMRLKIAIEAAK 293
           H  ++RL  +   +E  +LV E        +        G     L          +   
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP----LGEGPSRCFFGQVVA 150

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
            + + H   S  ++HRD+K  NIL++     A + DFG    L D       +   G+  
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRV 203

Query: 353 YIAP 356
           Y  P
Sbjct: 204 YSPP 207

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 38/183 (20%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G G  G V  G     G +VAVK    + +       +      EI+ L   RH +I++
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKI---LNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
           L    S      +V EY+  G L +    +G          RL    E+ +       G+
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEK-ESRRLFQQILSGV 129

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGY 353
            Y H     +++HRD+K  N+LL++   A +ADFGL+  + D     + C     GS  Y
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNY 181

Query: 354 IAP 356
            AP
Sbjct: 182 AAP 184

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 22/155 (14%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRNI 242
           +IGRG  G VY        + VA+KK+  +      ++ +       EI  L +++   I
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-----FEDLIDCKRILREITILNRLKSDYI 87

Query: 243 VRLK-AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
           +RL      +         +V E   +  L ++   K   FL  E    I      G ++
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF--KTPIFLTEEHIKTILYNLLLGENF 144

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           +H      IIHRD+K  N LLN D    V DFGLA
Sbjct: 145 IH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 33/170 (19%)

Query: 179 DILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIR 232
            +L+  ++   IG G  G+V           VA+KKL          N   A     E+ 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-----FQNQTHAKRAYRELV 113

Query: 233 TLGKIRHRNIVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGK----RGSFLKWE 282
            +  + H+NI+ L   F   K         LV E M   +L +V+  +    R S+L ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ 172

Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           M          G+ +LH   S  IIHRD+K +NI++ SD    + DFGLA
Sbjct: 173 M--------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 24/162 (14%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIRHRN 241
           + +G G  G V     T  G +VAVKKL          + + A     E+R L  ++H N
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-----FQSIIHAKRTYRELRLLKHMKHEN 89

Query: 242 IVRLK-AFCSNKETNL-----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
           ++ L   F   +         LV   M    L  ++  ++   L  +    +  +  +GL
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK---LTDDHVQFLIYQILRGL 145

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD 337
            Y+H   S  IIHRD+K +N+ +N D E  + DFGLA++  D
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 52/194 (26%), Positives = 80/194 (41%), Gaps = 35/194 (18%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVK-----KLL---------------GITKGSSHDNGLS 228
           IG+G  GVV       +    A+K     KL+                   G     G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 229 A----EIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWE 282
                EI  L K+ H N+V+L        E +L +V+E +  G + EV   K    L  +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSED 137

Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
                  +  KG+ YLH      IIHRD+K +N+L+  D    +ADFG++   + + A  
Sbjct: 138 QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL- 193

Query: 343 CMSAVAGSYGYIAP 356
            +S   G+  ++AP
Sbjct: 194 -LSNTVGTPAFMAP 206

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 32/147 (21%), Positives = 56/147 (38%), Gaps = 14/147 (9%)

Query: 221 SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL-HGKRGSFL 279
            S  +  S +IR +     +N V      S K    +  +     +L + +         
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG 339
           +  + L I I+ A+ + +LH   S  ++HRD+K +NI    D    V DFGL   +    
Sbjct: 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 340 ----------ASECMSAVAGSYGYIAP 356
                     A    +   G+  Y++P
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSP 245

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 12/130 (9%)

Query: 229 AEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
            E++ +  + H  +V L  +F    E ++ +V + +  G L   L  +   F +  ++L 
Sbjct: 64  KELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLF 120

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
           I  E    L YL    +  IIHRD+K +NILL+     H+ DF +A  L        ++ 
Sbjct: 121 IC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITT 173

Query: 347 VAGSYGYIAP 356
           +AG+  Y+AP
Sbjct: 174 MAGTKPYMAP 183

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 9/96 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHL--------SGPIPVQITQIHILNYLNVSWN 52
           +        +P  +     +  ++++ N                       +  + + +N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315

Query: 53  QLNA-SLPKEMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            L    +   +  MK L   +  +N   G++P FG 
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS 351

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 15/92 (16%), Positives = 34/92 (36%), Gaps = 8/92 (8%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLN---- 55
           ++ N  + I     G    +  L  + N L   P       + +++ ++ S+N++     
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419

Query: 56  ---ASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
                L        +++S + S+N  S    E
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 21/107 (19%), Positives = 39/107 (36%), Gaps = 15/107 (14%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-------PIPVQITQIHILNYLNVSWNQ 53
           +S N  S            L+ ++L  N L+                 ++L  +++ +N+
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499

Query: 54  LNASLPKE--MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTG 98
           L   L  +     +  L   D S+N+FS   P        NS++  G
Sbjct: 500 LT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPT----QPLNSSTLKG 540

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 10/88 (11%), Positives = 24/88 (27%), Gaps = 7/88 (7%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              NN + +    +     L    +  +        +          N  + Q   +   
Sbjct: 190 QLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICE-----AWENENSEYAQQYKTEDL 243

Query: 61  EMGNMKSLTSADFSHNNFSGEIP-EFGQ 87
           +  N+K LT  +  +     ++P     
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKA 271

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 17/100 (17%), Positives = 32/100 (32%), Gaps = 14/100 (14%)

Query: 1   MSRNNFSGI-------IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ 53
            S N    +       +       + ++ ++LS N +S       +    L+ +N+  N 
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468

Query: 54  LN-------ASLPKEMGNMKSLTSADFSHNNFSGEIPEFG 86
           L            +   N   LTS D   N  +    +F 
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 18/90 (20%), Positives = 27/90 (30%), Gaps = 9/90 (10%)

Query: 2   SRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQI------TQIHILNYLNVSWNQL 54
             N  + +           L  +DLS N  S   P Q           I N  +   N+ 
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554

Query: 55  NASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
               P+ +    SLT      N+    + E
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNE 583

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 10/91 (10%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYL------DLSQNHLSGPIPVQITQIHILNYLNVSWNQL 54
           +S N+FS   P +  +   L         D   N      P  IT    L  L +  N +
Sbjct: 520 LSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578

Query: 55  NASLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
              + +++    +++  D   N        +
Sbjct: 579 R-KVNEKI--TPNISVLDIKDNPNISIDLSY 606

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 20/89 (22%), Positives = 35/89 (39%), Gaps = 5/89 (5%)

Query: 1   MSRNNF-SGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
           +  NN  +  +   +     L  L+   N L G +P        L  LN+++NQ+   +P
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIP 369

Query: 60  KEM-GNMKSLTSADFSHNNFSGEIPEFGQ 87
               G  + + +  F+HN     IP    
Sbjct: 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFD 397

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 9/103 (8%), Positives = 29/103 (28%), Gaps = 13/103 (12%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL------- 54
                     ++  +   LT +++        +P  +  +  +  +NV+ N+        
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292

Query: 55  -NASLPKEMGNMKSLTSADFSHNNF-SGEIPEFGQYSFFNSTS 95
            +     +    + +      +NN  +  +      S      
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVET----SLQKMKK 331

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 20/135 (14%), Positives = 37/135 (27%), Gaps = 7/135 (5%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL----NAS 57
             + +     V +     +T L L     SG +P  I Q+  L  L +  +         
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124

Query: 58  LPKEMGNMKSLTSADFSHNNFSGEIPE---FGQYSFFNSTSFTGNPHLCGSYLNPCNYSS 114
            PK +    S         ++     +      +S         +P       +      
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184

Query: 115 TTPIHNQNGNKSHVP 129
            T I   + N + V 
Sbjct: 185 DTQIGQLSNNITFVS 199

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 12/77 (15%), Positives = 24/77 (31%), Gaps = 3/77 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N      P  I  C  LT L +  N +   +  +IT    ++ L++  N   +    
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP--NISVLDIKDNPNISIDLS 605

Query: 61  EMGNMKSLTSADFSHNN 77
            +            ++ 
Sbjct: 606 YVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 8/92 (8%), Positives = 19/92 (20%), Gaps = 6/92 (6%)

Query: 2   SRNNFSG----IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILN--YLNVSWNQLN 55
             +          P  I   +        + H          +    +     ++ +   
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172

Query: 56  ASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            S+ K        T      NN +       +
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITFVSKAVMR 204

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 43/210 (20%), Positives = 75/210 (35%), Gaps = 68/210 (32%)

Query: 176 GSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTL 234
           G +   +       +G G  G+V       +G++ A+KK+L   +  +       E+  +
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR------ELDIM 54

Query: 235 GKIRHRNIVRLK-AFCSNKETNL------------------------------------- 256
             + H NI++L   F +  +                                        
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA----------KGLSYLHHDCSPLI 306
           ++ EY+P     + LH      LK  +R   +I             + + ++H   S  I
Sbjct: 115 VIMEYVP-----DTLH----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGI 162

Query: 307 IHRDVKSNNILLNS-DFEAHVADFGLAKYL 335
            HRD+K  N+L+NS D    + DFG AK L
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 51/179 (28%), Positives = 78/179 (43%), Gaps = 26/179 (14%)

Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKI---RHR 240
           +IGRGG G VY       G+  A+K L    + + +G +       E   L  +      
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NERIMLSLVSTGDCP 252

Query: 241 NIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
            IV +  +  +    L  + + M  G L   L  + G F + +MR   A E   GL ++H
Sbjct: 253 FIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAA-EIILGLEHMH 309

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              +  +++RD+K  NILL  D   HV  +D GLA             A  G++GY+AP
Sbjct: 310 ---NRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAP 359

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 20/176 (11%)

Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           V+G+GG G V    V   G+  A KKL    +   KG +       E + L K+  R +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM---ALNEKQILEKVNSRFVV 247

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLH-GKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
            L      K+   LV   M  G L   ++   +  F +       A E   GL  LH   
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLH--- 303

Query: 303 SPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              I++RD+K  NILL  D   H+  +D GLA ++ +    + +    G+ GY+AP
Sbjct: 304 RERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAP 354

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 42/184 (22%), Positives = 64/184 (34%), Gaps = 24/184 (13%)

Query: 186 DNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIV 243
              V+G G  G V        G++ A+K    +    S       E+    +     +IV
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKL---LYD--SPK--ARQEVDHHWQASGGPHIV 85

Query: 244 RLKAFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
            +     N        L++ E M  G L   +  +           +I  +    + +LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 300 HDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                 I HRDVK  N+L  S   D    + DFG AK          +     +  Y+AP
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAP 198

Query: 357 -VLG 359
            VLG
Sbjct: 199 EVLG 202

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 39/183 (21%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA----EIRTLGKIRHRNIVR 244
           +G G  G V         ++VA+K    I++     + +      EI  L  +RH +I++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKF---ISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGE--VLHGKRGSFLKWEMRLKIAIEAAK-------GL 295
           L    +     ++V EY   G L +  V             R+    E  +        +
Sbjct: 74  LYDVITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTED-EGRRFFQQIICAI 121

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGY 353
            Y H      I+HRD+K  N+LL+ +    +ADFGL+  + D     + C     GS  Y
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSPNY 173

Query: 354 IAP 356
            AP
Sbjct: 174 AAP 176

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 54/179 (30%), Positives = 78/179 (43%), Gaps = 23/179 (12%)

Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
           V+GRGG G V+   +   G+  A KKL    L   KG         E + L K+  R IV
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG---AMVEKKILAKVHSRFIV 248

Query: 244 RLKAFCSNKETNL-LVYEYMPNGSLG---EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
            L  +    +T+L LV   M  G +      +      F +       A +   GL +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH 306

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                 II+RD+K  N+LL  D + +V  +D GLA  L+           AG+ G++AP
Sbjct: 307 ---QRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 32/211 (15%)

Query: 156 RKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKK 213
              +  ++  K     + DF   +IL       VIGRG  G V   +      +  A+K 
Sbjct: 57  EWAKPFTSKVKQMRLHREDF---EIL------KVIGRGAFGEVAVVKLKN-ADKVFAMKI 106

Query: 214 L----LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSL 267
           L    +     ++       E   L     + I  L  AF    + NL LV +Y   G L
Sbjct: 107 LNKWEMLKRAETACFR---EERDVLVNGDSKWITTLHYAFQD--DNNLYLVMDYYVGGDL 161

Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV- 326
             +L        +   R  +A E    +  +H       +HRD+K +NIL+  D   H+ 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILM--DMNGHIR 215

Query: 327 -ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            ADFG    L + G  +   AV G+  YI+P
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAV-GTPDYISP 245

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 45/188 (23%), Positives = 68/188 (36%), Gaps = 37/188 (19%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
           V+G G  G V +       E+ A+K    +            E+    +  +  +IVR+ 
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKM---LQDCPK----ARREVELHWRASQCPHIVRIV 121

Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA-------KGL 295
               N        L+V E +  G L   +  +       E       EA+       + +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-ER------EASEIMKSIGEAI 174

Query: 296 SYLHHDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAKYLQDTGASECMSAVAGSYG 352
            YLH   S  I HRDVK  N+L  S        + DFG AK          ++    +  
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPY 228

Query: 353 YIAP-VLG 359
           Y+AP VLG
Sbjct: 229 YVAPEVLG 236

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 34/211 (16%)

Query: 156 RKFRKNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVY--RGVTPNGEQVAVKK 213
            +++   N  +    +  D+   +++       VIGRG  G V   R  +   +  A+K 
Sbjct: 52  SRYKDTINKIRDLRMKAEDY---EVV------KVIGRGAFGEVQLVRHKS-TRKVYAMKL 101

Query: 214 L----LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK-AFCSNKETNL-LVYEYMPNGSL 267
           L    +     S+       E   +       +V+L  AF  ++   L +V EYMP G L
Sbjct: 102 LSKFEMIKRSDSAFFW---EERDIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDL 156

Query: 268 GEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV- 326
             V         +   R   A E    L  +H   S   IHRDVK +N+LL  D   H+ 
Sbjct: 157 --VNLMSNYDVPEKWARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLL--DKSGHLK 208

Query: 327 -ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            ADFG    +   G   C +AV G+  YI+P
Sbjct: 209 LADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 24/170 (14%)

Query: 172 KLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA- 229
           ++D     +L   +    +G+G  G+V++ +    GE VAVKK+          N   A 
Sbjct: 2   RVDR---HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-----FQNSTDAQ 53

Query: 230 ----EIRTLGKIR-HRNIVRLK-AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWE 282
               EI  L ++  H NIV L     ++ + ++ LV++YM    L  V+       L+  
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI---LEPV 109

Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
            +  +  +  K + YLH   S  ++HRD+K +NILLN++    VADFGL+
Sbjct: 110 HKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS 156

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.1 bits (180), Expect = 9e-15
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 35/174 (20%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-----EIRTLGKIR 238
            D   +G GG G+V+  V     ++VA+KK+          +  S      EI+ + ++ 
Sbjct: 14  MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-------VLTDPQSVKHALREIKIIRRLD 66

Query: 239 HRNIVRLK-------AFCSNKETNL-------LVYEYMPNGSLGEVLHGKRGSFLKWEMR 284
           H NIV++        +  ++   +L       +V EYM    L  VL       L  E  
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LLEEHA 122

Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQD 337
                +  +GL Y+H   S  ++HRD+K  N+ +N+ D    + DFGLA+ +  
Sbjct: 123 RLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 50/176 (28%), Positives = 71/176 (40%), Gaps = 19/176 (10%)

Query: 189 VIGRGGAGVVYRGVT--PNGEQVAVKKL--LGITKGS--SHDNGLSAEIRTLGKIRHRNI 242
           ++G G    V           + A+K L    I K +   +      E   + ++ H   
Sbjct: 37  ILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVT---RERDVMSRLDHPFF 92

Query: 243 VRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
           V+L  F    +  L     Y  NG L + +  K GSF +   R   A E    L YLH  
Sbjct: 93  VKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALEYLHGK 149

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                IIHRD+K  NILLN D    + DFG AK L         ++  G+  Y++P
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 26/103 (25%), Positives = 39/103 (37%), Gaps = 3/103 (2%)

Query: 1   MSRNNFSG-IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
           M+ N+F    +P        LT+LDLSQ  L    P     +  L  LN+S N   +   
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF--TGNP 100
                + SL   D+S N+      +  Q+   +      T N 
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 13/95 (13%), Positives = 27/95 (28%), Gaps = 4/95 (4%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N    +          L  LDLS+  +          +  L+ L ++ N + +    
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
               + SL        N +            +  +
Sbjct: 95  AFSGLSSLQKLVAVETNLASLENF----PIGHLKT 125

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 21/98 (21%), Positives = 37/98 (37%), Gaps = 5/98 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +SR     I          L+ L L+ N +        + +  L  L      L +    
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 61  EMGNMKSLTSADFSHNNF-SGEIPEFGQYSFFNSTSFT 97
            +G++K+L   + +HN   S ++PE     F N T+  
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPE----YFSNLTNLE 152

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 14/84 (16%), Positives = 27/84 (32%), Gaps = 2/84 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
           +S N    +          L +LD   ++L       +   +  L YL++S      +  
Sbjct: 380 LSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 60  KEMGNMKSLTSADFSHNNFSGEIP 83
                + SL     + N+F     
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 1/84 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S+     + P        L  L++S N+           ++ L  L+ S N +  S  +
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536

Query: 61  EMGNM-KSLTSADFSHNNFSGEIP 83
           E+ +   SL   + + N+F+    
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 2/83 (2%)

Query: 3   RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM 62
             +F G           L YLDLS N +   +      +  L +L+   + L       +
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

Query: 63  -GNMKSLTSADFSHNNFSGEIPE 84
             ++++L   D SH +       
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNG 439

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 3/84 (3%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASLP 59
           +  +  G           L +LDLS+N LS  G           L YL++S+N +  ++ 
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389

Query: 60  KEMGNMKSLTSADFSHNNFSGEIP 83
                ++ L   DF H+N      
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSE 413

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 17/125 (13%), Positives = 35/125 (28%), Gaps = 10/125 (8%)

Query: 1   MSRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNY----LNVSWNQLN 55
           ++ N      +P    +   L +LDLS N +       +  +H +      L++S N +N
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 56  ASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSST 115
             +         L      +N  S  + +    +     +      L             
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMK----TCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 116 TPIHN 120
                
Sbjct: 246 FDKSA 250

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 11/65 (16%), Positives = 20/65 (30%)

Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
             LDLS N L             L  L++S  ++         ++  L++   + N   
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 80 GEIPE 84
               
Sbjct: 90 SLALG 94

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 14/96 (14%), Positives = 29/96 (30%), Gaps = 13/96 (13%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
                  +      +     +L+L           Q   + + +   +++          
Sbjct: 290 VSVTIERVKD--FSYNFGWQHLELVNCKFG-----QFPTLKLKSLKRLTFTSNKGGNAFS 342

Query: 62  MGNMKSLTSADFSHN--NFSGEIPEFGQYSFFNSTS 95
             ++ SL   D S N  +F G   +    S F +TS
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQ----SDFGTTS 374

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 8/83 (9%), Positives = 22/83 (26%), Gaps = 5/83 (6%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
           + +   I         ++   L    +        +      +L +   +       ++ 
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLK 325

Query: 64  NMKSLTSADFSHNNFSGEIPEFG 86
           ++K L    F+ N       E  
Sbjct: 326 SLKRL---TFTSNKGGNAFSEVD 345

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 4/77 (5%)

Query: 1   MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQ--ITQIHILNYLNVSWNQLNAS 57
            S N+       E+ H    L +L+L+QN  +     Q  +  I     L V   ++  +
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584

Query: 58  LPKEMGNMKSLTSADFS 74
            P +      + S + +
Sbjct: 585 TPSDKQG-MPVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 12/83 (14%), Positives = 24/83 (28%), Gaps = 5/83 (6%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQL---NA 56
           +S N  + I P      + L  L L  N  S  +    I  +  L    +   +      
Sbjct: 184 LSLNPMNFIQP-GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 57  SLPKEMGNMKSLTSADFSHNNFS 79
               +   ++ L +        +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLA 265

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 54/176 (30%), Positives = 74/176 (42%), Gaps = 19/176 (10%)

Query: 189 VIGRGGAGVVY--RGVTPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
           VIGRG    V   +     G+  A+K +    + K          E   L     R I +
Sbjct: 68  VIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDMLKRGEVSCFR-EERDVLVNGDRRWITQ 125

Query: 245 LKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEM-RLKIAIEAAKGLSYLHHDC 302
           L  F    E  L LV EY   G L  +L  K G  +  EM R  +A E    +  +H   
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA-EIVMAIDSVH--- 179

Query: 303 SPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               +HRD+K +NILL  D   H+  ADFG    L+  G    + AV G+  Y++P
Sbjct: 180 RLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 21/168 (12%)

Query: 172 KLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAE 230
            +++G+ D  + V+    +GRG    V+  +   N E+V VK L    K          E
Sbjct: 29  VVEWGNQDDYQLVR---KLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKR-E 80

Query: 231 IRTLGKIR-HRNIVRLKAFC--SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
           I+ L  +R   NI+ L          T  LV+E++ N    ++        +++ M    
Sbjct: 81  IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY--- 137

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKY 334
             E  K L Y H   S  I+HRDVK +N++++ +  +  + D+GLA++
Sbjct: 138 --EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 20/153 (13%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKA 247
           IG G  G +  G      E VA+K    +    S    L  E R   ++     I ++  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 248 FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           F    + N +V E +  G SL ++      +F LK    L IAI+    + Y+H   S  
Sbjct: 73  FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVH---SKN 125

Query: 306 IIHRDVKSNNILL-----NSDFEAHVADFGLAK 333
           +I+RDVK  N L+      +    H+ DF LAK
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 15/106 (14%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS-------GPIPVQITQIHILNYLNVSWNQ 53
           +S N               ++ + LS N ++        P        ++L  +++ +N+
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739

Query: 54  LNASLPKEM--GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
           L  SL  +     +  L++ D S+N FS   P        NS+   
Sbjct: 740 LT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPT----QPLNSSQLK 779

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 10/92 (10%), Positives = 26/92 (28%), Gaps = 9/92 (9%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
            N    I   I     L  +  + +  +        +    +Y      +   +      
Sbjct: 434 TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYENEELSWS 488

Query: 64  NMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
           N+K LT  +  +     ++P+      ++   
Sbjct: 489 NLKDLTDVELYNCPNMTQLPD----FLYDLPE 516

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 18/105 (17%), Positives = 32/105 (30%), Gaps = 17/105 (16%)

Query: 1   MSRNNFSGI---------IPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVS 50
           ++ N              +  +      +    +  N+L   P    + ++  L  L+  
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581

Query: 51  WNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
            N++   L    G    LT     +N    EIPE     F   T 
Sbjct: 582 HNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPE----DFCAFTD 619

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 16/92 (17%), Positives = 31/92 (33%), Gaps = 11/92 (11%)

Query: 1   MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQI------TQIHILNYLNVSWN 52
           +  N  + +   +     L  L+ +D+S N  S   P Q           I +  +   N
Sbjct: 735 LRFNKLTSL-SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792

Query: 53  QLNASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
           ++    P  +    SL       N+   ++ E
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIR-KVDE 823

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 15/92 (16%), Positives = 32/92 (34%), Gaps = 8/92 (8%)

Query: 1   MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQL---- 54
           +  N    I P +       +  L  S N L   P       ++++  ++ S+N++    
Sbjct: 602 LDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEG 660

Query: 55  -NASLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
            N S   +     + ++   S+N       E 
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 12/96 (12%), Positives = 28/96 (29%), Gaps = 13/96 (13%)

Query: 1   MSRNNFSGIIP-----VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN 55
            S N            ++    +  + + LS N +             ++ + +S N + 
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710

Query: 56  A-------SLPKEMGNMKSLTSADFSHNNFSGEIPE 84
           +              N   LT+ D   N  +  + +
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSD 745

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 12/105 (11%), Positives = 29/105 (27%), Gaps = 2/105 (1%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           +     G +P  IG    L  L    +  +    +   +    +      +++     K 
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390

Query: 62  -MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGS 105
            +   + L  +D   +  +   PE       +  S         +
Sbjct: 391 FLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGNLT 434

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 14/107 (13%), Positives = 32/107 (29%), Gaps = 9/107 (8%)

Query: 2   SRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILN-----YLNVSWNQLN 55
           S N    I          ++  +D S N +          +          + +S+N++ 
Sbjct: 627 SHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686

Query: 56  ASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
               +       +++   S+N  +  IPE          ++     L
Sbjct: 687 KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK--DGNYKNTYLL 730

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 10/77 (12%), Positives = 22/77 (28%), Gaps = 3/77 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N      P  I  C  L  L +  N +   +  ++     L  L+++ N   +    
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVT 845

Query: 61  EMGNMKSLTSADFSHNN 77
            +            ++ 
Sbjct: 846 SVCPYIEAGMYVLLYDK 862

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 11/84 (13%), Positives = 27/84 (32%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              + +     V++ +   +T L L+     G +P  I Q+  L  L+   +    S   
Sbjct: 306 KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRL 365

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
                 +   ++   +       +
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKK 389

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 11/86 (12%), Positives = 28/86 (32%), Gaps = 6/86 (6%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLS-----GPIPVQITQIHILNYLNVSWNQLNASL 58
                   + + +   L   DL Q+ ++      PI            +    N++   +
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FI 440

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPE 84
            K +  +  L    F+++ F+ +   
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIA 466

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 39/131 (29%), Positives = 56/131 (42%), Gaps = 12/131 (9%)

Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
            E R L   RH  +  LK +       L  V EY   G L   L  +   F +   R   
Sbjct: 197 TENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYG 254

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMS 345
           A E    L YLH + +  +++RD+K  N++L  D + H+   DFGL K  +       M 
Sbjct: 255 A-EIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCK--EGIKDGATMK 307

Query: 346 AVAGSYGYIAP 356
              G+  Y+AP
Sbjct: 308 TFCGTPEYLAP 318

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 19/102 (18%), Positives = 33/102 (32%), Gaps = 10/102 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++ N    +          LT LD+  N +S   P    ++ +L  LN+  N+L+    K
Sbjct: 32  LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK 91

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
                 +LT      N+                  F    +L
Sbjct: 92  TFAFCTNLTELHLMSNSIQKIKNN----------PFVKQKNL 123

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 17/84 (20%), Positives = 30/84 (35%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  S +       C  LT L L  N +         +   L  L++S N L+++   
Sbjct: 80  LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
               +++L     S+N       E
Sbjct: 140 TQVQLENLQELLLSNNKIQALKSE 163

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 20/105 (19%), Positives = 33/105 (31%), Gaps = 2/105 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           + ++   G     +     L  L+L  N            +  L  +++  N LN     
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSF--TGNPHLC 103
              N  SL S +   N  +    +    +F N T      NP  C
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 5/114 (4%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N F  I          L  +DL  N+L+            L  LN+  N +  S+ K
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI-TSVEK 601

Query: 61  EM--GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNY 112
           ++     ++LT  D   N F         +  + + + T  P L   YL  CN 
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL--CNT 653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 8/93 (8%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--------GPIPVQITQIHILNYLNVSWN 52
           +S NN + I    +     L  LDL  N+L+        G     +  +  L+ LN+  N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546

Query: 53  QLNASLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
             +    +   ++  L   D   NN +      
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 5/89 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           +S N    +   E+       L  L+LS N +    P     I  L  L ++  QL  SL
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211

Query: 59  PKEMG---NMKSLTSADFSHNNFSGEIPE 84
            +++       S+ +   S++  S     
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNT 240

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 17/104 (16%), Positives = 32/104 (30%), Gaps = 3/104 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           +S +  S              LT LDLS N+L+         +  L Y  + +N +    
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
              +  + ++   +   +     I         +  SF     L
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSI-SLASLPKIDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 13/81 (16%), Positives = 25/81 (30%), Gaps = 1/81 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIHILNYLNVSWNQLNASLP 59
           +++N  S I          L  LDL  N +   +  Q    +  +  + +S+N+      
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447

Query: 60  KEMGNMKSLTSADFSHNNFSG 80
                + SL            
Sbjct: 448 NSFALVPSLQRLMLRRVALKN 468

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 5/89 (5%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHI---LNYLNVSWNQLNASL 58
           S N      P        L  L L+   L   +  ++        +  L++S +QL+ + 
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238

Query: 59  PKEMGNMK--SLTSADFSHNNFSGEIPEF 85
                 +K  +LT  D S+NN +    + 
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 23/99 (23%), Positives = 32/99 (32%), Gaps = 6/99 (6%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N+   I          L  LDLS N LS        Q+  L  L +S N++ A   +
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163

Query: 61  EMGNMK--SLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
           E+      SL   + S N      P      F       
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPG----CFHAIGRLF 198

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 17/94 (18%), Positives = 29/94 (30%), Gaps = 10/94 (10%)

Query: 1   MSRNNFSGI--IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN--- 55
           + R     +   P        LT LDLS N+++      +  +  L  L++  N L    
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520

Query: 56  -----ASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
                      +  +  L   +   N F     E
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 13/104 (12%), Positives = 30/104 (28%), Gaps = 9/104 (8%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQN---------HLSGPIPVQITQIHILNYLNVSW 51
           +  NN   +    +     + YL+L ++          L          +  L +LN+  
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338

Query: 52  NQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS 95
           N +          + +L     S++  S        +     + 
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 17/105 (16%), Positives = 39/105 (37%), Gaps = 16/105 (15%)

Query: 4   NNFSGIIPVEIGHCL-----LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           N+F+ +  +     +      L  L+L++N +S       + +  L  L++  N++   L
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421

Query: 59  PKEM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
             +    ++++     S+N +                SF   P L
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRN----------SFALVPSL 456

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 13/101 (12%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           S    + + P ++     +T L+L+ N L        T+   L  L+V +N ++   P+ 
Sbjct: 12  SHLKLTQV-PDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
              +  L   +  HN  S    +          +F    +L
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDK----------TFAFCTNL 99

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 18/66 (27%), Positives = 24/66 (36%), Gaps = 5/66 (7%)

Query: 20 LTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF 78
              D S   L+  +P  + T    +  LN++ NQL             LTS D   N  
Sbjct: 6  HEVADCSHLKLTQ-VPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 79 SGEIPE 84
          S   PE
Sbjct: 62 SKLEPE 67

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 26/177 (14%)

Query: 189 VIGRGGAGVVYRG-VTPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
            +G G  G V       +G   A+K L    +   K   H      E R L  +    +V
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL---NEKRILQAVNFPFLV 104

Query: 244 RLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HD 301
           +L+ F     +NL +V EY+  G +   L  + G F +   R   A +      YLH  D
Sbjct: 105 KLE-FSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA-QIVLTFEYLHSLD 161

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               +I+RD+K  N+L+  D + ++   DFG AK ++    + C     G+   +AP
Sbjct: 162 ----LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAP 207

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 65.2 bits (160), Expect = 4e-12
 Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 18/132 (13%)

Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
            E   L  + H  I+R+          + ++ +Y+  G L  +L  K   F     +   
Sbjct: 55  DERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYA 112

Query: 288 AIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECM 344
           A E    L YLH  D    II+RD+K  NILL  D   H+   DFG AKY+ D   + C 
Sbjct: 113 A-EVCLALEYLHSKD----IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDVTYTLC- 164

Query: 345 SAVAGSYGYIAP 356
               G+  YIAP
Sbjct: 165 ----GTPDYIAP 172

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 18/155 (11%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKA 247
           IG G  G +Y G     GE+VA+K    +    +    L  E +    ++    I  ++ 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 72

Query: 248 FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
             +  + N++V E +  G SL ++ +     F LK    L +A +    + Y+H   S  
Sbjct: 73  CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK--TVLLLADQMISRIEYIH---SKN 125

Query: 306 IIHRDVKSNNILL---NSDFEAHVADFGLAKYLQD 337
            IHRDVK +N L+         ++ DFGLAK  +D
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 64.3 bits (157), Expect = 8e-12
 Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 20/157 (12%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKA 247
           IG G  GV++ G    N +QVA+K         S    L  E RT   +     I  +  
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 248 FCSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           F      N+LV + +  G SL ++L      F +K       A +    +  +H      
Sbjct: 74  FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIH---EKS 126

Query: 306 IIHRDVKSNNILLNSDFEA-----HVADFGLAKYLQD 337
           +++RD+K +N L+           +V DFG+ K+ +D
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 29/181 (16%)

Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVK---KLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           V+G+G  G V+       +   +  A+K   K     +          E   L ++ H  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK---MERDILVEVNHPF 87

Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
           IV+L  +    E  L L+ +++  G L   L  K   F + +++  +A E A  L +LH 
Sbjct: 88  IVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLA-ELALALDHLH- 143

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGASECMSAVAGSYGYIA 355
             S  II+RD+K  NILL  D E H+   DFGL+K     +    S C     G+  Y+A
Sbjct: 144 --SLGIIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEKKAYSFC-----GTVEYMA 194

Query: 356 P 356
           P
Sbjct: 195 P 195

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 40/132 (30%), Positives = 55/132 (41%), Gaps = 15/132 (11%)

Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLH-GKRGSFLKWEMRLK 286
            E R L   RH  +  LK +       L  V EY   G L    H  +   F +   R  
Sbjct: 54  TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 110

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECM 344
            A E    L YLH   S  +++RD+K  N++L  D + H+   DFGL K  +       M
Sbjct: 111 GA-EIVSALEYLH---SRDVVYRDIKLENLML--DKDGHIKITDFGLCK--EGISDGATM 162

Query: 345 SAVAGSYGYIAP 356
               G+  Y+AP
Sbjct: 163 KTFCGTPEYLAP 174

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 16/150 (10%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKA 247
           IG G  G +Y G      E+VA+K    +    +    L  E +    ++    I  ++ 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSF-LKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
           F    + N+LV + +   SL ++ +       LK    L +A +    + ++H   S   
Sbjct: 71  FGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVH---SKSF 124

Query: 307 IHRDVKSNNILLNSDFEAH---VADFGLAK 333
           +HRD+K +N L+     A+   + DFGLAK
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 61.5 bits (150), Expect = 7e-11
 Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 2/75 (2%)

Query: 10  IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLT 69
            P +      L ++ +    L   +P  + Q   L  L ++ N L  +LP  + ++  L 
Sbjct: 96  FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLR 153

Query: 70  SADFSHNNFSGEIPE 84
                      E+PE
Sbjct: 154 ELSIRACPELTELPE 168

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 12/85 (14%), Positives = 29/85 (34%), Gaps = 3/85 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLS-QNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
           +         P   G    L  L L   ++L   +P+ I ++  L  L++      + LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
             +  + +         +   ++ +
Sbjct: 295 SLIAQLPANCIILVP-PHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 13/77 (16%), Positives = 23/77 (29%), Gaps = 5/77 (6%)

Query: 10  IPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKS 67
               +          L+L    L    P Q  ++  L ++ +    L   LP  M     
Sbjct: 71  TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAG 128

Query: 68  LTSADFSHNNFSGEIPE 84
           L +   + N     +P 
Sbjct: 129 LETLTLARNPLR-ALPA 144

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 16/85 (18%), Positives = 26/85 (30%), Gaps = 3/85 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSW-NQLNASLP 59
           +  +  S +    I H   L  LDL         P        L  L +   + L  +LP
Sbjct: 213 IRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLP 270

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
            ++  +  L   D         +P 
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPS 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 12/93 (12%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHI---------LNYLNVSW 51
           ++RN     +P  I     L  L +        +P  +              L  L + W
Sbjct: 134 LARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192

Query: 52  NQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE 84
             +  SLP  + N+++L S    ++  S  +  
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 32/174 (18%)

Query: 190 IGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNG-LSAEIR---------------T 233
           IG+GG G +Y     + E V       + K    DNG L  E++                
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVV-KVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 234 LGKIRHRNIVRLKAF----CSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLKI 287
             K+++  + +         + K    ++ +    G  L ++       F  K    L++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRK--TVLQL 157

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTG 339
           ++     L Y+H       +H D+K++N+LLN      V   D+GLA      G
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 19/85 (22%), Positives = 30/85 (35%), Gaps = 1/85 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN-ASLP 59
           ++ N      P        L  L   +  L+      I Q+  L  LNV+ N ++   LP
Sbjct: 87  LTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLP 146

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
               N+ +L   D S+N        
Sbjct: 147 AYFSNLTNLVHVDLSYNYIQTITVN 171

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 22/86 (25%), Positives = 32/86 (37%), Gaps = 1/86 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLL-LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
           M+ N+F       +      LT+LDLS+  L          +H L  LN+S N L     
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEF 85
                + SL++ D S N         
Sbjct: 515 SHYNQLYSLSTLDCSFNRIETSKGIL 540

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 14/84 (16%), Positives = 29/84 (34%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N    +      +   L +LDLS+  +          +H L+ L ++ N + +  P 
Sbjct: 39  LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
               + SL +        +     
Sbjct: 99  SFSGLTSLENLVAVETKLASLESF 122

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 15/85 (17%), Positives = 27/85 (31%), Gaps = 2/85 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIHILNYLNVSWNQLNASLP 59
           +S N    I+         L +LD   + L           +  L YL++S+        
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
                + SL +   + N+F      
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLS 466

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 17/79 (21%), Positives = 34/79 (43%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S+     I          L  L++S N+L         Q++ L+ L+ S+N++  S   
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

Query: 61  EMGNMKSLTSADFSHNNFS 79
                KSL   + ++N+ +
Sbjct: 540 LQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 5/85 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASL 58
           ++ N  S            L+YLDLS+N LS  G         + L +L++S+N     +
Sbjct: 335 LTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IM 391

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIP 83
                 ++ L   DF H+       
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTE 416

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 14/88 (15%), Positives = 30/88 (34%), Gaps = 6/88 (6%)

Query: 2   SRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILN----YLNVSWNQLNA 56
           + N      +P    +   L ++DLS N++       +  +         L++S N ++ 
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194

Query: 57  SLPKEMGNMKSLTSADFSHNNFSGEIPE 84
            +  +      L       N  S  I +
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMK 222

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 11/86 (12%), Positives = 27/86 (31%), Gaps = 5/86 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++  N      V+      ++ + L+   +       + +      L++   QL    P 
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLK-QFPT 324

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFG 86
              ++  L S   + N  S    +  
Sbjct: 325 --LDLPFLKSLTLTMNKGSISFKKVA 348

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 19/101 (18%), Positives = 33/101 (32%), Gaps = 13/101 (12%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
                S + P +I        +DLS N L        +    L +L++S  ++     K 
Sbjct: 19  MDQKLSKV-PDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
              +  L++   + N      P           SF+G   L
Sbjct: 76  WHGLHHLSNLILTGNPIQSFSPG----------SFSGLTSL 106

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 61.0 bits (149), Expect = 1e-10
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 21/178 (11%)

Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHRNI 242
           V+G+GG G V+          G+  A+K L    I + +       AE   L +++H  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 243 VRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-H 300
           V L  +       L L+ EY+  G L   L  + G F++      +A E +  L +LH  
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLA-EISMALGHLHQK 140

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                II+RD+K  NI+L  + + HV   DFGL K  +            G+  Y+AP
Sbjct: 141 G----IIYRDLKPENIML--NHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAP 190

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 38/162 (23%), Positives = 58/162 (35%), Gaps = 35/162 (21%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
           V+G G  G V +       E+ A+K    +            E+    +  +  +IVR+ 
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKM---LQDCPK----ARREVELHWRASQCPHIVRIV 77

Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA-------KGL 295
               N        L+V E +  G L   +  +       E       EA+       + +
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-ER------EASEIMKSIGEAI 130

Query: 296 SYLH-HDCSPLIIHRDVKSNNILLNSDFEAH---VADFGLAK 333
            YLH  +    I HRDVK  N+L  S        + DFG AK
Sbjct: 131 QYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 30/171 (17%), Positives = 56/171 (32%), Gaps = 26/171 (15%)

Query: 190 IGRGGAGVVYRGV---------TPNGEQVAVK-----KLLGITKGSSHDNGLSAEIR--- 232
             R   G++Y             P  ++ ++K       L   +          ++    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 233 TLGKIRHRNIVRLKAFCSNKET-NLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIE 290
            L       I     F  +++    LV   +  G SL   L       L     L++A  
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTG 339
               L +LH       +H +V + NI ++ + ++ V  A +G A     +G
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 14/92 (15%), Positives = 27/92 (29%), Gaps = 9/92 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT----QIHILNYLNVSWNQLNA 56
           +++ +       ++     L+ LDLS N   G   +       +   L  L +    +  
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME- 214

Query: 57  SLPKEM----GNMKSLTSADFSHNNFSGEIPE 84
           +              L   D SHN+       
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.8 bits (111), Expect = 4e-06
 Identities = 16/81 (19%), Positives = 30/81 (37%), Gaps = 6/81 (7%)

Query: 1   MSRNNFSGIIPVEI-GHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
           +S N+               L  L+LS   L   +P  +     L+ L++S+N+L+   P
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNP 290

Query: 60  KEMGNMKSLTSADFSHNNFSG 80
                +  + +     N F  
Sbjct: 291 SP-DELPQVGNLSLKGNPFLD 310

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 17/85 (20%), Positives = 27/85 (31%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
            S N    I        + LT+LDL++  +           H L+ L ++ N L      
Sbjct: 40  FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEF 85
            +   K+L    F     S      
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIP 124

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 20/83 (24%), Positives = 29/83 (34%), Gaps = 1/83 (1%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
            ++ F  I          L  LDL+  HLS  +P  +  +  L  L +S N+        
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQIS 320

Query: 62  MGNMKSLTSADFSHNNFSGEIPE 84
             N  SLT      N    E+  
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGT 343

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 13/84 (15%), Positives = 28/84 (33%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++ N    +    +     L +L   Q  +S    + +     L  L +  N +++    
Sbjct: 88  LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
           +    + L   DF +N       E
Sbjct: 148 KGFPTEKLKVLDFQNNAIHYLSKE 171

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 16/96 (16%), Positives = 28/96 (29%), Gaps = 4/96 (4%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           +R     I          L  L L+ N L       ++    L +L      +++     
Sbjct: 65  TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT 97
           + N K+L S     N+ S           F +    
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLP----KGFPTEKLK 156

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 19/103 (18%), Positives = 35/103 (33%), Gaps = 10/103 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++  + S + P  +     L  L LS N       +  +    L +L++  N     L  
Sbjct: 285 LTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 61  EM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
               N+++L   D SH++           S   +       HL
Sbjct: 344 GCLENLENLRELDLSHDDIET--------SDCCNLQLRNLSHL 378

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 2/101 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
             +   S I  + + +   L  L L  NH+S     +      L  L+   N ++    +
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171

Query: 61  EMGNMKSLTSA--DFSHNNFSGEIPEFGQYSFFNSTSFTGN 99
           +M +++  T+   + + N+ +G  P     + F S +F G 
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 18/88 (20%), Positives = 39/88 (44%), Gaps = 4/88 (4%)

Query: 1   MSRNNFSGIIPVEIG---HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNAS 57
           +  N+F      +         L  L LS   LS       T + ++N++++S N+L +S
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515

Query: 58  LPKEMGNMKSLTSADFSHNNFSGEIPEF 85
             + + ++K +   + + N+ S  +P  
Sbjct: 516 SIEALSHLKGIY-LNLASNHISIILPSL 542

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 12/87 (13%), Positives = 27/87 (31%), Gaps = 3/87 (3%)

Query: 1   MSRNNFSGIIPVEIGHC--LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
               +   I P        + +  ++L +++              L  L+++   L+  L
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPEF 85
           P  +  + +L     S N F       
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQIS 320

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 18/105 (17%), Positives = 37/105 (35%), Gaps = 13/105 (12%)

Query: 1   MSRNN--FSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           +S ++   S    +++ +   L  L+LS N           +   L  L++++ +L    
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416

Query: 59  PKE-MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
            +    N+  L   + SH+               +   F G P L
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDI----------SSEQLFDGLPAL 451

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 15/89 (16%), Positives = 25/89 (28%), Gaps = 4/89 (4%)

Query: 1   MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQL---NA 56
           ++               L LL  L+LS + L          +  L +LN+  N     N 
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

Query: 57  SLPKEMGNMKSLTSADFSHNNFSGEIPEF 85
                +  +  L     S  + S      
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHA 495

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 15/112 (13%)

Query: 1   MSRNNFSGIIPVEIGHC--LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
              N    +   ++          L+L+ N ++G I        +   LN    Q    +
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVI 218

Query: 59  PKEMGN--MKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLN 108
            K + N  ++SL    F   +              +   F G   +    +N
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDED----------ISPAVFEGLCEMSVESIN 260

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 9/86 (10%), Positives = 25/86 (29%), Gaps = 6/86 (6%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP-----VQITQIHILNYLNVSWNQLNASL 58
            N    I        +   L+         I        I  + +  + ++    ++ ++
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPE 84
            + +  M S+ S +   + F      
Sbjct: 248 FEGLCEM-SVESINLQKHYFFNISSN 272

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 11/83 (13%), Positives = 26/83 (31%), Gaps = 3/83 (3%)

Query: 2  SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
               + I P  + +      L+ S N L        +++  L +L+++  Q+       
Sbjct: 20 ENLGLNEI-PGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 62 MGNMKSLTSADFSHNNFSGEIPE 84
            +   L +   + N        
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAET 99

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 38/175 (21%), Positives = 68/175 (38%), Gaps = 37/175 (21%)

Query: 190 IGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG-LSAEIRTL------------- 234
           IG GG G++Y    T   E+ A      + K    +NG L +E++               
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARH----VVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100

Query: 235 --GKIRHRNIVRLKAF----CSNKETNLLVYEYMPNG-SLGEVLHGKRGSF-LKWEMRLK 286
              ++ +  I             +    +V E +  G  L + + G+ G+F       L+
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDL-QKISGQNGTFKKS--TVLQ 155

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVADFGLAKYLQDTG 339
           + I     L Y+H +     +H D+K+ N+LL        ++AD+GL+      G
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 53/186 (28%), Positives = 77/186 (41%), Gaps = 35/186 (18%)

Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVKKLLGITKGS--SHDNGLS---AEIRTLGKIRH 239
           V+G G  G V+          G+  A+K L    K +             E + L  IR 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVL---KKATIVQKAKTTEHTRTERQVLEHIRQ 117

Query: 240 RN-IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSY 297
              +V L  +    ET L L+ +Y+  G L   L  +R  F + E+++ +  E    L +
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVG-EIVLALEH 174

Query: 298 LH-HDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK----YLQDTGASECMSAVAGS 350
           LH       II+RD+K  NILL  D   HV   DFGL+K       +     C     G+
Sbjct: 175 LHKLG----IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFC-----GT 223

Query: 351 YGYIAP 356
             Y+AP
Sbjct: 224 IEYMAP 229

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 52/180 (28%), Positives = 74/180 (41%), Gaps = 28/180 (15%)

Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
           V+G+G  G V     +G     E  AVK L    K     +        E R L    + 
Sbjct: 348 VLGKGSFGKVMLSERKG---TDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALPGKP 401

Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             + +L   C      L  V EY+  G L   +  + G F +       A E A GL +L
Sbjct: 402 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFL 458

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               S  II+RD+K +N++L  D E H+  ADFG+ K  ++           G+  YIAP
Sbjct: 459 Q---SKGIIYRDLKLDNVML--DSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAP 511

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 56.5 bits (137), Expect = 3e-09
 Identities = 48/183 (26%), Positives = 71/183 (38%), Gaps = 34/183 (18%)

Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGK-IRH 239
           ++G+G  G V    ++      +  A+K L    K     +        E R L     H
Sbjct: 24  MLGKGSFGKVFLAEFKK---TNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEH 77

Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             +  +       + NL  V EY+  G L   +      F         A E   GL +L
Sbjct: 78  PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAA-EIILGLQFL 134

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGASECMSAVAGSYGY 353
           H   S  I++RD+K +NILL  D + H+  ADFG+ K          + C     G+  Y
Sbjct: 135 H---SKGIVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDAKTNTFC-----GTPDY 184

Query: 354 IAP 356
           IAP
Sbjct: 185 IAP 187

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 46/136 (33%), Positives = 63/136 (46%), Gaps = 22/136 (16%)

Query: 229 AEIRTLGK-IRHRNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +E   L K ++H  +V L  F       L  V +Y+  G L   L  +   FL  E R +
Sbjct: 87  SERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFL--EPRAR 142

Query: 287 I-AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGA 340
             A E A  L YLH   S  I++RD+K  NILL  D + H+   DFGL K       T +
Sbjct: 143 FYAAEIASALGYLH---SLNIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNSTTS 197

Query: 341 SECMSAVAGSYGYIAP 356
           + C     G+  Y+AP
Sbjct: 198 TFC-----GTPEYLAP 208

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 23/83 (27%), Positives = 41/83 (49%), Gaps = 12/83 (14%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           +R N S  +P  +     +T L+++QN L   +P        L YL+   N+L+ +LP+ 
Sbjct: 67  NRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPEL 118

Query: 62  MGNMKSLTSADFSHNNFSGEIPE 84
             ++K L   D  +N  +  +PE
Sbjct: 119 PASLKHL---DVDNNQLT-MLPE 137

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 9/81 (11%)

Query: 3   RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIH----ILNYLNVSWNQLNASL 58
           RNN    +P        L  LD+S N L   +P    + H       +     N++   +
Sbjct: 168 RNNQLTFLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THI 222

Query: 59  PKEMGNMKSLTSADFSHNNFS 79
           P+ + ++    +     N  S
Sbjct: 223 PENILSLDPTCTIILEDNPLS 243

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 13/84 (15%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  + ++P        L Y++   N L+  +P   T    L  L+V  NQL   LP+
Sbjct: 127 VDNNQLT-MLPELPAL---LEYINADNNQLTM-LPELPTS---LEVLSVRNNQLT-FLPE 177

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
              ++++L   D S N     +P 
Sbjct: 178 LPESLEAL---DVSTNLLE-SLPA 197

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 10/80 (12%), Positives = 24/80 (30%), Gaps = 6/80 (7%)

Query: 3   RNNFSGIIPVEIGHCL----LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
             N    +P              +    +N ++  IP  I  +     + +  N L+ S 
Sbjct: 188 STNLLESLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS-SR 245

Query: 59  PKEMGNMKSLTSADFSHNNF 78
            +E  + ++          +
Sbjct: 246 IRESLSQQTAQPDYHGPRIY 265

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 8/84 (9%)

Query: 4   NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
            N    +PV       L  L +S N L+  +P+  +    L  L+V  NQL   LP+ + 
Sbjct: 230 GNRLTSLPVLPSE---LKELMVSGNRLTS-LPMLPSG---LLSLSVYRNQL-TRLPESLI 281

Query: 64  NMKSLTSADFSHNNFSGEIPEFGQ 87
           ++ S T+ +   N  S    +  +
Sbjct: 282 HLSSETTVNLEGNPLSERTLQALR 305

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 13/84 (15%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N  + + P        L  L    N L+  +P+  +    L  L+VS NQL  SLP 
Sbjct: 148 VSDNQLASL-PALPSE---LCKLWAYNNQLTS-LPMLPSG---LQELSVSDNQLA-SLPT 198

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
               +  L +    +N  +  +P 
Sbjct: 199 LPSELYKLWA---YNNRLT-SLPA 218

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 21/83 (25%), Positives = 30/83 (36%), Gaps = 13/83 (15%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           S N  +  +PV     L L+       HL    P   +    L  L +  NQL  SLP  
Sbjct: 89  SGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLT-SLPVL 139

Query: 62  MGNMKSLTSADFSHNNFSGEIPE 84
              ++ L     S N  +  +P 
Sbjct: 140 PPGLQEL---SVSDNQLA-SLPA 158

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 20/90 (22%)

Query: 13  EIGHCLL--LTYLDLSQNHLSG-P--IPVQITQIHI--------------LNYLNVSWNQ 53
           ++  CL      L++ ++ L+  P  +P  IT + I              L  L VS NQ
Sbjct: 33  KMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQ 92

Query: 54  LNASLPKEMGNMKSLTSADFSHNNFSGEIP 83
           L  SLP     +  L+       +      
Sbjct: 93  LT-SLPVLPPGLLELSIFSNPLTHLPALPS 121

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 13/84 (15%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N  + + P+       L  L +S N L+  +P   ++++ L   N   N+L  SLP 
Sbjct: 168 AYNNQLTSL-PMLPSG---LQELSVSDNQLAS-LPTLPSELYKLWAYN---NRLT-SLPA 218

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
               +K L     S N  +  +P 
Sbjct: 219 LPSGLKEL---IVSGNRLT-SLPV 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 54/183 (29%), Positives = 76/183 (41%), Gaps = 34/183 (18%)

Query: 189 VIGRGGAGVV----YRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
           V+G+G  G V     +G     E  AVK L    K     +        E R L    + 
Sbjct: 27  VLGKGSFGKVMLSERKG---TDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALPGKP 80

Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             + +L   C      L  V EY+  G L   +  + G F +       A E A GL +L
Sbjct: 81  PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFL 137

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAK---YLQDTGASECMSAVAGSYGY 353
               S  II+RD+K +N++L  D E H+  ADFG+ K   +   T  + C     G+  Y
Sbjct: 138 Q---SKGIIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFC-----GTPDY 187

Query: 354 IAP 356
           IAP
Sbjct: 188 IAP 190

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 51/180 (28%), Positives = 71/180 (39%), Gaps = 28/180 (15%)

Query: 189 VIGRGGAGVVY----RGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
           V+G+G  G V     +     G+  AVK L    K     +        E R L     H
Sbjct: 30  VLGKGSFGKVMLARVKE---TGDLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNH 83

Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             + +L   C      L  V E++  G L   +  K   F +   R   A E    L +L
Sbjct: 84  PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAA-EIISALMFL 140

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H      II+RD+K +N+LL  D E H   ADFG+ K  +        +   G+  YIAP
Sbjct: 141 H---DKGIIYRDLKLDNVLL--DHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 28/180 (15%)

Query: 189 VIGRGGAG----VVYRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
           VIGRG       V  +         A+K +    K   +D+     +  E     +   H
Sbjct: 16  VIGRGSYAKVLLVRLKK---TDRIYAMKVV---KKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             +V L   C   E+ L  V EY+  G L   +  ++    +   R   A E +  L+YL
Sbjct: 70  PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYL 126

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H      II+RD+K +N+LL  D E H+   D+G+ K  +     +  S   G+  YIAP
Sbjct: 127 H---ERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 179

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 28/180 (15%)

Query: 189 VIGRGGAG----VVYRGVTPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKI-RH 239
           VIGRG       V  +         A++ +    K   +D+     +  E     +   H
Sbjct: 59  VIGRGSYAKVLLVRLKK---TDRIYAMRVV---KKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 240 RNIVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             +V L   C   E+ L  V EY+  G L   +  ++    +   R   A E +  L+YL
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYL 169

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H      II+RD+K +N+LL  D E H+   D+G+ K  +     +  S   G+  YIAP
Sbjct: 170 H---ERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.3 bits (127), Expect = 4e-08
 Identities = 30/206 (14%), Positives = 52/206 (25%), Gaps = 55/206 (26%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKL------LGITKGSSHDNGLS 228
             ++ +  C K    IG G  G V++    +   VA+K +      L           + 
Sbjct: 17  LPTEKLQRCEK----IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 229 AEIRTLGKI---------RHRNIVRLKAFC------------------------------ 249
            EI    ++         R    + L +                                
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
              +   +V E+   G   E +  K  S         I  +    L+           HR
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAEASLR--FEHR 186

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYL 335
           D+   N+LL       +      K  
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSS 212

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 21/96 (21%), Positives = 32/96 (33%), Gaps = 18/96 (18%)

Query: 1   MSRNNFSGIIPVEIG-----------HCLL--LTYLDLSQNHLSGPIPVQITQIHILNYL 47
            + + +    P   G            CL      L+L+   LS  +P        L  L
Sbjct: 41  NAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESL 96

Query: 48  NVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIP 83
             S N L   LP+   ++KSL   + +    S   P
Sbjct: 97  VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 8/82 (9%)

Query: 3   RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM 62
            NN    +P E+ +   L  +D+  N L   +P        L ++    NQL   LP E+
Sbjct: 139 SNNQLEKLP-ELQNSSFLKIIDVDNNSLKK-LPDLPPS---LEFIAAGNNQLE-ELP-EL 191

Query: 63  GNMKSLTSADFSHNNFSGEIPE 84
            N+  LT+    +N+   ++P+
Sbjct: 192 QNLPFLTAIYADNNSLK-KLPD 212

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 7/84 (8%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N     +P E+ +   LT +    N L   +P     +  LN  +   N L   LP+
Sbjct: 222 AGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRD---NYLT-DLPE 274

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
              ++  L  ++   +  S   P 
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPPN 298

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 13/84 (15%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N FSG+      +   L YL+ S N +   +         L  LNVS N+L   LP 
Sbjct: 284 VSENIFSGL-SELPPN---LYYLNASSNEIRS-LCDLPPS---LEELNVSNNKLI-ELPA 334

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
               ++ L     S N+ + E+PE
Sbjct: 335 LPPRLERL---IASFNHLA-EVPE 354

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 20/84 (23%), Positives = 31/84 (36%), Gaps = 13/84 (15%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
            S N    +          L  L++S N L   +P    +   L  L  S+N L   +P+
Sbjct: 304 ASSNEIRSL-CDLPPS---LEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 354

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
              N+K L      +N    E P+
Sbjct: 355 LPQNLKQL---HVEYNPLR-EFPD 374

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 14/84 (16%), Positives = 30/84 (35%), Gaps = 11/84 (13%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N+   + P        L  +    N L      ++  +  L  +    N L  +LP 
Sbjct: 202 ADNNSLKKL-PDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD 254

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
              ++++L   +   N  + ++PE
Sbjct: 255 LPPSLEAL---NVRDNYLT-DLPE 274

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 40/171 (23%), Positives = 59/171 (34%), Gaps = 18/171 (10%)

Query: 182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
           + +K    +GRG  G V          T     VAVK L       S    L +E++ L 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILI 80

Query: 236 KI-RHRNIVRLKAFCS-NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAK 293
            I  H N+V L   C+      +++ E+   G+L   L  KR  F+             K
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP---------YKTK 131

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
           G  +         I  D+K     + S   +  + F   K L D    E  
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 23/88 (26%), Positives = 40/88 (45%), Gaps = 3/88 (3%)

Query: 250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHR 309
           S+  +  +  + + +    E        FL  E  +  + + AKG+ +L    S   IHR
Sbjct: 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHR 217

Query: 310 DVKSNNILLNSDFEAHVADFGLAKYLQD 337
           D+ + NILL+      + DFGLA+ +  
Sbjct: 218 DLAARNILLSEKNVVKICDFGLARDIYK 245

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 3/88 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLP 59
           ++ N  + +  ++ G    + YLDL  N +              L +LN+ +N +   + 
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVK 185

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            ++     L + D S N  +   PEF  
Sbjct: 186 GQV-VFAKLKTLDLSSNKLAFMGPEFQS 212

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 4/79 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N     +  ++     L  LDLS N L+  +  +      + ++++  N+L   + K
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 61  EMGNMKSLTSADFSHNNFS 79
            +   ++L   D   N F 
Sbjct: 232 ALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 49.2 bits (118), Expect = 9e-07
 Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 3/84 (3%)

Query: 1  MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
          ++ ++    +         +  LDLS N LS      +     L  LN+S N L      
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74

Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
          ++ ++ +L + D ++N    E+  
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELLV 97

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 9/68 (13%), Positives = 21/68 (30%), Gaps = 1/68 (1%)

Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
               ++ + L   +         +  L++S N L+     ++     L   + S N   
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 80 GEIPEFGQ 87
           E  +   
Sbjct: 72 -ETLDLES 78

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 11/85 (12%), Positives = 32/85 (37%), Gaps = 5/85 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
            + NN S  +    G       + L+ N ++    +       + YL++  N+++  +  
Sbjct: 106 AANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
           +   +  +L   +  +N    ++  
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKG 186

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 11/78 (14%), Positives = 23/78 (29%), Gaps = 3/78 (3%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           S N  +  +  E      +T++ L  N L   I   +     L + ++  N  +      
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CGTLR 255

Query: 62  MGNMKSLTSADFSHNNFS 79
               K+      +     
Sbjct: 256 DFFSKNQRVQTVAKQTVK 273

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 5/87 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  S I    +     L  L++  N +S      +  +  LN L ++ NQL     +
Sbjct: 250 IGTNQISDINA--VKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDME 305

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            +G + +LT+   S N+ +  I     
Sbjct: 306 VIGGLTNLTTLFLSQNHITD-IRPLAS 331

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.5 bits (119), Expect = 6e-07
 Identities = 13/87 (14%), Positives = 35/87 (40%), Gaps = 6/87 (6%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++ N  + I P  + + + LT L +  N ++      +  +  L  L ++ + +  S   
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNI--SDIS 126

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            + N+  + S +   N+   ++     
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSPLSN 153

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.5 bits (114), Expect = 3e-06
 Identities = 16/87 (18%), Positives = 32/87 (36%), Gaps = 7/87 (8%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N  + I P  + +   L  L +  N ++   P  +  +  L +L +  NQ+  S   
Sbjct: 206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDIN 259

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            + ++  L   +   N  S +I     
Sbjct: 260 AVKDLTKLKMLNVGSNQIS-DISVLNN 285

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.5 bits (114), Expect = 3e-06
 Identities = 16/86 (18%), Positives = 35/86 (40%), Gaps = 7/86 (8%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           +    + I    I +   L YL+L+ N ++   P  ++ +  L  L +  N++  +    
Sbjct: 52  AGEKVASIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISA 105

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQ 87
           + N+ +L     + +N S  I     
Sbjct: 106 LQNLTNLRELYLNEDNISD-ISPLAN 130

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.4 bits (111), Expect = 7e-06
 Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 4/79 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  S I    + +   L  L L+ N L       I  +  L  L +S N +    P 
Sbjct: 272 VGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328

Query: 61  EMGNMKSLTSADFSHNNFS 79
            + ++  + SADF++    
Sbjct: 329 -LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 14/82 (17%), Positives = 33/82 (40%), Gaps = 5/82 (6%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
             N+    +   + +   L YL ++++ +    P  I  +  L  L++++NQ+       
Sbjct: 140 GANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SP 194

Query: 62  MGNMKSLTSADFSHNNFSGEIP 83
           + ++ SL       N  +   P
Sbjct: 195 LASLTSLHYFTAYVNQITDITP 216

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 7/68 (10%), Positives = 24/68 (35%), Gaps = 5/68 (7%)

Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
               L +  ++  +     ++  +  L V+  ++  S+   +  + +L   + + N  +
Sbjct: 24 GIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQIT 79

Query: 80 GEIPEFGQ 87
            I     
Sbjct: 80 D-ISPLSN 86

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 17/85 (20%), Positives = 30/85 (35%), Gaps = 1/85 (1%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
           ++ N    +          L  L   + +L+      I  +  L  LNV+ N + +  LP
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
           +   N+ +L   D S N        
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCT 167

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 15/86 (17%), Positives = 26/86 (30%), Gaps = 2/86 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N    +          L  LDLS+  +          +  L+ L ++ N +  SL  
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLAL 93

Query: 61  EM-GNMKSLTSADFSHNNFSGEIPEF 85
                + SL        N +      
Sbjct: 94  GAFSGLSSLQKLVAVETNLASLENFP 119

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 3/86 (3%)

Query: 1   MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
              +N   +    +   L  L YLD+S  H           +  L  L ++ N    +  
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 60  KEM-GNMKSLTSADFSHNNFSGEIPE 84
            ++   +++LT  D S      ++  
Sbjct: 463 PDIFTELRNLTFLDLSQCQLE-QLSP 487

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 21/69 (30%), Positives = 34/69 (49%), Gaps = 4/69 (5%)

Query: 20  LTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNN 77
           L +LDLS+N LS  G           L YL++S+N +  ++      ++ L   DF H+N
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN 407

Query: 78  FSGEIPEFG 86
              ++ EF 
Sbjct: 408 LK-QMSEFS 415

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 3/81 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
           +S  +              L  L ++ N         I T++  L +L++S  QL   L 
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS 486

Query: 60  KEM-GNMKSLTSADFSHNNFS 79
                ++ SL   + + N   
Sbjct: 487 PTAFNSLSSLQVLNMASNQLK 507

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 14/85 (16%), Positives = 26/85 (30%), Gaps = 2/85 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLP 59
           +S N     +         L +LD   ++L           +  L YL++S      +  
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
                + SL     + N+F      
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLP 463

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 16/106 (15%)

Query: 1   MSRN--NFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           +SRN  +F G           L YLDLS N +   +      +  L +L+   + L   +
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QM 411

Query: 59  PKE--MGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
            +     ++++L   D SH +               +  F G   L
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHT----------RVAFNGIFNGLSSL 447

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 16/87 (18%), Positives = 32/87 (36%), Gaps = 6/87 (6%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  NN S I P  +     L  L    N +S      +  +  +N+L+   NQ+  S   
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQI--SDLT 369

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            + N+  +T    +   ++     +  
Sbjct: 370 PLANLTRITQLGLNDQAWTNAPVNYKA 396

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 7/87 (8%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++ N    I P  I +   LTYL L  N++S   P  ++ +  L  L    N++  S   
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVS 347

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            + N+ ++      HN  S  +     
Sbjct: 348 SLANLTNINWLSAGHNQISD-LTPLAN 373

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 13/105 (12%), Positives = 27/105 (25%), Gaps = 25/105 (23%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPI----------------------PVQI 38
              N  S + P  + +   +T L L+    +                         P  I
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATI 417

Query: 39  TQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIP 83
           +        +++WN  +    +         +       FSG + 
Sbjct: 418 SDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 6/83 (7%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N  S I    +     L  L  + N +S   P  +  +  L+ L+++ NQL      
Sbjct: 184 ISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIG 237

Query: 61  EMGNMKSLTSADFSHNNFSGEIP 83
            + ++ +LT  D ++N  S   P
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 16/86 (18%), Positives = 32/86 (37%), Gaps = 7/86 (8%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
            R     I    + +   LT ++ S N L+   P  +  +  L  + ++ NQ+       
Sbjct: 54  DRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITP 107

Query: 62  MGNMKSLTSADFSHNNFSGEIPEFGQ 87
           + N+ +LT     +N  +  I     
Sbjct: 108 LANLTNLTGLTLFNNQITD-IDPLKN 132

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 11/99 (11%), Positives = 27/99 (27%), Gaps = 5/99 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N  S +    + +   + +L    N +S   P  +  +  +  L ++      + P 
Sbjct: 338 FYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPV 392

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGN 99
                 S+ +   +                +     T N
Sbjct: 393 NYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 18/87 (20%), Positives = 37/87 (42%), Gaps = 7/87 (8%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++ N    I    +     LT LDL+ N +S   P  ++ +  L  L +  NQ++ ++  
Sbjct: 228 LNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NIS- 281

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            +  + +LT+ + + N     I     
Sbjct: 282 PLAGLTALTNLELNENQLED-ISPISN 307

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 21/87 (24%), Positives = 37/87 (42%), Gaps = 8/87 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  + I P  + +   L  L+LS N +S      ++ +  L  L+   NQ+    P 
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKP- 172

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            + N+ +L   D S N  S +I    +
Sbjct: 173 -LANLTTLERLDISSNKVS-DISVLAK 197

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 10/84 (11%), Positives = 26/84 (30%), Gaps = 7/84 (8%)

Query: 4  NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG 63
             + I               L + +++  +    T +  +  L      + +     + 
Sbjct: 12 TPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVE 65

Query: 64 NMKSLTSADFSHNNFSGEIPEFGQ 87
           + +LT  +FS+N  +  I     
Sbjct: 66 YLNNLTQINFSNNQLTD-ITPLKN 88

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 3/84 (3%)

Query: 1  MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
          ++ ++    +         +  LDLS N LS      +     L  LN+S N L      
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74

Query: 61 EMGNMKSLTSADFSHNNFSGEIPE 84
          ++ ++ +L + D ++N    E+  
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELLV 97

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 21/147 (14%), Positives = 45/147 (30%), Gaps = 6/147 (4%)

Query: 20  LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
           L  LDLS N L+  +  +      + ++++  N+L   + K +   ++L   D   N F 
Sbjct: 193 LKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250

Query: 80  GEIPE--FGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQ--NGNKSHVPGKYKLL 135
                  F +     + +      L G     C   +             +    +   L
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310

Query: 136 FALGLLLCSLVFAVLAIIKTRKFRKNS 162
                 L S   +    ++  +  +  
Sbjct: 311 KRKEHALLSGQGSETERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 9/68 (13%), Positives = 21/68 (30%), Gaps = 1/68 (1%)

Query: 20 LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
               ++ + L   +         +  L++S N L+     ++     L   + S N   
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 80 GEIPEFGQ 87
           E  +   
Sbjct: 72 -ETLDLES 78

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 11/85 (12%), Positives = 32/85 (37%), Gaps = 5/85 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
            + NN S +     G       + L+ N ++    +       + YL++  N+++  +  
Sbjct: 106 AANNNISRV-SCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPE 84
           +   +  +L   +  +N    ++  
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKG 186

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 40.2 bits (94), Expect = 9e-04
 Identities = 11/77 (14%), Positives = 25/77 (32%), Gaps = 3/77 (3%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLN-ASLPK 60
           S N  + +   E      +T++ L  N L   I   +     L + ++  N  +  +L  
Sbjct: 199 SSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 61  EMGNMKSLTSADFSHNN 77
                + + +       
Sbjct: 257 FFSKNQRVQTVAKQTVK 273

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 17/79 (21%), Positives = 28/79 (35%), Gaps = 2/79 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N    I+         L  L +S N L   + +    I  L  L++S N L   + +
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 318

Query: 61  EMGNMKSLTSADFSHNNFS 79
                  L +    HN+  
Sbjct: 319 NQPQFDRLENLYLDHNSIV 337

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 24/163 (14%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTLGKIRHR----- 240
           VIG+G  G V +       + VA+K    + +     H      EIR L  +R +     
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK----MVRNEKRFHRQAAE-EIRILEHLRKQDKDNT 158

Query: 241 -NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAIEAAKGLSY 297
            N++ +    + +    + +E + + +L E++  K+  F  + + L  K A    + L  
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELI--KKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 298 LHHDCSPLIIHRDVKSNNILLNSDFEAH--VADFGLAKYLQDT 338
           LH      IIH D+K  NILL     +   V DFG + Y    
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 3/84 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N    I+         L  L +S N L   + +    I  L  L++S N L   + +
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 312

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE 84
                  L +    HN+    +  
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKL 335

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 48.6 bits (115), Expect = 2e-06
 Identities = 21/102 (20%), Positives = 38/102 (37%), Gaps = 7/102 (6%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++  + + +    +   LL+T+LDLS N L   +P  +  +  L  L  S N L  ++  
Sbjct: 448 LAHKDLTVLC--HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD- 502

Query: 61  EMGNMKSLTSADFSHNNFSG--EIPEFGQYSFFNSTSFTGNP 100
            + N+  L      +N       I            +  GN 
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 40.9 bits (95), Expect = 5e-04
 Identities = 16/87 (18%), Positives = 34/87 (39%), Gaps = 4/87 (4%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
             R+ F     V       +  L L+   L+    ++  Q+ ++ +L++S N+L  +LP 
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLR-ALPP 480

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQ 87
            +  ++ L     S N     +     
Sbjct: 481 ALAALRCLEVLQASDNALE-NVDGVAN 506

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 24/175 (13%)

Query: 178 DDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSS--HDNGLSAEIRTL 234
           +  ++  + +++IG+G  G V +       E VA+K    I K      +     E+R L
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQI-EVRLL 104

Query: 235 GKIRHR------NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRL--K 286
             +          IV LK     +    LV+E + + +L ++L  +  +F    + L  K
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL--RNTNFRGVSLNLTRK 161

Query: 287 IAIEAAKGLSYLH-HDCSPLIIHRDVKSNNILLNSDFEAH--VADFGLAKYLQDT 338
            A +    L +L   + S  IIH D+K  NILL +   +   + DFG +  L   
Sbjct: 162 FAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 18/87 (20%), Positives = 34/87 (39%), Gaps = 3/87 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S N  + I   ++  C  L  L L  + ++         +  L +L++S N L+ SL  
Sbjct: 33  LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSS 91

Query: 61  EM-GNMKSLTSADFSHNNFSGEIPEFG 86
              G + SL   +   N +   +    
Sbjct: 92  SWFGPLSSLKYLNLMGNPYQ-TLGVTS 117

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 22/103 (21%), Positives = 33/103 (32%), Gaps = 10/103 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLP 59
           +  +  + I          L +LDLS NHLS         +  L YLN+  N      + 
Sbjct: 57  LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
               N+ +L +    +     EI             F G   L
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRR---------IDFAGLTSL 150

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 16/88 (18%), Positives = 31/88 (35%), Gaps = 9/88 (10%)

Query: 16  HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG-NMKSLTSADFS 74
             + +  L + Q +L   +    + +  +  + V  +++   +P     ++KSL   D S
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342

Query: 75  HNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
            N    E          NS      P L
Sbjct: 343 ENLMVEEY-------LKNSACKGAWPSL 363

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 10/82 (12%), Positives = 25/82 (30%), Gaps = 3/82 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           + +      +         +  + +  + +          +  L +L++S N +     K
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352

Query: 61  EM---GNMKSLTSADFSHNNFS 79
                G   SL +   S N+  
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLR 374

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 5/66 (7%)

Query: 20  LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
           LT LD+S+N    P+P        + +LN+S   +   +       ++L   D S+NN  
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD 444

Query: 80  GEIPEF 85
                F
Sbjct: 445 -SFSLF 449

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 45.7 bits (109), Expect = 5e-06
 Identities = 13/86 (15%), Positives = 34/86 (39%), Gaps = 2/86 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           ++  + +   P  I     L  L +    ++      ++ +  L  L++S +  + S+  
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFG 86
           ++  +  + S D S+N    +I    
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLK 156

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 15/83 (18%), Positives = 32/83 (38%), Gaps = 4/83 (4%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           +  N + +  +E  +   +  L ++  H +   P  I+ +  L  L +    + +     
Sbjct: 52  ANINVTDLTGIE--YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPN 107

Query: 62  MGNMKSLTSADFSHNNFSGEIPE 84
           +  + SLT  D SH+     I  
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILT 130

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 20/82 (24%), Positives = 30/82 (36%), Gaps = 3/82 (3%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPI--PVQITQIHILNYLNVSWNQLNA-S 57
           +  +    + P        L  L L    LS  +        +  L  L++S NQ+ +  
Sbjct: 80  LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139

Query: 58  LPKEMGNMKSLTSADFSHNNFS 79
           L    G + SL S DFS N   
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIF 161

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 10/83 (12%)

Query: 20  LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS 79
           + +LDLS   +          +  L  LN+++N++N    +    + +L   + S+N   
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL- 326

Query: 80  GEIPEFGQYSFFNSTSFTGNPHL 102
                        S++F G P +
Sbjct: 327 ---------GELYSSNFYGLPKV 340

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 18/86 (20%), Positives = 33/86 (38%), Gaps = 8/86 (9%)

Query: 1   MSRNNFSGIIPVEIGHCLL-LTYLDLSQNHLSGPIPVQITQIHI-----LNYLNVSWNQL 54
           +++N FS     +       L  L L +N L      ++          L  L ++ N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492

Query: 55  NASLPKEM-GNMKSLTSADFSHNNFS 79
           N SLP  +  ++ +L     + N  +
Sbjct: 493 N-SLPPGVFSHLTALRGLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 18/125 (14%), Positives = 38/125 (30%), Gaps = 13/125 (10%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S      +          L  L+L+ N ++         +  L  LN+S+N L      
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNS-----------TSFTGNPHLCGSYLNP 109
               +  +   D   N+ +  I +   + F              T+    P +   +L+ 
Sbjct: 333 NFYGLPKVAYIDLQKNHIA-IIQD-QTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSG 390

Query: 110 CNYSS 114
               +
Sbjct: 391 NKLVT 395

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 16/84 (19%), Positives = 27/84 (32%), Gaps = 11/84 (13%)

Query: 20  LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNF 78
              L LS N++          +  L  L +       ++ KE   N+ +L   D   +  
Sbjct: 26  TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85

Query: 79  SGEIPEFGQYSFFNSTSFTGNPHL 102
                      F +  +F G  HL
Sbjct: 86  ----------YFLHPDAFQGLFHL 99

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 13/104 (12%), Positives = 28/104 (26%), Gaps = 11/104 (10%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
           +S N    +          L  L+L   +    I  +    +  L  L++  +++   L 
Sbjct: 31  LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLH 89

Query: 60  KEM-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
            +    +  L          S  + +           F     L
Sbjct: 90  PDAFQGLFHLFELRLYFCGLSDAVLK--------DGYFRNLKAL 125

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 34/169 (20%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIR-------- 238
            +G G    V+      N   VA+K    I +G       +  EI+ L ++         
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 239 ---HRNIVRLK---AFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRL--KIAI 289
                +I++L            ++ +V+E +   +L  ++  K+       +    +I+ 
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI--KKYEHRGIPLIYVKQISK 138

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH------VADFGLA 332
           +   GL Y+H  C   IIH D+K  N+L+             +AD G A
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 24/104 (23%), Positives = 38/104 (36%), Gaps = 12/104 (11%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS--GPIPVQITQIHILNYLNVSWNQLNASL 58
           +  N    +          LT L LS N LS  G           L YL++S+N +  ++
Sbjct: 35  LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITM 93

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
                 ++ L   DF H+N   ++ EF          F    +L
Sbjct: 94  SSNFLGLEQLEHLDFQHSNLK-QMSEFS--------VFLSLRNL 128

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 3/60 (5%)

Query: 20  LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNF 78
           +  LDL  N +   IP  +T +  L  LNV+ NQL  S+P  +   + SL       N +
Sbjct: 452 VKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 25/94 (26%), Positives = 38/94 (40%), Gaps = 20/94 (21%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHI--------LNYLNVSWN 52
           +S+N+ S +   +I     L  L LS N        +I  +          L YL+VS N
Sbjct: 59  LSQNSISELRMPDISFLSELRVLRLSHN--------RIRSLDFHVFLFNQDLEYLDVSHN 110

Query: 53  QLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFG 86
           +L  ++      M SL   D S N+F   +P   
Sbjct: 111 RL-QNIS--CCPMASLRHLDLSFNDFD-VLPVCK 140

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 43.1 bits (102), Expect = 8e-05
 Identities = 23/119 (19%), Positives = 38/119 (31%), Gaps = 6/119 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  + +    +     L  L LS N +S      +     L  L+++ N+L   +P 
Sbjct: 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPG 257

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIH 119
            + + K +      +NN    I   G   F      T      G  L   N      I 
Sbjct: 258 GLADHKYIQVVYLHNNN----ISAIGSNDFCPPGYNTKKASYSGVSLFS-NPVQYWEIQ 311

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 30/151 (19%), Positives = 50/151 (33%), Gaps = 10/151 (6%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +S+N  S +   +I     L  L +S N +             L YL++S N+L   +  
Sbjct: 28  ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-VKISC 86

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT----GNPHLCGSYLNPCNYSSTT 116
                 +L   D S N F   +P      F N +          HL  S + P  + + +
Sbjct: 87  --HPTVNLKHLDLSFNAFD-ALPICK--EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141

Query: 117 PIHNQNGNKSHVPGKYKLLFALGLLLCSLVF 147
            +    G         + L         +VF
Sbjct: 142 KVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 25/81 (30%), Positives = 36/81 (44%), Gaps = 9/81 (11%)

Query: 1   MSRNNFSGIIPVEIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           MS N  +  I      CL   +  LDL  N +   IP Q+ ++  L  LNV+ NQL  S+
Sbjct: 406 MSSNILTDTIF----RCLPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQL-KSV 459

Query: 59  PKEM-GNMKSLTSADFSHNNF 78
           P  +   + SL       N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 20/86 (23%), Positives = 32/86 (37%), Gaps = 4/86 (4%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           + +    +  +         +LD S N L+  +      +  L  L +  NQL   L K 
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKI 366

Query: 62  MG---NMKSLTSADFSHNNFSGEIPE 84
                 MKSL   D S N+ S +  +
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKK 392

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 22/106 (20%), Positives = 44/106 (41%), Gaps = 13/106 (12%)

Query: 1   MSRNNFSGIIPVEIGHCLL-LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP 59
           +S+N+ S             L  L++S N L+  I   +     +  L++  N++  S+P
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIP 437

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFT-----GNP 100
           K++  +++L   + + N     +P+     F   TS        NP
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVPDG---IFDRLTSLQKIWLHTNP 479

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 16/102 (15%), Positives = 38/102 (37%), Gaps = 12/102 (11%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE 61
           S   +   +     + L LT L ++  +L+    + +  +  L +LN+S+N + +++   
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGS 266

Query: 62  M-GNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHL 102
           M   +  L          +  +            +F G  +L
Sbjct: 267 MLHELLRLQEIQLVGGQLA-VVEP---------YAFRGLNYL 298

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 36/138 (26%), Positives = 54/138 (39%), Gaps = 36/138 (26%)

Query: 205 NGEQVAVKKLLGITKGSSHDNGLSA-EIRTLGKIR--------HRNIVRLK-AF------ 248
             + VA+K    + K + H    +  EIR L  +R           +V+L   F      
Sbjct: 61  GKKFVAMK----VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116

Query: 249 ----CSNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
               C       +V+E +  G  L + +       L      KI  +  +GL YLH  C 
Sbjct: 117 GTHIC-------MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR 167

Query: 304 PLIIHRDVKSNNILLNSD 321
             IIH D+K  NILL+ +
Sbjct: 168 --IIHTDIKPENILLSVN 183

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 25/120 (20%), Positives = 41/120 (34%), Gaps = 9/120 (7%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQI-TQIHILNYLNVSWNQLNASLP 59
           +  N    I   ++     L  L L  N +   I     + +  L  L++  N+L + +P
Sbjct: 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKL-SRVP 257

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYL--NPCNYSSTTP 117
             + ++K L       NN    I + G   F          +  G  L  NP  Y    P
Sbjct: 258 AGLPDLKLLQVVYLHTNN----ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 27/166 (16%), Positives = 56/166 (33%), Gaps = 23/166 (13%)

Query: 177 SDDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK 236
               ++ +    ++G G    V+   +    +  VK      K          E R  G 
Sbjct: 87  RSGKVDAI--GKLMGEGKESAVFNCYSEKFGECVVK----FHKVGHTSFKKVKEKRDYGD 140

Query: 237 IRHRNIVRLKAFCSNKETNLL----------VYEYMPNGSLGEVLHGKRGSFLKWEMRLK 286
           +    +    A     E   L          VY +  N  L E++  K    ++ E   +
Sbjct: 141 LHFSVLAIRSA---RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE 197

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA 332
           +     + ++  +H     I+H D+   N+L++ +    + DF  +
Sbjct: 198 VLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQS 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	362
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.98
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.98
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.98
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.98
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.98
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.98
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.98
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.98
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.98
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.98
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.98
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.98
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.94
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.69
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.56
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.56
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.54
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.53
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.49
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.48
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.48
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.47
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.45
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.45
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.44
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.4
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.4
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.39
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.39
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.39
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.39
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.39
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.38
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.36
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.36
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.35
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.35
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.35
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.35
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.34
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.34
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.33
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.32
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.32
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.32
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.32
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.31
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.29
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.29
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.29
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.29
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.29
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.27
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.27
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.23
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.22
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.22
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.21
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.2
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.2
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.2
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.17
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.16
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.14
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.14
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.13
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.1
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.1
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.03
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.03
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.02
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.02
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.0
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.99
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.99
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.96
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.96
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.96
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.94
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.94
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.93
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.93
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.93
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.93
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.92
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.91
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.9
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.9
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.9
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.87
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.87
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.85
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.85
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.84
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.8
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.79
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.78
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.77
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.77
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.77
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.76
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.75
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.74
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.71
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.68
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.63
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.58
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.57
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.53
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.5
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.44
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.26
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.24
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.21
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.15
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.05
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.99
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.96
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.75
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.57
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.51
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.51
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.5
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.44
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.32
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.31
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.29
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.28
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.26
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.03
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.0
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	96.77
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.58
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.49
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.24
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	95.97
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	95.71
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	95.28
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	95.14
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	93.82
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.13
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	92.37
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	91.73
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.71
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.92
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.05
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	83.19
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	81.94
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	81.55

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.1e-44  Score=327.99  Aligned_cols=176  Identities=25%  Similarity=0.373  Sum_probs=148.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      +++|+..+.||+|+||+||+|++ .+++.||||++..........+.+.+|++++++++|||||++++++.+++..||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            46899999999999999999987 46899999999765444444567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |||++|+|.+++...+...+++..+..|+.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|+.+... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999997666667899999999999999999999665   999999999999999999999999999977532 


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......+||+.|||||++.+
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~  199 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICEN  199 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTT
T ss_pred             -cccccccCCCccccCHHHHCC
Confidence             122456789999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=318.39  Aligned_cols=172  Identities=31%  Similarity=0.423  Sum_probs=141.2

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++++..+.||+|+||+||+|++.+  .||||+++.........++|.+|++++++++|||||++++++.. +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            556778899999999999999753  69999987554444445679999999999999999999999864 568999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      |++|+|.++|+.. ...++|.++..|+.|||+||+|||+.+   ||||||||+|||+++++.+||+|||+|+........
T Consensus       113 ~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          113 CEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999744 346999999999999999999999655   999999999999999999999999999977544333


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......+||+.|||||++.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~  207 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIR  207 (307)
T ss_dssp             -----CCCCTTSCCHHHHH
T ss_pred             eeecccccCCCccCHHHhh
Confidence            4456678999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.2e-43  Score=319.30  Aligned_cols=175  Identities=25%  Similarity=0.306  Sum_probs=152.8

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||++..... .....+.+.+|+++|++++|||||++++++++++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5689999999999999999987 4689999999965321 2233456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |||++|+|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999964  345999999999999999999999665   9999999999999999999999999999876444


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......+.+||+.|||||++.+
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~  208 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTE  208 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHH
T ss_pred             CcccccCcccCcccCCHHHHcC
Confidence            4444667899999999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-42  Score=318.54  Aligned_cols=172  Identities=24%  Similarity=0.341  Sum_probs=150.7

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      ..+.|+..+.||+|+||+||+|++. +|+.||||++.....  ...+.+.+|+++|++++|||||++++++.+++..|||
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3467888899999999999999974 689999999965433  2334589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      ||||++|+|.+++..   ..+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|+.+...
T Consensus       150 mEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          150 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             ECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999999964   34899999999999999999999665   999999999999999999999999999987543


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ......+||+.|||||++.+
T Consensus       224 ~--~~~~~~~GTp~YmAPEvl~~  244 (346)
T 4fih_A          224 V--PRRKSLVGTPYWMAPELISR  244 (346)
T ss_dssp             S--CCBCCCCSCGGGCCHHHHTT
T ss_pred             C--CcccccccCcCcCCHHHHCC
Confidence            2  23567899999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-42  Score=317.14  Aligned_cols=176  Identities=20%  Similarity=0.338  Sum_probs=148.2

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +.++..+.||+|+||+||+|++.      +++.||||+++.... ....++|.+|+.++++++|||||+++|+|.+++..
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            45666789999999999999862      467899999865432 23345699999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          256 LLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      +||||||++|||.++|....              ...++|..+.+|+.|||+||+|||+.+   ||||||||+|||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence            99999999999999996432              235899999999999999999999655   9999999999999999


Q ss_pred             CceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.+||+|||+|+.+............+||+.|||||++.+
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  221 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY  221 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence            9999999999998754433333456789999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.3e-43  Score=318.01  Aligned_cols=175  Identities=23%  Similarity=0.390  Sum_probs=147.0

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ++|...+.||+|+||+||+|++.      ++..||||+++...  ....++|.+|+++|++++|||||+++|+|.+++..
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            56778899999999999999863      46789999986432  23345699999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCce
Q 018036          256 LLVYEYMPNGSLGEVLHGK-----------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA  324 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~-----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  324 (362)
                      +||||||++|+|.++|+..           ....++|.++..|+.|||+||+|||+.+   ||||||||+|||+++++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            9999999999999999643           2356999999999999999999999655   9999999999999999999


Q ss_pred             EEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       325 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+|||+|+...............||+.|||||++.+
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  204 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  204 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence            9999999997754433333445679999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=318.95  Aligned_cols=175  Identities=25%  Similarity=0.368  Sum_probs=139.7

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +++...+.||+|+||+||+|++.      +++.||||+++...  ....++|.+|+++|++++|||||+++|+|.+.+..
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45667789999999999999863      47889999986432  23345699999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC
Q 018036          256 LLVYEYMPNGSLGEVLHGKR-------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF  322 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  322 (362)
                      +||||||++|+|.++++...             ...++|.+++.|+.|||+||+|||+.+   ||||||||+|||+++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            99999999999999997532             246999999999999999999999655   99999999999999999


Q ss_pred             ceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+||+|||+|+.+............+||+.|||||++.+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  234 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  234 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence            999999999997754433333456789999999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=320.43  Aligned_cols=173  Identities=25%  Similarity=0.346  Sum_probs=151.6

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +..+.|+..+.||+|+||.||+|++. +|+.||||++.....  ...+.+.+|+.+|++++|||||++++++.+.+..||
T Consensus       148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            44577899999999999999999974 689999999975432  334558999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||||++|+|.+++...   .+++..+..|+.||+.||+|||+.+   ||||||||+|||++.+|.+||+|||+|+.+..
T Consensus       226 VmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999999643   4899999999999999999999665   99999999999999999999999999998754


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|||||++.+
T Consensus       300 ~~--~~~~~~~GTp~YmAPEvl~~  321 (423)
T 4fie_A          300 EV--PRRKSLVGTPYWMAPELISR  321 (423)
T ss_dssp             SC--CCBCCCEECTTTCCHHHHTT
T ss_pred             CC--ccccccccCcCcCCHHHHCC
Confidence            32  23567789999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-41  Score=306.99  Aligned_cols=170  Identities=30%  Similarity=0.403  Sum_probs=143.6

Q ss_pred             cccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec----CCeeeEEE
Q 018036          185 KDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNLLVY  259 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  259 (362)
                      +..+.||+|+||+||+|.+. ++..||+|++..........++|.+|++++++++|||||++++++.+    ++..||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999874 68899999997654444445669999999999999999999999865    34679999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccccccccCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~  338 (362)
                      |||++|+|.+++..  ...+++..+..|+.||+.||+|||+. .++|+||||||+|||++. ++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            99999999999964  34689999999999999999999954 245999999999999984 799999999999865432


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                          ...+.+||+.|||||++.+
T Consensus       186 ----~~~~~~GTp~YmAPE~~~~  204 (290)
T 3fpq_A          186 ----FAKAVIGTPEFMAPEMYEE  204 (290)
T ss_dssp             ----SBEESCSSCCCCCGGGGGT
T ss_pred             ----ccCCcccCccccCHHHcCC
Confidence                2456789999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-41  Score=312.30  Aligned_cols=169  Identities=30%  Similarity=0.337  Sum_probs=142.2

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .+.|+..+.||+|+||+||+|++ .+|+.||||+++....       ..+|+.++++++|||||++++++.+++..||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35677788999999999999997 4689999999864321       357999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccccCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQDT  338 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~  338 (362)
                      |||++|+|.++++..  ..+++..+..++.||+.||+|||+.+   ||||||||+|||++.++ .+||+|||+|+.+...
T Consensus       130 Ey~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            999999999999643  45999999999999999999999555   99999999999999987 6999999999987643


Q ss_pred             CCce---eeccccCccCccccccccc
Q 018036          339 GASE---CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~---~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....   .....+||+.|||||++.+
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~  230 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMG  230 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTT
T ss_pred             CcccceecCCccccCccccCHHHHCC
Confidence            2211   1234689999999998764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-41  Score=301.49  Aligned_cols=172  Identities=24%  Similarity=0.372  Sum_probs=134.7

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||+||+|++ .+++.||+|++..... .....+++.+|++++++++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            46789999999999999999997 4689999999975433 223345699999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+ +|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+...+.
T Consensus        92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            9999 68999999643  45999999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .   ...+.+||+.|||||++.+
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~  185 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISG  185 (275)
T ss_dssp             ------------CTTSCHHHHSS
T ss_pred             C---ccCCeeECcccCChhhhcC
Confidence            2   2456789999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.9e-42  Score=311.93  Aligned_cols=173  Identities=25%  Similarity=0.253  Sum_probs=142.0

Q ss_pred             hhccccceeeccCcccEEEEEc----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||+||+|+.    .+++.||+|.+...........++.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5789999999999999999975    246899999987543333333458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||||++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+...+
T Consensus       104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999643  45999999999999999999999665   99999999999999999999999999987643


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ....+.+||+.|||||++.+
T Consensus       179 ~~--~~~~~~~GT~~YmAPE~~~~  200 (304)
T 3ubd_A          179 HE--KKAYSFCGTVEYMAPEVVNR  200 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHT
T ss_pred             CC--ccccccccCcccCCHHHhcc
Confidence            22  22456789999999998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-40  Score=303.29  Aligned_cols=177  Identities=23%  Similarity=0.343  Sum_probs=136.6

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  253 (362)
                      .++|+..+.||+|+||+||+|++ .+++.||||++..... ....+.+.+|+++|++++|||||++++++.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            46788999999999999999987 4689999999864432 223356899999999999999999999987544      


Q ss_pred             ------eeeEEEecCCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          254 ------TNLLVYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       254 ------~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                            ..|+|||||++|+|.+++..... ...++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence                  36899999999999999975432 23566778899999999999999665   999999999999999999999


Q ss_pred             ccccccccccCCCCc----------eeeccccCccCccccccccc
Q 018036          327 ADFGLAKYLQDTGAS----------ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       327 ~DFGla~~~~~~~~~----------~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|||+|+.+......          ......+||+.|||||++.+
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~  204 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG  204 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTT
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence            999999987543211          11344689999999998754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-40  Score=304.33  Aligned_cols=173  Identities=32%  Similarity=0.379  Sum_probs=139.2

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC----eeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l  257 (362)
                      ++|...+.||+|+||+||+|++ +|+.||||++....   .....+++|+..+.+++|||||+++++|..++    ..+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4577789999999999999998 68999999985321   12222455677777899999999999998654    5789


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      |||||++|+|.++++..   .++|..+.+++.|+++||+|||+++     .++||||||||+|||+|.++.+||+|||+|
T Consensus        79 V~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            99999999999999743   4899999999999999999999651     346999999999999999999999999999


Q ss_pred             ccccCCCCce--eeccccCccCccccccccc
Q 018036          333 KYLQDTGASE--CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.........  .....+||+.|||||++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~  186 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  186 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcc
Confidence            9875433221  2334689999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.6e-40  Score=303.65  Aligned_cols=177  Identities=28%  Similarity=0.372  Sum_probs=147.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc-CcceeEEEEEecC-
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNK-  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-  252 (362)
                      .++|+..+.||+|+||+||+|.+.      .++.||||++..... ....++|.+|+++|.+++| ||||+++|+|... 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            467888999999999999999853      235799999864332 2234569999999999965 8999999999765 


Q ss_pred             CeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL  318 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  318 (362)
                      +..+||||||++|+|.++|+...              ...++|..+..++.|||+||+|||+.+   ||||||||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence            56899999999999999996432              245899999999999999999999655   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       319 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++++.+||+|||+|+.+............+||+.|||||++.+
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  261 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  261 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence            9999999999999998765444444566789999999998753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=299.56  Aligned_cols=174  Identities=27%  Similarity=0.395  Sum_probs=145.8

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec------CCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------KET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  254 (362)
                      ++|+..+.||+|+||+||+|++ .+|+.||||++..........+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5788999999999999999987 478999999996544433344568899999999999999999999764      357


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .|||||||+ |+|.+++..  ...+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999995 789999964  356999999999999999999999665   99999999999999999999999999997


Q ss_pred             ccCCC--CceeeccccCccCccccccccc
Q 018036          335 LQDTG--ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~--~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +....  ........+||+.|||||++.+
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~  236 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLS  236 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTT
T ss_pred             cccCccccccccccceeChHhcCHHHhcC
Confidence            75322  1223456799999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.9e-37  Score=305.34  Aligned_cols=171  Identities=23%  Similarity=0.253  Sum_probs=144.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHH---HHHHHHhcCccCcceeEEEEEecCCee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLS---AEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +++|+..+.||+|+||+||+|++. +|+.||+|++..... .........   .++.+++.++|||||++++++++.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467899999999999999999874 689999999964321 111122233   346677888999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      |+|||||+||+|.+++..  ...+++..+..++.||+.||+|||+.+   ||||||||+|||++.+|.+||+|||+|+.+
T Consensus       268 ylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999999964  345999999999999999999999555   999999999999999999999999999977


Q ss_pred             cCCCCceeeccccCccCcccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....    ..+.+||+.|||||++.
T Consensus       343 ~~~~----~~t~~GTp~YmAPEvl~  363 (689)
T 3v5w_A          343 SKKK----PHASVGTHGYMAPEVLQ  363 (689)
T ss_dssp             SSCC----CCSCCSCGGGCCHHHHS
T ss_pred             CCCC----CCCccCCcCccCHHHHh
Confidence            5432    45679999999999885

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.9e-37  Score=287.90  Aligned_cols=171  Identities=26%  Similarity=0.377  Sum_probs=142.7

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      ++.+.|+..+.||+|+||+||+|+++    +++.||+|++...    ....++.+|++++..+ +|||||++++++.+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            34577999999999999999999753    4678999988543    2334588999999998 6999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEcccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGLA  332 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla  332 (362)
                      ..|+||||+++|+|.+++.     .+++.++..++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+|||+|
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            9999999999999999994     3899999999999999999999665   9999999999999876 79999999999


Q ss_pred             ccccCCCC--------------------------ceeeccccCccCccccccccc
Q 018036          333 KYLQDTGA--------------------------SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~--------------------------~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +...+...                          .......+||+.|||||++.+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~  220 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK  220 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence            86543211                          112345689999999998764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.5e-37  Score=301.02  Aligned_cols=177  Identities=24%  Similarity=0.409  Sum_probs=152.5

Q ss_pred             ChhhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          176 GSDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       176 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      ..+.++++|+..+.||+|+||+||+|.+ .+|+.||+|++....  ....+.+.+|+++|+.++|||||++++++.+.+.
T Consensus       151 ~~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             BSSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             CCCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3455678999999999999999999987 468999999986432  2234558899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC--CceEEcccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD--FEAHVADFGLA  332 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DFGla  332 (362)
                      .+||||||++|+|.+++... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.+  +.+||+|||+|
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             EEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence            99999999999999999643 346899999999999999999999665   9999999999999854  89999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.+...   ......+||+.|||||++.+
T Consensus       305 ~~~~~~---~~~~~~~GT~~y~APEv~~~  330 (573)
T 3uto_A          305 AHLDPK---QSVKVTTGTAEFAAPEVAEG  330 (573)
T ss_dssp             EECCTT---SEEEEECSSGGGCCHHHHTT
T ss_pred             eEccCC---CceeeeEECccccCHHHhCC
Confidence            987543   22456789999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-34  Score=265.45  Aligned_cols=173  Identities=26%  Similarity=0.354  Sum_probs=151.4

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||||++..........+++.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46788899999999999999997 57899999999765444444456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999999643  35899999999999999999999665   9999999999999999999999999998765322


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         .....+||+.|+|||++.+
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~  187 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQG  187 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHT
T ss_pred             ---ccccccCCcceeCcccccC
Confidence               2456789999999998754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.9e-34  Score=271.73  Aligned_cols=175  Identities=25%  Similarity=0.242  Sum_probs=148.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||+||+|++. +++.||+|++..... .......+.+|..++..++||||+++++++.+.+..++|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            367888999999999999999975 478899999865221 112223488999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      ||||++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.....
T Consensus       153 ~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             ECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            9999999999999753 345899999999999999999999665   999999999999999999999999999876543


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .. ......+||+.|||||++.
T Consensus       229 ~~-~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          229 GT-VQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             SC-EECCSCCSCGGGCCHHHHH
T ss_pred             CC-cccccccCCcCeeChHHHh
Confidence            22 2244578999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-33  Score=260.95  Aligned_cols=177  Identities=24%  Similarity=0.341  Sum_probs=151.8

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC----chhhHHHHHHHHhcCccCcceeEEEEEec
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS----HDNGLSAEIRTLGKIRHRNIVRLKAFCSN  251 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~  251 (362)
                      ..++.+.|+..+.||+|+||.||+|.+. +++.||+|.+........    ..+.+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            3456678999999999999999999875 689999999976543221    23568999999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC----ceEEc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVA  327 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~  327 (362)
                      .+..++||||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence            9999999999999999999954  346899999999999999999999665   99999999999998776    79999


Q ss_pred             cccccccccCCCCceeeccccCccCccccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |||+++......   .....+||+.|+|||++.+
T Consensus       162 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  192 (361)
T 2yab_A          162 DFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY  192 (361)
T ss_dssp             CCSSCEECCTTC---CCCCCCSCGGGCCHHHHTT
T ss_pred             ecCCceEcCCCC---ccccCCCCccEECchHHcC
Confidence            999998775422   2455689999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-33  Score=255.15  Aligned_cols=173  Identities=25%  Similarity=0.377  Sum_probs=150.1

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +..++|+..+.||+|+||.||+|.+ .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            3457899999999999999999986 5789999999865433  234458999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999999999643   4899999999999999999999665   99999999999999999999999999987754


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...  ......||+.|+|||++.+
T Consensus       169 ~~~--~~~~~~gt~~y~aPE~~~~  190 (297)
T 3fxz_A          169 EQS--KRSTMVGTPYWMAPEVVTR  190 (297)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHC
T ss_pred             ccc--ccCCccCCcCccChhhhcC
Confidence            322  2445689999999998643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-33  Score=259.92  Aligned_cols=176  Identities=24%  Similarity=0.304  Sum_probs=148.8

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +.++|+..+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4578999999999999999999875 7889999998644322 2234589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           84 LEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999999964  345899999999999999999999665   999999999999999999999999999876543


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .........+||+.|+|||++.+
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~  181 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKR  181 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHC
T ss_pred             CcccccCCCccCcCccCcHHhcc
Confidence            33333456789999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.7e-34  Score=269.39  Aligned_cols=173  Identities=25%  Similarity=0.251  Sum_probs=147.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||+||+|++. +++.||+|++..... .....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            367888999999999999999875 588999999865221 112233488999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       148 ~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             ECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            9999999999999643   4899999999999999999999665   999999999999999999999999999877543


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      . .......+||+.|+|||++.
T Consensus       222 ~-~~~~~~~~gt~~Y~APE~l~  242 (410)
T 3v8s_A          222 G-MVRCDTAVGTPDYISPEVLK  242 (410)
T ss_dssp             S-EEECCSCCSCGGGCCHHHHH
T ss_pred             C-cccccCCcCCccccCHHHhh
Confidence            2 22244678999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-33  Score=257.71  Aligned_cols=177  Identities=27%  Similarity=0.338  Sum_probs=148.2

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +.+.++|+..+.||+|+||.||+|.+.+++.||+|++............+.+|++++++++||||+++++++.+.+..++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            45668899999999999999999999889999999997554444444568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           97 VFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999997 5888888643 345899999999999999999999665   99999999999999999999999999987653


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...  ......||+.|+|||++.+
T Consensus       172 ~~~--~~~~~~~t~~y~aPE~~~~  193 (311)
T 3niz_A          172 PVR--SYTHEVVTLWYRAPDVLMG  193 (311)
T ss_dssp             CCC-----CCCCCCTTCCHHHHTT
T ss_pred             Ccc--cccCCcccCCcCCHHHhcC
Confidence            221  2345678999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-33  Score=260.73  Aligned_cols=174  Identities=25%  Similarity=0.279  Sum_probs=148.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467888999999999999999874 689999999865321 222334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999999864  345899999999999999999999665   999999999999999999999999999865322


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ......+||+.|+|||++.+
T Consensus       159 ~--~~~~~~~gt~~y~aPE~~~~  179 (337)
T 1o6l_A          159 G--ATMKTFCGTPEYLAPEVLED  179 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSS
T ss_pred             C--CcccccccChhhCChhhhcC
Confidence            2  22456789999999998754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-33  Score=259.05  Aligned_cols=176  Identities=39%  Similarity=0.623  Sum_probs=150.9

Q ss_pred             HhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ..++|+..+.||+|+||.||+|.+.+++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            346788899999999999999999889999999875432  233456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGKRG--SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999965432  35899999999999999999999665   99999999999999999999999999987653


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...........||+.|+|||++.
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~  214 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFI  214 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHH
T ss_pred             ccccccccccCCCccccCHHHhc
Confidence            33333344567999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.9e-33  Score=255.79  Aligned_cols=179  Identities=22%  Similarity=0.317  Sum_probs=145.7

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC----
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----  253 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  253 (362)
                      .+.++|+..+.||+|+||.||+|++. +++.||||++.... .....+.+.+|++++++++||||+++++++.+..    
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            45688999999999999999999975 78999999987543 2334456999999999999999999999986543    


Q ss_pred             -----------------------------------------------------eeeEEEecCCCCChhhhhcCCCC-CCC
Q 018036          254 -----------------------------------------------------TNLLVYEYMPNGSLGEVLHGKRG-SFL  279 (362)
Q Consensus       254 -----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~~  279 (362)
                                                                           ..++||||+++++|.+++..... ...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 37899999999999999975433 345


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc----------eeeccccC
Q 018036          280 KWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS----------ECMSAVAG  349 (362)
Q Consensus       280 ~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~G  349 (362)
                      ++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            67778999999999999999665   999999999999999999999999999987643211          11234579


Q ss_pred             ccCccccccccc
Q 018036          350 SYGYIAPVLGWY  361 (362)
Q Consensus       350 t~~y~aPE~~~~  361 (362)
                      |+.|+|||++.+
T Consensus       239 t~~y~aPE~~~~  250 (332)
T 3qd2_B          239 TKLYMSPEQIHG  250 (332)
T ss_dssp             CGGGSCHHHHHC
T ss_pred             CcCccChHHhcC
Confidence            999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=255.65  Aligned_cols=174  Identities=25%  Similarity=0.428  Sum_probs=146.5

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            67888999999999999999874 6889999988432  22334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        88 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           88 YIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999743 345899999999999999999999665   99999999999999999999999999987653322


Q ss_pred             ce------------eeccccCccCccccccccc
Q 018036          341 SE------------CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~------------~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..            ......||+.|+|||++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  196 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING  196 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC
Confidence            11            1125679999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-33  Score=262.48  Aligned_cols=172  Identities=24%  Similarity=0.317  Sum_probs=149.4

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+..... .......+.+|+++++.++|||||++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            578899999999999999999874 578999999864321 222334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999964  345899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                         ......+||+.|+|||++.
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~  187 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFS  187 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTC
T ss_pred             ---CceeccCCCccccCCeeec
Confidence               2245678999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-32  Score=253.79  Aligned_cols=177  Identities=25%  Similarity=0.343  Sum_probs=151.8

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC----CchhhHHHHHHHHhcCccCcceeEEEEEec
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSN  251 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  251 (362)
                      .+++.+.|+..+.||+|+||.||+|.+. +++.||+|.+.......    ...+.+.+|+.++++++||||+++++++.+
T Consensus         6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A            6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            3456788999999999999999999874 68999999987654322    124568999999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC----ceEEc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVA  327 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~  327 (362)
                      .+..++||||+++++|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            9999999999999999999954  346899999999999999999999665   99999999999999887    79999


Q ss_pred             cccccccccCCCCceeeccccCccCccccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |||+++......   ......||+.|+|||++.+
T Consensus       161 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  191 (326)
T 2y0a_A          161 DFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY  191 (326)
T ss_dssp             CCTTCEECCTTS---CCCCCCSCTTTCCHHHHTT
T ss_pred             ECCCCeECCCCC---ccccccCCcCcCCceeecC
Confidence            999998775322   2345679999999998753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-33  Score=264.52  Aligned_cols=174  Identities=25%  Similarity=0.279  Sum_probs=147.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||+||+|++. +++.||+|+++..... ....+.+.+|..++.++ +|||||++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467889999999999999999875 5788999999764332 22334588999999887 89999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999643  45899999999999999999999665   99999999999999999999999999986432


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|+|||++.+
T Consensus       206 ~~--~~~~~~~gt~~Y~aPE~l~~  227 (396)
T 4dc2_A          206 PG--DTTSTFCGTPNYIAPEILRG  227 (396)
T ss_dssp             TT--CCBCCCCBCGGGCCHHHHTT
T ss_pred             CC--CccccccCCcccCCchhhcC
Confidence            22  23566789999999998754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.7e-33  Score=259.80  Aligned_cols=176  Identities=27%  Similarity=0.372  Sum_probs=150.7

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||+|.+..........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            345688999999999999999999874 6899999999755443334456889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC---CceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~  333 (362)
                      +||||+++|+|.+.+..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.+   +.+||+|||+++
T Consensus       105 lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999999854  345899999999999999999999665   9999999999999865   459999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...+..   .....+||+.|+|||++.+
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~  204 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKK  204 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTT
T ss_pred             EecCCc---ccccCCCCccccCHHHHcc
Confidence            775332   2345689999999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-33  Score=261.27  Aligned_cols=172  Identities=15%  Similarity=0.185  Sum_probs=145.9

Q ss_pred             hhccccceeeccCcccEEEEE------cCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc---cCcceeEEEEEecC
Q 018036          182 ECVKDNNVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNK  252 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  252 (362)
                      +.|...+.||+|+||.||+|.      ..+++.||+|++...     ...++.+|++++.+++   |+||+++++++...
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            568888999999999999994      346889999998532     2334788888888886   99999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---------
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGK---RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---------  320 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---------  320 (362)
                      +..++||||+++|+|.+++...   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999632   3456999999999999999999999655   999999999999998         


Q ss_pred             --CCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          321 --DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       321 --~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ++.+||+|||+|+.+............+||+.|||||++.+
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  259 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN  259 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence              89999999999987654444444667789999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-33  Score=256.07  Aligned_cols=171  Identities=27%  Similarity=0.335  Sum_probs=147.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467888999999999999999874 689999999865321 122334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999999643  45899999999999999999999555   999999999999999999999999999876432


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           ....+||+.|+|||++.+
T Consensus       160 -----~~~~~gt~~y~aPE~~~~  177 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVST  177 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTT
T ss_pred             -----cccccCCccccCHhHhcC
Confidence                 345689999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=267.24  Aligned_cols=175  Identities=25%  Similarity=0.237  Sum_probs=148.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||+||+|+.. +++.||+|++..... .....+.+.+|..++..++||||+++++++.+.+..|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            367888999999999999999974 689999999864321 112233488999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++... +..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       140 mE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            9999999999999642 235899999999999999999999665   999999999999999999999999999877543


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .. ......+||+.|+|||++.
T Consensus       216 ~~-~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          216 GT-VRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             SC-EECSSCCSCGGGCCHHHHH
T ss_pred             Cc-cccceeccccCcCCHHHHh
Confidence            22 2234568999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-33  Score=262.69  Aligned_cols=177  Identities=24%  Similarity=0.362  Sum_probs=147.6

Q ss_pred             hhhccccceeeccCcccEEEEEc--------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT--------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  251 (362)
                      .++|+..+.||+|+||.||+|.+        .++..||||+++... .....+++.+|+++++++ +||||+++++++..
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            46788899999999999999975        234579999986432 122334589999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      .+..++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+.+   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            999999999999999999997543              235899999999999999999999665   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.++.+||+|||+++...............||+.|+|||++.+
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  279 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD  279 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence            99999999999999997754333233345568899999998643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-33  Score=254.88  Aligned_cols=173  Identities=21%  Similarity=0.284  Sum_probs=148.6

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++.++|+..+.||+|+||.||+|.+. +++.+|+|.+...   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            34578899999999999999999875 5788999988532   2334458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC--CCceEEccccccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--DFEAHVADFGLAKYL  335 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~~~  335 (362)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++..
T Consensus        79 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           79 IFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999999999643 346899999999999999999999665   999999999999987  789999999999887


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....   ......||+.|+|||++.+
T Consensus       155 ~~~~---~~~~~~gt~~y~aPE~~~~  177 (321)
T 1tki_A          155 KPGD---NFRLLFTAPEYYAPEVHQH  177 (321)
T ss_dssp             CTTC---EEEEEESCGGGSCHHHHTT
T ss_pred             CCCC---ccccccCChhhcCcHHhcC
Confidence            5322   2445679999999998754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.7e-33  Score=255.34  Aligned_cols=178  Identities=42%  Similarity=0.714  Sum_probs=150.6

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|...+++.||||++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  107 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP  107 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred             hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence            46789999999999999999998889999999986543322 22348999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          261 YMPNGSLGEVLHGKRG--SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+|||+++.....
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  187 (326)
T 3uim_A          108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK  187 (326)
T ss_dssp             CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred             eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence            9999999999976432  45999999999999999999999763335999999999999999999999999999877533


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .. .......||+.|+|||++.
T Consensus       188 ~~-~~~~~~~gt~~y~aPE~~~  208 (326)
T 3uim_A          188 DT-HVTTAVRGTIGHIAPEYLS  208 (326)
T ss_dssp             SS-CEECCCCSCGGGCCHHHHH
T ss_pred             cc-cccccccCCcCccCHHHhc
Confidence            22 2345567999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.3e-33  Score=252.61  Aligned_cols=176  Identities=26%  Similarity=0.368  Sum_probs=144.3

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +.++|+..+.||+|+||.||+|.+ .+++.||+|.+....... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            346789999999999999999986 468899999986544332 223568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        89 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999999643  35899999999999999999999665   99999999999999999999999999987653


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ... .......||+.|+|||++.+
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~  186 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKG  186 (294)
T ss_dssp             ------------CCSSCCHHHHHT
T ss_pred             ccc-cccCccccCccccCHhHhcC
Confidence            322 22345679999999998653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-32  Score=250.11  Aligned_cols=173  Identities=27%  Similarity=0.371  Sum_probs=147.2

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||+||+|.+. +++.||+|++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            56888899999999999999874 68899999997665544445668899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++ ++.+.+... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred             cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence            9965 666666432 345899999999999999999999665   9999999999999999999999999998765322 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......||+.|+|||++.+
T Consensus       156 -~~~~~~~~t~~y~aPE~~~~  175 (292)
T 3o0g_A          156 -RCYSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             -SCCCSCCSCGGGCCHHHHTT
T ss_pred             -ccccCCccccCCcChHHHcC
Confidence             22445679999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=262.29  Aligned_cols=173  Identities=24%  Similarity=0.274  Sum_probs=142.4

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|++. +++.||+|++..... .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            467888999999999999999874 689999999865321 122334578899999988 69999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            99999999999999643  45899999999999999999999665   99999999999999999999999999986432


Q ss_pred             CCCceeeccccCccCcccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  .......+||+.|+|||++.
T Consensus       177 ~--~~~~~~~~gt~~y~aPE~~~  197 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAPEILQ  197 (353)
T ss_dssp             -----------CCGGGCCHHHHH
T ss_pred             C--CccccccCCCcCeEChhhcC
Confidence            2  22245678999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.1e-33  Score=265.96  Aligned_cols=177  Identities=23%  Similarity=0.317  Sum_probs=150.1

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ..+.++|+..+.||+|+||.||+|.+ .+++.+|+|++..........+.+.+|++++++++||||+++++++.+.+..+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            45678999999999999999999986 47889999998765433334456899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC---CCCceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~  333 (362)
                      +||||+++|+|.+.+...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++   .++.+||+|||+++
T Consensus        87 lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999998643  45899999999999999999999665   99999999999998   46789999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......  ......+||+.|+|||++.+
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~  187 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRK  187 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTT
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcC
Confidence            775432  22345789999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.2e-33  Score=252.39  Aligned_cols=172  Identities=28%  Similarity=0.358  Sum_probs=144.0

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||+|.+.+++.||+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            56888899999999999999998899999999865543333345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      ++ ++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (288)
T 1ob3_A           82 LD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (288)
T ss_dssp             CS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence            97 4999998743 345899999999999999999999665   9999999999999999999999999998764321  


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......||+.|+|||++.
T Consensus       155 ~~~~~~~~t~~y~aPE~~~  173 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLM  173 (288)
T ss_dssp             -------CCCTTCCHHHHT
T ss_pred             cccccccccccccCchhee
Confidence            1234457899999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-32  Score=251.53  Aligned_cols=170  Identities=25%  Similarity=0.331  Sum_probs=146.6

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ..|+..+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            34666789999999999999975 78999999986543  2334558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus       123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence            9999999999864   34899999999999999999999665   99999999999999999999999999987754321


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ......||+.|+|||++.+
T Consensus       197 --~~~~~~gt~~y~aPE~~~~  215 (321)
T 2c30_A          197 --KRKSLVGTPYWMAPEVISR  215 (321)
T ss_dssp             --CBCCCCSCGGGCCHHHHTT
T ss_pred             --ccccccCCccccCHhhhcC
Confidence              2345679999999998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-32  Score=248.41  Aligned_cols=173  Identities=27%  Similarity=0.340  Sum_probs=142.3

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC------------------------CchhhHHHHHHHHh
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS------------------------SHDNGLSAEIRTLG  235 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~  235 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|.+.......                        ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46788899999999999999986 468899999986543211                        11245899999999


Q ss_pred             cCccCcceeEEEEEec--CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCC
Q 018036          236 KIRHRNIVRLKAFCSN--KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS  313 (362)
Q Consensus       236 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  313 (362)
                      +++||||+++++++.+  .+..++||||+++++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence            9999999999999987  5678999999999999887642   45899999999999999999999665   99999999


Q ss_pred             CceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          314 NNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       314 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +||+++.++.+||+|||+++......  .......||+.|+|||++.+
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  211 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSE  211 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCT
T ss_pred             HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhcc
Confidence            99999999999999999998775432  22445689999999998753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.6e-33  Score=254.86  Aligned_cols=177  Identities=31%  Similarity=0.442  Sum_probs=139.8

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+ +++.||||++..........+++.+|++++++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            46788899999999999999987 67899999986554333344568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          261 YMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            9999999999975432 24899999999999999999999431 239999999999999999999999999998654321


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .......||+.|+|||++.+
T Consensus       194 --~~~~~~~gt~~y~aPE~~~~  213 (309)
T 3p86_A          194 --LSSKSAAGTPEWMAPEVLRD  213 (309)
T ss_dssp             ----------CCTTSCHHHHTT
T ss_pred             --cccccCCCCccccChhhhcC
Confidence              12345679999999998754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.1e-33  Score=255.97  Aligned_cols=173  Identities=29%  Similarity=0.405  Sum_probs=144.4

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC----eeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l  257 (362)
                      ++|+..+.||+|+||.||+|++. ++.||||++....   .......+|+.++++++||||+++++++....    ..++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            67888999999999999999875 7899999985332   22334677899999999999999999998754    4699


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-------CSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||+.       .+++|+||||||+|||++.++.+||+|||
T Consensus       100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            99999999999999643   389999999999999999999955       01159999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++...............||+.|+|||++.+
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEG  207 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred             cccccccccCccccccCccCccccCHhhccc
Confidence            9987764433333445689999999998753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.4e-33  Score=256.60  Aligned_cols=174  Identities=25%  Similarity=0.280  Sum_probs=148.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|++. +++.||+|++....... ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467888999999999999999975 58899999997544322 2234578899999988 89999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999999643  35899999999999999999999665   99999999999999999999999999986432


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|+|||++.+
T Consensus       163 ~~--~~~~~~~gt~~y~aPE~~~~  184 (345)
T 3a8x_A          163 PG--DTTSTFCGTPNYIAPEILRG  184 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTT
T ss_pred             CC--CcccccCCCccccCccccCC
Confidence            22  22456789999999998753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-32  Score=252.76  Aligned_cols=175  Identities=25%  Similarity=0.273  Sum_probs=144.0

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      .+.++|+..+.||+|+||+||+|.+. +++.||||++...........+...|+..+.++ +||||+++++++.+.+..+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            44578999999999999999999975 789999999865443333334456666666655 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       134 lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            999999 77999988643 346999999999999999999999665   9999999999999999999999999998765


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...   ......||+.|+|||++.+
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~  230 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG  230 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT
T ss_pred             cCC---CCcccCCCccccCHhHhcC
Confidence            322   2345679999999998753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.8e-33  Score=257.61  Aligned_cols=171  Identities=22%  Similarity=0.240  Sum_probs=148.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|++. +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478889999999999999999874 689999999865321 222334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999999643  35899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           ....+||+.|+|||++.+
T Consensus       195 -----~~~~~gt~~y~aPE~~~~  212 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILS  212 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTT
T ss_pred             -----cccccCCccccCHHHhcC
Confidence                 345689999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-32  Score=269.85  Aligned_cols=175  Identities=26%  Similarity=0.303  Sum_probs=150.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|++..... .......+.+|++++++++|||||++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888899999999999999874 689999999865321 122334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999997655556999999999999999999999665   999999999999999999999999999877533


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .   .....+||+.|+|||++.+
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~  359 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKN  359 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTT
T ss_pred             c---cccccCCCccccCHHHHcC
Confidence            2   2345689999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-33  Score=257.52  Aligned_cols=174  Identities=25%  Similarity=0.289  Sum_probs=147.4

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|++. +++.||+|.++.... .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            467888999999999999999975 688999999865321 122334578899999877 89999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        96 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            99999999999999642  35899999999999999999999665   99999999999999999999999999986532


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|+|||++.+
T Consensus       171 ~~--~~~~~~~gt~~y~aPE~~~~  192 (345)
T 1xjd_A          171 GD--AKTNTFCGTPDYIAPEILLG  192 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTT
T ss_pred             CC--CcccCCCCCcccCChhhhcC
Confidence            21  22456789999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.98  E-value=2.2e-32  Score=257.82  Aligned_cols=178  Identities=20%  Similarity=0.311  Sum_probs=150.1

Q ss_pred             CChhhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC
Q 018036          175 FGSDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE  253 (362)
Q Consensus       175 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  253 (362)
                      .....+.+.|+..+.||+|+||.||+|.+. +++.||+|.+....  ......+.+|++++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY  121 (387)
T ss_dssp             CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             ccCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence            334456788999999999999999999874 68899999886432  122345889999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC--CCceEEccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--DFEAHVADFGL  331 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DFGl  331 (362)
                      ..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence            999999999999999999643 346899999999999999999999665   999999999999974  47799999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++......   ......||+.|+|||++.+
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~  224 (387)
T 1kob_A          198 ATKLNPDE---IVKVTTATAEFAAPEIVDR  224 (387)
T ss_dssp             CEECCTTS---CEEEECSSGGGCCHHHHTT
T ss_pred             ceecCCCc---ceeeeccCCCccCchhccC
Confidence            99875432   2344579999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.98  E-value=1.7e-32  Score=258.92  Aligned_cols=178  Identities=20%  Similarity=0.197  Sum_probs=152.1

Q ss_pred             hhhccccceeecc--CcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRG--GAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|  +||.||+|++. +++.||||++..........+.+.+|+.++++++|||||++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3678999999999  99999999975 68999999997654433444568889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999997665566999999999999999999999665   99999999999999999999999999876543


Q ss_pred             CCCc-----eeeccccCccCccccccccc
Q 018036          338 TGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....     .......||+.|+|||++.+
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQ  209 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred             ccccccccccccccccccccccCHHHHhc
Confidence            2211     11233579999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.98  E-value=1.1e-32  Score=254.28  Aligned_cols=174  Identities=28%  Similarity=0.361  Sum_probs=138.5

Q ss_pred             hhhccccceeeccCcccEEEEEc----CCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|+.    .+++.||+|++.....  .......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46789999999999999999986    4789999999875432  12233457889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999642  45889999999999999999999665   99999999999999999999999999986


Q ss_pred             ccCCCCceeeccccCccCccccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....  ......+||+.|+|||++.+
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~  195 (327)
T 3a62_A          171 SIHDG--TVTHTFCGTIEYMAPEILMR  195 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTT
T ss_pred             cccCC--ccccccCCCcCccCHhhCcC
Confidence            54222  22445689999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.98  E-value=1.9e-32  Score=255.27  Aligned_cols=177  Identities=25%  Similarity=0.325  Sum_probs=148.2

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccC---CCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGIT---KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +.+.|+..+.||+|+||.||+|.+ .+++.||+|.+....   ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457899999999999999999987 468999999986432   1122345689999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc---eEEcccc
Q 018036          256 LLVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADFG  330 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFG  330 (362)
                      ++||||+++++|.+.+...  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998887532  2345899999999999999999999665   999999999999986654   9999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++......  ......+||+.|+|||++.+
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  207 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKR  207 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTT
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcC
Confidence            998775432  22345679999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.98  E-value=1.8e-32  Score=252.75  Aligned_cols=175  Identities=25%  Similarity=0.375  Sum_probs=144.0

Q ss_pred             hhhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||.||+|.+.    .+..||||++.... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            467888999999999999999874    34569999986432 2223356899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       127 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999999643 345899999999999999999999665   9999999999999999999999999999875


Q ss_pred             CCCCc-eeeccccCccCcccccccc
Q 018036          337 DTGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..... .......+|+.|+|||++.
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~  227 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIA  227 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHH
T ss_pred             cCccceeeccCCCCcccccCHhHhc
Confidence            43221 1233345688999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.98  E-value=8e-33  Score=266.80  Aligned_cols=174  Identities=23%  Similarity=0.328  Sum_probs=133.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-----CCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-----KET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~  254 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||||++..........+++.+|++++++++|||||++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468899999999999999999874 68999999986544433444568999999999999999999999943     356


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .|+||||+ +++|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 57999999643  45999999999999999999999665   99999999999999999999999999997


Q ss_pred             ccCCCCc-------------------------eeeccccCccCcccccccc
Q 018036          335 LQDTGAS-------------------------ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~-------------------------~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......                         ......+||+.|+|||++.
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  256 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL  256 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence            6532111                         1234567999999999753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=1.3e-33  Score=261.50  Aligned_cols=167  Identities=17%  Similarity=0.163  Sum_probs=138.8

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCC------CCchhhHHHHHHHHhcCc---------cCcceeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG------SSHDNGLSAEIRTLGKIR---------HRNIVRL  245 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~---------h~niv~l  245 (362)
                      .++|+..+.||+|+||+||+|++ +++.||||++......      ....+.+.+|+.++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            47889999999999999999998 6899999999765321      222356889999998886         7777777


Q ss_pred             EEEEe-----------------c-------------CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 018036          246 KAFCS-----------------N-------------KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL  295 (362)
Q Consensus       246 ~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L  295 (362)
                      .+.+.                 +             .+..++||||+++|++.+.+..   ..+++..+..++.|++.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            76642                 2             6788999999999987777643   4589999999999999999


Q ss_pred             HHHh-cCCCCCeEEeCCCCCceeeCCCC--------------------ceEEccccccccccCCCCceeeccccCccCcc
Q 018036          296 SYLH-HDCSPLIIHRDVKSNNILLNSDF--------------------EAHVADFGLAKYLQDTGASECMSAVAGSYGYI  354 (362)
Q Consensus       296 ~~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~  354 (362)
                      +||| +.+   |+||||||+|||++.++                    .+||+|||+|+...+       ...+||+.||
T Consensus       175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~  244 (336)
T 2vuw_A          175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred             HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence            9999 777   99999999999999887                    899999999997653       2347999999


Q ss_pred             ccccccc
Q 018036          355 APVLGWY  361 (362)
Q Consensus       355 aPE~~~~  361 (362)
                      |||++.+
T Consensus       245 aPE~~~g  251 (336)
T 2vuw_A          245 DEDLFTG  251 (336)
T ss_dssp             CSGGGCC
T ss_pred             ChhhhcC
Confidence            9999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=1.7e-32  Score=245.84  Aligned_cols=171  Identities=24%  Similarity=0.425  Sum_probs=147.0

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||+|.+.+++.||+|++....   ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            5788889999999999999999888999999986432   2334599999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...... .
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  161 (269)
T 4hcu_A           87 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  161 (269)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-c
Confidence            9999999999643 346899999999999999999999665   9999999999999999999999999998764321 1


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......||+.|+|||++.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~  180 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFS  180 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHH
T ss_pred             ccccCcccccccCCHHHhc
Confidence            1133455788899999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.98  E-value=3.6e-32  Score=251.72  Aligned_cols=176  Identities=25%  Similarity=0.341  Sum_probs=150.4

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCC------chhhHHHHHHHHhcCccCcceeEEEEEe
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKIRHRNIVRLKAFCS  250 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~  250 (362)
                      .++.++|+..+.||+|+||.||+|.+ .+++.||||.+........      ....+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            35668999999999999999999986 5688999999976543221      2335888999999999999999999999


Q ss_pred             cCCeeeEEEecCCCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          251 NKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       251 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                      +.+..++||||+..| +|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            999999999999777 999999643  35899999999999999999999665   999999999999999999999999


Q ss_pred             cccccccCCCCceeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+++......   ......||+.|+|||++.+
T Consensus       175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  203 (335)
T 3dls_A          175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMG  203 (335)
T ss_dssp             TTCEECCTTC---CBCEECSCGGGCCHHHHTT
T ss_pred             ccceECCCCC---ceeccCCCccccChhhhcC
Confidence            9998775432   2345679999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.98  E-value=1.6e-32  Score=254.03  Aligned_cols=172  Identities=24%  Similarity=0.345  Sum_probs=147.1

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      ..+|+..+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46788899999999999999997 5789999999864321 122234589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+ +|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...+.
T Consensus        88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999 78999988543  45899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .   .....+||+.|+|||++.+
T Consensus       162 ~---~~~~~~gt~~y~aPE~~~~  181 (336)
T 3h4j_B          162 N---FLKTSCGSPNYAAPEVING  181 (336)
T ss_dssp             B---TTCCCTTSTTTSCGGGSCC
T ss_pred             c---ccccccCCcCcCCHHHHcC
Confidence            2   2445689999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.98  E-value=1.9e-32  Score=257.01  Aligned_cols=174  Identities=26%  Similarity=0.270  Sum_probs=139.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHH-HhcCccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRT-LGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|++. +++.||+|++...... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467888999999999999999975 5789999999765432 2223346677776 567899999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999964  245889999999999999999999665   99999999999999999999999999986543


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|+|||++.+
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~  213 (373)
T 2r5t_A          192 HN--STTSTFCGTPEYLAPEVLHK  213 (373)
T ss_dssp             CC--CCCCSBSCCCCCCCHHHHTT
T ss_pred             CC--CccccccCCccccCHHHhCC
Confidence            22  22456789999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=4.2e-32  Score=265.20  Aligned_cols=175  Identities=29%  Similarity=0.335  Sum_probs=149.6

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||+|++. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            66788899999999999999974 689999999865322 1223345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||+++|+|.+++....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986543  346999999999999999999999665   99999999999999999999999999997754


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...  .....+||+.|+|||++.+
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~  363 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLG  363 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTT
T ss_pred             CCc--ccccccCCccccChhhhcC
Confidence            321  2345689999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.98  E-value=1.5e-32  Score=255.89  Aligned_cols=174  Identities=27%  Similarity=0.282  Sum_probs=147.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+.+|..++..+ +||+|+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467888999999999999999975 478899999865421 122334588899999988 79999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999643  35899999999999999999999665   99999999999999999999999999986432


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|+|||++.+
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~  195 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAY  195 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTT
T ss_pred             CC--cccccccCCccccChhhhcC
Confidence            22  22456789999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.98  E-value=7.6e-33  Score=260.38  Aligned_cols=175  Identities=27%  Similarity=0.369  Sum_probs=144.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||||.++... .....+++.+|++++++++||||+++++++...+..++||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            367888899999999999999985 78999999986432 1222345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++.. .+..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...+..
T Consensus       192 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          192 ELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             ECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999963 2345899999999999999999999665   9999999999999999999999999998654321


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .........+|+.|+|||++.
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~  288 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALN  288 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHH
T ss_pred             eeecCCCCCCCcCcCCHhHhc
Confidence            111111233577899999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=6.4e-32  Score=248.06  Aligned_cols=173  Identities=25%  Similarity=0.367  Sum_probs=133.5

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            57888899999999999999874 688999999875442 2233458899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          261 YMPNGSLGEVLHGK----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       261 ~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      |++ |+|.+++...    ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 6999988532    1245899999999999999999999665   9999999999999999999999999998765


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....  ......||+.|+|||++.+
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~  182 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMG  182 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTT
T ss_pred             CCcc--cCCCCcccccccCchHhhC
Confidence            3221  2345679999999998753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.98  E-value=4.4e-32  Score=261.83  Aligned_cols=173  Identities=28%  Similarity=0.404  Sum_probs=149.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|...+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467888999999999999999975 789999999865321 122334589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           95 MEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999999964  345899999999999999999999555   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         ......+||+.|+|||++.+
T Consensus       170 ---~~~~~~~gt~~y~aPE~~~~  189 (476)
T 2y94_A          170 ---EFLRTSCGSPNYAAPEVISG  189 (476)
T ss_dssp             ---CCBCCCCSCSTTCCHHHHTT
T ss_pred             ---ccccccCCCcCeEChhhccC
Confidence               22456689999999998754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.98  E-value=1.6e-32  Score=262.66  Aligned_cols=176  Identities=27%  Similarity=0.366  Sum_probs=144.5

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----  252 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  252 (362)
                      ++.++|+..+.||+|+||.||+|.+. +++.||||++..........+++.+|++++++++||||+++++++...     
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            34578999999999999999999874 678999999975444334445689999999999999999999999766     


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      +..|+||||++ ++|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            56899999995 699999964  345899999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCc--------------------eeeccccCccCcccccccc
Q 018036          333 KYLQDTGAS--------------------ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~--------------------~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +........                    ......+||+.|+|||++.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  224 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL  224 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence            987533211                    1235678999999999753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=3e-32  Score=256.74  Aligned_cols=177  Identities=25%  Similarity=0.355  Sum_probs=148.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC--------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  251 (362)
                      .++|...+.||+|+||.||+|.+.        ++..||+|++.... ......++.+|+++++++ +||||+++++++..
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            367888999999999999999852        23579999986432 222335688999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      .+..++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            999999999999999999997543              245899999999999999999999665   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.++.+||+|||+++...............||+.|+|||++.+
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  267 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  267 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence            99999999999999997764433333455678899999998653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=4.2e-32  Score=242.97  Aligned_cols=172  Identities=26%  Similarity=0.378  Sum_probs=147.7

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.++..||+|++....   ...+++.+|++++.+++||||+++++++...+..++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            36788899999999999999999888899999986432   233558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           84 YISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             ccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999999999643 345899999999999999999999665   99999999999999999999999999987754322


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......||+.|+|||++.
T Consensus       160 -~~~~~~~~~~~y~aPE~~~  178 (268)
T 3sxs_A          160 -VSSVGTKFPVKWSAPEVFH  178 (268)
T ss_dssp             -EECCSCCCCGGGCCHHHHH
T ss_pred             -hcccCCCcCcccCCHHHHh
Confidence             2233455778899999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=2.3e-32  Score=256.73  Aligned_cols=175  Identities=26%  Similarity=0.376  Sum_probs=135.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||.||+|++.    ++..||||.++... .....+++.+|+.++++++||||+++++++...+..+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            467889999999999999999864    56789999986432 2223456899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       123 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999999743 346899999999999999999999665   9999999999999999999999999998775


Q ss_pred             CCCCce-eeccccCccCcccccccc
Q 018036          337 DTGASE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...... ......+|+.|+|||++.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~  223 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIA  223 (373)
T ss_dssp             ---------------CTTSCHHHHH
T ss_pred             cCCccceeccCCCcCCCccChhhhc
Confidence            432111 122234678899999865

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=1.2e-32  Score=257.04  Aligned_cols=176  Identities=28%  Similarity=0.388  Sum_probs=145.6

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|.+      .+++.||||++.... .....+.+.+|++++.++ +||||+++++++...+
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            47788999999999999999973      356789999986432 122234589999999999 7999999999998765


Q ss_pred             e-eeEEEecCCCCChhhhhcCCCC--------------------------------------------------------
Q 018036          254 T-NLLVYEYMPNGSLGEVLHGKRG--------------------------------------------------------  276 (362)
Q Consensus       254 ~-~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  276 (362)
                      . .++||||+++|+|.+++.....                                                        
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence            4 8999999999999999975432                                                        


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCceeecccc
Q 018036          277 --------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA  348 (362)
Q Consensus       277 --------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  348 (362)
                              ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...............
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence                    12899999999999999999999665   9999999999999999999999999998775444333455667


Q ss_pred             CccCcccccccc
Q 018036          349 GSYGYIAPVLGW  360 (362)
Q Consensus       349 Gt~~y~aPE~~~  360 (362)
                      ||+.|+|||++.
T Consensus       257 ~t~~y~aPE~~~  268 (359)
T 3vhe_A          257 LPLKWMAPETIF  268 (359)
T ss_dssp             ECGGGCCHHHHH
T ss_pred             CCceeEChhhhc
Confidence            899999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=3.1e-32  Score=257.16  Aligned_cols=177  Identities=28%  Similarity=0.443  Sum_probs=137.7

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCC--
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKE--  253 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--  253 (362)
                      ..+.++|+..+.||+|+||.||+|.+ .+++.||||++...........++.+|+.++.++. ||||+++++++...+  
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            35678899999999999999999986 46899999998654444444556889999999997 999999999997654  


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++|||||+ ++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            6899999996 699999864   35899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCC-------------------CceeeccccCccCccccccccc
Q 018036          334 YLQDTG-------------------ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~-------------------~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+....                   ........+||+.|+|||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG  204 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence            764211                   1112345689999999998754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.9e-32  Score=251.40  Aligned_cols=176  Identities=28%  Similarity=0.410  Sum_probs=146.6

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|.+      .++..||+|.+.... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            46788899999999999999985      245689999986433 223345699999999999 8999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCC
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRG---------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK  312 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  312 (362)
                      ..++||||+++|+|.+++.....                     ..+++..+..++.|++.||+|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            99999999999999999975432                     23799999999999999999999665   9999999


Q ss_pred             CCceeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       313 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+||+++.++.+||+|||+++...............||+.|+|||++.
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  247 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF  247 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence            999999999999999999998776544333345567889999999764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=1.7e-31  Score=239.80  Aligned_cols=176  Identities=24%  Similarity=0.308  Sum_probs=151.1

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +.++|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4678999999999999999999875 688999999865432 23345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++..  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           84 LEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999999964  345899999999999999999999665   999999999999999999999999999876533


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..........||+.|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~  181 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKR  181 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTC
T ss_pred             cchhcccCCccccCccChHHHhc
Confidence            32223445679999999998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=4.1e-32  Score=248.42  Aligned_cols=176  Identities=24%  Similarity=0.332  Sum_probs=147.6

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|...+.||+|+||.||+|.+      .+++.||+|.+.... .....+.+.+|++++++++||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            46788899999999999999985      245789999886432 22233568899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCC
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRG----------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK  312 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  312 (362)
                      .++||||+++++|.+++.....                      ..+++..+..++.|++.||+|||+.+   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999975432                      34899999999999999999999665   9999999


Q ss_pred             CCceeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       313 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+||+++.++.+||+|||+++...............||+.|+|||++.
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  225 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF  225 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence            999999999999999999998775443333334556889999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=7.2e-32  Score=247.82  Aligned_cols=173  Identities=26%  Similarity=0.368  Sum_probs=146.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC--eeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE--TNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  257 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||||++...... ...+.+.+|++++++++||||+++++++....  ..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            367888999999999999999875 5899999998654322 22345889999999999999999999998765  7799


Q ss_pred             EEecCCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee----CCCCceEEcccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFGLA  332 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFGla  332 (362)
                      ||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999975432 34899999999999999999999665   9999999999999    78888999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.......   .....||+.|+|||++.
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHH
T ss_pred             eecCCCCc---eeecccCCCccCHHHhh
Confidence            87754322   34567999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=7.3e-32  Score=243.35  Aligned_cols=174  Identities=21%  Similarity=0.336  Sum_probs=148.5

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      .+.++|+..+.||+|+||.||+|.+. +++.||+|.+...........++.+|+..+.++ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            35678999999999999999999975 789999999876555455556688999999999 9999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-------------
Q 018036          257 LVYEYMPNGSLGEVLHGKR--GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-------------  321 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-------------  321 (362)
                      +||||+++++|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999996432  245899999999999999999999665   9999999999999844             


Q ss_pred             ------CceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          322 ------FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       322 ------~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                            ..+||+|||.+......      ....||+.|+|||++.+
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~  204 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQE  204 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTT
T ss_pred             cccCCceEEEEcccccccccCCc------cccCCCccccChhHhcC
Confidence                  47999999999877542      23459999999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=1.5e-31  Score=245.90  Aligned_cols=176  Identities=23%  Similarity=0.345  Sum_probs=151.4

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC----chhhHHHHHHHHhcCccCcceeEEEEEecC
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS----HDNGLSAEIRTLGKIRHRNIVRLKAFCSNK  252 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  252 (362)
                      ..+.+.|+..+.||+|+||.||+|.+. +++.||+|.+........    ..+++.+|+.++++++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            456788999999999999999999875 688999999876543221    245689999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC----ceEEcc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVAD  328 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~D  328 (362)
                      +..++||||+++++|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            999999999999999999964  345899999999999999999999665   99999999999999887    799999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+++......   ......||+.|+|||++.+
T Consensus       163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~  192 (321)
T 2a2a_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY  192 (321)
T ss_dssp             CTTCEECCTTC---CCCCCCSCGGGCCHHHHTT
T ss_pred             CccceecCccc---cccccCCCCCccCcccccC
Confidence            99998775432   1345679999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=1.2e-31  Score=247.67  Aligned_cols=171  Identities=24%  Similarity=0.275  Sum_probs=145.6

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+.....    .+.+.+|+++++++ +||||+++++++...+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            5788899999999999999986 5788999998864322    23489999999999 9999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc-----eEEcccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-----AHVADFGLAKY  334 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DFGla~~  334 (362)
                      ||+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            999 99999999743 346999999999999999999999665   999999999999998887     99999999997


Q ss_pred             ccCCCCce-----eeccccCccCccccccccc
Q 018036          335 LQDTGASE-----CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........     ......||+.|+|||++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLG  191 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcC
Confidence            75433211     1245689999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=1.8e-32  Score=254.10  Aligned_cols=176  Identities=26%  Similarity=0.382  Sum_probs=145.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|.+.      +++.||+|.+.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            467888999999999999999874      34789999986432 12233568999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCC
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR----------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK  312 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  312 (362)
                      .++||||+++|+|.+++....                      ...+++..++.++.|++.||+|||+.+   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            999999999999999996532                      146899999999999999999999665   9999999


Q ss_pred             CCceeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       313 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+||+++.++.+||+|||+++...............||+.|+|||++.
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  249 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF  249 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence            999999999999999999998765332222234567899999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=4.7e-32  Score=253.50  Aligned_cols=170  Identities=27%  Similarity=0.276  Sum_probs=137.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||++... +++.||+|++.....   ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            467899999999999999999975 788999999864332   2345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc--eEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla~~~~~  337 (362)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++....
T Consensus        96 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           96 EYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             EeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            999999999998543  35899999999999999999999665   999999999999987765  99999999985432


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .   .......||+.|+|||++.+
T Consensus       171 ~---~~~~~~~gt~~y~aPE~~~~  191 (361)
T 3uc3_A          171 H---SQPKSTVGTPAYIAPEVLLR  191 (361)
T ss_dssp             -------------CTTSCHHHHHC
T ss_pred             c---CCCCCCcCCCCcCChhhhcC
Confidence            2   12345679999999998743

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=5.2e-32  Score=247.66  Aligned_cols=173  Identities=27%  Similarity=0.372  Sum_probs=141.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            467888999999999999999975 5899999998654433333456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        82 e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             ECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999988643  45899999999999999999999665   9999999999999999999999999998765322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        .......||+.|+|||++.
T Consensus       157 --~~~~~~~~~~~y~aPE~~~  175 (311)
T 4agu_A          157 --DYYDDEVATRWYRSPELLV  175 (311)
T ss_dssp             -----------GGGCCHHHHH
T ss_pred             --cccCCCcCCccccChHHHh
Confidence              1234567999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=2.6e-31  Score=242.52  Aligned_cols=170  Identities=41%  Similarity=0.649  Sum_probs=145.4

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      .+.||+|+||.||+|.. +++.||+|++.....  .....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  114 (307)
T 2nru_A           36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN  114 (307)
T ss_dssp             CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence            48999999999999987 678999999865432  223345689999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCcee
Q 018036          265 GSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC  343 (362)
Q Consensus       265 gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  343 (362)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..........
T Consensus       115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            99999996432 346899999999999999999999665   99999999999999999999999999987764433333


Q ss_pred             eccccCccCcccccccc
Q 018036          344 MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~  360 (362)
                      .....||+.|+|||++.
T Consensus       192 ~~~~~g~~~y~aPE~~~  208 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALR  208 (307)
T ss_dssp             CSSCCSCGGGCCHHHHT
T ss_pred             ccccCCCcCcCChHHhc
Confidence            44567999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=1.7e-32  Score=263.64  Aligned_cols=174  Identities=25%  Similarity=0.280  Sum_probs=138.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46788999999999999999986 4689999999875321 222234478899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++....
T Consensus       227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999999643  458999999999999999999995 54   99999999999999999999999999986543


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|+|||++.+
T Consensus       302 ~~--~~~~~~~gt~~y~aPE~~~~  323 (446)
T 4ejn_A          302 DG--ATMKTFCGTPEYLAPEVLED  323 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHT
T ss_pred             CC--cccccccCCccccCHhhcCC
Confidence            22  22456789999999998753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=1.2e-31  Score=241.10  Aligned_cols=173  Identities=27%  Similarity=0.331  Sum_probs=148.9

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++.++|+..+.||+|+||.||+|.+. ++..+|+|++.....  ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            356788999999999999999999875 577899999875433  23455999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee---CCCCceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~  333 (362)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++.
T Consensus        83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999988643  45899999999999999999999665   9999999999999   788999999999998


Q ss_pred             cccCCCCceeeccccCccCcccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......   ......||+.|+|||++.
T Consensus       158 ~~~~~~---~~~~~~~t~~y~aPE~~~  181 (277)
T 3f3z_A          158 RFKPGK---MMRTKVGTPYYVSPQVLE  181 (277)
T ss_dssp             ECCTTS---CBCCCCSCTTTCCHHHHT
T ss_pred             eccCcc---chhccCCCCCccChHHhc
Confidence            765332   234567999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=2.1e-31  Score=243.50  Aligned_cols=174  Identities=29%  Similarity=0.394  Sum_probs=144.3

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCC---CCchhhHHHHHHHHhcCc---cCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG---SSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||+||+|++ .+++.||+|++......   ......+.+|+.++++++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            46889999999999999999997 56889999998654321   122234778888887775   999999999998765


Q ss_pred             -----eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          254 -----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       254 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                           ..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence                 4789999996 69999998766666999999999999999999999665   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+++......   ......||+.|+|||++.+
T Consensus       164 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  193 (308)
T 3g33_A          164 FGLARIYSYQM---ALTPVVVTLWYRAPEVLLQ  193 (308)
T ss_dssp             CSCTTTSTTCC---CSGGGGCCCSSCCHHHHHT
T ss_pred             CccccccCCCc---ccCCccccccccCchHHcC
Confidence            99998765322   2455689999999998743

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.6e-32  Score=253.41  Aligned_cols=172  Identities=22%  Similarity=0.252  Sum_probs=141.8

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc--CcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  259 (362)
                      +.|+..+.||+|+||.||+|.+.+++.||||++..........+.+.+|+.++.+++|  |||+++++++...+..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            5688889999999999999999889999999987554433344568999999999986  99999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      |+ .+++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++......
T Consensus        89 e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           89 EC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             CC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             eC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            95 588999999643  45899999999999999999999665   99999999999997 5789999999999876443


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........+||+.|+|||++.
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~  182 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIK  182 (343)
T ss_dssp             --------CCCCSSCCHHHHH
T ss_pred             ccccCCCCcCCcCcCCHHHHh
Confidence            332344568999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=4.7e-32  Score=263.75  Aligned_cols=173  Identities=24%  Similarity=0.337  Sum_probs=148.4

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+.. +..||||.++...   ...+++.+|+.++++++|||||+++++|...+..++||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            3668888999999999999999854 7899999986432   23456999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999997655567999999999999999999999665   9999999999999999999999999999775322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ........+|+.|+|||++.
T Consensus       373 -~~~~~~~~~~~~y~aPE~~~  392 (495)
T 1opk_A          373 -YTAHAGAKFPIKWTAPESLA  392 (495)
T ss_dssp             -EECCTTCCCCGGGCCHHHHH
T ss_pred             -eeecCCCcCCcceeCHhHHh
Confidence             12233445678999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=9.8e-33  Score=252.75  Aligned_cols=179  Identities=25%  Similarity=0.368  Sum_probs=140.5

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCe-
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET-  254 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  254 (362)
                      ..+.++|+..+.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.++++++||||+++++++..... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            44568899999999999999999996 578899999986543322 223458899999999999999999999876543 


Q ss_pred             ---eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          255 ---NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       255 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                         .++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence               39999999999999999643  35899999999999999999999665   99999999999999999999999999


Q ss_pred             cccccCCCCc-eeeccccCccCccccccccc
Q 018036          332 AKYLQDTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++........ .......||+.|+|||++.+
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  193 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARG  193 (311)
T ss_dssp             C------------------CCTTCCHHHHHT
T ss_pred             cccccccccccccccccCcCcccCCHHHhcC
Confidence            9876543221 22344679999999998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.1e-32  Score=258.35  Aligned_cols=176  Identities=27%  Similarity=0.336  Sum_probs=145.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|.+.      +++.||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            467888999999999999999842      46689999985332 22233458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC---ceEE
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHV  326 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl  326 (362)
                      .++||||+++|+|.+++....     ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999996432     245899999999999999999999665   99999999999999555   5999


Q ss_pred             ccccccccccCCCCceeeccccCccCcccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+++...............||+.|+|||++.
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  259 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM  259 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhc
Confidence            9999998764332222234567899999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=7.2e-32  Score=251.11  Aligned_cols=171  Identities=27%  Similarity=0.415  Sum_probs=132.2

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      .+.+.|+..+.||+|+||.||+|.+. +++.||+|.+....    ..+.+.+|++++++++||||+++++++...+..++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            34577889999999999999999975 57899999986432    22348899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEEcccccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKY  334 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGla~~  334 (362)
                      ||||+++++|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++.
T Consensus       126 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999999964  345899999999999999999999665   999999999999975   88999999999987


Q ss_pred             ccCCCCceeeccccCccCccccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....   .......||+.|+|||++.+
T Consensus       201 ~~~~---~~~~~~~gt~~y~aPE~~~~  224 (349)
T 2w4o_A          201 VEHQ---VLMKTVCGTPGYCAPEILRG  224 (349)
T ss_dssp             ---------------CGGGSCHHHHTT
T ss_pred             cCcc---cccccccCCCCccCHHHhcC
Confidence            6532   12345679999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=5.8e-32  Score=241.99  Aligned_cols=172  Identities=20%  Similarity=0.319  Sum_probs=147.5

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--CeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|++. ++.||+|.+..........+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            467888999999999999999984 88999999876544444445699999999999999999999999887  778999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||+. .++|+||||||+||+++.++.++|+|||++....  
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            9999999999999876655799999999999999999999943 2339999999999999999999999998876543  


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           .....||+.|+|||++.+
T Consensus       165 -----~~~~~~t~~y~aPE~~~~  182 (271)
T 3kmu_A          165 -----SPGRMYAPAWVAPEALQK  182 (271)
T ss_dssp             -----CTTCBSCGGGSCHHHHHS
T ss_pred             -----ccCccCCccccChhhhcc
Confidence                 233468999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=1e-31  Score=254.62  Aligned_cols=170  Identities=25%  Similarity=0.297  Sum_probs=134.9

Q ss_pred             hHhhhcccc-ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhc-CccCcceeEEEEEec----
Q 018036          179 DILECVKDN-NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK-IRHRNIVRLKAFCSN----  251 (362)
Q Consensus       179 ~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----  251 (362)
                      .+.++|... +.||+|+||+||+|.+. +++.||||++...       ..+.+|+.++.+ .+||||+++++++..    
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            455667665 78999999999999874 6889999998521       237889888754 489999999999875    


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEEcc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVAD  328 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D  328 (362)
                      .+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEe
Confidence            567899999999999999998655567999999999999999999999665   999999999999997   78999999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+++......   .....+||+.|+|||++.+
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  237 (400)
T 1nxk_A          208 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGP  237 (400)
T ss_dssp             CTTCEECC--------------CTTCCGGGSCC
T ss_pred             cccccccCCCC---ccccCCCCCCccCHhhcCC
Confidence            99998764321   2456789999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=1.7e-31  Score=259.85  Aligned_cols=175  Identities=26%  Similarity=0.355  Sum_probs=145.2

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ..+.+.|+..+.||+|+||.||+|.+. ++..||+|++............+.+|+.+++.++||||+++++++.+.+..+
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            356788999999999999999999975 6889999999765544444556899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC---CceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~  333 (362)
                      +||||+++|+|.+.+...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++..   +.+||+|||+++
T Consensus       113 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999999988543  45899999999999999999999665   9999999999999764   559999999998


Q ss_pred             cccCCCCceeeccccCccCcccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......   .....+||+.|+|||++.
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~  211 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLR  211 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHT
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHc
Confidence            775332   245567999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=5.1e-32  Score=255.84  Aligned_cols=172  Identities=22%  Similarity=0.248  Sum_probs=142.6

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc--cCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  259 (362)
                      +.|+..+.||+|+||.||+|...+++.||||++..........+.+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458888999999999999999988999999998755443334456899999999996  599999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      | +.+++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++.+....
T Consensus       136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 5588999999643  35889999999999999999999554   99999999999996 5799999999999875433


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........+||+.|+|||++.
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~  229 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIK  229 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHH
T ss_pred             ccccCCCCCcCCCccChHHhh
Confidence            222244568999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=5.7e-32  Score=244.08  Aligned_cols=172  Identities=22%  Similarity=0.341  Sum_probs=144.3

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.++..||+|++....   ...+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            46788899999999999999999888899999986432   233558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus       100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  174 (283)
T 3gen_A          100 YMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  174 (283)
T ss_dssp             CCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred             ccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence            99999999999743 345899999999999999999999665   9999999999999999999999999998764321 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........||+.|+|||++.
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~  194 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLM  194 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHH
T ss_pred             cccccCCccCcccCCHHHhc
Confidence            11123445788899999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=1.5e-31  Score=254.89  Aligned_cols=175  Identities=27%  Similarity=0.382  Sum_probs=138.4

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC------CCCchhhHHHHHHHHhcCccCcceeEEEEE
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK------GSSHDNGLSAEIRTLGKIRHRNIVRLKAFC  249 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  249 (362)
                      ...+.++|...+.||+|+||.||+|.+ .+++.||+|.+.....      .......+.+|++++++++||||+++++++
T Consensus       130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            345678899999999999999999987 4678999999875421      112223488999999999999999999998


Q ss_pred             ecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC---CceEE
Q 018036          250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHV  326 (362)
Q Consensus       250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl  326 (362)
                      .. +..++||||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.+   +.+||
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence            64 457899999999999999854  345899999999999999999999665   9999999999999754   45999


Q ss_pred             ccccccccccCCCCceeeccccCccCcccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+++.....   ......+||+.|+|||++.
T Consensus       284 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~  314 (419)
T 3i6u_A          284 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLV  314 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC
T ss_pred             eecccceecCCC---ccccccCCCCCccCceeee
Confidence            999999976532   2245678999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=8.9e-32  Score=261.40  Aligned_cols=176  Identities=25%  Similarity=0.358  Sum_probs=149.9

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||||++............+.+|++++++++||||+++++++.+....+
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            467799999999999999999999874 7899999998654433344556899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC---CCCceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~  333 (362)
                      +||||+++|+|.+.+...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++   .++.+||+|||+++
T Consensus        98 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999999988543  45899999999999999999999665   99999999999995   45679999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......   .....+||+.|+|||++.+
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~  197 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG  197 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC
Confidence            765322   2445679999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=3e-32  Score=262.49  Aligned_cols=172  Identities=26%  Similarity=0.397  Sum_probs=145.7

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.++..||||+++...   ...+.+.+|+.++++++|||||++++++. .+..++|||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            46788889999999999999999888999999986432   23456999999999999999999999986 567899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            999999999997544446889999999999999999999665   99999999999999999999999999987643211


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......+|+.|+|||++.
T Consensus       340 -~~~~~~~~~~~y~aPE~~~  358 (454)
T 1qcf_A          340 -TAREGAKFPIKWTAPEAIN  358 (454)
T ss_dssp             -HTTCSSSSCGGGSCHHHHH
T ss_pred             -eccCCCcccccccCHHHhc
Confidence             1122345678999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=8.2e-32  Score=248.19  Aligned_cols=173  Identities=27%  Similarity=0.414  Sum_probs=140.1

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|.+. +++    .|++|.+..... ......+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            56888899999999999999864 344    377787754322 222344789999999999999999999986 45678


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999999753 346899999999999999999999665   9999999999999999999999999999876


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............||+.|+|||++.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~  190 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIH  190 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHH
T ss_pred             cccccccccCCCCcccccChHHhc
Confidence            544333345567889999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=6.8e-32  Score=253.43  Aligned_cols=168  Identities=23%  Similarity=0.346  Sum_probs=137.6

Q ss_pred             cccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCC
Q 018036          185 KDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      ...+.||+|+||.||+|.. .+++.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            3357899999999999986 4689999999865322  234568999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee--CCCCceEEccccccccccCCCCc
Q 018036          264 NGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL--NSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       264 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+  +.++.+||+|||+++......  
T Consensus       170 ~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--  243 (373)
T 2x4f_A          170 GGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--  243 (373)
T ss_dssp             TCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--
Confidence            99999988633 345899999999999999999999665   9999999999999  677899999999999775432  


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......||+.|+|||++.+
T Consensus       244 -~~~~~~gt~~y~aPE~~~~  262 (373)
T 2x4f_A          244 -KLKVNFGTPEFLAPEVVNY  262 (373)
T ss_dssp             -BCCCCCSSCTTCCHHHHTT
T ss_pred             -ccccccCCCcEeChhhccC
Confidence             2345579999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=1.6e-31  Score=257.08  Aligned_cols=168  Identities=29%  Similarity=0.403  Sum_probs=142.3

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-eeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-TNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. ++.||||.++...    ..+.+.+|++++++++||||+++++++...+ ..++||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            367888899999999999999885 7799999986432    3345999999999999999999999987665 789999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999997655555799999999999999999999665   999999999999999999999999999865422 


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                          .....+|+.|+|||++.+
T Consensus       343 ----~~~~~~~~~y~aPE~~~~  360 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALRE  360 (450)
T ss_dssp             --------CCCTTTSCHHHHHS
T ss_pred             ----ccCCCCCcceeCHHHhcC
Confidence                223367899999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=2.1e-31  Score=245.75  Aligned_cols=178  Identities=22%  Similarity=0.370  Sum_probs=148.5

Q ss_pred             hhHhhhcccc-ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCe
Q 018036          178 DDILECVKDN-NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKET  254 (362)
Q Consensus       178 ~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  254 (362)
                      +.+.+.|... +.||+|+||.||+|.+. +++.||+|++............+.+|+.++.+++ ||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            4556777776 89999999999999875 6899999998765544444566899999999995 6999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEEccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGL  331 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGl  331 (362)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            999999999999999997665677999999999999999999999665   999999999999997   78999999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++......   ......||+.|+|||++.+
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~  207 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNY  207 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTT
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecC
Confidence            98765322   1345679999999998753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=1.5e-31  Score=246.47  Aligned_cols=170  Identities=23%  Similarity=0.310  Sum_probs=127.2

Q ss_pred             Hhhhccc---cceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCe
Q 018036          180 ILECVKD---NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKET  254 (362)
Q Consensus       180 ~~~~~~~---~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  254 (362)
                      +.++|+.   .+.||+|+||.||+|.+. +++.||||++...     ....+.+|+.++..+. ||||+++++++.+...
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            3455554   378999999999999874 6899999998532     2345889999999997 9999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC---ceEEccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---EAHVADFGL  331 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGl  331 (362)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             EEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccc
Confidence            99999999999999999643  45899999999999999999999665   99999999999997665   899999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++......  ......+||+.|+|||++.+
T Consensus       156 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~  183 (325)
T 3kn6_A          156 ARLKPPDN--QPLKTPCFTLHYAAPELLNQ  183 (325)
T ss_dssp             CEECCC------------------------
T ss_pred             ceecCCCC--CcccccCCCcCccCHHHhcC
Confidence            98764322  22445678999999998753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=1.3e-31  Score=241.76  Aligned_cols=174  Identities=27%  Similarity=0.385  Sum_probs=148.9

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +.++|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4578899999999999999999874 688999999876544434445688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc---eEEccccccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADFGLAKYL  335 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFGla~~~  335 (362)
                      |||+++++|.+.+...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999988643  45899999999999999999999665   999999999999986655   999999999876


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....   ......||+.|+|||++.+
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~  181 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKK  181 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTT
T ss_pred             ccCc---cccCCCCCcCCcCchhhcC
Confidence            5432   2345679999999998653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=2e-31  Score=240.25  Aligned_cols=171  Identities=25%  Similarity=0.446  Sum_probs=146.9

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-----
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-----  251 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----  251 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||+|.+....      +.+.+|++++++++||||+++++++..     
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            345688999999999999999999975 78999999986432      248899999999999999999998864     


Q ss_pred             -----------CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC
Q 018036          252 -----------KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS  320 (362)
Q Consensus       252 -----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~  320 (362)
                                 ....++||||+++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD  157 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence                       345789999999999999997555567999999999999999999999665   999999999999999


Q ss_pred             CCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          321 DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       321 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.+||+|||+++.......   .....||+.|+|||++.
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~  194 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQIS  194 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHH
T ss_pred             CCCEEECcchhheecccccc---ccccCCcccccChhhhc
Confidence            99999999999987754321   34457999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=2.2e-31  Score=242.20  Aligned_cols=170  Identities=29%  Similarity=0.365  Sum_probs=139.4

Q ss_pred             HhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhc--CccCcceeEEEEEec----CC
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK--IRHRNIVRLKAFCSN----KE  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~  253 (362)
                      +.++|+..+.||+|+||.||+|++ +++.||||++...     ....+.+|.+++..  ++||||+++++++..    ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            357889999999999999999988 6889999998532     22335566666665  799999999998654    34


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEEeCCCCCceeeCCCCceE
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH--------HDCSPLIIHRDVKSNNILLNSDFEAH  325 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~~k  325 (362)
                      ..++||||+++|+|.+++..   ..+++..+..++.|++.||+|||        +.+   |+||||||+|||++.++.+|
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred             eeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence            57899999999999999953   35899999999999999999999        555   99999999999999999999


Q ss_pred             EccccccccccCCCCce--eeccccCccCccccccccc
Q 018036          326 VADFGLAKYLQDTGASE--CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       326 l~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|||+++.........  ......||+.|+|||++.+
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE  191 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence            99999998765433221  1234579999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=4.4e-32  Score=249.56  Aligned_cols=177  Identities=22%  Similarity=0.290  Sum_probs=130.2

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee-
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-  255 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-  255 (362)
                      .++|+..+.||+|+||.||+|.+....    .||||.+..........+++.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            367888999999999999999975432    799999865544444456799999999999999999999999887655 


Q ss_pred             -----eEEEecCCCCChhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          256 -----LLVYEYMPNGSLGEVLHGKR----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       256 -----~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                           ++||||+++|+|.+++....    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 89999999999999985322    225899999999999999999999665   999999999999999999999


Q ss_pred             ccccccccccCCCCceeeccccCccCcccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+++...............+|+.|+|||++.
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  212 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA  212 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHH
T ss_pred             eeccccccccccccccccccccCcccccCchhhc
Confidence            9999998775433222233456788999999764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=4.2e-31  Score=245.95  Aligned_cols=177  Identities=25%  Similarity=0.355  Sum_probs=147.7

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------  252 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  252 (362)
                      ..++|+..+.||+|+||.||+|.+ .+++.||+|++............+.+|++++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            457899999999999999999997 5789999999866554444455688999999999999999999999873      


Q ss_pred             --CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          253 --ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       253 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                        +..++||||++ ++|.+.+... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence              46899999996 5888877643 345899999999999999999999665   9999999999999999999999999


Q ss_pred             ccccccCCCC--ceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGA--SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++.+.....  ........||+.|+|||++.+
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG  202 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred             hcccccccccccccccCCcccccCccCchhhcC
Confidence            9987653221  122345679999999998753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.9e-32  Score=253.50  Aligned_cols=175  Identities=26%  Similarity=0.270  Sum_probs=147.3

Q ss_pred             hhhccccceeeccCcccEEEEEc----CCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|+.    .+++.||||+++....  .....+.+.+|++++.++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46788999999999999999987    4689999999864321  112234477899999999 6999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999999643  35899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....... ......+||+.|+|||++.+
T Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~  234 (355)
T 1vzo_A          208 EFVADET-ERAYDFCGTIEYMAPDIVRG  234 (355)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTT
T ss_pred             ecccCCC-CcccCcccCcCccChhhhcC
Confidence            7643222 22345679999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=2.1e-31  Score=240.83  Aligned_cols=175  Identities=23%  Similarity=0.323  Sum_probs=144.6

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++.++|...+.||+|+||.||+|.. .++..+|+|++..... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            4568899999999999999999987 4688999999875542 2334568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee---CCCCceEEcccccc
Q 018036          258 VYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLA  332 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla  332 (362)
                      ||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999988532  2356899999999999999999999665   9999999999999   45678999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +......   ......||+.|+|||++.
T Consensus       175 ~~~~~~~---~~~~~~~t~~y~aPE~~~  199 (285)
T 3is5_A          175 ELFKSDE---HSTNAAGTALYMAPEVFK  199 (285)
T ss_dssp             CC-------------CTTGGGCCHHHHT
T ss_pred             eecCCcc---cCcCcccccCcCChHHhc
Confidence            8765322   234567999999999764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=2.8e-31  Score=246.37  Aligned_cols=170  Identities=24%  Similarity=0.329  Sum_probs=143.6

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  255 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||+|.+.....      ...+|++++.++ +||||+++++++.+.+..
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            356788999999999999999999875 688999999864322      156788888888 799999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC----CceEEccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFGL  331 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGl  331 (362)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+.++    +.+||+|||+
T Consensus        92 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999999643  45899999999999999999999665   9999999999998543    3599999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++......  ......+||+.|+|||++.
T Consensus       167 a~~~~~~~--~~~~~~~gt~~y~aPE~~~  193 (342)
T 2qr7_A          167 AKQLRAEN--GLLMTPCYTANFVAPEVLE  193 (342)
T ss_dssp             CEECBCTT--CCBCCSSCCSSCCCHHHHH
T ss_pred             cccCcCCC--CceeccCCCccccCHHHhc
Confidence            99765432  2245668999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=5.8e-32  Score=247.33  Aligned_cols=176  Identities=27%  Similarity=0.375  Sum_probs=148.7

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|++      .+++.||+|.+..... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            46788899999999999999974      3567899999864322 22345689999999999 9999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRG----------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      ..++||||+++|+|.+++.....                ..+++..+..++.|++.||+|||+.+   |+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999975432                24899999999999999999999665   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.++.+||+|||+++...............||+.|+|||++.
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  220 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF  220 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc
Confidence            9999999999999999876544333344556889999999764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=1.5e-31  Score=247.30  Aligned_cols=176  Identities=24%  Similarity=0.371  Sum_probs=146.4

Q ss_pred             hhhccccceeeccCcccEEEEEcC--------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  251 (362)
                      .++|+..+.||+|+||.||+|.+.        ++..||+|++.... .....+.+.+|+++++++ +||||+++++++..
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            468889999999999999999862        46789999986432 222334588999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRG--------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      .+..++||||+++|+|.+++.....              ..+++..+..++.|++.||+|||+.+   |+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999975432              24899999999999999999999665   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.++.+||+|||+++...............+|+.|+|||++.
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  232 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF  232 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence            9999999999999998776443333344456789999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=1.2e-31  Score=248.76  Aligned_cols=180  Identities=25%  Similarity=0.315  Sum_probs=145.1

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccC---CCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGIT---KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE  253 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  253 (362)
                      .++.++|+..+.||+|+||.||+|.+ .+++.||+|.+....   ......+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            46678999999999999999999987 467899999986532   12334456899999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCC--------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 018036          254 TNLLVYEYMPNGSLGEVLHGK--------------------------------------RGSFLKWEMRLKIAIEAAKGL  295 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~--------------------------------------~~~~~~~~~~~~i~~~i~~~L  295 (362)
                      ..++||||+++|+|.+++...                                      ....+++..+..++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998521                                      011245777889999999999


Q ss_pred             HHHhcCCCCCeEEeCCCCCceeeCCCC--ceEEccccccccccCCCCc--eeeccccCccCcccccccc
Q 018036          296 SYLHHDCSPLIIHRDVKSNNILLNSDF--EAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       296 ~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+.+   |+||||||+||+++.++  .+||+|||+++.+......  .......||+.|+|||++.
T Consensus       182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  247 (345)
T 3hko_A          182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN  247 (345)
T ss_dssp             HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred             HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence            9999665   99999999999998776  8999999999876532221  1234567999999999875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=1.2e-31  Score=249.55  Aligned_cols=171  Identities=32%  Similarity=0.406  Sum_probs=145.8

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +..+.|+..+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++...+..+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            4456788899999999999999986 578899999986543322 22345889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       131 lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            9999996 6888888532 345899999999999999999999665   9999999999999999999999999998764


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .      .....||+.|+|||++.
T Consensus       206 ~------~~~~~gt~~y~aPE~~~  223 (348)
T 1u5q_A          206 P------ANSFVGTPYWMAPEVIL  223 (348)
T ss_dssp             S------BCCCCSCGGGCCHHHHH
T ss_pred             C------CCcccCCcceeCHhhhc
Confidence            3      23457999999999873

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=9.8e-32  Score=248.12  Aligned_cols=176  Identities=21%  Similarity=0.319  Sum_probs=137.7

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ....++|+..+.||+|+||.||+|.+ .+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34468899999999999999999986 47889999998655444434455889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee-----CCCCceEEccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL-----NSDFEAHVADFGL  331 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-----~~~~~~kl~DFGl  331 (362)
                      +||||++ |+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+     +.++.+||+|||+
T Consensus       110 lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999997 5999999643  34899999999999999999999665   9999999999999     4555699999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++......  .......||+.|+|||++.+
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~  211 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLG  211 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTT
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcC
Confidence            98765322  12345678999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=6.2e-32  Score=260.11  Aligned_cols=172  Identities=30%  Similarity=0.472  Sum_probs=140.6

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.++..||||+++...   ...+++.+|++++++++||||+++++++.. +..++|||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            46788889999999999999999888889999986433   234569999999999999999999999876 67899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++....+..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...+...
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999999999996544456899999999999999999999665   99999999999999999999999999987653221


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......+|+.|+|||++.
T Consensus       336 -~~~~~~~~~~~y~aPE~~~  354 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAAL  354 (452)
T ss_dssp             --------CCGGGSCHHHHH
T ss_pred             -ecccCCcccccccCHhHHh
Confidence             1123445788999999764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=9e-32  Score=248.16  Aligned_cols=173  Identities=25%  Similarity=0.392  Sum_probs=136.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|++. +++    .||+|.+.... .....+++.+|+.++++++||||+++++++.... .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            67888999999999999999864 444    35777765332 2233456999999999999999999999998765 67


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999999753 346899999999999999999999665   9999999999999999999999999999876


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............||+.|+|||++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~  192 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESIL  192 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHH
T ss_pred             CCcccccccCCCccccccChHHhc
Confidence            443333344556788999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=3e-31  Score=238.68  Aligned_cols=175  Identities=25%  Similarity=0.395  Sum_probs=134.1

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46788999999999999999987 5789999999864321 122335589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999743 356899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......||+.|+|||++.+
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~  186 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATR  186 (278)
T ss_dssp             -----------------------
T ss_pred             CC--cceeccCCCCcCCcchhcC
Confidence            21  1334679999999998753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=3.5e-31  Score=245.99  Aligned_cols=173  Identities=21%  Similarity=0.361  Sum_probs=150.5

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCch---------------hhHHHHHHHHhcCccCcceeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHD---------------NGLSAEIRTLGKIRHRNIVRL  245 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~h~niv~l  245 (362)
                      .++|+..+.||+|+||.||+|.+ +++.||+|.+..........               +.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47889999999999999999999 89999999986543222111               569999999999999999999


Q ss_pred             EEEEecCCeeeEEEecCCCCChhhh------hcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEeCCCCCceee
Q 018036          246 KAFCSNKETNLLVYEYMPNGSLGEV------LHGKRGSFLKWEMRLKIAIEAAKGLSYLHH-DCSPLIIHRDVKSNNILL  318 (362)
Q Consensus       246 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll  318 (362)
                      ++++.+.+..++||||+++++|.++      +.......+++..+..++.|++.||+|||+ .+   |+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence            9999999999999999999999999      654445679999999999999999999996 54   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       319 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.++.+||+|||++......    ......||+.|+|||++.+
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~  224 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSN  224 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSS
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcC
Confidence            99999999999999876432    2455679999999998764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=1e-31  Score=259.09  Aligned_cols=171  Identities=27%  Similarity=0.348  Sum_probs=138.3

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------  252 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  252 (362)
                      +.++|+..+.||+|+||.||+|.+ .+++.||||++..........+++.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            357899999999999999999986 4688999999975543334455688999999999999999999999655      


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      ...++||||+++ +|.+.+..    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            356999999965 67777742    3899999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....   ......+||+.|+|||++.+
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~  237 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILG  237 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTT
T ss_pred             eecCCC---cccCCCcccccccCHHHHcC
Confidence            876532   22456789999999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=1.2e-31  Score=242.96  Aligned_cols=173  Identities=31%  Similarity=0.421  Sum_probs=134.1

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.+  .||+|+++.........+.+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            3578889999999999999998743  599999876544444456689999999999999999999965 4556799999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus       100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999643 356899999999999999999999665   99999999999999999999999999987654333


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........||+.|+|||++.
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             --------CCCTTCCHHHHC
T ss_pred             cccccccCCCccccCchhhc
Confidence            33345567999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=3.2e-31  Score=241.29  Aligned_cols=175  Identities=30%  Similarity=0.436  Sum_probs=144.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--C
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--E  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  253 (362)
                      .+.|+..+.||+|+||.||+|++     .+++.||+|++..... ....+.+.+|++++++++||||+++++++...  .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            35688889999999999999983     4688999999865432 23345689999999999999999999999876  5


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            679999999999999999533 245899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCCc-eeeccccCccCcccccccc
Q 018036          334 YLQDTGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........ .......||..|+|||++.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLM  202 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeec
Confidence            87643321 2234566899999999764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=2.5e-31  Score=245.51  Aligned_cols=174  Identities=28%  Similarity=0.426  Sum_probs=143.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            578999999999999999999875 5899999998655443333455789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus       104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999998887533  34899999999999999999999665   9999999999999999999999999998765322


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .......||+.|+|||++.+
T Consensus       179 --~~~~~~~~t~~y~aPE~~~~  198 (331)
T 4aaa_A          179 --EVYDDEVATRWYRAPELLVG  198 (331)
T ss_dssp             -------CCCCCTTCCHHHHTT
T ss_pred             --cccCCCcCCccccCcccccC
Confidence              12345679999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=2.4e-31  Score=258.20  Aligned_cols=175  Identities=27%  Similarity=0.390  Sum_probs=150.8

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            345688999999999999999999975 7899999998654432 33445689999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee---CCCCceEEcccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLA  332 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla  332 (362)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||++
T Consensus       102 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999999999643  45899999999999999999999665   9999999999999   46789999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +......   .....+||+.|+|||++.
T Consensus       177 ~~~~~~~---~~~~~~gt~~y~aPE~~~  201 (484)
T 3nyv_A          177 THFEASK---KMKDKIGTAYYIAPEVLH  201 (484)
T ss_dssp             HHBCCCC---SHHHHTTGGGTCCHHHHH
T ss_pred             EEccccc---ccccCCCCccccCceeec
Confidence            8775432   234567999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=2.6e-31  Score=239.26  Aligned_cols=172  Identities=29%  Similarity=0.426  Sum_probs=145.7

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.++..||+|.+....   ...+.+.+|++++++++||||+++++++.. +..++|||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            46788899999999999999998888899999986432   234568999999999999999999999864 56899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++...... 
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  163 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence            999999999996543346899999999999999999999665   9999999999999999999999999998775432 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........+|+.|+|||++.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~  183 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAIN  183 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHH
T ss_pred             cccccCCCCccCccChhhhc
Confidence            12233456788999999864

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.97  E-value=2.9e-31  Score=241.24  Aligned_cols=175  Identities=26%  Similarity=0.369  Sum_probs=145.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      +++|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   81 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence            357888899999999999999875 6899999998655443344456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||++ ++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  157 (299)
T 2r3i_A           82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  157 (299)
T ss_dssp             ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence            9996 69999997665566899999999999999999999665   9999999999999999999999999998764321


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .......||+.|+|||++.+
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~  177 (299)
T 2r3i_A          158 --RTYTHEVVTLWYRAPEILLG  177 (299)
T ss_dssp             --BCTTSCBCCCTTCCHHHHTT
T ss_pred             --cccCcccccccccCcHHhhc
Confidence              12344578999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=251.54  Aligned_cols=170  Identities=29%  Similarity=0.427  Sum_probs=139.1

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  253 (362)
                      +.++|+..+.||+|+||.||+|.+ .+++.||||++..........+++.+|+++++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            346788899999999999999987 46899999998654333333456889999999999999999999998763     


Q ss_pred             -eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       254 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                       ..++||||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence             459999999 8899999964   34899999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....     .....||+.|+|||++.+
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~  199 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILN  199 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHT
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhC
Confidence            876432     345679999999998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.9e-31  Score=252.54  Aligned_cols=173  Identities=26%  Similarity=0.368  Sum_probs=145.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC--eeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE--TNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  257 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||||++..... ....+.+.+|++++++++||||+++++++...+  ..++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            357888999999999999999875 589999999865432 222345789999999999999999999998765  6799


Q ss_pred             EEecCCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee----CCCCceEEcccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDFEAHVADFGLA  332 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFGla  332 (362)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999975432 33899999999999999999999665   9999999999999    77888999999999


Q ss_pred             ccccCCCCceeeccccCccCcccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +......   ......||+.|+|||++.
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~  188 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYE  188 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhh
Confidence            8765322   234567999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=5.7e-31  Score=256.82  Aligned_cols=174  Identities=26%  Similarity=0.336  Sum_probs=145.5

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-----------CchhhHHHHHHHHhcCccCcceeEE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-----------SHDNGLSAEIRTLGKIRHRNIVRLK  246 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~  246 (362)
                      .+.++|+..+.||+|+||.||+|.+. +++.||+|.+.......           ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            45688999999999999999999974 57899999987543221           2345689999999999999999999


Q ss_pred             EEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC---c
Q 018036          247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF---E  323 (362)
Q Consensus       247 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~  323 (362)
                      +++.+....++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999998543  45899999999999999999999665   99999999999998775   6


Q ss_pred             eEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       324 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +||+|||+++......   ......||+.|+|||++.
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~  221 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK  221 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc
Confidence            9999999998775432   244567999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=1.9e-31  Score=268.05  Aligned_cols=174  Identities=27%  Similarity=0.282  Sum_probs=147.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||||+++.... .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            367888899999999999999874 678999999875321 122334578899999988 79999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+....
T Consensus       420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999643  35899999999999999999999665   99999999999999999999999999986543


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......+||+.|||||++.+
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~  516 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAY  516 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTC
T ss_pred             CC--cccccccCCCcccCHhhhcC
Confidence            22  22556789999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=1.3e-30  Score=235.65  Aligned_cols=169  Identities=31%  Similarity=0.542  Sum_probs=141.8

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCch-----hhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHD-----NGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ++|+..+.||+|+||.||+|.+ .+++.||+|++..........     +.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6788889999999999999987 478899999986544332221     56899999999999999999999997665  


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc-----eEEcccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-----AHVADFG  330 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DFG  330 (362)
                      ++||||+++|+|.+.+... ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.     +||+|||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            6999999999999988643 356899999999999999999999431 23999999999999988776     9999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      +++....     ......||+.|+|||++
T Consensus       175 ~~~~~~~-----~~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          175 LSQQSVH-----SVSGLLGNFQWMAPETI  198 (287)
T ss_dssp             TCBCCSS-----CEECCCCCCTTSCGGGS
T ss_pred             ccccccc-----cccccCCCccccCchhh
Confidence            9985542     14456799999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=1.6e-31  Score=241.59  Aligned_cols=173  Identities=24%  Similarity=0.336  Sum_probs=149.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. ++..||+|.+...   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            467888999999999999999975 4788999998532   233456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999998666667999999999999999999999665   9999999999999999999999999998775432


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ........||+.|+|||++.
T Consensus       166 -~~~~~~~~~~~~y~aPE~~~  185 (288)
T 3kfa_A          166 -YTAHAGAKFPIKWTAPESLA  185 (288)
T ss_dssp             -SEEETTEEECGGGCCHHHHH
T ss_pred             -cccccCCccccCcCChhhhc
Confidence             22344556788999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=5.4e-32  Score=245.74  Aligned_cols=174  Identities=30%  Similarity=0.398  Sum_probs=139.7

Q ss_pred             hhhccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--C
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--E  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  253 (362)
                      .++|+..+.||+|+||.||+|++     .+++.||||++....  ....+.+.+|++++++++||||+++++++...  .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            46788999999999999999983     367899999986332  22334589999999999999999999998654  4


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             ceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            579999999999999999643 335899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCCc-eeeccccCccCcccccccc
Q 018036          334 YLQDTGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........ .......||..|+|||++.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLT  190 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhc
Confidence            77533221 1233445788899999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=5e-31  Score=246.88  Aligned_cols=175  Identities=28%  Similarity=0.413  Sum_probs=149.7

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC------chhhHHHHHHHHhcC-ccCcceeEEEEE
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKI-RHRNIVRLKAFC  249 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~  249 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +|+.||||++........      ..+.+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            345578999999999999999999975 789999999875443211      124578899999999 799999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                      ......++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence            9999999999999999999999632  45899999999999999999999665   999999999999999999999999


Q ss_pred             cccccccCCCCceeeccccCccCcccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |++..+....   ......||+.|+|||++.
T Consensus       245 G~~~~~~~~~---~~~~~~gt~~y~aPE~~~  272 (365)
T 2y7j_A          245 GFSCHLEPGE---KLRELCGTPGYLAPEILK  272 (365)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred             CcccccCCCc---ccccCCCCCCccChhhcc
Confidence            9998775332   234568999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=1.4e-31  Score=246.60  Aligned_cols=172  Identities=25%  Similarity=0.360  Sum_probs=137.5

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            56888899999999999999975 78899999986443221 12235679999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |++ |+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           81 YLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            996 6999988643 346899999999999999999999665   9999999999999999999999999998664322 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......||+.|+|||++.+
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~  174 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLG  174 (324)
T ss_dssp             ---------CGGGCCHHHHTT
T ss_pred             -cccccccCcccccChhhhcC
Confidence             12345578999999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=7.8e-31  Score=236.48  Aligned_cols=174  Identities=25%  Similarity=0.370  Sum_probs=145.7

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCC----chhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSS----HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      +.++|+..+.||+|+||.||+|.+. +++.||+|.+........    ..+.+.+|+.++++++||||+++++++...+.
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3467899999999999999999975 689999999876543221    34568999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC----ceEEcccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVADFG  330 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFG  330 (362)
                      .++||||+++++|.+++..  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++    .+||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999999964  245899999999999999999999665   99999999999998877    89999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.......   ......||+.|+|||++.+
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  185 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNY  185 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTT
T ss_pred             cceeccCCC---cccccCCCcCccCcceecC
Confidence            998765322   1345579999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=5.7e-31  Score=245.83  Aligned_cols=169  Identities=25%  Similarity=0.276  Sum_probs=145.7

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-----cCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----HRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|++ .+++.||||++...   ......+..|+.++++++     ||||+++++++...+.
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            47899999999999999999987 46889999998532   222344778999999886     9999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC--------------
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--------------  320 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------------  320 (362)
                      .++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.              
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence            99999999 999999998666566999999999999999999999665   999999999999985              


Q ss_pred             -----------CCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          321 -----------DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       321 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                                 ++.+||+|||+++.....     .....||+.|+|||++.+
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~  233 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILN  233 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTT
T ss_pred             ccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcC
Confidence                       788999999999875432     345679999999998754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=9.3e-32  Score=243.30  Aligned_cols=168  Identities=21%  Similarity=0.332  Sum_probs=142.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-C-------CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-G-------EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  252 (362)
                      .++|+..+.||+|+||.||+|.+.. +       ..||+|.+....  ....+.+.+|++++++++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            3678889999999999999998643 2       479999885432  23345589999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc--------e
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--------A  324 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~  324 (362)
                      +..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.        +
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999743 344899999999999999999999665   999999999999998877        9


Q ss_pred             EEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          325 HVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       325 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+|||++.....      .....||+.|+|||++.
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~  190 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIE  190 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHH
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhC
Confidence            9999999976542      23456899999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.8e-31  Score=245.18  Aligned_cols=175  Identities=26%  Similarity=0.367  Sum_probs=141.1

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC---CchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ..++|+..+.||+|+||.||+|.+. +++.||+|++.......   ...+.+.+|++++++++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578899999999999999999985 58999999986533221   1224588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            999999975 899888643 346888999999999999999999665   999999999999999999999999999877


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....  .......||+.|+|||++.+
T Consensus       163 ~~~~--~~~~~~~~t~~y~aPE~~~~  186 (346)
T 1ua2_A          163 GSPN--RAYTHQVVTRWYRAPELLFG  186 (346)
T ss_dssp             TSCC--CCCCCSCCCCTTCCHHHHTT
T ss_pred             cCCc--ccCCcccccccccCchHhhC
Confidence            5332  22345679999999998743

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=3.3e-31  Score=237.43  Aligned_cols=172  Identities=32%  Similarity=0.511  Sum_probs=133.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCC--CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG--SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. ++.||||.+......  ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888899999999999999974 789999998654332  22335689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC--------CCceEEcccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS--------DFEAHVADFG  330 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------~~~~kl~DFG  330 (362)
                      |||+++++|.+++..   ..+++..+..++.|++.||+|||+.+..+|+||||||+||+++.        ++.+||+|||
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999999853   35899999999999999999999765445899999999999986        6789999999


Q ss_pred             ccccccCCCCceeeccccCccCcccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +++......    .....||+.|+|||++.
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~  187 (271)
T 3dtc_A          162 LAREWHRTT----KMSAAGAYAWMAPEVIR  187 (271)
T ss_dssp             C-----------------CCGGGSCHHHHH
T ss_pred             ccccccccc----ccCCCCccceeCHHHhc
Confidence            998765322    23457999999999764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=8.9e-31  Score=241.94  Aligned_cols=175  Identities=30%  Similarity=0.378  Sum_probs=140.8

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC--ccCcceeEEEEEecC---
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI--RHRNIVRLKAFCSNK---  252 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~---  252 (362)
                      ..+.++|+..+.||+|+||.||+|++. ++.||||++....     ...+.+|.+++...  +||||+++++++...   
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            345688999999999999999999885 8999999985321     22355566666555  899999999999887   


Q ss_pred             -CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEeCCCCCceeeCCCCceEE
Q 018036          253 -ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-----SPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       253 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                       ...++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+     .++|+||||||+|||++.++.+||
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence             6889999999999999999643   4899999999999999999999650     115999999999999999999999


Q ss_pred             ccccccccccCCCCce--eeccccCccCccccccccc
Q 018036          327 ADFGLAKYLQDTGASE--CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|||+++.........  ......||+.|+|||++.+
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  220 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE  220 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence            9999998765332211  1235579999999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=8.6e-31  Score=238.78  Aligned_cols=177  Identities=23%  Similarity=0.330  Sum_probs=146.0

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcCccCcceeEEEEEe--cCCe
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKET  254 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~  254 (362)
                      +.++|+..+.||+|+||.||+|.+. +++.||+|.+.....  .....+.+.+|++++++++||||+++++++.  ..+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4568899999999999999999974 688999999865321  2233456899999999999999999999984  4457


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||++++ |.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999765 778776555667999999999999999999999665   99999999999999999999999999987


Q ss_pred             ccCCCCceeeccccCccCcccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..............||+.|+|||++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~  184 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIAN  184 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHT
T ss_pred             cCccccccccccCCCCCCCcChhhcc
Confidence            75433333345667999999999865

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=3.2e-31  Score=238.73  Aligned_cols=172  Identities=28%  Similarity=0.387  Sum_probs=142.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999874 577999999854321 122234588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999998643  35899999999999999999999554   999999999999999999999999998765432


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                          ......||+.|+|||++.+
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~  181 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEG  181 (279)
T ss_dssp             ---------CCCCTTCCHHHHTT
T ss_pred             ----cccccCCCCCccCHhHhcc
Confidence                1345679999999998643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=3.1e-31  Score=237.02  Aligned_cols=171  Identities=24%  Similarity=0.411  Sum_probs=146.4

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||.||+|.+.+++.||+|.+.....   ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            57888899999999999999998888999999864332   235589999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...... .
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~  159 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  159 (267)
T ss_dssp             CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence            9999999999643 345899999999999999999999665   9999999999999999999999999998764321 1


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......||+.|+|||++.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~  178 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFS  178 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHH
T ss_pred             cccccccccccccChhhhc
Confidence            1123446788999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=8.4e-31  Score=237.78  Aligned_cols=174  Identities=25%  Similarity=0.328  Sum_probs=148.4

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. +++.+|+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467888999999999999999975 5788999988654332 22345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999988542  45899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  ......||+.|+|||++.+
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~  189 (294)
T 2rku_A          169 GE--RKKVLCGTPNYIAPEVLSK  189 (294)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHTT
T ss_pred             cc--ccccccCCCCcCCcchhcc
Confidence            22  2345679999999998653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=1.4e-31  Score=245.95  Aligned_cols=176  Identities=23%  Similarity=0.347  Sum_probs=146.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|.+.      +++.||+|.+.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            467889999999999999999764      36789999886332 12233458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEE
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR--------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV  326 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  326 (362)
                      .++||||+++|+|.+++....        ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence            999999999999999986421        135789999999999999999999665   999999999999999999999


Q ss_pred             ccccccccccCCCCceeeccccCccCcccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+++...............||+.|+|||++.
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  213 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK  213 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhc
Confidence            9999998765433222233456789999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=8.1e-31  Score=237.42  Aligned_cols=172  Identities=30%  Similarity=0.397  Sum_probs=144.0

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec----CCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  256 (362)
                      +.|+..+.||+|+||.||+|.+ .++..||+|.+..........+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4577788999999999999987 467899999987655444445668999999999999999999999865    35679


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCceEEccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYL  335 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~  335 (362)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+ .+|+||||||+||+++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999999643  45899999999999999999999442 2399999999999998 7899999999999765


Q ss_pred             cCCCCceeeccccCccCcccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....    .....||+.|+|||++.
T Consensus       183 ~~~~----~~~~~~t~~y~aPE~~~  203 (290)
T 1t4h_A          183 RASF----AKAVIGTPEFMAPEMYE  203 (290)
T ss_dssp             CTTS----BEESCSSCCCCCGGGGG
T ss_pred             cccc----cccccCCcCcCCHHHHh
Confidence            4321    34457999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=2.4e-30  Score=234.90  Aligned_cols=172  Identities=23%  Similarity=0.288  Sum_probs=145.6

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|.+....    ..+.+.+|+.++.++ +|+|++++++++......++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            46788999999999999999996 578999999885432    223488999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc-----eEEccccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-----AHVADFGLAK  333 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DFGla~  333 (362)
                      |||+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.     +||+|||+++
T Consensus        85 ~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999 99999999743 345899999999999999999999554   999999999999987776     9999999999


Q ss_pred             cccCCCCc-----eeeccccCccCccccccccc
Q 018036          334 YLQDTGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........     .......||+.|+|||++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  192 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG  192 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcC
Confidence            87643321     12345679999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=7.1e-31  Score=242.98  Aligned_cols=173  Identities=25%  Similarity=0.334  Sum_probs=148.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|...+.||+|+||.||++.+. +++.+|+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467888999999999999999975 5788999998654322 22345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999998643  45899999999999999999999665   999999999999999999999999999877533


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..  ......||+.|+|||++.
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~  214 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLS  214 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHH
T ss_pred             cc--cccccCCCccccCHHHhc
Confidence            22  234567999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=263.48  Aligned_cols=172  Identities=30%  Similarity=0.472  Sum_probs=145.4

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.++..||||+++...   ...++|.+|+++|++++||||+++++++.. +..++|||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            46788889999999999999999888889999986433   234569999999999999999999999876 67899999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++.......+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...+.. 
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  417 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence            999999999996544456899999999999999999999665   9999999999999999999999999998764321 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........+|..|+|||++.
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~  437 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAAL  437 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHH
T ss_pred             eecccCCcCcccccCHHHhc
Confidence            11122345788999999764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2.4e-30  Score=235.77  Aligned_cols=174  Identities=28%  Similarity=0.344  Sum_probs=149.3

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +..+.|+..+.||+|+||.||+|.+ .+++.||+|.+..... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            3456788899999999999999986 4688999999865432 2334568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        98 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence            9999999999999953   35899999999999999999999665   99999999999999999999999999987654


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  .......||+.|+|||++.+
T Consensus       172 ~~--~~~~~~~~~~~y~aPE~~~~  193 (303)
T 3a7i_A          172 TQ--IKRNTFVGTPFWMAPEVIKQ  193 (303)
T ss_dssp             TB--CCBCCCCSCGGGCCHHHHTT
T ss_pred             cc--cccCccCCCcCccCHHHHhc
Confidence            32  12345679999999998753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=7.1e-31  Score=240.63  Aligned_cols=174  Identities=24%  Similarity=0.347  Sum_probs=139.4

Q ss_pred             Hhhhccc-cceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          180 ILECVKD-NNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       180 ~~~~~~~-~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      +.+.|+. .+.||+|+||.||+|.+ .+++.||||++....  ....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3456766 47899999999999986 468999999986543  23345589999999985 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc---eEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFGla~  333 (362)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||+++
T Consensus        88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999999643  45899999999999999999999665   999999999999998776   9999999998


Q ss_pred             cccCCCC-----ceeeccccCccCcccccccc
Q 018036          334 YLQDTGA-----SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~-----~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......     .......+||+.|+|||++.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  194 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVE  194 (316)
T ss_dssp             -------------------CCSGGGCCHHHHH
T ss_pred             ccccCCccccccccccccccCCcCccChHHhh
Confidence            7642211     11123456999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=2.5e-31  Score=239.74  Aligned_cols=173  Identities=24%  Similarity=0.317  Sum_probs=131.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||.||+|.+..    +..||+|.+.... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            4788899999999999999998743    4568999875432 2223456889999999999999999999984 56788


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            999999999999999643 345899999999999999999999665   9999999999999999999999999998775


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... .......+|+.|+|||++.
T Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~  190 (281)
T 1mp8_A          168 DSTY-YKASKGKLPIKWMAPESIN  190 (281)
T ss_dssp             ------------CCGGGCCHHHHH
T ss_pred             cccc-cccccCCCcccccChhhcc
Confidence            4322 1233445788999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=1.1e-30  Score=238.31  Aligned_cols=173  Identities=27%  Similarity=0.388  Sum_probs=146.0

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||+|.+......  ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            356788999999999999999999874 7899999998754322  2345889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee---CCCCceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~  333 (362)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           83 LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999998543  35899999999999999999999665   9999999999999   788999999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....    ......||+.|+|||++.+
T Consensus       158 ~~~~~----~~~~~~~~~~y~aPE~~~~  181 (304)
T 2jam_A          158 MEQNG----IMSTACGTPGYVAPEVLAQ  181 (304)
T ss_dssp             CCCCB----TTHHHHSCCCBCCTTTBSS
T ss_pred             ecCCC----ccccccCCCCccChHHhcc
Confidence            65422    1334579999999998754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=1.3e-31  Score=247.40  Aligned_cols=176  Identities=26%  Similarity=0.367  Sum_probs=146.3

Q ss_pred             hhhccccceeeccCcccEEEEEcCC------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|.+..      ...||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            3678888999999999999998632      2479999986432 122335589999999999 8999999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKR------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD  321 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  321 (362)
                      ..++||||+++|+|.+++....            ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            9999999999999999986421            235799999999999999999999665   9999999999999999


Q ss_pred             CceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       322 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.+||+|||+++...............||+.|+|||++.
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  239 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF  239 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhc
Confidence            999999999998775443333344556889999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=6.6e-31  Score=240.62  Aligned_cols=176  Identities=23%  Similarity=0.314  Sum_probs=133.2

Q ss_pred             hhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe---
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET---  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  254 (362)
                      ++|...+.||+|+||.||+|.+.    ++..||+|.+..........+.+.+|+.++++++||||+++++++...+.   
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            67888899999999999999763    34589999986544333334568999999999999999999999987653   


Q ss_pred             --eeEEEecCCCCChhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          255 --NLLVYEYMPNGSLGEVLHG----KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       255 --~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                        .++||||+++++|.+++..    .....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEee
Confidence              4899999999999999842    22356999999999999999999999554   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCcccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+++...............+|+.|+|||++.
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  222 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA  222 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHH
T ss_pred             cCcceecccccccCcccccCCCccccCchhhc
Confidence            99998765432222234456788999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=1.2e-30  Score=240.01  Aligned_cols=173  Identities=28%  Similarity=0.398  Sum_probs=142.4

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC------CCCchhhHHHHHHHHhcCccCcceeEEEEEe
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK------GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS  250 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  250 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||||.+.....      .......+.+|++++++++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            456789999999999999999999874 578999999864321      1122235889999999999999999999997


Q ss_pred             cCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc---eEEc
Q 018036          251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVA  327 (362)
Q Consensus       251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~  327 (362)
                      ..+ .++||||+++++|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            665 7999999999999999853  346899999999999999999999665   999999999999987654   9999


Q ss_pred             cccccccccCCCCceeeccccCccCccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      |||+++.....   .......||+.|+|||++
T Consensus       160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~  188 (322)
T 2ycf_A          160 DFGHSKILGET---SLMRTLCGTPTYLAPEVL  188 (322)
T ss_dssp             CCTTCEECCCC---HHHHHHHSCCTTCCHHHH
T ss_pred             cCccceecccc---cccccccCCcCccCchhh
Confidence            99999876432   123456799999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=7.6e-31  Score=240.03  Aligned_cols=177  Identities=23%  Similarity=0.290  Sum_probs=140.5

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ...++|+..+.||+|+||.||+|.+. +++.||+|.+....... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34578899999999999999999974 68899999986543222 22356889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       111 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999999643  45899999999999999999999665   9999999999999999999999999998765


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .... .......||+.|+|||++.+
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~  209 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSE  209 (309)
T ss_dssp             ------------CCGGGCCGGGTCC
T ss_pred             cccc-ccccccCCCcCccCHHHHcC
Confidence            3321 12345679999999998753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=3.4e-31  Score=242.56  Aligned_cols=176  Identities=28%  Similarity=0.393  Sum_probs=146.2

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  253 (362)
                      .++|+..+.||+|+||.||+|.+      .+++.||+|.+..... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            46788999999999999999973      3567899999864321 22334588999999999 7999999999998765


Q ss_pred             -eeeEEEecCCCCChhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee
Q 018036          254 -TNLLVYEYMPNGSLGEVLHGKRG--------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL  318 (362)
Q Consensus       254 -~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  318 (362)
                       ..++||||+++++|.+++.....              ..+++..+..++.|++.||+|||+.+   |+||||||+||++
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~  181 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  181 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEE
Confidence             48999999999999999975442              22889999999999999999999665   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       319 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.++.+||+|||+++...............||+.|+|||++.
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  223 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  223 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc
Confidence            999999999999998775443333345567899999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=1e-30  Score=239.01  Aligned_cols=169  Identities=32%  Similarity=0.495  Sum_probs=134.8

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+. ++.||+|++..    ....+.+.+|++++++++||||+++++++.+  ..++|||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            357888899999999999999884 68899998742    2334568999999999999999999998874  4789999


Q ss_pred             cCCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc-eEEccccccccccCC
Q 018036          261 YMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE-AHVADFGLAKYLQDT  338 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DFGla~~~~~~  338 (362)
                      |+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999975432 34788999999999999999999732256999999999999998876 799999999866432


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           .....||+.|+|||++.+
T Consensus       160 -----~~~~~gt~~y~aPE~~~~  177 (307)
T 2eva_A          160 -----MTNNKGSAAWMAPEVFEG  177 (307)
T ss_dssp             ----------CCTTSSCHHHHTC
T ss_pred             -----cccCCCCCceEChhhhCC
Confidence                 234469999999998754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=1.1e-30  Score=235.82  Aligned_cols=172  Identities=25%  Similarity=0.371  Sum_probs=146.7

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467889999999999999999875 577899999864321 122334589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999999643  35899999999999999999999555   999999999999999999999999999766432


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .    .....||+.|+|||++.+
T Consensus       168 ~----~~~~~~~~~y~aPE~~~~  186 (284)
T 2vgo_A          168 R----RRTMCGTLDYLPPEMIEG  186 (284)
T ss_dssp             C----BCCCCSCGGGCCHHHHTT
T ss_pred             c----cccccCCCCcCCHHHhcc
Confidence            1    345679999999998753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=1e-30  Score=234.85  Aligned_cols=173  Identities=26%  Similarity=0.374  Sum_probs=140.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367888999999999999999975 789999999865321 122334588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999999643  35899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .   ......||+.|+|||++.+
T Consensus       165 ~---~~~~~~~~~~y~aPE~~~~  184 (276)
T 2h6d_A          165 E---FLRTSCGSPNYAAPEVISG  184 (276)
T ss_dssp             ---------------CCTGGGTT
T ss_pred             c---ceecccCCccccCHHHHcC
Confidence            2   2345579999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=2.9e-30  Score=237.14  Aligned_cols=171  Identities=31%  Similarity=0.425  Sum_probs=141.5

Q ss_pred             ccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC--Ceee
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK--ETNL  256 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  256 (362)
                      |+..+.||+|+||.||++.+     .+++.||||++.... .....+.+.+|++++++++||||+++++++.+.  ...+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            48889999999999998864     257899999986432 223345689999999999999999999999874  5789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999999643   3899999999999999999999665   9999999999999999999999999999875


Q ss_pred             CCCCc-eeeccccCccCccccccccc
Q 018036          337 DTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..... .......||+.|+|||++.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~  211 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKE  211 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcC
Confidence            43221 12344568899999998753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.1e-30  Score=244.22  Aligned_cols=168  Identities=26%  Similarity=0.350  Sum_probs=137.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-------  252 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  252 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|++.....      ...+|+++++.++||||+++++++...       
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            46788999999999999999986 5789999999864322      144799999999999999999998443       


Q ss_pred             -------------------------------CeeeEEEecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 018036          253 -------------------------------ETNLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLH  299 (362)
Q Consensus       253 -------------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH  299 (362)
                                                     ...++||||++ |+|.+.+..  .....+++..+..++.|++.||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           34789999997 588877753  23456999999999999999999999


Q ss_pred             cCCCCCeEEeCCCCCceeeC-CCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          300 HDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       300 ~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.+   |+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||++.+
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~  215 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLG  215 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTT
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcC
Confidence            554   99999999999998 68899999999999765332   2345678999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=1.3e-30  Score=244.55  Aligned_cols=171  Identities=27%  Similarity=0.347  Sum_probs=135.3

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  253 (362)
                      +.++|+..+.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4578999999999999999999864 6889999998754433334456889999999999999999999997665     


Q ss_pred             -eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       254 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                       ..++||||++ ++|.+.+..    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence             7799999996 588888852    3889999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....   .......||+.|+|||++.+
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~  200 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILG  200 (371)
T ss_dssp             ------------------CTTCCHHHHTT
T ss_pred             cccccc---cccCCceecCCccCHHHhcC
Confidence            876432   12345679999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=5.6e-31  Score=245.93  Aligned_cols=172  Identities=27%  Similarity=0.345  Sum_probs=145.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+.... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            367888999999999999999875 68899999986542 2223356899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.  .+|+||||||+||+++.++.+||+|||+++..... 
T Consensus       111 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             ECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            999999999999643  3589999999999999999999963  13999999999999999999999999999866432 


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         ......||+.|+|||++.+
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~  204 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQG  204 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTT
T ss_pred             ---cccCCCCCCCeECHHHHcC
Confidence               1344679999999998754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=1.8e-30  Score=238.81  Aligned_cols=174  Identities=26%  Similarity=0.348  Sum_probs=145.4

Q ss_pred             hhhccccceeeccCcccEEEEEc--CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC---ccCcceeEEEEEe-----
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT--PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCS-----  250 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----  250 (362)
                      .++|+..+.||+|+||.||+|.+  .+++.||+|++............+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            46789999999999999999987  4678999999875544333334477888887776   8999999999987     


Q ss_pred             cCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      .....++||||++ |+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence            4567899999997 69999997665566999999999999999999999665   9999999999999999999999999


Q ss_pred             ccccccCCCCceeeccccCccCccccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++.....   .......||+.|+|||++.+
T Consensus       166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  193 (326)
T 1blx_A          166 LARIYSFQ---MALTSVVVTLWYRAPEVLLQ  193 (326)
T ss_dssp             SCCCCCGG---GGGCCCCCCCTTCCHHHHTT
T ss_pred             ccccccCC---CCccccccccceeCHHHHhc
Confidence            99876432   12345679999999998753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=240.90  Aligned_cols=173  Identities=25%  Similarity=0.392  Sum_probs=134.4

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|.+. +++    .|++|.+.... .....+++.+|+.++++++||||+++++++.... .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            67888999999999999999864 444    35777665332 2334456899999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999999743 345899999999999999999999665   9999999999999999999999999998875


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ............||+.|+|||++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~  192 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESIL  192 (327)
T ss_dssp             -----------CCCGGGSCHHHHH
T ss_pred             CccccccccCCCccccccCHHHHc
Confidence            433333334456788999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=1.3e-30  Score=243.67  Aligned_cols=174  Identities=25%  Similarity=0.331  Sum_probs=137.3

Q ss_pred             HhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCc---------hhhHHHHHHHHhcCccCcceeEEEEEe
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSH---------DNGLSAEIRTLGKIRHRNIVRLKAFCS  250 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~  250 (362)
                      +.++|+..+.||+|+||.||+|.+.+++.||||++.........         .+.+.+|++++++++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            34778889999999999999999988999999998654332221         156899999999999999999999985


Q ss_pred             c-----CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceE
Q 018036          251 N-----KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAH  325 (362)
Q Consensus       251 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  325 (362)
                      .     ....++||||++ |+|.+.+... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEE
Confidence            4     346799999997 6898888743 346899999999999999999999665   99999999999999999999


Q ss_pred             EccccccccccCCCCceeeccccCccCccccccccc
Q 018036          326 VADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       326 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|||+++......   ......||+.|+|||++.+
T Consensus       175 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~  207 (362)
T 3pg1_A          175 ICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQ  207 (362)
T ss_dssp             ECCTTC------------------CGGGCCHHHHTT
T ss_pred             EEecCccccccccc---ccceecccceecCcHHhcC
Confidence            99999998654322   2345679999999998653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=2.9e-30  Score=237.94  Aligned_cols=173  Identities=28%  Similarity=0.422  Sum_probs=140.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCE--EEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQ--VAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||.||+|.+. ++..  +++|.+..... ....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            467888999999999999999874 4554  48898864332 22334589999999999 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC
Q 018036          257 LVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF  322 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  322 (362)
                      +||||+++++|.+++....              ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence            9999999999999997543              246899999999999999999999665   99999999999999999


Q ss_pred             ceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          323 EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .+||+|||+++......   ......+|+.|+|||++.
T Consensus       180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  214 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLN  214 (327)
T ss_dssp             CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHH
T ss_pred             eEEEcccCcCccccccc---cccCCCCCccccChhhhc
Confidence            99999999998543211   123445788999999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=3.6e-30  Score=233.39  Aligned_cols=172  Identities=30%  Similarity=0.445  Sum_probs=142.2

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.+.....||+|+||.||+|.+ .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            3455567999999999999996 568899999986543  2334558999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEccccccccccCC
Q 018036          261 YMPNGSLGEVLHGKRG-SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~  338 (362)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9999999999975432 35678889999999999999999665   999999999999987 899999999999876532


Q ss_pred             CCceeeccccCccCcccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .  .......||+.|+|||++.
T Consensus       177 ~--~~~~~~~~~~~y~aPE~~~  196 (295)
T 2clq_A          177 N--PCTETFTGTLQYMAPEIID  196 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHH
T ss_pred             C--CcccccCCCccccChhhhc
Confidence            2  1234567999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=5.4e-31  Score=246.79  Aligned_cols=170  Identities=28%  Similarity=0.398  Sum_probs=127.2

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------  252 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  252 (362)
                      +.++|+..+.||+|+||.||+|.+ .+++.||||++..........+++.+|+++++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            347889999999999999999986 5688999999865433333445688999999999999999999999754      


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      ...++||||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            5679999999 7899998864   35899999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....     .....||+.|+|||++.+
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~  203 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLN  203 (367)
T ss_dssp             ----------------CCCTTCCHHHHTT
T ss_pred             cccccc-----CCCcCcCcCccChHHHcC
Confidence            875432     345679999999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=5.9e-31  Score=243.26  Aligned_cols=172  Identities=32%  Similarity=0.471  Sum_probs=134.9

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHH--HhcCccCcceeEEEEEec-----CC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRT--LGKIRHRNIVRLKAFCSN-----KE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~  253 (362)
                      .++|+..+.||+|+||.||+|+. +++.||||++....     ...+..|.++  +..++||||+++++.+..     ..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            46788899999999999999987 67899999985332     2224444444  556899999999986542     23


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEEeCCCCCceeeCCCCceEEc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC------SPLIIHRDVKSNNILLNSDFEAHVA  327 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~kl~  327 (362)
                      ..++||||+++|+|.+++....   .++..+..++.|++.||+|||+..      .++|+||||||+|||++.++.+||+
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             eEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            5689999999999999996433   589999999999999999999650      0159999999999999999999999


Q ss_pred             cccccccccCCCC------ceeeccccCccCccccccccc
Q 018036          328 DFGLAKYLQDTGA------SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       328 DFGla~~~~~~~~------~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |||+++.+.....      ........||+.|+|||++.+
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG  202 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence            9999987653221      112335579999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=7.9e-31  Score=241.70  Aligned_cols=173  Identities=28%  Similarity=0.358  Sum_probs=144.4

Q ss_pred             hhccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEe--cCCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~  254 (362)
                      ++|+..+.||+|+||.||+|++     .+++.||+|++....  ....+.+.+|++++++++||||+++++++.  ....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            6788899999999999999983     467899999986432  223345899999999999999999999987  4556


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            889999999999999996422 35899999999999999999999665   99999999999999999999999999997


Q ss_pred             ccCCCCce-eeccccCccCcccccccc
Q 018036          335 LQDTGASE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                      ........ ......||+.|+|||++.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLS  203 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhc
Confidence            75433221 233456889999999764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=1.6e-30  Score=236.22  Aligned_cols=175  Identities=25%  Similarity=0.380  Sum_probs=140.0

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec------
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------  251 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  251 (362)
                      .+.++|+..+.||+|+||.||+|++ .+++.||+|.+...   ....+.+.+|+.++++++||||+++++++.+      
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            3467899999999999999999996 47899999998532   1233458899999999999999999998865      


Q ss_pred             -------CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCce
Q 018036          252 -------KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEA  324 (362)
Q Consensus       252 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  324 (362)
                             .+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCE
Confidence                   35678999999999999999743 345788999999999999999999665   9999999999999999999


Q ss_pred             EEccccccccccCCC------------CceeeccccCccCcccccccc
Q 018036          325 HVADFGLAKYLQDTG------------ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       325 kl~DFGla~~~~~~~------------~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||+|||+++......            .........||+.|+|||++.
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD  203 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHT
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCccccc
Confidence            999999998764221            011234567999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=2.7e-30  Score=236.19  Aligned_cols=176  Identities=21%  Similarity=0.318  Sum_probs=137.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++...... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46789999999999999999986 57899999998754322 22345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          259 YEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      |||+++++|.+++...  ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998531  2456899999999999999999999665   9999999999999999999999999998765


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...  .......||+.|+|||++.+
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~  210 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHE  210 (310)
T ss_dssp             -------------CCSSCCHHHHTT
T ss_pred             CCC--ccccccCCCeeEeChHHhCC
Confidence            322  12334579999999998653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=5.7e-31  Score=246.36  Aligned_cols=175  Identities=16%  Similarity=0.191  Sum_probs=138.1

Q ss_pred             hhccccceeeccCcccEEEEEcCC------CCEEEEEEeeccCCCCC---------chhhHHHHHHHHhcCccCcceeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSS---------HDNGLSAEIRTLGKIRHRNIVRLK  246 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~  246 (362)
                      ++|+..+.||+|+||.||+|.+..      ++.||||.+........         ....+..|+..+..++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            588999999999999999998754      47899999864321100         011234556677788899999999


Q ss_pred             EEEecC----CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC--C
Q 018036          247 AFCSNK----ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN--S  320 (362)
Q Consensus       247 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~  320 (362)
                      +++...    ...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++  .
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence            998764    4579999999 99999999743 356999999999999999999999665   99999999999998  8


Q ss_pred             CCceEEccccccccccCCCCc-----eeeccccCccCccccccccc
Q 018036          321 DFEAHVADFGLAKYLQDTGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       321 ~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.+||+|||+++.+......     .......||+.|+|||++.+
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  235 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG  235 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence            899999999999876532211     11234569999999998754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=3.4e-30  Score=238.58  Aligned_cols=172  Identities=31%  Similarity=0.390  Sum_probs=145.2

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhc--CccCcceeEEEEEecCC--
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGK--IRHRNIVRLKAFCSNKE--  253 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~--  253 (362)
                      ..+.++|+..+.||+|+||.||+|++ +++.||+|.+...     ....+.+|.+++..  ++||||+++++++...+  
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            34568899999999999999999998 5899999998532     23447788888877  78999999999998876  


Q ss_pred             --eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEEeCCCCCceeeCCCCc
Q 018036          254 --TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH--------HDCSPLIIHRDVKSNNILLNSDFE  323 (362)
Q Consensus       254 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~  323 (362)
                        ..++||||+++|+|.+++...   .+++..+..++.|++.||+|||        +.+   |+||||||+||+++.++.
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred             cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence              789999999999999999643   4899999999999999999999        555   999999999999999999


Q ss_pred             eEEccccccccccCCCCce--eeccccCccCccccccccc
Q 018036          324 AHVADFGLAKYLQDTGASE--CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       324 ~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +||+|||+++.........  ......||+.|+|||++.+
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  225 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  225 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence            9999999998775433211  2345579999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=1.2e-30  Score=237.06  Aligned_cols=174  Identities=28%  Similarity=0.385  Sum_probs=139.3

Q ss_pred             hhccccceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEe-cCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS-NKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~  256 (362)
                      ..|+..+.||+|+||.||+|.+.+    ...+|+|.+.... .....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            457778999999999999998642    2358888875422 2223355889999999999999999999865 456788


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999999974 3456899999999999999999999665   9999999999999999999999999998765


Q ss_pred             CCCC--ceeeccccCccCcccccccc
Q 018036          337 DTGA--SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~--~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +...  ........||+.|+|||.+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQ  205 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHH
T ss_pred             ccchhccccccCCCCCccccChHHhc
Confidence            3221  11233456888999999764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.3e-30  Score=241.01  Aligned_cols=176  Identities=30%  Similarity=0.447  Sum_probs=138.0

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      .++|+..+.||+|+||.||+|.+..     +..||+|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            3567778999999999999998642     2369999986432 222334588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999999643 346899999999999999999999665   999999999999999999999999999877


Q ss_pred             cCCCCc-eeeccccCccCccccccccc
Q 018036          336 QDTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...... .......+|+.|+|||++.+
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~  224 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISY  224 (333)
T ss_dssp             -------------CCCGGGSCHHHHHS
T ss_pred             ccccccccccCCCCccccccCchhccc
Confidence            533211 11223456889999998653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=2.7e-30  Score=233.72  Aligned_cols=175  Identities=25%  Similarity=0.369  Sum_probs=149.9

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||+|.+..........+.+.+|++++++++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            456789999999999999999999875 6889999998765544445566999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC---CceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD---FEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~  333 (362)
                      +||||+++++|.+.+...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.+   +.+||+|||++.
T Consensus        98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999999988533  35899999999999999999999665   9999999999999754   469999999998


Q ss_pred             cccCCCCceeeccccCccCcccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......   .....||+.|+|||++.
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~  196 (287)
T 2wei_A          173 CFQQNTK---MKDRIGTAYYIAPEVLR  196 (287)
T ss_dssp             TBCCCSS---CSCHHHHHTTCCHHHHT
T ss_pred             eecCCCc---cccccCcccccChHHhc
Confidence            7653221   23456899999999764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=8.3e-31  Score=246.00  Aligned_cols=173  Identities=28%  Similarity=0.404  Sum_probs=130.3

Q ss_pred             hccccceeeccCcccEEEEEcC--CC--CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-CCeeeE
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP--NG--EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLL  257 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l  257 (362)
                      .|+..+.||+|+||.||+|.+.  ++  ..||+|.+.... .....+++.+|+.++++++||||+++++++.. .+..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            3556789999999999999863  22  368888875422 22334568999999999999999999999764 457899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999999974 3345889999999999999999999665   99999999999999999999999999987643


Q ss_pred             CCCc--eeeccccCccCcccccccc
Q 018036          338 TGAS--ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~--~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....  .......||+.|+|||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~  269 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQ  269 (373)
T ss_dssp             -------------CCGGGSCHHHHH
T ss_pred             cccccccccCCCCCcccccChHHhc
Confidence            2211  1123456788999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=3.3e-31  Score=249.21  Aligned_cols=170  Identities=16%  Similarity=0.218  Sum_probs=137.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHH---HHHhcCccCcceeEE-------EE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEI---RTLGKIRHRNIVRLK-------AF  248 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  248 (362)
                      .++|+..+.||+|+||.||+|++ .+++.||||++..... .....+.+.+|+   +.+++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            36788889999999999999997 5689999999975432 233445688999   555666899999998       77


Q ss_pred             EecCCe-----------------eeEEEecCCCCChhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018036          249 CSNKET-----------------NLLVYEYMPNGSLGEVLHGKR-----GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI  306 (362)
Q Consensus       249 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i  306 (362)
                      +...+.                 .++||||+ +|+|.+++....     ...+++..+..|+.|++.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            766542                 78999999 689999996421     122446888899999999999999665   9


Q ss_pred             EEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCcccccccc
Q 018036          307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       307 vH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +||||||+|||++.++.+||+|||+++....     .....+| +.|+|||++.
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~  275 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEA  275 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhc
Confidence            9999999999999999999999999986432     2455678 9999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=9.5e-31  Score=236.66  Aligned_cols=173  Identities=26%  Similarity=0.330  Sum_probs=131.8

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|++..........+.+.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999987 57889999998654332222233445555688889999999999999999999999


Q ss_pred             ecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          260 EYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       260 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||++ |+|.+++..  .....+++..+..++.|++.||+|||+.  .+|+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9996 588887753  1345699999999999999999999965  1499999999999999999999999999987654


Q ss_pred             CCCceeeccccCccCccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ..   ......||+.|+|||++
T Consensus       163 ~~---~~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          163 DV---AKDIDAGCKPYMAPERI  181 (290)
T ss_dssp             ----------CCCCCCSCHHHH
T ss_pred             cc---cccccCCCccccChhhc
Confidence            32   13345799999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=1.6e-30  Score=235.65  Aligned_cols=173  Identities=25%  Similarity=0.352  Sum_probs=139.9

Q ss_pred             hhccccc-eeeccCcccEEEEEc---CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNN-VIGRGGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~-~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+ .||+|+||.||+|.+   .+++.||||.+..........+++.+|++++++++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5677777 999999999999954   3467899999875544444456699999999999999999999999 5567889


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        95 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999999643  45899999999999999999999665   99999999999999999999999999987754


Q ss_pred             CCCce-eeccccCccCcccccccc
Q 018036          338 TGASE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..... ......||+.|+|||++.
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~  193 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECIN  193 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHH
T ss_pred             CCCcccccccCCCCceeeChHHhc
Confidence            33221 122345778999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=1.1e-30  Score=240.87  Aligned_cols=176  Identities=27%  Similarity=0.343  Sum_probs=141.0

Q ss_pred             hhhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||.||+|.+      .+++.||+|.+.... ......++.+|+.++++++||||+++++++...+.
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            46788899999999999999984      346789999985332 22233458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEE
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRG-----SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHV  326 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl  326 (362)
                      .++||||+++++|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999975432     45899999999999999999999665   999999999999984   446999


Q ss_pred             ccccccccccCCCCceeeccccCccCcccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+++...............||+.|+|||++.
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  218 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM  218 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhc
Confidence            9999998765433222234556899999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.1e-30  Score=233.33  Aligned_cols=173  Identities=26%  Similarity=0.346  Sum_probs=141.4

Q ss_pred             hhccccc-eeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNN-VIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|...+ .||+|+||.||+|.+.   ++..||+|.+.... .....+.+.+|++++++++||||+++++++ ..+..++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            4455555 8999999999999853   57789999986542 222345689999999999999999999999 4556899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        87 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            9999999999999963 3456899999999999999999999665   99999999999999999999999999987753


Q ss_pred             CCCc-eeeccccCccCcccccccc
Q 018036          338 TGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       338 ~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... .......||+.|+|||++.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~  186 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECIN  186 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             CcceeeccccccccccccCHHHhc
Confidence            3221 1123345789999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.1e-30  Score=258.13  Aligned_cols=166  Identities=27%  Similarity=0.362  Sum_probs=134.0

Q ss_pred             eeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .||+|+||.||+|.+.   ++..||||+++.... ....+++.+|++++++++|||||++++++.. +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            7999999999999763   456799999865432 2334569999999999999999999999976 5689999999999


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc-eee
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-ECM  344 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~  344 (362)
                      +|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus       421 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          421 PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             BHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             cHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            999999643 456899999999999999999999665   999999999999999999999999999876532211 112


Q ss_pred             ccccCccCcccccccc
Q 018036          345 SAVAGSYGYIAPVLGW  360 (362)
Q Consensus       345 ~~~~Gt~~y~aPE~~~  360 (362)
                      ....+|+.|+|||++.
T Consensus       497 ~~~~~~~~y~APE~~~  512 (613)
T 2ozo_A          497 SAGKWPLKWYAPECIN  512 (613)
T ss_dssp             -----CCTTSCHHHHH
T ss_pred             cCCCCccceeCHhhhc
Confidence            2334678999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=5.5e-30  Score=234.50  Aligned_cols=173  Identities=29%  Similarity=0.377  Sum_probs=142.2

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      ...+.|+..+.||+|+||.||+|.+. +++.||+|.+....    ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34577888999999999999999875 58999999986432    23458999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       102 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          102 VMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            9999999999999862 2345899999999999999999999665   99999999999999999999999999987653


Q ss_pred             CCCceeeccccCccCccccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...  ......||+.|+|||++.+
T Consensus       178 ~~~--~~~~~~~~~~y~aPE~~~~  199 (314)
T 3com_A          178 TMA--KRNTVIGTPFWMAPEVIQE  199 (314)
T ss_dssp             TBS--CBCCCCSCGGGCCHHHHSS
T ss_pred             hcc--ccCccCCCCCccChhhcCC
Confidence            221  2345679999999998653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=4.2e-30  Score=233.40  Aligned_cols=175  Identities=29%  Similarity=0.391  Sum_probs=148.0

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-------CchhhHHHHHHHHhcCc-cCcceeEEEE
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-------SHDNGLSAEIRTLGKIR-HRNIVRLKAF  248 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~l~~~  248 (362)
                      ..+.++|+..+.||+|+||.||+|.+. +++.||+|.+.......       ...+.+.+|+++++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            345688999999999999999999974 68899999986543221       11245788999999995 9999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcc
Q 018036          249 CSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVAD  328 (362)
Q Consensus       249 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  328 (362)
                      +...+..++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999999643  45899999999999999999999665   99999999999999999999999


Q ss_pred             ccccccccCCCCceeeccccCccCcccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ||++.......   ......||+.|+|||++.
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  196 (298)
T 1phk_A          168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIE  196 (298)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred             ccchhhcCCCc---ccccccCCccccCHHHhc
Confidence            99998765322   234567999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=2.8e-30  Score=246.85  Aligned_cols=173  Identities=24%  Similarity=0.270  Sum_probs=145.5

Q ss_pred             hhhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC------ccCcceeEEEEE
Q 018036          177 SDDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI------RHRNIVRLKAFC  249 (362)
Q Consensus       177 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~  249 (362)
                      .+.+..+|+..+.||+|+||.||+|.+. +++.||||++...   ......+.+|+++++.+      +|+||+++++++
T Consensus        92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            3445678999999999999999999864 5889999998532   12234477888888777      577999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc--eEEc
Q 018036          250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE--AHVA  327 (362)
Q Consensus       250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~  327 (362)
                      ...+..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence            99999999999995 79999997666566999999999999999999999665   999999999999999887  9999


Q ss_pred             cccccccccCCCCceeeccccCccCccccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |||+++.....     ....+||+.|+|||++.+
T Consensus       245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~  273 (429)
T 3kvw_A          245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILG  273 (429)
T ss_dssp             CCTTCEETTCC-----CCSSCSCGGGCCHHHHHT
T ss_pred             ecccceecCCc-----ccccCCCCCccChHHHhC
Confidence            99999765432     345689999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=5.3e-31  Score=237.11  Aligned_cols=179  Identities=24%  Similarity=0.325  Sum_probs=145.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEe--cCCeeeE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS--NKETNLL  257 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  257 (362)
                      .++|+..+.||+|+||.||+|... +++.||+|.+..........+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467888999999999999999874 6899999998755443344556899999999999999999999875  3568899


Q ss_pred             EEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          258 VYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ||||+++++|.+++...  ....+++..+..++.|++.||+|||+.+  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999642  2345899999999999999999999543  1239999999999999999999999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......  .......||+.|+|||++.+
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~  190 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNR  190 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHC
T ss_pred             eecccc--ccccccCCCccccChHHhcc
Confidence            765321  11234579999999998653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.7e-30  Score=235.93  Aligned_cols=174  Identities=25%  Similarity=0.328  Sum_probs=141.5

Q ss_pred             hccccceeeccCcccEEEEEcC-C---CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee-eE
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-N---GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-LL  257 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l  257 (362)
                      .|+..+.||+|+||.||+|.+. +   +..+|+|.+.... .....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            4556689999999999999853 2   2378999885422 122335688999999999999999999999876655 89


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...+
T Consensus       101 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999975 3456899999999999999999999665   99999999999999999999999999987643


Q ss_pred             CC--CceeeccccCccCccccccccc
Q 018036          338 TG--ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~--~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..  .........||+.|+|||.+.+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~  202 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQT  202 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred             CcccccccCcCCCCCccccChhhhcc
Confidence            22  1122344578999999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=9.2e-31  Score=238.13  Aligned_cols=176  Identities=28%  Similarity=0.403  Sum_probs=129.2

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            367888899999999999999874 688999998754322 222345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          260 EYMPNGSLGEVLHG------KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       260 e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ||+++++|.+++..      .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999863      12356899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCC---ceeeccccCccCcccccccc
Q 018036          334 YLQDTGA---SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~---~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......   ........||+.|+|||++.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVME  199 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHH
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhc
Confidence            7653211   11233457999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=9.6e-31  Score=261.32  Aligned_cols=168  Identities=26%  Similarity=0.384  Sum_probs=135.9

Q ss_pred             ceeeccCcccEEEEEc---CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVT---PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||.||+|.+   ..++.||||+++.........+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965   346789999997654444445679999999999999999999999975 457899999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc-ee
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS-EC  343 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~  343 (362)
                      |+|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus       454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            999999964  345899999999999999999999665   999999999999999999999999999877533221 12


Q ss_pred             eccccCccCccccccccc
Q 018036          344 MSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....||+.|+|||++.+
T Consensus       529 ~~~~~~t~~y~APE~~~~  546 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY  546 (635)
T ss_dssp             ------CGGGSCHHHHHH
T ss_pred             ccCCCCceeeeChhhhcC
Confidence            334457889999998743

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=1.1e-29  Score=234.23  Aligned_cols=165  Identities=25%  Similarity=0.353  Sum_probs=141.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEec--CCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSN--KETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~  256 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||+|.+...     ..+.+.+|++++++++ ||||+++++++..  ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            36788999999999999999986 57899999998532     2345899999999997 9999999999987  56789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYL  335 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~  335 (362)
                      +||||+++++|.+++..     +++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++..
T Consensus       110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999999852     889999999999999999999665   99999999999999776 8999999999876


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....   ......||+.|+|||++.+
T Consensus       182 ~~~~---~~~~~~~~~~y~aPE~~~~  204 (330)
T 3nsz_A          182 HPGQ---EYNVRVASRYFKGPELLVD  204 (330)
T ss_dssp             CTTC---CCCSCCSCGGGCCHHHHTT
T ss_pred             CCCC---ccccccccccccChhhhcC
Confidence            5332   2345679999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=3.2e-30  Score=237.33  Aligned_cols=173  Identities=29%  Similarity=0.411  Sum_probs=141.8

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec------
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN------  251 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------  251 (362)
                      ..++|+..+.||+|+||.||+|.+ .+++.||+|.+....   ...+.+.+|+.+++++ +||||+++++++..      
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            357788999999999999999987 478899999986432   2334589999999999 79999999999977      


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                      .+..++||||+++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            467899999999999999997655567899999999999999999999665   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.......  .......||+.|+|||++.
T Consensus       176 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          176 SAQLDRTV--GRRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC
T ss_pred             ceecCcCc--cccccccCCccccChhhhc
Confidence            98765321  1134557999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=2.8e-30  Score=242.37  Aligned_cols=169  Identities=25%  Similarity=0.372  Sum_probs=140.2

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee---
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN---  255 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  255 (362)
                      +.++|...+.||+|+||.||+|.+. +++.||+|++..........+++.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3468888999999999999999864 688999999865443333345688999999999999999999999887655   


Q ss_pred             ---eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          256 ---LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       256 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                         ++||||++ ++|.+++.    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence               99999996 68988874    23899999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....     .....||+.|+|||++.+
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~  215 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILS  215 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSC
T ss_pred             cccccC-----cCCcccCccccCHHHhcC
Confidence            866432     345679999999998754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=4.1e-30  Score=236.85  Aligned_cols=174  Identities=29%  Similarity=0.383  Sum_probs=143.7

Q ss_pred             hhhccccceeeccCcccEEEEEc-----CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC--
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-----PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE--  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  253 (362)
                      .++|+..+.||+|+||.||+|.+     .+++.||+|++...  .....+.+.+|++++++++||||+++++++...+  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            36688889999999999999983     46889999998643  2233456899999999999999999999987654  


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            678999999999999999743 345899999999999999999999665   9999999999999999999999999999


Q ss_pred             cccCCCCce-eeccccCccCcccccccc
Q 018036          334 YLQDTGASE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                      ......... ......+|..|+|||++.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~  221 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLT  221 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhc
Confidence            875433211 123345788899999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=2.9e-30  Score=245.03  Aligned_cols=174  Identities=23%  Similarity=0.369  Sum_probs=127.6

Q ss_pred             Hhhhccc-cceeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--CC
Q 018036          180 ILECVKD-NNVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KE  253 (362)
Q Consensus       180 ~~~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  253 (362)
                      +.+.|+. +++||+|+||.||+|.+.   +++.||+|++....    ....+.+|+.++++++||||+++++++..  ..
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            3456665 568999999999999864   57899999985322    22348899999999999999999999954  67


Q ss_pred             eeeEEEecCCCCChhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee----CCCC
Q 018036          254 TNLLVYEYMPNGSLGEVLHGK-------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL----NSDF  322 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~  322 (362)
                      ..++||||++ ++|.+++...       ....+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence            8899999995 6888887521       1234899999999999999999999665   9999999999999    6779


Q ss_pred             ceEEccccccccccCCCC-ceeeccccCccCccccccccc
Q 018036          323 EAHVADFGLAKYLQDTGA-SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+||+|||+++....... .......+||+.|+|||++.+
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG  209 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence            999999999987753221 122345689999999998754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=1.2e-30  Score=237.55  Aligned_cols=173  Identities=23%  Similarity=0.306  Sum_probs=141.6

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +..+.|+..+.||+|+||.||+|.+. +++.||+|.+....  ....+.+.+|++++++++||||+++++++...+..++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            44578999999999999999999975 58899999886443  2334558999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      ||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        94 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999988642 345899999999999999999999665   99999999999999999999999999865432


Q ss_pred             CCCceeeccccCccCccccccc
Q 018036          338 TGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       338 ~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ..  .......||+.|+|||++
T Consensus       170 ~~--~~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          170 TL--QKRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             HH--HC-----CCGGGCCHHHH
T ss_pred             cc--cccccccCChhhcCCeee
Confidence            11  112345799999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=1.4e-30  Score=234.43  Aligned_cols=167  Identities=29%  Similarity=0.410  Sum_probs=134.7

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-CeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-ETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+ +++.||+|.+...    ...+.+.+|++++++++||||+++++++... +..++||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            47888999999999999999987 4789999988532    2334589999999999999999999997655 4789999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..... 
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            9999999999996543334789999999999999999999665   999999999999999999999999999865432 


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                          .....+|+.|+|||++.
T Consensus       171 ----~~~~~~~~~y~aPE~~~  187 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALR  187 (278)
T ss_dssp             ---------CCTTTSCHHHHH
T ss_pred             ----ccCCCccccccCHHHhC
Confidence                22346789999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.3e-30  Score=242.82  Aligned_cols=169  Identities=19%  Similarity=0.221  Sum_probs=141.6

Q ss_pred             hhccccceeeccCcccEEEEEcCC---------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCccee--------
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN---------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR--------  244 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------  244 (362)
                      ++|+..+.||+|+||.||+|.+..         ++.||+|.+...       +.+.+|++++++++||||++        
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            678899999999999999998753         789999998643       23899999999999999998        


Q ss_pred             -------EEEEEec-CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCce
Q 018036          245 -------LKAFCSN-KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI  316 (362)
Q Consensus       245 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI  316 (362)
                             +++++.. .+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                   6777776 67889999999 999999997654467999999999999999999999665   99999999999


Q ss_pred             eeCCCC--ceEEccccccccccCCCCc-----eeeccccCccCccccccccc
Q 018036          317 LLNSDF--EAHVADFGLAKYLQDTGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       317 ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++.++  .+||+|||+++.+......     .......||+.|+|||++.+
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG  242 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence            999998  8999999999876532211     11234579999999998754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=1.7e-30  Score=238.18  Aligned_cols=174  Identities=24%  Similarity=0.296  Sum_probs=141.8

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEe----cCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS----NKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~  256 (362)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++.    .....+
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            5788899999999999999987 578999999886432  233456899999999999999999999987    345778


Q ss_pred             EEEecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      +||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999998642  3456899999999999999999999665   99999999999999999999999999886


Q ss_pred             ccCCCCc-------eeeccccCccCcccccccc
Q 018036          335 LQDTGAS-------ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       335 ~~~~~~~-------~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......       .......||+.|+|||++.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  216 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFS  216 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred             cccccccccccccccccccccCCcccCCHhHhc
Confidence            5421110       0012346899999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=4.2e-30  Score=245.03  Aligned_cols=167  Identities=32%  Similarity=0.390  Sum_probs=134.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------Ce
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  254 (362)
                      ..|+..+.||+|+||.||+|++. +++.||||++.....      ...+|++++++++|||||++++++...      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            46788899999999999999974 689999999864321      145799999999999999999988542      23


Q ss_pred             eeEEEecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-CceEEccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-FEAHVADFGL  331 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGl  331 (362)
                      .++||||+++ +|.+.+..  .....+++..+..++.|+++||+|||+.+   |+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence            5799999975 67666542  22356899999999999999999999555   9999999999999965 6689999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.+....   ......||+.|+|||++.+
T Consensus       204 a~~~~~~~---~~~~~~~t~~y~aPE~~~~  230 (420)
T 1j1b_A          204 AKQLVRGE---PNVSYICSRYYRAPELIFG  230 (420)
T ss_dssp             CEECCTTC---CCCSCCSCTTSCCHHHHTT
T ss_pred             hhhcccCC---CceeeeeCCCcCCHHHHcC
Confidence            99765322   2345679999999998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=3e-30  Score=236.32  Aligned_cols=172  Identities=22%  Similarity=0.241  Sum_probs=139.8

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc--cCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||.||+|.+.+++.||+|++..........+.+.+|++++.+++  ||||+++++++...+..++||
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            568889999999999999999988999999998755443334456899999999997  599999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      | +.+++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||++++ +.+||+|||+++......
T Consensus       108 e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          108 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             C-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             e-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            9 5588999999643  45899999999999999999999665   999999999999964 899999999998775433


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .........||+.|+|||++.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~  201 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIK  201 (313)
T ss_dssp             ---------CCGGGCCHHHHT
T ss_pred             ccccccCCCCCCCcCCHHHHh
Confidence            222234567999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=4.7e-30  Score=242.72  Aligned_cols=168  Identities=29%  Similarity=0.342  Sum_probs=136.2

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC------e
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE------T  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  254 (362)
                      ..+|+..+.||+|+||.||+|++..+..+|+|++.....      ...+|+++++.++||||+++++++...+      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            457888999999999999999987777899999864322      1347999999999999999999996543      3


Q ss_pred             eeEEEecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCceEEccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGL  331 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGl  331 (362)
                      .++||||++++ +.+.+..  .....+++..+..++.|++.||+|||+.+   |+||||||+|||++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            78999999764 4443321  12346899999999999999999999665   99999999999999 789999999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++......   ......||+.|+|||++.+
T Consensus       189 a~~~~~~~---~~~~~~~t~~y~aPE~~~~  215 (394)
T 4e7w_A          189 AKILIAGE---PNVSYICSRYYRAPELIFG  215 (394)
T ss_dssp             CEECCTTC---CCCSSCSCGGGCCHHHHTT
T ss_pred             cccccCCC---CCcccccCcCccCHHHHcC
Confidence            98764322   2345678999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=2.2e-30  Score=240.66  Aligned_cols=174  Identities=17%  Similarity=0.178  Sum_probs=136.5

Q ss_pred             hhccccceeeccCcccEEEEEcC----CCCEEEEEEeeccCCCC---------CchhhHHHHHHHHhcCccCcceeEEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP----NGEQVAVKKLLGITKGS---------SHDNGLSAEIRTLGKIRHRNIVRLKAF  248 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~  248 (362)
                      ++|+..+.||+|+||.||+|.+.    ++..+|+|++.......         .....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888999999999999999975    56789999886442210         011236678889999999999999999


Q ss_pred             Eec----CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC--
Q 018036          249 CSN----KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF--  322 (362)
Q Consensus       249 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~--  322 (362)
                      +..    ....++||||+ +++|.+++....  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence            988    77889999999 999999996433  6899999999999999999999665   99999999999998877  


Q ss_pred             ceEEccccccccccCCCCc-----eeeccccCccCccccccccc
Q 018036          323 EAHVADFGLAKYLQDTGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+||+|||+++.+......     .......||+.|+|||++.+
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  234 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG  234 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence            9999999999876532211     11245679999999998754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=4.4e-30  Score=240.37  Aligned_cols=171  Identities=25%  Similarity=0.372  Sum_probs=142.4

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----Cee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  255 (362)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++.... .....+.+.+|++++.+++||||+++++++...     ...
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            57899999999999999999864 67889999986422 222235688999999999999999999999765     367


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||++ |+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999996 6999998643   4899999999999999999999665   999999999999999999999999999876


Q ss_pred             cCCCCc-eeeccccCccCcccccccc
Q 018036          336 QDTGAS-ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~-~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...... ......+||+.|+|||++.
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~  204 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIML  204 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhc
Confidence            532211 1134568999999999754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.1e-30  Score=257.30  Aligned_cols=162  Identities=20%  Similarity=0.147  Sum_probs=123.2

Q ss_pred             eeccCcccEEEEEc-CCCCEEEEEEeeccCCCC--------CchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEE
Q 018036          190 IGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS--------SHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       190 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .+.|+.|.+..++. ..|+.+++|.+.......        ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45555555554432 247889999987543221        1224599999999999 6999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||++|++|.+++...  ..++..   +|+.||+.||+|+|+++   ||||||||+|||+++++.+||+|||+|+......
T Consensus       322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            999999999999643  346654   58899999999999666   9999999999999999999999999999775432


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ....+.+||++|||||++.+
T Consensus       394 --~~~~t~vGTp~YmAPE~l~g  413 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVNELFAE  413 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC--
T ss_pred             --ccccCceechhhccHHHhCC
Confidence              22456789999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=3.1e-30  Score=232.51  Aligned_cols=173  Identities=27%  Similarity=0.356  Sum_probs=139.1

Q ss_pred             hhhccccceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||.||+|.+..    +..||+|.+.... .....+.+.+|+.++++++||||+++++++.. +..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            4678889999999999999998532    3469999876432 22234568999999999999999999999865 4568


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999999643 345899999999999999999999665   9999999999999999999999999998765


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... .......||+.|+|||++.
T Consensus       165 ~~~~-~~~~~~~~~~~y~aPE~~~  187 (281)
T 3cc6_A          165 DEDY-YKASVTRLPIKWMSPESIN  187 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHH
T ss_pred             cccc-cccccCCCCcceeCchhhc
Confidence            4321 1233456788999999764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=4.2e-30  Score=259.35  Aligned_cols=166  Identities=24%  Similarity=0.350  Sum_probs=138.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC--CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe----
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP--NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET----  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  254 (362)
                      .++|+..+.||+|+||.||+|.+.  +++.||||++.... .......+.+|++++.+++||||+++++++...+.    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            478999999999999999999874  58899999875422 22233458899999999999999999999987655    


Q ss_pred             -eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          255 -NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       255 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                       .|+||||+++++|.+++..    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.+ .+||+|||+++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence             6999999999999988753    5899999999999999999999665   9999999999999986 89999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....      ....||+.|+|||++.+
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~  251 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRT  251 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHH
T ss_pred             hcccC------CccCCCccccCHHHHcC
Confidence            76532      44579999999998653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=6.4e-30  Score=238.18  Aligned_cols=168  Identities=26%  Similarity=0.364  Sum_probs=138.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe-----
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET-----  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  254 (362)
                      .++|...+.||+|+||.||+|.+. +++.||||++..........+++.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467888999999999999999874 68899999986543333334568899999999999999999999987654     


Q ss_pred             -eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          255 -NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       255 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                       .++||||++ ++|.+++..    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence             489999996 699888742    3899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....     .....||+.|+|||++.+
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSC
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhC
Confidence            75432     344578999999998653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=3.1e-30  Score=236.59  Aligned_cols=173  Identities=23%  Similarity=0.333  Sum_probs=141.0

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||.||+|.+.+  .+|+|++..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3678889999999999999998754  49999987654444444558899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC-
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG-  339 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~-  339 (362)
                      |+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++ ++.+||+|||+++...... 
T Consensus       110 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          110 LCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             CCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             cccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            99999999999643 346899999999999999999999665   99999999999998 6799999999987653211 


Q ss_pred             --CceeeccccCccCcccccccc
Q 018036          340 --ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 --~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                        .........||+.|+|||++.
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~  207 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIR  207 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHS
T ss_pred             cccccccccCCCcccccChHHhh
Confidence              111233456999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=1.3e-29  Score=233.96  Aligned_cols=170  Identities=22%  Similarity=0.323  Sum_probs=144.7

Q ss_pred             HhhhccccceeeccCcccEEEEEc--CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc------ceeEEEEEec
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT--PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN------IVRLKAFCSN  251 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  251 (362)
                      +.++|+..+.||+|+||.||+|.+  .+++.||+|++...   ....+.+.+|+++++.++|++      ++++++++..
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            457899999999999999999986  36789999998532   223345889999999997765      9999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-----------
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-----------  320 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----------  320 (362)
                      .+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.           
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999 899999997665557899999999999999999999665   999999999999987           


Q ss_pred             --------CCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          321 --------DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       321 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                              ++.+||+|||+++.....     .....||+.|+|||++.+
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~  208 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILA  208 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTT
T ss_pred             ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhC
Confidence                    668999999999875432     345679999999998754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=8.1e-30  Score=240.66  Aligned_cols=170  Identities=24%  Similarity=0.249  Sum_probs=141.0

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc--------cCcceeEEEEEe-
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR--------HRNIVRLKAFCS-  250 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~-  250 (362)
                      .++|+..+.||+|+||.||+|++ .+++.||+|++...   ....+.+.+|++++++++        |+||+++++++. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            47789999999999999999986 46789999998532   223345889999999986        788999999987 


Q ss_pred             ---cCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-----
Q 018036          251 ---NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-----  322 (362)
Q Consensus       251 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----  322 (362)
                         .....++||||+ +++|.+.+.......+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++     
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence               556789999999 667777776555466999999999999999999999651  499999999999999775     


Q ss_pred             --------------------------------------------ceEEccccccccccCCCCceeeccccCccCcccccc
Q 018036          323 --------------------------------------------EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL  358 (362)
Q Consensus       323 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~  358 (362)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876532     344579999999998


Q ss_pred             ccc
Q 018036          359 GWY  361 (362)
Q Consensus       359 ~~~  361 (362)
                      +.+
T Consensus       265 ~~~  267 (397)
T 1wak_A          265 LIG  267 (397)
T ss_dssp             HHT
T ss_pred             hcC
Confidence            754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=2.9e-29  Score=227.41  Aligned_cols=173  Identities=24%  Similarity=0.316  Sum_probs=139.1

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEE-ecCCeeeE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNLL  257 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l  257 (362)
                      +.++|+..+.||+|+||.||+|.+ .+++.||+|.+......    +.+.+|+++++.++|++++..+.++ ...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            347789999999999999999986 57889999986543322    2388999999999988877766655 66778899


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee---CCCCceEEcccccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKY  334 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~  334 (362)
                      ||||+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.
T Consensus        83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            99999 99999999632 345899999999999999999999665   9999999999999   7889999999999998


Q ss_pred             ccCCCCc-----eeeccccCccCccccccccc
Q 018036          335 LQDTGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......     .......||+.|+|||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  189 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLG  189 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcC
Confidence            7643221     12335679999999998754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=1.3e-29  Score=235.72  Aligned_cols=173  Identities=26%  Similarity=0.386  Sum_probs=141.2

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----C
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----E  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  253 (362)
                      +.++|+..+.||+|+||.||+|.+. +++.||||++.... .......+.+|++++++++||||+++++++...     .
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            3478889999999999999999974 68899999985322 122234578999999999999999999988654     6


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..++||||++ ++|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            7899999996 699999864   34899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCCce--------eeccccCccCcccccccc
Q 018036          334 YLQDTGASE--------CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       334 ~~~~~~~~~--------~~~~~~Gt~~y~aPE~~~  360 (362)
                      .........        ......||+.|+|||++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML  195 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeec
Confidence            775322110        123457999999999764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=3.4e-30  Score=241.72  Aligned_cols=169  Identities=13%  Similarity=0.033  Sum_probs=124.0

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHH---HHHhcCccCcceeEE-------EEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEI---RTLGKIRHRNIVRLK-------AFC  249 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~  249 (362)
                      ..|+..+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+   ..++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            34788899999999999999964 78899999997654322 2334577775   45555 699988755       455


Q ss_pred             ecC-----------------CeeeEEEecCCCCChhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCe
Q 018036          250 SNK-----------------ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMR------LKIAIEAAKGLSYLHHDCSPLI  306 (362)
Q Consensus       250 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~~i  306 (362)
                      ..+                 ...++||||++ |+|.+++.... ..+++..+      ..++.|++.||+|||+.+   |
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            433                 33799999998 89999997432 23455666      788899999999999665   9


Q ss_pred             EEeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       307 vH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +||||||+|||++.++.+||+|||+++.....     .....||+.|+|||++.+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~  265 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNA  265 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccC
Confidence            99999999999999999999999999876421     224567799999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=3e-29  Score=232.15  Aligned_cols=169  Identities=24%  Similarity=0.304  Sum_probs=122.0

Q ss_pred             hHhhhcccc-ceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHH-HHHhcCccCcceeEEEEEec----
Q 018036          179 DILECVKDN-NVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEI-RTLGKIRHRNIVRLKAFCSN----  251 (362)
Q Consensus       179 ~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~----  251 (362)
                      .+.++|... +.||+|+||.||+|.+. +++.||+|++....      . ..+|+ ..++.++||||+++++++..    
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~-~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------K-ARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------H-HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------H-HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            456778884 57999999999999875 68999999985321      1 23333 34566799999999999876    


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEEcc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVAD  328 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D  328 (362)
                      ....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEec
Confidence            445789999999999999998766667999999999999999999999665   999999999999986   45599999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+++.....    ......||+.|+|||++.+
T Consensus       175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~  203 (336)
T 3fhr_A          175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGP  203 (336)
T ss_dssp             CTTCEEC--------------------------
T ss_pred             cccceecccc----ccccCCCCcCccChhhhCC
Confidence            9999876432    1345678999999998743

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=7.2e-30  Score=234.71  Aligned_cols=172  Identities=22%  Similarity=0.332  Sum_probs=145.7

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC----CchhhHHHHHHHHhcCc--cCcceeEEEEEecC
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNK  252 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~  252 (362)
                      +.++|+..+.||+|+||.||+|.+ .+++.||||.+.......    ...+.+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            457789999999999999999986 568899999987654322    12244788999999996  59999999999999


Q ss_pred             CeeeEEEecCCC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCceEEcccc
Q 018036          253 ETNLLVYEYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFG  330 (362)
Q Consensus       253 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFG  330 (362)
                      +..++||||+.+ ++|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++ +++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            999999999976 899999864  345899999999999999999999665   99999999999999 78999999999


Q ss_pred             ccccccCCCCceeeccccCccCcccccccc
Q 018036          331 LAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       331 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +++......    .....||+.|+|||++.
T Consensus       196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~  221 (320)
T 3a99_A          196 SGALLKDTV----YTDFDGTRVYSPPEWIR  221 (320)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHH
T ss_pred             ccccccccc----ccCCCCCccCCChHHhc
Confidence            998775422    34567999999999764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=3.1e-29  Score=233.87  Aligned_cols=172  Identities=26%  Similarity=0.346  Sum_probs=129.4

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe---
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET---  254 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  254 (362)
                      ...++|+..+.||+|+||.||+|.+. +++.||||++.....   ......+|++.+..++||||+++++++...+.   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            44688999999999999999999974 689999999864332   22336788888899999999999999965433   


Q ss_pred             ----eeEEEecCCCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEEeCCCCCceeeCC-CCceE
Q 018036          255 ----NLLVYEYMPNGSLGEVLHG--KRGSFLKWEMRLKIAIEAAKGLSYLH--HDCSPLIIHRDVKSNNILLNS-DFEAH  325 (362)
Q Consensus       255 ----~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~NIll~~-~~~~k  325 (362)
                          .++||||+++ +|.+.+..  .....+++..+..++.|++.||+|||  +.+   |+||||||+|||++. ++.+|
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence                7899999975 55544431  23456889999999999999999999  555   999999999999996 89999


Q ss_pred             EccccccccccCCCCceeeccccCccCcccccccc
Q 018036          326 VADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       326 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |+|||+++.......   .....||+.|+|||++.
T Consensus       173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~  204 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIF  204 (360)
T ss_dssp             ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHT
T ss_pred             EeeCCCceecCCCCC---cccccCCcceeCHHHHc
Confidence            999999987754322   34567999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=232.83  Aligned_cols=173  Identities=27%  Similarity=0.404  Sum_probs=135.4

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEe-------
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS-------  250 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-------  250 (362)
                      ++.++|+..+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++.       
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            44578899999999999999999975 48899999986432  223355889999999999999999999874       


Q ss_pred             -------cCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCC
Q 018036          251 -------NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDF  322 (362)
Q Consensus       251 -------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~  322 (362)
                             ..+..++||||++ |+|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ +++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTT
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence                   3467899999997 699999953   34899999999999999999999665   99999999999997 567


Q ss_pred             ceEEccccccccccCCCC-ceeeccccCccCcccccccc
Q 018036          323 EAHVADFGLAKYLQDTGA-SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .+||+|||+++....... ........||+.|+|||++.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL  197 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhc
Confidence            999999999987653211 11234456899999999764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=5.7e-30  Score=234.26  Aligned_cols=174  Identities=24%  Similarity=0.302  Sum_probs=137.7

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC----CchhhHHHHHHHHhcC----ccCcceeEEEE
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKI----RHRNIVRLKAF  248 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~  248 (362)
                      +.+.++|+..+.||+|+||.||+|.+ .+++.||+|.+.......    .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999987 468899999986543221    1223467899999988    89999999999


Q ss_pred             EecCCeeeEEEec-CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCceEE
Q 018036          249 CSNKETNLLVYEY-MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHV  326 (362)
Q Consensus       249 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl  326 (362)
                      +...+..++|||| +++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ .++.+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            9999999999999 7899999999643  35899999999999999999999665   99999999999999 8899999


Q ss_pred             ccccccccccCCCCceeeccccCccCcccccccc
Q 018036          327 ADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       327 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +|||+++......    .....||+.|+|||++.
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~  211 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWIS  211 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHH
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeee
Confidence            9999998775422    34567999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=5.5e-29  Score=225.71  Aligned_cols=172  Identities=24%  Similarity=0.318  Sum_probs=141.9

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEE-ecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFC-SNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|++ .+++.||+|.+.....    .+.+.+|+.+++.++|++++..+.++ ...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            46788999999999999999996 5789999998864332    23489999999999988877666655 566788999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee---CCCCceEEccccccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKYL  335 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~  335 (362)
                      |||+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++..
T Consensus        84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            9999 99999999633 345899999999999999999999665   9999999999999   47889999999999987


Q ss_pred             cCCCCce-----eeccccCccCccccccccc
Q 018036          336 QDTGASE-----CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~-----~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......     ......||+.|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  189 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLG  189 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred             cccccccccccccccccccccccCChhhhcC
Confidence            6433211     1345679999999998754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=9.3e-29  Score=239.04  Aligned_cols=172  Identities=24%  Similarity=0.315  Sum_probs=142.4

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc-CcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||||++.....    ...+.+|++++..++| +++..+..++...+..++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            46789999999999999999986 5789999998764432    2238899999999986 5566666777788899999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee---CCCCceEEccccccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKYL  335 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~  335 (362)
                      |||+ +++|.+++... ...+++..++.|+.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus        82 me~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999 99999999632 345899999999999999999999665   9999999999999   58899999999999987


Q ss_pred             cCCCCce-----eeccccCccCccccccccc
Q 018036          336 QDTGASE-----CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~-----~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .......     ......||+.|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  187 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG  187 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             cCCccccccccccccccCCCccccCHHHhcC
Confidence            6433211     1235689999999998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=1e-29  Score=229.93  Aligned_cols=175  Identities=26%  Similarity=0.335  Sum_probs=133.8

Q ss_pred             hhhccccceeeccCcccEEEEEcC--CCC--EEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP--NGE--QVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      .++|+..+.||+|+||.||+|.+.  +++  .||+|.+..... .....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367888999999999999999852  333  689998865432 2233456899999999999999999999998765 7


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence            8999999999999999643 245899999999999999999999665   999999999999999999999999999887


Q ss_pred             cCCCCce-eeccccCccCcccccccc
Q 018036          336 QDTGASE-CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~~-~~~~~~Gt~~y~aPE~~~  360 (362)
                      ....... ......||+.|+|||++.
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLK  197 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             cccccchhhhccCCCCceeeCchhhc
Confidence            5433221 123456888999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=1.4e-29  Score=253.79  Aligned_cols=173  Identities=24%  Similarity=0.317  Sum_probs=138.7

Q ss_pred             hhhccccceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||.||+|.+..    +..||+|++.... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            3667888999999999999998642    4578999875432 2223356899999999999999999999985 45689


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999999743 345899999999999999999999665   9999999999999999999999999999775


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      +... .......||+.|+|||++.
T Consensus       543 ~~~~-~~~~~~~~t~~y~aPE~~~  565 (656)
T 2j0j_A          543 DSTY-YKASKGKLPIKWMAPESIN  565 (656)
T ss_dssp             C-----------CCGGGCCHHHHH
T ss_pred             CCcc-eeccCCCCCcceeCHHHhc
Confidence            4322 1233456788999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=233.51  Aligned_cols=174  Identities=26%  Similarity=0.350  Sum_probs=127.5

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEe--------c
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCS--------N  251 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~  251 (362)
                      .+|+..+.||+|+||.||+|.+ .+++.||+|++....  ....+.+.+|+.++.++. ||||+++++++.        .
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4688889999999999999996 478999999885432  223345889999999996 999999999994        3


Q ss_pred             CCeeeEEEecCCCCChhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGK-RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      ....++||||++ |+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            345789999995 7999988542 2346999999999999999999999431 239999999999999999999999999


Q ss_pred             ccccccCCCCce----------eeccccCccCccccccc
Q 018036          331 LAKYLQDTGASE----------CMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       331 la~~~~~~~~~~----------~~~~~~Gt~~y~aPE~~  359 (362)
                      +++.........          ......||+.|+|||++
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             TCBCCSSCC------------------------------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence            998775322110          11245699999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=3.5e-29  Score=230.61  Aligned_cols=172  Identities=27%  Similarity=0.335  Sum_probs=124.6

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHH-HHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIR-TLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||||++..... .....++..|+. +++.++||||+++++++...+..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            367888899999999999999974 688999999865432 122233555665 77778999999999999999999999


Q ss_pred             EecCCCCChhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          259 YEYMPNGSLGEVLHG---KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      |||++ ++|.+++..   .....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99997 588887752   2245689999999999999999999965  14999999999999999999999999999876


Q ss_pred             cCCCCceeeccccCccCccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ....   ......||+.|+|||++
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~  197 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERI  197 (327)
T ss_dssp             ------------------------
T ss_pred             cccc---ccccCCCCccccCceee
Confidence            5322   12344799999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=4.7e-29  Score=238.43  Aligned_cols=168  Identities=26%  Similarity=0.333  Sum_probs=131.4

Q ss_pred             hccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEec
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      +|+..+.||+|+||+||.....+++.||||++....     ...+.+|+++++++ +|||||++++++.+.+..++||||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            477788999999999665555678999999985321     12367899999999 799999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-----CCceEEcccccccccc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-----DFEAHVADFGLAKYLQ  336 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DFGla~~~~  336 (362)
                      ++ |+|.+++..... ...+..+..++.|++.||+|||+.+   |+||||||+|||++.     ...+||+|||+++...
T Consensus       100 ~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            95 699999975442 3444556789999999999999665   999999999999953     3458899999998775


Q ss_pred             CCCC-ceeeccccCccCcccccccc
Q 018036          337 DTGA-SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~-~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... .......+||+.|+|||++.
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~  199 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLS  199 (432)
T ss_dssp             -----------CCSCTTSCCGGGTS
T ss_pred             CCCcceeeccccCCCcCccChhhhh
Confidence            3321 12244567999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=5.4e-29  Score=234.45  Aligned_cols=174  Identities=25%  Similarity=0.284  Sum_probs=143.6

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cC-----cceeEEEEEe
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HR-----NIVRLKAFCS  250 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~  250 (362)
                      +.+.++|+..+.||+|+||.||+|.+. +++.||||++...   ......+.+|+.+++.++ |+     +|+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            345678999999999999999999874 6789999998532   122344778888888875 44     4999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC--CCCceEEcc
Q 018036          251 NKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN--SDFEAHVAD  328 (362)
Q Consensus       251 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~D  328 (362)
                      ..+..++||||++ ++|.+++.......+++..+..++.|++.||+|||.. ..+|+||||||+|||++  .++.+||+|
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            9999999999995 6999999766556699999999999999999999943 24599999999999994  578899999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+++.....     .....||+.|+|||++.+
T Consensus       205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~  232 (382)
T 2vx3_A          205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLG  232 (382)
T ss_dssp             CTTCEETTCC-----CCSSCSCGGGCCHHHHTT
T ss_pred             ccCceecccc-----cccccCCccccChHHHcC
Confidence            9999876432     345679999999998754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=8.7e-29  Score=229.98  Aligned_cols=170  Identities=22%  Similarity=0.302  Sum_probs=142.4

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CC-CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc------ceeEEEEEec
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NG-EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN------IVRLKAFCSN  251 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  251 (362)
                      +.++|+..+.||+|+||.||+|.+. ++ +.||+|.+...   ....+.+.+|+.++++++|++      ++.+++++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            4578999999999999999999874 34 68999998532   223445888999999998776      9999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee-------------
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL-------------  318 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-------------  318 (362)
                      .+..++||||+ +++|.+.+.......+++..+..++.|++.||+|||+.+   |+||||||+|||+             
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            99999999999 678888876555567999999999999999999999554   9999999999999             


Q ss_pred             ------CCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          319 ------NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       319 ------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                            +.++.+||+|||+++.....     .....||+.|+|||++.+
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~  213 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILE  213 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTT
T ss_pred             cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeec
Confidence                  56789999999999875432     345679999999998754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.96  E-value=4.1e-29  Score=239.18  Aligned_cols=171  Identities=27%  Similarity=0.326  Sum_probs=129.6

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.|...+.||+|+||+||.+...+|+.||||++...     ..+.+.+|++++.++ +|||||++++++.+.+..++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            445567889999999998776668999999998542     223478999999886 89999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC-------------C
Q 018036          261 YMPNGSLGEVLHGKRGSF-----LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD-------------F  322 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~  322 (362)
                      |++ |+|.+++.......     .++..+..++.|++.||+|||+.+   |+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            995 69999997543211     123345789999999999999665   9999999999999754             4


Q ss_pred             ceEEccccccccccCCCCc--eeeccccCccCccccccccc
Q 018036          323 EAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 ~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+||+|||+++........  ......+||+.|+|||++.+
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  206 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE  206 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence            8999999999987543221  11335679999999998753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=4.6e-29  Score=228.56  Aligned_cols=173  Identities=23%  Similarity=0.262  Sum_probs=126.4

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||||.+..........+.+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            477888999999999999999974 6899999998654332222233445556788889999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+ ++.+..+.. .....+++..+..++.|++.||+|||+.  .+|+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 555555543 2235689999999999999999999963  139999999999999999999999999998765322


Q ss_pred             CceeeccccCccCcccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                         ......||+.|+|||++.
T Consensus       180 ---~~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERID  197 (318)
T ss_dssp             ----------CCTTCCHHHHC
T ss_pred             ---cccccCCCccccChhhcc
Confidence               133457999999999873

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=4.8e-29  Score=233.60  Aligned_cols=169  Identities=21%  Similarity=0.279  Sum_probs=141.6

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-----------cCcceeEEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----------HRNIVRLKAF  248 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~  248 (362)
                      .++|+..+.||+|+||.||+|.+ .+++.||||.+...   ....+.+.+|+.++++++           ||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            36788899999999999999986 56889999998532   223345888999998886           8999999999


Q ss_pred             EecCC----eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEeCCCCCceeeC----
Q 018036          249 CSNKE----TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-CSPLIIHRDVKSNNILLN----  319 (362)
Q Consensus       249 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~~~~ivH~Dlk~~NIll~----  319 (362)
                      +...+    ..++||||+ +++|.+++.......+++..+..++.|++.||+|||+. +   |+||||||+|||++    
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            87654    788999999 89999999766556699999999999999999999965 5   99999999999994    


Q ss_pred             --CCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          320 --SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       320 --~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ..+.+||+|||+++.....     .....||+.|+|||++.+
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~  209 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLG  209 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHT
T ss_pred             CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhC
Confidence              4458999999999876532     334579999999998754

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3e-29  Score=245.82  Aligned_cols=159  Identities=18%  Similarity=0.233  Sum_probs=122.8

Q ss_pred             ccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCC------chhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSS------HDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ..+.||+|+||.||+|.. .++.+++|+.........      ..+++.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            457899999999999955 578899998755332211      1234799999999999999997666666777889999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++++|.+++..          +..++.|+++||+|||+.+   |+||||||+|||++.  .+||+|||+++......
T Consensus       419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            99999999999964          4589999999999999665   999999999999998  99999999999875421


Q ss_pred             Cce-----eeccccCccCcccccccc
Q 018036          340 ASE-----CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       340 ~~~-----~~~~~~Gt~~y~aPE~~~  360 (362)
                      ...     .....+||+.|||||++.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~  509 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWE  509 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHH
Confidence            111     124678999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=9e-29  Score=245.16  Aligned_cols=176  Identities=28%  Similarity=0.379  Sum_probs=143.2

Q ss_pred             hHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec------
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------  251 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  251 (362)
                      ...++|+..+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|++++++++||||+++++++..      
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3457899999999999999999987 468899999875432 22234568899999999999999999999765      


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc---eEEc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE---AHVA  327 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~  327 (362)
                      .+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence            667799999999999999997543 235889999999999999999999665   999999999999997665   8999


Q ss_pred             cccccccccCCCCceeeccccCccCccccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |||+++......   ......||+.|+|||++.+
T Consensus       167 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~  197 (676)
T 3qa8_A          167 DLGYAKELDQGE---LCTEFVGTLQYLAPELLEQ  197 (676)
T ss_dssp             SCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCC
T ss_pred             cccccccccccc---ccccccCCcccCChHHhcc
Confidence            999999775432   2345689999999998753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.94  E-value=9.5e-27  Score=211.72  Aligned_cols=152  Identities=26%  Similarity=0.321  Sum_probs=131.1

Q ss_pred             ChhhHhhhcccc-ceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHH-hcCccCcceeEEEEEec-
Q 018036          176 GSDDILECVKDN-NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTL-GKIRHRNIVRLKAFCSN-  251 (362)
Q Consensus       176 ~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~-  251 (362)
                      ...++.++|... +.||+|+||.||+|.+ .+++.||+|.+..       ...+.+|+.++ +..+||||+++++++.. 
T Consensus        11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            344566778776 7899999999999987 5688999999853       23378899888 55689999999999876 


Q ss_pred             ---CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceE
Q 018036          252 ---KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAH  325 (362)
Q Consensus       252 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~k  325 (362)
                         ....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEE
Confidence               667899999999999999998665567999999999999999999999665   999999999999998   78899


Q ss_pred             EccccccccccC
Q 018036          326 VADFGLAKYLQD  337 (362)
Q Consensus       326 l~DFGla~~~~~  337 (362)
                      |+|||++.....
T Consensus       161 l~Dfg~a~~~~~  172 (299)
T 3m2w_A          161 LTDFGFAKETTG  172 (299)
T ss_dssp             ECCCTTCEECTT
T ss_pred             Eecccccccccc
Confidence            999999987653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.94  E-value=5.1e-27  Score=223.19  Aligned_cols=168  Identities=16%  Similarity=0.213  Sum_probs=126.5

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCcc-Ccc---------ee-----
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRH-RNI---------VR-----  244 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~ni---------v~-----  244 (362)
                      ..|...+.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.+++.++| +|.         +.     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3466778999999999999995 5789999999874332 22334569999999999977 221         11     


Q ss_pred             -------EEEEEec-----CCeeeEEEecCCCCChhhhhc-----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 018036          245 -------LKAFCSN-----KETNLLVYEYMPNGSLGEVLH-----GKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII  307 (362)
Q Consensus       245 -------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv  307 (362)
                             +..++..     ....+++|+++ +++|.+++.     ......+++..+..++.|++.||+|||+.+   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                   1111111     12346777776 789999984     233456888899999999999999999665   99


Q ss_pred             EeCCCCCceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccc
Q 018036          308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLG  359 (362)
Q Consensus       308 H~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~  359 (362)
                      ||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhh
Confidence            9999999999999999999999999875432     455678 999999987

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=2.1e-26  Score=208.29  Aligned_cols=146  Identities=13%  Similarity=0.018  Sum_probs=126.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.+....... ...+.+.+|+..+.+++||||+++++++...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467899999999999999999975 58899999986543322 2235689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      |||+++++|.+++...    .....+.+++.|++.||+|||+.+   |+||||||+|||++.++.+||+++|...
T Consensus       110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence            9999999999999532    355678899999999999999665   9999999999999999999999887654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=7.8e-26  Score=203.92  Aligned_cols=145  Identities=15%  Similarity=0.083  Sum_probs=112.8

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCC----------------CchhhHHHHHHHHhcCccCcceeEEE
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGS----------------SHDNGLSAEIRTLGKIRHRNIVRLKA  247 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~niv~l~~  247 (362)
                      |...+.||+|+||.||+|.+.+++.||+|.++......                .....+.+|++++++++|   +++.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence            34458999999999999999779999999986432111                023458899999999994   55555


Q ss_pred             EEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEc
Q 018036          248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA  327 (362)
Q Consensus       248 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  327 (362)
                      ++.. +..++||||+++++|.+ +..        .....++.|++.||+|||+.+   |+||||||+|||++ ++.+||+
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred             EEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence            4433 55699999999999998 521        123479999999999999665   99999999999999 9999999


Q ss_pred             cccccccccCCCCceeeccccCccCcccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      |||+|+..               ..|+|||++.
T Consensus       235 DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             CCTTCEET---------------TSTTHHHHHH
T ss_pred             ECCCCeEC---------------CCCCHHHHHH
Confidence            99999743               3467777653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=8.5e-22  Score=175.25  Aligned_cols=140  Identities=21%  Similarity=0.189  Sum_probs=106.7

Q ss_pred             ccccceeeccCcccEEEEEc-CCCCE--EEEEEeeccCCCCC----------------------chhhHHHHHHHHhcCc
Q 018036          184 VKDNNVIGRGGAGVVYRGVT-PNGEQ--VAVKKLLGITKGSS----------------------HDNGLSAEIRTLGKIR  238 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~  238 (362)
                      |+..+.||+|+||.||+|.+ .+|+.  ||||.++.......                      ....+.+|+..+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            44568899999999999998 67888  99998754321100                      0125789999999999


Q ss_pred             cCcc--eeEEEEEecCCeeeEEEecCCC-C----ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEEeC
Q 018036          239 HRNI--VRLKAFCSNKETNLLVYEYMPN-G----SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH-HDCSPLIIHRD  310 (362)
Q Consensus       239 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~D  310 (362)
                      |+++  +.++++    +..++||||+.+ |    +|.++...     .++..+..++.|++.||.||| +.+   |+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence            8864  344432    356899999942 4    67666432     234567789999999999999 776   99999


Q ss_pred             CCCCceeeCCCCceEEccccccccccC
Q 018036          311 VKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       311 lk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||+|||++.  .++|+|||+|.....
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETTS
T ss_pred             CCHHHEEEcC--cEEEEECcccccCCC
Confidence            9999999998  999999999987643

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.86  E-value=5.3e-22  Score=202.90  Aligned_cols=113  Identities=43%  Similarity=0.709  Sum_probs=109.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+|+|.||.+++++++|+.|||++|+|+|.||.+++++++|+.||||+|+|+|.||..++++++|++||+|+|+|+|
T Consensus       639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g  718 (768)
T 3rgz_A          639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG  718 (768)
T ss_dssp             CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred             CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccCCccCCCCCCCCCCCCCcCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYS  113 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~~lc~~~l~~c~~~  113 (362)
                      .||..+++..++..+|.||+.+||.++.+|...
T Consensus       719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~  751 (768)
T 3rgz_A          719 PIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS  751 (768)
T ss_dssp             ECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred             cCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence            999999999999999999999999998888643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.5e-19  Score=166.24  Aligned_cols=140  Identities=12%  Similarity=0.074  Sum_probs=99.3

Q ss_pred             ccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCC---CC---------chh--------hHHHHHHHHhcCccCcce
Q 018036          184 VKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG---SS---------HDN--------GLSAEIRTLGKIRHRNIV  243 (362)
Q Consensus       184 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~---------~~~--------~~~~e~~~l~~l~h~niv  243 (362)
                      |+....||+|++|.||+|...+|+.||||.++.....   ..         ...        ...+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            6778999999999999999999999999987542110   00         000        123456666666544432


Q ss_pred             eEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-
Q 018036          244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-  322 (362)
Q Consensus       244 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-  322 (362)
                      ...-+...  ..+|||||+++++|.++...        .....++.|++.+|.|||+.+   ||||||||.|||+++++ 
T Consensus       177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEEE--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             CCeeeecc--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence            22111111  23799999999888766421        123568899999999999766   99999999999998776 


Q ss_pred             ---------ceEEcccccccccc
Q 018036          323 ---------EAHVADFGLAKYLQ  336 (362)
Q Consensus       323 ---------~~kl~DFGla~~~~  336 (362)
                               .+.|+||+-+....
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccccceEEEEeCCcccCC
Confidence                     38999999876543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.69  E-value=2.6e-17  Score=150.43  Aligned_cols=109  Identities=31%  Similarity=0.465  Sum_probs=98.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++.+|..++.+++|+.|+|++|++++.+|. +..+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+|+|
T Consensus       204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  282 (313)
T 1ogq_A          204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG  282 (313)
T ss_dssp             CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred             CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence            567888888888888888888888888888877776 8888999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccCCccCCCCCCCCCCCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNPHLCGSYLNPC  110 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~~lc~~~l~~c  110 (362)
                      .+|....+..+....+.+|+.+||.|+..|
T Consensus       283 ~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C  312 (313)
T 1ogq_A          283 EIPQGGNLQRFDVSAYANNKCLCGSPLPAC  312 (313)
T ss_dssp             ECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred             cCCCCccccccChHHhcCCCCccCCCCCCC
Confidence            999998888888999999999999887767

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.56  E-value=3.5e-15  Score=152.45  Aligned_cols=99  Identities=27%  Similarity=0.497  Sum_probs=90.0

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE   81 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~   81 (362)
                      +.|.++|.+|..++.+++|+.|||++|+|+|.||.+|+++++|+.|||++|+|+|.||.+++++++|+.||||+|+|+|.
T Consensus       616 ~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~  695 (768)
T 3rgz_A          616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR  695 (768)
T ss_dssp             TSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEC
T ss_pred             ccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCc
Confidence            46899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCC-CcccccccCCccCCC
Q 018036           82 IPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        82 ~p~~-~~~~~~~~~~~~~n~  100 (362)
                      ||.. ..+..+....+.+|+
T Consensus       696 ip~~l~~l~~L~~L~ls~N~  715 (768)
T 3rgz_A          696 IPQAMSALTMLTEIDLSNNN  715 (768)
T ss_dssp             CCGGGGGCCCCSEEECCSSE
T ss_pred             CChHHhCCCCCCEEECcCCc
Confidence            9963 445555566666664

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.56  E-value=2.8e-17  Score=159.18  Aligned_cols=98  Identities=20%  Similarity=0.235  Sum_probs=81.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhh-cccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.+++..|..++.+++|+.|||++|+|+|.+|..+. .+++|+.|+|++|.|++ +|. +..+++|+.|+|++|+|+
T Consensus       127 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~  204 (487)
T 3oja_A          127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA  204 (487)
T ss_dssp             CCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc-ccc-cccCCCCCEEECCCCCCC
Confidence            578899988888899999999999999999998888886 78999999999999986 444 446889999999999999


Q ss_pred             CCCCCCCcccccccCCccCCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n~  100 (362)
                      +.+|.+..+..+..+.+.+|.
T Consensus       205 ~~~~~~~~l~~L~~L~Ls~N~  225 (487)
T 3oja_A          205 FMGPEFQSAAGVTWISLRNNK  225 (487)
T ss_dssp             EECGGGGGGTTCSEEECTTSC
T ss_pred             CCCHhHcCCCCccEEEecCCc
Confidence            988877666666666676664

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.54  E-value=1.5e-14  Score=122.60  Aligned_cols=104  Identities=26%  Similarity=0.404  Sum_probs=82.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++ .||..+.++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        38 L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~  116 (193)
T 2wfh_A           38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV  116 (193)
T ss_dssp             CCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             CCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCe
Confidence            5678887 788888888888888888888887666778888888888888888887656678888888888888888887


Q ss_pred             CCCC-CCcccccccCCccCCCCCCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~~lc~~  105 (362)
                      .++. +..+..+..+.+.+|+..|..
T Consensus       117 ~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A          117 VPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             eChhhhhcCccccEEEeCCCCeecCC
Confidence            6664 445566666777888877753

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.53  E-value=1.3e-14  Score=122.72  Aligned_cols=104  Identities=21%  Similarity=0.322  Sum_probs=80.2

Q ss_pred             CCCCcccccCCc-ccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPV-EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~-~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|. .++.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++|+|+
T Consensus        36 l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  115 (192)
T 1w8a_A           36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS  115 (192)
T ss_dssp             CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred             CCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence            567888754443 3788888888888888888877888888888888888888888766666888888888888888888


Q ss_pred             CCCCC-CCcccccccCCccCCCCCCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGNPHLCG  104 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n~~lc~  104 (362)
                      +.+|. +..+..+..+.+.+|+..|.
T Consensus       116 ~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A          116 CVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             EECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             eeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            88775 34455566667777876654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=2.4e-14  Score=119.25  Aligned_cols=101  Identities=20%  Similarity=0.265  Sum_probs=87.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~   79 (362)
                      +++|+++ .||..+.  ++|++|+|++|+|++..|..+..+++|+.|+|++|+|++ +|.. +.++++|+.|+|++|+|+
T Consensus        19 ~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~l~   94 (174)
T 2r9u_A           19 CQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLK   94 (174)
T ss_dssp             CCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCC
T ss_pred             eCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCCccc
Confidence            4678885 9998875  899999999999998889999999999999999999996 6654 689999999999999999


Q ss_pred             CCCCC-CCcccccccCCccCCCCCCCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n~~lc~~  105 (362)
                      +.+|. +..+..+..+.+.+|+..|.+
T Consensus        95 ~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           95 SIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             eeCHHHhccccCCCEEEeCCCCccccc
Confidence            88876 566777777888899877653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=2.7e-14  Score=118.38  Aligned_cols=102  Identities=19%  Similarity=0.243  Sum_probs=87.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|.|+ .||..+.  ++|++|+|++|+|++..|..+..+++|++|+|++|+|++..|..+..+++|+.|+|++|+|++
T Consensus        16 ~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~   92 (170)
T 3g39_A           16 CSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS   92 (170)
T ss_dssp             CTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             eCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCE
Confidence            5788898 7998774  899999999999998889999999999999999999996444457899999999999999999


Q ss_pred             CCCC-CCcccccccCCccCCCCCCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~~lc~~  105 (362)
                      .+|. +..+..+..+.+.+|+..|..
T Consensus        93 ~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           93 IPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             eCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            8885 566777778888999887754

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.49  E-value=4.7e-14  Score=122.01  Aligned_cols=99  Identities=16%  Similarity=0.125  Sum_probs=61.3

Q ss_pred             CCCCcccccCCc-ccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPV-EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~-~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|. .++.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+++
T Consensus        39 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  118 (220)
T 2v70_A           39 LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT  118 (220)
T ss_dssp             CCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCC
T ss_pred             cCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCC
Confidence            456777655443 3566777777777777777555556777777777777777776544555666777777777777777


Q ss_pred             CCCCC-CCcccccccCCccCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n   99 (362)
                      +.+|. +..+..+..+.+.+|
T Consensus       119 ~~~~~~~~~l~~L~~L~L~~N  139 (220)
T 2v70_A          119 CVGNDSFIGLSSVRLLSLYDN  139 (220)
T ss_dssp             CBCTTSSTTCTTCSEEECTTS
T ss_pred             eECHhHcCCCccCCEEECCCC
Confidence            66553 233334444444444

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.6e-13  Score=121.68  Aligned_cols=145  Identities=15%  Similarity=0.083  Sum_probs=111.6

Q ss_pred             HhhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  258 (362)
                      ..+.|+....++.|+.+.||++... ++.+++|.........  ...+.+|+++++.+. +..+.++++++...+..|+|
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            3455666677788888999999864 6889999876432111  234899999999884 67788999999988899999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-------------------------------------  301 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------  301 (362)
                      |||++|.+|.+.+.       +......++.+++++|+.||+.                                     
T Consensus        89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999999987642       1122346788999999999971                                     


Q ss_pred             -------------------CCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          302 -------------------CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       302 -------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                                         ....++|+|++|.||+++++..+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               014589999999999998765667999998764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.48  E-value=1.8e-14  Score=121.99  Aligned_cols=106  Identities=24%  Similarity=0.345  Sum_probs=87.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++.+|..++.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|.|++
T Consensus        61 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            68999999889999999999999999999999888889999999999999999999889999999999999999999998


Q ss_pred             CCCCCCcccccccCCccCCCCCCCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNPHLCGSY  106 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~~lc~~~  106 (362)
                      ..+.......+....+.++...|+.|
T Consensus       141 ~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A          141 NCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             SGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            87632111122222344555566543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.48  E-value=6.6e-14  Score=121.08  Aligned_cols=98  Identities=24%  Similarity=0.267  Sum_probs=65.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++|+|+ .+|.. +..+++|+.|+|++|+++
T Consensus        39 l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~  117 (220)
T 2v9t_B           39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN  117 (220)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCC
Confidence            4667777555556777777777777777777666777777777777777777776 45544 566777777777777777


Q ss_pred             CCCCC-CCcccccccCCccCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n   99 (362)
                      +.+|. +..+..+..+.+.+|
T Consensus       118 ~~~~~~~~~l~~L~~L~L~~N  138 (220)
T 2v9t_B          118 CLRVDAFQDLHNLNLLSLYDN  138 (220)
T ss_dssp             CCCTTTTTTCTTCCEEECCSS
T ss_pred             EeCHHHcCCCCCCCEEECCCC
Confidence            76654 233344444444444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.47  E-value=9.4e-14  Score=128.41  Aligned_cols=102  Identities=18%  Similarity=0.163  Sum_probs=88.0

Q ss_pred             CCC-cccccCCcccccccCCCEEECcC-CcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            2 SRN-NFSGIIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         2 ~~n-~~~g~ip~~~~~l~~l~~l~l~~-n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      ++| +|+ .||. |+.+++|+.|+|++ |+|++..|..|+.|++|+.|||++|+|+|..|..|.++++|+.|||++|+|+
T Consensus        16 ~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~   93 (347)
T 2ifg_A           16 TRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (347)
T ss_dssp             CSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             CCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc
Confidence            455 788 6999 99999999999996 9999877789999999999999999999977888999999999999999999


Q ss_pred             CCCCCCCcccccccCCccCCCCCCCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n~~lc~~  105 (362)
                      +.+|.......+..+.+.+|+..|..
T Consensus        94 ~~~~~~~~~~~L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           94 SLSWKTVQGLSLQELVLSGNPLHCSC  119 (347)
T ss_dssp             CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             eeCHHHcccCCceEEEeeCCCccCCC
Confidence            98876544333666778888887754

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.45  E-value=2.1e-13  Score=113.57  Aligned_cols=103  Identities=17%  Similarity=0.186  Sum_probs=64.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+|++
T Consensus        35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  114 (177)
T 2o6r_A           35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS  114 (177)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             eCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE
Confidence            45666664444445667777777777777774444445677777777777777765444445667777777777777776


Q ss_pred             CCCCC-CcccccccCCccCCCCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNPHLC  103 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~~lc  103 (362)
                      .++.. ..+..+..+.+.+|+..|
T Consensus       115 ~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A          115 VPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             eCHHHhcCCcccCEEEecCCCeec
Confidence            55543 334455555566665544

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.45  E-value=4.9e-14  Score=128.60  Aligned_cols=100  Identities=29%  Similarity=0.554  Sum_probs=87.1

Q ss_pred             CCCCcccc--cCCcccccccCCCEEECcC-CcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCc
Q 018036            1 MSRNNFSG--IIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNN   77 (362)
Q Consensus         1 l~~n~~~g--~ip~~~~~l~~l~~l~l~~-n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~   77 (362)
                      |++|+++|  .+|..++++++|++|+|++ |+++|.+|..++++++|++|+|++|+++|.+|..+.++++|++|++++|+
T Consensus        57 L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~  136 (313)
T 1ogq_A           57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence            46889999  9999999999999999994 99999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCC-CCcccccccCCccCCC
Q 018036           78 FSGEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        78 l~g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      ++|.+|. +..+..+....+.+|.
T Consensus       137 l~~~~p~~~~~l~~L~~L~L~~N~  160 (313)
T 1ogq_A          137 LSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EESCCCGGGGGCTTCCEEECCSSC
T ss_pred             cCCcCChHHhcCCCCCeEECcCCc
Confidence            9998885 3445555555565653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.44  E-value=2.5e-13  Score=118.13  Aligned_cols=99  Identities=15%  Similarity=0.145  Sum_probs=67.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+.
T Consensus        47 Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~  126 (229)
T 3e6j_A           47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE  126 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS
T ss_pred             cCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccc
Confidence            56788887777778888888888888888863333446778888888888888875444446777788888888888774


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                      .++.+..+..+..+.+.+|
T Consensus       127 lp~~~~~l~~L~~L~L~~N  145 (229)
T 3e6j_A          127 LPRGIERLTHLTHLALDQN  145 (229)
T ss_dssp             CCTTGGGCTTCSEEECCSS
T ss_pred             cCcccccCCCCCEEECCCC
Confidence            4334444444445555555

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.40  E-value=1.7e-13  Score=110.77  Aligned_cols=97  Identities=14%  Similarity=0.141  Sum_probs=81.9

Q ss_pred             CCCCccc-ccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFS-GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~-g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|+++ |.+|..++.+++|++|+|++|++++.  ..++++++|+.|+|++|.+++.+|..+..+++|+.|++++|+++
T Consensus        24 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~  101 (149)
T 2je0_A           24 LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK  101 (149)
T ss_dssp             CTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCC
T ss_pred             ccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCC
Confidence            5789998 89999999999999999999999965  78999999999999999999889998888999999999999999


Q ss_pred             CCC--CCCCcccccccCCccCC
Q 018036           80 GEI--PEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~--p~~~~~~~~~~~~~~~n   99 (362)
                      +..  +.+..+..+....+.+|
T Consensus       102 ~~~~~~~~~~l~~L~~L~l~~N  123 (149)
T 2je0_A          102 DLSTIEPLKKLENLKSLDLFNC  123 (149)
T ss_dssp             SHHHHGGGGGCTTCCEEECTTC
T ss_pred             ChHHHHHHhhCCCCCEEeCcCC
Confidence            843  44444455555555565

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.40  E-value=6.8e-13  Score=116.98  Aligned_cols=100  Identities=16%  Similarity=0.173  Sum_probs=72.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..+..+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        66 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  145 (251)
T 3m19_A           66 LDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS  145 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc
Confidence            56788887666667888888888888888886656667788888888888888875333446778888888888888887


Q ss_pred             CCCC-CCcccccccCCccCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      .+|. +..+..+..+.+.+|.
T Consensus       146 ~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A          146 IPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             cCHHHcCcCcCCCEEECCCCc
Confidence            7663 4445555555555553

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.39  E-value=8.1e-13  Score=117.94  Aligned_cols=100  Identities=19%  Similarity=0.200  Sum_probs=69.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++..|..++++++|++|+|++|++++..|..++.+++|+.|+|++|++++..|..++.+++|+.|++++|++++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            46777775555556778888888888888886666667778888888888888875444456777788888888888877


Q ss_pred             CCCCC-CcccccccCCccCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~  100 (362)
                      .+|.. ..+..+..+.+.+|.
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             cCHHHhcCCccCCEEECCCCc
Confidence            66643 344445555555553

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.39  E-value=1e-12  Score=112.42  Aligned_cols=99  Identities=19%  Similarity=0.205  Sum_probs=67.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++.+++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+.++++|+.|++++|++++
T Consensus        35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  114 (208)
T 2o6s_A           35 LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS  114 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             cCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc
Confidence            46777875444456778888888888888885444456778888888888888875334446778888888888888877


Q ss_pred             CCCC-CCcccccccCCccCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n   99 (362)
                      .+|. +..+..+..+.+.+|
T Consensus       115 ~~~~~~~~l~~L~~L~l~~N  134 (208)
T 2o6s_A          115 LPDGVFDKLTQLKDLRLYQN  134 (208)
T ss_dssp             CCTTTTTTCTTCCEEECCSS
T ss_pred             cCHhHhccCCcCCEEECCCC
Confidence            6664 344444554555555

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.39  E-value=4e-13  Score=132.13  Aligned_cols=95  Identities=21%  Similarity=0.308  Sum_probs=84.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+|++ ||. ++.+++|+.|+|++|+|+ .||..++++++|+.|+|++|+|++ || .++++++|+.|+|++|+|++
T Consensus       448 Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~  522 (567)
T 1dce_A          448 LAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQ  522 (567)
T ss_dssp             CTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCS
T ss_pred             ecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCC
Confidence            68899995 886 999999999999999999 999999999999999999999996 88 89999999999999999999


Q ss_pred             CC-C-CCCcccccccCCccCCC
Q 018036           81 EI-P-EFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~-p-~~~~~~~~~~~~~~~n~  100 (362)
                      .+ | .+..+..+..+.+.+|+
T Consensus       523 ~~~p~~l~~l~~L~~L~L~~N~  544 (567)
T 1dce_A          523 SAAIQPLVSCPRLVLLNLQGNS  544 (567)
T ss_dssp             SSTTGGGGGCTTCCEEECTTSG
T ss_pred             CCCcHHHhcCCCCCEEEecCCc
Confidence            85 4 45666677777777775

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.39  E-value=3e-13  Score=111.66  Aligned_cols=98  Identities=16%  Similarity=0.166  Sum_probs=81.5

Q ss_pred             CCCCccc-ccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFS-GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~-g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|+++ |.+|..+..+++|++|+|++|++++.  ..+..+++|+.|+|++|++++.+|..+.++++|+.|++++|+++
T Consensus        31 l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  108 (168)
T 2ell_A           31 LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK  108 (168)
T ss_dssp             CCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC
T ss_pred             CCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC
Confidence            5788998 89999999999999999999999965  78899999999999999999878888888999999999999998


Q ss_pred             CCC--CCCCcccccccCCccCCC
Q 018036           80 GEI--PEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~--p~~~~~~~~~~~~~~~n~  100 (362)
                      +..  +.+..+..+....+.+|+
T Consensus       109 ~~~~~~~l~~l~~L~~L~l~~N~  131 (168)
T 2ell_A          109 DISTLEPLKKLECLKSLDLFNCE  131 (168)
T ss_dssp             SSGGGGGGSSCSCCCEEECCSSG
T ss_pred             cchhHHHHhcCCCCCEEEeeCCc
Confidence            854  444445555555555653

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.39  E-value=2.6e-13  Score=135.63  Aligned_cols=70  Identities=11%  Similarity=0.167  Sum_probs=38.7

Q ss_pred             ccccCchhhhcccccCeeeccccccccC-----------------cchhhc--CCCCCCEEEccCCcccCCCCC-CCccc
Q 018036           30 LSGPIPVQITQIHILNYLNVSWNQLNAS-----------------LPKEMG--NMKSLTSADFSHNNFSGEIPE-FGQYS   89 (362)
Q Consensus        30 l~g~ip~~~~~l~~l~~l~l~~n~l~g~-----------------~p~~~~--~~~~l~~l~ls~n~l~g~~p~-~~~~~   89 (362)
                      |+| ||+.++++++|++|+|++|.|+|.                 +|++++  ++++|++|++++|++.|.+|. +..+.
T Consensus       195 l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~  273 (636)
T 4eco_A          195 ITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP  273 (636)
T ss_dssp             EEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCS
T ss_pred             Ccc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCC
Confidence            344 566666666666666666666654                 666655  666666666666666665553 23333


Q ss_pred             ccccCCccCCC
Q 018036           90 FFNSTSFTGNP  100 (362)
Q Consensus        90 ~~~~~~~~~n~  100 (362)
                      .+..+.+.+|.
T Consensus       274 ~L~~L~Ls~n~  284 (636)
T 4eco_A          274 EMQLINVACNR  284 (636)
T ss_dssp             SCCEEECTTCT
T ss_pred             CCCEEECcCCC
Confidence            44444444443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.38  E-value=8.9e-13  Score=109.21  Aligned_cols=86  Identities=23%  Similarity=0.219  Sum_probs=75.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++.+++|++|||++|+|++..|..+..+++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++
T Consensus        37 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           37 LYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             cCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            68999998888899999999999999999996555567999999999999999996444469999999999999999998


Q ss_pred             CCCCCC
Q 018036           81 EIPEFG   86 (362)
Q Consensus        81 ~~p~~~   86 (362)
                      ..+...
T Consensus       117 ~c~~l~  122 (170)
T 3g39_A          117 ACSDIL  122 (170)
T ss_dssp             TBGGGH
T ss_pred             CchhHH
Confidence            876543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.38  E-value=2.3e-12  Score=113.75  Aligned_cols=130  Identities=17%  Similarity=0.090  Sum_probs=98.0

Q ss_pred             eccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc--ceeEEEEEecCCeeeEEEecCCCCChh
Q 018036          191 GRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN--IVRLKAFCSNKETNLLVYEYMPNGSLG  268 (362)
Q Consensus       191 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~  268 (362)
                      +.|..+.||++...+|..+++|.....     ....+.+|+++++.+.+.+  +.+++++....+..++||||++|.+|.
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            355669999998877888999986432     1134889999999886544  556888888888889999999998884


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 018036          269 EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC----------------------------------------------  302 (362)
Q Consensus       269 ~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------------  302 (362)
                        ...     .+   ...++.++++.|..||...                                              
T Consensus       104 --~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 --SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             --TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             --cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence              211     11   2356778888888888532                                              


Q ss_pred             ---------CCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          303 ---------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       303 ---------~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                               ...++|+|++|.||+++++..+.|+||+.+...
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                     112999999999999987766779999998654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.36  E-value=1.6e-12  Score=112.36  Aligned_cols=103  Identities=16%  Similarity=0.184  Sum_probs=59.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++.+++|++|+|++|+|++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        64 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  143 (220)
T 2v70_A           64 FSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT  143 (220)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC
T ss_pred             CCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE
Confidence            35566665444456666666666666666665555556666666666666666665555556666666666666666666


Q ss_pred             CCCC-CCcccccccCCccCCCCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNPHLC  103 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~~lc  103 (362)
                      .+|. +..+..+..+.+.+|+..|
T Consensus       144 ~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A          144 VAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             BCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             ECHHHhcCCCCCCEEEecCcCCcC
Confidence            5443 2333444444555555544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.36  E-value=3.5e-13  Score=138.23  Aligned_cols=67  Identities=16%  Similarity=0.226  Sum_probs=38.7

Q ss_pred             CchhhhcccccCeeecccccccc-----------------Ccchhhc--CCCCCCEEEccCCcccCCCCC-CCccccccc
Q 018036           34 IPVQITQIHILNYLNVSWNQLNA-----------------SLPKEMG--NMKSLTSADFSHNNFSGEIPE-FGQYSFFNS   93 (362)
Q Consensus        34 ip~~~~~l~~l~~l~l~~n~l~g-----------------~~p~~~~--~~~~l~~l~ls~n~l~g~~p~-~~~~~~~~~   93 (362)
                      ||..+++|++|+.|+|++|+|+|                 .||++++  ++++|+.|+|++|++.|.+|. +..+..+..
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~  519 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS  519 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence            56666666666666666666665                 2666655  666666666666666666663 233334444


Q ss_pred             CCccCCC
Q 018036           94 TSFTGNP  100 (362)
Q Consensus        94 ~~~~~n~  100 (362)
                      +.+.+|.
T Consensus       520 L~Ls~N~  526 (876)
T 4ecn_A          520 LNIACNR  526 (876)
T ss_dssp             EECTTCT
T ss_pred             EECcCCC
Confidence            4444443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.35  E-value=1.3e-12  Score=124.98  Aligned_cols=99  Identities=20%  Similarity=0.178  Sum_probs=56.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++.+|..++++++|++|+|++|++++..|..+..+++|+.|+|++|.+++..|..++++++|+.|++++|++++
T Consensus       282 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  361 (455)
T 3v47_A          282 LSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA  361 (455)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred             ecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence            35566666666666666666666666666665556566666666666666666655445555666666666666666665


Q ss_pred             CCCC-CCcccccccCCccCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n   99 (362)
                      .+|. +..+..+....+.+|
T Consensus       362 ~~~~~~~~l~~L~~L~L~~N  381 (455)
T 3v47_A          362 LGDQSFLGLPNLKELALDTN  381 (455)
T ss_dssp             ECTTTTTTCTTCCEEECCSS
T ss_pred             cChhhccccccccEEECCCC
Confidence            5443 233333333344444

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.35  E-value=8.5e-13  Score=109.77  Aligned_cols=85  Identities=22%  Similarity=0.323  Sum_probs=74.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++.+|..++++++|++|+|++|+|++..|..+..+++|+.|||++|+|++ +|. .+..+++|+.|+|++|.++
T Consensus        40 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           40 LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCBC
T ss_pred             eCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce-eCHHHhccccCCCEEEeCCCCcc
Confidence            68999998889899999999999999999996444456899999999999999995 665 4999999999999999999


Q ss_pred             CCCCCCC
Q 018036           80 GEIPEFG   86 (362)
Q Consensus        80 g~~p~~~   86 (362)
                      ...+...
T Consensus       119 c~~~~~~  125 (174)
T 2r9u_A          119 CECRDIM  125 (174)
T ss_dssp             TTBGGGH
T ss_pred             cccccHH
Confidence            8766543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.35  E-value=9.3e-13  Score=120.90  Aligned_cols=97  Identities=16%  Similarity=0.208  Sum_probs=66.1

Q ss_pred             CCCcccccCCccccc---------ccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEE
Q 018036            2 SRNNFSGIIPVEIGH---------CLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSAD   72 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~---------l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~   72 (362)
                      ++|++.|.+|..++.         +++|++|+|++|+|+ .+|..++++++|+.|+|++|++++ +|+.++.+++|+.|+
T Consensus       158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~  235 (328)
T 4fcg_A          158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD  235 (328)
T ss_dssp             EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred             CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence            456677777776654         777777777777777 777777777777777777777773 666777777777777


Q ss_pred             ccCCcccCCCCC-CCcccccccCCccCCC
Q 018036           73 FSHNNFSGEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        73 ls~n~l~g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      +++|++.+.+|. +..+..+..+.+.+|.
T Consensus       236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~  264 (328)
T 4fcg_A          236 LRGCTALRNYPPIFGGRAPLKRLILKDCS  264 (328)
T ss_dssp             CTTCTTCCBCCCCTTCCCCCCEEECTTCT
T ss_pred             CcCCcchhhhHHHhcCCCCCCEEECCCCC
Confidence            777777777665 3344444444555543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.35  E-value=1.9e-12  Score=112.57  Aligned_cols=95  Identities=19%  Similarity=0.208  Sum_probs=64.5

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|+++ .||..+.  ++|++|+|++|++++..|..+..+++|+.|+|++|+++ .+|. .+..+++|+.|+|++|+|++
T Consensus        27 ~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~  102 (229)
T 3e6j_A           27 RSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV  102 (229)
T ss_dssp             TTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             cCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCc
Confidence            455554 7776553  67778888888887777777777778888888888875 4553 45777778888888887777


Q ss_pred             CCCCC-CcccccccCCccCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~  100 (362)
                      .+|.. ..+..+..+.+.+|.
T Consensus       103 l~~~~~~~l~~L~~L~Ls~N~  123 (229)
T 3e6j_A          103 LPSAVFDRLVHLKELFMCCNK  123 (229)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             cChhHhCcchhhCeEeccCCc
Confidence            66643 444555555555553

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.35  E-value=1.2e-12  Score=130.19  Aligned_cols=105  Identities=26%  Similarity=0.293  Sum_probs=90.2

Q ss_pred             CCCCcc-cccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNF-SGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~-~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++ .+.+|..+..+++|++|||++|+|++..|..|.++++|+.|+|++|+|++-.|..+..+++|+.|||++|+|+
T Consensus       476 Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~  555 (635)
T 4g8a_A          476 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM  555 (635)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCC
T ss_pred             hhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCC
Confidence            466764 4457778999999999999999999999999999999999999999999877778999999999999999999


Q ss_pred             CCCCCCC-cc-cccccCCccCCCCCCCC
Q 018036           80 GEIPEFG-QY-SFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        80 g~~p~~~-~~-~~~~~~~~~~n~~lc~~  105 (362)
                      +.+|... .+ ..+..+.+.+||..|..
T Consensus       556 ~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          556 TSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             BCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             CCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            9988643 33 45666788999999864

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.34  E-value=2.2e-12  Score=111.39  Aligned_cols=101  Identities=19%  Similarity=0.291  Sum_probs=49.3

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchh-hhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~-~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|++++..|..+..+++|++|+|++|+|+ .+|.. +..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        64 s~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  142 (220)
T 2v9t_B           64 SNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT  142 (220)
T ss_dssp             CSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCE
Confidence            445555444555555555555555555555 23332 3445555555555555554444445555555555555555555


Q ss_pred             CCCC-CCcccccccCCccCCCCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNPHLC  103 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~~lc  103 (362)
                      .+|. +..+..+..+.+.+|+..|
T Consensus       143 ~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          143 IAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ECHHHHhCCCCCCEEEeCCCCcCC
Confidence            4443 2233333344444554444

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.34  E-value=2.6e-12  Score=115.78  Aligned_cols=99  Identities=19%  Similarity=0.187  Sum_probs=70.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++ .+|..+..+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  162 (290)
T 1p9a_G           84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (290)
T ss_dssp             CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence            5678887 788878888888888888888886555678888888888888888875444456778888888888888886


Q ss_pred             CCCCC-CcccccccCCccCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~  100 (362)
                      .++.. ..+..+..+.+.+|.
T Consensus       163 l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          163 LPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             cCHHHhcCcCCCCEEECCCCc
Confidence            65543 334444444444553

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.33  E-value=4.8e-13  Score=133.75  Aligned_cols=98  Identities=17%  Similarity=0.303  Sum_probs=84.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCc-ccc-cCchhhhcc------cccCeeeccccccccCcch--hhcCCCCCCE
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNH-LSG-PIPVQITQI------HILNYLNVSWNQLNASLPK--EMGNMKSLTS   70 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~-l~g-~ip~~~~~l------~~l~~l~l~~n~l~g~~p~--~~~~~~~l~~   70 (362)
                      |++|+++|.+|..++++++|++|+|++|+ |+| .+|..++++      ++|+.|+|++|+++ .+|.  .++++++|+.
T Consensus       256 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~  334 (636)
T 4eco_A          256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGM  334 (636)
T ss_dssp             EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCE
T ss_pred             ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCE
Confidence            46789999999999999999999999998 999 899999887      89999999999998 8998  8999999999


Q ss_pred             EEccCCcccCCCCCCCcccccccCCccCC
Q 018036           71 ADFSHNNFSGEIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        71 l~ls~n~l~g~~p~~~~~~~~~~~~~~~n   99 (362)
                      |++++|+++|.+|.+..+..+..+.+.+|
T Consensus       335 L~L~~N~l~g~ip~~~~l~~L~~L~L~~N  363 (636)
T 4eco_A          335 LECLYNQLEGKLPAFGSEIKLASLNLAYN  363 (636)
T ss_dssp             EECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred             EeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence            99999999999996655555555555555

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.32  E-value=2.1e-12  Score=127.04  Aligned_cols=83  Identities=19%  Similarity=0.206  Sum_probs=78.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCc-chhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASL-PKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~-p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|+|+ .||..+++|++|+.|+|++|+|++ || .++++++|+.|+|++|+|++.+ |..++.+++|+.|+|++|+|+
T Consensus       470 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~  546 (567)
T 1dce_A          470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  546 (567)
T ss_dssp             CCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence            6899999 999999999999999999999996 88 8999999999999999999866 999999999999999999999


Q ss_pred             CCCCCCC
Q 018036           80 GEIPEFG   86 (362)
Q Consensus        80 g~~p~~~   86 (362)
                      +.+|...
T Consensus       547 ~~~~~~~  553 (567)
T 1dce_A          547 QEEGIQE  553 (567)
T ss_dssp             GSSSCTT
T ss_pred             CCccHHH
Confidence            9988654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.32  E-value=1.5e-12  Score=129.24  Aligned_cols=105  Identities=24%  Similarity=0.246  Sum_probs=61.2

Q ss_pred             CCCCccccc-CCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~-ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.+++. +|..++.+++|++|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+.++++|+.|++++|+|+
T Consensus       455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  534 (606)
T 3vq2_A          455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE  534 (606)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred             CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence            345555552 4555566666666666666666655666666666666666666666555666666666666666666666


Q ss_pred             CCCCCCCccc-ccccCCccCCCCCCCC
Q 018036           80 GEIPEFGQYS-FFNSTSFTGNPHLCGS  105 (362)
Q Consensus        80 g~~p~~~~~~-~~~~~~~~~n~~lc~~  105 (362)
                      ..++.+..+. .+....+.+|+..|..
T Consensus       535 ~~p~~~~~l~~~L~~l~l~~N~~~c~c  561 (606)
T 3vq2_A          535 TSKGILQHFPKSLAFFNLTNNSVACIC  561 (606)
T ss_dssp             CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred             ccCHhHhhhcccCcEEEccCCCcccCC
Confidence            4333333332 2444556677766654

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.32  E-value=1.3e-12  Score=119.97  Aligned_cols=101  Identities=15%  Similarity=0.179  Sum_probs=86.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++ .+|..++++++|++|+|++|+++ .+|..++.+++|+.|+|++|++.+.+|..++.+++|+.|++++|++.+
T Consensus       190 L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~  267 (328)
T 4fcg_A          190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL  267 (328)
T ss_dssp             EEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred             CcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchh
Confidence            4578888 99999999999999999999999 488889999999999999999999999999999999999999999999


Q ss_pred             CCCC-CCcccccccCCccCCCCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNPHLC  103 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~~lc  103 (362)
                      .+|. +..+..+..+.+.+|+.+.
T Consensus       268 ~~p~~~~~l~~L~~L~L~~n~~~~  291 (328)
T 4fcg_A          268 TLPLDIHRLTQLEKLDLRGCVNLS  291 (328)
T ss_dssp             BCCTTGGGCTTCCEEECTTCTTCC
T ss_pred             hcchhhhcCCCCCEEeCCCCCchh
Confidence            9985 4455566666777776443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.32  E-value=3.6e-12  Score=112.30  Aligned_cols=100  Identities=14%  Similarity=0.145  Sum_probs=86.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++++++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        42 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  121 (251)
T 3m19_A           42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS  121 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             ccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCC
Confidence            67899998888889999999999999999998888889999999999999999996555678999999999999999998


Q ss_pred             CCCCC-CcccccccCCccCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~  100 (362)
                      .+|.. ..+..+..+.+.+|.
T Consensus       122 ~~~~~~~~l~~L~~L~Ls~N~  142 (251)
T 3m19_A          122 LPSGVFDRLTKLKELRLNTNQ  142 (251)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             cChhHhccCCcccEEECcCCc
Confidence            87763 455666666666664

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.32  E-value=1.5e-12  Score=110.41  Aligned_cols=96  Identities=14%  Similarity=0.113  Sum_probs=65.3

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE   81 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~   81 (362)
                      ++|.+  ..++.+..+++|++|+|++|++++..|..++.+++|+.|+|++|.+++..|..++.+++|+.|++++|.+.+.
T Consensus        74 ~~n~~--~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~  151 (197)
T 4ezg_A           74 NNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD  151 (197)
T ss_dssp             ESCCC--SCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC
T ss_pred             cCCCC--CcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc
Confidence            34533  3344677777778888888877777777777777788888888877776777777777778888877774444


Q ss_pred             CCCCCcccccccCCccCC
Q 018036           82 IPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        82 ~p~~~~~~~~~~~~~~~n   99 (362)
                      +|.+..+..+....+.+|
T Consensus       152 ~~~l~~l~~L~~L~l~~n  169 (197)
T 4ezg_A          152 IMPLKTLPELKSLNIQFD  169 (197)
T ss_dssp             CGGGGGCSSCCEEECTTB
T ss_pred             cHhhcCCCCCCEEECCCC
Confidence            555444444555555555

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.32  E-value=1.6e-12  Score=131.57  Aligned_cols=97  Identities=31%  Similarity=0.369  Sum_probs=59.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.++ .||..+.++++|++|+|++|+|+ .||..|++|++|+.|||++|+|+ .||.+++++++|++|+|++|.|+.
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~  307 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT  307 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc
Confidence            4556665 66666666666666666666666 66666666666666666666666 566666666666666666666653


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      .++.+..+..+..+.+.+|.
T Consensus       308 lp~~~~~l~~L~~L~L~~N~  327 (727)
T 4b8c_D          308 LPWEFGNLCNLQFLGVEGNP  327 (727)
T ss_dssp             CCSSTTSCTTCCCEECTTSC
T ss_pred             cChhhhcCCCccEEeCCCCc
Confidence            33334444445445555554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.31  E-value=5.4e-12  Score=112.40  Aligned_cols=99  Identities=17%  Similarity=0.264  Sum_probs=62.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++++
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            45677774444455777777777777777776555666777777777777777764333346677777777777777776


Q ss_pred             CCCC-CCcccccccCCccCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n   99 (362)
                      .+|. +..+..+..+.+.+|
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N  191 (270)
T 2o6q_A          172 VPEGAFDKLTELKTLKLDNN  191 (270)
T ss_dssp             CCTTTTTTCTTCCEEECCSS
T ss_pred             eChhHhccCCCcCEEECCCC
Confidence            6553 333444444444444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.29  E-value=1.6e-12  Score=131.68  Aligned_cols=82  Identities=27%  Similarity=0.416  Sum_probs=78.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.|+ .||.+|++|++|++|||++|+|+ .||..|++|++|++|+|++|.|+ .||.+|+++++|+.|+|++|.|+|
T Consensus       254 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~  330 (727)
T 4b8c_D          254 LNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK  330 (727)
T ss_dssp             CTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred             eeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence            6899999 99999999999999999999999 99999999999999999999997 899999999999999999999999


Q ss_pred             CCCCC
Q 018036           81 EIPEF   85 (362)
Q Consensus        81 ~~p~~   85 (362)
                      .+|..
T Consensus       331 ~~p~~  335 (727)
T 4b8c_D          331 QFLKI  335 (727)
T ss_dssp             HHHHH
T ss_pred             CChHH
Confidence            98864

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.29  E-value=1.7e-12  Score=104.90  Aligned_cols=81  Identities=22%  Similarity=0.245  Sum_probs=73.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeecccccccc-CcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g-~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.+++.  ..++.+++|++|+|++|++++.+|..+..+++|+.|+|++|.+++ ..|..+..+++|+.|++++|+++
T Consensus        49 l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           49 TINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             CTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            578999855  789999999999999999998899999999999999999999986 23488999999999999999999


Q ss_pred             CCCC
Q 018036           80 GEIP   83 (362)
Q Consensus        80 g~~p   83 (362)
                      +.++
T Consensus       127 ~~~~  130 (149)
T 2je0_A          127 NLND  130 (149)
T ss_dssp             GSTT
T ss_pred             chHH
Confidence            8765

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.29  E-value=7.3e-12  Score=106.98  Aligned_cols=94  Identities=20%  Similarity=0.217  Sum_probs=49.4

Q ss_pred             CCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCC
Q 018036            3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEI   82 (362)
Q Consensus         3 ~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~   82 (362)
                      +|.++ .+|..+  .++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|++|++++|++++.+
T Consensus        16 ~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~   92 (208)
T 2o6s_A           16 SQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLP   92 (208)
T ss_dssp             SSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccC
Confidence            34444 455433  345666666666666433344556666666666666665322233456666666666666666554


Q ss_pred             CCC-CcccccccCCccCC
Q 018036           83 PEF-GQYSFFNSTSFTGN   99 (362)
Q Consensus        83 p~~-~~~~~~~~~~~~~n   99 (362)
                      +.. ..+..+..+.+.+|
T Consensus        93 ~~~~~~l~~L~~L~L~~N  110 (208)
T 2o6s_A           93 NGVFDKLTQLKELALNTN  110 (208)
T ss_dssp             TTTTTTCTTCCEEECCSS
T ss_pred             HhHhcCccCCCEEEcCCC
Confidence            432 33334444444444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.29  E-value=2.6e-12  Score=105.89  Aligned_cols=97  Identities=16%  Similarity=0.190  Sum_probs=80.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcc--hhhcCCCCCCEEEccCCcc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP--KEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p--~~~~~~~~l~~l~ls~n~l   78 (362)
                      |++|.+++.  ..++.+++|++|+|++|++++.+|..+.++++|+.|+|++|++++ +|  ..+..+++|+.|++++|.+
T Consensus        56 l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l  132 (168)
T 2ell_A           56 LINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEV  132 (168)
T ss_dssp             EESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGG
T ss_pred             CcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcC
Confidence            467888854  789999999999999999998899999999999999999999985 55  7899999999999999999


Q ss_pred             cCCCC----CCCcccccccCCccCCC
Q 018036           79 SGEIP----EFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        79 ~g~~p----~~~~~~~~~~~~~~~n~  100 (362)
                      ++.++    .+..+..+..+...+|.
T Consensus       133 ~~~~~~~~~~~~~l~~L~~L~l~~n~  158 (168)
T 2ell_A          133 TNLNDYRESVFKLLPQLTYLDGYDRE  158 (168)
T ss_dssp             GTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred             cchHHHHHHHHHhCccCcEecCCCCC
Confidence            98776    34444444444555543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.29  E-value=2.4e-12  Score=115.49  Aligned_cols=99  Identities=17%  Similarity=0.178  Sum_probs=71.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..+.++++|++|+|++|++++..+..++.+++|+.|+|++|++++..+..+..+++|+.|++++|++++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            56788887667778888888888888888886555567888888888888888875333357788888888888888887


Q ss_pred             CCCC-CCcccccccCCccCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n   99 (362)
                      .+|. +..+..+..+.+.+|
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n  211 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFAN  211 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSS
T ss_pred             cCHhHccCcccccEeeCCCC
Confidence            7664 333444555555555

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.28  E-value=9.1e-12  Score=105.31  Aligned_cols=96  Identities=22%  Similarity=0.308  Sum_probs=82.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|+++ .||..+.  ++|++|+|++|+|+ .||..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++
T Consensus        17 ~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~   92 (193)
T 2wfh_A           17 CSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC   92 (193)
T ss_dssp             CTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             cCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCE
Confidence            4678887 8998764  69999999999999 899999999999999999999997666789999999999999999999


Q ss_pred             CCCC-CCcccccccCCccCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      .+|. +..+..+..+.+.+|.
T Consensus        93 i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           93 IPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             eCHHHhCCCCCCCEEECCCCC
Confidence            8884 4555666666666764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.28  E-value=2e-11  Score=113.36  Aligned_cols=142  Identities=15%  Similarity=0.227  Sum_probs=105.4

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEee--ccCCCCCchhhHHHHHHHHhcCc--cCcceeEEEEEecC---CeeeEEE
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLL--GITKGSSHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNK---ETNLLVY  259 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  259 (362)
                      .+.++.|.++.||+....+ ..+++|+..  .... ......+.+|..+++.+.  +..+++++.++.+.   +..|+||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4578899999999998754 678888764  2211 111234889999999986  45688899988776   4579999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-------------------------------------  302 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  302 (362)
                      ||++|..+.+...    ..++...+..++.++++.|+.||...                                     
T Consensus       121 e~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          121 EFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             ECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999888754221    23677888899999999999999621                                     


Q ss_pred             ------------------CCCeEEeCCCCCceeeCCCCc--eEEcccccccc
Q 018036          303 ------------------SPLIIHRDVKSNNILLNSDFE--AHVADFGLAKY  334 (362)
Q Consensus       303 ------------------~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla~~  334 (362)
                                        ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              246999999999999997753  68999998865

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.28  E-value=4.7e-12  Score=124.54  Aligned_cols=104  Identities=18%  Similarity=0.258  Sum_probs=64.0

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCccc-ccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLS-GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~-g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.+++.+|..+..+++|++|+|++|+++ |.+|..+..+++|+.|+|++|++++..|..+.++++|+.|++++|+++
T Consensus       428 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  507 (570)
T 2z63_A          428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK  507 (570)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCC
Confidence            3456666666666666666666666666665 456666666666666666666666555666666666666666666666


Q ss_pred             CCCCC-CCcccccccCCccCCCCCCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGNPHLCG  104 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n~~lc~  104 (362)
                      +.+|. +..+..+....+.+|+..|.
T Consensus       508 ~~~~~~~~~l~~L~~L~l~~N~~~~~  533 (570)
T 2z63_A          508 SVPDGIFDRLTSLQKIWLHTNPWDCS  533 (570)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCHHHhhcccCCcEEEecCCcccCC
Confidence            66554 33444455555666665554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.27  E-value=5.9e-12  Score=114.14  Aligned_cols=100  Identities=20%  Similarity=0.225  Sum_probs=72.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccc-cCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g-~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.+++.+|..+..+++|++|+|++|++++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+++
T Consensus       133 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  212 (306)
T 2z66_A          133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF  212 (306)
T ss_dssp             CTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC
Confidence            46777777777777788888888888888876 57777888888888888888887666777777888888888888887


Q ss_pred             CCCCC-CCcccccccCCccCCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      +..+. +..+..+....+.+|.
T Consensus       213 ~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          213 SLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             BCCSGGGTTCTTCCEEECTTSC
T ss_pred             ccChhhccCcccCCEeECCCCC
Confidence            76552 3334444455555554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.27  E-value=9.2e-12  Score=111.05  Aligned_cols=98  Identities=19%  Similarity=0.208  Sum_probs=78.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++ +| .++.+++|++|+|++|++++..|..++.+++|+.|+|++|++++..|..++.+++|++|++++|++++
T Consensus        70 l~~n~l~~-~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  147 (272)
T 3rfs_A           70 LGGNKLHD-IS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS  147 (272)
T ss_dssp             CTTSCCCC-CG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCCCC-ch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc
Confidence            57888885 44 78899999999999999997666778999999999999999987656668889999999999999998


Q ss_pred             CCCCC-CcccccccCCccCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~  100 (362)
                      .+|.. ..+..+..+.+.+|.
T Consensus       148 ~~~~~~~~l~~L~~L~l~~n~  168 (272)
T 3rfs_A          148 LPKGVFDKLTNLTELDLSYNQ  168 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             cCHHHhccCccCCEEECCCCC
Confidence            77753 455556666666663

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.25  E-value=3e-12  Score=131.36  Aligned_cols=97  Identities=18%  Similarity=0.242  Sum_probs=61.0

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCc-ccc-cCchhhhccc-------ccCeeeccccccccCcch--hhcCCCCCCE
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNH-LSG-PIPVQITQIH-------ILNYLNVSWNQLNASLPK--EMGNMKSLTS   70 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~-l~g-~ip~~~~~l~-------~l~~l~l~~n~l~g~~p~--~~~~~~~l~~   70 (362)
                      ++|+++|.+|..+++|++|+.|+|++|+ |+| .+|..+++++       +|+.|+|++|+++ .||.  .++++++|+.
T Consensus       499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~  577 (876)
T 4ecn_A          499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL  577 (876)
T ss_dssp             ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred             cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence            4566666666666666666666666666 666 6666666555       6666666666666 6666  6666666666


Q ss_pred             EEccCCcccCCCCCCCcccccccCCccCCC
Q 018036           71 ADFSHNNFSGEIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        71 l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~  100 (362)
                      |+|++|+++ .+|.+..+..+..+.+.+|.
T Consensus       578 L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N~  606 (876)
T 4ecn_A          578 LDCVHNKVR-HLEAFGTNVKLTDLKLDYNQ  606 (876)
T ss_dssp             EECTTSCCC-BCCCCCTTSEESEEECCSSC
T ss_pred             EECCCCCcc-cchhhcCCCcceEEECcCCc
Confidence            666666666 55555544444444444443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.23  E-value=1.2e-11  Score=118.00  Aligned_cols=103  Identities=24%  Similarity=0.327  Sum_probs=83.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++ .+| .+..+++|+.|||++|++++..|..+..+++|+.|+|++|++++..|..+.++++|+.|+|++|+|++
T Consensus       192 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  269 (440)
T 3zyj_A          192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL  269 (440)
T ss_dssp             CTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred             CCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence            4677777 676 47788888888889998888888888899999999999999987777788889999999999999998


Q ss_pred             CCCCC-CcccccccCCccCCCCCCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~~lc~~  105 (362)
                      .++.. ..+..+..+.+.+||..|..
T Consensus       270 ~~~~~~~~l~~L~~L~L~~Np~~CdC  295 (440)
T 3zyj_A          270 LPHDLFTPLHHLERIHLHHNPWNCNC  295 (440)
T ss_dssp             CCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred             cChhHhccccCCCEEEcCCCCccCCC
Confidence            77653 44566667788899988864

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.22  E-value=1.4e-11  Score=102.36  Aligned_cols=84  Identities=21%  Similarity=0.254  Sum_probs=72.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..++.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++ +|.. +..+++|+.|++++|.++
T Consensus        59 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           59 LSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE-eCHHHhcCCcccCEEEecCCCee
Confidence            57899995555557999999999999999997666678999999999999999985 6654 688999999999999999


Q ss_pred             CCCCCC
Q 018036           80 GEIPEF   85 (362)
Q Consensus        80 g~~p~~   85 (362)
                      +..|..
T Consensus       138 ~~~~~l  143 (177)
T 2o6r_A          138 CSCPRI  143 (177)
T ss_dssp             CCHHHH
T ss_pred             ccCccH
Confidence            988754

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.22  E-value=2.2e-11  Score=109.64  Aligned_cols=97  Identities=23%  Similarity=0.336  Sum_probs=74.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +|.. +.+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        62 L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~  138 (290)
T 1p9a_G           62 LDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT  138 (290)
T ss_dssp             CTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred             CCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence            56788874 4543 78888999999999988 788888888899999999999986545678888899999999999887


Q ss_pred             CCCCC-CcccccccCCccCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~  100 (362)
                      .+|.. ..+..+..+.+.+|.
T Consensus       139 ~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G          139 LPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             CCTTTTTTCTTCCEEECTTSC
T ss_pred             cChhhcccccCCCEEECCCCc
Confidence            76653 344455555566664

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.22  E-value=1.3e-11  Score=122.58  Aligned_cols=100  Identities=15%  Similarity=0.069  Sum_probs=80.0

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++-.|..|.++++|++|||++|+|++-.|..|.+|++|++|+|++|+|++-.|..|.++++|++|+|++|+|++
T Consensus        59 Ls~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~  138 (635)
T 4g8a_A           59 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS  138 (635)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC
T ss_pred             eeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC
Confidence            68899996666689999999999999999996666679999999999999999985334568999999999999999998


Q ss_pred             CCCC-CCcccccccCCccCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      .+|. ++.+..+..+.+.+|.
T Consensus       139 l~~~~~~~L~~L~~L~Ls~N~  159 (635)
T 4g8a_A          139 LENFPIGHLKTLKELNVAHNL  159 (635)
T ss_dssp             STTCCCTTCTTCCEEECCSSC
T ss_pred             CChhhhhcCcccCeeccccCc
Confidence            7764 4555555555555553

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.22  E-value=1.7e-11  Score=117.43  Aligned_cols=103  Identities=20%  Similarity=0.282  Sum_probs=86.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++ .+| .+..+++|+.|+|++|+|++..|..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus       203 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  280 (452)
T 3zyi_A          203 LGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS  280 (452)
T ss_dssp             CTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence            5678887 455 57888899999999999998889999999999999999999998778889999999999999999998


Q ss_pred             CCCCC-CcccccccCCccCCCCCCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~~lc~~  105 (362)
                      .++.. ..+..+..+.+.+||..|..
T Consensus       281 ~~~~~~~~l~~L~~L~L~~Np~~CdC  306 (452)
T 3zyi_A          281 LPHDLFTPLRYLVELHLHHNPWNCDC  306 (452)
T ss_dssp             CCTTSSTTCTTCCEEECCSSCEECST
T ss_pred             cChHHhccccCCCEEEccCCCcCCCC
Confidence            77653 44566677788899988864

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.22  E-value=3e-12  Score=116.55  Aligned_cols=99  Identities=17%  Similarity=0.172  Sum_probs=68.4

Q ss_pred             CCCCcc-cccCCcccc-------cccCCCEEECcCCcccccCchhh--hcccccCeeeccccccccCcchhhcCC-----
Q 018036            1 MSRNNF-SGIIPVEIG-------HCLLLTYLDLSQNHLSGPIPVQI--TQIHILNYLNVSWNQLNASLPKEMGNM-----   65 (362)
Q Consensus         1 l~~n~~-~g~ip~~~~-------~l~~l~~l~l~~n~l~g~ip~~~--~~l~~l~~l~l~~n~l~g~~p~~~~~~-----   65 (362)
                      |++|++ .+.+|..+.       ++++|++|+|++|+++|.+|..+  ..+++|+.|+|++|++++. |..++.+     
T Consensus        70 L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~  148 (312)
T 1wwl_A           70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLK  148 (312)
T ss_dssp             CCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCC
T ss_pred             cccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhc
Confidence            456667 566776665       67777777777777777777766  7777777777777777764 7666665     


Q ss_pred             CCCCEEEccCCcccCCCCC-CCcccccccCCccCCC
Q 018036           66 KSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        66 ~~l~~l~ls~n~l~g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      ++|++|++++|++++.+|. +..+..+....+.+|.
T Consensus       149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  184 (312)
T 1wwl_A          149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP  184 (312)
T ss_dssp             TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCT
T ss_pred             CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCC
Confidence            7777777777777776643 4445555555555554

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.21  E-value=1.6e-11  Score=117.44  Aligned_cols=106  Identities=18%  Similarity=0.200  Sum_probs=91.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++.+++|++|+|++|++++..|..+..+++|+.|||++|++++..|..+..+++|+.|++++|++++
T Consensus       306 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  385 (455)
T 3v47_A          306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS  385 (455)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence            57899998888899999999999999999998888899999999999999999998778889999999999999999998


Q ss_pred             CCCCC-CcccccccCCccCCCCCCCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNPHLCGSY  106 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~~lc~~~  106 (362)
                      .++.. ..+..+....+.+|+..|..+
T Consensus       386 ~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          386 VPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCHhHhccCCcccEEEccCCCcccCCC
Confidence            77653 456677777888898777543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.21  E-value=1.6e-11  Score=114.14  Aligned_cols=100  Identities=21%  Similarity=0.165  Sum_probs=75.9

Q ss_pred             CCCCcccccCCcccc-cccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIG-HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~-~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..+. .+++|+.|+|++|+|++..|..+.++++|+.|||++|+|++..|..+..+++|+.|+|++|+++
T Consensus        46 Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  125 (361)
T 2xot_A           46 LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV  125 (361)
T ss_dssp             CCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCccc
Confidence            578888866666666 8888999999999998766677888889999999999988644456888888899999999888


Q ss_pred             CCCCC-CCcccccccCCccCCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      +..|. +..+..+..+.+.+|.
T Consensus       126 ~~~~~~~~~l~~L~~L~L~~N~  147 (361)
T 2xot_A          126 VVDRNAFEDMAQLQKLYLSQNQ  147 (361)
T ss_dssp             EECTTTTTTCTTCCEEECCSSC
T ss_pred             EECHHHhCCcccCCEEECCCCc
Confidence            77664 3444555555555553

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.21  E-value=3.2e-11  Score=110.48  Aligned_cols=82  Identities=20%  Similarity=0.179  Sum_probs=51.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++
T Consensus       199 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~  277 (330)
T 1xku_A          199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA  277 (330)
T ss_dssp             CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCc
Confidence            3456666555666666666666666666666555556666666666666666665 566666666666666666666665


Q ss_pred             CCC
Q 018036           81 EIP   83 (362)
Q Consensus        81 ~~p   83 (362)
                      ..+
T Consensus       278 ~~~  280 (330)
T 1xku_A          278 IGS  280 (330)
T ss_dssp             CCT
T ss_pred             cCh
Confidence            444

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.20  E-value=2.5e-11  Score=119.50  Aligned_cols=100  Identities=19%  Similarity=0.280  Sum_probs=56.1

Q ss_pred             CCCcccccCCcc-cccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIPVE-IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip~~-~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|++++.+|.. +..+++|++|+|++|+++|.+|..+.  ++|+.|||++|+++ .||..+..+++|+.|+|++|+|++
T Consensus       411 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~  487 (562)
T 3a79_B          411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS  487 (562)
T ss_dssp             TTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC
T ss_pred             CCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC
Confidence            344444444433 34444555555555555444444333  46666666666665 566666667777777777777775


Q ss_pred             CCCC-CCcccccccCCccCCCCCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNPHLCG  104 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~~lc~  104 (362)
                      .++. +..+..+....+.+|+..|.
T Consensus       488 l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          488 VPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             CCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             CCHHHHhcCCCCCEEEecCCCcCCC
Confidence            4443 44445555556666666553

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.20  E-value=1.7e-11  Score=111.12  Aligned_cols=100  Identities=20%  Similarity=0.256  Sum_probs=82.8

Q ss_pred             CCCCcccccCC-cccccccCCCEEECcCCcccccCchhhhcccccCeeecccccccc-CcchhhcCCCCCCEEEccCCcc
Q 018036            1 MSRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n~~~g~ip-~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g-~~p~~~~~~~~l~~l~ls~n~l   78 (362)
                      |++|++++..+ ..+..+++|++|+|++|++++.+|..+..+++|+.|+|++|.+++ .+|..+..+++|+.|++++|++
T Consensus       108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  187 (306)
T 2z66_A          108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  187 (306)
T ss_dssp             CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence            57888885544 478899999999999999999899999999999999999999987 5788899999999999999999


Q ss_pred             cCCCCC-CCcccccccCCccCCC
Q 018036           79 SGEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        79 ~g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      ++.+|. +..+..+..+.+.+|.
T Consensus       188 ~~~~~~~~~~l~~L~~L~L~~N~  210 (306)
T 2z66_A          188 EQLSPTAFNSLSSLQVLNMSHNN  210 (306)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSC
T ss_pred             CCcCHHHhcCCCCCCEEECCCCc
Confidence            988774 3445555556666664

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.20  E-value=1.3e-11  Score=104.57  Aligned_cols=96  Identities=18%  Similarity=0.179  Sum_probs=77.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.++ .+| .+..+++|++|+|++|.++  .++.+..+++|++|+|++|++++..|..++.+++|+.|++++|++++
T Consensus        51 l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~  126 (197)
T 4ezg_A           51 LANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD  126 (197)
T ss_dssp             EESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBG
T ss_pred             ccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCc
Confidence            3578887 788 7889999999999999765  44588999999999999999998888889999999999999999998


Q ss_pred             CCCC-CCcccccccCCccCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      ..|. +..+..+....+.+|.
T Consensus       127 ~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A          127 SILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             GGHHHHTTCSSCCEEECCSCT
T ss_pred             HhHHHHhhCCCCCEEEccCCC
Confidence            5553 4445555555666664

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.19  E-value=1.2e-11  Score=122.73  Aligned_cols=83  Identities=18%  Similarity=0.193  Sum_probs=46.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCccccc---CchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGP---IPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNN   77 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~---ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~   77 (362)
                      |++|.+++.+|..++.+++|++|+|++|++++.   .+..+..+++|+.|+|++|++++..|..++.+++|+.|++++|+
T Consensus       432 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~  511 (606)
T 3t6q_A          432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR  511 (606)
T ss_dssp             CTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence            345666655555566666666666666666542   22345555555555555555555445555555555555555555


Q ss_pred             ccCCCC
Q 018036           78 FSGEIP   83 (362)
Q Consensus        78 l~g~~p   83 (362)
                      +++.+|
T Consensus       512 l~~~~~  517 (606)
T 3t6q_A          512 LTSSSI  517 (606)
T ss_dssp             CCGGGG
T ss_pred             cCcCCh
Confidence            555544

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.19  E-value=2.7e-11  Score=117.91  Aligned_cols=101  Identities=20%  Similarity=0.258  Sum_probs=52.0

Q ss_pred             CCCcccc--cCCcccccccCCCEEECcCCcccccCchh-hhccc----------------------ccCeeecccccccc
Q 018036            2 SRNNFSG--IIPVEIGHCLLLTYLDLSQNHLSGPIPVQ-ITQIH----------------------ILNYLNVSWNQLNA   56 (362)
Q Consensus         2 ~~n~~~g--~ip~~~~~l~~l~~l~l~~n~l~g~ip~~-~~~l~----------------------~l~~l~l~~n~l~g   56 (362)
                      ++|++++  .+|..++.+++|++|||++|++++.+|.. +..++                      +|+.|||++|+++ 
T Consensus       356 ~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-  434 (520)
T 2z7x_B          356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-  434 (520)
T ss_dssp             CSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-
T ss_pred             cCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCccc-
Confidence            4555554  44455555555555555555555545543 34444                      5555555555554 


Q ss_pred             CcchhhcCCCCCCEEEccCCcccCCCCC-CCcccccccCCccCCCCCC
Q 018036           57 SLPKEMGNMKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHLC  103 (362)
Q Consensus        57 ~~p~~~~~~~~l~~l~ls~n~l~g~~p~-~~~~~~~~~~~~~~n~~lc  103 (362)
                      .+|..+..+++|+.|++++|+|+..++. +..+..+....+.+|+..|
T Consensus       435 ~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence            4555555555556666666655543332 3333444444555555544

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.18  E-value=2.6e-11  Score=118.76  Aligned_cols=100  Identities=17%  Similarity=0.158  Sum_probs=80.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++++++|++|+|++|++++..|..++++++|++|||++|++++..|..++++++|++|++++|++++
T Consensus        33 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  112 (549)
T 2z81_A           33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT  112 (549)
T ss_dssp             CCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred             CcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccc
Confidence            57888988888889999999999999999998888889999999999999999987666669999999999999999986


Q ss_pred             C-C-CCCCcccccccCCccCCC
Q 018036           81 E-I-PEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~-~-p~~~~~~~~~~~~~~~n~  100 (362)
                      . + +.+..+..+....+.+|.
T Consensus       113 ~~~~~~~~~l~~L~~L~L~~n~  134 (549)
T 2z81_A          113 LGVTSLFPNLTNLQTLRIGNVE  134 (549)
T ss_dssp             SCSSCSCTTCTTCCEEEEEESS
T ss_pred             cchhhhhhccCCccEEECCCCc
Confidence            3 3 345555555555555553

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.17  E-value=5.4e-11  Score=106.63  Aligned_cols=100  Identities=20%  Similarity=0.221  Sum_probs=81.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccc-cccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ-LNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~-l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..+.++++|++|+|++|++++..|..+..+++|++|+|++|. ++...|..+..+++|+.|++++|+++
T Consensus        39 l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~  118 (285)
T 1ozn_A           39 LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ  118 (285)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred             eeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCC
Confidence            57889987666778999999999999999998778899999999999999997 76544778899999999999999999


Q ss_pred             CCCCC-CCcccccccCCccCCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      +.+|. +..+..+..+.+.+|.
T Consensus       119 ~~~~~~~~~l~~L~~L~l~~n~  140 (285)
T 1ozn_A          119 ELGPGLFRGLAALQYLYLQDNA  140 (285)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECHhHhhCCcCCCEEECCCCc
Confidence            88765 3445555555666653

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.17  E-value=3.9e-11  Score=110.02  Aligned_cols=82  Identities=18%  Similarity=0.187  Sum_probs=50.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++
T Consensus       200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~  278 (332)
T 2ft3_A          200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK  278 (332)
T ss_dssp             CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence            3455565555555666666666666666666555556666666666666666665 566666666666666666666665


Q ss_pred             CCC
Q 018036           81 EIP   83 (362)
Q Consensus        81 ~~p   83 (362)
                      ..+
T Consensus       279 ~~~  281 (332)
T 2ft3_A          279 VGV  281 (332)
T ss_dssp             CCT
T ss_pred             cCh
Confidence            444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.17  E-value=2.2e-11  Score=101.17  Aligned_cols=96  Identities=16%  Similarity=0.177  Sum_probs=71.2

Q ss_pred             CCCCcccccCCccccccc-CCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCcc
Q 018036            1 MSRNNFSGIIPVEIGHCL-LLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~-~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l   78 (362)
                      |++|+++ .+|. +..+. +|++|||++|+|++.  +.+..+++|+.|+|++|++++ +|+. +..+++|+.|++++|++
T Consensus        26 l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i  100 (176)
T 1a9n_A           26 LRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSL  100 (176)
T ss_dssp             CTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCC
T ss_pred             eeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcC
Confidence            5788888 6764 55555 899999999999864  678889999999999999984 6654 48889999999999998


Q ss_pred             cCCCC--CCCcccccccCCccCCCC
Q 018036           79 SGEIP--EFGQYSFFNSTSFTGNPH  101 (362)
Q Consensus        79 ~g~~p--~~~~~~~~~~~~~~~n~~  101 (362)
                      +...+  .+..+..+....+.+|+.
T Consensus       101 ~~~~~~~~l~~l~~L~~L~l~~N~i  125 (176)
T 1a9n_A          101 VELGDLDPLASLKSLTYLCILRNPV  125 (176)
T ss_dssp             CCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred             CcchhhHhhhcCCCCCEEEecCCCC
Confidence            64333  344444555566677753

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.16  E-value=4.9e-11  Score=106.38  Aligned_cols=99  Identities=15%  Similarity=0.089  Sum_probs=58.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++++++|++|+|++|++++..|..+.++++|++|+|++|.+++..|..+.++++|+.|++++|++++
T Consensus        35 ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  114 (276)
T 2z62_A           35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS  114 (276)
T ss_dssp             CTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred             CCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccc
Confidence            45566665444466666666666666666665445566666666666666666665444556666666666666666666


Q ss_pred             CCC-CCCcccccccCCccCC
Q 018036           81 EIP-EFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p-~~~~~~~~~~~~~~~n   99 (362)
                      ..+ .+..+..+..+.+.+|
T Consensus       115 ~~~~~~~~l~~L~~L~l~~n  134 (276)
T 2z62_A          115 LENFPIGHLKTLKELNVAHN  134 (276)
T ss_dssp             STTCCCTTCTTCCEEECCSS
T ss_pred             cCchhcccCCCCCEEECcCC
Confidence            544 2333333333444444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.16  E-value=4e-11  Score=110.62  Aligned_cols=80  Identities=19%  Similarity=0.123  Sum_probs=69.8

Q ss_pred             CCC-CcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSR-NNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~-n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++ |+|++..|..|+.|++|+.|||++|+|+|..|..|.+|++|+.|||++|+|++ +|..+.....|+.|+|++|.|.
T Consensus        38 l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L~~l~l~~N~~~  116 (347)
T 2ifg_A           38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH  116 (347)
T ss_dssp             CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcccCCceEEEeeCCCcc
Confidence            565 99997777889999999999999999999899999999999999999999995 6665444334999999999998


Q ss_pred             CC
Q 018036           80 GE   81 (362)
Q Consensus        80 g~   81 (362)
                      ..
T Consensus       117 c~  118 (347)
T 2ifg_A          117 CS  118 (347)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.16  E-value=3.7e-11  Score=111.63  Aligned_cols=95  Identities=22%  Similarity=0.212  Sum_probs=58.1

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhh-cccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|+|+ .||..+.  ..|+.|||++|+|++..+..+. .+++|+.|+|++|++++..|..+.++++|+.|+|++|+|++
T Consensus        26 ~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~  102 (361)
T 2xot_A           26 SKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT  102 (361)
T ss_dssp             CSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCc
Confidence            456665 5666553  3466777777777755555555 67777777777777765444456777777777777777766


Q ss_pred             CCCC-CCcccccccCCccCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n   99 (362)
                      .+|. +..+..+..+.+.+|
T Consensus       103 ~~~~~~~~l~~L~~L~L~~N  122 (361)
T 2xot_A          103 LDEFLFSDLQALEVLLLYNN  122 (361)
T ss_dssp             ECTTTTTTCTTCCEEECCSS
T ss_pred             CCHHHhCCCcCCCEEECCCC
Confidence            5553 333444444444444

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.16  E-value=4.2e-11  Score=106.81  Aligned_cols=85  Identities=20%  Similarity=0.294  Sum_probs=57.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccc-cCchhhhcccccCeeeccccccccCcchhhcCCCCCC----EEEccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLT----SADFSH   75 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g-~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~----~l~ls~   75 (362)
                      |++|++++..+..++++++|++|+|++|++++ .+|..+.++++|+.|+|++|++++..|..+..+++|+    .|++++
T Consensus       107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~  186 (276)
T 2z62_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (276)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred             CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence            45777776555567778888888888888875 4677888888888888888887764444554444444    566666


Q ss_pred             CcccCCCCCC
Q 018036           76 NNFSGEIPEF   85 (362)
Q Consensus        76 n~l~g~~p~~   85 (362)
                      |.+++.+|..
T Consensus       187 n~l~~~~~~~  196 (276)
T 2z62_A          187 NPMNFIQPGA  196 (276)
T ss_dssp             SCCCEECTTS
T ss_pred             CcccccCccc
Confidence            6666555543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.16  E-value=1.3e-11  Score=112.41  Aligned_cols=80  Identities=16%  Similarity=0.172  Sum_probs=63.5

Q ss_pred             CCCCcccccCCccc--ccccCCCEEECcCCcccccCchhhhcc-----cccCeeeccccccccCcchhhcCCCCCCEEEc
Q 018036            1 MSRNNFSGIIPVEI--GHCLLLTYLDLSQNHLSGPIPVQITQI-----HILNYLNVSWNQLNASLPKEMGNMKSLTSADF   73 (362)
Q Consensus         1 l~~n~~~g~ip~~~--~~l~~l~~l~l~~n~l~g~ip~~~~~l-----~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~l   73 (362)
                      |++|+++|.+|..+  +.+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..++++++|+.|++
T Consensus       102 L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  180 (312)
T 1wwl_A          102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL  180 (312)
T ss_dssp             EEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEEC
T ss_pred             ccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEEC
Confidence            35678888888876  7888888888888888865 7777777     78888888888887766677888888888888


Q ss_pred             cCCcccCC
Q 018036           74 SHNNFSGE   81 (362)
Q Consensus        74 s~n~l~g~   81 (362)
                      ++|+++|.
T Consensus       181 s~N~l~~~  188 (312)
T 1wwl_A          181 SDNPELGE  188 (312)
T ss_dssp             CSCTTCHH
T ss_pred             CCCCcCcc
Confidence            88887765

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.15  E-value=9.2e-11  Score=104.37  Aligned_cols=99  Identities=18%  Similarity=0.211  Sum_probs=80.7

Q ss_pred             CCCCcccccCCcc-cccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVE-IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~-~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|+++ .+|.. +..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|++|++++|+++
T Consensus        68 l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  146 (270)
T 2o6q_A           68 LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ  146 (270)
T ss_dssp             CCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC
Confidence            5788998 56655 588999999999999999655567799999999999999999766667899999999999999999


Q ss_pred             CCCCC-CCcccccccCCccCCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      +.++. +..+..+..+.+.+|.
T Consensus       147 ~~~~~~~~~l~~L~~L~L~~n~  168 (270)
T 2o6q_A          147 SLPKGVFDKLTSLKELRLYNNQ  168 (270)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCHhHccCCcccceeEecCCc
Confidence            87765 4455556666666664

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.14  E-value=7.3e-11  Score=117.04  Aligned_cols=98  Identities=19%  Similarity=0.245  Sum_probs=61.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.+++..|..++.+++|++|+|++|.+++..|..++.+++|++|+|++|.++ .+|.. ++++++|++|+|++|.++
T Consensus        82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~  160 (597)
T 3oja_B           82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE  160 (597)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCC
Confidence            4566666666666677777777777777777655556677777777777777776 34444 466777777777777777


Q ss_pred             CCCCC-CCcccccccCCccCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n   99 (362)
                      +.+|. +..+..+..+.+.+|
T Consensus       161 ~~~~~~~~~l~~L~~L~L~~N  181 (597)
T 3oja_B          161 RIEDDTFQATTSLQNLQLSSN  181 (597)
T ss_dssp             BCCTTTTTTCTTCCEEECTTS
T ss_pred             CCChhhhhcCCcCcEEECcCC
Confidence            66663 334444444444444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.14  E-value=9.5e-13  Score=111.75  Aligned_cols=95  Identities=16%  Similarity=0.226  Sum_probs=79.7

Q ss_pred             CCCCcccccCCc------ccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEcc
Q 018036            1 MSRNNFSGIIPV------EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFS   74 (362)
Q Consensus         1 l~~n~~~g~ip~------~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls   74 (362)
                      |+.|.|+|.+|.      .++.+++|++|+|++|++++ +| .+..+++|+.|+|++|.++ .+|..+..+++|+.|+++
T Consensus        25 l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~  101 (198)
T 1ds9_A           25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS  101 (198)
T ss_dssp             CSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEE
T ss_pred             hheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECc
Confidence            467889999887      89999999999999999996 88 9999999999999999998 799988888999999999


Q ss_pred             CCcccCCCCCCCcccccccCCccCC
Q 018036           75 HNNFSGEIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        75 ~n~l~g~~p~~~~~~~~~~~~~~~n   99 (362)
                      +|++++ +|.+..+..+....+.+|
T Consensus       102 ~N~l~~-l~~~~~l~~L~~L~l~~N  125 (198)
T 1ds9_A          102 YNQIAS-LSGIEKLVNLRVLYMSNN  125 (198)
T ss_dssp             EEECCC-HHHHHHHHHSSEEEESEE
T ss_pred             CCcCCc-CCccccCCCCCEEECCCC
Confidence            999998 454444444444455555

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.13  E-value=4e-11  Score=99.61  Aligned_cols=84  Identities=13%  Similarity=0.109  Sum_probs=59.2

Q ss_pred             ccccccCCCEEECcCCcccccCchhhhccc-ccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCCCCC-Ccccc
Q 018036           13 EIGHCLLLTYLDLSQNHLSGPIPVQITQIH-ILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEF-GQYSF   90 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~-~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~   90 (362)
                      ++.++++|+.|+|++|+++ .+|. +..+. +|+.|||++|.+++ + ..++.+++|++|++++|++++.+|.. ..+..
T Consensus        14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            4556778888888888888 5664 45544 88888888888875 4 56778888888888888888765554 44455


Q ss_pred             cccCCccCCC
Q 018036           91 FNSTSFTGNP  100 (362)
Q Consensus        91 ~~~~~~~~n~  100 (362)
                      +....+.+|.
T Consensus        90 L~~L~L~~N~   99 (176)
T 1a9n_A           90 LTELILTNNS   99 (176)
T ss_dssp             CCEEECCSCC
T ss_pred             CCEEECCCCc
Confidence            5555555664

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.13  E-value=8.1e-11  Score=116.73  Aligned_cols=99  Identities=17%  Similarity=0.160  Sum_probs=70.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..+.++++|++|||++|++++..|..+.++++|++|+|++|.+++..|..++++++|++|++++|++++
T Consensus        39 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~  118 (606)
T 3vq2_A           39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS  118 (606)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCC
T ss_pred             CCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccc
Confidence            56777776666677788888888888888887667777888888888888888876667777788888888888887776


Q ss_pred             CCCC-CCcccccccCCccCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n   99 (362)
                      .+|. +..+..+....+.+|
T Consensus       119 ~~~~~~~~l~~L~~L~L~~n  138 (606)
T 3vq2_A          119 LESFPIGQLITLKKLNVAHN  138 (606)
T ss_dssp             SSSSCCTTCTTCCEEECCSS
T ss_pred             ccccccCCCCCCCEEeCCCC
Confidence            6542 334444444444444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.13  E-value=8.2e-11  Score=112.62  Aligned_cols=83  Identities=18%  Similarity=0.099  Sum_probs=68.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++++++|+.|+|++|++++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++
T Consensus        82 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  161 (452)
T 3zyi_A           82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES  161 (452)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred             CcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcce
Confidence            57888888778888888999999999999988777888889999999999999885444458888889999999998886


Q ss_pred             CCC
Q 018036           81 EIP   83 (362)
Q Consensus        81 ~~p   83 (362)
                      .++
T Consensus       162 ~~~  164 (452)
T 3zyi_A          162 IPS  164 (452)
T ss_dssp             ECT
T ss_pred             eCH
Confidence            655

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.13  E-value=4.8e-11  Score=116.16  Aligned_cols=82  Identities=29%  Similarity=0.252  Sum_probs=41.3

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccc--cCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCcc
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNF   78 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g--~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l   78 (362)
                      ++|++++.+|..++++++|++|+|++|++++  .+|..++.+++|+.|||++|.+++.+|.. +..+++|+.|++++|++
T Consensus       332 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l  411 (520)
T 2z7x_B          332 SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL  411 (520)
T ss_dssp             CSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCC
T ss_pred             ECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCC
Confidence            4455555455555555555555555555554  44444555555555555555555444443 44445555555555555


Q ss_pred             cCCCC
Q 018036           79 SGEIP   83 (362)
Q Consensus        79 ~g~~p   83 (362)
                      ++.+|
T Consensus       412 ~~~~~  416 (520)
T 2z7x_B          412 TDTIF  416 (520)
T ss_dssp             CGGGG
T ss_pred             Ccchh
Confidence            44443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.12  E-value=3.5e-11  Score=109.31  Aligned_cols=97  Identities=15%  Similarity=0.110  Sum_probs=65.9

Q ss_pred             CCCCccccc--CCcc--cccccCCCEEECcCCcccccCch---h-hhcccccCeeeccccccccCcchhhcCC---CCCC
Q 018036            1 MSRNNFSGI--IPVE--IGHCLLLTYLDLSQNHLSGPIPV---Q-ITQIHILNYLNVSWNQLNASLPKEMGNM---KSLT   69 (362)
Q Consensus         1 l~~n~~~g~--ip~~--~~~l~~l~~l~l~~n~l~g~ip~---~-~~~l~~l~~l~l~~n~l~g~~p~~~~~~---~~l~   69 (362)
                      |++|++.|.  +|..  ++.+++|++|+|++|+++ .+|.   . ++.+++|+.|||++|++++.+|..++.+   ++|+
T Consensus       176 Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~  254 (310)
T 4glp_A          176 LSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALN  254 (310)
T ss_dssp             CCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCC
T ss_pred             CCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCC
Confidence            567777653  3322  367888888888888886 3443   2 4677888888888888887778777776   5888


Q ss_pred             EEEccCCcccCCCCCCCcccccccCCccCCC
Q 018036           70 SADFSHNNFSGEIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        70 ~l~ls~n~l~g~~p~~~~~~~~~~~~~~~n~  100 (362)
                      .|+|++|+|+ .+|... ...+....+.+|.
T Consensus       255 ~L~Ls~N~l~-~lp~~~-~~~L~~L~Ls~N~  283 (310)
T 4glp_A          255 SLNLSFAGLE-QVPKGL-PAKLRVLDLSSNR  283 (310)
T ss_dssp             CEECCSSCCC-SCCSCC-CSCCSCEECCSCC
T ss_pred             EEECCCCCCC-chhhhh-cCCCCEEECCCCc
Confidence            8888888888 444422 1344445555553

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.11  E-value=8.1e-11  Score=116.72  Aligned_cols=99  Identities=19%  Similarity=0.119  Sum_probs=75.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++++++|++|||++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++
T Consensus        40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  119 (606)
T 3t6q_A           40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS  119 (606)
T ss_dssp             CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred             ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence            57888887778888888888888888888888778888888888888888888887777788888888888888888887


Q ss_pred             CCCC-CCcccccccCCccCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n   99 (362)
                      ..|. +..+..+....+.+|
T Consensus       120 l~~~~~~~l~~L~~L~L~~n  139 (606)
T 3t6q_A          120 IDFIPLHNQKTLESLYLGSN  139 (606)
T ss_dssp             GGGSCCTTCTTCCEEECCSS
T ss_pred             CCcchhccCCcccEEECCCC
Confidence            5332 333334444444444

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.11  E-value=9.3e-11  Score=108.46  Aligned_cols=98  Identities=19%  Similarity=0.230  Sum_probs=60.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..+..+.++++|++|+|++|++++..|..+.++++|++|||++|++++ +|.. ++++++|++|++++|+++
T Consensus        59 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~  137 (353)
T 2z80_A           59 LSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYK  137 (353)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCS
T ss_pred             CCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCc
Confidence            45666664444466677777777777777776556667777777777777777763 4443 666777777777777776


Q ss_pred             CCCC--CCCcccccccCCccCC
Q 018036           80 GEIP--EFGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p--~~~~~~~~~~~~~~~n   99 (362)
                      +.++  .+..+..+....+.+|
T Consensus       138 ~l~~~~~~~~l~~L~~L~l~~n  159 (353)
T 2z80_A          138 TLGETSLFSHLTKLQILRVGNM  159 (353)
T ss_dssp             SSCSSCSCTTCTTCCEEEEEES
T ss_pred             ccCchhhhccCCCCcEEECCCC
Confidence            5433  2333444444444444

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.10  E-value=4.9e-11  Score=122.99  Aligned_cols=97  Identities=23%  Similarity=0.255  Sum_probs=52.8

Q ss_pred             CCcccccC-CcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh--hcCCCCCCEEEccCCccc
Q 018036            3 RNNFSGII-PVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE--MGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         3 ~n~~~g~i-p~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~--~~~~~~l~~l~ls~n~l~   79 (362)
                      +|.+.+.| |..+++|++|++|+|++|++++..|..++++++|++|+|++|.+++.+|..  ++++++|+.|||++|+++
T Consensus        57 ~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~  136 (844)
T 3j0a_A           57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR  136 (844)
T ss_dssp             TTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCC
T ss_pred             CCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccc
Confidence            34344444 344555566666666666666555556666666666666666665555544  556666666666666665


Q ss_pred             CCCCC--CCcccccccCCccCC
Q 018036           80 GEIPE--FGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~--~~~~~~~~~~~~~~n   99 (362)
                      +..|.  +..+..+..+.+.+|
T Consensus       137 ~~~~~~~~~~L~~L~~L~Ls~N  158 (844)
T 3j0a_A          137 SLYLHPSFGKLNSLKSIDFSSN  158 (844)
T ss_dssp             CCCCCGGGGTCSSCCEEEEESS
T ss_pred             ccccchhHhhCCCCCEEECCCC
Confidence            54432  333444444444444

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.10  E-value=5.8e-11  Score=107.87  Aligned_cols=80  Identities=21%  Similarity=0.146  Sum_probs=63.5

Q ss_pred             CCCCcccccCCccc--ccccCCCEEECcCCcccccCc----hhhhcccccCeeeccccccccCcchhhcCCCCCCEEEcc
Q 018036            1 MSRNNFSGIIPVEI--GHCLLLTYLDLSQNHLSGPIP----VQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFS   74 (362)
Q Consensus         1 l~~n~~~g~ip~~~--~~l~~l~~l~l~~n~l~g~ip----~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls   74 (362)
                      |++|.++|.+|..+  +.+++|++|+|++|++++.+|    ..+..+++|++|+|++|++++..|..++.+++|++|||+
T Consensus        98 l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  177 (310)
T 4glp_A           98 LEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLS  177 (310)
T ss_dssp             EESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECC
T ss_pred             eeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECC
Confidence            35788888888877  788888888888888887666    345668888888888888887666778888888888888


Q ss_pred             CCcccC
Q 018036           75 HNNFSG   80 (362)
Q Consensus        75 ~n~l~g   80 (362)
                      +|++.+
T Consensus       178 ~N~l~~  183 (310)
T 4glp_A          178 DNPGLG  183 (310)
T ss_dssp             SCTTCH
T ss_pred             CCCCcc
Confidence            888765

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.09  E-value=5.3e-11  Score=114.61  Aligned_cols=103  Identities=18%  Similarity=0.280  Sum_probs=82.3

Q ss_pred             CCCcccccCC-cccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip-~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|+++ .+| ..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus       232 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  310 (477)
T 2id5_A          232 THCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT  310 (477)
T ss_dssp             ESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC
T ss_pred             cCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce
Confidence            467777 555 467888899999999999987777788889999999999999988778888889999999999999988


Q ss_pred             CCCCC-CcccccccCCccCCCCCCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~~lc~~  105 (362)
                      .++.. ..+..+..+.+.+|+..|..
T Consensus       311 ~~~~~~~~l~~L~~L~l~~N~l~c~c  336 (477)
T 2id5_A          311 LEESVFHSVGNLETLILDSNPLACDC  336 (477)
T ss_dssp             CCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred             eCHhHcCCCcccCEEEccCCCccCcc
Confidence            76643 44556666778888877753

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.09  E-value=7.1e-11  Score=121.82  Aligned_cols=82  Identities=23%  Similarity=0.214  Sum_probs=40.9

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchh--hhcccccCeeeccccccccCcc-hhhcCCCCCCEEEccCCcc
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQ--ITQIHILNYLNVSWNQLNASLP-KEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~--~~~l~~l~~l~l~~n~l~g~~p-~~~~~~~~l~~l~ls~n~l   78 (362)
                      ++|++++..|..++++++|++|+|++|++++.+|..  ++++++|+.|||++|.+++..| ..++++++|+.|+|++|++
T Consensus        81 s~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i  160 (844)
T 3j0a_A           81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI  160 (844)
T ss_dssp             TTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC
T ss_pred             CCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC
Confidence            445555444555555555555555555555444443  4555555555555555544322 3445555555555555555


Q ss_pred             cCCCC
Q 018036           79 SGEIP   83 (362)
Q Consensus        79 ~g~~p   83 (362)
                      ++..|
T Consensus       161 ~~~~~  165 (844)
T 3j0a_A          161 FLVCE  165 (844)
T ss_dssp             CCCCS
T ss_pred             CeeCH
Confidence            54443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.09  E-value=1.3e-10  Score=111.90  Aligned_cols=98  Identities=21%  Similarity=0.251  Sum_probs=74.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..+.++++|++|+|++|++++..|..+.++++|++|+|++|++++ +|. .+.++++|+.|+|++|+++
T Consensus        39 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~  117 (477)
T 2id5_A           39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIV  117 (477)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCTTSSTTCTTCCEEECTTSCCC
T ss_pred             CCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc-cCcccccCCCCCCEEECCCCccc
Confidence            57888887777888888888888888888888778888888888888888888874 554 4788888888888888888


Q ss_pred             CCCCC-CCcccccccCCccCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n   99 (362)
                      +.+|. +..+..+..+.+.+|
T Consensus       118 ~~~~~~~~~l~~L~~L~l~~n  138 (477)
T 2id5_A          118 ILLDYMFQDLYNLKSLEVGDN  138 (477)
T ss_dssp             EECTTTTTTCTTCCEEEECCT
T ss_pred             cCChhHccccccCCEEECCCC
Confidence            87664 333334444444444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.08  E-value=6.7e-11  Score=107.87  Aligned_cols=98  Identities=20%  Similarity=0.235  Sum_probs=73.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhh-cccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~-~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..++.+++|++|+|++|++++..|..+. .+++|+.|+|++|.+++ +|. ...+++|+.|++++|+++
T Consensus       127 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~  204 (317)
T 3o53_A          127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA  204 (317)
T ss_dssp             CCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCC
Confidence            578888877777888888999999999999877777764 68888888888888874 444 335778888888888888


Q ss_pred             CCCCCCCcccccccCCccCCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n~  100 (362)
                      +.+|.+..+..+....+.+|.
T Consensus       205 ~l~~~~~~l~~L~~L~L~~N~  225 (317)
T 3o53_A          205 FMGPEFQSAAGVTWISLRNNK  225 (317)
T ss_dssp             EECGGGGGGTTCSEEECTTSC
T ss_pred             cchhhhcccCcccEEECcCCc
Confidence            777765555555555666664

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.08  E-value=5.4e-11  Score=111.57  Aligned_cols=97  Identities=23%  Similarity=0.193  Sum_probs=75.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++.  +.++.+++|++|+|++|++++..|..+..+++|+.|+|++|++++ +|..+..+++|+.|++++|++++
T Consensus       233 l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~  309 (390)
T 3o6n_A          233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH  309 (390)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC
T ss_pred             CCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee
Confidence            567888753  478888889999999998888888888888888888888888874 78777888888888888888887


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      .++....+..+....+.+|.
T Consensus       310 ~~~~~~~l~~L~~L~L~~N~  329 (390)
T 3o6n_A          310 VERNQPQFDRLENLYLDHNS  329 (390)
T ss_dssp             CGGGHHHHTTCSEEECCSSC
T ss_pred             cCccccccCcCCEEECCCCc
Confidence            66555555555555666664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.08  E-value=8.7e-11  Score=115.03  Aligned_cols=99  Identities=21%  Similarity=0.221  Sum_probs=82.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeecccccccc-CcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g-~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..++++++|++|||++|++++..|..++++++|++|||++|.+++ .+|..++++++|+.|++++|++.
T Consensus        57 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~  136 (549)
T 2z81_A           57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF  136 (549)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred             CCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc
Confidence            67899998888899999999999999999998777789999999999999999986 46788999999999999999866


Q ss_pred             CCCC--CCCcccccccCCccCC
Q 018036           80 GEIP--EFGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p--~~~~~~~~~~~~~~~n   99 (362)
                      +.+|  .+..+..+....+.+|
T Consensus       137 ~~~~~~~~~~l~~L~~L~L~~n  158 (549)
T 2z81_A          137 SEIRRIDFAGLTSLNELEIKAL  158 (549)
T ss_dssp             CEECTTTTTTCCEEEEEEEEET
T ss_pred             cccCHhhhhcccccCeeeccCC
Confidence            6665  3444444544555554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.08  E-value=1.8e-10  Score=105.64  Aligned_cols=74  Identities=22%  Similarity=0.229  Sum_probs=38.9

Q ss_pred             CCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         3 ~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      +|.++ .+|.++.  ++|+.|+|++|++++..|..+.++++|++|+|++|++++..|..++++++|++|++++|+++
T Consensus        42 ~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  115 (332)
T 2ft3_A           42 DLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV  115 (332)
T ss_dssp             SSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC
T ss_pred             CCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC
Confidence            44444 4554442  35555555555555444445555555555555555555444555555555555555555555

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.08  E-value=6.9e-11  Score=103.16  Aligned_cols=99  Identities=10%  Similarity=0.109  Sum_probs=71.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCc-ccccCchhhhcccccCeeeccc-cccccCcchhhcCCCCCCEEEccCCcc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNH-LSGPIPVQITQIHILNYLNVSW-NQLNASLPKEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~-l~g~ip~~~~~l~~l~~l~l~~-n~l~g~~p~~~~~~~~l~~l~ls~n~l   78 (362)
                      |++|++++..|..++++++|++|+|++|+ +++.-|..+..+++|+.|+|++ |++++-.|..+.++++|+.|++++|++
T Consensus        38 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l  117 (239)
T 2xwt_C           38 LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL  117 (239)
T ss_dssp             EESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECC
T ss_pred             EeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCC
Confidence            35778875555578888888888888886 7744444778888888888887 888753335678888888888888888


Q ss_pred             cCCCCCCCcccccc---cCCccCCC
Q 018036           79 SGEIPEFGQYSFFN---STSFTGNP  100 (362)
Q Consensus        79 ~g~~p~~~~~~~~~---~~~~~~n~  100 (362)
                      ++ +|.+..+..+.   ...+.+|+
T Consensus       118 ~~-lp~~~~l~~L~~L~~L~l~~N~  141 (239)
T 2xwt_C          118 KM-FPDLTKVYSTDIFFILEITDNP  141 (239)
T ss_dssp             CS-CCCCTTCCBCCSEEEEEEESCT
T ss_pred             cc-ccccccccccccccEEECCCCc
Confidence            87 55555555554   55556663

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.06  E-value=2.5e-10  Score=108.81  Aligned_cols=98  Identities=17%  Similarity=0.110  Sum_probs=75.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..+.++++|++|+|++|++++..|..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++
T Consensus        71 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~  150 (440)
T 3zyj_A           71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES  150 (440)
T ss_dssp             CCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE
T ss_pred             ccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc
Confidence            57888887777888899999999999999987777888899999999999999985333468888999999999998887


Q ss_pred             CCCC-CCcccccccCCccC
Q 018036           81 EIPE-FGQYSFFNSTSFTG   98 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~   98 (362)
                      .++. +..+..+..+.+.+
T Consensus       151 ~~~~~~~~l~~L~~L~l~~  169 (440)
T 3zyj_A          151 IPSYAFNRIPSLRRLDLGE  169 (440)
T ss_dssp             ECTTTTTTCTTCCEEECCC
T ss_pred             cCHHHhhhCcccCEeCCCC
Confidence            6653 33333343344444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.06  E-value=3.2e-10  Score=106.30  Aligned_cols=81  Identities=21%  Similarity=0.220  Sum_probs=39.2

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|.+++..|..++.+++|++|+|++|++++..|..++++++|++|+|++|.++ .+|.. +.++++|++|++++|++++
T Consensus        77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~  155 (390)
T 3o6n_A           77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER  155 (390)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCc
Confidence            344444333344455555555555555555444444455555555555555554 34433 2445555555555555554


Q ss_pred             CCC
Q 018036           81 EIP   83 (362)
Q Consensus        81 ~~p   83 (362)
                      .+|
T Consensus       156 ~~~  158 (390)
T 3o6n_A          156 IED  158 (390)
T ss_dssp             CCT
T ss_pred             cCh
Confidence            444

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.05  E-value=1.5e-10  Score=113.86  Aligned_cols=77  Identities=30%  Similarity=0.298  Sum_probs=49.0

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++..|..++++++|++|+|++|++++..|..+.++++|++|||++|+++ .+|..  .+++|++|++++|++++
T Consensus        59 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~  135 (562)
T 3a79_B           59 LSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDV  135 (562)
T ss_dssp             CCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSB
T ss_pred             CCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccc
Confidence            4566666555556666666666666666666655666666666666666666665 56655  56666666666666665

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.05  E-value=2e-10  Score=112.85  Aligned_cols=87  Identities=26%  Similarity=0.336  Sum_probs=80.5

Q ss_pred             CCCCccc-ccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFS-GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~-g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.++ +.+|..++.+++|++|+|++|++++..|..+.++++|+.|+|++|++++..|..+.++++|+.|++++|.++
T Consensus       452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  531 (570)
T 2z63_A          452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD  531 (570)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCccc
Confidence            5789998 789999999999999999999999988999999999999999999999877778999999999999999999


Q ss_pred             CCCCCCCc
Q 018036           80 GEIPEFGQ   87 (362)
Q Consensus        80 g~~p~~~~   87 (362)
                      +..|....
T Consensus       532 ~~~~~~~~  539 (570)
T 2z63_A          532 CSCPRIDY  539 (570)
T ss_dssp             CCTTTTHH
T ss_pred             CCCcchHH
Confidence            99987543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.03  E-value=4.1e-12  Score=107.79  Aligned_cols=95  Identities=22%  Similarity=0.273  Sum_probs=77.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +| .++.+++|++|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|++++|++++
T Consensus        55 ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~  129 (198)
T 1ds9_A           55 LSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN  129 (198)
T ss_dssp             CSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred             CCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence            57888985 88 8999999999999999999 899999999999999999999985 77 68889999999999999986


Q ss_pred             CCC--CCCcccccccCCccCCC
Q 018036           81 EIP--EFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p--~~~~~~~~~~~~~~~n~  100 (362)
                      ..+  .+..+..+....+.+|+
T Consensus       130 ~~~~~~l~~l~~L~~L~l~~N~  151 (198)
T 1ds9_A          130 WGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             HHHHHHHTTTTTCSEEEECSCH
T ss_pred             hhHHHHHhcCCCCCEEEecCCc
Confidence            432  33444445555555654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.03  E-value=4.4e-10  Score=113.02  Aligned_cols=98  Identities=19%  Similarity=0.246  Sum_probs=68.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|..++++++|++|||++|++++..|..++++++|++|+|++|+++ .+|. .++++++|++|++++|+++
T Consensus        32 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~  110 (680)
T 1ziw_A           32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQ  110 (680)
T ss_dssp             CCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCC
T ss_pred             CCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccC
Confidence            5677777655556778888888888888888777777778888888888888777 4555 5777777777777777777


Q ss_pred             CCCCC-CCcccccccCCccCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n   99 (362)
                      +.+|. +..+..+....+.+|
T Consensus       111 ~~~~~~~~~l~~L~~L~Ls~n  131 (680)
T 1ziw_A          111 KIKNNPFVKQKNLITLDLSHN  131 (680)
T ss_dssp             CCCSCTTTTCTTCCEEECCSS
T ss_pred             ccChhHccccCCCCEEECCCC
Confidence            66653 334444444444444

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.02  E-value=7.6e-10  Score=101.25  Aligned_cols=80  Identities=18%  Similarity=0.275  Sum_probs=41.8

Q ss_pred             CCCCccc--ccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcc
Q 018036            1 MSRNNFS--GIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n~~~--g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l   78 (362)
                      |++|.++  |..|..+..+++|++|+|++|+++ .+|..+.  ++|+.|+|++|++++..|..+..+++|+.|++++|++
T Consensus       152 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  228 (330)
T 1xku_A          152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI  228 (330)
T ss_dssp             CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCC
T ss_pred             CCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence            3455553  355555666666666666655555 3444332  4555555555555544444455555555555555555


Q ss_pred             cCCCC
Q 018036           79 SGEIP   83 (362)
Q Consensus        79 ~g~~p   83 (362)
                      ++.+|
T Consensus       229 ~~~~~  233 (330)
T 1xku_A          229 SAVDN  233 (330)
T ss_dssp             CEECT
T ss_pred             ceeCh
Confidence            54444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.02  E-value=4.2e-10  Score=113.12  Aligned_cols=98  Identities=21%  Similarity=0.198  Sum_probs=72.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|.+++..|..+++|++|++|+|++|+++ .+|. .++++++|++|+|++|++++..|..++++++|++|++++|+++
T Consensus        56 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  134 (680)
T 1ziw_A           56 VGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS  134 (680)
T ss_dssp             CCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCS
T ss_pred             CCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCccc
Confidence            5678888777888888888888888888888 4554 6888888888888888887655567888888888888888888


Q ss_pred             CCCCC-CCcccccccCCccCC
Q 018036           80 GEIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~-~~~~~~~~~~~~~~n   99 (362)
                      +.+|. +..+..+....+.+|
T Consensus       135 ~~~~~~~~~l~~L~~L~L~~n  155 (680)
T 1ziw_A          135 STKLGTQVQLENLQELLLSNN  155 (680)
T ss_dssp             CCCCCSSSCCTTCCEEECCSS
T ss_pred             ccCchhhcccccCCEEEccCC
Confidence            87665 233333433344443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.00  E-value=3.7e-10  Score=111.92  Aligned_cols=98  Identities=14%  Similarity=0.187  Sum_probs=83.0

Q ss_pred             CCCcccccCCcc-cccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            2 SRNNFSGIIPVE-IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         2 ~~n~~~g~ip~~-~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|.++ .+|+. ++++++|++|+|++|++++..|..++.+++|+.|+|++|.+++..|..++++++|++|+|++|.|++
T Consensus        59 ~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  137 (597)
T 3oja_B           59 KNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS  137 (597)
T ss_dssp             SSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             eCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCC
Confidence            566676 56655 6889999999999999998888899999999999999999998777778999999999999999998


Q ss_pred             CCCCC-CcccccccCCccCCC
Q 018036           81 EIPEF-GQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~-~~~~~~~~~~~~~n~  100 (362)
                      .+|.. ..+..+..+.+.+|.
T Consensus       138 l~~~~~~~l~~L~~L~Ls~N~  158 (597)
T 3oja_B          138 LPRGIFHNTPKLTTLSMSNNN  158 (597)
T ss_dssp             CCTTTTTTCTTCCEEECCSSC
T ss_pred             CCHHHhccCCCCCEEEeeCCc
Confidence            77764 566666666666664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.99  E-value=2.5e-10  Score=104.05  Aligned_cols=95  Identities=13%  Similarity=0.106  Sum_probs=66.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhh-cCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~-~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..+.   .+++|++|+|++|++++..|..++.+++|+.|+|++|.+++..|..+ ..+++|+.|++++|+++
T Consensus       106 l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~  182 (317)
T 3o53_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (317)
T ss_dssp             CCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence            456777754432   36778888888888887667788888888888888888887666665 36788888888888887


Q ss_pred             CCCCCCCcccccccCCccCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n   99 (362)
                      +.. ....+..+....+.+|
T Consensus       183 ~~~-~~~~l~~L~~L~Ls~N  201 (317)
T 3o53_A          183 DVK-GQVVFAKLKTLDLSSN  201 (317)
T ss_dssp             EEE-CCCCCTTCCEEECCSS
T ss_pred             ccc-cccccccCCEEECCCC
Confidence            663 3333444444555555

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.99  E-value=2.2e-10  Score=110.76  Aligned_cols=96  Identities=13%  Similarity=0.120  Sum_probs=77.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhc-CCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMG-NMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~-~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++..|   ..+++|+.|+|++|+|++..|..++.+++|+.|||++|.+++.+|..+. .+++|+.|+|++|.|+
T Consensus       106 L~~N~l~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          106 AANNNISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CCSSCCCCEEE---CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CcCCcCCCCCc---cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            46777775544   3468899999999999998899999999999999999999998888886 7999999999999999


Q ss_pred             CCCCCCCcccccccCCccCCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n~  100 (362)
                      +.++. ..+..+..+.+.+|.
T Consensus       183 ~~~~~-~~l~~L~~L~Ls~N~  202 (487)
T 3oja_A          183 DVKGQ-VVFAKLKTLDLSSNK  202 (487)
T ss_dssp             EEECC-CCCTTCCEEECCSSC
T ss_pred             ccccc-ccCCCCCEEECCCCC
Confidence            87543 335555555666664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.96  E-value=5.3e-10  Score=103.34  Aligned_cols=97  Identities=24%  Similarity=0.255  Sum_probs=81.0

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|+++ .||..+.  ++|++|+|++|++++..+..+.++++|+.|+|++|++++..|..+.++++|++|++++|++++
T Consensus        38 ~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  114 (353)
T 2z80_A           38 GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN  114 (353)
T ss_dssp             CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS
T ss_pred             CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc
Confidence            3678887 8998775  599999999999997555689999999999999999998667789999999999999999998


Q ss_pred             CCCC-CCcccccccCCccCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~  100 (362)
                      .++. +..+..+....+.+|.
T Consensus       115 ~~~~~~~~l~~L~~L~L~~n~  135 (353)
T 2z80_A          115 LSSSWFKPLSSLTFLNLLGNP  135 (353)
T ss_dssp             CCHHHHTTCTTCSEEECTTCC
T ss_pred             CCHhHhCCCccCCEEECCCCC
Confidence            7665 4555566666666664

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.96  E-value=9.4e-10  Score=101.26  Aligned_cols=76  Identities=24%  Similarity=0.376  Sum_probs=37.0

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE   81 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~   81 (362)
                      ++|.++ .+|. +..+++|++|+|++|++++ + +.+..+++|+.|+|++|++++ +| .+..+++|+.|++++|++++.
T Consensus       229 ~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~  302 (347)
T 4fmz_A          229 GNNKIT-DLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNE  302 (347)
T ss_dssp             CSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGG
T ss_pred             cCCccC-CCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCc
Confidence            455554 2332 5555555555555555553 2 234455555555555555543 32 244455555555555555444


Q ss_pred             CC
Q 018036           82 IP   83 (362)
Q Consensus        82 ~p   83 (362)
                      +|
T Consensus       303 ~~  304 (347)
T 4fmz_A          303 DM  304 (347)
T ss_dssp             GH
T ss_pred             Ch
Confidence            43

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.96  E-value=1.1e-09  Score=96.96  Aligned_cols=63  Identities=13%  Similarity=0.208  Sum_probs=30.5

Q ss_pred             cccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036           14 IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        14 ~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +..+++|+.|+|++|+++ .+| .+..+++|+.|+|++|++++ +|. +.++++|+.|++++|++++
T Consensus        37 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~   99 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN   99 (263)
T ss_dssp             HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC
T ss_pred             hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC
Confidence            444455555555555544 344 34445555555555555542 333 4445555555555555544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.94  E-value=1.5e-09  Score=97.64  Aligned_cols=93  Identities=15%  Similarity=0.295  Sum_probs=68.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +|+ ++++++|++|+|++|++++ +| .+..+++|+.|+|++|++++ + +.+..+++|+.|++++|++++
T Consensus        75 L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~  148 (291)
T 1h6t_A           75 LNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD  148 (291)
T ss_dssp             CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC
T ss_pred             ccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc
Confidence            57788874 454 8888888888888888885 55 48888888888888888875 4 457788888888888888887


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      . +.+..+..+..+.+.+|.
T Consensus       149 ~-~~l~~l~~L~~L~L~~N~  167 (291)
T 1h6t_A          149 I-TVLSRLTKLDTLSLEDNQ  167 (291)
T ss_dssp             C-GGGGGCTTCSEEECCSSC
T ss_pred             c-hhhccCCCCCEEEccCCc
Confidence            5 555555555555555553

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.94  E-value=4.6e-10  Score=97.88  Aligned_cols=98  Identities=12%  Similarity=0.160  Sum_probs=78.0

Q ss_pred             CCCCc-ccccCCcccccccCCCEEECcC-CcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCC---EEEccC
Q 018036            1 MSRNN-FSGIIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLT---SADFSH   75 (362)
Q Consensus         1 l~~n~-~~g~ip~~~~~l~~l~~l~l~~-n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~---~l~ls~   75 (362)
                      |++|. +++-.|..+..+++|++|+|++ |++++..|..+..+++|+.|+|++|++++ +|. +..+++|+   .|++++
T Consensus        62 l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~  139 (239)
T 2xwt_C           62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITD  139 (239)
T ss_dssp             EECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEES
T ss_pred             CCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCC
Confidence            35776 7744445789999999999998 99996556788999999999999999986 887 88888888   999999


Q ss_pred             C-cccCCCCC-CCcccccc-cCCccCCC
Q 018036           76 N-NFSGEIPE-FGQYSFFN-STSFTGNP  100 (362)
Q Consensus        76 n-~l~g~~p~-~~~~~~~~-~~~~~~n~  100 (362)
                      | ++++.++. +..+..+. ...+.+|.
T Consensus       140 N~~l~~i~~~~~~~l~~L~~~L~l~~n~  167 (239)
T 2xwt_C          140 NPYMTSIPVNAFQGLCNETLTLKLYNNG  167 (239)
T ss_dssp             CTTCCEECTTTTTTTBSSEEEEECCSCC
T ss_pred             CcchhhcCcccccchhcceeEEEcCCCC
Confidence            9 99887764 44455555 55665653

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.93  E-value=1.1e-09  Score=108.35  Aligned_cols=93  Identities=16%  Similarity=0.300  Sum_probs=67.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +| .++.|++|+.|+|++|+|++ +| .+..|++|+.|+|++|++++ + ..+..+++|+.|+|++|+|++
T Consensus        94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~  167 (605)
T 1m9s_A           94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISD  167 (605)
T ss_dssp             CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCC
T ss_pred             CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCC
Confidence            56778874 55 67888888888888888885 44 57788888888888888875 4 567788888888888888887


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      .+| +..+..+..+.+.+|.
T Consensus       168 ~~~-l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          168 IVP-LAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             CGG-GTTCTTCCEEECCSSC
T ss_pred             chh-hccCCCCCEEECcCCC
Confidence            766 5555555555555553

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.93  E-value=1.8e-09  Score=97.92  Aligned_cols=92  Identities=14%  Similarity=0.207  Sum_probs=62.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.++ .+| .+..+++|++|+|++|++++ +|. +..+++|+.|+|++|++++ +| .+..+++|+.|++++|++++
T Consensus        48 l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~  121 (308)
T 1h6u_A           48 AFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD  121 (308)
T ss_dssp             CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC
T ss_pred             eeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC
Confidence            4566666 566 57777888888888888773 554 7778888888888888764 44 57777778888888887776


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                      .. .+..+..+..+.+.+|
T Consensus       122 ~~-~l~~l~~L~~L~l~~n  139 (308)
T 1h6u_A          122 VT-PLAGLSNLQVLYLDLN  139 (308)
T ss_dssp             CG-GGTTCTTCCEEECCSS
T ss_pred             ch-hhcCCCCCCEEECCCC
Confidence            43 3444444444555555

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.93  E-value=2.1e-09  Score=97.55  Aligned_cols=92  Identities=16%  Similarity=0.294  Sum_probs=63.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +| .++.+++|++|+|++|++++ +|. +..+++|+.|+|++|.+++ +|. +..+++|+.|++++|++++
T Consensus        92 L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~  165 (308)
T 1h6u_A           92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD  165 (308)
T ss_dssp             CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC
T ss_pred             ccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC
Confidence            46777763 44 67778888888888888874 554 7778888888888888874 444 7777778888888887776


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                      ..| +..+..+..+.+.+|
T Consensus       166 ~~~-l~~l~~L~~L~l~~n  183 (308)
T 1h6u_A          166 LTP-LANLSKLTTLKADDN  183 (308)
T ss_dssp             CGG-GTTCTTCCEEECCSS
T ss_pred             Chh-hcCCCCCCEEECCCC
Confidence            544 444444444455554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.93  E-value=1.6e-09  Score=96.07  Aligned_cols=91  Identities=19%  Similarity=0.212  Sum_probs=58.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.++ .+| .++.+++|++|+|++|++++ +|. +..+++|+.|+|++|++++ +|....  ++|+.|++++|++++
T Consensus        48 l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~  120 (263)
T 1xeu_A           48 GDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD  120 (263)
T ss_dssp             CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB
T ss_pred             CcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC
Confidence            4667776 666 67778888888888888874 454 7778888888888888764 554322  666777777776665


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                      . |.+..+..+..+.+.+|
T Consensus       121 ~-~~l~~l~~L~~L~Ls~N  138 (263)
T 1xeu_A          121 T-DSLIHLKNLEILSIRNN  138 (263)
T ss_dssp             S-GGGTTCTTCCEEECTTS
T ss_pred             C-hhhcCcccccEEECCCC
Confidence            3 33444444444444444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.92  E-value=2e-09  Score=106.56  Aligned_cols=93  Identities=15%  Similarity=0.286  Sum_probs=68.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +|+ ++.|++|+.|+|++|+|++ +| .+..|++|+.|+|++|++++ +| .+..+++|+.|+|++|+|++
T Consensus        72 Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~  145 (605)
T 1m9s_A           72 LNGNKLTD-IKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITD  145 (605)
T ss_dssp             CTTSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCC
T ss_pred             eeCCCCCC-Chh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCC
Confidence            56788875 443 7888888888888888884 55 68888888888888888874 44 47888888888888888887


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      . +.+..+..+..+.+.+|.
T Consensus       146 l-~~l~~l~~L~~L~Ls~N~  164 (605)
T 1m9s_A          146 I-TVLSRLTKLDTLSLEDNQ  164 (605)
T ss_dssp             C-GGGGSCTTCSEEECCSSC
T ss_pred             c-hhhcccCCCCEEECcCCc
Confidence            5 555555555555555553

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.91  E-value=1.8e-09  Score=97.11  Aligned_cols=93  Identities=20%  Similarity=0.258  Sum_probs=75.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|.++ .+| .+..+++|++|+|++|++++ +|. +.++++|+.|+|++|++++ +|. +..+++|+.|++++|++++
T Consensus        53 l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~  126 (291)
T 1h6t_A           53 ANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD  126 (291)
T ss_dssp             CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC
T ss_pred             ccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC
Confidence            4678887 566 48899999999999999995 555 9999999999999999985 554 8999999999999999987


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      . |.+..+..+..+.+.+|.
T Consensus       127 ~-~~l~~l~~L~~L~l~~n~  145 (291)
T 1h6t_A          127 I-NGLVHLPQLESLYLGNNK  145 (291)
T ss_dssp             C-GGGGGCTTCCEEECCSSC
T ss_pred             C-hhhcCCCCCCEEEccCCc
Confidence            4 555555555555666664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.90  E-value=2.5e-09  Score=102.51  Aligned_cols=89  Identities=19%  Similarity=0.235  Sum_probs=60.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +| .++.+++|++|+|++|+|++ +|  ++.+++|++|+|++|++++ +|  ++++++|++|++++|++++
T Consensus        49 Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~  120 (457)
T 3bz5_A           49 CHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK  120 (457)
T ss_dssp             CCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC
T ss_pred             ccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe
Confidence            46777774 45 67778888888888888875 45  7777788888888888775 44  7777777777777777776


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                      . | +..+..+....+.+|
T Consensus       121 l-~-~~~l~~L~~L~l~~N  137 (457)
T 3bz5_A          121 L-D-VSQNPLLTYLNCARN  137 (457)
T ss_dssp             C-C-CTTCTTCCEEECTTS
T ss_pred             e-c-CCCCCcCCEEECCCC
Confidence            3 3 444444443444443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.90  E-value=1.3e-10  Score=111.40  Aligned_cols=75  Identities=19%  Similarity=0.102  Sum_probs=37.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhccccc-------------CeeeccccccccCcchhhcCCCC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHIL-------------NYLNVSWNQLNASLPKEMGNMKS   67 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l-------------~~l~l~~n~l~g~~p~~~~~~~~   67 (362)
                      |++|+| |.||.++++|++|++|+|++|+++|.+|.+++++.+|             +.|++++|.+++ +|..   .++
T Consensus        18 l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~   92 (454)
T 1jl5_A           18 RHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPH   92 (454)
T ss_dssp             -----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTT
T ss_pred             cccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCC
Confidence            467888 7999999999999999999999999999888876654             556666666553 3331   133


Q ss_pred             CCEEEccCCcccC
Q 018036           68 LTSADFSHNNFSG   80 (362)
Q Consensus        68 l~~l~ls~n~l~g   80 (362)
                      |+.|++++|++++
T Consensus        93 L~~L~l~~n~l~~  105 (454)
T 1jl5_A           93 LESLVASCNSLTE  105 (454)
T ss_dssp             CSEEECCSSCCSS
T ss_pred             CCEEEccCCcCCc
Confidence            4444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.90  E-value=2e-09  Score=105.53  Aligned_cols=69  Identities=30%  Similarity=0.488  Sum_probs=37.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+|++ ||..+.  ++|++|+|++|+|+ .||   ..+++|+.|+|++|+|++ ||. +.+  +|+.|+|++|+|++
T Consensus        66 Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~  134 (571)
T 3cvr_A           66 LNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM  134 (571)
T ss_dssp             CCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC
T ss_pred             eCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC
Confidence            35556654 565542  45566666666555 455   334555555555555554 555 433  55555555555555

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.87  E-value=1.6e-09  Score=106.30  Aligned_cols=67  Identities=31%  Similarity=0.434  Sum_probs=45.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|+|++ ||.   .+++|+.|+|++|+|++ ||.   .+++|+.|+|++|+|++ +|. +.  ++|+.|+|++|+|+
T Consensus       127 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          127 VDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE  193 (571)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred             CCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC
Confidence            45666664 665   56677777777777774 665   46677777777777765 666 54  66777777777776

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.87  E-value=2.3e-09  Score=102.93  Aligned_cols=92  Identities=25%  Similarity=0.363  Sum_probs=54.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++ +|+ +..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++
T Consensus       272 l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~  345 (466)
T 1o6v_A          272 LGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD  345 (466)
T ss_dssp             CCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             CCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence            45666664 333 6667777777777777764333  6666677777777777665443  5566666666666666665


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                      . |.+..+..+....+.+|
T Consensus       346 ~-~~l~~l~~L~~L~l~~n  363 (466)
T 1o6v_A          346 V-SSLANLTNINWLSAGHN  363 (466)
T ss_dssp             C-GGGTTCTTCCEEECCSS
T ss_pred             c-hhhccCCCCCEEeCCCC
Confidence            4 33333444444444444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.85  E-value=4.1e-09  Score=100.85  Aligned_cols=72  Identities=28%  Similarity=0.453  Sum_probs=43.3

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +| +++++++|++|+|++|++++ +|..+   .+|++|+|++|++++ +| +++++++|+.|++++|++++
T Consensus       138 L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~  209 (454)
T 1jl5_A          138 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK  209 (454)
T ss_dssp             CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS
T ss_pred             CcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc
Confidence            34566653 55 46666666666666666663 55433   356666666666654 55 46666666666666666665

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.85  E-value=6.9e-10  Score=103.04  Aligned_cols=84  Identities=23%  Similarity=0.125  Sum_probs=70.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCc----hhhhccc-ccCeeeccccccccCcchhhcCC-----CCCCE
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIP----VQITQIH-ILNYLNVSWNQLNASLPKEMGNM-----KSLTS   70 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip----~~~~~l~-~l~~l~l~~n~l~g~~p~~~~~~-----~~l~~   70 (362)
                      |+.|+++|.+|..+...++|++|||++|++++.-+    ..+..++ +|+.|+|++|++++..+..+..+     ++|+.
T Consensus         5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~   84 (362)
T 3goz_A            5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS   84 (362)
T ss_dssp             CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred             cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence            57899999999888777789999999999987666    6777888 89999999999988777777765     88999


Q ss_pred             EEccCCcccCCCCC
Q 018036           71 ADFSHNNFSGEIPE   84 (362)
Q Consensus        71 l~ls~n~l~g~~p~   84 (362)
                      |+|++|++++..+.
T Consensus        85 L~Ls~n~l~~~~~~   98 (362)
T 3goz_A           85 LNLSGNFLSYKSSD   98 (362)
T ss_dssp             EECCSSCGGGSCHH
T ss_pred             EECcCCcCChHHHH
Confidence            99999999887654

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.84  E-value=1.2e-09  Score=96.35  Aligned_cols=68  Identities=24%  Similarity=0.283  Sum_probs=58.1

Q ss_pred             ccccCCCEEECcCCcccc--cCchhhhcccccCeeeccccccccCcchhhcCCC--CCCEEEccCCcccCCCCC
Q 018036           15 GHCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVSWNQLNASLPKEMGNMK--SLTSADFSHNNFSGEIPE   84 (362)
Q Consensus        15 ~~l~~l~~l~l~~n~l~g--~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~--~l~~l~ls~n~l~g~~p~   84 (362)
                      .++++|+.|+||+|+|++  .+|..+..+++|+.|||++|+|++ + .++..++  +|+.|+|++|.+++.+|.
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~-~-~~l~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-E-RELDKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS-G-GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC-c-hhhhhcccCCcceEEccCCcCccccCc
Confidence            568899999999999998  778888999999999999999986 3 3455555  899999999999988774

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.80  E-value=7.7e-09  Score=99.25  Aligned_cols=76  Identities=24%  Similarity=0.398  Sum_probs=40.6

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE   81 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~   81 (362)
                      ++|++++ +| .+..+++|+.|+|++|++++..|  +..+++|+.|+|++|.+++ +|. +..+++|+.|++++|++++.
T Consensus       229 ~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~  302 (466)
T 1o6v_A          229 NGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDI  302 (466)
T ss_dssp             CSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCC
T ss_pred             CCCCccc-ch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCc
Confidence            4555552 33 45555666666666666654333  5555555555555555553 333 55555555555555555554


Q ss_pred             CC
Q 018036           82 IP   83 (362)
Q Consensus        82 ~p   83 (362)
                      +|
T Consensus       303 ~~  304 (466)
T 1o6v_A          303 SP  304 (466)
T ss_dssp             GG
T ss_pred             hh
Confidence            33

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.79  E-value=1.1e-08  Score=92.53  Aligned_cols=137  Identities=22%  Similarity=0.219  Sum_probs=97.4

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCc--ceeEEEEEecCC---eeeEEEe
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRN--IVRLKAFCSNKE---TNLLVYE  260 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e  260 (362)
                      .+.++.|....||+..    ..+++|.....    .....+.+|.++++.+. +..  +.+++......+   ..|+|||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3568999999999873    45888875321    22345889999998873 333  445555544333   3489999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD---------------------------------------  301 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  301 (362)
                      +++|.+|.+...    ..++..++..++.++++.++.||..                                       
T Consensus        97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999988875332    1256777778888888888888851                                       


Q ss_pred             ----------------CCCCeEEeCCCCCceeeCC--CCceEEccccccccc
Q 018036          302 ----------------CSPLIIHRDVKSNNILLNS--DFEAHVADFGLAKYL  335 (362)
Q Consensus       302 ----------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~~~  335 (362)
                                      ..+.++|+|++|.||++++  ...+.|+||+.+..-
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                            1245899999999999997  456789999998753

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.78  E-value=1.1e-09  Score=100.20  Aligned_cols=98  Identities=13%  Similarity=0.118  Sum_probs=76.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCccccc-CchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCC-cc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGP-IPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN-NF   78 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~-ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n-~l   78 (362)
                      |++|.+++.+|. +..+++|++|+|++|++++. +|..+..+++|+.|+|++|.+++.+|..++++++|+.|++++| .+
T Consensus        77 l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l  155 (336)
T 2ast_B           77 CPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF  155 (336)
T ss_dssp             CTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred             cCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCC
Confidence            467888866654 66899999999999999877 8989999999999999999999888999999999999999999 67


Q ss_pred             cCC-CCC-CCcccccccCCccCC
Q 018036           79 SGE-IPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        79 ~g~-~p~-~~~~~~~~~~~~~~n   99 (362)
                      ++. +|. ...+..+..+.+.+|
T Consensus       156 ~~~~l~~~~~~~~~L~~L~l~~~  178 (336)
T 2ast_B          156 SEFALQTLLSSCSRLDELNLSWC  178 (336)
T ss_dssp             CHHHHHHHHHHCTTCCEEECCCC
T ss_pred             CHHHHHHHHhcCCCCCEEcCCCC
Confidence            752 333 222333444444444

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.77  E-value=1.3e-09  Score=102.08  Aligned_cols=100  Identities=17%  Similarity=0.222  Sum_probs=80.0

Q ss_pred             CCCCccc--c---cCCcccccccCCCEEECcCCccc----ccCchhhhcccccCeeeccccccccC----cchhh--cCC
Q 018036            1 MSRNNFS--G---IIPVEIGHCLLLTYLDLSQNHLS----GPIPVQITQIHILNYLNVSWNQLNAS----LPKEM--GNM   65 (362)
Q Consensus         1 l~~n~~~--g---~ip~~~~~l~~l~~l~l~~n~l~----g~ip~~~~~l~~l~~l~l~~n~l~g~----~p~~~--~~~   65 (362)
                      |++|+++  |   .+|..+.++++|+.|+|++|+++    +.+|..+..+++|+.|+|++|.+++.    +|..+  +++
T Consensus       194 L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~  273 (386)
T 2ca6_A          194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN  273 (386)
T ss_dssp             CCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSS
T ss_pred             CcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccC
Confidence            5778887  3   45558899999999999999997    78999999999999999999999876    67777  449


Q ss_pred             CCCCEEEccCCcccC----CCCCC--CcccccccCCccCCC
Q 018036           66 KSLTSADFSHNNFSG----EIPEF--GQYSFFNSTSFTGNP  100 (362)
Q Consensus        66 ~~l~~l~ls~n~l~g----~~p~~--~~~~~~~~~~~~~n~  100 (362)
                      ++|+.|+|++|.+++    .+|..  ..+..+..+.+.+|+
T Consensus       274 ~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~  314 (386)
T 2ca6_A          274 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR  314 (386)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred             CCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence            999999999999998    35542  223445555666664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.77  E-value=7.8e-09  Score=99.00  Aligned_cols=74  Identities=23%  Similarity=0.263  Sum_probs=66.6

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++ +|  ++.+++|+.|+|++|++++.   .++.+++|+.|+|++|++++ +|  ++.+++|+.|++++|+|++
T Consensus       177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~  247 (457)
T 3bz5_A          177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE  247 (457)
T ss_dssp             CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred             CCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence            57899986 77  88999999999999999964   48999999999999999997 88  8899999999999999999


Q ss_pred             CCC
Q 018036           81 EIP   83 (362)
Q Consensus        81 ~~p   83 (362)
                      .++
T Consensus       248 ~~~  250 (457)
T 3bz5_A          248 LDV  250 (457)
T ss_dssp             CCC
T ss_pred             cCH
Confidence            764

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.76  E-value=5.1e-09  Score=103.88  Aligned_cols=54  Identities=33%  Similarity=0.282  Sum_probs=26.7

Q ss_pred             cCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036           18 LLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus        18 ~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      ++|+.|+|++|+|++ ||   ..+++|+.|+|++|+|+ .||.   .+++|+.|+|++|+|+
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC
Confidence            445555555555553 44   23344555555555554 3444   3344555555555555

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.75  E-value=6.3e-10  Score=101.88  Aligned_cols=81  Identities=21%  Similarity=0.247  Sum_probs=72.9

Q ss_pred             CCCCccccc-CCcccccccCCCEEECcCCcccccCchhhhcccccCeeecccc-cccc-CcchhhcCCCCCCEEEccCC-
Q 018036            1 MSRNNFSGI-IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWN-QLNA-SLPKEMGNMKSLTSADFSHN-   76 (362)
Q Consensus         1 l~~n~~~g~-ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n-~l~g-~~p~~~~~~~~l~~l~ls~n-   76 (362)
                      |++|.+++. +|..+..+++|++|+|++|++++.+|..++++++|+.|+|++| .+++ .+|..+.++++|+.|++++| 
T Consensus       100 L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~  179 (336)
T 2ast_B          100 LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF  179 (336)
T ss_dssp             CTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred             ccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence            578888876 8888999999999999999999999999999999999999999 7886 37888899999999999999 


Q ss_pred             cccCC
Q 018036           77 NFSGE   81 (362)
Q Consensus        77 ~l~g~   81 (362)
                      ++++.
T Consensus       180 ~l~~~  184 (336)
T 2ast_B          180 DFTEK  184 (336)
T ss_dssp             TCCHH
T ss_pred             CcChH
Confidence            88863

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.74  E-value=9.7e-09  Score=94.40  Aligned_cols=95  Identities=24%  Similarity=0.339  Sum_probs=82.0

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++ + +.+..+++|++|+|++|++++ +| .+..+++|+.|+|++|.+++..|..++.+++|+.|++++|++++
T Consensus       250 l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~  325 (347)
T 4fmz_A          250 IGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD  325 (347)
T ss_dssp             CCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred             CCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence            57888884 5 468999999999999999995 54 68999999999999999999888999999999999999999999


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      .+| ...+..+....+.+|+
T Consensus       326 ~~~-~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          326 IRP-LASLSKMDSADFANQV  344 (347)
T ss_dssp             CGG-GGGCTTCSEESSSCC-
T ss_pred             ccC-hhhhhccceeehhhhc
Confidence            888 6666667777777775

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.74  E-value=1e-09  Score=102.69  Aligned_cols=81  Identities=17%  Similarity=0.233  Sum_probs=72.0

Q ss_pred             CCCCccc-ccCC---cccccccCCCEEECcCCccc--c---cCchhhhcccccCeeeccccccc----cCcchhhcCCCC
Q 018036            1 MSRNNFS-GIIP---VEIGHCLLLTYLDLSQNHLS--G---PIPVQITQIHILNYLNVSWNQLN----ASLPKEMGNMKS   67 (362)
Q Consensus         1 l~~n~~~-g~ip---~~~~~l~~l~~l~l~~n~l~--g---~ip~~~~~l~~l~~l~l~~n~l~----g~~p~~~~~~~~   67 (362)
                      |++|+++ +.+|   ..+..+++|++|+|++|+++  |   .+|..+..+++|+.|+|++|.++    +.+|..+..+++
T Consensus       166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~  245 (386)
T 2ca6_A          166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  245 (386)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence            5789997 6677   57788999999999999998  4   45668999999999999999997    789999999999


Q ss_pred             CCEEEccCCcccCC
Q 018036           68 LTSADFSHNNFSGE   81 (362)
Q Consensus        68 l~~l~ls~n~l~g~   81 (362)
                      |+.|+|++|++++.
T Consensus       246 L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          246 LRELGLNDCLLSAR  259 (386)
T ss_dssp             CCEEECTTCCCCHH
T ss_pred             cCEEECCCCCCchh
Confidence            99999999999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.71  E-value=1.1e-07  Score=84.09  Aligned_cols=136  Identities=19%  Similarity=0.192  Sum_probs=96.3

Q ss_pred             eeeccCcc-cEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAG-VVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .+..|..+ .||+.... ++..+++|.-...     ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            45556655 58988764 4567888875322     2334888999888774 334678899999999999999999998


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-------------------------------------------  302 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------  302 (362)
                      ++.+.....      ......++.+++..|.-||...                                           
T Consensus       106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            887765321      1223345566666666666421                                           


Q ss_pred             ------------CCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          303 ------------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       303 ------------~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                                  .+.++|+|+.+.|||+++++.+-|+||+.+..-
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                        123799999999999998777789999988653

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.68  E-value=2.4e-08  Score=99.05  Aligned_cols=35  Identities=31%  Similarity=0.224  Sum_probs=19.5

Q ss_pred             cccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036           42 HILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        42 ~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ++|+.|+|++|++++ +|   ..+++|+.|++++|+|+.
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~  255 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS  255 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc
Confidence            445556666666653 55   234556666666666654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.64  E-value=1.1e-08  Score=94.80  Aligned_cols=83  Identities=28%  Similarity=0.275  Sum_probs=68.7

Q ss_pred             CCCCcccccCC----ccccccc-CCCEEECcCCcccccCchhhhcc-----cccCeeeccccccccCcchhhcC----C-
Q 018036            1 MSRNNFSGIIP----VEIGHCL-LLTYLDLSQNHLSGPIPVQITQI-----HILNYLNVSWNQLNASLPKEMGN----M-   65 (362)
Q Consensus         1 l~~n~~~g~ip----~~~~~l~-~l~~l~l~~n~l~g~ip~~~~~l-----~~l~~l~l~~n~l~g~~p~~~~~----~-   65 (362)
                      |++|++++.-+    ..+.+++ +|++|+|++|++++..|..+..+     ++|+.|||++|.+++..+..++.    + 
T Consensus        29 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~  108 (362)
T 3goz_A           29 LSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP  108 (362)
T ss_dssp             CTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred             ccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCC
Confidence            57888886666    6677788 89999999999998888888886     89999999999998777765444    4 


Q ss_pred             CCCCEEEccCCcccCCCC
Q 018036           66 KSLTSADFSHNNFSGEIP   83 (362)
Q Consensus        66 ~~l~~l~ls~n~l~g~~p   83 (362)
                      ++|+.|+|++|++++..+
T Consensus       109 ~~L~~L~Ls~N~l~~~~~  126 (362)
T 3goz_A          109 FTITVLDLGWNDFSSKSS  126 (362)
T ss_dssp             TTCCEEECCSSCGGGSCH
T ss_pred             CCccEEECcCCcCCcHHH
Confidence            889999999999987655

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.63  E-value=2.1e-07  Score=84.16  Aligned_cols=137  Identities=19%  Similarity=0.180  Sum_probs=93.5

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccC---cceeEEEEEe-cCCeeeEEEecC
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHR---NIVRLKAFCS-NKETNLLVYEYM  262 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~  262 (362)
                      .+.++.|....||+.    +..+++|....    ......+.+|.++|+.+.+.   .+.+.+.++. ..+..++||||+
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            356788888899998    46688887421    12234588999999998642   3566777764 455678999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-----------------------------------------  301 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  301 (362)
                      +|.++.+....    .++......++.++++.|+.||..                                         
T Consensus        96 ~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           96 QGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            99888763211    134444455555555555555532                                         


Q ss_pred             ----------------CCCCeEEeCCCCCceeeCC---CCce-EEccccccccc
Q 018036          302 ----------------CSPLIIHRDVKSNNILLNS---DFEA-HVADFGLAKYL  335 (362)
Q Consensus       302 ----------------~~~~ivH~Dlk~~NIll~~---~~~~-kl~DFGla~~~  335 (362)
                                      ..+.++|+|+++.||+++.   ++.+ .|+||+.+..-
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                            1335799999999999987   4554 89999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.58  E-value=2.2e-07  Score=85.78  Aligned_cols=83  Identities=6%  Similarity=0.040  Sum_probs=56.1

Q ss_pred             ccee-eccCcccEEEEEcC-------CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCc-c--CcceeEEEEEecC--
Q 018036          187 NNVI-GRGGAGVVYRGVTP-------NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIR-H--RNIVRLKAFCSNK--  252 (362)
Q Consensus       187 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--  252 (362)
                      .+.| +.|....+|+....       ++..+++|....... .......+.+|..+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999998754       256788887543220 0001134889999998885 3  3567788887665  


Q ss_pred             -CeeeEEEecCCCCChhh
Q 018036          253 -ETNLLVYEYMPNGSLGE  269 (362)
Q Consensus       253 -~~~~lv~e~~~~gsL~~  269 (362)
                       +..++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877654

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.57  E-value=3.6e-08  Score=86.94  Aligned_cols=70  Identities=21%  Similarity=0.208  Sum_probs=60.4

Q ss_pred             CCCCcccc--cCCcccccccCCCEEECcCCcccccCchhhhccc--ccCeeeccccccccCcch-------hhcCCCCCC
Q 018036            1 MSRNNFSG--IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIH--ILNYLNVSWNQLNASLPK-------EMGNMKSLT   69 (362)
Q Consensus         1 l~~n~~~g--~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~--~l~~l~l~~n~l~g~~p~-------~~~~~~~l~   69 (362)
                      |++|+|++  .+|..+..+++|+.|||++|+|++.  .++..+.  +|+.|+|++|.+++++|.       .+..+++|+
T Consensus       177 Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~  254 (267)
T 3rw6_A          177 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLL  254 (267)
T ss_dssp             CTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCC
T ss_pred             CCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccC
Confidence            68999998  7888889999999999999999965  4566666  999999999999998883       367889999


Q ss_pred             EEE
Q 018036           70 SAD   72 (362)
Q Consensus        70 ~l~   72 (362)
                      .||
T Consensus       255 ~LD  257 (267)
T 3rw6_A          255 RLD  257 (267)
T ss_dssp             EES
T ss_pred             eEC
Confidence            886

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.53  E-value=3.8e-08  Score=90.76  Aligned_cols=94  Identities=15%  Similarity=0.106  Sum_probs=64.2

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcch-hhcCCCCCCE-EEccCCcc
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTS-ADFSHNNF   78 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~-l~ls~n~l   78 (362)
                      ++|+|+ +||..+  .++|++|+|++|+|+ .||+ .+.++++|++|||++|++.+.+|. .|.++++|.. +++++|++
T Consensus        17 ~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l   92 (350)
T 4ay9_X           17 QESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL   92 (350)
T ss_dssp             ESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred             cCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence            356777 788766  357888888888888 5665 578888888888888888777775 3567777654 55667788


Q ss_pred             cCCCCCC-CcccccccCCccCC
Q 018036           79 SGEIPEF-GQYSFFNSTSFTGN   99 (362)
Q Consensus        79 ~g~~p~~-~~~~~~~~~~~~~n   99 (362)
                      +...|.. ..+..+....+.+|
T Consensus        93 ~~l~~~~f~~l~~L~~L~l~~n  114 (350)
T 4ay9_X           93 LYINPEAFQNLPNLQYLLISNT  114 (350)
T ss_dssp             CEECTTSBCCCTTCCEEEEEEE
T ss_pred             cccCchhhhhcccccccccccc
Confidence            7776653 33444444444444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.50  E-value=1.1e-07  Score=87.80  Aligned_cols=83  Identities=16%  Similarity=0.081  Sum_probs=66.8

Q ss_pred             CCCCcccccCCc-ccccccCCCEEECcCCcccccCch-hhhcccccCe-eeccccccccCcchhhcCCCCCCEEEccCCc
Q 018036            1 MSRNNFSGIIPV-EIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNY-LNVSWNQLNASLPKEMGNMKSLTSADFSHNN   77 (362)
Q Consensus         1 l~~n~~~g~ip~-~~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~-l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~   77 (362)
                      |++|+++ .||+ .+.+|++|++|||++|++.+.||. .+.++++|.. +++++|+++.-.|..+..+++|++|++++|+
T Consensus        37 Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~  115 (350)
T 4ay9_X           37 FVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG  115 (350)
T ss_dssp             EESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEEC
T ss_pred             ccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccc
Confidence            4688888 6765 578999999999999999888886 4678888765 6677899986446678899999999999999


Q ss_pred             ccCCCCC
Q 018036           78 FSGEIPE   84 (362)
Q Consensus        78 l~g~~p~   84 (362)
                      +++.++.
T Consensus       116 l~~~~~~  122 (350)
T 4ay9_X          116 IKHLPDV  122 (350)
T ss_dssp             CSSCCCC
T ss_pred             cccCCch
Confidence            9876553

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.44  E-value=3.3e-08  Score=94.38  Aligned_cols=80  Identities=15%  Similarity=0.088  Sum_probs=54.6

Q ss_pred             CCCCcccccCCcccccc-----cCCCEEECcCCccccc----CchhhhcccccCeeeccccccccCcchhhcC-----CC
Q 018036            1 MSRNNFSGIIPVEIGHC-----LLLTYLDLSQNHLSGP----IPVQITQIHILNYLNVSWNQLNASLPKEMGN-----MK   66 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l-----~~l~~l~l~~n~l~g~----ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~-----~~   66 (362)
                      |++|.+++.-+..+...     ++|++|+|++|.+++.    +|..+..+++|+.|||++|.+++.-+..+.+     .+
T Consensus       291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  370 (461)
T 1z7x_W          291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS  370 (461)
T ss_dssp             CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence            46677765544444432     5788888888887765    5667777788888888888777654554443     56


Q ss_pred             CCCEEEccCCcccC
Q 018036           67 SLTSADFSHNNFSG   80 (362)
Q Consensus        67 ~l~~l~ls~n~l~g   80 (362)
                      +|+.|++++|++++
T Consensus       371 ~L~~L~L~~n~i~~  384 (461)
T 1z7x_W          371 VLRVLWLADCDVSD  384 (461)
T ss_dssp             CCCEEECTTSCCCH
T ss_pred             ceEEEECCCCCCCh
Confidence            78888888887775

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.26  E-value=1.4e-07  Score=90.07  Aligned_cols=81  Identities=12%  Similarity=0.055  Sum_probs=54.2

Q ss_pred             CCCCcccccCC----cc-cccccCCCEEECcCCccccc----CchhhhcccccCeeeccccccccCcchhhcC-----CC
Q 018036            1 MSRNNFSGIIP----VE-IGHCLLLTYLDLSQNHLSGP----IPVQITQIHILNYLNVSWNQLNASLPKEMGN-----MK   66 (362)
Q Consensus         1 l~~n~~~g~ip----~~-~~~l~~l~~l~l~~n~l~g~----ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~-----~~   66 (362)
                      |++|.+++.-.    +. ...+++|++|+|++|++++.    +|..+.++++|+.|||++|.+++.-+..+..     .+
T Consensus       234 Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  313 (461)
T 1z7x_W          234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGC  313 (461)
T ss_dssp             CCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTC
T ss_pred             ccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCc
Confidence            45666664321    22 22477888888888888754    7777777888888888888876544443332     25


Q ss_pred             CCCEEEccCCcccCC
Q 018036           67 SLTSADFSHNNFSGE   81 (362)
Q Consensus        67 ~l~~l~ls~n~l~g~   81 (362)
                      +|+.|++++|.+++.
T Consensus       314 ~L~~L~L~~n~l~~~  328 (461)
T 1z7x_W          314 QLESLWVKSCSFTAA  328 (461)
T ss_dssp             CCCEEECTTSCCBGG
T ss_pred             cceeeEcCCCCCchH
Confidence            788888888877764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.26  E-value=5.6e-06  Score=77.51  Aligned_cols=77  Identities=17%  Similarity=0.171  Sum_probs=49.7

Q ss_pred             cceeeccCcccEEEEEcC-CCCEEEEEEeeccCC--C---CCchhhHHHHHHHHhcCcc--Cc-ceeEEEEEecCCeeeE
Q 018036          187 NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK--G---SSHDNGLSAEIRTLGKIRH--RN-IVRLKAFCSNKETNLL  257 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  257 (362)
                      .+.+|.|.++.||++... +++.+++|.......  .   ....+++..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999764 468899998653221  0   1123446789888887742  33 4455544  3445689


Q ss_pred             EEecCCCC
Q 018036          258 VYEYMPNG  265 (362)
Q Consensus       258 v~e~~~~g  265 (362)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.24  E-value=3.6e-06  Score=76.83  Aligned_cols=140  Identities=17%  Similarity=0.268  Sum_probs=79.2

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc--CcceeEEE------EEecCCeeeEEE
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKA------FCSNKETNLLVY  259 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~  259 (362)
                      +.|+.|..+.||+....++ .+++|.....      ..++..|..+++.+..  -.+.+++.      +....+..+++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            4566677889999987554 5888887531      1234556666655531  12333332      123456788999


Q ss_pred             ecCCCCChh--------------hhhcC----C--C-C-----CCCCHHHH-----------------------------
Q 018036          260 EYMPNGSLG--------------EVLHG----K--R-G-----SFLKWEMR-----------------------------  284 (362)
Q Consensus       260 e~~~~gsL~--------------~~l~~----~--~-~-----~~~~~~~~-----------------------------  284 (362)
                      ||++|.++.              ..+|.    .  . .     ....|...                             
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986542              01111    0  0 0     01123211                             


Q ss_pred             --HHHHHHHHHHHHHHhc----------CCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          285 --LKIAIEAAKGLSYLHH----------DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       285 --~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                        ..+..++..++++|+.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              0111223445666653          0145699999999999998888999999998754

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.22  E-value=2.1e-07  Score=86.55  Aligned_cols=80  Identities=15%  Similarity=0.147  Sum_probs=61.0

Q ss_pred             CCCCcccccCCcccc-----cccCCCEEECcCCcccc----cCchhhhcccccCeeecccccccc----CcchhhcCCCC
Q 018036            1 MSRNNFSGIIPVEIG-----HCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNA----SLPKEMGNMKS   67 (362)
Q Consensus         1 l~~n~~~g~ip~~~~-----~l~~l~~l~l~~n~l~g----~ip~~~~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~   67 (362)
                      |++|+++..-...++     ..++|++|+|++|+|+.    .++..+..+++|+.|||++|.++.    .++..+...++
T Consensus       133 Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~  212 (372)
T 3un9_A          133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQ  212 (372)
T ss_dssp             CCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSC
T ss_pred             cCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCC
Confidence            577888754444442     35789999999999864    366667888999999999999874    34566777788


Q ss_pred             CCEEEccCCcccC
Q 018036           68 LTSADFSHNNFSG   80 (362)
Q Consensus        68 l~~l~ls~n~l~g   80 (362)
                      |+.|+|++|.++.
T Consensus       213 L~~L~Ls~N~i~~  225 (372)
T 3un9_A          213 LQELNVAYNGAGD  225 (372)
T ss_dssp             CCEEECCSSCCCH
T ss_pred             cCeEECCCCCCCH
Confidence            9999999998875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.21  E-value=1.2e-05  Score=72.57  Aligned_cols=137  Identities=17%  Similarity=0.160  Sum_probs=91.3

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc---cCcceeEEEEEecCCeeeEEEecCC
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR---HRNIVRLKAFCSNKETNLLVYEYMP  263 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  263 (362)
                      .+.|+.|....+|+... ++..+++|.....     ....+.+|.+.|+.+.   ...+.++++++...+..++||||++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            45789999999999987 4678888876432     2345889999888884   3568889999888888999999999


Q ss_pred             CCChhh-----------hhcCCCC-C-------------------CCCHHHHH---HHHH----------------HHHH
Q 018036          264 NGSLGE-----------VLHGKRG-S-------------------FLKWEMRL---KIAI----------------EAAK  293 (362)
Q Consensus       264 ~gsL~~-----------~l~~~~~-~-------------------~~~~~~~~---~i~~----------------~i~~  293 (362)
                      +..+..           .|+.... .                   .-+|....   ++..                ++..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            876521           1222111 0                   12444321   1111                1111


Q ss_pred             H-HHHHh-cCCCCCeEEeCCCCCceeeCCCCceEEcccc
Q 018036          294 G-LSYLH-HDCSPLIIHRDVKSNNILLNSDFEAHVADFG  330 (362)
Q Consensus       294 ~-L~~LH-~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  330 (362)
                      . ...|. ....+.++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 12342 12256799999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.15  E-value=7.9e-06  Score=72.96  Aligned_cols=77  Identities=17%  Similarity=0.139  Sum_probs=54.1

Q ss_pred             cccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-c--CcceeEEEEEecCCeeeEEEec
Q 018036          185 KDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-H--RNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ...+.+|.|..+.||+.+..+|+.+++|+......  .....+.+|.+.|+.+. .  --+.+++++.    ..++||||
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            34567899999999999999999999997543322  22234889999888874 2  2244555542    24799999


Q ss_pred             CCCCCh
Q 018036          262 MPNGSL  267 (362)
Q Consensus       262 ~~~gsL  267 (362)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.05  E-value=1e-06  Score=81.89  Aligned_cols=80  Identities=18%  Similarity=0.131  Sum_probs=61.0

Q ss_pred             CCCCcccccCCccc-ccccCCCEEECcCCcccccCchhhh-----cccccCeeecccccccc----CcchhhcCCCCCCE
Q 018036            1 MSRNNFSGIIPVEI-GHCLLLTYLDLSQNHLSGPIPVQIT-----QIHILNYLNVSWNQLNA----SLPKEMGNMKSLTS   70 (362)
Q Consensus         1 l~~n~~~g~ip~~~-~~l~~l~~l~l~~n~l~g~ip~~~~-----~l~~l~~l~l~~n~l~g----~~p~~~~~~~~l~~   70 (362)
                      |++|.++..-...+ ..+++|+.|||++|+|+..-...+.     ..++|+.|+|++|.++.    .++..+...++|++
T Consensus       108 Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~  187 (372)
T 3un9_A          108 LASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH  187 (372)
T ss_dssp             CTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCE
T ss_pred             ecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCE
Confidence            57788865433343 3467899999999999755444443     46789999999999974    35566688899999


Q ss_pred             EEccCCcccC
Q 018036           71 ADFSHNNFSG   80 (362)
Q Consensus        71 l~ls~n~l~g   80 (362)
                      |||++|.|+.
T Consensus       188 L~Ls~N~l~~  197 (372)
T 3un9_A          188 LSLLHTGLGD  197 (372)
T ss_dssp             EECTTSSCHH
T ss_pred             EeCCCCCCCc
Confidence            9999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.99  E-value=4.3e-05  Score=72.07  Aligned_cols=75  Identities=17%  Similarity=0.273  Sum_probs=45.9

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCC--CCC-----chhhHHHHHHHHhc-CccCcceeEEEEEecCCeeeEE
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITK--GSS-----HDNGLSAEIRTLGK-IRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~-----~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .+.+|.|....||++.. +++.++||.......  ...     ....++.|+..+.. .....+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            35688999999999975 567899995432211  111     22234444433321 1234566777665  5667899


Q ss_pred             EecC-CC
Q 018036          259 YEYM-PN  264 (362)
Q Consensus       259 ~e~~-~~  264 (362)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.96  E-value=1.1e-06  Score=86.53  Aligned_cols=79  Identities=11%  Similarity=0.082  Sum_probs=55.1

Q ss_pred             CCccccc-----CCcccccccCCCEEECcC--CcccccCchhhhc-ccccCeeecccccccc-CcchhhcCCCCCCEEEc
Q 018036            3 RNNFSGI-----IPVEIGHCLLLTYLDLSQ--NHLSGPIPVQITQ-IHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADF   73 (362)
Q Consensus         3 ~n~~~g~-----ip~~~~~l~~l~~l~l~~--n~l~g~ip~~~~~-l~~l~~l~l~~n~l~g-~~p~~~~~~~~l~~l~l   73 (362)
                      .|.+++.     ++..+..|++|++|+|+.  |.+++..+..++. +++|+.|+|++|++++ .+|..+..+++|+.|++
T Consensus       416 ~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l  495 (592)
T 3ogk_B          416 EERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEM  495 (592)
T ss_dssp             CSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEE
T ss_pred             CccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeec
Confidence            5666652     444466788888888874  3467666666655 7788888888888875 35555677788888888


Q ss_pred             cCCcccCC
Q 018036           74 SHNNFSGE   81 (362)
Q Consensus        74 s~n~l~g~   81 (362)
                      ++|.|++.
T Consensus       496 ~~n~l~~~  503 (592)
T 3ogk_B          496 RGCCFSER  503 (592)
T ss_dssp             ESCCCBHH
T ss_pred             cCCCCcHH
Confidence            88877653

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.80  E-value=6.4e-06  Score=68.55  Aligned_cols=68  Identities=15%  Similarity=0.136  Sum_probs=45.8

Q ss_pred             ccccccCCCEEECcCC-ccccc----CchhhhcccccCeeecccccccc----CcchhhcCCCCCCEEEccCCcccC
Q 018036           13 EIGHCLLLTYLDLSQN-HLSGP----IPVQITQIHILNYLNVSWNQLNA----SLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n-~l~g~----ip~~~~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      .+...+.|++|+|++| .+...    +...+...++|+.|||++|.++.    .|...+...++|+.|+|++|.++.
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            3456777888888887 77532    44456666778888888888753    233445555778888888887764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.75  E-value=0.00017  Score=65.51  Aligned_cols=140  Identities=16%  Similarity=0.135  Sum_probs=72.7

Q ss_pred             eeeccCccc-EEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc--CcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGAGV-VYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .|+.|.... +|+....++..+++|......     ...+..|+.++..+..  -.+.+++.+....+  +++||++.+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            455554444 677766446777776532211     0226677777777743  23556776644333  7899999776


Q ss_pred             Chhhhhc---------------------CCCC---CCCCHHHHH-------HH-------------HHHHHHHHHHHh--
Q 018036          266 SLGEVLH---------------------GKRG---SFLKWEMRL-------KI-------------AIEAAKGLSYLH--  299 (362)
Q Consensus       266 sL~~~l~---------------------~~~~---~~~~~~~~~-------~i-------------~~~i~~~L~~LH--  299 (362)
                      .+.+.+.                     ....   ..++.....       .+             ...+...++.+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6644332                     1100   011111100       00             001111222221  


Q ss_pred             -cCCCCCeEEeCCCCCceeeCCC----CceEEccccccccc
Q 018036          300 -HDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKYL  335 (362)
Q Consensus       300 -~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGla~~~  335 (362)
                       ......++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence             1124569999999999999874    67899999988653

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.74  E-value=6.2e-06  Score=68.64  Aligned_cols=80  Identities=13%  Similarity=0.125  Sum_probs=60.4

Q ss_pred             CCCC-ccccc----CCcccccccCCCEEECcCCcccc----cCchhhhcccccCeeeccccccccC----cchhhcCCCC
Q 018036            1 MSRN-NFSGI----IPVEIGHCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKS   67 (362)
Q Consensus         1 l~~n-~~~g~----ip~~~~~l~~l~~l~l~~n~l~g----~ip~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~   67 (362)
                      |++| .+...    +...+...++|++|||++|++..    .|...+...++|+.|||++|.++..    +...+...++
T Consensus        43 L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~  122 (185)
T 1io0_A           43 LNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTS  122 (185)
T ss_dssp             CTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSS
T ss_pred             ecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCC
Confidence            4555 55432    34455667899999999999863    2555666778999999999999743    5666777889


Q ss_pred             CCEEEc--cCCcccC
Q 018036           68 LTSADF--SHNNFSG   80 (362)
Q Consensus        68 l~~l~l--s~n~l~g   80 (362)
                      |+.|+|  ++|.++.
T Consensus       123 L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          123 LIELRIDNQSQPLGN  137 (185)
T ss_dssp             CCEEECCCCSSCCCH
T ss_pred             ceEEEecCCCCCCCH
Confidence            999999  8898874

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.74  E-value=0.0002  Score=64.13  Aligned_cols=71  Identities=11%  Similarity=0.085  Sum_probs=44.7

Q ss_pred             cceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcc-eeEEEEEecCCeeeEEEecC-CC
Q 018036          187 NNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI-VRLKAFCSNKETNLLVYEYM-PN  264 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~  264 (362)
                      .+.|+.|....+|+.     ..+++|.........   ....+|..+++.+....+ .+++++  +.+..++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence            567889999999999     457888764322111   124678888877753333 355544  344457999999 65


Q ss_pred             CCh
Q 018036          265 GSL  267 (362)
Q Consensus       265 gsL  267 (362)
                      .++
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.57  E-value=0.00017  Score=65.20  Aligned_cols=142  Identities=14%  Similarity=0.114  Sum_probs=78.2

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc--ceeEEEE------EecCCeeeEEE
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN--IVRLKAF------CSNKETNLLVY  259 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~  259 (362)
                      +.|+.|....+|+....++ .+++|.....    ...+.+..|..++..+....  +.+++..      ....+..+++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4567788889999987655 5778876532    11223677888877764222  2333321      12235678999


Q ss_pred             ecCCCCChhh--------------hhcCC----CCC------CCCHHHHHH------------HHHHHHHHHHHHhc---
Q 018036          260 EYMPNGSLGE--------------VLHGK----RGS------FLKWEMRLK------------IAIEAAKGLSYLHH---  300 (362)
Q Consensus       260 e~~~~gsL~~--------------~l~~~----~~~------~~~~~~~~~------------i~~~i~~~L~~LH~---  300 (362)
                      +|++|..+..              .++..    ...      ...|.....            +...+...++++.+   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865421              01110    000      011222110            00113344555542   


Q ss_pred             -CCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          301 -DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       301 -~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                       .....++|+|+.+.|||++++..+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             1134589999999999999876668999988754

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.51  E-value=1.2e-05  Score=79.00  Aligned_cols=87  Identities=16%  Similarity=0.140  Sum_probs=64.6

Q ss_pred             ccccccCCCEEECcCCcccccCchhhhc-ccccCeeeccccccccCcchhh-cCCCCCCEEEccCCcccCCCCC--CCcc
Q 018036           13 EIGHCLLLTYLDLSQNHLSGPIPVQITQ-IHILNYLNVSWNQLNASLPKEM-GNMKSLTSADFSHNNFSGEIPE--FGQY   88 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n~l~g~ip~~~~~-l~~l~~l~l~~n~l~g~~p~~~-~~~~~l~~l~ls~n~l~g~~p~--~~~~   88 (362)
                      -+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++..+.  ...+
T Consensus       427 l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l  505 (594)
T 2p1m_B          427 IVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKL  505 (594)
T ss_dssp             HHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGG
T ss_pred             HHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhC
Confidence            367889999999987 777777777777 8999999999999987666555 6689999999999998654332  1223


Q ss_pred             cccccCCccCCC
Q 018036           89 SFFNSTSFTGNP  100 (362)
Q Consensus        89 ~~~~~~~~~~n~  100 (362)
                      ..+..+.+.+|+
T Consensus       506 ~~L~~L~l~~~~  517 (594)
T 2p1m_B          506 ETMRSLWMSSCS  517 (594)
T ss_dssp             GGSSEEEEESSC
T ss_pred             CCCCEEeeeCCC
Confidence            444445555553

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.51  E-value=5.3e-05  Score=74.39  Aligned_cols=75  Identities=13%  Similarity=0.022  Sum_probs=63.8

Q ss_pred             CCCCccccc----CCcccccccCCCEEECcCCccc----ccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEE
Q 018036            1 MSRNNFSGI----IPVEIGHCLLLTYLDLSQNHLS----GPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSAD   72 (362)
Q Consensus         1 l~~n~~~g~----ip~~~~~l~~l~~l~l~~n~l~----g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~   72 (362)
                      |++|.+++.    ++..+..+++|++|+|++|.++    +.++..+.++++|+.|+|++|.+++ +|..+.++++|+.|+
T Consensus       171 L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~  249 (592)
T 3ogk_B          171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFC  249 (592)
T ss_dssp             CTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEE
T ss_pred             CccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhc
Confidence            567887766    5556678999999999999997    5677778889999999999999986 888899999999999


Q ss_pred             ccCC
Q 018036           73 FSHN   76 (362)
Q Consensus        73 ls~n   76 (362)
                      ++.+
T Consensus       250 l~~~  253 (592)
T 3ogk_B          250 GGSL  253 (592)
T ss_dssp             ECBC
T ss_pred             cccc
Confidence            9863

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.50  E-value=0.00026  Score=66.88  Aligned_cols=72  Identities=18%  Similarity=0.256  Sum_probs=48.2

Q ss_pred             ceeeccCcccEEEEEcCC--------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcc-eeEEEEEecCCeeeEE
Q 018036          188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI-VRLKAFCSNKETNLLV  258 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  258 (362)
                      +.|+.|-...+|++...+        ++.+++|+....    ...+.+.+|..+++.+...++ .++++.+.+    .+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            567788889999998643        478888876321    111336689998888853333 566766542    389


Q ss_pred             EecCCCCCh
Q 018036          259 YEYMPNGSL  267 (362)
Q Consensus       259 ~e~~~~gsL  267 (362)
                      |||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.44  E-value=0.00048  Score=63.82  Aligned_cols=140  Identities=17%  Similarity=0.220  Sum_probs=81.7

Q ss_pred             ceeeccCcccEEEEEcC--------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEE
Q 018036          188 NVIGRGGAGVVYRGVTP--------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  258 (362)
                      +.+..|-...+|++...        +++.+++|+.-..   ......+.+|.++++.+. +.-..++++++.+    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            46777888899999874        2478888875221   112334678999998884 3223566666543    299


Q ss_pred             EecCCCCChhhh-----------------hcCCC---CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 018036          259 YEYMPNGSLGEV-----------------LHGKR---GSFL--KWEMRLKIAIEAAK-------------------GLSY  297 (362)
Q Consensus       259 ~e~~~~gsL~~~-----------------l~~~~---~~~~--~~~~~~~i~~~i~~-------------------~L~~  297 (362)
                      |||++|.+|..-                 ||...   +...  -|.+..++..++..                   .+++
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999987655311                 12111   1112  24455555544322                   1222


Q ss_pred             ----HhcC-CCCCeEEeCCCCCceeeCCC----CceEEcccccccc
Q 018036          298 ----LHHD-CSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKY  334 (362)
Q Consensus       298 ----LH~~-~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGla~~  334 (362)
                          |... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                2221 13458999999999999876    7899999998864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.41  E-value=3.3e-05  Score=71.26  Aligned_cols=65  Identities=12%  Similarity=0.038  Sum_probs=41.2

Q ss_pred             cccCCCEEECcC--Cccccc-----Cchhh--hcccccCeeeccccccccCcchhhc---CCCCCCEEEccCCcccC
Q 018036           16 HCLLLTYLDLSQ--NHLSGP-----IPVQI--TQIHILNYLNVSWNQLNASLPKEMG---NMKSLTSADFSHNNFSG   80 (362)
Q Consensus        16 ~l~~l~~l~l~~--n~l~g~-----ip~~~--~~l~~l~~l~l~~n~l~g~~p~~~~---~~~~l~~l~ls~n~l~g   80 (362)
                      .+++|+.|+|+.  |...|.     |-..+  ..+++|+.|+|++|.++...+..+.   .+++|+.|+||.|.+++
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence            678888888753  322222     11122  2467888888888887754444443   46778888888888766

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.32  E-value=0.0017  Score=58.57  Aligned_cols=141  Identities=16%  Similarity=0.147  Sum_probs=79.5

Q ss_pred             ceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc--ceeEEEE-----EecCCeeeEEEe
Q 018036          188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN--IVRLKAF-----CSNKETNLLVYE  260 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e  260 (362)
                      ..++ |....||+....+|+.+++|......   .....+..|..++..+....  +++++..     ....+..+++||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3456 77889999887777789999875321   12334777888887774222  3444432     122456678999


Q ss_pred             cCCCCChhh-----h---------hcC----CC---CCCCCHHHH----------------------HHHHHHHHHHHHH
Q 018036          261 YMPNGSLGE-----V---------LHG----KR---GSFLKWEMR----------------------LKIAIEAAKGLSY  297 (362)
Q Consensus       261 ~~~~gsL~~-----~---------l~~----~~---~~~~~~~~~----------------------~~i~~~i~~~L~~  297 (362)
                      |++|.++..     .         +|.    ..   ....++...                      ...+.++...++-
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            998754321     0         110    00   011222111                      0111111222221


Q ss_pred             Hhc-CCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          298 LHH-DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       298 LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      +-. .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            111 1234588999999999999 4 899999987754

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.31  E-value=5.8e-05  Score=74.12  Aligned_cols=65  Identities=12%  Similarity=0.131  Sum_probs=35.7

Q ss_pred             cccCCCEEECcCCcccccCchhhh-cccccCeeecccc-ccccC-cchhhcCCCCCCEEEccCCcccC
Q 018036           16 HCLLLTYLDLSQNHLSGPIPVQIT-QIHILNYLNVSWN-QLNAS-LPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        16 ~l~~l~~l~l~~n~l~g~ip~~~~-~l~~l~~l~l~~n-~l~g~-~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      .+++|++|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|+.|++++|.+++
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~  170 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDD  170 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEEC
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCC
Confidence            455666666666666655555554 4566666666655 33321 33333455666666666665554

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.29  E-value=0.0018  Score=61.47  Aligned_cols=74  Identities=14%  Similarity=0.111  Sum_probs=46.6

Q ss_pred             cceeeccCcccEEEEEcCC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcc-eeEEEEEecCCeeeEEEecCCC
Q 018036          187 NNVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI-VRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      .+.|+.|-...+|+....+ +..+++|.......   ..-...+|..++..+...++ .++++.+.  +  .+||||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            3567888889999998754 47788887632211   11113688888888864444 56777663  2  359999987


Q ss_pred             CCh
Q 018036          265 GSL  267 (362)
Q Consensus       265 gsL  267 (362)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.28  E-value=0.0005  Score=63.40  Aligned_cols=73  Identities=10%  Similarity=0.004  Sum_probs=43.1

Q ss_pred             ceeeccCcccEEEEEcCC---------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc-ceeEEEEEecCCeeeE
Q 018036          188 NVIGRGGAGVVYRGVTPN---------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKETNLL  257 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l  257 (362)
                      ..++.|..-.+|+....+         ++.+++|.......   .......|.++++.+...+ +.++++..  .  -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            456778888999988653         26788887533211   1112467888888875334 34666544  2  368


Q ss_pred             EEecCCCCCh
Q 018036          258 VYEYMPNGSL  267 (362)
Q Consensus       258 v~e~~~~gsL  267 (362)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.26  E-value=0.00037  Score=54.20  Aligned_cols=55  Identities=22%  Similarity=0.366  Sum_probs=42.4

Q ss_pred             CEEECcCCccc-ccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCcc
Q 018036           21 TYLDLSQNHLS-GPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNF   78 (362)
Q Consensus        21 ~~l~l~~n~l~-g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l   78 (362)
                      ..+|.+++.|+ ..+|..|.  .+|+.|||++|+|+ .||.. |..+++|+.|+|++|.+
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence            57899999886 46775533  36888999999998 57664 67788899998888865

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.03  E-value=0.0055  Score=55.77  Aligned_cols=32  Identities=16%  Similarity=0.332  Sum_probs=28.0

Q ss_pred             CCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       304 ~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            45899999999999998888999999877653

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.00  E-value=0.00078  Score=52.34  Aligned_cols=51  Identities=20%  Similarity=0.297  Sum_probs=40.8

Q ss_pred             CCCccc-ccCCcccccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccc
Q 018036            2 SRNNFS-GIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLN   55 (362)
Q Consensus         2 ~~n~~~-g~ip~~~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~   55 (362)
                      ++++|+ ..||..+.  .+|+.|||++|+|+ .||. .+..+++|+.|+|++|.+.
T Consensus        16 s~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           16 GRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            466665 47886542  47999999999999 6765 5688999999999999885

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=96.77  E-value=0.0014  Score=59.30  Aligned_cols=59  Identities=20%  Similarity=0.307  Sum_probs=45.1

Q ss_pred             ccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcch-hhcCCCCCC-EEEccCCccc
Q 018036           17 CLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLT-SADFSHNNFS   79 (362)
Q Consensus        17 l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~-~l~ls~n~l~   79 (362)
                      |++|+.|+|++|+++ .||+ .+..|.+|+.|+|++| ++ .|+. .|.++++|+ .+++++ +++
T Consensus       225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~  286 (329)
T 3sb4_A          225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT  286 (329)
T ss_dssp             CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC
T ss_pred             cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce
Confidence            778888888888888 6665 5778888888888887 65 5665 477888888 888877 444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.49  E-value=0.021  Score=53.55  Aligned_cols=73  Identities=11%  Similarity=0.024  Sum_probs=46.7

Q ss_pred             ceeeccCcccEEEEEcCC--------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCc-ceeEEEEEecCCeeeEE
Q 018036          188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLKAFCSNKETNLLV  258 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  258 (362)
                      +.+..|-...+|+....+        ++.+++++.....   ...-...+|..+++.+.-.+ ..++++.+.    -++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            456677888999998653        5788888753321   11112467888888875323 345565432    3789


Q ss_pred             EecCCCCCh
Q 018036          259 YEYMPNGSL  267 (362)
Q Consensus       259 ~e~~~~gsL  267 (362)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.24  E-value=0.00058  Score=62.88  Aligned_cols=65  Identities=15%  Similarity=0.177  Sum_probs=54.3

Q ss_pred             cccCCCEEECcCCcccccCchhhh---cccccCeeeccccccccC----cchhhcCCCCCCEEEccCCcccC
Q 018036           16 HCLLLTYLDLSQNHLSGPIPVQIT---QIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        16 ~l~~l~~l~l~~n~l~g~ip~~~~---~l~~l~~l~l~~n~l~g~----~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      .+++|++|+|++|.++...+..+.   .+++|+.|||+.|.+++.    ++..+.++++|+.|+|++|.++.
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            578999999999999876666555   488999999999999863    55555678999999999998874

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=95.97  E-value=0.0023  Score=52.30  Aligned_cols=72  Identities=7%  Similarity=0.096  Sum_probs=47.0

Q ss_pred             cCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccc-cccCcchhhcCC----CCCCEEEccCC-cccC
Q 018036            9 IIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQ-LNASLPKEMGNM----KSLTSADFSHN-NFSG   80 (362)
Q Consensus         9 ~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~-l~g~~p~~~~~~----~~l~~l~ls~n-~l~g   80 (362)
                      .+|...-.-..|+.||||++.++-.=-..+..+++|+.|+|+++. ++..==..++.+    ++|+.|+||++ ++|.
T Consensus        52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD  129 (176)
T 3e4g_A           52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTD  129 (176)
T ss_dssp             GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCH
T ss_pred             cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCH
Confidence            345433223478999999988764333457788999999999885 553222235554    36899999887 4653

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=95.71  E-value=0.014  Score=52.72  Aligned_cols=62  Identities=13%  Similarity=0.128  Sum_probs=30.3

Q ss_pred             cccccCCCEEECcCCcccccCch-hhhcccccC-eeeccccccccCcc-hhhcCCCCCCEEEccCCccc
Q 018036           14 IGHCLLLTYLDLSQNHLSGPIPV-QITQIHILN-YLNVSWNQLNASLP-KEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus        14 ~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~-~l~l~~n~l~g~~p-~~~~~~~~l~~l~ls~n~l~   79 (362)
                      +.+|++|+.|+|++| ++ .|++ .+.+|.+|+ .|+|++ +++ .|+ ..|.++++|+.++++.|+++
T Consensus       246 F~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~  310 (329)
T 3sb4_A          246 FAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKIT  310 (329)
T ss_dssp             TTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCC
T ss_pred             hhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccC
Confidence            445555555555554 43 3332 345555555 555554 343 333 23555555555555555444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=95.28  E-value=0.0071  Score=49.34  Aligned_cols=64  Identities=8%  Similarity=0.058  Sum_probs=37.1

Q ss_pred             ccccccCCCEEECcCCc-ccccCchhhhcc----cccCeeeccccc-cccCcchhhcCCCCCCEEEccCC
Q 018036           13 EIGHCLLLTYLDLSQNH-LSGPIPVQITQI----HILNYLNVSWNQ-LNASLPKEMGNMKSLTSADFSHN   76 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n~-l~g~ip~~~~~l----~~l~~l~l~~n~-l~g~~p~~~~~~~~l~~l~ls~n   76 (362)
                      .+..|++|++|+|+++. ++-.-=..|+.+    ++|+.|||+++. +|..==..+.++++|+.|+|++.
T Consensus        80 ~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c  149 (176)
T 3e4g_A           80 HMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL  149 (176)
T ss_dssp             GGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred             HhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence            35567777777777764 442222234443    367777777753 54211124566777777777765

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=95.14  E-value=0.013  Score=48.71  Aligned_cols=65  Identities=9%  Similarity=0.075  Sum_probs=47.2

Q ss_pred             cccCCCEEECcCC-cccc----cCchhhhcccccCeeecccccccc----CcchhhcCCCCCCEEEccCCcccC
Q 018036           16 HCLLLTYLDLSQN-HLSG----PIPVQITQIHILNYLNVSWNQLNA----SLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        16 ~l~~l~~l~l~~n-~l~g----~ip~~~~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +-+.|++|+|++| ++.-    .|-..+..=+.|+.|+|++|.+..    .|-..+..=+.|+.|+|++|+++.
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            3467999999986 6642    133456666789999999999972    233344455789999999999874

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=93.82  E-value=0.043  Score=45.55  Aligned_cols=64  Identities=17%  Similarity=0.116  Sum_probs=47.2

Q ss_pred             ccccccCCCEEECcCCcccc----cCchhhhcccccCeeeccccccccC----cchhhcCCCCCCEEEccCC
Q 018036           13 EIGHCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHN   76 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n~l~g----~ip~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~l~~l~ls~n   76 (362)
                      .+..=+.|+.|+|++|++.-    .|-..+..=+.|+.|+|++|.++..    |-..+..-+.|+.|+|++|
T Consensus        65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            34455789999999999962    2444555668999999999999732    2234445567999999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.13  E-value=0.43  Score=44.18  Aligned_cols=29  Identities=31%  Similarity=0.546  Sum_probs=24.8

Q ss_pred             eEEeCCCCCceee------CCCCceEEcccccccc
Q 018036          306 IIHRDVKSNNILL------NSDFEAHVADFGLAKY  334 (362)
Q Consensus       306 ivH~Dlk~~NIll------~~~~~~kl~DFGla~~  334 (362)
                      ++|+|+.+.|||+      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999998865

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=92.37  E-value=0.13  Score=47.71  Aligned_cols=54  Identities=9%  Similarity=0.033  Sum_probs=29.6

Q ss_pred             CCCEEECcCCcccccCc-hhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccC
Q 018036           19 LLTYLDLSQNHLSGPIP-VQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSH   75 (362)
Q Consensus        19 ~l~~l~l~~n~l~g~ip-~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~   75 (362)
                      +|+.++|.+ .++ .|+ ..+..|.+|+.++|++|+++ .||...-...+|+.+.+.+
T Consensus       158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~  212 (401)
T 4fdw_A          158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPV  212 (401)
T ss_dssp             CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCT
T ss_pred             CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCC
Confidence            466666654 444 233 34555666666666666665 4555433345666666653

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=91.73  E-value=0.19  Score=46.56  Aligned_cols=35  Identities=11%  Similarity=0.233  Sum_probs=15.0

Q ss_pred             hhcccccCeeeccccccccCcch-hhcCCCCCCEEEcc
Q 018036           38 ITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFS   74 (362)
Q Consensus        38 ~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls   74 (362)
                      +..|++|+.++|. |+++ .|+. .|.++++|+.+++.
T Consensus       296 F~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          296 LEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             TTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEEC
T ss_pred             hhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEEC
Confidence            4444444444444 2233 3332 24444445544443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.71  E-value=0.035  Score=52.69  Aligned_cols=60  Identities=8%  Similarity=-0.054  Sum_probs=16.4

Q ss_pred             ceeeccCcccEEEEEcCC-CCEEEE------EEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEe
Q 018036          188 NVIGRGGAGVVYRGVTPN-GEQVAV------KKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCS  250 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  250 (362)
                      +.+|   ||.||+|.+.. ..+|||      |..+...........+.+|..++...+|||+++.+++..
T Consensus       148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4555   99999999854 357888      665443322223345788889999999999999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.92  E-value=1.7  Score=36.47  Aligned_cols=87  Identities=13%  Similarity=0.073  Sum_probs=63.2

Q ss_pred             ccCcceeEEEEEecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEEeCCCCCce
Q 018036          238 RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS-YLHHDCSPLIIHRDVKSNNI  316 (362)
Q Consensus       238 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlk~~NI  316 (362)
                      .||++  -..+-.+.+...+.++.-+++.=...++     ..+...+++++.+++.... +++.     -+|--+.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            57877  4444566777777777654443333342     2678888999999888776 5552     47888999999


Q ss_pred             eeCCCCceEEcccccccccc
Q 018036          317 LLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       317 ll~~~~~~kl~DFGla~~~~  336 (362)
                      ++|.++.+++.-.|+-..+.
T Consensus       116 ~f~~~~~p~i~hRGi~~~lp  135 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESLP  135 (219)
T ss_dssp             EECTTCCEEESCCEETTTBS
T ss_pred             EEeCCCcEEEEEcCCcccCC
Confidence            99999999999999866553

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.05  E-value=1.8  Score=36.16  Aligned_cols=87  Identities=7%  Similarity=0.078  Sum_probs=64.1

Q ss_pred             ccCcceeEEEEEecCCeeeEEEecCCCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCce
Q 018036          238 RHRNIVRLKAFCSNKETNLLVYEYMPNG-SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNI  316 (362)
Q Consensus       238 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI  316 (362)
                      .||+.+.. .+-.+.+...+.++.-+.+ ++.. ++     ..+...+++++.+|+...++++.     -+|--+.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            68888876 5666667666666654422 3332 32     36788899999999988877662     37888999999


Q ss_pred             eeCCCCceEEcccccccccc
Q 018036          317 LLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       317 ll~~~~~~kl~DFGla~~~~  336 (362)
                      +++.++.+++.-.|+-..+.
T Consensus       111 ~f~~~~~p~i~~RGik~~l~  130 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVD  130 (215)
T ss_dssp             EECTTSCEEESCCEETTTBS
T ss_pred             EEcCCCCEEEEEccCccCCC
Confidence            99999999999999865554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=83.19  E-value=1.1  Score=41.04  Aligned_cols=59  Identities=17%  Similarity=0.235  Sum_probs=37.8

Q ss_pred             cccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCC
Q 018036           14 IGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHN   76 (362)
Q Consensus        14 ~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n   76 (362)
                      +..+.+|+.+.+.+| ++ .|++ .+.++.+|+.++|..+ ++ .|+. .|.++++|+.+++..|
T Consensus       293 F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          293 FYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             TTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred             ccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence            456777777777654 44 4443 4667777777777644 54 4644 4667777777777654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=81.94  E-value=2.1  Score=39.19  Aligned_cols=58  Identities=10%  Similarity=0.255  Sum_probs=34.3

Q ss_pred             ccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCC
Q 018036           15 GHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHN   76 (362)
Q Consensus        15 ~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n   76 (362)
                      .+|++|+.+++. +.++ .|+. .+..+.+|+.++|..| ++ .|.. .|.++.+|+.+.+..+
T Consensus       285 ~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s  344 (394)
T 4gt6_A          285 MNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS  344 (394)
T ss_dssp             TTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT
T ss_pred             ccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc
Confidence            456777777775 3344 3443 4566677777777644 43 4543 4666677777766543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=81.55  E-value=1.1  Score=40.77  Aligned_cols=60  Identities=13%  Similarity=0.231  Sum_probs=44.5

Q ss_pred             cccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCC
Q 018036           14 IGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHN   76 (362)
Q Consensus        14 ~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n   76 (362)
                      +.++.+|+.+++..+ +. .|+. .+..+.+|+.+++.+|.++ .|++ .|.++.+|+.+++..+
T Consensus       259 F~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~  320 (379)
T 4h09_A          259 LQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA  320 (379)
T ss_dssp             TTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT
T ss_pred             cceeehhcccccccc-ce-eccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcCcc
Confidence            345778888888654 44 4544 5677889999999888886 5765 5788889999988654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	362
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-48
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-43
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-40
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-40
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-37
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-35
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-30
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-28
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 4e-48
 Identities = 54/169 (31%), Positives = 75/169 (44%), Gaps = 7/169 (4%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             IG G  G VY+G       VAVK L               E+  L K RH NI+    
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
           + +  +   +V ++    SL   LH     F +    + IA + A+G+ YLH      II
Sbjct: 72  YSTAPQL-AIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 126

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+KSNNI L+ D    + DFGLA        S     ++GS  ++AP
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 8e-46
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 8/169 (4%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             +G G  G V+ G      +VAVK    + +GS   +   AE   + +++H+ +VRL A
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
             + +    ++ EYM NGSL + L    G  L     L +A + A+G++++        I
Sbjct: 76  VVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+++ NIL++      +ADFGLA+ ++D               + AP
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAP 179

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-45
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 10/170 (5%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           + +G G  GVV++    P+G  +A K +    K +  +  +  E++ L +     IV   
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHECNSPYIVGFY 70

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               +     +  E+M  GSL +VL   +   +  ++  K++I   KGL+YL       I
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRDVK +NIL+NS  E  + DFG++  L D+ A+  +    G+  Y++P
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSP 172

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 6e-43
 Identities = 56/184 (30%), Positives = 84/184 (45%), Gaps = 13/184 (7%)

Query: 175 FGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHD-NGLSAEIR 232
           F  DD  +   D   IG G  G VY      N E VA+KK+    K S+     +  E+R
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 233 TLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAA 292
            L K+RH N ++ +     + T  LV EY    +   +   K+   L+      +   A 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGAL 125

Query: 293 KGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
           +GL+YLH   S  +IHRDVK+ NILL+      + DFG A  +         ++  G+  
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPY 176

Query: 353 YIAP 356
           ++AP
Sbjct: 177 WMAP 180

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 8e-43
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 8/175 (4%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
           E ++    +G+G  G V+ G      +VA+K    +  G+        E + + K+RH  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEK 73

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           +V+L A  S +    +V EYM  GSL + L G+ G +L+    + +A + A G++Y+   
Sbjct: 74  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
                +HRD+++ NIL+  +    VADFGLA+ ++D   +           + AP
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP 183

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-42
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 9/176 (5%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             IG G  G   +     +G+ +  K+L   +   +    L +E+  L +++H NIVR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 247 AFCSNKETNLL--VYEYMPNGSLGEVLH--GKRGSFLKWEMRLKIAIEAAKGLSYLH--H 300
               ++    L  V EY   G L  V+    K   +L  E  L++  +    L   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           D    ++HRD+K  N+ L+      + DFGLA+ L     +    A  G+  Y++P
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSP 183

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-41
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 8/169 (4%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             +G G  GVV  G       VA+K    I +GS  ++    E + +  + H  +V+L  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
            C+ +    ++ EYM NG L   L   R  F + +  L++  +  + + YL        +
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLESKQ---FL 122

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+ + N L+N      V+DFGL++Y+ D   +           +  P
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPP 170

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-41
 Identities = 55/179 (30%), Positives = 80/179 (44%), Gaps = 18/179 (10%)

Query: 189 VIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAF 248
            IG+G  G V+RG    GE+VAVK     +          AEI     +RH NI+   A 
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 249 CSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-- 302
            +          LV +Y  +GSL + L+      +  E  +K+A+  A GL++LH +   
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 303 ---SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG--ASECMSAVAGSYGYIAP 356
               P I HRD+KS NIL+  +    +AD GLA              +   G+  Y+AP
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-40
 Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 7/170 (4%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             +G G  G V   V     E VAVK +  + +       +  EI     + H N+V+  
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFY 69

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
                     L  EY   G L + +    G  +      +   +   G+ YLH      I
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG---I 124

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            HRD+K  N+LL+      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-40
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 14/170 (8%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             IG+G  G V  G    G +VAVK +    K  +      AE   + ++RH N+V+L  
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 248 FCSNKETNL-LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               ++  L +V EYM  GSL + L  +  S L  +  LK +++  + + YL  +     
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 124

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRD+ + N+L++ D  A V+DFGL K    T              + AP
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAP 169

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-40
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 8/169 (4%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             IG G  G+V+ G   N ++VA+K    I +G+  +     E   + K+ H  +V+L  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
            C  +    LV+E+M +G L +     +      E  L + ++  +G++YL   C   +I
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           HRD+ + N L+  +    V+DFG+ +++ D   +           + +P
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASP 171

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-40
 Identities = 46/186 (24%), Positives = 74/186 (39%), Gaps = 12/186 (6%)

Query: 172 KLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAE 230
             D   +D  E +     +G G  G VY+          A K +   TK          E
Sbjct: 5   TRDLNPEDFWEIIG---ELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVE 59

Query: 231 IRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIE 290
           I  L    H NIV+L      +    ++ E+   G++  V+  +    L       +  +
Sbjct: 60  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQ 118

Query: 291 AAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGS 350
               L+YLH      IIHRD+K+ NIL   D +  +ADFG++     T   +   +  G+
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGT 173

Query: 351 YGYIAP 356
             ++AP
Sbjct: 174 PYWMAP 179

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-40
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 13/190 (6%)

Query: 171 QKLDFGSDDILECVKDNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHDNGL 227
           +KL    D++L     +  +G G  G V +GV         VA+K L   T+ +  +  +
Sbjct: 1   KKLFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-M 56

Query: 228 SAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKI 287
             E + + ++ +  IVRL   C  +   +LV E    G L + L GKR   +      ++
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE-IPVSNVAEL 114

Query: 288 AIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ-DTGASECMSA 346
             + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L  D       SA
Sbjct: 115 LHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

Query: 347 VAGSYGYIAP 356
                 + AP
Sbjct: 172 GKWPLKWYAP 181

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 6e-40
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 13/176 (7%)

Query: 187 NNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
           +  IGRG    VY+G+ T    +VA  +L       S       E   L  ++H NIVR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 246 KAFC----SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
                     K+  +LV E M +G+L   L   R   +K ++      +  KGL +LH  
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 302 CSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             P IIHRD+K +NI +        + D GLA   + +       AV G+  ++AP
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 7e-40
 Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 10/175 (5%)

Query: 186 DNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
           ++  +G G  G V +G        + VAVK L       +  + L AE   + ++ +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           VR+   C   E+ +LV E    G L + L   R   +K +  +++  + + G+ YL    
Sbjct: 71  VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN 127

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ-DTGASECMSAVAGSYGYIAP 356
               +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +       + AP
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 12/195 (6%)

Query: 165 WKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSH 223
           WK    Q ++   D +L+    +  +G G  GVV+R      G   A K ++  T   S 
Sbjct: 9   WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESD 66

Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEM 283
              +  EI+T+  +RH  +V L     +    +++YE+M  G L E +  +    +  + 
Sbjct: 67  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDE 125

Query: 284 RLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGAS 341
            ++   +  KGL ++H +     +H D+K  NI+  +     +   DFGL  +L      
Sbjct: 126 AVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 179

Query: 342 ECMSAVAGSYGYIAP 356
           + +    G+  + AP
Sbjct: 180 QSVKVTTGTAEFAAP 194

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-39
 Identities = 51/196 (26%), Positives = 75/196 (38%), Gaps = 32/196 (16%)

Query: 189 VIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRN 241
           V+G G  G V          T    QVAVK L      SS    L +E++ + ++  H N
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHEN 102

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF---------------------LK 280
           IV L   C+      L++EY   G L   L  KR  F                     L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 281 WEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA 340
           +E  L  A + AKG+ +L        +HRD+ + N+L+       + DFGLA+ +     
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 341 SECMSAVAGSYGYIAP 356
                       ++AP
Sbjct: 220 YVVRGNARLPVKWMAP 235

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 50/192 (26%), Positives = 75/192 (39%), Gaps = 27/192 (14%)

Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHR 240
             +G G  G V          +     VAVK L   +   +    L +E++ L  +  H 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNHM 87

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF----------------LKWEMR 284
           NIV L   C+     L++ EY   G L   L  KR SF                L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 285 LKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECM 344
           L  + + AKG+++L        IHRD+ + NILL       + DFGLA+ +++       
Sbjct: 148 LSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 345 SAVAGSYGYIAP 356
                   ++AP
Sbjct: 205 GNARLPVKWMAP 216

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 3e-39
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 12/190 (6%)

Query: 174 DFGSDDILECVKDNNVIGRGGAGVVYRGV----TPNGEQVAVKKLLGITKGSSHDNGLSA 229
           +F  +  + CVK   VIG G  G V  G           VA+K L          +   +
Sbjct: 18  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLS 76

Query: 230 EIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAI 289
           E   +G+  H N++ L+   +     +++ E+M NGSL   L    G F      + +  
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLR 135

Query: 290 EAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAG 349
             A G+ YL        +HRD+ + NIL+NS+    V+DFGL+++L+D  +    ++  G
Sbjct: 136 GIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192

Query: 350 SYG---YIAP 356
                 + AP
Sbjct: 193 GKIPIRWTAP 202

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-39
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 11/171 (6%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
             +G+G  G VY      +   +A+K L     + +  ++ L  E+     +RH NI+RL
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
             +  +     L+ EY P G++   L          +       E A  LSY H   S  
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKR 126

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +IHRD+K  N+LL S  E  +ADFG + +   +      + + G+  Y+ P
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPP 173

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 2e-38
 Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 12/188 (6%)

Query: 170 FQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLS 228
           + K +    DI       + +G G  G VY GV       VAVK    + + +       
Sbjct: 9   YDKWEMERTDI----TMKHKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFL 61

Query: 229 AEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIA 288
            E   + +I+H N+V+L   C+ +    ++ E+M  G+L + L       +   + L +A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 289 IEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVA 348
            + +  + YL        IHRD+ + N L+  +    VADFGL++ +     +   +   
Sbjct: 122 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAK 177

Query: 349 GSYGYIAP 356
               + AP
Sbjct: 178 FPIKWTAP 185

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (342), Expect = 5e-38
 Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 36/215 (16%)

Query: 170 FQKLDFGSDDILECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSH 223
              L++  ++ +E V+    IG G  G V++   P          VAVK L         
Sbjct: 5   LLSLEYPRNN-IEYVR---DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 224 DNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF----- 278
            +    E   + +  + NIV+L   C+  +   L++EYM  G L E L            
Sbjct: 61  AD-FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 279 -----------------LKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD 321
                            L    +L IA + A G++YL        +HRD+ + N L+  +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176

Query: 322 FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               +ADFGL++ +      +     A    ++ P
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-37
 Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 7/171 (4%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
            ++G G    V          + A+K L        +    ++ E   + ++ H   V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                + E       Y  NG L + +  K GSF +   R   A    + +S L +     
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA----EIVSALEYLHGKG 128

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IIHRD+K  NILLN D    + DFG AK L         ++  G+  Y++P
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-35
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 11/174 (6%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            V+G G  G VY+G+  P GE+    VA+K+L   T   ++   +  E   +  + + ++
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHV 73

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
            RL   C    T  L+ + MP G L + +   + +    +  L   ++ AKG++YL    
Sbjct: 74  CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRR 131

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
              ++HRD+ + N+L+ +     + DFGLAK L                 ++A 
Sbjct: 132 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 12/171 (7%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +G G  GVV+R V    G     K +   T        +  EI  + ++ H  ++ L  
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHPKLINLHD 93

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
              +K   +L+ E++  G L + +       +     +    +A +GL ++H      I+
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149

Query: 308 HRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H D+K  NI+  +   + V   DFGLA  L      E +     +  + AP
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAP 197

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 3e-35
 Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 11/175 (6%)

Query: 188 NVIGRGGAGVVYRGV----TPNGEQVAVKKLLGITKGSSHD-NGLSAEIRTLGKIRHRNI 242
             +G G  GVV RG     +     VAVK L           +    E+  +  + HRN+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           +RL           +V E  P GSL + L   +G FL      + A++ A+G+ YL    
Sbjct: 74  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR 131

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS-AVAGSYGYIAP 356
               IHRD+ + N+LL +     + DFGL + L        M       + + AP
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-35
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 11/170 (6%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             IG+G +G VY  +    G++VA++++    +       +  EI  + + ++ NIV   
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
                 +   +V EY+  GSL +V+               +  E  + L +LH +    +
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSNQ---V 137

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           IHRD+KS+NILL  D    + DFG    +         S + G+  ++AP
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAP 185

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-34
 Identities = 51/201 (25%), Positives = 79/201 (39%), Gaps = 14/201 (6%)

Query: 163 NSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV----TPNGEQVAVKKLLGIT 218
           N   + A Q +  G   ++  V  N VIGRG  G VY G            AVK L  IT
Sbjct: 10  NPELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67

Query: 219 KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN-LLVYEYMPNGSLGEVLHGKRGS 277
                      E   +    H N++ L   C   E + L+V  YM +G L          
Sbjct: 68  DIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETH 125

Query: 278 FLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL-- 335
               +  +   ++ AKG   +    S   +HRD+ + N +L+  F   VADFGLA+ +  
Sbjct: 126 NPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182

Query: 336 QDTGASECMSAVAGSYGYIAP 356
           ++  +    +       ++A 
Sbjct: 183 KEFDSVHNKTGAKLPVKWMAL 203

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 4e-34
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 11/181 (6%)

Query: 182 ECVKDNNVIGRGGAGVVYRGVTPNGEQ-----VAVKKLLGITKGSSHDNGLSAEIRTLGK 236
            CV    VIG G  G VY+G+           VA+K L               E   +G+
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 65

Query: 237 IRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLS 296
             H NI+RL+   S  +  +++ EYM NG+L +    ++         + +    A G+ 
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGM- 123

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG-ASECMSAVAGSYGYIA 355
              +  +   +HRD+ + NIL+NS+    V+DFGL++ L+D   A+   S       + A
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 356 P 356
           P
Sbjct: 182 P 182

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-33
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 31/207 (14%)

Query: 168 TAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV---TPNGEQVAVKKLLGITKGSSHD 224
           T +  LD+  +DI    K  +VIG G  G V +            A+K++        H 
Sbjct: 2   TIYPVLDW--NDI----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 225 NGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGK--------- 274
           +  + E+  L K+  H NI+ L   C ++    L  EY P+G+L + L            
Sbjct: 56  D-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114

Query: 275 -----RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF 329
                  S L  +  L  A + A+G+    +      IHRD+ + NIL+  ++ A +ADF
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADF 171

Query: 330 GLAKYLQDTGASECMSAVAGSYGYIAP 356
           GL++  +                ++A 
Sbjct: 172 GLSRGQEVYVKKTM---GRLPVRWMAI 195

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 7e-33
 Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 11/171 (6%)

Query: 189 VIGRGGAGVVYRGVTPNGEQ----VAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR 244
            IG G  G V++G+  + E     VA+K     T  S  +     E  T+ +  H +IV+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVK 72

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           L    +      ++ E    G L   L  ++ S L     +  A + +  L+YL      
Sbjct: 73  LIGVITENPV-WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKR-- 128

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
             +HRD+ + N+L++S+    + DFGL++Y++D+      S       ++A
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMA 177

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  120 bits (303), Expect = 1e-32
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 17/178 (9%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLS-------AEIRTLGKIR- 238
            ++GRG + VV R +  P  ++ AVK +     GS     +         E+  L K+  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 239 HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           H NI++LK          LV++ M  G L + L  K    L  +   KI     + +  L
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 126

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H      I+HRD+K  NILL+ D    + DFG +  L      E +  V G+  Y+AP
Sbjct: 127 HKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAP 178

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-32
 Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 13/171 (7%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +GRG  G+V+R V T + +    K    +    +    +  EI  L   RHRNI+ L  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKF---VKVKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
              + E  ++++E++    + E ++      L     +    +  + L +LH   S  I 
Sbjct: 69  SFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 308 HRDVKSNNILLNSDFEAHV--ADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H D++  NI+  +   + +   +FG A+ L+     +    +  +  Y AP
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAP 172

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 13/186 (6%)

Query: 177 SDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLG 235
           ++DI +     +V+G G    V         + VA+K +         +  +  EI  L 
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLH 62

Query: 236 KIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGL 295
           KI+H NIV L     +     L+ + +  G L + +  K   F       ++  +    +
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 120

Query: 296 SYLHHDCSPLIIHRDVKSNNILL---NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
            YLH      I+HRD+K  N+L    + D +  ++DFGL+K          +S   G+ G
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPG 174

Query: 353 YIAPVL 358
           Y+AP +
Sbjct: 175 YVAPEV 180

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-32
 Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 18/183 (9%)

Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
             +G+G  G+VY GV           +VA+K +               E   + +    +
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHH 84

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF--------LKWEMRLKIAIEAAK 293
           +VRL    S  +  L++ E M  G L   L   R +               +++A E A 
Sbjct: 85  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGY 353
           G++YL+ +     +HRD+ + N ++  DF   + DFG+ + + +T              +
Sbjct: 145 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201

Query: 354 IAP 356
           ++P
Sbjct: 202 MSP 204

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  119 bits (298), Expect = 8e-32
 Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 12/175 (6%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           ++G GG   V+          VAVK L   + +  S       E +    + H  IV + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 247 AFCSNKETNL----LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                +        +V EY+   +L +++H +    +  +  +++  +A + L++ H + 
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG 131

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAP 356
              IIHRDVK  NI++++     V DFG+A+ + D+G S    +AV G+  Y++P
Sbjct: 132 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-31
 Identities = 48/190 (25%), Positives = 70/190 (36%), Gaps = 24/190 (12%)

Query: 188 NVIGRGGAGVVYRGV------TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN 241
             +GRG  G V          T     VAVK L      S H   +S     +    H N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 242 IVRLKAFCSNKETNL-LVYEYMPNGSLGEVLHGKRGSF--------------LKWEMRLK 286
           +V L   C+     L ++ E+   G+L   L  KR  F              L  E  + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 287 IAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSA 346
            + + AKG+ +L        IHRD+ + NILL+      + DFGLA+ +           
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 347 VAGSYGYIAP 356
                 ++AP
Sbjct: 196 ARLPLKWMAP 205

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-31
 Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 11/173 (6%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSA---EIRTLGKIRHRNIV 243
           + +G G    VY+       + VA+KK+    +  + D        EI+ L ++ H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
            L     +K    LV+++M       V+       L         +   +GL YLH    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             I+HRD+K NN+LL+ +    +ADFGLAK       +        +  Y AP
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAP 169

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  119 bits (298), Expect = 4e-31
 Identities = 39/173 (22%), Positives = 67/173 (38%), Gaps = 14/173 (8%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIRHRNI 242
            +IGRGG G VY       G+  A+K L    + + +G +        +  +       I
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 243 VRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
           V +       +    + + M  G L   L   +            A E   GL ++H+  
Sbjct: 70  VCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF 127

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
              +++RD+K  NILL+      ++D GLA           +    G++GY+A
Sbjct: 128 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  116 bits (290), Expect = 1e-30
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 5/164 (3%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
             IG G  GVVY+     GE  A+KK+    +     +    EI  L +++H NIV+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 248 FCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLII 307
               K+  +LV+E++       +   + G  L+        ++   G++Y H      ++
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR---VL 122

Query: 308 HRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSY 351
           HRD+K  N+L+N + E  +ADFGLA+             V   Y
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 7/170 (4%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             IG G  GVVY+      GE VA+KK+   T+     +    EI  L ++ H NIV+L 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
                +    LV+E++ +  L + +     + +   +      +  +GL++ H      +
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRD+K  N+L+N++    +ADFGLA+           +    +  Y AP
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAP 171

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (290), Expect = 2e-30
 Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 12/171 (7%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
             +G G  G V+      NG   A+K L   I          + E   L  + H  I+R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
                + +   ++ +Y+  G L  +L   +             +        L +  S  
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKD 124

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           II+RD+K  NILL+ +    + DFG AKY+ D         + G+  YIAP
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAP 170

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-30
 Identities = 56/181 (30%), Positives = 78/181 (43%), Gaps = 21/181 (11%)

Query: 185 KDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIV 243
            D  VIG G  GVVY+     +GE VA+KK+L            + E++ + K+ H NIV
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCNIV 76

Query: 244 RLKAFCSNKETN------LLVYEYMPNGSLGEVLHGKR-GSFLKWEMRLKIAIEAAKGLS 296
           RL+ F  +           LV +Y+P        H  R    L          +  + L+
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 297 YLHHDCSPLIIHRDVKSNNILLNSDFEAH-VADFGLAKYLQDTGASECMSAVAGSYGYIA 355
           Y+H   S  I HRD+K  N+LL+ D     + DFG AK L      E   +   S  Y A
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRA 190

Query: 356 P 356
           P
Sbjct: 191 P 191

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 3e-30
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 13/175 (7%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           + IG G  G+V       N  +VA+KK+      +     L  EI+ L + RH NI+ + 
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 72

Query: 247 AFCSNKETNLLVYEYMPNGSLG----EVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
                     +   Y+    +G    ++L  +    L  +       +  +GL Y+H   
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH--- 126

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASEC-MSAVAGSYGYIAP 356
           S  ++HRD+K +N+LLN+  +  + DFGLA+           ++    +  Y AP
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 8e-30
 Identities = 44/172 (25%), Positives = 65/172 (37%), Gaps = 10/172 (5%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGK-IRHRNIVR 244
            ++G+G  G V+        +  A+K L   +            E R L     H  +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 245 LKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSP 304
           +      KE    V EY+  G L   +                A E   GL +LH     
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG-- 123

Query: 305 LIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
            I++RD+K +NILL+ D    +ADFG+ K      A    +   G+  YIAP
Sbjct: 124 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAP 172

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 3e-29
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 16/180 (8%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             IG+G  G V++      G++VA+KK+L   +          EI+ L  ++H N+V L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 247 AFCSNKETN--------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
             C  K +          LV+++  +   G + +      L    R+   +     L+ L
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS--ECMSAVAGSYGYIAP 356
           ++     I+HRD+K+ N+L+  D    +ADFGLA+       S     +    +  Y  P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 5e-29
 Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 22/198 (11%)

Query: 168 TAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG 226
           T F++ +   DD  +  +    +G G   VV +      G Q A K +      SS    
Sbjct: 1   TVFRQENV--DDYYDTGE---ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55

Query: 227 ----LSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWE 282
               +  E+  L +I+H N++ L     NK   +L+ E +  G L + L  K    L  E
Sbjct: 56  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEE 113

Query: 283 MRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD----FEAHVADFGLAKYLQDT 338
              +   +   G   +++  S  I H D+K  NI+L           + DFGLA  +   
Sbjct: 114 EATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170

Query: 339 GASECMSAVAGSYGYIAP 356
              + +    G+  ++AP
Sbjct: 171 NEFKNI---FGTPEFVAP 185

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 37/174 (21%), Positives = 63/174 (36%), Gaps = 16/174 (9%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLK 246
           V+G G  G V +       E+ A+K L               E+    +  +  +IVR+ 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 71

Query: 247 AFCSNKETN----LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC 302
               N        L+V E +  G L   +  +           +I     + + YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128

Query: 303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           S  I HRDVK  N+L  S     +       + ++T +   ++    +  Y+AP
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-28
 Identities = 39/176 (22%), Positives = 76/176 (43%), Gaps = 16/176 (9%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKL----LGITKGSSHDNGLSAEIRTLGKIR--HRN 241
           ++G GG G VY G+   +   VA+K +    +       +   +  E+  L K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 242 IVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
           ++RL  +    ++ +L+ E             +RG+ L+ E+      +  + + + H+ 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 129

Query: 302 CSPLIIHRDVKSNNILLNSD-FEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               ++HRD+K  NIL++ +  E  + DFG    L+DT      +   G+  Y  P
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 178

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-28
 Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 33/195 (16%)

Query: 188 NVIGRGGAGVVYRGV--------TPNGEQVAVKKLLGITKGSSHDNGLS---AEIRTLGK 236
             +G G  G V                 +VAVK L    K  + +  LS   +E+  +  
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLSDLISEMEMMKM 74

Query: 237 I-RHRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSF--------------LKW 281
           I +H+NI+ L   C+      ++ EY   G+L E L  +R                 L  
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 282 EMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS 341
           +  +  A + A+G+ YL    S   IHRD+ + N+L+  D    +ADFGLA+ +      
Sbjct: 135 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 342 ECMSAVAGSYGYIAP 356
           +  +       ++AP
Sbjct: 192 KKTTNGRLPVKWMAP 206

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  108 bits (270), Expect = 9e-28
 Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 21/180 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLK 246
            IG G  GV++ G    N +QVA+K         S    L  E RT   +     I  + 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
            F      N+LV + +  G   E L    G     +     A +    +  +H      +
Sbjct: 68  YFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122

Query: 307 IHRDVKSNNILLNSDFEAH-----VADFGLAKYLQDTGASEC-----MSAVAGSYGYIAP 356
           ++RD+K +N L+      +     V DFG+ K+ +D    +         ++G+  Y++ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 7e-27
 Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 15/178 (8%)

Query: 188 NVIGRGGAGVVYRG--VTPNGEQVAVKKLLGITKGSSHDNGLSAEI---RTLGKIRHRNI 242
             IG G  G V++   +   G  VA+K++   T           E+   R L    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 243 VRLKAFCSNKETNLLVYEYMPN----GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYL 298
           VRL   C+   T+      +        L   L       +  E    +  +  +GL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 299 HHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           H      ++HRD+K  NIL+ S  +  +ADFGLA+          +++V  +  Y AP
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAP 184

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 43/173 (24%), Positives = 63/173 (36%), Gaps = 9/173 (5%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKL-LGITKGSSHDNGLSAEIRTLGKIRHRNIVRL 245
            ++G+G  G V        G   A+K L   +            E R L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 246 KAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPL 305
           K      +    V EY   G L   L   R      E       E    L    +  S  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSAL---EYLHSRD 125

Query: 306 IIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVL 358
           +++RD+K  N++L+ D    + DFGL K     GA+       G+  Y+AP +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 19/178 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRN-IVRLK 246
            IG G  G +Y G     GE+VA+K         +    L  E +    ++    I  ++
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
              +  + N++V E +            R      +  L +A +    + Y+H   S   
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNF 124

Query: 307 IHRDVKSNNILLNS---DFEAHVADFGLAKYLQDTGASECM-----SAVAGSYGYIAP 356
           IHRDVK +N L+         ++ DFGLAK  +D    + +       + G+  Y + 
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-26
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 8/170 (4%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
             IG G  G V++       E VA+K++          +    EI  L +++H+NIVRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 247 AFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLI 306
               + +   LV+E+                 L  E+      +  KGL + H      +
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---V 122

Query: 307 IHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
           +HRD+K  N+L+N + E  +A+FGLA+         C SA   +  Y  P
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPP 170

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 5e-25
 Identities = 50/175 (28%), Positives = 72/175 (41%), Gaps = 19/175 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +G G  G V   V    G +VA+KKL    +          E+R L  +RH N++ L  
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 248 FCSNKETN------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
             +  ET        LV  +M       + H K    L  +    +  +  KGL Y+H  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAA 140

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               IIHRD+K  N+ +N D E  + DFGLA+          M+    +  Y AP
Sbjct: 141 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAP 187

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 98.8 bits (245), Expect = 5e-24
 Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 24/208 (11%)

Query: 160 KNSNSWKLTAFQKLDFGSDDILECVKDNNVIGRGGAGVVYRGV-TPNGEQVAVKKLLGIT 218
                +       +++G+ D  + V+    +GRG    V+  +   N E+V VK L    
Sbjct: 16  HRPREYWDYESHVVEWGNQDDYQLVR---KLGRGKYSEVFEAINITNNEKVVVKILK--- 69

Query: 219 KGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNL--LVYEYMPNGSLGEVLHGKR 275
                   +  EI+ L  +R   NI+ L     +  +    LV+E++ N    ++     
Sbjct: 70  --PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-- 125

Query: 276 GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKY 334
              L          E  K L Y H      I+HRDVK +N++++ +  +  + D+GLA++
Sbjct: 126 ---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179

Query: 335 LQDTGASECMSAVAGSYGYIAPVLGWYC 362
                  +  +    S  +  P L    
Sbjct: 180 YHP---GQEYNVRVASRYFKGPELLVDY 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 98.3 bits (244), Expect = 9e-24
 Identities = 37/173 (21%), Positives = 61/173 (35%), Gaps = 18/173 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNG----LSAEIRTLGKIRHRNIV 243
            +G G  G V       +G   A+K    + K              E R L  +    +V
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 244 RLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCS 303
           +L+    +     +V EY+  G +   L                A +      YLH    
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD- 161

Query: 304 PLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
             +I+RD+K  N+L++      V DFG AK ++          + G+   +AP
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAP 207

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 3e-23
 Identities = 43/175 (24%), Positives = 68/175 (38%), Gaps = 13/175 (7%)

Query: 188 NVIGRGGAGVVYRGV----TPNGEQVAVKKL--LGITKGSSHDNGLSAEIRTLGKIRHR- 240
            V+G G  G V+          G+  A+K L    I + +        E + L  IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 241 NIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHH 300
            +V L      +    L+ +Y+  G L   L  +            + I   + +  L H
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEH 144

Query: 301 DCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIA 355
                II+RD+K  NILL+S+    + DFGL+K       +E      G+  Y+A
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMA 198

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.0 bits (235), Expect = 1e-22
 Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 18/175 (10%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            IG G  G+V           VA+KKL    +  +H      E+  +  + H+NI+ L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 248 FCSNKETN------LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
             + ++T        LV E M       +           E    +  +   G+ +LH  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAP 356
               IIHRD+K +NI++ SD    + DFGLA+     G S  M+    +  Y AP
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 3e-21
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 12/164 (7%)

Query: 188 NVIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLK 246
           + +G G  G V     T  G +VAVKKL    +   H      E+R L  ++H N++ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 247 AFCSNKET-----NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD 301
              +   +     ++ +  ++    L  ++  ++   L  +    +  +  +GL Y+H  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSA 140

Query: 302 CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASECMS 345
               IIHRD+K +N+ +N D E  + DFGLA++  D       +
Sbjct: 141 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.5 bits (216), Expect = 4e-21
 Identities = 29/163 (17%), Positives = 59/163 (36%), Gaps = 17/163 (10%)

Query: 188 NVIGRGGAGVVYRGVTPNGEQVAVKKL-LGITKGSS-------HDNGLSAEIRTLGKIRH 239
            ++G G    V+   +    +  VK   +G T            D   S       +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 240 RNIVRLKAFCSNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLH 299
           R + +L+     K      Y +  N  L E++  K    ++ E   ++     + ++  +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 300 HDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE 342
           H     I+H D+   N+L+ S+    + DF  +  + + G  E
Sbjct: 121 HRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE 159

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 84.3 bits (207), Expect = 7e-19
 Identities = 34/184 (18%), Positives = 63/184 (34%), Gaps = 21/184 (11%)

Query: 189 VIGRGGAGVVYRGV-TPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKA 247
            +G G    V+      N   VA+K    +     +      EI+ L ++   +  +  +
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKI---VRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 248 FCSNKETNLLVY--EYMPNGSLGEV------------LHGKRGSFLKWEMRLKIAIEAAK 293
             +N    LL +     PNG    +            +       +      +I+ +   
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 294 GLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLAKYLQDTGASECMSAVAGSYG 352
           GL Y+H  C   IIH D+K  N+L+   D   ++    +A         E  +    +  
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 353 YIAP 356
           Y +P
Sbjct: 195 YRSP 198

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.8 bits (182), Expect = 1e-15
 Identities = 24/66 (36%), Positives = 38/66 (57%)

Query: 45  NYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCG 104
           N L++  N++  +LP+ +  +K L S + S NN  GEIP+ G    F+ +++  N  LCG
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306

Query: 105 SYLNPC 110
           S L  C
Sbjct: 307 SPLPAC 312

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 3e-08
 Identities = 16/76 (21%), Positives = 31/76 (40%), Gaps = 6/76 (7%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  NN S I P  +     L  L  + N +S      +  +  +N+L+   NQ++   P 
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS--LANLTNINWLSAGHNQISDLTP- 368

Query: 61  EMGNMKSLTSADFSHN 76
            + N+  +T    +  
Sbjct: 369 -LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 3e-08
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 4/68 (5%)

Query: 16  HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSH 75
           +   LTYL L  N++S   P  ++ +  L  L  + N++  S    + N+ ++      H
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGH 360

Query: 76  NNFSGEIP 83
           N  S   P
Sbjct: 361 NQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 3e-04
 Identities = 23/122 (18%), Positives = 42/122 (34%), Gaps = 7/122 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
            + N  S I P+ I   L    L L+ N L       +  +  L  L+++ NQ++   P 
Sbjct: 204 ATNNQISDITPLGILTNL--DELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP- 258

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
            +  +  LT      N  S  I      +   +     N     S ++     +   ++ 
Sbjct: 259 -LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316

Query: 121 QN 122
            N
Sbjct: 317 NN 318

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 48.1 bits (113), Expect = 7e-07
 Identities = 16/117 (13%), Positives = 32/117 (27%), Gaps = 2/117 (1%)

Query: 10  IPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLT 69
           +P ++        LDL  N ++         +  L+ L +  N+++   P     +  L 
Sbjct: 25  VPKDLPPDT--ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 70  SADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHNQNGNKS 126
               S N       +  +              +  S  N  N      +       S
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.4 bits (106), Expect = 5e-06
 Identities = 19/129 (14%), Positives = 34/129 (26%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  + I   +  +   L  L L  N +S   P     +  L  L +S NQL     K
Sbjct: 38  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK 97

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPIHN 120
               ++ L   +         +                                 + I  
Sbjct: 98  MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 157

Query: 121 QNGNKSHVP 129
            + N + +P
Sbjct: 158 ADTNITTIP 166

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 22/183 (12%), Positives = 56/183 (30%), Gaps = 8/183 (4%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDL--SQNHLSGPIPVQITQIHILNYLNVSWNQLNASL 58
           +  N  + +          +  ++L  +    SG        +  L+Y+ ++   +  ++
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165

Query: 59  PKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTP- 117
           P+  G   SLT      N  +       +     +        +          +     
Sbjct: 166 PQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 223

Query: 118 IHNQNGNKSHVPGKYKLLFALGLLLCSLVFAVLAIIKTRKFRKNSNSWKLTAFQKLDFGS 177
           +H  N     VPG       + ++   L    ++ I +  F     + K  ++  +   S
Sbjct: 224 LHLNNNKLVKVPGGLADHKYIQVV--YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281

Query: 178 DDI 180
           + +
Sbjct: 282 NPV 284

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 9e-06
 Identities = 21/85 (24%), Positives = 31/85 (36%), Gaps = 9/85 (10%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
              N  S  I         L  L++S N L   +P    +   L  L  S+N L   +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 321

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEF 85
              N+K L      +N    E P+ 
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDI 342

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 36.7 bits (83), Expect = 0.003
 Identities = 18/102 (17%), Positives = 29/102 (28%), Gaps = 10/102 (9%)

Query: 13  EIGHCLL--LTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTS 70
            +  CL      L+L+   LS  +P        L  L  S N L   LP+   +   L S
Sbjct: 31  RLRDCLDRQAHELELNNLGLSS-LPELPPH---LESLVASCNSLT-ELPELPQS---LKS 82

Query: 71  ADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNY 112
               +NN            +   ++            +    
Sbjct: 83  LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKI 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 2e-04
 Identities = 17/103 (16%), Positives = 35/103 (33%), Gaps = 24/103 (23%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV---------------------QIT 39
           ++  + + +    +   LL+T+LDLS N L    P                       + 
Sbjct: 5   LAHKDLTVLC--HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 40  QIHILNYLNVSWNQLNA-SLPKEMGNMKSLTSADFSHNNFSGE 81
            +  L  L +  N+L   +  + + +   L   +   N+   E
Sbjct: 63  NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (93), Expect = 2e-04
 Identities = 16/105 (15%), Positives = 36/105 (34%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  N  S +          L  L L QN ++   P     +  L  L +  N L+A   +
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219

Query: 61  EMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTSFTGNPHLCGS 105
            +  +++L     + N +  +      +++      + +   C  
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 6e-04
 Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 4/80 (5%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           +  NN S +    +     L YL L+ N               L     S +++  SLP+
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ 266

Query: 61  EMGNMKSLTSADFSHNNFSG 80
            +           + N+  G
Sbjct: 267 RLAGRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (87), Expect = 0.001
 Identities = 17/115 (14%), Positives = 31/115 (26%), Gaps = 1/115 (0%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK 60
           + R     + P        L YL L  N L          +  L +L +  N++++   +
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171

Query: 61  EMGNMKSLTSADFSHNNFSGEIPE-FGQYSFFNSTSFTGNPHLCGSYLNPCNYSS 114
               + SL       N  +   P  F       +     N              +
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 7e-04
 Identities = 7/70 (10%), Positives = 17/70 (24%), Gaps = 5/70 (7%)

Query: 20 LTYLDLSQNHLS-GPIPVQITQIHILNYLNVSWNQLN----ASLPKEMGNMKSLTSADFS 74
          +  LD+    LS       +  +     + +    L       +   +    +L   +  
Sbjct: 4  IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 75 HNNFSGEIPE 84
           N        
Sbjct: 64 SNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.001
 Identities = 13/79 (16%), Positives = 26/79 (32%), Gaps = 9/79 (11%)

Query: 16  HCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNASLPKEMG-----NMK 66
              +L  L L+   +S      +   +   H L  L++S N L  +   ++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 67  SLTSADFSHNNFSGEIPEF 85
            L         +S E+ + 
Sbjct: 427 LLEQLVLYDIYWSEEMEDR 445

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 8e-04
 Identities = 16/129 (12%), Positives = 39/129 (30%), Gaps = 3/129 (2%)

Query: 1   MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG-PIPVQITQIHILNYLNVSWNQLNASLP 59
             R+     +  E      + ++DLS + +    +   ++Q   L  L++   +L+  + 
Sbjct: 30  CPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV 88

Query: 60  KEMGNMKSLTSADFSHN-NFSGEIPEFGQYSFFNSTSFTGNPHLCGSYLNPCNYSSTTPI 118
             +    +L   + S    FS    +    S         +     +  +     +    
Sbjct: 89  NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE 148

Query: 119 HNQNGNKSH 127
                N S 
Sbjct: 149 TITQLNLSG 157

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 9e-04
 Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 2/89 (2%)

Query: 2   SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVSWNQLNASLP 59
            R++ +  + +   +   L  L+LS N L     +   + +   L  LN+S N+L +   
Sbjct: 49  RRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 108

Query: 60  KEMGNMKSLTSADFSHNNFSGEIPEFGQY 88
            +      L       N+ S    +   Y
Sbjct: 109 LDKIKGLKLEELWLDGNSLSDTFRDQSTY 137

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	362
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.98
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.98
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.73
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.47
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.44
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.43
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.28
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.25
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.2
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.17
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.17
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.14
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.06
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.97
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.93
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.91
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.84
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.82
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.81
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.75
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.64
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.62
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.62
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.61
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.59
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.47
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.45
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.33
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.31
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.14
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.1
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.07
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.99
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.94
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.62
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.6
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.55
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.48
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.33
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.33
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.22
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.86
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.36
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.35
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.24
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	93.57
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.02

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-42  Score=305.31  Aligned_cols=175  Identities=25%  Similarity=0.302  Sum_probs=149.6

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||+||+|++ .+++.||||++...... ...+++.+|++++++++|||||++++++.+++..|+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            46788999999999999999997 46899999998654322 22345899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+......
T Consensus        83 Ey~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          83 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             eccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999999963  346999999999999999999999665   9999999999999999999999999999876443


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........+||+.|||||++.+
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~  179 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKR  179 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHC
T ss_pred             ccccccceeeCcCccCHhHhcC
Confidence            3333556789999999998753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-41  Score=299.89  Aligned_cols=172  Identities=31%  Similarity=0.420  Sum_probs=142.2

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||+||+|+++  ..||||+++.........++|.+|++++++++|||||++++++.. +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            56788899999999999999874  369999987655555556679999999999999999999998764 567999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|+|.+++... ...+++..+..++.|+++||+|||+.+   ||||||||+|||++.++.+||+|||+|+........
T Consensus        85 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          85 CEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999743 345999999999999999999999655   999999999999999999999999999887644333


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......||+.|||||++.
T Consensus       161 ~~~~~~~gt~~y~APE~l~  179 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIR  179 (276)
T ss_dssp             -----CCCCGGGCCHHHHT
T ss_pred             ccccccccCcccCCHHHHh
Confidence            3456678999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=297.23  Aligned_cols=172  Identities=25%  Similarity=0.369  Sum_probs=150.1

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      ..++|+..+.||+|+||+||+|.+ .+|+.||||++.....  ...+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            346799999999999999999987 4689999999875432  2345599999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        96 mEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            9999999999988643   4899999999999999999999665   999999999999999999999999999987543


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ......+||+.|||||++.+
T Consensus       170 ~--~~~~~~~gt~~Y~aPE~~~~  190 (293)
T d1yhwa1         170 Q--SKRSTMVGTPYWMAPEVVTR  190 (293)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHSS
T ss_pred             c--ccccccccCCCccChhhhcC
Confidence            2  22456689999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-40  Score=294.97  Aligned_cols=173  Identities=30%  Similarity=0.440  Sum_probs=148.5

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||+||+|.+++++.||||++...   ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            3678888999999999999999988889999998643   2334569999999999999999999998854 56799999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++.......+++..+.+|+.||++||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+.+.. 
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-  163 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-
Confidence            999999999886555456899999999999999999999655   9999999999999999999999999999876432 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........||+.|||||++.+
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~  184 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINY  184 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHH
T ss_pred             cccccccCCcccccChHHHhC
Confidence            222445679999999998753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-40  Score=293.27  Aligned_cols=172  Identities=24%  Similarity=0.436  Sum_probs=138.8

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||+||+|.+.+++.||||++...   ....++|.+|++++++++|||||+++|+|..++..++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            356778899999999999999988889999998642   33345699999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|+|.+++... ...+++..+..++.|+|.||+|||+.+   |+||||||+|||+|+++.+||+|||+++...+....
T Consensus        82 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             cCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            9999999998743 356899999999999999999999665   999999999999999999999999999887543322


Q ss_pred             eeeccccCccCccccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       ......||+.|||||++.+
T Consensus       158 -~~~~~~gt~~y~aPE~l~~  176 (263)
T d1sm2a_         158 -SSTGTKFPVKWASPEVFSF  176 (263)
T ss_dssp             --------CTTSCCHHHHTT
T ss_pred             -eecceecCcccCChHHhcC
Confidence             2344679999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-40  Score=293.49  Aligned_cols=172  Identities=28%  Similarity=0.391  Sum_probs=149.3

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      .++|+..+.||+|+||+||+|+++ +++.||+|++..... .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            367888999999999999999974 688999999864321 223345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 mEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999999643  45899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .    ....+||+.|||||++.+
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~  178 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEG  178 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTT
T ss_pred             c----ccccCCCCcccCHHHHcC
Confidence            2    345689999999998864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=297.83  Aligned_cols=175  Identities=25%  Similarity=0.311  Sum_probs=146.8

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||++..... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5689999999999999999987 4689999999864321 2233456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999998643  45999999999999999999999665   9999999999999999999999999999876443


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ........+||+.|||||++.+
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~  184 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTE  184 (288)
T ss_dssp             -------CCCCGGGCCHHHHHT
T ss_pred             cccccccccCCccccCceeecc
Confidence            3333556789999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-40  Score=296.85  Aligned_cols=174  Identities=25%  Similarity=0.348  Sum_probs=151.1

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  259 (362)
                      .++|+..+.||+|+||+||+|++. +++.||||+++..   ....+++.+|++++++++|||||+++++|.+.+..++||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            356788899999999999999875 5889999998543   233456999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+......
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            9999999999997666678999999999999999999999665   9999999999999999999999999999876433


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      . .......||+.|||||++.+
T Consensus       170 ~-~~~~~~~g~~~y~aPE~~~~  190 (287)
T d1opja_         170 Y-TAHAGAKFPIKWTAPESLAY  190 (287)
T ss_dssp             S-EEETTEEECGGGCCHHHHHH
T ss_pred             c-eeeccccccccccChHHHcC
Confidence            2 23445568999999998753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.1e-40  Score=297.52  Aligned_cols=172  Identities=31%  Similarity=0.371  Sum_probs=148.1

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ++..+.|+..+.||+|+||+||+|++ .+++.||||++....... ...+.+.+|++++++++|||||++++++.+++..
T Consensus        11 ~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             SCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             cCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence            34556799999999999999999986 468899999987544322 2234588999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      ++|||||++|+|..++..  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus        91 ~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence            999999999999776643  345899999999999999999999665   999999999999999999999999999876


Q ss_pred             cCCCCceeeccccCccCcccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ..      ....+||+.|||||++.
T Consensus       166 ~~------~~~~~GT~~Y~APE~~~  184 (309)
T d1u5ra_         166 AP------ANSFVGTPYWMAPEVIL  184 (309)
T ss_dssp             SS------BCCCCSCGGGCCHHHHT
T ss_pred             CC------CCccccCccccCHHHHh
Confidence            43      23467999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-40  Score=295.73  Aligned_cols=171  Identities=24%  Similarity=0.307  Sum_probs=147.5

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      +.|+..+.||+|+||+||+|++ .+++.||||++....  ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4678889999999999999987 468899999986543  2334569999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.....  
T Consensus        90 y~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--  163 (288)
T d2jfla1          90 FCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--  163 (288)
T ss_dssp             CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred             cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence            99999999987532 345999999999999999999999665   999999999999999999999999999876432  


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .......+||+.|||||++.
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~  183 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVM  183 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHT
T ss_pred             cccccccccccccCCHHHHh
Confidence            11234578999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-40  Score=302.49  Aligned_cols=171  Identities=28%  Similarity=0.366  Sum_probs=147.1

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||+|+++... .....+++.+|+.+|++++|||||+++++|.+++..++|||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            6788899999999999999997 468899999987543 23334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ||++|+|.+++...  ..+++..+..++.|++.||+|||+.  .+|+||||||+|||+++++.+||+|||+|+...+.. 
T Consensus        85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            99999999999643  4589999999999999999999953  139999999999999999999999999999775322 


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                         ....+||+.|||||++.+
T Consensus       160 ---~~~~~GT~~Y~APEvl~~  177 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQG  177 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHC
T ss_pred             ---cccccCCccccCchHHcC
Confidence               345789999999998865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-40  Score=294.11  Aligned_cols=178  Identities=25%  Similarity=0.338  Sum_probs=138.1

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--CCeeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--KETNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  258 (362)
                      ++|+..+.||+|+||+||+|++ .+|+.||||.+..........+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6788899999999999999987 468999999987654444444568999999999999999999999865  4567899


Q ss_pred             EecCCCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          259 YEYMPNGSLGEVLHGK--RGSFLKWEMRLKIAIEAAKGLSYLHHDC--SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998532  2456999999999999999999999643  23599999999999999999999999999998


Q ss_pred             ccCCCCceeeccccCccCccccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +....  ......+||+.|||||++.+
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~  188 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNR  188 (269)
T ss_dssp             C-------------CCCSCCCHHHHTT
T ss_pred             cccCC--CccccCCCCcccCCHHHHcC
Confidence            75432  22456789999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.9e-39  Score=299.18  Aligned_cols=180  Identities=24%  Similarity=0.405  Sum_probs=153.7

Q ss_pred             cCCChhhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec
Q 018036          173 LDFGSDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN  251 (362)
Q Consensus       173 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  251 (362)
                      .++..+.++++|+..+.||+|+||.||+|++ .+|+.||||++....  ....+.+.+|+.++++++|||||++++++.+
T Consensus        17 ~~l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   94 (350)
T d1koaa2          17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED   94 (350)
T ss_dssp             CCCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CcCCCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3444456788999999999999999999987 468999999986432  2234568999999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC--CCCceEEccc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN--SDFEAHVADF  329 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DF  329 (362)
                      .+..++|||||++|+|.+++... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++  .++.+||+||
T Consensus        95 ~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2          95 DNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             TTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeec
Confidence            99999999999999999998643 345999999999999999999999665   99999999999996  4578999999


Q ss_pred             cccccccCCCCceeeccccCccCccccccccc
Q 018036          330 GLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       330 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|+.+....   ......||+.|||||++.+
T Consensus       171 G~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~  199 (350)
T d1koaa2         171 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEG  199 (350)
T ss_dssp             TTCEECCTTS---CEEEECSCTTTCCHHHHHT
T ss_pred             chheeccccc---ccceecCcccccCHHHHcC
Confidence            9999875432   2456789999999998754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-39  Score=287.47  Aligned_cols=170  Identities=30%  Similarity=0.407  Sum_probs=142.8

Q ss_pred             cccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec----CCeeeEEE
Q 018036          185 KDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN----KETNLLVY  259 (362)
Q Consensus       185 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  259 (362)
                      +..+.||+|+||+||+|.+. +++.||+|++..........+.+.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999874 68899999987655444445568999999999999999999999865    34678999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC-CCCceEEccccccccccCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN-SDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~~  338 (362)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus        92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            999999999999643  4589999999999999999999954 24499999999999996 5789999999999865432


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                          .....+||+.|||||++.+
T Consensus       169 ----~~~~~~GT~~Y~aPE~~~~  187 (270)
T d1t4ha_         169 ----FAKAVIGTPEFMAPEMYEE  187 (270)
T ss_dssp             ----SBEESCSSCCCCCGGGGGT
T ss_pred             ----ccCCcccCccccCHHHhCC
Confidence                1345689999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-39  Score=294.14  Aligned_cols=175  Identities=26%  Similarity=0.384  Sum_probs=134.6

Q ss_pred             hhHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +++.+.|+..+.||+|+||+||+|++. +++.||||.+....... ....+.+|++++++++|||||++++++.+++..|
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            456778999999999999999999874 68899999987544322 2345889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC---CCCceEEccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN---SDFEAHVADFGLAK  333 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~  333 (362)
                      +|||||++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+.   +++.+||+|||+|+
T Consensus        84 lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence            99999999999999964  346999999999999999999999665   99999999999994   57899999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....   ......+||+.|||||++.+
T Consensus       159 ~~~~~---~~~~~~~GT~~y~APE~~~~  183 (307)
T d1a06a_         159 MEDPG---SVLSTACGTPGYVAPEVLAQ  183 (307)
T ss_dssp             -----------------CTTSCHHHHTT
T ss_pred             EccCC---CeeeeeeeCccccCcHHHcC
Confidence            76532   22456789999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.5e-39  Score=290.69  Aligned_cols=171  Identities=27%  Similarity=0.335  Sum_probs=148.5

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +++|+..+.||+|+||+||+|++ .+|+.||||++..... .....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            36788999999999999999997 4689999999864321 223345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+...+.
T Consensus        83 mE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999999999999864  345788899999999999999999554   999999999999999999999999999987542


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           ....+||+.|||||++.+
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~  175 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVST  175 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTT
T ss_pred             -----cccccCcccccCHHHHcC
Confidence                 345789999999998754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-39  Score=292.58  Aligned_cols=176  Identities=28%  Similarity=0.412  Sum_probs=146.3

Q ss_pred             hhccccceeeccCcccEEEEEcCC------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  254 (362)
                      ++|+..+.||+|+||+||+|++..      ...||+|.+..... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            678889999999999999998632      23689998864432 23344589999999998 89999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCC
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRG---------------------SFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKS  313 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  313 (362)
                      .++|||||++|+|.++++....                     ..+++..++.++.|++.||+|||+.+   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999975432                     35899999999999999999999655   99999999


Q ss_pred             CceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          314 NNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       314 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +|||++.++.+||+|||+|+...............||+.|||||++.+
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  240 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  240 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence            999999999999999999998765544444556779999999998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-39  Score=292.98  Aligned_cols=174  Identities=25%  Similarity=0.280  Sum_probs=150.7

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCC-CCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITK-GSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +++|+..+.||+|+||+||+|+. .+++.||+|++..... .....+.+.+|+.+|++++|||||++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46789999999999999999997 5789999999865321 223345588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      ||||++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.+|.+||+|||+|+.....
T Consensus        84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999999864  345899999999999999999999665   999999999999999999999999999976532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  ......+||+.|||||++.+
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~  179 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLED  179 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSS
T ss_pred             C--cccccceeCHHHhhhhhccC
Confidence            2  23456789999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-38  Score=285.59  Aligned_cols=176  Identities=26%  Similarity=0.355  Sum_probs=151.0

Q ss_pred             hhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC----CchhhHHHHHHHHhcCccCcceeEEEEEecC
Q 018036          178 DDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK  252 (362)
Q Consensus       178 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  252 (362)
                      +++.++|+..+.||+|+||+||+|++ .+|+.||||++.......    ...+.+.+|+++|++++|||||++++++.++
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            44567899999999999999999997 578999999987543322    2345689999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC----ceEEcc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF----EAHVAD  328 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~D  328 (362)
                      +..++|||||++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             CEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence            9999999999999999999643  45999999999999999999999665   99999999999998776    499999


Q ss_pred             ccccccccCCCCceeeccccCccCccccccccc
Q 018036          329 FGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       329 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ||+|+......   ......||+.|||||++.+
T Consensus       161 fG~a~~~~~~~---~~~~~~~t~~y~APE~~~~  190 (293)
T d1jksa_         161 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY  190 (293)
T ss_dssp             CTTCEECTTSC---BCSCCCCCGGGCCHHHHTT
T ss_pred             hhhhhhcCCCc---cccccCCCCcccCHHHHcC
Confidence            99998875432   2455689999999998753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-38  Score=293.09  Aligned_cols=177  Identities=20%  Similarity=0.310  Sum_probs=151.6

Q ss_pred             ChhhHhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          176 GSDDILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       176 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      ....+.+.|+..+.||+|+||+||+|.+ .+++.||||++....  ....+.+.+|++++++++|||||++++++.+++.
T Consensus        23 ~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             CCCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3345678899999999999999999987 578999999986432  2233458899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC--CCCceEEcccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN--SDFEAHVADFGLA  332 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DFGla  332 (362)
                      .|+|||||++|+|.+++.. ....+++..+..|+.||+.||+|||+.+   |+||||||+|||++  .++.+||+|||+|
T Consensus       101 ~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla  176 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA  176 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence            9999999999999998753 3446999999999999999999999665   99999999999998  5789999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.+....   ......||+.|||||++.+
T Consensus       177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~  202 (352)
T d1koba_         177 TKLNPDE---IVKVTTATAEFAAPEIVDR  202 (352)
T ss_dssp             EECCTTS---CEEEECSSGGGCCHHHHTT
T ss_pred             eecCCCC---ceeeccCcccccCHHHHcC
Confidence            9876432   2455689999999998753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-39  Score=291.28  Aligned_cols=176  Identities=28%  Similarity=0.430  Sum_probs=134.5

Q ss_pred             hhhccccceeeccCcccEEEEEcCC-C---CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN-G---EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||+||+|.++. +   ..||||++.... .....++|.+|+++|++++|||||++++++..++..+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            4667888999999999999998742 3   257888775332 2223356999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +|||||++|+|.+++... ...++|.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       104 iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999999988743 346899999999999999999999655   9999999999999999999999999999876


Q ss_pred             CCCCce---eeccccCccCccccccccc
Q 018036          337 DTGASE---CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~---~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......   ......||+.|||||++.+
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~  207 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQY  207 (299)
T ss_dssp             ----------------CGGGSCHHHHHS
T ss_pred             CCCCcceeeecccccCCccccCHHHHhc
Confidence            432211   1223468999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=282.24  Aligned_cols=171  Identities=22%  Similarity=0.349  Sum_probs=148.8

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||+||+|++++++.||||+++...   ...++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            4677889999999999999999888899999987533   2345699999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +++|+|.+++... ...+++..+.+++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++.+......
T Consensus        81 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          81 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             CTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             cCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999997643 345889999999999999999999655   999999999999999999999999999877644322


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ......||+.|+|||++.
T Consensus       157 -~~~~~~~t~~y~aPE~~~  174 (258)
T d1k2pa_         157 -SSVGSKFPVRWSPPEVLM  174 (258)
T ss_dssp             -CCCCSCCCGGGCCHHHHH
T ss_pred             -eecccCCCCCcCCcHHhc
Confidence             244567999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-39  Score=288.14  Aligned_cols=173  Identities=29%  Similarity=0.482  Sum_probs=142.3

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      .++|+..+.||+|+||+||+|++++++.||||++...   ....+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc---cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            3678999999999999999999988889999998533   2334569999999999999999999999854 56799999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+++|+|.+++.......++|.+++.++.||+.||+|||+.+   |+||||||+|||+|+++.+||+|||+|+...+...
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            999999999987655567999999999999999999999665   99999999999999999999999999987753322


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .......||+.|+|||++.+
T Consensus       169 -~~~~~~~gt~~y~aPE~~~~  188 (285)
T d1fmka3         169 -TARQGAKFPIKWTAPEAALY  188 (285)
T ss_dssp             --------CCGGGSCHHHHHH
T ss_pred             -eeeccccccccccChHHHhC
Confidence             22344679999999998753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=285.22  Aligned_cols=168  Identities=26%  Similarity=0.373  Sum_probs=137.0

Q ss_pred             ceeeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecCCC
Q 018036          188 NVIGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYMPN  264 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  264 (362)
                      +.||+|+||+||+|.++   .++.||||+++.........+++.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999863   346899999865544444456799999999999999999999999754 56899999999


Q ss_pred             CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce-e
Q 018036          265 GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE-C  343 (362)
Q Consensus       265 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~  343 (362)
                      |+|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+....... .
T Consensus        92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9999999643  45999999999999999999999655   9999999999999999999999999999875433222 2


Q ss_pred             eccccCccCccccccccc
Q 018036          344 MSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       344 ~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....||+.|||||++.+
T Consensus       167 ~~~~~gt~~y~APE~l~~  184 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINY  184 (277)
T ss_dssp             ----CCCGGGCCHHHHHH
T ss_pred             ccccCCCceecCchhhcC
Confidence            334679999999998753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-38  Score=283.32  Aligned_cols=174  Identities=26%  Similarity=0.363  Sum_probs=142.6

Q ss_pred             hhccccce-eeccCcccEEEEEcC---CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNV-IGRGGAGVVYRGVTP---NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~-ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +++...+. ||+|+||+||+|.++   ++..||||+++... .....++|.+|+++|++++|||||++++++.+ +..++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            44555664 999999999999764   34579999986432 22334569999999999999999999999975 45789


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccC
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQD  337 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  337 (362)
                      |||||++|+|.+++... ...+++..+.+++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999998533 346899999999999999999999655   99999999999999999999999999998764


Q ss_pred             CCCc-eeeccccCccCccccccccc
Q 018036          338 TGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       338 ~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .... .......||+.|||||++.+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~  186 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINF  186 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH
T ss_pred             cccccccccccccCccccChHHHhC
Confidence            3322 12334578999999998753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-38  Score=284.67  Aligned_cols=175  Identities=30%  Similarity=0.456  Sum_probs=138.0

Q ss_pred             hhccccceeeccCcccEEEEEcCCC-----CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNG-----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      +.|+..++||+|+||+||+|.++++     ..||||++.... ......+|.+|++++++++|||||+++|++.+.+..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            4577889999999999999987432     379999985432 2223345899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||++++++.+++... ...+++..+.+++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        86 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          86 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999988643 356999999999999999999999655   9999999999999999999999999999875


Q ss_pred             CCCCc-eeeccccCccCccccccccc
Q 018036          337 DTGAS-ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~-~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.... .......||+.|||||++.+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~  187 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISY  187 (283)
T ss_dssp             ------------CCCGGGSCHHHHHS
T ss_pred             CCCccceEeccCCCCccccCHHHHcc
Confidence            43221 22334578999999998753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.9e-38  Score=288.42  Aligned_cols=171  Identities=22%  Similarity=0.240  Sum_probs=149.4

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccC-CCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGIT-KGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      +++|+..+.||+|+||.||+|++ .+|+.||||++.... ......+.+.+|+++|+.++|||||++++++.+.+..++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            47899999999999999999987 478999999986432 1223345589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      |||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+...
T Consensus       120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999999643  35899999999999999999999665   999999999999999999999999999987532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                           ....+||+.|||||++.+
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~  212 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILS  212 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTT
T ss_pred             -----cccccCccccCCHHHHcC
Confidence                 345689999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-37  Score=277.14  Aligned_cols=172  Identities=30%  Similarity=0.408  Sum_probs=149.7

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCc-------hhhHHHHHHHHhcCc-cCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSH-------DNGLSAEIRTLGKIR-HRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~-h~niv~l~~~~~~  251 (362)
                      .++|+..+.||+|+||+||+|++ .+++.||||++.........       .+.+.+|+.++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47889999999999999999987 57889999999765433221       235889999999997 9999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                      ++..|||||||++|+|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999999643  45899999999999999999999665   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCcccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      ++.+....   ......||+.|+|||++.
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~  182 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIE  182 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhh
Confidence            99875432   245578999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-37  Score=281.67  Aligned_cols=173  Identities=24%  Similarity=0.292  Sum_probs=145.3

Q ss_pred             ChhhHhhhcccc-ceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec-
Q 018036          176 GSDDILECVKDN-NVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN-  251 (362)
Q Consensus       176 ~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  251 (362)
                      ....+.++|+.. +.||+|+||+||+|++ .+++.||||++..       ...+.+|++++.++ +|||||++++++.+ 
T Consensus         5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            344567888875 5699999999999987 5789999999853       23488999987655 89999999999875 


Q ss_pred             ---CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceE
Q 018036          252 ---KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAH  325 (362)
Q Consensus       252 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~k  325 (362)
                         ....|+|||||++|+|.+++.......+++.++..|+.|++.||+|||+.+   |+||||||+|||+++   ++.+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccc
Confidence               456899999999999999998655567999999999999999999999665   999999999999985   46799


Q ss_pred             EccccccccccCCCCceeeccccCccCccccccccc
Q 018036          326 VADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       326 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|||+|+......   .....+||+.|||||++.+
T Consensus       155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  187 (335)
T d2ozaa1         155 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGP  187 (335)
T ss_dssp             ECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCG
T ss_pred             ccccceeeeccCCC---ccccccCCcccCCcHHHcC
Confidence            99999999775432   2456789999999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-37  Score=286.79  Aligned_cols=172  Identities=23%  Similarity=0.251  Sum_probs=143.9

Q ss_pred             hhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHH---HHHHHHhcCccCcceeEEEEEecCCee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLS---AEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      +++|+..+.||+|+||.||+|++. +|+.||||++..... .......+.   +|+++++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            357888999999999999999974 689999999854321 111122233   447778888999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYL  335 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  335 (362)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999999643  45889999999999999999999665   999999999999999999999999999977


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....    ....+||+.|||||++..
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~  179 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQK  179 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHST
T ss_pred             CCCc----ccccccccccchhHHhhc
Confidence            5432    345689999999998753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-37  Score=279.14  Aligned_cols=173  Identities=21%  Similarity=0.287  Sum_probs=148.5

Q ss_pred             hHhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeE
Q 018036          179 DILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       179 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  257 (362)
                      +++++|+..+.||+|+||+||+|.+. +++.||||.+...   ......+.+|+++|++++|||||++++++.+.+..|+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            56789999999999999999999874 6889999998543   2233458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCC--CceEEccccccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSD--FEAHVADFGLAKYL  335 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DFGla~~~  335 (362)
                      |||||++|+|.+++... +..+++.++..++.|++.||+|||+.+   |+||||||+|||++.+  ..+||+|||+++..
T Consensus        79 vmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999999643 345899999999999999999999665   9999999999999854  57999999999876


Q ss_pred             cCCCCceeeccccCccCccccccccc
Q 018036          336 QDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       336 ~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...   .......||+.|+|||...+
T Consensus       155 ~~~---~~~~~~~~t~~y~ape~~~~  177 (321)
T d1tkia_         155 KPG---DNFRLLFTAPEYYAPEVHQH  177 (321)
T ss_dssp             CTT---CEEEEEESCGGGSCHHHHTT
T ss_pred             ccC---CcccccccccccccchhccC
Confidence            532   22455679999999997653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-37  Score=277.44  Aligned_cols=173  Identities=27%  Similarity=0.372  Sum_probs=144.9

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||+++.........+.+.+|++++++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6788899999999999999997 578999999996554433344569999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      |+. +++.+++.......+++..+..++.|++.||+|||+.+   ||||||||+|||++.++.+||+|||+|+...... 
T Consensus        82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            996 45556665455567999999999999999999999665   9999999999999999999999999998775322 


Q ss_pred             ceeeccccCccCcccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~  360 (362)
                       .......||+.|+|||++.
T Consensus       157 -~~~~~~~gt~~y~apE~~~  175 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAPEILL  175 (298)
T ss_dssp             -BCTTCCBCCCTTCCHHHHT
T ss_pred             -ccceeecccceeeehhhhc
Confidence             2244568999999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-37  Score=277.03  Aligned_cols=168  Identities=27%  Similarity=0.352  Sum_probs=138.7

Q ss_pred             cceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCC---CchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEecC
Q 018036          187 NNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGS---SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEYM  262 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  262 (362)
                      .++||+|+||+||+|++. +++.||||++.......   ...+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999974 68999999986543322   12345899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCce
Q 018036          263 PNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGASE  342 (362)
Q Consensus       263 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  342 (362)
                      +++++..+..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+...+...  
T Consensus        83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            8887776653  3456889999999999999999999665   99999999999999999999999999987754322  


Q ss_pred             eeccccCccCccccccccc
Q 018036          343 CMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       343 ~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .....+||+.|||||++.+
T Consensus       156 ~~~~~~gt~~y~aPE~~~~  174 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFG  174 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTT
T ss_pred             cccceecChhhccHHHHcc
Confidence            2345689999999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-37  Score=279.31  Aligned_cols=174  Identities=25%  Similarity=0.391  Sum_probs=138.4

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCC----EEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGE----QVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||+||+|.+. +|+    .||+|++.... .....+++.+|++++++++|||||+++++|.++ ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            35888899999999999999874 343    58888886432 233345699999999999999999999999875 467


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ++|||+.+|+|.+.+... ...+++..+.+++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        87 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            888999999999988643 456999999999999999999999655   9999999999999999999999999999876


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ............||+.|||||++.+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~  187 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILH  187 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHH
T ss_pred             cccccccccccccCccccChHHHhc
Confidence            5443333445679999999998753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-36  Score=275.92  Aligned_cols=172  Identities=32%  Similarity=0.384  Sum_probs=138.6

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC----eeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l  257 (362)
                      ++|...+.||+|+||.||+|++ +|+.||||++....   ......+.|+..+.+++|||||+++++|.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            5677788999999999999997 67899999985321   12222344555666789999999999997654    5789


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD-----CSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      |||||++|+|.++++..   .++|..+.+++.|++.||+|+|+.     ..++|+||||||+|||++.++.+||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            99999999999999753   489999999999999999999963     1357999999999999999999999999999


Q ss_pred             ccccCCCCce--eeccccCccCcccccccc
Q 018036          333 KYLQDTGASE--CMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       333 ~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~  360 (362)
                      +.........  ......||+.|||||++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLD  185 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHT
T ss_pred             ccccCCCcceeccccceecccCcCChhhcc
Confidence            9876433221  234568999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.1e-37  Score=274.62  Aligned_cols=177  Identities=24%  Similarity=0.352  Sum_probs=140.7

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC-CchhhHHHHHHHHhcCccCcceeEEEEEecCC----
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS-SHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  253 (362)
                      +.++|+..+.||+|+||+||+|++ .+++.||||++....... ...+++.+|++++++++|||||++++++...+    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            457799999999999999999986 578999999997544322 23356899999999999999999999987654    


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..|+||||+++++|.+++...  ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++..+|+|||.++
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             eEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            378999999999999988543  45899999999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCC-ceeeccccCccCccccccccc
Q 018036          334 YLQDTGA-SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....... .......+||+.|||||++.+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  188 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARG  188 (277)
T ss_dssp             ECC----------------TTCCHHHHTT
T ss_pred             hhccccccccccccccCcccccCHHHHcC
Confidence            6643221 223455689999999998764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-37  Score=277.70  Aligned_cols=177  Identities=26%  Similarity=0.395  Sum_probs=147.0

Q ss_pred             hhhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCe
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  254 (362)
                      .++|+..+.||+|+||+||+|+++      +++.||||++.... .....++|.+|++++++++||||++++++|...+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            457888999999999999999853      45789999986432 22234569999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCC
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR----------------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVK  312 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  312 (362)
                      .++||||+++|+|.+++....                      ...+++..+..++.|++.||+|||+.+   |||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999986322                      134889999999999999999999655   9999999


Q ss_pred             CCceeeCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          313 SNNILLNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       313 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |+|||+|.++.+||+|||+|+.+.+...........||+.|||||++.+
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  216 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence            9999999999999999999987754443334456789999999998653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=277.23  Aligned_cols=173  Identities=25%  Similarity=0.287  Sum_probs=145.8

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCC-CCCchhhHHHHHHHHh-cCccCcceeEEEEEecCCeeeEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITK-GSSHDNGLSAEIRTLG-KIRHRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  258 (362)
                      ++|+..+.||+|+||+||+|++. +++.||||++..... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888999999999999999874 688999999964321 1222334667777665 68999999999999999999999


Q ss_pred             EecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCC
Q 018036          259 YEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDT  338 (362)
Q Consensus       259 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  338 (362)
                      ||||++|+|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999643  45899999999999999999999665   999999999999999999999999999876532


Q ss_pred             CCceeeccccCccCccccccccc
Q 018036          339 GASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       339 ~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .  .......||+.|+|||++.+
T Consensus       157 ~--~~~~~~~gt~~y~aPE~~~~  177 (320)
T d1xjda_         157 D--AKTNTFCGTPDYIAPEILLG  177 (320)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTT
T ss_pred             c--ccccccCCCCCcCCHHHHcC
Confidence            2  22455689999999998864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-37  Score=271.95  Aligned_cols=168  Identities=30%  Similarity=0.406  Sum_probs=135.7

Q ss_pred             hhhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-CCeeeEEE
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLVY  259 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  259 (362)
                      .++|+..+.||+|+||.||+|.+ .++.||||+++..    ...+.+.+|++++++++|||||+++|+|.+ ++..++||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            45678889999999999999998 4788999998532    233459999999999999999999999865 45679999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCC
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTG  339 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  339 (362)
                      ||+++|+|.+++.......++|..+++|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999997544446899999999999999999999654   999999999999999999999999999876432 


Q ss_pred             CceeeccccCccCccccccccc
Q 018036          340 ASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       340 ~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                          .....+|+.|+|||++.+
T Consensus       157 ----~~~~~~~~~y~aPE~l~~  174 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALRE  174 (262)
T ss_dssp             ---------CCTTTSCHHHHHH
T ss_pred             ----CccccccccCCChHHHhC
Confidence                334568999999998754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=274.71  Aligned_cols=176  Identities=28%  Similarity=0.381  Sum_probs=136.4

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCC-
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKE-  253 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  253 (362)
                      ++|+..+.||+|+||+||+|.+.      +++.||||++..... ....+.+.+|...+.++ +|+|||.+++++...+ 
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            67888999999999999999853      346899999864322 22334577888888777 6899999999987654 


Q ss_pred             eeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeC
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLN  319 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  319 (362)
                      ..++|||||++|+|.++++...              ...+++..+..++.||++||+|||+.+   |+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            6789999999999999996432              235899999999999999999999655   99999999999999


Q ss_pred             CCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          320 SDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       320 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +++.+||+|||+|+...............||+.|||||++.+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  210 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  210 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence            999999999999997765444334556789999999998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=271.32  Aligned_cols=173  Identities=24%  Similarity=0.317  Sum_probs=132.0

Q ss_pred             hhhccccceeeccCcccEEEEEcCC----CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN----GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      .++|+..+.||+|+||+||+|++..    +..||||.+.... .....+.+.+|++++++++|||||++++++. .+..+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            3678889999999999999998643    3468888874332 2223456899999999999999999999996 46789


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|+|.+++... ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+|+...
T Consensus        84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999999987643 346899999999999999999999665   9999999999999999999999999999775


Q ss_pred             CCCCceeeccccCccCcccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~  360 (362)
                      .... .......||+.|+|||++.
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~  182 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESIN  182 (273)
T ss_dssp             ------------CCGGGCCHHHHH
T ss_pred             CCcc-eeccceecCcccchhhHhc
Confidence            3322 2244567899999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3e-36  Score=270.84  Aligned_cols=172  Identities=27%  Similarity=0.322  Sum_probs=144.9

Q ss_pred             hhccccceeeccCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEec
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYEY  261 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  261 (362)
                      ++|+..+.||+|+||+||+|++++++.||||++..........+.+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            67888999999999999999998999999999966544444456699999999999999999999999999999999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      +.++.+..+..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||.|........ 
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            98776666653  3456999999999999999999999665   99999999999999999999999999988754322 


Q ss_pred             eeeccccCccCcccccccc
Q 018036          342 ECMSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       342 ~~~~~~~Gt~~y~aPE~~~  360 (362)
                       ......||+.|+|||.+.
T Consensus       156 -~~~~~~~~~~y~~pE~~~  173 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLM  173 (286)
T ss_dssp             -------CCCTTCCHHHHT
T ss_pred             -ccceecccchhhhHHHHh
Confidence             234557999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-36  Score=271.61  Aligned_cols=173  Identities=28%  Similarity=0.427  Sum_probs=141.5

Q ss_pred             hhccccceeeccCcccEEEEEcCC-CC--EEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTPN-GE--QVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  257 (362)
                      ++|+..+.||+|+||+||+|++++ +.  .||||++...... ...+++.+|+++|.++ +|||||+++++|.+.+..++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            677888999999999999998753 33  5778887543322 2334599999999999 79999999999999999999


Q ss_pred             EEecCCCCChhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCc
Q 018036          258 VYEYMPNGSLGEVLHGK--------------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFE  323 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  323 (362)
                      ||||+++|+|.++++..              ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            99999999999999643              2357999999999999999999999655   999999999999999999


Q ss_pred             eEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          324 AHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       324 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +||+|||+|+.......   .....||+.|+|||.+.+
T Consensus       166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~  200 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNY  200 (309)
T ss_dssp             EEECCTTCEESSCEECC---C----CCTTTCCHHHHHH
T ss_pred             eEEcccccccccccccc---ccceecCCcccchHHhcc
Confidence            99999999987653221   334579999999998753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=269.31  Aligned_cols=171  Identities=23%  Similarity=0.349  Sum_probs=143.5

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCC----CchhhHHHHHHHHhcCc--cCcceeEEEEEecCCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGS----SHDNGLSAEIRTLGKIR--HRNIVRLKAFCSNKET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  254 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||++.......    ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5788999999999999999997 478999999987543221    12234789999999986  8999999999999999


Q ss_pred             eeEEEecCCC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-CCceEEcccccc
Q 018036          255 NLLVYEYMPN-GSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-DFEAHVADFGLA  332 (362)
Q Consensus       255 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla  332 (362)
                      .++||||+.+ +++.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence            9999999975 678888753  345899999999999999999999655   999999999999985 579999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....    .....+||+.|||||++.+
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~  183 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRY  183 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHH
T ss_pred             eecccc----cccccccCCCcCCHHHHcC
Confidence            876532    2456789999999998753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-36  Score=273.87  Aligned_cols=176  Identities=27%  Similarity=0.374  Sum_probs=150.3

Q ss_pred             hhccccceeeccCcccEEEEEc------CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEecCCe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT------PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSNKET  254 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  254 (362)
                      ++|+..+.||+|+||.||+|++      .+++.||||+++.... .....++.+|+.+++++ +|||||+++++|.+.+.
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            6788899999999999999975      3467899999864432 23344689999999999 69999999999999999


Q ss_pred             eeEEEecCCCCChhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceee
Q 018036          255 NLLVYEYMPNGSLGEVLHGKR----------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILL  318 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  318 (362)
                      .++|||||++|+|.++++...                ...+++..+..++.||+.||+|||.++   ++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986432                135899999999999999999999665   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          319 NSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       319 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.++.+|++|||+++..............+||+.|+|||++.+
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  221 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence            9999999999999998875544444556789999999998754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-36  Score=271.14  Aligned_cols=176  Identities=22%  Similarity=0.334  Sum_probs=148.4

Q ss_pred             hhccccceeeccCcccEEEEEcC------CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP------NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETN  255 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  255 (362)
                      ++|+..+.||+|+||+||+|.+.      ++..||||+++... .......+.+|++++++++|||||+++++|...+..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            67888899999999999999863      35789999986432 223334589999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEc
Q 018036          256 LLVYEYMPNGSLGEVLHGK--------RGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVA  327 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  327 (362)
                      ++||||+++|+|.+++...        ....+++..+.+++.|+++||.|||+.+   |+||||||+|||+|+++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999988532        1235789999999999999999999655   9999999999999999999999


Q ss_pred             cccccccccCCCCceeeccccCccCccccccccc
Q 018036          328 DFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       328 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      |||+|+.+.............||+.|+|||.+.+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~  209 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD  209 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHcc
Confidence            9999998765444443455679999999998653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-36  Score=269.08  Aligned_cols=177  Identities=25%  Similarity=0.357  Sum_probs=144.8

Q ss_pred             hhhccccceeeccCcccEEEEEcCC--------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcC-ccCcceeEEEEEec
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI-RHRNIVRLKAFCSN  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  251 (362)
                      .++|+..+.||+|+||.||+|+...        +..||||+++.... .....++.+|...+.++ +|||||+++++|.+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            4678889999999999999998522        24799998864322 22335688899999888 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCcee
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKR--------------GSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNIL  317 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  317 (362)
                      ++..++||||+++|+|.+++....              ...+++.+++.++.|++.||+|||+.+   ||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence            999999999999999999997543              245899999999999999999999665   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          318 LNSDFEAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       318 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.++.+||+|||+++...............||+.|+|||++.+
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~  211 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  211 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence            99999999999999998876555444566789999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-36  Score=265.87  Aligned_cols=174  Identities=26%  Similarity=0.342  Sum_probs=133.6

Q ss_pred             hhccccceeeccCcccEEEEEcC--CC--CEEEEEEeeccCCC-CCchhhHHHHHHHHhcCccCcceeEEEEEecCCeee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP--NG--EQVAVKKLLGITKG-SSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  256 (362)
                      ++|+..+.||+|+||+||+|++.  ++  ..||||++...... ....++|.+|++++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888899999999999999853  22  37899988654332 2334569999999999999999999999976 4678


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      +||||+++|++.+.+... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999999999999988643 345999999999999999999999655   9999999999999999999999999999876


Q ss_pred             CCCCcee-eccccCccCcccccccc
Q 018036          337 DTGASEC-MSAVAGSYGYIAPVLGW  360 (362)
Q Consensus       337 ~~~~~~~-~~~~~Gt~~y~aPE~~~  360 (362)
                      ....... .....||..|+|||++.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~  187 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLK  187 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHH
T ss_pred             cCCCcceecCccccCcccCCHHHHh
Confidence            4433222 33456888999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-35  Score=266.45  Aligned_cols=170  Identities=27%  Similarity=0.398  Sum_probs=139.6

Q ss_pred             cceeeccCcccEEEEEcCCC----CEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec-CCeeeEEEec
Q 018036          187 NNVIGRGGAGVVYRGVTPNG----EQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN-KETNLLVYEY  261 (362)
Q Consensus       187 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  261 (362)
                      .++||+|+||+||+|++.++    ..||||++.... .....++|.+|++++++++|||||+++|++.. ++..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            57899999999999987432    258999985422 23334569999999999999999999999875 5688999999


Q ss_pred             CCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCCc
Q 018036          262 MPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGAS  341 (362)
Q Consensus       262 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  341 (362)
                      |++|+|.+++.. .....++..+++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       111 ~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         111 MKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             eecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999999874 3445788899999999999999999554   999999999999999999999999999987543221


Q ss_pred             --eeeccccCccCccccccccc
Q 018036          342 --ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       342 --~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        .......||+.|+|||++.+
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~  208 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQT  208 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHH
T ss_pred             cceecccccccccccChHHHhc
Confidence              12334579999999998653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=263.03  Aligned_cols=173  Identities=26%  Similarity=0.336  Sum_probs=140.8

Q ss_pred             hhccccceeeccCcccEEEEEc-CC-CCEEEEEEeeccCCCCCchhhHHHHHHHHhcC---ccCcceeEEEEEec-----
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PN-GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKI---RHRNIVRLKAFCSN-----  251 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  251 (362)
                      ++|+..+.||+|+||+||+|++ .+ ++.||||+++...........+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6789999999999999999987 34 56799999876544444444477888887766   79999999999853     


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                      ....+++|||++++++..... .....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence            346789999998776654443 44566899999999999999999999665   99999999999999999999999999


Q ss_pred             cccccCCCCceeeccccCccCccccccccc
Q 018036          332 AKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++.....   .......||+.|||||++.+
T Consensus       163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~  189 (305)
T d1blxa_         163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQ  189 (305)
T ss_dssp             CCCCCGG---GGGCCCCCCCTTCCHHHHTT
T ss_pred             hhhhccc---ccCCCcccChhhcCcchhcC
Confidence            9865432   22456789999999998754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-35  Score=269.13  Aligned_cols=170  Identities=29%  Similarity=0.427  Sum_probs=139.2

Q ss_pred             HhhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC-----
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE-----  253 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  253 (362)
                      +.++|+..+.||+|+||+||+|.+ .+++.||||++..........+.+.+|+++|++++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            457889999999999999999997 46899999998654333333456889999999999999999999997665     


Q ss_pred             -eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          254 -TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       254 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                       ..++||||+ +.+|.++.+.   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||+|
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence             468999999 6788887753   34999999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....     .....||+.|+|||++++
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~  192 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILN  192 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHT
T ss_pred             eccCCc-----cccccccccccCHHHHcC
Confidence            876532     345689999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-34  Score=260.72  Aligned_cols=176  Identities=26%  Similarity=0.353  Sum_probs=141.8

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec--------
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN--------  251 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  251 (362)
                      .++|+..+.||+|+||+||+|++ .+++.||||++...........++.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57899999999999999999997 578999999986655444555668999999999999999999999865        


Q ss_pred             CCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccc
Q 018036          252 KETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGL  331 (362)
Q Consensus       252 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  331 (362)
                      .+..++||||++++.+....  .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            34578999999877665554  33456889999999999999999999665   99999999999999999999999999


Q ss_pred             cccccCCCCc--eeeccccCccCccccccccc
Q 018036          332 AKYLQDTGAS--ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       332 a~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ++........  ......+||+.|+|||++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~  195 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG  195 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcC
Confidence            9876532211  12344679999999998753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-34  Score=255.14  Aligned_cols=173  Identities=26%  Similarity=0.336  Sum_probs=149.8

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCCeeeEEEe
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKETNLLVYE  260 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  260 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||+++..........++.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5788899999999999999997 578899999997655444555678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccccccCCCC
Q 018036          261 YMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQDTGA  340 (362)
Q Consensus       261 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  340 (362)
                      ++.+++|..++..  .+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.|+.......
T Consensus        82 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            9999999888753  346889999999999999999999665   99999999999999999999999999998754322


Q ss_pred             ceeeccccCccCccccccccc
Q 018036          341 SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       341 ~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                        ......+++.|+|||++..
T Consensus       157 --~~~~~~~~~~~~~pe~~~~  175 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTT
T ss_pred             --cceeeccccchhhhhHhcc
Confidence              2344568889999998653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-34  Score=264.80  Aligned_cols=173  Identities=23%  Similarity=0.357  Sum_probs=139.0

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecCC----eee
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNKE----TNL  256 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  256 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||++.... .....+++.+|+++|++++||||+++++++....    ..+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            5688899999999999999986 579999999986432 2223346889999999999999999999997653    234


Q ss_pred             EEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccccc
Q 018036          257 LVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKYLQ  336 (362)
Q Consensus       257 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  336 (362)
                      ++++|+.+|+|.+++...   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            455566699999999643   4899999999999999999999665   9999999999999999999999999998765


Q ss_pred             CCCC-ceeeccccCccCccccccccc
Q 018036          337 DTGA-SECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~-~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .... .......+||+.|+|||++..
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~  186 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLN  186 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred             CCCccceeeccccccceechHHHhhc
Confidence            3222 122345679999999998743

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-33  Score=252.63  Aligned_cols=171  Identities=23%  Similarity=0.297  Sum_probs=142.7

Q ss_pred             hhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc-CcceeEEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||+||+|++. +++.||||.+.....    ...+.+|++.++.++| +|++.+++++......++||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            57888999999999999999964 688999998754322    2237889999999975 89999999999999999999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC-----CCceEEcccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS-----DFEAHVADFGLAKY  334 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DFGla~~  334 (362)
                      ||+ +++|.+++.. .+..+++.++..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        81 e~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          81 DLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999 7899999864 3456899999999999999999999554   999999999999974     57899999999998


Q ss_pred             ccCCCCc-----eeeccccCccCccccccccc
Q 018036          335 LQDTGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ..+....     ......+||+.|||||.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~  187 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG  187 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcC
Confidence            7643221     12345689999999998754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-33  Score=258.16  Aligned_cols=164  Identities=26%  Similarity=0.355  Sum_probs=139.7

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecC--CeeeE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNK--ETNLL  257 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l  257 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||+++..     ..+++.+|+++|++++ ||||+++++++...  ...++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            6799999999999999999997 56889999998532     2345899999999995 99999999999754  56889


Q ss_pred             EEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEcccccccccc
Q 018036          258 VYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAKYLQ  336 (362)
Q Consensus       258 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~  336 (362)
                      ||||+++++|.++..     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+|+...
T Consensus       110 v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         110 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            999999999987652     4899999999999999999999665   99999999999998655 68999999998775


Q ss_pred             CCCCceeeccccCccCccccccccc
Q 018036          337 DTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ...   .....+||+.|+|||.+.+
T Consensus       182 ~~~---~~~~~~~t~~y~aPE~~~~  203 (328)
T d3bqca1         182 PGQ---EYNVRVASRYFKGPELLVD  203 (328)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTT
T ss_pred             CCC---cccccccCccccCcccccC
Confidence            432   2456689999999998653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-34  Score=262.57  Aligned_cols=167  Identities=32%  Similarity=0.382  Sum_probs=134.8

Q ss_pred             hccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC------Cee
Q 018036          183 CVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK------ETN  255 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  255 (362)
                      .|+..++||+|+||+||+|++. +++.||||++.....      ...+|+++|++++|||||++++++...      .+.
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            5778899999999999999974 689999999864321      145799999999999999999998543      346


Q ss_pred             eEEEecCCCCChhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-ceEEccccccc
Q 018036          256 LLVYEYMPNGSLGEVLHG-KRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-EAHVADFGLAK  333 (362)
Q Consensus       256 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~  333 (362)
                      ++|||||+++.+..+... .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence            899999976543333321 23456999999999999999999999554   99999999999999775 89999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ......   .....+||+.|+|||++.+
T Consensus       172 ~~~~~~---~~~~~~gt~~y~aPE~~~~  196 (350)
T d1q5ka_         172 QLVRGE---PNVSYICSRYYRAPELIFG  196 (350)
T ss_dssp             ECCTTS---CCCSCCSCTTSCCHHHHTT
T ss_pred             hccCCc---ccccccccccccChHHhhc
Confidence            775332   2445689999999997653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=257.67  Aligned_cols=175  Identities=26%  Similarity=0.278  Sum_probs=147.4

Q ss_pred             hhhccccceeeccCcccEEEEEc----CCCCEEEEEEeeccCC--CCCchhhHHHHHHHHhcCcc-CcceeEEEEEecCC
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT----PNGEQVAVKKLLGITK--GSSHDNGLSAEIRTLGKIRH-RNIVRLKAFCSNKE  253 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~  253 (362)
                      +++|+..+.||+|+||+||+|+.    .+|+.||||.+.....  .....+.+.+|++++++++| |||+++++++.+.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            47799999999999999999975    2578999999864321  22233458899999999977 89999999999999


Q ss_pred             eeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccccccc
Q 018036          254 TNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAK  333 (362)
Q Consensus       254 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  333 (362)
                      ..+++|||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             ceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999999643  34778889999999999999999665   9999999999999999999999999998


Q ss_pred             cccCCCCceeeccccCccCccccccccc
Q 018036          334 YLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       334 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      .+..... .......||+.|+|||.+.+
T Consensus       178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~  204 (322)
T d1vzoa_         178 EFVADET-ERAYDFCGTIEYMAPDIVRG  204 (322)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTT
T ss_pred             hhccccc-ccccccccccccchhHHhhc
Confidence            7754322 22445679999999998753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=2.6e-32  Score=246.57  Aligned_cols=171  Identities=24%  Similarity=0.298  Sum_probs=137.1

Q ss_pred             hhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCccee-EEEEEecCCeeeEEE
Q 018036          182 ECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVR-LKAFCSNKETNLLVY  259 (362)
Q Consensus       182 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~  259 (362)
                      ++|+..+.||+|+||+||+|++ .+++.||||.+.....    .+++.+|+++++.++|+|++. +.++....+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4688899999999999999986 5688999998764322    234889999999998776555 555667788889999


Q ss_pred             ecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCC---CCceEEcccccccccc
Q 018036          260 EYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNS---DFEAHVADFGLAKYLQ  336 (362)
Q Consensus       260 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGla~~~~  336 (362)
                      ||+ +++|.+.+.. ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.   +..+||+|||+|+.+.
T Consensus        83 e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          83 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            999 5677776643 3356899999999999999999999665   999999999999863   4579999999999876


Q ss_pred             CCCCc-----eeeccccCccCccccccccc
Q 018036          337 DTGAS-----ECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       337 ~~~~~-----~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +....     .......||+.|||||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  187 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLG  187 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhC
Confidence            43322     12345689999999998754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.3e-33  Score=258.86  Aligned_cols=170  Identities=26%  Similarity=0.376  Sum_probs=140.2

Q ss_pred             hhhccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEecC-----Ce
Q 018036          181 LECVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSNK-----ET  254 (362)
Q Consensus       181 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  254 (362)
                      .++|+..+.||+|+||+||+|++ .+++.||||++..........+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999986 5789999999875544334445688999999999999999999998643     33


Q ss_pred             eeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          255 NLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       255 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      .+++|||+.+|+|.+++..   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence            4677788889999999954   34999999999999999999999665   99999999999999999999999999986


Q ss_pred             ccCCCCceeeccccCccCccccccccc
Q 018036          335 LQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       335 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      ....     .....||+.|+|||+..+
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~  192 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLN  192 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTT
T ss_pred             cCcc-----cccccccccccCchhhcC
Confidence            5432     445679999999997643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.7e-33  Score=256.81  Aligned_cols=171  Identities=27%  Similarity=0.347  Sum_probs=133.2

Q ss_pred             HhhhccccceeeccCcccEEEEEcC-CCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcceeEEEEEec------C
Q 018036          180 ILECVKDNNVIGRGGAGVVYRGVTP-NGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNIVRLKAFCSN------K  252 (362)
Q Consensus       180 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~  252 (362)
                      +.++|+..+.||+|+||+||+|.+. +|+.||||++...........++.+|+.++++++|||||++++++..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            4578999999999999999999975 68999999997655444444568899999999999999999999964      3


Q ss_pred             CeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEcccccc
Q 018036          253 ETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADFGLA  332 (362)
Q Consensus       253 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  332 (362)
                      ...|+||||+.+ ++.+.+.    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||++
T Consensus        95 ~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            678999999965 5555553    24899999999999999999999665   999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccCccCccccccccc
Q 018036          333 KYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       333 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                      +.....   ......+||+.|+|||++.+
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~  192 (355)
T d2b1pa1         167 RTAGTS---FMMTPYVVTRYYRAPEVILG  192 (355)
T ss_dssp             -----------------CCTTCCHHHHTT
T ss_pred             hccccc---cccccccccccccChhhhcC
Confidence            876532   22456679999999999865

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.93  E-value=6.1e-27  Score=216.55  Aligned_cols=169  Identities=20%  Similarity=0.232  Sum_probs=130.9

Q ss_pred             hccccceeeccCcccEEEEEc-CCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-----------cCcceeEEEEEe
Q 018036          183 CVKDNNVIGRGGAGVVYRGVT-PNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-----------HRNIVRLKAFCS  250 (362)
Q Consensus       183 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  250 (362)
                      +|+..+.||+|+||+||+|++ .+|+.||||+++...   ...+.+.+|+.++++++           |+||+++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            589999999999999999987 578999999985321   22345788998888775           578999998875


Q ss_pred             c--CCeeeEEEecCCCCC-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCC-----
Q 018036          251 N--KETNLLVYEYMPNGS-LGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDF-----  322 (362)
Q Consensus       251 ~--~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----  322 (362)
                      .  ....+++|+++..+. ............+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++     
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence            4  355667776664443 33333334456789999999999999999999961  3499999999999998654     


Q ss_pred             -ceEEccccccccccCCCCceeeccccCccCccccccccc
Q 018036          323 -EAHVADFGLAKYLQDTGASECMSAVAGSYGYIAPVLGWY  361 (362)
Q Consensus       323 -~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~  361 (362)
                       .++++|||.+......     ....+||+.|+|||++.+
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~  203 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLG  203 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHT
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccc
Confidence             3999999999866432     345679999999998753

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.6e-24  Score=181.99  Aligned_cols=134  Identities=16%  Similarity=0.193  Sum_probs=104.4

Q ss_pred             ccceeeccCcccEEEEEcCCCCEEEEEEeeccCCC----CC------------chhhHHHHHHHHhcCccCcceeEEEEE
Q 018036          186 DNNVIGRGGAGVVYRGVTPNGEQVAVKKLLGITKG----SS------------HDNGLSAEIRTLGKIRHRNIVRLKAFC  249 (362)
Q Consensus       186 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~------------~~~~~~~e~~~l~~l~h~niv~l~~~~  249 (362)
                      .++.||+|+||+||+|.+.+|+.||||.++.....    ..            ......+|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            46899999999999999888999999987532110    00            012245688899999999999988663


Q ss_pred             ecCCeeeEEEecCCCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEeCCCCCceeeCCCCceEEccc
Q 018036          250 SNKETNLLVYEYMPNGSLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHDCSPLIIHRDVKSNNILLNSDFEAHVADF  329 (362)
Q Consensus       250 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  329 (362)
                      .    .+++|||+++..+.+         +++..+..++.|++.+++|||+.+   |+||||||+|||++++ .++|+||
T Consensus        84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred             C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence            2    379999998765543         233445678999999999999665   9999999999999965 5899999


Q ss_pred             ccccccc
Q 018036          330 GLAKYLQ  336 (362)
Q Consensus       330 Gla~~~~  336 (362)
                      |.|....
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9998764

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.73  E-value=1.4e-18  Score=156.57  Aligned_cols=110  Identities=31%  Similarity=0.471  Sum_probs=102.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|.+.|.+|..++.+++|+.|++++|+++|.+| +++.+++|+.|||++|+|+|.+|++++++++|++|||++|+|+|
T Consensus       204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g  282 (313)
T d1ogqa_         204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG  282 (313)
T ss_dssp             CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred             ccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence            35778888999999999999999999999998776 68999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccCCccCCCCCCCCCCCCCc
Q 018036           81 EIPEFGQYSFFNSTSFTGNPHLCGSYLNPCN  111 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~~lc~~~l~~c~  111 (362)
                      .+|+.+.++.+....+.||+.+||.|+++|.
T Consensus       283 ~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~  313 (313)
T d1ogqa_         283 EIPQGGNLQRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             ECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred             cCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence            9999988899999999999999999888883

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.47  E-value=5.2e-14  Score=108.34  Aligned_cols=95  Identities=21%  Similarity=0.352  Sum_probs=79.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++ .+| .++++++|++|||++|+|+ .+|+.++.+++|+.|+|++|.++ .+|. ++++++|+.|++++|+++.
T Consensus         5 Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~   79 (124)
T d1dcea3           5 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ   79 (124)
T ss_dssp             CTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCS
T ss_pred             cCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCccCC
Confidence            6899998 777 5999999999999999999 79999999999999999999998 5774 8999999999999999986


Q ss_pred             CCC--CCCcccccccCCccCCC
Q 018036           81 EIP--EFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p--~~~~~~~~~~~~~~~n~  100 (362)
                      ..+  .+..+..+....+.||+
T Consensus        80 ~~~~~~l~~~~~L~~L~l~~N~  101 (124)
T d1dcea3          80 SAAIQPLVSCPRLVLLNLQGNS  101 (124)
T ss_dssp             SSTTGGGGGCTTCCEEECTTSG
T ss_pred             CCCchhhcCCCCCCEEECCCCc
Confidence            432  23334445556677775

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.44  E-value=3.1e-14  Score=127.62  Aligned_cols=99  Identities=29%  Similarity=0.563  Sum_probs=84.5

Q ss_pred             CCCCcccc--cCCcccccccCCCEEECcC-CcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCc
Q 018036            1 MSRNNFSG--IIPVEIGHCLLLTYLDLSQ-NHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNN   77 (362)
Q Consensus         1 l~~n~~~g--~ip~~~~~l~~l~~l~l~~-n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~   77 (362)
                      |++|+++|  .||+++++|++|++|||++ |+|+|.||++|++|++|++|||++|+++|..|..+.++..|+.+++++|+
T Consensus        57 L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~  136 (313)
T d1ogqa_          57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence            46788888  6899999999999999986 89999999999999999999999999999888889999999999999999


Q ss_pred             ccCCCCC-CCcccccccCCccCC
Q 018036           78 FSGEIPE-FGQYSFFNSTSFTGN   99 (362)
Q Consensus        78 l~g~~p~-~~~~~~~~~~~~~~n   99 (362)
                      +.+.+|. +..+..+....+.+|
T Consensus       137 ~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_         137 LSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EESCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccCchhhccCcccceeecccc
Confidence            9999885 333444444444444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.43  E-value=9.6e-14  Score=115.41  Aligned_cols=104  Identities=20%  Similarity=0.290  Sum_probs=67.1

Q ss_pred             CCCCcccccCCc-ccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPV-EIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~-~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|++++.++. .++++++|+.|+|++|++++..|..+..+++|+.|+|++|++++-.|..|.++++|+.|+|++|+|+
T Consensus        36 Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~  115 (192)
T d1w8aa_          36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS  115 (192)
T ss_dssp             CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred             eCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCcccc
Confidence            466777655543 3566777777777777777666667777777777777777776433445677777777777777777


Q ss_pred             CCCCCC-CcccccccCCccCCCCCCC
Q 018036           80 GEIPEF-GQYSFFNSTSFTGNPHLCG  104 (362)
Q Consensus        80 g~~p~~-~~~~~~~~~~~~~n~~lc~  104 (362)
                      +.+|.. ..+..+....+.+|+..|.
T Consensus       116 ~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_         116 CVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             EECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             ccCHHHhcCCcccccccccccccccc
Confidence            766642 3344445555666665553

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.28  E-value=4.8e-12  Score=97.08  Aligned_cols=77  Identities=19%  Similarity=0.262  Sum_probs=69.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcc--hhhcCCCCCCEEEccCCcc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLP--KEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p--~~~~~~~~l~~l~ls~n~l   78 (362)
                      |++|.++ .+|+.++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|+++ .+|  ..++.+++|+.|++++|.+
T Consensus        27 ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~l~~N~i  102 (124)
T d1dcea3          27 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL  102 (124)
T ss_dssp             CCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             CCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEECCCCcC
Confidence            6899998 89999999999999999999999 577 5999999999999999998 465  4689999999999999999


Q ss_pred             cCC
Q 018036           79 SGE   81 (362)
Q Consensus        79 ~g~   81 (362)
                      +..
T Consensus       103 ~~~  105 (124)
T d1dcea3         103 CQE  105 (124)
T ss_dssp             GGS
T ss_pred             CcC
Confidence            864

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=9.8e-12  Score=99.34  Aligned_cols=102  Identities=17%  Similarity=0.135  Sum_probs=82.5

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCc-ccccCc-hhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCccc
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNH-LSGPIP-VQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~-l~g~ip-~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      +++++. .+|..+..+++|++|+|++|+ |+ .|| ..|.++++|+.|+|++|+|+.--|..|..+++|++|+|++|+|+
T Consensus        16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             CSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             cCCCCc-cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence            456666 789999999999999998764 88 555 57999999999999999999544567999999999999999999


Q ss_pred             CCCCCCCcccccccCCccCCCCCCCC
Q 018036           80 GEIPEFGQYSFFNSTSFTGNPHLCGS  105 (362)
Q Consensus        80 g~~p~~~~~~~~~~~~~~~n~~lc~~  105 (362)
                      ...+.......+..+.+.+||.-|..
T Consensus        94 ~l~~~~~~~~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          94 SLSWKTVQGLSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             ccChhhhccccccccccCCCcccCCc
Confidence            76665544334556778899987753

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.20  E-value=3.6e-12  Score=105.61  Aligned_cols=83  Identities=25%  Similarity=0.370  Sum_probs=74.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++.+|..+..+++|++|+|++|+|++-.|..|.++++|+.|+|++|+|++-.|..|..+++|++|+|++|.+..
T Consensus        61 L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             ccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence            67899998888899999999999999999997667789999999999999999996445568999999999999999987


Q ss_pred             CCC
Q 018036           81 EIP   83 (362)
Q Consensus        81 ~~p   83 (362)
                      ..+
T Consensus       141 ~~~  143 (192)
T d1w8aa_         141 NCH  143 (192)
T ss_dssp             SGG
T ss_pred             ccc
Confidence            554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.17  E-value=9.6e-12  Score=109.47  Aligned_cols=104  Identities=19%  Similarity=0.221  Sum_probs=82.9

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|++++..|..+..+++|+.|+|++|+|++..|..+..+++|+.|++++|++++..|..|..+++|+.||+++|++++
T Consensus       136 l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~  215 (284)
T d1ozna_         136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA  215 (284)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             hccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccc
Confidence            46788885445567788889999999999987777788889999999999999988778888888999999999999988


Q ss_pred             CCCC-CCcccccccCCccCCCCCCC
Q 018036           81 EIPE-FGQYSFFNSTSFTGNPHLCG  104 (362)
Q Consensus        81 ~~p~-~~~~~~~~~~~~~~n~~lc~  104 (362)
                      .+|. +.....+....+.+|+.-|.
T Consensus       216 ~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         216 LPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             CCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             ccccccccccccCEEEecCCCCCCC
Confidence            7764 34455566667788887774

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.17  E-value=7.9e-12  Score=100.56  Aligned_cols=76  Identities=14%  Similarity=0.155  Sum_probs=45.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchh-hcCCCCCCEEEccCCccc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKE-MGNMKSLTSADFSHNNFS   79 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~-~~~~~~l~~l~ls~n~l~   79 (362)
                      |++|+++ .||.....+++|+.||||+|+++ .++ .+..+++|+.|+|++|+++ .+|+. +..+++|+.|++++|+++
T Consensus        25 L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~  100 (162)
T d1a9na_          25 LRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV  100 (162)
T ss_dssp             CTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC
T ss_pred             CCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccceecccccc
Confidence            4556665 55554455666666666666666 453 3566666666666666665 34443 345666666666666665


Q ss_pred             C
Q 018036           80 G   80 (362)
Q Consensus        80 g   80 (362)
                      .
T Consensus       101 ~  101 (162)
T d1a9na_         101 E  101 (162)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=5.6e-11  Score=103.46  Aligned_cols=90  Identities=21%  Similarity=0.187  Sum_probs=62.5

Q ss_pred             cccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCCCCCCcccccccCC
Q 018036           16 HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNSTS   95 (362)
Q Consensus        16 ~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~   95 (362)
                      .+.+|+.|++++|.+++.-|..+..+++|+.|++++|++++..|..+..+++|+.|||++|+|+..++.+.....+..+.
T Consensus       122 ~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~  201 (266)
T d1p9ag_         122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAF  201 (266)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEE
T ss_pred             cccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEE
Confidence            33444444444455553333445667888889999999986555668888999999999999984444455566667778


Q ss_pred             ccCCCCCCCC
Q 018036           96 FTGNPHLCGS  105 (362)
Q Consensus        96 ~~~n~~lc~~  105 (362)
                      +.|||..|..
T Consensus       202 L~~Np~~CdC  211 (266)
T d1p9ag_         202 LHGNPWLCNC  211 (266)
T ss_dssp             CCSCCBCCSG
T ss_pred             ecCCCCCCCc
Confidence            8899988863

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.06  E-value=1.9e-10  Score=101.95  Aligned_cols=80  Identities=20%  Similarity=0.201  Sum_probs=72.2

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|..++.+|..+..++.++.|++++|.+++..|..+.++++|+.|+|++|+|+ +||.++.++++|+.|+|++|+|+.
T Consensus       178 l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             CCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence            4678888888888999999999999999999877888999999999999999998 799999999999999999999985


Q ss_pred             C
Q 018036           81 E   81 (362)
Q Consensus        81 ~   81 (362)
                      .
T Consensus       257 i  257 (305)
T d1xkua_         257 I  257 (305)
T ss_dssp             C
T ss_pred             c
Confidence            4

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=4.9e-10  Score=89.20  Aligned_cols=77  Identities=21%  Similarity=0.156  Sum_probs=65.5

Q ss_pred             CCCC-cccccCC-cccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcc
Q 018036            1 MSRN-NFSGIIP-VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNF   78 (362)
Q Consensus         1 l~~n-~~~g~ip-~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l   78 (362)
                      |++| .++ .|| ..|.++++|+.|+|++|+|+.--|..+..+++|+.|||++|+|+ .+|..+....+|+.|+|++|.|
T Consensus        38 l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          38 IENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL  115 (156)
T ss_dssp             CCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred             cCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcc
Confidence            3445 477 555 56899999999999999999655777999999999999999998 7888776667899999999988


Q ss_pred             c
Q 018036           79 S   79 (362)
Q Consensus        79 ~   79 (362)
                      .
T Consensus       116 ~  116 (156)
T d2ifga3         116 H  116 (156)
T ss_dssp             C
T ss_pred             c
Confidence            4

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.95  E-value=4e-10  Score=98.79  Aligned_cols=83  Identities=18%  Similarity=0.166  Sum_probs=76.5

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|++++-.|..+..+++|+.|+|++|++++..|..|..+++|++||+++|++++..|..++++++|++|++++|.+.+
T Consensus       160 l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             cccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            57899997777788999999999999999999999999999999999999999998777789999999999999999987


Q ss_pred             CCC
Q 018036           81 EIP   83 (362)
Q Consensus        81 ~~p   83 (362)
                      .-+
T Consensus       240 ~C~  242 (284)
T d1ozna_         240 DCR  242 (284)
T ss_dssp             SGG
T ss_pred             Ccc
Confidence            654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.93  E-value=7.1e-10  Score=96.29  Aligned_cols=79  Identities=20%  Similarity=0.170  Sum_probs=69.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|.+++-.|..+..+++|+.|++++|+|++..|..+..+++|++|||++|+|+ .||.++..+++|+.|+|++|.+.-
T Consensus       131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            4678888444555678999999999999999877778999999999999999999 899999999999999999998753

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.91  E-value=7.9e-10  Score=88.54  Aligned_cols=77  Identities=21%  Similarity=0.148  Sum_probs=66.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcch--hhcCCCCCCEEEccCCc
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK--EMGNMKSLTSADFSHNN   77 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~--~~~~~~~l~~l~ls~n~   77 (362)
                      |++|+++ .++ .+..+++|++|+|++|+++. +|+ .+..+++|+.|+|++|+++ .++.  .+..+++|+.|++++|.
T Consensus        48 Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~  123 (162)
T d1a9na_          48 FSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNP  123 (162)
T ss_dssp             CCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSG
T ss_pred             CCCCCCC-ccC-CcccCcchhhhhcccccccC-CCccccccccccccceecccccc-ccccccccccccccchhhcCCCc
Confidence            6899998 675 58899999999999999994 554 4578999999999999997 5664  68899999999999999


Q ss_pred             ccCC
Q 018036           78 FSGE   81 (362)
Q Consensus        78 l~g~   81 (362)
                      ++..
T Consensus       124 i~~~  127 (162)
T d1a9na_         124 VTNK  127 (162)
T ss_dssp             GGGS
T ss_pred             cccc
Confidence            8754

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.84  E-value=2e-09  Score=97.87  Aligned_cols=91  Identities=21%  Similarity=0.332  Sum_probs=66.5

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE   81 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~   81 (362)
                      ++|++++ + ..+..+++++.|+|++|++++ ++ .+..+++|+.|+|++|++++ +| +++++++|+.|++++|++++.
T Consensus       293 ~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l  366 (384)
T d2omza2         293 NENQLED-I-SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL  366 (384)
T ss_dssp             CSSCCSC-C-GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred             ccccccc-c-cccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCC
Confidence            3455553 2 357778888999999999985 44 38889999999999999874 65 588899999999999999887


Q ss_pred             CCCCCcccccccCCccCC
Q 018036           82 IPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        82 ~p~~~~~~~~~~~~~~~n   99 (362)
                      +| +..+..+..+...+|
T Consensus       367 ~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         367 TP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GG-GTTCTTCSEEECCCE
T ss_pred             hh-hccCCCCCEeeCCCC
Confidence            66 444444444444433

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.82  E-value=4.1e-11  Score=99.57  Aligned_cols=66  Identities=17%  Similarity=0.191  Sum_probs=49.1

Q ss_pred             cccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036           12 VEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        12 ~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      .++..+++|++|+|++|+++ .|+ .+..+++|+.|+|++|.++ .+|.....+++|+.|++++|+++.
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~  107 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS  107 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC
T ss_pred             hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc
Confidence            45777888888888888887 665 4777888888888888876 677655555667777777777765

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.81  E-value=1.7e-08  Score=86.94  Aligned_cols=132  Identities=16%  Similarity=0.113  Sum_probs=91.5

Q ss_pred             cCcccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEEEecCCCCChhhhh
Q 018036          193 GGAGVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLVYEYMPNGSLGEVL  271 (362)
Q Consensus       193 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  271 (362)
                      ++.+.||+... +++.+++|+..........  .+.+|...+..+. +--+.+++.+...++..++||+++++.++.+..
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~--~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTY--DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTT--CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchh--hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence            33468999875 5566788877544333222  3788888877663 434677888888889999999999998886654


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 018036          272 HGKRGSFLKWEMRLKIAIEAAKGLSYLHHDC-------------------------------------------------  302 (362)
Q Consensus       272 ~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------------  302 (362)
                      ...       .....++.++++.++.||+..                                                 
T Consensus       102 ~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         102 EDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             TTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             ccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            211       112334556666666666421                                                 


Q ss_pred             -------CCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          303 -------SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       303 -------~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                             ...++|+|+.|.|||+++++..-|+||+.+..
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                   12378999999999999876677999998765

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.75  E-value=4.8e-09  Score=95.26  Aligned_cols=70  Identities=21%  Similarity=0.375  Sum_probs=61.8

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN   76 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n   76 (362)
                      |++|++++ ++ .+..+++|++|+|++|+|+ .+| .++++++|++|+|++|++++ +|+ +.++++|+.|+|++|
T Consensus       314 ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~-l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         314 LYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISD-LTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEECCCE
T ss_pred             CCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCC-Chh-hccCCCCCEeeCCCC
Confidence            57899985 44 4889999999999999999 466 69999999999999999996 544 899999999999998

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.72  E-value=1.1e-08  Score=90.30  Aligned_cols=97  Identities=18%  Similarity=0.239  Sum_probs=79.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +++|+++ .+|..+  +++|+.|++++|..++.+|..+..++.++.|++++|.+++..|..+..+++|+.|+|++|+|+.
T Consensus       157 l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~  233 (305)
T d1xkua_         157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK  233 (305)
T ss_dssp             CCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS
T ss_pred             cccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc
Confidence            3567776 677554  6789999999999999999999999999999999999997667788999999999999999986


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      .++.+..+..+....+.+|.
T Consensus       234 lp~~l~~l~~L~~L~Ls~N~  253 (305)
T d1xkua_         234 VPGGLADHKYIQVVYLHNNN  253 (305)
T ss_dssp             CCTTTTTCSSCCEEECCSSC
T ss_pred             cccccccccCCCEEECCCCc
Confidence            65556666666666676664

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.64  E-value=4.4e-08  Score=80.78  Aligned_cols=61  Identities=20%  Similarity=0.247  Sum_probs=32.8

Q ss_pred             cccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036           16 HCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        16 ~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      .+.+|++|++++|.++ .++ .+..+++|++|+|++|++++ +|+ ++++++|+.|++++|.+..
T Consensus        38 ~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~   98 (199)
T d2omxa2          38 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD   98 (199)
T ss_dssp             HHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC
T ss_pred             HhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCccccccccccccccc
Confidence            4455555555555555 343 35555555555555555553 332 5555555555555555543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.62  E-value=1.4e-09  Score=90.13  Aligned_cols=95  Identities=23%  Similarity=0.273  Sum_probs=76.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|+++ .|| .+..|++|+.|+|++|+++ .||.....+++|+.|++++|+++ .++ .+..+++|+.|++++|+++.
T Consensus        55 Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~  129 (198)
T d1m9la_          55 LSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITN  129 (198)
T ss_dssp             CSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCC
T ss_pred             CcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhcc
Confidence            5788888 776 5899999999999999998 78887777889999999999998 465 47888999999999999975


Q ss_pred             CC--CCCCcccccccCCccCCC
Q 018036           81 EI--PEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~--p~~~~~~~~~~~~~~~n~  100 (362)
                      ..  ..+..+..+....+.||+
T Consensus       130 ~~~~~~l~~l~~L~~L~L~~N~  151 (198)
T d1m9la_         130 WGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             HHHHHHHTTTTTCSEEEECSSH
T ss_pred             ccccccccCCCccceeecCCCc
Confidence            32  233445556666777775

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.62  E-value=3.8e-08  Score=81.92  Aligned_cols=90  Identities=12%  Similarity=0.180  Sum_probs=54.5

Q ss_pred             CCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCC
Q 018036            3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEI   82 (362)
Q Consensus         3 ~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~   82 (362)
                      .+.+++.++.  ..+.+|+.|++++|.++ .++ .+..+++|+.|+|++|++++ +|+ ++.+++|+.|++++|++++ +
T Consensus        33 ~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~~-l  105 (210)
T d1h6ta2          33 KKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-L  105 (210)
T ss_dssp             CSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-G
T ss_pred             cCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-ccc-cccCccccccccccccccc-c
Confidence            4445544443  34667777777777776 344 36677777777777777764 553 5677777777777777765 3


Q ss_pred             CCCCcccccccCCccCC
Q 018036           83 PEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        83 p~~~~~~~~~~~~~~~n   99 (362)
                      |.+..+..+......+|
T Consensus       106 ~~l~~l~~L~~L~l~~~  122 (210)
T d1h6ta2         106 SSLKDLKKLKSLSLEHN  122 (210)
T ss_dssp             GGGTTCTTCCEEECTTS
T ss_pred             ccccccccccccccccc
Confidence            33443444444444444

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.61  E-value=2.2e-08  Score=84.43  Aligned_cols=76  Identities=17%  Similarity=0.318  Sum_probs=61.3

Q ss_pred             CCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCC
Q 018036            2 SRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGE   81 (362)
Q Consensus         2 ~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~   81 (362)
                      +++.+...  ..+..+++|+.|++++|++++. + .++++++|+.|||++|++++ +|. +.++++|+.|+|++|++++.
T Consensus       137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i  210 (227)
T d1h6ua2         137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV  210 (227)
T ss_dssp             CSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC
T ss_pred             hhhhhchh--hhhccccccccccccccccccc-h-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCC
Confidence            34555432  2467889999999999999843 3 38999999999999999984 665 88999999999999999975


Q ss_pred             CC
Q 018036           82 IP   83 (362)
Q Consensus        82 ~p   83 (362)
                      .|
T Consensus       211 ~~  212 (227)
T d1h6ua2         211 SP  212 (227)
T ss_dssp             GG
T ss_pred             cc
Confidence            44

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.59  E-value=3e-08  Score=83.55  Aligned_cols=81  Identities=19%  Similarity=0.256  Sum_probs=54.3

Q ss_pred             cccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCCCCCCccccccc
Q 018036           14 IGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPEFGQYSFFNS   93 (362)
Q Consensus        14 ~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~   93 (362)
                      +...+.+..++++++.+....  .+.++++|+.|++++|.+++ ++ .++++++|+.|||++|++++. |.+..+..+..
T Consensus       125 ~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~  199 (227)
T d1h6ua2         125 LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISDI-SPLASLPNLIE  199 (227)
T ss_dssp             GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCE
T ss_pred             hccccchhhhhchhhhhchhh--hhcccccccccccccccccc-ch-hhcccccceecccCCCccCCC-hhhcCCCCCCE
Confidence            456677788888888776433  36677788888888887763 33 367778888888888887763 43444455555


Q ss_pred             CCccCC
Q 018036           94 TSFTGN   99 (362)
Q Consensus        94 ~~~~~n   99 (362)
                      +.+.+|
T Consensus       200 L~Ls~N  205 (227)
T d1h6ua2         200 VHLKNN  205 (227)
T ss_dssp             EECTTS
T ss_pred             EECcCC
Confidence            555555

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.56  E-value=7.3e-08  Score=79.43  Aligned_cols=93  Identities=19%  Similarity=0.270  Sum_probs=71.7

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.++ .++ .+..+++|++|+|++|++++ +|+ ++++++|++|++++|.+. .+|. +..++.|+.|++++|.+..
T Consensus        47 l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~  120 (199)
T d2omxa2          47 ADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITD  120 (199)
T ss_dssp             CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCC
T ss_pred             CCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-cccc-ccccccccccccccccccc
Confidence            4567776 564 58889999999999999995 553 899999999999999987 5664 8899999999999998876


Q ss_pred             CCCCCCcccccccCCccCCC
Q 018036           81 EIPEFGQYSFFNSTSFTGNP  100 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n~  100 (362)
                      ..+ ...+..+....+.+|.
T Consensus       121 ~~~-~~~l~~L~~L~l~~n~  139 (199)
T d2omxa2         121 IDP-LKNLTNLNRLELSSNT  139 (199)
T ss_dssp             CGG-GTTCTTCSEEECCSSC
T ss_pred             ccc-cchhhhhHHhhhhhhh
Confidence            433 4444445555555553

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.47  E-value=5.5e-07  Score=76.69  Aligned_cols=131  Identities=18%  Similarity=0.097  Sum_probs=86.5

Q ss_pred             eeeccCc-ccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCcc--CcceeEEEEEecCCeeeEEEecCCCC
Q 018036          189 VIGRGGA-GVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRH--RNIVRLKAFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       189 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  265 (362)
                      .+..|.. +.||+....++..+++|......     ...+..|...++.+..  -.+.+++++..+++..++|||+++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3445543 57899998888888888753221     2237788888877743  33567788888888899999999886


Q ss_pred             ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 018036          266 SLGEVLHGKRGSFLKWEMRLKIAIEAAKGLSYLHHD--------------------------------------------  301 (362)
Q Consensus       266 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  301 (362)
                      ++.+..       ...   ...+.++++.|+-||..                                            
T Consensus        92 ~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          92 DLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             ETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            654321       111   11222333333333321                                            


Q ss_pred             -----------CCCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          302 -----------CSPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       302 -----------~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                                 ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                       022379999999999999876678999998765

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.45  E-value=1.9e-07  Score=77.56  Aligned_cols=92  Identities=15%  Similarity=0.295  Sum_probs=68.1

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.+++ +| .++.+++|++|+|++|+++ .+| .+..+++|+.|++++|.++ .++ .+..++.|+.+++++|.+++
T Consensus        75 L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~  148 (210)
T d1h6ta2          75 LNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD  148 (210)
T ss_dssp             CCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC
T ss_pred             CCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-cccccccccccccccccccc
Confidence            57889984 66 4788999999999999998 577 5888999999999999886 444 47778888888888888775


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                      .. ....+..+....+.+|
T Consensus       149 ~~-~~~~l~~L~~l~l~~n  166 (210)
T d1h6ta2         149 IT-VLSRLTKLDTLSLEDN  166 (210)
T ss_dssp             CG-GGGGCTTCSEEECCSS
T ss_pred             cc-cccccccccccccccc
Confidence            43 2333334444444444

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.33  E-value=7e-07  Score=79.28  Aligned_cols=86  Identities=26%  Similarity=0.279  Sum_probs=58.4

Q ss_pred             CCCCcccccCCcccccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccC
Q 018036            1 MSRNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus         1 l~~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      |++|.++ ++|+.   +++|++|+|++|+|+ .||..+   .+|+.|++++|+++ .|+. +  .+.|++|++++|.++.
T Consensus        45 Ls~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~~  112 (353)
T d1jl5a_          45 LNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLEK  112 (353)
T ss_dssp             CTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCSS
T ss_pred             eCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--cccccccccccccccc
Confidence            5788887 78853   568899999999999 888765   46777778888776 4553 1  1358888888888874


Q ss_pred             CCCCCCcccccccCCccCC
Q 018036           81 EIPEFGQYSFFNSTSFTGN   99 (362)
Q Consensus        81 ~~p~~~~~~~~~~~~~~~n   99 (362)
                       +|....+..+......+|
T Consensus       113 -lp~~~~l~~L~~L~l~~~  130 (353)
T d1jl5a_         113 -LPELQNSSFLKIIDVDNN  130 (353)
T ss_dssp             -CCCCTTCTTCCEEECCSS
T ss_pred             -ccchhhhccceeeccccc
Confidence             454444444443333333

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=3.7e-08  Score=78.47  Aligned_cols=66  Identities=24%  Similarity=0.185  Sum_probs=35.4

Q ss_pred             cccCCCEEECcCCcccc--cCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCcccCCC
Q 018036           16 HCLLLTYLDLSQNHLSG--PIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFSGEI   82 (362)
Q Consensus        16 ~l~~l~~l~l~~n~l~g--~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~g~~   82 (362)
                      ++++|++||||+|+++.  .++..+..+++|+.|||++|+++ ++++ .......|+.|++++|.++...
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~  131 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTF  131 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCc
Confidence            45566666666666652  12334555666666666666665 3443 2223334566666666665443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.14  E-value=1.5e-06  Score=76.97  Aligned_cols=61  Identities=25%  Similarity=0.304  Sum_probs=48.7

Q ss_pred             ccccCCCEEECcCCcccccCchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCCcccCCCCC
Q 018036           15 GHCLLLTYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHNNFSGEIPE   84 (362)
Q Consensus        15 ~~l~~l~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n~l~g~~p~   84 (362)
                      ..+++|++|+|++|+|+ .||..   +++|+.|+|++|+|+ +||..   +++|+.|++++|+|+. +|.
T Consensus       281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~  341 (353)
T d1jl5a_         281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPD  341 (353)
T ss_dssp             CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCC
T ss_pred             ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCc
Confidence            34678999999999998 78864   567888999999997 78864   4678899999999884 453

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.10  E-value=8.5e-07  Score=74.87  Aligned_cols=93  Identities=15%  Similarity=0.141  Sum_probs=67.7

Q ss_pred             CCcccccCCcccccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcch-hhcCCCCCCEEEcc-CCccc
Q 018036            3 RNNFSGIIPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFS-HNNFS   79 (362)
Q Consensus         3 ~n~~~g~ip~~~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls-~n~l~   79 (362)
                      +++++ .||.++-  +++++|||++|+++ .||. .+.++++|++|+|++|.+...+|. .+..++.++.++++ .|++.
T Consensus        17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~   92 (242)
T d1xwdc1          17 ESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL   92 (242)
T ss_dssp             SCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred             CCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence            45677 8887663  58999999999998 5665 688999999999999999876765 57788899998876 46777


Q ss_pred             CCCCCC-CcccccccCCccCC
Q 018036           80 GEIPEF-GQYSFFNSTSFTGN   99 (362)
Q Consensus        80 g~~p~~-~~~~~~~~~~~~~n   99 (362)
                      ...|.. ..+..+....+.+|
T Consensus        93 ~~~~~~~~~l~~L~~l~l~~~  113 (242)
T d1xwdc1          93 YINPEAFQNLPNLQYLLISNT  113 (242)
T ss_dssp             EECTTSEECCTTCCEEEEESC
T ss_pred             ccccccccccccccccccchh
Confidence            666543 23334444444444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.07  E-value=1.3e-06  Score=73.59  Aligned_cols=58  Identities=16%  Similarity=0.230  Sum_probs=29.5

Q ss_pred             CEEECcCCcccccCchhhhcccccCeeeccccccccCcch-hhcCCCCCCEEEccCCcccCCC
Q 018036           21 TYLDLSQNHLSGPIPVQITQIHILNYLNVSWNQLNASLPK-EMGNMKSLTSADFSHNNFSGEI   82 (362)
Q Consensus        21 ~~l~l~~n~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~-~~~~~~~l~~l~ls~n~l~g~~   82 (362)
                      +.++.+++.|+ .+|..+.  +++++|||++|+++ .+|. .|.++++|++|++++|.+...+
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i   69 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVI   69 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEE
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhcccccccee
Confidence            45555555555 5554432  34555555555554 3443 3455555555555555554433

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.99  E-value=1.5e-05  Score=72.18  Aligned_cols=77  Identities=17%  Similarity=0.145  Sum_probs=48.5

Q ss_pred             ceeeccCcccEEEEEcCC-CCEEEEEEeeccCC-----CCCchhhHHHHHHHHhcCc-c--CcceeEEEEEecCCeeeEE
Q 018036          188 NVIGRGGAGVVYRGVTPN-GEQVAVKKLLGITK-----GSSHDNGLSAEIRTLGKIR-H--RNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  258 (362)
                      +.||.|....||+....+ ++.++||.-....+     .....++...|.+.|+.+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998754 67899997543211     1112234567888777662 2  345566654  44556899


Q ss_pred             EecCCCCC
Q 018036          259 YEYMPNGS  266 (362)
Q Consensus       259 ~e~~~~gs  266 (362)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.94  E-value=1.9e-06  Score=68.26  Aligned_cols=75  Identities=19%  Similarity=0.177  Sum_probs=56.7

Q ss_pred             CCCCccccc--CCcccccccCCCEEECcCCcccccCch-hhhcccccCeeeccccccccCcchh-------hcCCCCCCE
Q 018036            1 MSRNNFSGI--IPVEIGHCLLLTYLDLSQNHLSGPIPV-QITQIHILNYLNVSWNQLNASLPKE-------MGNMKSLTS   70 (362)
Q Consensus         1 l~~n~~~g~--ip~~~~~l~~l~~l~l~~n~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~~p~~-------~~~~~~l~~   70 (362)
                      |++|+++.-  ++..+..|++|+.|||++|+++ .+++ .......|+.|+|++|.++......       +..+++|+.
T Consensus        72 Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~  150 (162)
T d1koha1          72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR  150 (162)
T ss_dssp             CCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCE
T ss_pred             CCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCE
Confidence            689999832  3455778999999999999999 6665 3334457999999999998765532       567899998


Q ss_pred             EEccCCcc
Q 018036           71 ADFSHNNF   78 (362)
Q Consensus        71 l~ls~n~l   78 (362)
                      ||  ++.+
T Consensus       151 LD--g~~v  156 (162)
T d1koha1         151 LD--GHEL  156 (162)
T ss_dssp             ET--TEEC
T ss_pred             EC--cCCC
Confidence            86  4444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.62  E-value=6.7e-06  Score=75.31  Aligned_cols=62  Identities=23%  Similarity=0.224  Sum_probs=26.7

Q ss_pred             cCCCEEECcCCccccc----Cchhhh-cccccCeeecccccccc----CcchhhcCCCCCCEEEccCCccc
Q 018036           18 LLLTYLDLSQNHLSGP----IPVQIT-QIHILNYLNVSWNQLNA----SLPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus        18 ~~l~~l~l~~n~l~g~----ip~~~~-~l~~l~~l~l~~n~l~g----~~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      .+|++|||++|+++..    ++..+. ..+.|+.|+|++|+++.    .|+..+..+++|++|||++|+|+
T Consensus       340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  410 (460)
T ss_dssp             SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence            3455555555554321    222222 23345555555555542    13333344445555555555443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.60  E-value=6.5e-06  Score=75.37  Aligned_cols=39  Identities=21%  Similarity=0.125  Sum_probs=17.7

Q ss_pred             cccCCCEEECcCCccc----ccCchhhhcccccCeeecccccc
Q 018036           16 HCLLLTYLDLSQNHLS----GPIPVQITQIHILNYLNVSWNQL   54 (362)
Q Consensus        16 ~l~~l~~l~l~~n~l~----g~ip~~~~~l~~l~~l~l~~n~l   54 (362)
                      .+++|++|+|++|.++    ..|+..+..+++|+.|||++|.+
T Consensus        25 ~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i   67 (460)
T d1z7xw1          25 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL   67 (460)
T ss_dssp             HHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC
T ss_pred             hCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcC
Confidence            3444445555555443    12333344444455555554444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.55  E-value=2.4e-05  Score=67.51  Aligned_cols=67  Identities=18%  Similarity=0.179  Sum_probs=56.6

Q ss_pred             ccccccCCCEEECcCCccccc-CchhhhcccccCeeeccccccccCcchhhcCCCCCCEEEccCC-ccc
Q 018036           13 EIGHCLLLTYLDLSQNHLSGP-IPVQITQIHILNYLNVSWNQLNASLPKEMGNMKSLTSADFSHN-NFS   79 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n~l~g~-ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~l~~l~ls~n-~l~   79 (362)
                      ......+|++|||+++.+++. ++.-+.++++|++|+|+++.+++..+..++++++|+.|+++++ .++
T Consensus        41 ~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it  109 (284)
T d2astb2          41 EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS  109 (284)
T ss_dssp             SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred             hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence            334567899999999998755 5566788999999999999999888899999999999999984 554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.48  E-value=5.5e-05  Score=65.22  Aligned_cols=60  Identities=23%  Similarity=0.282  Sum_probs=27.4

Q ss_pred             cccCCCEEECcCC-cccccCchhhhcccccCeeeccc-cccccCcchhhcCCCCCCEEEccC
Q 018036           16 HCLLLTYLDLSQN-HLSGPIPVQITQIHILNYLNVSW-NQLNASLPKEMGNMKSLTSADFSH   75 (362)
Q Consensus        16 ~l~~l~~l~l~~n-~l~g~ip~~~~~l~~l~~l~l~~-n~l~g~~p~~~~~~~~l~~l~ls~   75 (362)
                      +|++|++|||++| .+++..+..+.++++|++|+|++ +.+++.-...++++++|+.|++++
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~  234 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG  234 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence            3444455555442 34444444444444555555544 334433333444444455554444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.33  E-value=4.1e-05  Score=67.83  Aligned_cols=69  Identities=14%  Similarity=0.133  Sum_probs=50.5

Q ss_pred             cccccccCCCEEECcCCccccc-----CchhhhcccccCeeeccccccccC----cchhhcCCCCCCEEEccCCcccC
Q 018036           12 VEIGHCLLLTYLDLSQNHLSGP-----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        12 ~~~~~l~~l~~l~l~~n~l~g~-----ip~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ..+..++.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|++++|++++
T Consensus       180 ~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            3455677888888888887632     334567788888888888887632    44556778888888888888764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.33  E-value=0.00052  Score=60.07  Aligned_cols=67  Identities=9%  Similarity=0.033  Sum_probs=43.7

Q ss_pred             ccEEEEEcCCCCEEEEEEeeccCCCCCchhhHHHHHHHHhcCccCcc--eeEE-----EEEecCCeeeEEEecCCCC
Q 018036          196 GVVYRGVTPNGEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIRHRNI--VRLK-----AFCSNKETNLLVYEYMPNG  265 (362)
Q Consensus       196 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g  265 (362)
                      -.||++..++|+.+++|..+...   ...+++..|...+..+....+  +...     ......+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            47999999999999999875332   223447888888877743222  1111     1223456678899999764

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.22  E-value=3.6e-05  Score=68.20  Aligned_cols=66  Identities=15%  Similarity=0.199  Sum_probs=49.8

Q ss_pred             ccccCCCEEECcCCccc----ccCchhhhcccccCeeeccccccccC-----cchhhcCCCCCCEEEccCCcccC
Q 018036           15 GHCLLLTYLDLSQNHLS----GPIPVQITQIHILNYLNVSWNQLNAS-----LPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        15 ~~l~~l~~l~l~~n~l~----g~ip~~~~~l~~l~~l~l~~n~l~g~-----~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      ...+.|+.|++++|+++    ..+...+..++.|+.|+|++|.++..     +...+..+++|+.|+|++|.++.
T Consensus       155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~  229 (344)
T d2ca6a1         155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH  229 (344)
T ss_dssp             HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred             ccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccc
Confidence            35678899999999876    23455567788999999999988632     33346678889999999998754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.86  E-value=0.0021  Score=57.55  Aligned_cols=72  Identities=17%  Similarity=0.182  Sum_probs=46.2

Q ss_pred             ceeeccCcccEEEEEcCC--------CCEEEEEEeeccCCCCCchhhHHHHHHHHhcCc-cCcceeEEEEEecCCeeeEE
Q 018036          188 NVIGRGGAGVVYRGVTPN--------GEQVAVKKLLGITKGSSHDNGLSAEIRTLGKIR-HRNIVRLKAFCSNKETNLLV  258 (362)
Q Consensus       188 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  258 (362)
                      +.|+.|-.=.+|+....+        .+.|+++..- ..   .......+|..+++.+. +.-..++++++..    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            467778888999987643        3456666542 21   11223668888888885 4334467777643    689


Q ss_pred             EecCCCCCh
Q 018036          259 YEYMPNGSL  267 (362)
Q Consensus       259 ~e~~~~gsL  267 (362)
                      |||+++.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.36  E-value=0.0012  Score=51.72  Aligned_cols=65  Identities=9%  Similarity=0.070  Sum_probs=43.7

Q ss_pred             cccCCCEEECcCC-ccccc----CchhhhcccccCeeecccccccc----CcchhhcCCCCCCEEEccCCcccC
Q 018036           16 HCLLLTYLDLSQN-HLSGP----IPVQITQIHILNYLNVSWNQLNA----SLPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        16 ~l~~l~~l~l~~n-~l~g~----ip~~~~~l~~l~~l~l~~n~l~g----~~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      +.++|++|+|+++ .++..    +-..+...+.|+.|+|++|.++.    .+...+...+.|+.|+|++|.++.
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence            4578888888864 45321    22345667788888888888863    222344556788888888888764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.35  E-value=0.0036  Score=54.03  Aligned_cols=32  Identities=25%  Similarity=0.307  Sum_probs=27.9

Q ss_pred             CCCeEEeCCCCCceeeCCCCceEEcccccccc
Q 018036          303 SPLIIHRDVKSNNILLNSDFEAHVADFGLAKY  334 (362)
Q Consensus       303 ~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  334 (362)
                      ..++||+|+.+.||+++.+...-|+||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            45699999999999999887778999998754

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.24  E-value=0.0014  Score=51.33  Aligned_cols=67  Identities=18%  Similarity=0.110  Sum_probs=50.9

Q ss_pred             ccccccCCCEEECcCCcccc----cCchhhhcccccCeeeccccccccC----cchhhcCCCCCCEEEccCCccc
Q 018036           13 EIGHCLLLTYLDLSQNHLSG----PIPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFS   79 (362)
Q Consensus        13 ~~~~l~~l~~l~l~~n~l~g----~ip~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~l~~l~ls~n~l~   79 (362)
                      .+...+.|++|+|++|.+.-    .+-..+...+.|+.|+|++|.++..    +-..+..-++|+.|++++|.+.
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            35567889999999999863    2334566678999999999999742    2234666788999999998654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=93.57  E-value=0.016  Score=44.73  Aligned_cols=66  Identities=15%  Similarity=0.163  Sum_probs=47.8

Q ss_pred             ccccCCCEEECcC-Cccccc----CchhhhcccccCeeeccccccccC----cchhhcCCCCCCEEEccCCcccC
Q 018036           15 GHCLLLTYLDLSQ-NHLSGP----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADFSHNNFSG   80 (362)
Q Consensus        15 ~~l~~l~~l~l~~-n~l~g~----ip~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~l~~l~ls~n~l~g   80 (362)
                      .+.++|++|+|++ |.++-.    +-..+...++|+.|+|++|.++..    |-..+...++++.+++++|.++.
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            4678999999997 456422    223455788999999999998743    22234567889999999988763

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.02  E-value=0.03  Score=43.03  Aligned_cols=66  Identities=15%  Similarity=0.196  Sum_probs=47.6

Q ss_pred             cccccCCCEEECcCCccccc----CchhhhcccccCeeeccccccccC----cchhhcCCCCCCEEEc--cCCccc
Q 018036           14 IGHCLLLTYLDLSQNHLSGP----IPVQITQIHILNYLNVSWNQLNAS----LPKEMGNMKSLTSADF--SHNNFS   79 (362)
Q Consensus        14 ~~~l~~l~~l~l~~n~l~g~----ip~~~~~l~~l~~l~l~~n~l~g~----~p~~~~~~~~l~~l~l--s~n~l~   79 (362)
                      +...+.|++|+|++|.++..    |-..+...++|+.|++++|.++..    +-..+...++|+.++|  ++|.+.
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence            44678999999999998644    223456678999999999998632    2245677788987665  456553